<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
  <url>
    <loc>https://trialagents.com/</loc>
    <changefreq>weekly</changefreq>
    <priority>1.0</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials</loc>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://trialagents.com/reports</loc>
    <changefreq>daily</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://trialagents.com/privacy-policy</loc>
    <changefreq>yearly</changefreq>
    <priority>0.3</priority>
  </url>
  <url>
    <loc>https://trialagents.com/terms-of-service</loc>
    <changefreq>yearly</changefreq>
    <priority>0.3</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=2</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=3</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=4</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=5</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=6</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=7</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=8</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=9</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=10</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=11</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=12</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=13</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=14</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=15</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=16</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=17</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=18</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=19</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=20</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=21</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=22</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=23</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=24</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=25</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=26</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=27</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=28</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=29</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=30</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=31</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=32</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=33</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=34</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=35</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=36</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=37</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=38</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=39</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=40</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=41</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=42</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=43</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=44</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=45</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=46</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=47</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=48</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=49</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=50</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=51</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=52</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=53</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=54</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=55</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=56</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=57</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=58</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=59</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=60</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=61</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=62</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=63</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=64</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=65</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=66</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=67</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=68</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=69</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=70</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=71</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=72</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=73</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=74</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=75</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=76</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=77</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=78</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=79</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=80</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=81</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=82</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=83</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=84</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=85</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=86</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=87</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=88</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=89</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=90</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=91</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=92</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=93</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=94</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=95</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=96</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=97</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=98</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=99</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=100</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=101</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=102</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=103</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=104</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=105</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=106</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=107</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=108</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=109</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=110</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=111</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=112</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=113</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=114</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=115</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=116</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=117</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=118</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=119</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=120</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=121</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=122</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=123</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=124</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=125</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=126</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=127</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=128</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=129</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=130</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=131</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=132</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=133</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=134</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=135</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=136</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=137</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=138</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=139</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=140</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=141</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=142</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=143</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=144</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=145</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=146</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=147</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=148</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=149</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=150</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=151</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=152</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=153</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=154</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=155</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=156</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=157</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=158</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=159</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=160</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=161</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=162</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=163</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=164</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=165</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=166</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=167</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=168</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=169</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=170</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=171</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=172</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=173</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=174</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=175</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=176</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=177</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=178</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=179</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=180</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=181</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=182</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=183</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=184</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=185</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=186</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=187</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=188</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=189</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=190</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=191</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=192</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=193</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=194</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=195</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=196</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=197</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=198</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=199</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=200</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=201</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=202</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=203</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=204</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=205</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=206</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=207</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=208</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=209</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=210</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=211</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=212</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=213</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=214</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=215</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=216</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=217</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=218</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=219</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=220</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=221</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=222</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=223</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=224</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=225</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=226</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=227</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=228</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=229</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=230</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=231</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=232</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=233</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=234</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=235</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=236</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=237</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=238</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=239</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=240</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=241</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=242</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=243</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=244</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=245</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=246</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=247</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=248</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=249</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=250</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=251</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=252</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=253</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=254</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=255</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=256</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=257</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=258</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=259</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=260</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=261</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=262</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=263</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=264</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=265</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=266</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=267</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=268</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=269</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=270</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=271</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=272</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=273</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=274</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=275</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=276</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=277</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=278</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=279</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=280</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=281</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=282</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=283</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=284</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=285</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=286</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=287</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=288</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=289</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=290</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=291</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=292</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=293</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=294</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=295</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=296</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=297</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=298</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=299</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=300</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=301</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=302</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=303</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=304</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=305</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=306</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=307</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=308</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=309</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=310</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=311</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=312</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=313</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=314</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=315</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=316</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=317</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=318</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=319</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=320</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=321</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=322</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=323</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=324</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=325</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=326</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=327</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=328</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=329</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=330</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=331</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=332</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=333</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=334</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=335</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=336</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=337</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=338</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=339</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=340</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=341</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=342</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=343</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=344</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=345</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=346</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=347</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=348</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=349</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=350</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=351</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=352</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=353</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=354</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=355</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=356</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=357</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=358</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=359</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=360</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=361</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=362</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=363</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=364</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=365</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=366</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=367</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=368</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=369</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=370</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=371</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=372</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=373</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=374</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=375</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=376</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=377</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=378</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=379</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=380</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=381</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=382</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=383</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=384</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=385</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=386</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=387</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=388</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=389</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=390</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=391</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=392</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=393</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=394</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=395</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=396</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=397</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=398</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=399</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=400</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=401</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=402</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=403</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=404</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=405</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=406</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=407</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=408</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=409</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=410</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=411</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=412</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=413</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=414</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=415</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=416</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=417</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=418</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=419</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=420</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=421</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=422</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=423</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=424</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=425</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=426</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=427</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=428</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=429</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=430</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=431</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=432</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=433</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=434</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=435</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=436</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=437</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=438</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=439</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=440</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=441</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=442</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=443</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=444</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=445</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=446</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=447</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=448</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=449</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=450</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=451</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=452</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=453</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=454</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=455</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=456</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=457</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=458</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=459</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=460</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=461</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=462</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=463</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=464</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=465</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=466</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=467</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=468</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=469</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=470</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=471</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=472</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=473</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=474</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=475</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=476</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=477</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=478</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=479</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=480</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=481</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=482</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=483</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=484</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=485</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=486</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=487</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=488</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=489</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=490</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=491</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=492</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=493</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=494</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=495</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=496</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=497</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=498</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=499</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=500</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=501</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=502</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=503</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=504</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=505</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=506</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=507</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=508</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=509</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=510</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=511</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=512</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=513</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=514</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=515</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=516</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=517</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=518</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=519</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=520</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=521</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=522</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=523</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=524</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=525</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=526</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=527</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=528</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=529</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=530</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=531</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=532</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=533</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=534</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=535</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=536</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=537</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=538</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=539</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=540</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=541</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=542</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=543</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=544</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=545</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=546</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=547</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=548</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=549</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=550</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=551</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=552</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=553</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=554</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=555</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=556</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=557</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=558</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=559</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=560</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=561</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=562</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=563</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=564</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=565</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=566</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=567</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=568</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=569</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=570</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=571</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=572</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=573</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=574</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=575</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=576</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=577</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=578</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=579</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=580</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=581</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=582</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=583</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=584</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=585</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=586</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=587</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=588</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=589</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=590</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=591</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=592</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=593</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=594</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=595</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=596</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=597</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=598</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=599</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials?page=600</loc>
    <changefreq>daily</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/reports?page=2</loc>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/reports/top-lymphoma-trial-sites-phase-2-3</loc>
    <lastmod>2026-06-02T20:05:03.905Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://trialagents.com/reports/top-colorectal-cancer-trial-sites-phase-ii-iii</loc>
    <lastmod>2026-06-02T20:02:08.586Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://trialagents.com/reports/top-liver-cancer-trial-sites-phase-2-3</loc>
    <lastmod>2026-06-02T19:58:51.873Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://trialagents.com/reports/top-kidney-cancer-trial-sites-phase-ii-iii</loc>
    <lastmod>2026-06-02T19:45:59.651Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://trialagents.com/reports/top-eu-diabetes-trial-sites-phase-2-3</loc>
    <lastmod>2026-06-02T19:41:49.158Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://trialagents.com/reports/cardiology-top-sites-patient-volume-eu</loc>
    <lastmod>2026-06-01T21:33:21.293Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://trialagents.com/reports/pfs-primary-endpoints-oncology-haematology-phase-iii</loc>
    <lastmod>2026-06-01T11:16:58.417Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://trialagents.com/reports/oncology-phase-iii-endpoint-architecture</loc>
    <lastmod>2026-05-30T17:55:12.518Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://trialagents.com/reports/lymphoma-phase-iii-os-vs-pfs-endpoints</loc>
    <lastmod>2026-05-30T08:59:25.424Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://trialagents.com/reports/os-vs-pfs-primary-endpoints-colorectal-phase-iii</loc>
    <lastmod>2026-05-29T21:26:14.005Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://trialagents.com/reports/kidney-cancer-os-pfs-phase-iii-trials</loc>
    <lastmod>2026-05-29T19:41:49.798Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://trialagents.com/reports/os-pfs-phase-iii-pancreatic-cancer-trials</loc>
    <lastmod>2026-05-29T20:50:04.306Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://trialagents.com/reports/how-os-pfs-used-phase-iii-oncology-trials</loc>
    <lastmod>2026-05-29T20:56:08.970Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://trialagents.com/reports/is-overall-survival-still-the-primary-endpoint-anchor-european-phase-iii-oncology-trials</loc>
    <lastmod>2026-05-29T05:45:00.167Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://trialagents.com/reports/overall-survival-primary-endpoint-phase-iii-gastric-cancer-trials</loc>
    <lastmod>2026-05-29T05:45:11.247Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://trialagents.com/reports/digital-recruitment-gastric-esophageal-phase-iii-trials</loc>
    <lastmod>2026-05-29T05:45:14.721Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://trialagents.com/reports/breast-cancer-phase-iii-endpoint-architecture-2024-2026</loc>
    <lastmod>2026-05-29T05:45:18.418Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://trialagents.com/reports/overall-survival-endpoint-strategy-european-phase-iii-lung-cancer-trials</loc>
    <lastmod>2026-05-29T05:45:21.926Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://trialagents.com/reports/digital-recruitment-channels-in-phase-iii-breast-cancer-trials</loc>
    <lastmod>2026-05-29T11:14:07.950Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://trialagents.com/reports/eligibility-breast-cancer-phiii</loc>
    <lastmod>2026-05-29T11:13:43.583Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ocrelizumab-relapsing-multiple-sclerosis-relapsing-r-phase-iii</loc>
    <lastmod>2026-05-28T21:41:24.612Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methylprednisolone-fulminant-myocarditis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:24.649Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/izaflortaucipir-18f-down-syndrome-alzheimer-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:24.666Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ustekinumab-crohn-s-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:41:24.683Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gdc-9545-locally-advanced-or-metastatic-estrogen-phase-iii</loc>
    <lastmod>2026-05-28T21:41:24.700Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/darovasertib-metastatic-uveal-melanoma-hla-a2-negativ-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:24.716Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abemaciclib-stage-iv-lung-cancer-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:24.734Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/concizumab-haemophilia-a-with-inhibitors-haemophili-phase-iii</loc>
    <lastmod>2026-05-28T21:41:24.750Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cenobamate-partial-onset-focal-seizures-phase-iii</loc>
    <lastmod>2026-05-28T21:41:24.767Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bgb-43395-advanced-or-metastatic-solid-tumors-horm-phase-i</loc>
    <lastmod>2026-05-28T21:41:24.785Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd9833-estrogen-receptor-positive-her2-negative-phase-i</loc>
    <lastmod>2026-05-28T21:41:24.799Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-classical-hodgkin-lymphoma-melanoma-soli-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:24.816Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adagrasib-advanced-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:24.832Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mb097-advanced-melanoma-malignant-melanoma-phase-i</loc>
    <lastmod>2026-05-28T21:41:24.854Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-4-5-dihydro-2-2-hydroxy-4-3-6-dioxahep-transfusion-dependent-alpha-thalassemia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:24.870Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rezpegaldesleukin-atopic-dermatitis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:24.886Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tretinoin-acute-myeloid-leukemia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:24.903Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/raludotatug-deruxtecan-small-cell-lung-cancer-extensive-stage-phase-i-ii-phase-ii</loc>
    <lastmod>2026-05-28T21:41:24.921Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/conditioned-medium-from-a-co-culture-of-acute-respiratory-distress-syndrome-ards-phase-i</loc>
    <lastmod>2026-05-28T21:41:24.936Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pirtobrutinib-chronic-lymphocytic-leukemia-small-lymph-phase-iii</loc>
    <lastmod>2026-05-28T21:41:24.950Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ruxolitinib-chronic-graft-versus-host-disease-steroi-phase-ii</loc>
    <lastmod>2026-05-28T21:41:24.967Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pancreas-powder-pancreatin-pancreatic-exocrine-insufficiency-phase-iv</loc>
    <lastmod>2026-05-28T21:41:24.985Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/luspatercept-myelofibrosis-anemia-associated-with-mye-phase-iii</loc>
    <lastmod>2026-05-28T21:41:25.001Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tulmimetostat-advanced-solid-tumors-lymphoma-urothelia-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:25.018Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belimumab-antibody-mediated-rejection-kidney-trans-phase-iv</loc>
    <lastmod>2026-05-28T21:41:25.035Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-low-grade-serous-ovarian-cancer-fallopia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:25.049Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capmatinib-unresectable-metastatic-non-small-cell-l-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:25.063Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pelacarsen-cardiovascular-disease-arteriosclerotic-phase-iii</loc>
    <lastmod>2026-05-28T21:41:25.079Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nipocalimab-chronic-inflammatory-demyelinating-polyn-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:25.095Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sigvotatug-vedotin-esophageal-cancer-pancreatic-cancer-skin-phase-i</loc>
    <lastmod>2026-05-28T21:41:25.110Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-alport-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:41:25.126Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/phospholipid-fraction-bovine-lung-idiopathic-pulmonary-fibrosis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:25.141Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/girentuximab-labelled-with-zirconium-89-gastroenteropancreatic-neuroendocrine-ne-not-applicable</loc>
    <lastmod>2026-05-28T21:41:25.155Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bim2b-glioblastoma-phase-i</loc>
    <lastmod>2026-05-28T21:41:25.169Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-resectable-non-small-cell-lung-cancer-st-phase-iii</loc>
    <lastmod>2026-05-28T21:41:25.185Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/repotrectinib-stage-iii-iv-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:25.201Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/follitropin-beta-subfertility-phase-iv</loc>
    <lastmod>2026-05-28T21:41:25.217Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elafibranor-primary-biliary-cholangitis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:25.232Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belimumab-systemic-lupus-erythematosus-phase-iv</loc>
    <lastmod>2026-05-28T21:41:25.247Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ocrelizumab-relapsing-multiple-sclerosis-relapsing-r</loc>
    <lastmod>2026-05-28T21:41:25.260Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/parkinson-s-disease-phase-i</loc>
    <lastmod>2026-05-28T21:41:25.274Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/givinostat-chronic-myeloproliferative-neoplasm-phase-iv</loc>
    <lastmod>2026-05-28T21:41:25.289Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/crinecerfont-classic-congenital-adrenal-hyperplasia-2-phase-iii</loc>
    <lastmod>2026-05-28T21:41:25.303Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clopidogrel-acute-coronary-syndrome-cardiovascular-d-phase-iv</loc>
    <lastmod>2026-05-28T21:41:25.319Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trabectedin-advanced-metastatic-soft-tissue-sarcoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:25.335Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methotrexate-rheumatoid-arthritis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:25.351Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rozanolixizumab-myelin-oligodendrocyte-glycoprotein-anti-phase-iii</loc>
    <lastmod>2026-05-28T21:41:25.367Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rivaroxaban-advanced-chronic-kidney-disease-ckd-stag-phase-iii</loc>
    <lastmod>2026-05-28T21:41:25.380Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/actinium-ac-225-oxodotreotide-gastroenteropancreatic-neuroendocrine-tu-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:41:25.396Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-bone-marrow-derived-mesenchym-chronic-lung-allograft-dysfunction-clad-phase-iv</loc>
    <lastmod>2026-05-28T21:41:25.411Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dostarlimab-resectable-colon-cancer-pmmr-mss-phase-ii</loc>
    <lastmod>2026-05-28T21:41:25.428Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acalabrutinib-mantle-cell-lymphoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:25.444Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/paclitaxel-obaluronate-carcinoma-in-situ-of-the-bladder-bcg-unr-phase-iii</loc>
    <lastmod>2026-05-28T21:41:25.457Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acalabrutinib-waldenstrom-macroglobulinemia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:25.472Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-advanced-and-or-metastatic-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:41:25.487Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acalabrutinib-mantle-cell-lymphoma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:25.503Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glofitamab-mantle-cell-lymphoma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:25.518Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abemaciclib-breast-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:25.535Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/letetresgene-autoleucel-synovial-sarcoma-myxoid-liposarcoma-roun-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:25.551Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mjk2134025-stroke-phase-i</loc>
    <lastmod>2026-05-28T21:41:25.566Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ponatinib-chronic-myeloid-leukaemia-cml-acute-lymp-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:25.581Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tildrakizumab-chronic-spontaneous-urticaria-phase-iv</loc>
    <lastmod>2026-05-28T21:41:25.595Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dolutegravir-sodium-hiv-1-infection-phase-iv</loc>
    <lastmod>2026-05-28T21:41:25.609Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/barzolvolimab-chronic-spontaneous-urticaria-phase-iii</loc>
    <lastmod>2026-05-28T21:41:25.626Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/d-l-lysine-acetylsalicylate-metastatic-colorectal-cancer-chemo-resis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:25.639Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/irinotecan-hydrochloride-locally-advanced-rectal-cancer-rectal-ca-phase-ii</loc>
    <lastmod>2026-05-28T21:41:25.655Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/faricimab-diabetic-macular-edema-macular-edema-phase-iv</loc>
    <lastmod>2026-05-28T21:41:25.669Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sotorasib-advanced-solid-tumours-with-kras-g12c-mu-phase-i</loc>
    <lastmod>2026-05-28T21:41:25.684Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/citalopram-osteoarthritis-of-hip-and-knee-not-applicable</loc>
    <lastmod>2026-05-28T21:41:25.698Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lipiodol-hand-digital-osteoarthritis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:25.713Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/msv-as-degenerative-disc-disease-chronic-low-ba-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:25.729Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inebilizumab-myasthenia-gravis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:25.744Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/encorafenib-melanoma-braf-v600-mutated-melanoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:25.758Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ketamine-hydrochloride-traumatic-injury-phase-iii</loc>
    <lastmod>2026-05-28T21:41:25.775Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-87562761-relapsed-refractory-multiple-myeloma-phase-i</loc>
    <lastmod>2026-05-28T21:41:25.789Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rebisufligene-etisparvovec-mucopolysaccharidosis-type-iiia-phase-i-phase-ii-phase-iii</loc>
    <lastmod>2026-05-28T21:41:25.802Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tenecteplase-acute-ischaemic-stroke-due-to-basilar-ar-phase-iii</loc>
    <lastmod>2026-05-28T21:41:25.818Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/giredestrant-er-positive-her2-negative-early-breast-c-phase-ii</loc>
    <lastmod>2026-05-28T21:41:25.834Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clostridium-botulinum-neurotoxin-type-a-postmastectomy-pain-syndrome-not-applicable</loc>
    <lastmod>2026-05-28T21:41:25.847Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apixaban-venous-thromboembolism-phase-iv</loc>
    <lastmod>2026-05-28T21:41:25.860Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ivx-121-human-metapneumovirus-virus-like-respiratory-syncytial-virus-infection-hu-phase-iii</loc>
    <lastmod>2026-05-28T21:41:25.874Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aciclovir-recurrent-herpes-labialis-herpes-simplex-phase-iii</loc>
    <lastmod>2026-05-28T21:41:25.888Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sotagliflozin-obstructive-hypertrophic-cardiomyopathy-phase-iii</loc>
    <lastmod>2026-05-28T21:41:25.901Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/doxribtimine-doxecitine-thymidine-kinase-2-deficiency-mitochondr-phase-ii</loc>
    <lastmod>2026-05-28T21:41:25.915Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/navtemadlin-primary-myelofibrosis-post-polycythemia-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:25.930Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methotrexate-erosive-hand-osteoarthritis-hand-osteoar-phase-iv</loc>
    <lastmod>2026-05-28T21:41:25.945Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rapcabtagene-autoleucel-non-active-progressive-multiple-sclerosi-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:25.958Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/odronextamab-relapsed-and-refractory-b-cell-non-hodgk-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:25.972Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amikacin-sulfate-sepsis-neutropenia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:25.985Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tovorafenib-low-grade-glioma-advanced-solid-tumor-phase-ii</loc>
    <lastmod>2026-05-28T21:41:26.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oatd-02-colorectal-cancer-ovarian-cancer-pancrea-phase-i</loc>
    <lastmod>2026-05-28T21:41:26.013Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenacapavir-islatravir-hiv-1-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:41:26.028Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/relacorilant-platinum-resistant-high-grade-epithelial-phase-iii</loc>
    <lastmod>2026-05-28T21:41:26.043Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lecanemab-mild-cognitive-impairment-due-to-alzheim-phase-iii</loc>
    <lastmod>2026-05-28T21:41:26.057Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/temozolomide-well-differentiated-neuroendocrine-neopl-phase-ii</loc>
    <lastmod>2026-05-28T21:41:26.071Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elranatamab-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:26.084Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lisocabtagene-maraleucel-follicular-lymphoma-marginal-zone-lympho-phase-ii</loc>
    <lastmod>2026-05-28T21:41:26.099Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prednisone-granulomatosis-with-polyangiitis-wegener-phase-iii</loc>
    <lastmod>2026-05-28T21:41:26.114Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/panitumumab-metastatic-colorectal-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:26.131Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/futibatinib-advanced-solid-tumour-malignant-solid-tu-phase-ii</loc>
    <lastmod>2026-05-28T21:41:26.144Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tub-040-active-substance-name-as-listed-platinum-resistant-high-grade-ovarian-ca-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:26.157Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alglucosidase-alfa-pompe-disease-not-applicable</loc>
    <lastmod>2026-05-28T21:41:26.172Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adeno-associated-virus-vector-containing-x-linked-retinitis-pigmentosa-xlrp-retin-phase-iii</loc>
    <lastmod>2026-05-28T21:41:26.186Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nvl-655-non-small-cell-lung-cancer-advanced-alk-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:26.203Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amg-193-gastrointestinal-cancer-biliary-tract-ca-phase-iii</loc>
    <lastmod>2026-05-28T21:41:26.218Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ifinatamab-deruxtecan-esophageal-squamous-cell-carcinoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:26.231Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/kyv-101-lupus-nephritis-systemic-sclerosis-myast-not-applicable</loc>
    <lastmod>2026-05-28T21:41:26.248Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-advanced-hepatocellular-carcinoma-liver-phase-ii</loc>
    <lastmod>2026-05-28T21:41:26.263Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/maralixibat-chloride-cholestatic-pruritus-phase-iii</loc>
    <lastmod>2026-05-28T21:41:26.278Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pneumococcal-polysaccharide-serotype-1-c-lymphoma-diffuse-large-b-cell-lymphoma-f-phase-iv</loc>
    <lastmod>2026-05-28T21:41:26.291Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dersimelagon-phosphate-erythropoietic-protoporphyria-epp-x-link-phase-iii</loc>
    <lastmod>2026-05-28T21:41:26.304Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/golcadomide-follicular-lymphoma-advanced-stage-phase-ii</loc>
    <lastmod>2026-05-28T21:41:26.319Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dinutuximab-beta-low-risk-neuroblastoma-intermediate-risk-phase-iii</loc>
    <lastmod>2026-05-28T21:41:26.334Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/daunorubicin-hydrochloride-acute-myeloid-leukemia-relapsed-or-refra-not-applicable</loc>
    <lastmod>2026-05-28T21:41:26.347Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clioquinol-drug-resistant-epilepsy-phase-iv</loc>
    <lastmod>2026-05-28T21:41:26.361Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vidofludimus-calcium-relapsing-multiple-sclerosis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:26.374Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cemiplimab-non-small-cell-lung-cancer-stage-iii-unr-phase-ii</loc>
    <lastmod>2026-05-28T21:41:26.389Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cc-1-psmaxcd3-bispecific-antibody-recurrent-prostate-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:41:26.404Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-metastatic-melanoma-urothelial-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:26.418Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/irinotecan-hydrochloride-hepatoblastoma-hepatocellular-carcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:26.431Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isatuximab-acute-lymphoblastic-leukaemia-t-lymphobl-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:26.445Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obinutuzumab-marginal-zone-lymphoma-nodal-marginal-zo-phase-ii</loc>
    <lastmod>2026-05-28T21:41:26.458Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/exagamglogene-autotemcel-transfusion-dependent-beta-thalassemia-s-phase-iii</loc>
    <lastmod>2026-05-28T21:41:26.471Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/filgotinib-ulcerative-colitis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:26.485Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/birch-pollen-allergoid-glutaraldehyde-mo-allergic-rhinitis-due-to-birch-pollen-al-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:26.511Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-metastatic-renal-cell-carcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:26.524Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/posaconazole-allogeneic-hematopoietic-stem-cell-trans-phase-ii</loc>
    <lastmod>2026-05-28T21:41:26.537Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dazodalibep-sjogren-s-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:41:26.550Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bimekizumab-plaque-psoriasis-psoriasis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:26.564Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/brentuximab-vedotin-peripheral-t-cell-lymphoma-ptcl-anaplast-phase-ii</loc>
    <lastmod>2026-05-28T21:41:26.577Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abo21009-rheumatoid-arthritis-phase-i</loc>
    <lastmod>2026-05-28T21:41:26.592Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cisplatin-figo-stage-iii-high-grade-serous-ovarian-phase-ii</loc>
    <lastmod>2026-05-28T21:41:26.605Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lyophilized-bacterial-lysates-of-haemoph-respiratory-tract-infections-with-wheezi-phase-iv</loc>
    <lastmod>2026-05-28T21:41:26.620Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zimberelimab-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:26.633Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/enzalutamide-prostate-cancer-localized-high-risk-pros-phase-iv</loc>
    <lastmod>2026-05-28T21:41:26.648Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/axicabtagene-ciloleucel-relapsed-refractory-follicular-lymphoma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:26.661Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/entr-601-44-duchenne-muscular-dystrophy-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:26.675Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-igg2-monoclonal-antibody-against-i-thyroid-eye-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:26.690Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oleclumab-metastatic-triple-negative-breast-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:26.704Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fapi-46-labelled-with-gallium-68-advanced-liver-fibrosis-hepatic-fibrosis-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:41:26.717Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:26.730Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-diffuse-large-b-cell-lymphoma-abc-phase-ii</loc>
    <lastmod>2026-05-28T21:41:26.745Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/edoxaban-acute-ischemic-stroke</loc>
    <lastmod>2026-05-28T21:41:26.757Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/riluzole-spasticity-spinal-cord-injury-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:26.772Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/seladelpar-primary-biliary-cholangitis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:26.786Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clostridium-botulinum-neurotoxin-type-a-severe-multifocal-spasticity-due-to-acqu-phase-iv</loc>
    <lastmod>2026-05-28T21:41:26.802Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/thiotepa-neuroblastoma-high-risk-neuroblastoma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:26.815Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-2-2-10-2-4-3-4-2-2-cyano-4-4-difluor-nonalcoholic-steatohepatitis-nash-liver-phase-ii</loc>
    <lastmod>2026-05-28T21:41:26.829Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tranexamic-acid-chronic-subdural-hematoma-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:26.842Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-natural-killer-cells-amplifie-diffuse-large-b-cell-lymphoma-relapsed-r-phase-i</loc>
    <lastmod>2026-05-28T21:41:26.857Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abiraterone-decanoate-prostate-cancer-advanced-prostate-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:26.871Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/osimertinib-mesylate-advanced-solid-tumors-non-small-cell-lun-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:26.885Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/piperacillin-sodium-tazobactam-sodium-extended-spectrum-beta-lactamase-esbl-pr-phase-iii</loc>
    <lastmod>2026-05-28T21:41:26.899Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tak-360-narcolepsy-without-cataplexy-nt2-phase-ii</loc>
    <lastmod>2026-05-28T21:41:26.912Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ambroxol-hydrochloride-clenbuterol-hydro-parkinson-s-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:41:26.927Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-small-cell-lung-cancer-extensive-stage-s-phase-iv</loc>
    <lastmod>2026-05-28T21:41:26.940Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-6r-7-7-difluoro-2-5-fluoro-4-2-4-6-tri-idiopathic-hypersomnia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:26.953Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avelumab-penile-squamous-cell-carcinoma-phase-iv</loc>
    <lastmod>2026-05-28T21:41:26.968Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cirtuvivint-advanced-soft-tissue-sarcoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:26.984Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/platelet-concentrate-female-infertility-low-ovarian-reserve-phase-iii</loc>
    <lastmod>2026-05-28T21:41:26.999Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ab521-metastatic-clear-cell-renal-cell-carcino-phase-iii</loc>
    <lastmod>2026-05-28T21:41:27.012Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apalutamide-prostate-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:27.026Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/roginolisib-advanced-non-squamous-non-small-cell-lun-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:27.039Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/temozolomide-glioblastoma-phase-i</loc>
    <lastmod>2026-05-28T21:41:27.053Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rifaximin-alcoholic-liver-cirrhosis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:27.066Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fludrocortisone-acetate-neurogenic-orthostatic-hypotension-phase-iv</loc>
    <lastmod>2026-05-28T21:41:27.079Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly3410738-advanced-hematologic-malignancies-with-i-phase-i</loc>
    <lastmod>2026-05-28T21:41:27.093Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efanesoctocog-alfa-haemophilia-a-phase-iv</loc>
    <lastmod>2026-05-28T21:41:27.107Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-autosomal-dominant-polycystic-kidney-dis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:27.120Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aln-f1202-healthy-volunteer-hereditary-angioedema-phase-i</loc>
    <lastmod>2026-05-28T21:41:27.133Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-triple-negative-breast-cancer-untreated-phase-iv</loc>
    <lastmod>2026-05-28T21:41:27.146Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zelenectide-pevedotin-nectin4-amplified-advanced-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:27.159Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bgb-58067-prmt5-inhibitor-advanced-solid-tumours-with-mtap-homozyg-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:27.172Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levobupivacaine-supratentorial-brain-tumour-not-applicable</loc>
    <lastmod>2026-05-28T21:41:27.185Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nelarabine-melanoma-breast-cancer-non-small-cell-lu-phase-ii</loc>
    <lastmod>2026-05-28T21:41:27.198Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenalidomide-primary-central-nervous-system-lymphoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:27.211Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pf-07220060-monohydrate-hormone-receptor-positive-her2-negative-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:27.224Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/daratumumab-toxic-epidermal-necrolysis-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:27.251Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-pertuzumab-breast-cancer-her2-positive-breast-cance-phase-iii</loc>
    <lastmod>2026-05-28T21:41:27.237Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/luspatercept-myelodysplastic-syndrome-low-risk-non-si-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:27.264Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methadone-hydrochloride-orthopedic-surgery-total-hip-arthroplast-phase-iii</loc>
    <lastmod>2026-05-28T21:41:27.277Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cytarabine-daunorubicin-myelodysplastic-syndrome-higher-risk-oli-phase-ii</loc>
    <lastmod>2026-05-28T21:41:27.290Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colchicine-atherosclerosis-cancer-not-applicable</loc>
    <lastmod>2026-05-28T21:41:27.303Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ifosfamide-soft-tissue-sarcoma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:27.317Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/meropenem-bacterial-infection-critical-illness-not-applicable</loc>
    <lastmod>2026-05-28T21:41:27.331Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alkaline-phosphatase-bovine-end-stage-kidney-disease-kidney-transpla-phase-ii</loc>
    <lastmod>2026-05-28T21:41:27.345Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nadofaragene-firadenovec-non-muscle-invasive-bladder-cancer-high-phase-iii</loc>
    <lastmod>2026-05-28T21:41:27.359Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anakinra-acute-respiratory-distress-syndrome-ards-phase-iv</loc>
    <lastmod>2026-05-28T21:41:27.372Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/suicide-gene-transduced-cytotoxic-t-cell-hematological-malignancies-post-allogene-phase-i</loc>
    <lastmod>2026-05-28T21:41:27.386Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cannabidiol-alcohol-dependence-phase-iv</loc>
    <lastmod>2026-05-28T21:41:27.400Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/emicizumab-congenital-haemophilia-a-phase-iv</loc>
    <lastmod>2026-05-28T21:41:27.414Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ruxolitinib-polycythemia-vera-phase-iv</loc>
    <lastmod>2026-05-28T21:41:27.427Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/niraparib-pleural-mesothelioma-non-small-cell-lung-phase-ii</loc>
    <lastmod>2026-05-28T21:41:27.440Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-psychotic-disorders-autoimmune-psychosis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:27.454Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/18f-alf-nota-octreotide-carotid-artery-atherosclerosis-phase-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:41:27.467Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hydrocortisone-glucocorticoid-induced-adrenal-insuffici-phase-iv</loc>
    <lastmod>2026-05-28T21:41:27.481Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elexacaftor-tezacaftor-ivacaftor-cystic-fibrosis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:27.495Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pep-010-recurrent-and-or-metastatic-solid-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:41:27.508Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cladribine-acute-leukemia-myelodysplastic-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:41:27.521Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/siponimod-fumaric-acid-secondary-progressive-multiple-sclerosis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:27.534Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/v540a-vaccine-human-papillomavirus-infection-phase-i</loc>
    <lastmod>2026-05-28T21:41:27.548Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apixaban-aortic-valve-disease-patients-post-trans-phase-iv</loc>
    <lastmod>2026-05-28T21:41:27.561Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-early-stage-triple-negative-breast-cance-phase-iii</loc>
    <lastmod>2026-05-28T21:41:27.574Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/telisotuzumab-adizutecan-non-small-cell-lung-cancer-non-squamous-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:27.587Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxybutynin-posterior-urethral-valves-phase-iv</loc>
    <lastmod>2026-05-28T21:41:27.599Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/botulinum-toxin-type-a-post-surgical-scar-pain-not-applicable</loc>
    <lastmod>2026-05-28T21:41:27.614Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tarlatamab-small-cell-lung-cancer-metastatic-locall-phase-ii</loc>
    <lastmod>2026-05-28T21:41:27.627Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aln-4324-type-2-diabetes-mellitus-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:27.641Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cenerimod-systemic-lupus-erythematosus-moderate-to-phase-iii</loc>
    <lastmod>2026-05-28T21:41:27.654Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ziltivekimab-coronary-artery-disease</loc>
    <lastmod>2026-05-28T21:41:27.667Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eprosartan-mesilate-type-2-diabetes-phase-iv</loc>
    <lastmod>2026-05-28T21:41:27.684Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-large-cell-neuroendocrine-carcinoma-of-t-phase-ii</loc>
    <lastmod>2026-05-28T21:41:27.699Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-gastric-adenocarcinoma-gastroesophageal-phase-ii</loc>
    <lastmod>2026-05-28T21:41:27.712Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-stage-iii-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:27.725Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rheumatoid-arthritis-phase-i</loc>
    <lastmod>2026-05-28T21:41:27.739Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ivermectin-strongyloidiasis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:27.752Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mk-2214-alzheimer-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:27.764Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pneumococcal-conjugate-vaccine-pneumococcal-infection-phase-i</loc>
    <lastmod>2026-05-28T21:41:27.778Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pf-07985631-iga-nephropathy-phase-i</loc>
    <lastmod>2026-05-28T21:41:27.790Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acute-lymphoblastic-leukemia-all-phase-iv</loc>
    <lastmod>2026-05-28T21:41:27.804Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bnt326-non-small-cell-lung-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:27.817Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sulfur-hexafluoride-recurrent-primary-supratentorial-maligna-phase-i</loc>
    <lastmod>2026-05-28T21:41:27.832Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/letrozole-polycystic-ovary-syndrome</loc>
    <lastmod>2026-05-28T21:41:27.845Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azithromycin-dihydrate-chronic-obstructive-pulmonary-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:41:27.857Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zoledronic-acid-monohydrate-glioblastoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:27.870Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/valemetostat-tosilate-relapsed-refractory-b-cell-lymphoma-diff-phase-ii</loc>
    <lastmod>2026-05-28T21:41:27.883Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-stage-iii-melanoma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:27.897Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/propranolol-von-hippel-lindau-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:41:27.911Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sugammadex-residual-neuromuscular-blockade-neuromus-not-applicable</loc>
    <lastmod>2026-05-28T21:41:27.925Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/neodidro-0-266-mg-vitamin-d-deficiency-phase-iii</loc>
    <lastmod>2026-05-28T21:41:27.938Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fesoterodine-alzheimer-s-disease-psychosis-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:27.950Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bexicaserin-hydrochloride-developmental-and-epileptic-encephalopat-phase-iii</loc>
    <lastmod>2026-05-28T21:41:27.964Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/thytreg-cardiac-transplant-rejection-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:27.977Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bay-3401016-alport-syndrome-chronic-kidney-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:27.990Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obinutuzumab-sjogren-s-syndrome-phase-iv</loc>
    <lastmod>2026-05-28T21:41:28.003Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cabozantinib-differentiated-thyroid-cancer-radioiodin-phase-iii</loc>
    <lastmod>2026-05-28T21:41:28.016Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dabrafenib-advanced-melanoma-malignant-melanoma-of-phase-iv-ctis-2024-516585-11-00</loc>
    <lastmod>2026-05-28T21:12:23.476Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:28.031Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-triple-negative-androgen-receptor-positi-phase-ii</loc>
    <lastmod>2026-05-28T21:41:28.044Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cyclophosphamide-hematological-malignancy-phase-iii</loc>
    <lastmod>2026-05-28T21:41:28.057Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-melanoma-renal-cell-carcinoma-phase-iv</loc>
    <lastmod>2026-05-28T21:41:28.071Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fosfomycin-acute-bacterial-prostatitis-escherichia-phase-iv</loc>
    <lastmod>2026-05-28T21:41:28.083Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anastrozole-endometrial-adenocarcinoma-advanced-meta-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:28.096Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alfa-d-mannose-1-phosphate-dipotassium-pmm2-cdg-congenital-disorder-of-glycosyl-phase-ii</loc>
    <lastmod>2026-05-28T21:41:28.111Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cd40-pan-cov-vaccine-healthy-volunteers-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:28.124Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vosoritide-idiopathic-short-stature-phase-ii</loc>
    <lastmod>2026-05-28T21:41:28.137Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/infigratinib-hypochondroplasia-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:28.151Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/morphine-hydrochloride-trihydrate-colorectal-disease-requiring-resection-not-applicable</loc>
    <lastmod>2026-05-28T21:41:28.164Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-acute-myeloid-leukemia-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:28.177Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/molgramostim-peritonitis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:28.192Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ine963-malaria-phase-i</loc>
    <lastmod>2026-05-28T21:41:28.205Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/incb160058-myeloproliferative-neoplasms-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:41:28.217Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-melanoma-advanced-or-metastatic-melanoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:28.231Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/descartes-08-generalized-myasthenia-gravis-myasthenia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:28.244Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tev-53408-celiac-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:28.257Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/everolimus-postmenopausal-women-healthy-elderly-wom-phase-iv</loc>
    <lastmod>2026-05-28T21:41:28.271Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/surzetoclax-multiple-myeloma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:28.284Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/c1-esterase-inhibitor-human-aneurysmal-subarachnoid-hemorrhage-phase-ii</loc>
    <lastmod>2026-05-28T21:41:28.299Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bjt-778-chronic-hepatitis-d-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:41:28.312Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sonelokimab-hidradenitis-suppurativa-phase-iii</loc>
    <lastmod>2026-05-28T21:41:28.325Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metronidazole-perianal-abscess-not-applicable</loc>
    <lastmod>2026-05-28T21:41:28.338Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trospium-chloride-xanomeline-tartrate-agitation-associated-with-alzheimer-s-di-phase-iii</loc>
    <lastmod>2026-05-28T21:41:28.351Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/choline-alfoscerate-mild-cognitive-dysfunction-phase-iv</loc>
    <lastmod>2026-05-28T21:41:28.365Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gallium-68ga-edotreotide-nasopharyngeal-carcinoma-not-applicable</loc>
    <lastmod>2026-05-28T21:41:28.378Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ivonescimab-gastric-adenocarcinoma-esophagogastric-j-phase-ii</loc>
    <lastmod>2026-05-28T21:41:28.391Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etentamig-multiple-myeloma-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:28.405Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lactobacillales-multiple-sclerosis-relapsing-remitting-m-phase-ii</loc>
    <lastmod>2026-05-28T21:41:28.419Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ribociclib-early-breast-cancer-hormone-receptor-pos-phase-iii</loc>
    <lastmod>2026-05-28T21:41:28.433Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zelenectide-pevedotin-advanced-or-metastatic-non-small-cell-lu-phase-ii</loc>
    <lastmod>2026-05-28T21:41:28.448Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/depemokimab-chronic-obstructive-pulmonary-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:41:28.462Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/petosemtamab-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:28.476Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pneumococcal-polysaccharide-conjugates-m-community-acquired-pneumonia-phase-iv</loc>
    <lastmod>2026-05-28T21:41:28.489Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etrasimod-arginine-ulcerative-colitis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:28.510Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zasocitinib-moderately-to-severely-active-ulcerative-phase-ii</loc>
    <lastmod>2026-05-28T21:41:28.523Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/kt-621-uncontrolled-moderate-to-severe-eosinoph-phase-ii</loc>
    <lastmod>2026-05-28T21:41:28.539Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-barrett-s-esophagus-colon-carcinoma-gast-phase-ii</loc>
    <lastmod>2026-05-28T21:41:28.552Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/asp2957-x-linked-myotubular-myopathy-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:28.567Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/niraparib-abiraterone-acetate-metastatic-castration-sensitive-prostate-phase-iii</loc>
    <lastmod>2026-05-28T21:41:28.580Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/68ga-nota-abscint-her2-breast-cancer-her2-positive-early-breast-phase-ii</loc>
    <lastmod>2026-05-28T21:41:28.593Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trabectedin-uterine-leiomyosarcoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:28.608Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cemiplimab-melanoma-advanced-solid-tumours-clear-ce-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:28.622Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/spinal-and-bulbar-muscular-atrophy-phase-i</loc>
    <lastmod>2026-05-28T21:41:28.635Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-advanced-malignancies-locally-advanced-b-phase-iii</loc>
    <lastmod>2026-05-28T21:41:28.649Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gallium-68ga-pentixafor-cardiac-sarcoidosis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:28.663Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/deucravacitinib-moderate-to-severe-plaque-psoriasis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:28.677Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pf-08065010-rheumatoid-arthritis-systemic-lupus-eryt-phase-i</loc>
    <lastmod>2026-05-28T21:41:28.691Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/h-cys-ss-glu-val-ser-gln-leu-leu-lys-gly-ovarian-cancer-metastatic-colorectal-can-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:28.706Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gentamicin-infective-endocarditis-not-applicable</loc>
    <lastmod>2026-05-28T21:41:28.721Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ethacizine-atrial-fibrillation-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:28.735Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ketamine-hydrochloride-major-depressive-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:41:28.748Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ibuzatrelvir-covid-19-phase-iii</loc>
    <lastmod>2026-05-28T21:41:28.761Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-autosomal-dominant-polycystic-kidney-dis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:28.774Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aflibercept-neovascular-age-related-macular-degenera-phase-iii</loc>
    <lastmod>2026-05-28T21:41:28.791Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/buloxibutid-idiopathic-pulmonary-fibrosis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:28.805Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/naproxen-sodium-healthy-volunteers-phase-ii</loc>
    <lastmod>2026-05-28T21:41:28.819Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluticasone-furoate-vilanterol-asthma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:28.834Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cor-1167-chronic-heart-failure-phase-iii</loc>
    <lastmod>2026-05-28T21:41:28.848Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/silymarin-hormone-receptor-positive-her2-negative-phase-ii</loc>
    <lastmod>2026-05-28T21:41:28.861Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tirzepatide-obesity-phase-iv</loc>
    <lastmod>2026-05-28T21:41:28.874Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gvv858-hormone-receptor-positive-her2-negative-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:28.887Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/indapamide-phase-ii</loc>
    <lastmod>2026-05-28T21:41:28.901Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-n-diethyl-2-4-2-18f-fluoroethoxy-pheny-intracerebral-hemorrhage-phase-ii</loc>
    <lastmod>2026-05-28T21:41:28.914Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/canagliflozin-healthy-volunteers-phase-ii</loc>
    <lastmod>2026-05-28T21:41:28.927Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mirdametinib-neurofibromatosis-type-1-associated-plex-phase-i</loc>
    <lastmod>2026-05-28T21:41:28.940Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tadalafil-healthy-volunteers-phase-iii</loc>
    <lastmod>2026-05-28T21:41:28.959Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ro7812653-early-symptomatic-alzheimer-s-disease-mi-phase-i</loc>
    <lastmod>2026-05-28T21:41:28.973Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lidocaine-healthy-volunteers-bioavailability-study-phase-i</loc>
    <lastmod>2026-05-28T21:41:28.986Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aganirsen-herpetic-keratitis-corneal-neovascularis-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:29.001Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glpg3667-autoimmune-disorder-inflammatory-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:41:29.014Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mk-4605-dementia-phase-i</loc>
    <lastmod>2026-05-28T21:41:29.028Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prednisone-septic-arthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:29.041Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/indapamide-healthy-volunteers-phase-ii</loc>
    <lastmod>2026-05-28T21:41:29.055Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/combination-of-two-adeno-associated-vira-stargardt-disease-stgd1-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:29.068Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mk-1824-heart-failure-with-preserved-ejection-fr-phase-i</loc>
    <lastmod>2026-05-28T21:41:29.081Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mv-niv-nipah-virus-infection-phase-i</loc>
    <lastmod>2026-05-28T21:41:29.094Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/immune-related-adverse-events-ctcae-grad-phase-iii</loc>
    <lastmod>2026-05-28T21:41:29.107Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glutaraldehyde-modified-l-tyrosine-adsor-allergic-rhinoconjunctivitis-grass-polle</loc>
    <lastmod>2026-05-28T21:41:29.121Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mk-6050-hidradenitis-suppurativa-phase-iii</loc>
    <lastmod>2026-05-28T21:41:29.134Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prednisolone-vestibular-neuritis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:29.147Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ctx-187-bacterial-infection-phase-i</loc>
    <lastmod>2026-05-28T21:41:29.160Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/morphine-sulfate-amyotrophic-lateral-sclerosis-chronic-re-phase-iii</loc>
    <lastmod>2026-05-28T21:41:29.173Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/losartan-potassium-hydrochlorothiazide-paraffin-oil-induced-granulomatous-disea</loc>
    <lastmod>2026-05-28T21:41:29.187Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ritlecitinib-tosilate-chronic-spontaneous-urticaria-phase-ii</loc>
    <lastmod>2026-05-28T21:41:29.201Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/klr-003-psoriasis-phase-i</loc>
    <lastmod>2026-05-28T21:41:29.214Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/diroximel-fumarate-intracerebral-haemorrhage-stroke-phase-ii</loc>
    <lastmod>2026-05-28T21:41:29.227Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colchicine-ischemic-heart-disease-coronary-artery-d-phase-iv</loc>
    <lastmod>2026-05-28T21:41:29.240Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxygen-vitiligo-phase-iv</loc>
    <lastmod>2026-05-28T21:41:29.253Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vtx-002-amyotrophic-lateral-sclerosis-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:29.266Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/melflufen-recurrent-glioblastoma-glioblastoma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:29.280Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ciprofloxacin-urinary-tract-infection-with-systemic-in</loc>
    <lastmod>2026-05-28T21:41:29.294Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ndi-219216-advanced-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:41:29.307Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pitolisant-migraine-without-aura-not-applicable</loc>
    <lastmod>2026-05-28T21:41:29.320Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ro7763505-stable-coronary-artery-disease-phase-i</loc>
    <lastmod>2026-05-28T21:41:29.333Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/izicopan-inf904-healthy-volunteers-phase-i</loc>
    <lastmod>2026-05-28T21:41:29.346Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rosuvastatin-coronary-artery-disease-dyslipidaemia-no-not-applicable</loc>
    <lastmod>2026-05-28T21:41:29.361Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tub-040-high-grade-epithelial-serous-ovarian-can-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:29.374Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/parkinson-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:29.387Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glimepiride-hnf1a-mody-hnf4a-mody-phase-iv</loc>
    <lastmod>2026-05-28T21:41:29.400Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rilzabrutinib-immune-thrombocytopenic-purpura-immune-t-phase-iii</loc>
    <lastmod>2026-05-28T21:41:29.414Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sul-238-parkinson-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:29.429Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/annexin-a5-diabetic-retinopathy-retinal-vein-occlus-phase-ii</loc>
    <lastmod>2026-05-28T21:41:29.442Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-faecal-microbiota-autism-spectrum-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:41:29.454Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/resomelagon-polymyalgia-rheumatica-phase-ii</loc>
    <lastmod>2026-05-28T21:41:29.467Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-peripheral-blood-mononuclear-knee-osteoarthritis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:29.481Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tafamidis-free-acid-transthyretin-amyloidosis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:29.494Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-diabetic-foot-ulcer-type-2-diabetes-mell-not-applicable</loc>
    <lastmod>2026-05-28T21:41:29.508Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/68ga-ath001-gallium-68-labeled-pdgfr-tar-systemic-sclerosis-associated-interstiti-phase-iii</loc>
    <lastmod>2026-05-28T21:41:29.521Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mesalazine-ulcerative-colitis-not-applicable</loc>
    <lastmod>2026-05-28T21:41:29.533Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eik1005-sodium-advanced-solid-tumors-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:29.547Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylsalicylic-acid-preeclampsia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:29.560Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mifamurtide-osteosarcoma-relapsed-refractory-osteosa-phase-ii</loc>
    <lastmod>2026-05-28T21:41:29.573Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cd5-car-nk-cells-refractory-invasive-mold-disease-fungal-phase-i</loc>
    <lastmod>2026-05-28T21:41:29.586Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ifinatamab-deruxtecan-esophageal-squamous-cell-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:29.599Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/omalizumab-food-allergy-ltp-sensitization-food-alle-phase-iv</loc>
    <lastmod>2026-05-28T21:41:29.612Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenalidomide-hiv-1-infection-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:29.625Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fludeoxyglucose-18f-cardiovascular-device-infections-device-phase-iv</loc>
    <lastmod>2026-05-28T21:41:29.638Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/loperamide-healthy-volunteers-phase-ii</loc>
    <lastmod>2026-05-28T21:41:29.650Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/duvakitug-healthy-volunteers-phase-iii</loc>
    <lastmod>2026-05-28T21:41:29.663Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-mismatch-repair-deficient-dmmr-colon-can-phase-ii</loc>
    <lastmod>2026-05-28T21:41:29.676Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aztreonam-avibactam-sepsis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:29.690Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imu-838-multiple-sclerosis-phase-i</loc>
    <lastmod>2026-05-28T21:41:29.703Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zanidatamab-her2-positive-advanced-breast-cancer-bre-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:29.716Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ev25-influenza-phase-iii</loc>
    <lastmod>2026-05-28T21:41:29.731Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/1-3s-2-3-dihydro-1-4-benzodioxin-3-yl-me-parkinson-s-disease-normal-aging-phase-iv</loc>
    <lastmod>2026-05-28T21:41:29.744Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/somatropin-growth-hormone-deficiency-phase-ii</loc>
    <lastmod>2026-05-28T21:41:29.757Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/recombinant-varicella-zoster-virus-glyco-dementia-alzheimer-s-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:41:29.770Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/modafinil-inflammatory-bowel-disease-fatigue-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:29.783Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/68ga-oncoacp3-prostate-cancer-recurrent-prostate-cance-phase-i</loc>
    <lastmod>2026-05-28T21:41:29.796Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/argipressin-chronic-thromboembolic-pulmonary-hyperte-phase-iii</loc>
    <lastmod>2026-05-28T21:41:29.808Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vididencel-chronic-myeloid-leukemia-chronic-phase-phase-i</loc>
    <lastmod>2026-05-28T21:41:29.821Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aur200-generalized-myasthenia-gravis-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:29.834Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/guselkumab-crohn-s-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:41:29.848Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/migraine-phase-ii</loc>
    <lastmod>2026-05-28T21:41:29.861Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mk-6916-acute-pain-chronic-pain-phase-iii</loc>
    <lastmod>2026-05-28T21:41:29.874Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belatacept-kidney-transplant-recipient-phase-iv</loc>
    <lastmod>2026-05-28T21:41:29.887Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/argatroban-monohydrate-respiratory-failure-heart-failure-phase-ii</loc>
    <lastmod>2026-05-28T21:41:29.900Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/verteporfin-scar-formation-following-surgical-wounds-phase-iv</loc>
    <lastmod>2026-05-28T21:41:29.913Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prexasertib-lactate-monohydrate-endometrial-cancer-endometrial-adenocarc-phase-ii</loc>
    <lastmod>2026-05-28T21:41:29.926Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gsk4771261-autosomal-dominant-polycystic-kidney-dis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:29.939Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lyophilized-bacterial-lysates-of-haemoph-copd-exacerbation-chronic-obstructive-pu-phase-iv</loc>
    <lastmod>2026-05-28T21:41:29.952Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/survodutide-chronic-kidney-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:29.965Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/r-n-4-1-2-4-triazolo-1-5-c-pyrimidin-7-y-her2-positive-breast-cancer-brain-metast-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:29.979Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/losartan-healthy-volunteers-phase-iii</loc>
    <lastmod>2026-05-28T21:41:29.994Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/insulin-human-delirium-phase-iv</loc>
    <lastmod>2026-05-28T21:41:30.007Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2s-2-2-2s-5-amino-2-2s-2-aminopropanoyl-coronary-artery-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:41:30.021Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s072-pain-phase-i</loc>
    <lastmod>2026-05-28T21:41:30.036Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vancomycin-hydrochloride-ulcerative-colitis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:30.049Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/meropenem-anhydrous-infection-sepsis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:30.062Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ladarixin-ocular-inflammatory-conditions-eye-infla-phase-i</loc>
    <lastmod>2026-05-28T21:41:30.075Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/letrozole-endometriosis-adenomyosis-infertility-not-applicable</loc>
    <lastmod>2026-05-28T21:41:30.088Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cx11-trometamol-monohydrate-type-2-diabetes-mellitus-phase-ii</loc>
    <lastmod>2026-05-28T21:41:30.101Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ati-052-asthma-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:41:30.113Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/18f-cpfpx-drug-resistant-epilepsy-focal-epilepsy-i-phase-ii</loc>
    <lastmod>2026-05-28T21:41:30.126Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imatinib-mesylate-acute-lymphoblastic-leukemia-ph-chronic-phase-ii</loc>
    <lastmod>2026-05-28T21:41:30.139Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dupilumab-chronic-rhinosinusitis-with-nasal-polyps-not-applicable</loc>
    <lastmod>2026-05-28T21:41:30.152Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dalbavancin-acute-bacterial-skin-and-skin-structure</loc>
    <lastmod>2026-05-28T21:41:30.165Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ap-2-amyotrophic-lateral-sclerosis-frontotemp-phase-i</loc>
    <lastmod>2026-05-28T21:41:30.178Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/petadeferitrin-iron-overload-thalassemia-beta-transfusi-phase-iii</loc>
    <lastmod>2026-05-28T21:41:30.191Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/technetium-99mtc-galactosyl-serum-albumi-hepatic-tumor-hepatic-tumor-s-not-applicable</loc>
    <lastmod>2026-05-28T21:41:30.204Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-uveal-melanoma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:30.217Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cd19-car-t-cells-autologous-chronic-graft-versus-host-disease-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:41:30.230Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/recombinant-varicella-zoster-virus-glyco-herpes-zoster-major-adverse-cardiovascul-phase-iv</loc>
    <lastmod>2026-05-28T21:41:30.243Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mst-0312-solid-malignancies-phase-i</loc>
    <lastmod>2026-05-28T21:41:30.256Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methylphenidate-hydrochloride-coma-due-to-acute-brain-injury-phase-iv</loc>
    <lastmod>2026-05-28T21:41:30.269Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bupropion-hydrochloride-post-covid-syndrome-post-covid-syndrome-phase-ii</loc>
    <lastmod>2026-05-28T21:41:30.281Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gub-ucn2-type-2-diabetes-obesity-phase-i</loc>
    <lastmod>2026-05-28T21:41:30.295Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abiraterone-acetate-metastatic-castration-resistant-prostate-phase-iv</loc>
    <lastmod>2026-05-28T21:41:30.308Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iomeprol-thoracic-neoplasm-primary-pulmonary-mali-not-applicable</loc>
    <lastmod>2026-05-28T21:41:30.321Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adeno-associated-virus-serotype-9-contai-type-2-diabetes-mellitus-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:30.333Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mr-l45-autosomal-dominant-polycystic-kidney-dis-phase-i</loc>
    <lastmod>2026-05-28T21:41:30.346Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lebrikizumab-localized-scleroderma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:30.359Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nolasiban-infertility-indication-for-ivf-icsi-phase-ii</loc>
    <lastmod>2026-05-28T21:41:30.372Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-2-2-10-2-4-3-4-2-2-cyano-4-4-difluor-gastric-cancer-gastric-adenocarcinoma-si-phase-ii</loc>
    <lastmod>2026-05-28T21:41:30.384Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/valproic-acid-pulmonary-hypertension-idiopathic-pulmon-phase-i</loc>
    <lastmod>2026-05-28T21:41:30.397Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ibuprofen-paracetamol-acetaminophen-acute-pain-postoperative-pain-phase-iii</loc>
    <lastmod>2026-05-28T21:41:30.410Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-genetically-modified-t-lympho-relapsed-refractory-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:30.423Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bupivacaine-hydrochloride-monohydrate-head-and-neck-cancer-oral-mucositis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:30.437Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-rheumatoid-arthritis-associated-intersti-phase-iv</loc>
    <lastmod>2026-05-28T21:41:30.450Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/temazepam-insomnia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:30.462Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rubella-virus-wistar-ra-27-3-strain-live-measles-mumps-rubella-phase-iv</loc>
    <lastmod>2026-05-28T21:41:30.475Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rectal-cancer-proficient-mismatch-repair-phase-iii</loc>
    <lastmod>2026-05-28T21:41:30.488Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pbgene-hbv-chronic-hepatitis-b-phase-i</loc>
    <lastmod>2026-05-28T21:41:30.501Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bg-c0979-advanced-solid-tumors-phase-i-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:30.514Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lanifibranor-non-alcoholic-steatohepatitis-nash-phase-ii</loc>
    <lastmod>2026-05-28T21:41:30.527Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tislelizumab-advanced-or-metastatic-solid-tumors-hepa-phase-i</loc>
    <lastmod>2026-05-28T21:41:30.539Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ro7795068-obesity-phase-iii</loc>
    <lastmod>2026-05-28T21:41:30.553Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methotrexate-differentiated-vulvar-intraepithelial-ne-not-applicable</loc>
    <lastmod>2026-05-28T21:41:30.565Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mk-3214-hypercholesterolemia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:30.591Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bleomycin-sulfate-vascular-malformation-phase-iv</loc>
    <lastmod>2026-05-28T21:41:30.578Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-sodium-phosphate-total-hip-arthroplasty-phase-iv</loc>
    <lastmod>2026-05-28T21:41:30.603Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rilvegostomig-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:30.618Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexmedetomidine-septic-shock-sepsis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:30.631Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-4-1r-4r-4-hydroxy-4-methylcyclohexyl-m-chronic-lymphocytic-leukemia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:30.644Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anakinra-pancreas-transplant-type-1-diabetes-mell-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:30.657Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fre01-fre02-fre04-fre03-bacterial-vaginosis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:30.670Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/otp-01-advanced-solid-tumors-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:30.683Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vafidemstat-healthy-volunteers-phase-i</loc>
    <lastmod>2026-05-28T21:41:30.696Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-acetate-benign-parotid-tumor-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:30.709Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vicadrostat-healthy-volunteer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:30.722Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/doxycycline-sexually-transmitted-infections-not-applicable</loc>
    <lastmod>2026-05-28T21:41:30.735Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nicotinamide-leber-s-hereditary-optic-neuropathy-phase-iii</loc>
    <lastmod>2026-05-28T21:41:30.748Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-vein-tissue-segment-decellula-chronic-venous-insufficiency-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:30.761Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-obstructive-sleep-apnea-not-applicable</loc>
    <lastmod>2026-05-28T21:41:30.774Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/botulinum-toxin-type-a-rectal-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:41:30.787Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-alginate-calcium-carbonate-sodium-phase-iii</loc>
    <lastmod>2026-05-28T21:41:30.800Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/arsenic-trioxide-acute-promyelocytic-leukemia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:30.813Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bms-986500-advanced-or-metastatic-solid-tumors-gast-phase-i</loc>
    <lastmod>2026-05-28T21:41:30.825Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/om336-sjogren-s-syndrome-idiopathic-inflammato-phase-i</loc>
    <lastmod>2026-05-28T21:41:30.838Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/diclofenac-acute-soft-tissue-injuries-bruises-strai-phase-iii</loc>
    <lastmod>2026-05-28T21:41:30.851Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levonorgestrel-healthy-volunteers-phase-i</loc>
    <lastmod>2026-05-28T21:41:30.864Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexmedetomidine-emergence-delirium-phase-iii</loc>
    <lastmod>2026-05-28T21:41:30.877Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/idiopathic-intracranial-hypertension-not-applicable</loc>
    <lastmod>2026-05-28T21:41:30.892Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/grt-001-ulcerative-colitis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:30.904Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carperitide-acute-kidney-injury-phase-ii</loc>
    <lastmod>2026-05-28T21:41:30.917Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/genetically-modified-t-lymphocytes-secre-malignant-b-cell-neoplasms-b-cell-non-ho-phase-i</loc>
    <lastmod>2026-05-28T21:41:30.930Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/progesterone-infertility-female-infertility-not-applicable</loc>
    <lastmod>2026-05-28T21:41:30.943Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gxv813-schizophrenia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:30.956Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/daridorexant-major-depressive-disorder-insomnia-disor-phase-iv</loc>
    <lastmod>2026-05-28T21:41:30.969Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methylprednisolone-st-segment-elevation-myocardial-infarcti-phase-iii</loc>
    <lastmod>2026-05-28T21:41:30.982Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/achilles-tendinopathy-phase-iv</loc>
    <lastmod>2026-05-28T21:41:30.996Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/maribavir-epstein-barr-virus-ebv-infection-in-soli-phase-iv</loc>
    <lastmod>2026-05-28T21:41:31.009Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/5-7-dichloro-2-ethylamino-methyl-8-hydro-multiple-system-atrophy-phase-iv</loc>
    <lastmod>2026-05-28T21:41:31.023Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amg-436-microsatellite-instability-high-msi-h-mi-phase-i</loc>
    <lastmod>2026-05-28T21:41:31.035Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azathioprine-autosomal-dominant-polycystic-kidney-dis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:31.048Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vtx2735-sodium-recurrent-pericarditis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:31.062Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lca-0321-graves-disease-phase-i</loc>
    <lastmod>2026-05-28T21:41:31.079Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ponatinib-ponatinib-hydrochloride-chronic-myeloid-leukemia-philadelphia-ch-phase-ii</loc>
    <lastmod>2026-05-28T21:41:31.092Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rifaximin-opioid-use-disorder-substance-use-disord-phase-iv</loc>
    <lastmod>2026-05-28T21:41:31.106Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ro7795068-obesity-overweight-phase-iii</loc>
    <lastmod>2026-05-28T21:41:31.118Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/qrl-101-novel-formulation-epilepsy-amyotrophic-lateral-sclerosis-n-phase-iii</loc>
    <lastmod>2026-05-28T21:41:31.131Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/leflutrozole-non-obstructive-azoospermia-male-inferti-phase-iv</loc>
    <lastmod>2026-05-28T21:41:31.144Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/plasmodium-falciparum-malaria</loc>
    <lastmod>2026-05-28T21:41:31.157Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-faecal-microbiota-pooled-gastrointestinal-acute-graft-versus-host-phase-ii</loc>
    <lastmod>2026-05-28T21:41:31.170Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zongertinib-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:31.183Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/esomeprazole-dyspepsia-not-applicable</loc>
    <lastmod>2026-05-28T21:41:31.197Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ladarixin-new-onset-autoimmune-type-1-diabetes-typ-phase-ii</loc>
    <lastmod>2026-05-28T21:41:31.210Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-vulvar-squamous-cell-carcinoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:31.223Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atrial-fibrillation-transient-ischemic-a-phase-iii</loc>
    <lastmod>2026-05-28T21:41:31.236Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clopidogrel-chronic-limb-threatening-ischemia-clti-p-phase-iii</loc>
    <lastmod>2026-05-28T21:41:31.250Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ramipril-acetylsalicylic-acid-atorvastat-acute-coronary-syndrome-not-applicable</loc>
    <lastmod>2026-05-28T21:41:31.263Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vormatrigine-focal-epilepsy-focal-seizures-phase-iii</loc>
    <lastmod>2026-05-28T21:41:31.276Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carbidopa-levodopa-parkinson-s-disease-not-applicable</loc>
    <lastmod>2026-05-28T21:41:31.289Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gemcitabine-unresectable-locally-advanced-pancreatic-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:31.302Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/7-8-dibromo-5-6-dihydro-9-methyl-2-1-pip-medulloblastoma-recurrent-or-progressive-phase-i</loc>
    <lastmod>2026-05-28T21:41:31.315Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rimonabant-spinal-cord-injury-cervical-spinal-cord-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:31.328Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tocilizumab-acute-myeloid-leukaemia-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:31.341Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cefepime-febrile-neutropenia-acute-myeloid-leukae-phase-iv</loc>
    <lastmod>2026-05-28T21:41:31.354Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elranatamab-multiple-myeloma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:31.367Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gentamicin-diabetic-foot-osteomyelitis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:31.380Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fludarabine-phosphate-hematological-malignancy-phase-iv</loc>
    <lastmod>2026-05-28T21:41:31.394Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/brimonidine-tartrate-capecitabine-induced-hand-and-foot-syndr-phase-ii</loc>
    <lastmod>2026-05-28T21:41:31.408Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mb-001-ulcerative-colitis-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:31.420Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/opioid-induced-respiratory-depression-phase-i</loc>
    <lastmod>2026-05-28T21:41:31.434Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imeroprubart-graves-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:41:31.447Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trametinib-adjuvant-braf-v600e-or-v600k-mutation-po-phase-ii</loc>
    <lastmod>2026-05-28T21:41:31.461Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/csx-1004-opioid-use-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:41:31.475Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obicetrapib-dyslipidemia-primary-non-familial-hyperc-phase-iii</loc>
    <lastmod>2026-05-28T21:41:31.488Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gadopiclenol-cardiomyopathy-tetralogy-of-fallot-compl-phase-iii</loc>
    <lastmod>2026-05-28T21:41:31.513Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amoxicillin-acute-otitis-media</loc>
    <lastmod>2026-05-28T21:41:31.526Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pridopidine-hydrochloride-amyotrophic-lateral-sclerosis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:31.539Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tnv108-diabetic-peripheral-neuropathy-phase-i</loc>
    <lastmod>2026-05-28T21:41:31.553Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dasiglucagon-type-1-diabetes-mellitus-not-applicable</loc>
    <lastmod>2026-05-28T21:41:31.566Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/chronic-obstructive-pulmonary-disease</loc>
    <lastmod>2026-05-28T21:41:31.578Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capivasertib-healthy-volunteers-phase-iii</loc>
    <lastmod>2026-05-28T21:41:31.592Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cemiplimab-cutaneous-squamous-cell-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:31.605Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nnc0497-0040-type-1-diabetes-overweight-obesity-phase-i</loc>
    <lastmod>2026-05-28T21:41:31.618Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-triple-negative-breast-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:31.631Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-non-st-elevation-myocardial-infarction-n</loc>
    <lastmod>2026-05-28T21:41:31.645Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lerodalcibep-heterozygous-familial-hypercholesterolem-phase-iii</loc>
    <lastmod>2026-05-28T21:41:31.659Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/l-phenylalanyl-2-methylalanyl-l-alfa-glu-obesity-type-2-diabetes-phase-iii</loc>
    <lastmod>2026-05-28T21:41:31.672Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/haemophilus-influenzae-klebsiella-ozaena-respiratory-tract-infections-phase-iv</loc>
    <lastmod>2026-05-28T21:41:31.686Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rafutrombopag-ethanolamine-chemotherapy-induced-thrombocytopenia-so-phase-iii</loc>
    <lastmod>2026-05-28T21:41:31.699Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/l-phenylalanyl-2-methylalanyl-l-alfa-glu-obesity-phase-iii</loc>
    <lastmod>2026-05-28T21:41:31.712Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cagrilintide-obesity-phase-iii</loc>
    <lastmod>2026-05-28T21:41:31.725Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ibi3009-extensive-stage-small-cell-lung-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:41:31.741Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atopic-dermatitis-phase-i</loc>
    <lastmod>2026-05-28T21:41:31.755Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/qel-005-diffuse-cutaneous-systemic-sclerosis-dif-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:31.768Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/omn6-hospital-acquired-bacterial-pneumonia-ve-phase-ii</loc>
    <lastmod>2026-05-28T21:41:31.782Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/al-18f-f-fapi-74-non-small-cell-lung-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:41:31.796Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/4-fluoro-n-2-4-2-methoxyphenyl-piperazin-dravet-syndrome-drug-resistant-focal-epi-phase-ii</loc>
    <lastmod>2026-05-28T21:41:31.808Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adcx-020-locally-advanced-or-metastatic-solid-tum-phase-i</loc>
    <lastmod>2026-05-28T21:41:31.822Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clemastine-fumarate-pitt-hopkins-syndrome-phase-ii</loc>
    <lastmod>2026-05-28T21:41:31.835Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/diclofenac-sodium-primary-open-angle-glaucoma-pseudoexfoli</loc>
    <lastmod>2026-05-28T21:41:31.848Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/propranolol-hydrochloride-traumatic-brain-injury-head-injury</loc>
    <lastmod>2026-05-28T21:41:31.861Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/volrustomig-malignant-pleural-mesothelioma-esophagea-phase-ii</loc>
    <lastmod>2026-05-28T21:41:31.874Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nurandociguat-chronic-kidney-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:41:31.887Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vorolanib-diabetic-macular-edema-phase-iii</loc>
    <lastmod>2026-05-28T21:41:31.900Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-substance-use-disorder-chemsex-related-d-phase-iv</loc>
    <lastmod>2026-05-28T21:41:31.913Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vorolanib-diabetic-macular-edema-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:31.926Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/chronic-kidney-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:41:31.940Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/advanced-malignant-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:41:31.953Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/14c-ltp001-healthy-volunteers-phase-i</loc>
    <lastmod>2026-05-28T21:41:31.966Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/palopegteriparatide-hypoparathyroidism-not-applicable</loc>
    <lastmod>2026-05-28T21:41:31.979Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-cannabis-use-disorder-phase-iv</loc>
    <lastmod>2026-05-28T21:41:31.992Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/palopegteriparatide-chronic-hypoparathyroidism-phase-iii</loc>
    <lastmod>2026-05-28T21:41:32.005Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belzutifan-renal-cell-carcinoma-hepatocellular-carc-phase-iii</loc>
    <lastmod>2026-05-28T21:41:32.020Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-hydrogen-carbonate-metabolic-acidosis-acute-kidney-injury-c-phase-iv</loc>
    <lastmod>2026-05-28T21:41:32.033Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/survodutide-healthy-volunteer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:32.047Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/covid-19-sars-cov-2-booster-vaccination-phase-iii</loc>
    <lastmod>2026-05-28T21:41:32.061Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nbi-921355-epilepsy-phase-iii</loc>
    <lastmod>2026-05-28T21:41:32.075Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/db-1311-antibody-drug-conjugate-adc-non-small-cell-lung-cancer-cervical-canc-phase-ii</loc>
    <lastmod>2026-05-28T21:41:32.088Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nolasiban-healthy-volunteers-phase-iii</loc>
    <lastmod>2026-05-28T21:41:32.101Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methotrexate-crohn-s-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:41:32.114Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aci-19764-healthy-volunteers-phase-i</loc>
    <lastmod>2026-05-28T21:41:32.127Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/advanced-or-metastatic-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:41:32.141Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atorvastatin-cholelithiasis-gallstones-following-bari</loc>
    <lastmod>2026-05-28T21:41:32.154Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/omaveloxolone-friedreich-s-ataxia-not-applicable</loc>
    <lastmod>2026-05-28T21:41:32.167Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trospium-chloride-xanomeline-tartrate-schizophrenia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:32.181Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-atrial-fibrillation-phase-iv</loc>
    <lastmod>2026-05-28T21:41:32.194Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/al-18f-f-fapi-74-giant-cell-arteritis-not-applicable</loc>
    <lastmod>2026-05-28T21:41:32.207Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sevoflurane-acute-ischemic-stroke-phase-iii</loc>
    <lastmod>2026-05-28T21:41:32.220Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levothyroxine-hypothyroidism-incident-kidney-dysfuncti-phase-iv</loc>
    <lastmod>2026-05-28T21:41:32.233Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fwy003-tosilate-geographic-atrophy-secondary-to-age-rela-phase-ii</loc>
    <lastmod>2026-05-28T21:41:32.245Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/igg-like-t-cell-engager-binding-to-dll3-extrapulmonary-neuroendocrine-carcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:32.261Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/men2501-platinum-resistant-ovarian-cancer-ovaria-phase-i</loc>
    <lastmod>2026-05-28T21:41:32.275Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogenic-adipose-tissue-derived-mesench-autism-spectrum-disorder-gastrointestina-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:41:32.292Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avelumab-metastatic-urothelial-carcinoma-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:32.305Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ntrx-07-neuroinflammation-related-diseases-alzhe-phase-iii</loc>
    <lastmod>2026-05-28T21:41:32.320Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rptr-1-201-advanced-solid-tumor-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:32.333Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxaliplatin-locally-advanced-rectal-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:32.347Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lesigercept-chronic-spontaneous-urticaria-phase-ii</loc>
    <lastmod>2026-05-28T21:41:32.360Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tozorakimab-chronic-obstructive-pulmonary-disease-co-phase-iii</loc>
    <lastmod>2026-05-28T21:41:32.373Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methenamine-hippurate-recurrent-urinary-tract-infection-phase-iv</loc>
    <lastmod>2026-05-28T21:41:32.387Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/exemestane-early-breast-cancer-hormone-receptor-pos-phase-iii</loc>
    <lastmod>2026-05-28T21:41:32.400Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sr-878-rheumatoid-arthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:32.413Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-3821001-healthy-volunteers-phase-i</loc>
    <lastmod>2026-05-28T21:41:32.426Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/asundexian-thromboembolism-phase-i</loc>
    <lastmod>2026-05-28T21:41:32.439Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/indocyanine-green-solid-malignancy-head-and-neck-cancer-ga-not-applicable</loc>
    <lastmod>2026-05-28T21:41:32.452Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/landiolol-hydrochloride-st-elevation-acute-coronary-syndrome-phase-iv</loc>
    <lastmod>2026-05-28T21:41:32.465Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nicotine-nicotine-dependence-phase-ii</loc>
    <lastmod>2026-05-28T21:41:32.478Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/giroctocogene-fitelparvovec-hemophilia-a-hemophilia-b-severe-to-mode-phase-iii</loc>
    <lastmod>2026-05-28T21:41:32.492Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tirzepatide-endometrial-adenocarcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:32.506Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly3841136-sodium-obesity-overweight-phase-iii</loc>
    <lastmod>2026-05-28T21:41:32.519Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hypochlorous-acid-chronic-airway-infections-cystic-fibrosi-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:32.532Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly3841136-sodium-obesity-overweight-type-2-diabetes-phase-iii</loc>
    <lastmod>2026-05-28T21:41:32.545Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nrg5051-parkinson-s-disease-amyotrophic-lateral-phase-i</loc>
    <lastmod>2026-05-28T21:41:32.558Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly3841136-sodium-obesity-overweight-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:32.572Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colesevelam-hydrochloride-bile-acid-diarrhoea-phase-ii</loc>
    <lastmod>2026-05-28T21:41:32.585Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/petrelintide-hepatic-impairment-healthy-volunteers-phase-iii</loc>
    <lastmod>2026-05-28T21:41:32.598Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/olea-europaea-pollen-extract-allergies-phase-ii</loc>
    <lastmod>2026-05-28T21:41:32.612Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/delgocitinib-vitiligo-non-segmental-vitiligo-phase-iv</loc>
    <lastmod>2026-05-28T21:41:32.625Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iadademstat-essential-thrombocythemia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:32.638Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/darizmetinib-hydrochloride-colorectal-liver-metastases-colon-carcin-phase-i-phase-ii</loc>
    <lastmod>2026-05-28T21:41:32.653Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxygen-chronic-wounds-diabetic-ulcer-vascular-u-not-applicable</loc>
    <lastmod>2026-05-28T21:41:32.666Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-non-small-cell-lung-cancer-renal-cell-ca-phase-iv</loc>
    <lastmod>2026-05-28T21:41:32.680Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/budiodarone-tartrate-non-permanent-atrial-fibrillation-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:32.693Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mrna3771-grna1599-chronic-hepatitis-b-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:32.706Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eloralintide-hepatic-impairment-phase-iii</loc>
    <lastmod>2026-05-28T21:41:32.719Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/irl757-parkinson-s-disease-apathy-phase-i</loc>
    <lastmod>2026-05-28T21:41:32.733Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bnt351-hiv-1-infection-phase-i</loc>
    <lastmod>2026-05-28T21:41:32.746Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pumitamig-hepatocellular-carcinoma-advanced-or-unr-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:32.760Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/emavusertib-chronic-lymphocytic-leukemia-b-cell-mali-phase-ii</loc>
    <lastmod>2026-05-28T21:41:32.773Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ctx112-relapsed-refractory-hematologic-autoimmu-phase-iii</loc>
    <lastmod>2026-05-28T21:41:32.787Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amiloride-hydrochloride-furosemide-acute-heart-failure-not-applicable</loc>
    <lastmod>2026-05-28T21:41:32.800Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elasomeran-elasomeran-mrna-1273-sars-cov-2-infection-phase-iv</loc>
    <lastmod>2026-05-28T21:41:32.813Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/grt6019-phase-iii</loc>
    <lastmod>2026-05-28T21:41:32.826Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/deucravacitinib-plaque-psoriasis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:32.840Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ezabenlimab-locally-advanced-head-and-neck-squamous-phase-ii</loc>
    <lastmod>2026-05-28T21:41:32.853Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/l-acetylleucine-cacna1a-disorders-neurodevelopmental-dis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:32.868Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capsaicin-painful-diabetic-peripheral-neuropathy-d-phase-ii</loc>
    <lastmod>2026-05-28T21:41:32.881Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sar447754-atopic-dermatitis-phase-i</loc>
    <lastmod>2026-05-28T21:41:32.894Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pumitamig-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:32.907Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ibutamoren-mesylate-growth-hormone-deficiency-ghd-phase-iii</loc>
    <lastmod>2026-05-28T21:41:32.923Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regn22044-healthy-volunteer-phase-i</loc>
    <lastmod>2026-05-28T21:41:32.936Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ketamine-healthy-volunteers-phase-ii</loc>
    <lastmod>2026-05-28T21:41:32.948Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/air-001-alpha-1-antitrypsin-deficiency-phase-i</loc>
    <lastmod>2026-05-28T21:41:32.961Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glofitamab-relapsed-refractory-diffuse-large-b-cell-phase-ii</loc>
    <lastmod>2026-05-28T21:41:32.974Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nav-240-moderate-to-severe-hidradenitis-suppurat-phase-ii</loc>
    <lastmod>2026-05-28T21:41:32.987Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zenagamtide-obesity-phase-iii</loc>
    <lastmod>2026-05-28T21:41:33.007Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bg-75202-advanced-and-metastatic-solid-tumors-hor-phase-i</loc>
    <lastmod>2026-05-28T21:41:33.021Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd0120-relapsed-or-refractory-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:33.035Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/guselkumab-psoriatic-arthritis-psoriasis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:33.048Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hlx43-advanced-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:33.071Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/18f-ded-dementia-cadasil-late-onset-alzheimer-s-phase-ii</loc>
    <lastmod>2026-05-28T21:41:33.084Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/melatonin-bipolar-disorder</loc>
    <lastmod>2026-05-28T21:41:33.098Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gen1106-metastatic-solid-tumors-advanced-maligna-phase-i</loc>
    <lastmod>2026-05-28T21:41:33.112Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/orforglipron-hemicalcium-peripheral-arterial-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:41:33.128Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bms-986523-advanced-solid-tumor-malignancies-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:33.141Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bitopertin-erythropoietic-protoporphyria-epp-x-link-phase-iv</loc>
    <lastmod>2026-05-28T21:41:33.155Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bmn-333-achondroplasia-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:33.168Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elritercept-myelodysplastic-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:41:33.181Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/td001-metastatic-castration-resistant-prostate-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:33.194Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/urokinase-catalytic-domain-fused-with-a-immune-mediated-thrombotic-thrombocytope-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:33.211Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/flumazenil-pediatric-emergence-delirium-not-applicable</loc>
    <lastmod>2026-05-28T21:41:33.226Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pioglitazone-vitiligo-phase-iv</loc>
    <lastmod>2026-05-28T21:41:33.239Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/orka-001-moderate-to-severe-plaque-psoriasis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:33.252Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/visugromab-cancer-associated-cachexia-cancer-cachex-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:33.265Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bupropion-hydrochloride-seasonal-affective-disorder-major-depres-phase-iii</loc>
    <lastmod>2026-05-28T21:41:33.279Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vamifeport-trihydrochloride-hfe-related-hereditary-haemochromatosis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:33.292Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ss0331-nebulised-respiratory-tract-infection-biologic-cou-phase-i</loc>
    <lastmod>2026-05-28T21:41:33.306Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gadopiclenol-perianal-fistula-associated-with-crohn-s-phase-iv</loc>
    <lastmod>2026-05-28T21:41:33.318Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/evim-vaccine-cvx1-muscle-invasive-bladder-cancer-renal-cel-phase-i</loc>
    <lastmod>2026-05-28T21:41:33.332Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sigvotatug-vedotin-advanced-solid-tumors-non-small-cell-lun-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:33.345Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hormone-receptor-positive-early-breast-c-phase-iii</loc>
    <lastmod>2026-05-28T21:41:33.358Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lidocaine-hydrochloride-sickle-cell-anaemia-vaso-occlusive-crisi-not-applicable</loc>
    <lastmod>2026-05-28T21:41:33.371Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pf-08634404-hepatocellular-carcinoma-unresectable-lo-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:33.384Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/flortaucipir-18f-semantic-variant-primary-progressive-aph-not-applicable</loc>
    <lastmod>2026-05-28T21:41:33.399Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pf-08634404-advanced-or-metastatic-renal-cell-carcin-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:33.413Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pm54-advanced-malignancies-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:33.427Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pumitamig-gastric-cancer-gastroesophageal-junction-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:33.440Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pf-08634404-extensive-stage-small-cell-lung-cancer-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:33.453Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-3814916-healthy-volunteers-phase-i</loc>
    <lastmod>2026-05-28T21:41:33.467Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly3841136-sodium-overweight-obesity-obstructive-sleep-apn-phase-iii</loc>
    <lastmod>2026-05-28T21:41:33.480Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pf-08634404-metastatic-colorectal-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:33.493Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxaliplatin-colorectal-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:33.507Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly3841136-sodium-osteoarthritis-of-the-knee-obesity-overw-phase-iii</loc>
    <lastmod>2026-05-28T21:41:33.520Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dnl628-early-alzheimer-s-disease-alzheimer-s-di-phase-i</loc>
    <lastmod>2026-05-28T21:41:33.535Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nnc0662-0419-type-2-diabetes-phase-ii</loc>
    <lastmod>2026-05-28T21:41:33.548Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dt-7012-cancer-malignant-solid-tumour-advanced-s-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:33.561Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tyrosyl-2-aminoisobutyryl-glutamyl-glycy-obesity-type-2-diabetes-phase-iii</loc>
    <lastmod>2026-05-28T21:41:33.574Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ax-5006-parkinson-s-disease-phase-i</loc>
    <lastmod>2026-05-28T21:41:33.588Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ublituximab-multiple-sclerosis-relapsing-multiple-sc-phase-ii</loc>
    <lastmod>2026-05-28T21:41:33.601Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/infigratinib-hypochondroplasia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:33.617Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/filgotinib-juvenile-idiopathic-arthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:33.634Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/advanced-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:41:33.647Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amphotericin-b-simple-pulmonary-aspergilloma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:33.661Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/decitabine-cedazuridine-acute-myeloid-leukemia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:33.673Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/angiotensin-ii-distributive-shock-refractory-hypotensio-phase-iii</loc>
    <lastmod>2026-05-28T21:41:33.687Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/donidalorsen-hereditary-angioedema-phase-iii</loc>
    <lastmod>2026-05-28T21:41:33.700Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/kpl-387-recurrent-pericarditis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:33.713Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/simeticone-potassium-chloride-sodium-chl-colorectal-cancer-colorectal-adenoma-phase-iv</loc>
    <lastmod>2026-05-28T21:41:33.726Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/12m-1s-2s-n-63s-4s-z-11-ethyl-12-2-s-1-m-resected-pancreatic-ductal-adenocarcinom-phase-iii</loc>
    <lastmod>2026-05-28T21:41:33.743Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anti-ly6e-exatecan-advanced-solid-tumors-non-small-cell-lun-phase-i</loc>
    <lastmod>2026-05-28T21:41:33.756Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-690517-heart-failure-cardiovascular-disease-chr-phase-iv</loc>
    <lastmod>2026-05-28T21:41:33.770Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tyrosyl-2-aminoisobutyryl-glutamyl-glycy-obesity-phase-iii</loc>
    <lastmod>2026-05-28T21:41:33.783Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/onfekafusp-alfa-cutaneous-squamous-cell-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:33.796Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/remdesivir-tick-borne-encephalitis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:33.809Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/yl201-advanced-solid-tumors-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:33.822Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/timolol-brimonidine-tartrate-ocular-hypertension-glaucoma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:33.836Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obinutuzumab-mantle-cell-lymphoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:33.849Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ezetimibe-pitavastatin-hypercholesterolemia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:33.862Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pumitamig-colorectal-cancer-metastatic-colorectal-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:33.875Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lidocaine-hydrochloride-coronary-artery-disease-cardiac-valve-di-phase-iv</loc>
    <lastmod>2026-05-28T21:41:33.889Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mrm-3379-fragile-x-syndrome-phase-ii</loc>
    <lastmod>2026-05-28T21:41:33.902Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/om336-end-stage-renal-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:33.915Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tyrosyl-2-aminoisobutyryl-glutamyl-glycy-obesity-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:33.927Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cntx-0066-knee-osteoarthritis-osteoarthritis-of-th-phase-iii</loc>
    <lastmod>2026-05-28T21:41:33.941Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/estradiol-diabetes-mellitus-perimenopause-early-po-phase-iv</loc>
    <lastmod>2026-05-28T21:41:33.953Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-3000202-systemic-lupus-erythematosus-phase-ii</loc>
    <lastmod>2026-05-28T21:41:33.967Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levonorgestrel-healthy-volunteers-phase-ii</loc>
    <lastmod>2026-05-28T21:41:33.980Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anhydrous-lidocaine-hydrochloride-colorectal-cancer-not-applicable</loc>
    <lastmod>2026-05-28T21:41:33.993Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/maribavir-cytomegalovirus-cmv-infection-phase-ii</loc>
    <lastmod>2026-05-28T21:41:34.006Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zanidatamab-her2-positive-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:34.019Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zenagamtide-heart-failure-with-preserved-ejection-fr-phase-iii</loc>
    <lastmod>2026-05-28T21:41:34.034Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nio752-progressive-supranuclear-palsy-richardso-phase-iii</loc>
    <lastmod>2026-05-28T21:41:34.047Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azetukalner-major-depressive-disorder-phase-iii</loc>
    <lastmod>2026-05-28T21:41:34.060Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aflibercept-neovascular-age-related-macular-degenera</loc>
    <lastmod>2026-05-28T21:41:34.074Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-systemic-sclerosis-diffuse-cutaneous-sys-phase-ii</loc>
    <lastmod>2026-05-28T21:41:34.087Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bosentan-healthy-volunteer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:34.100Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/caffeine-citrate-apnea-of-prematurity-not-applicable</loc>
    <lastmod>2026-05-28T21:41:34.113Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/odi-2001-vaccine-pancreatic-cancer-metastatic-or-locally-phase-i</loc>
    <lastmod>2026-05-28T21:41:34.127Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-241656-malignant-solid-tumor-ras-mapk-mutation-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:34.141Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/6qc-icg-breast-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:34.154Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-fibromyalgia</loc>
    <lastmod>2026-05-28T21:41:34.167Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/im-250-herpes-simplex-virus-encephalitis-herpes-phase-i</loc>
    <lastmod>2026-05-28T21:41:34.180Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pf-08634404-non-small-cell-lung-cancer-locally-advan-phase-iii</loc>
    <lastmod>2026-05-28T21:41:34.194Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-88545223-active-psoriatic-arthritis-psoriatic-art-phase-ii</loc>
    <lastmod>2026-05-28T21:41:34.207Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fulvestrant-hr-positive-her2-negative-metastatic-bre-phase-ii</loc>
    <lastmod>2026-05-28T21:41:34.221Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/onfekafusp-alfa-basal-cell-carcinoma-locally-advanced-ba-phase-ii</loc>
    <lastmod>2026-05-28T21:41:34.234Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bifikafusp-alfa-locally-advanced-basal-cell-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:34.247Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cenegermin-persistent-corneal-epithelial-defect-phase-iii</loc>
    <lastmod>2026-05-28T21:41:34.260Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bg-75098-advanced-solid-tumors-ovarian-cancer-tri-phase-i</loc>
    <lastmod>2026-05-28T21:41:34.274Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nintedanib-idiopathic-pulmonary-fibrosis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:34.287Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/advanced-solid-tumors-advanced-b-cell-ly-phase-i</loc>
    <lastmod>2026-05-28T21:41:34.300Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/psoriasis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:34.313Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pralsetinib-advanced-or-metastatic-solid-tumors-phase-iv</loc>
    <lastmod>2026-05-28T21:41:34.325Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2-methoxyestradiol-phase-iii</loc>
    <lastmod>2026-05-28T21:41:34.339Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fenfluramine-hydrochloride-rett-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:41:34.353Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mk-1045-systemic-lupus-erythematosus-rheumatoid-phase-iii</loc>
    <lastmod>2026-05-28T21:41:34.366Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bupropion-hydrochloride-seasonal-affective-disorder-major-depres-phase-ii</loc>
    <lastmod>2026-05-28T21:41:34.379Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/a-polycyclic-compound-having-nitrogen-co-respiratory-syncytial-virus-infection-phase-ii</loc>
    <lastmod>2026-05-28T21:41:34.392Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lfd-200-rheumatoid-arthritis-moderate-to-severe-phase-i</loc>
    <lastmod>2026-05-28T21:41:34.406Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/thiocolchicoside-diclofenac-potassium-low-back-pain-phase-iii</loc>
    <lastmod>2026-05-28T21:41:34.419Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/3-3as-6ar-5-5-chloro-2-1-methyl-1h-pyraz-prurigo-nodularis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:34.432Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexmedetomidine-breast-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:41:34.446Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lb-208-relapsed-or-refractory-acute-myeloid-leu-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:34.458Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-plasma-haemorrhagic-shock-not-applicable</loc>
    <lastmod>2026-05-28T21:41:34.471Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atrial-fibrillation-coronary-artery-dise</loc>
    <lastmod>2026-05-28T21:41:34.486Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ketamine-hydrochloride-acute-respiratory-failure-requiring-unpl-phase-ii</loc>
    <lastmod>2026-05-28T21:41:34.498Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tirabrutinib-primary-central-nervous-system-lymphoma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:34.511Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bbt002-chronic-obstructive-pulmonary-disease-ch-phase-i</loc>
    <lastmod>2026-05-28T21:41:34.524Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/canagliflozin-acute-myocardial-infarction-diabetes-mel-phase-iii</loc>
    <lastmod>2026-05-28T21:41:34.538Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-adipocyte-derived-mesenchymal-acute-graft-versus-host-disease-agvhd-st-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:34.551Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zinc-wilson-s-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:41:34.565Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-dendritic-cells-loaded-with-a-borderline-resectable-pancreatic-cancer-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:34.578Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-sodium-phosphate-nepafenac-postoperative-inflammation-after-catarac-phase-iii</loc>
    <lastmod>2026-05-28T21:41:34.592Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anifrolumab-cutaneous-lupus-erythematosus-phase-iv-ctis-2025-523133-26</loc>
    <lastmod>2026-05-28T21:12:20.306Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-dexamethasone-sodium-phosp-postoperative-pain-rebound-pain-after-re-not-applicable</loc>
    <lastmod>2026-05-28T21:41:34.605Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/orforglipron-hemicalcium-chronic-kidney-disease-atherosclerotic-c-phase-iii</loc>
    <lastmod>2026-05-28T21:41:34.619Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/morphine-sulfate-postoperative-pain-following-major-lapar</loc>
    <lastmod>2026-05-28T21:41:34.632Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cefuroxime-diverticular-disease-acute-uncomplicated-not-applicable</loc>
    <lastmod>2026-05-28T21:41:34.646Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mesenchymal-stromal-cells-ex-vivo-cultur-acute-graft-versus-host-disease-agvhd-re-phase-ii</loc>
    <lastmod>2026-05-28T21:41:34.659Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ciprofloxacin-hydrochloride-ciprofloxaci-graft-pyelonephritis-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:34.672Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-type-2-diabetes-not-applicable</loc>
    <lastmod>2026-05-28T21:41:34.685Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dermatophagoides-pteronyssinus-extract-allergic-rhinitis-due-to-house-dust-mite-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:34.698Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/km04-functional-female-infertility-female-inf-phase-ii</loc>
    <lastmod>2026-05-28T21:41:34.712Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belantamab-mafodotin-relapsed-or-refractory-multiple-myeloma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:34.725Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/drospirenone-estetrol-contraception-not-applicable</loc>
    <lastmod>2026-05-28T21:41:34.739Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ckd-706-atopic-dermatitis-asthma-chronic-rhinosi-phase-i</loc>
    <lastmod>2026-05-28T21:41:34.754Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/drospirenone-estetrol-polycystic-ovary-syndrome-contraception-not-applicable</loc>
    <lastmod>2026-05-28T21:41:34.767Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bal2420-gram-negative-bacterial-infection-phase-i</loc>
    <lastmod>2026-05-28T21:41:34.780Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ql0911-immune-thrombocytopenia-hematopoietic-sy-phase-i</loc>
    <lastmod>2026-05-28T21:41:34.793Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hydrocortisone-post-traumatic-stress-disorder-ptsd-phase-ii</loc>
    <lastmod>2026-05-28T21:41:34.807Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-2-3-cyano-5-fluorophenyl-2-methyl-1-ox-obesity-overweight-type-2-diabetes-phase-iii</loc>
    <lastmod>2026-05-28T21:41:34.820Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methoxyflurane-99-9-acute-myocardial-infarction-phase-iii</loc>
    <lastmod>2026-05-28T21:41:34.834Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gen3018-relapsed-or-refractory-acute-myeloid-leu-phase-i</loc>
    <lastmod>2026-05-28T21:41:34.847Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/upadacitinib-atopic-dermatitis-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:34.860Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mirikizumab-crohn-s-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:41:34.874Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lad603-alopecia-areata-phase-ii</loc>
    <lastmod>2026-05-28T21:41:34.887Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-2-3-cyano-5-fluorophenyl-2-methyl-1-ox-obesity-overweight-phase-iii</loc>
    <lastmod>2026-05-28T21:41:34.900Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glioma-glioblastoma-multiforme-phase-iii</loc>
    <lastmod>2026-05-28T21:41:34.914Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/melphalan-metastatic-breast-cancer-liver-dominant-phase-ii</loc>
    <lastmod>2026-05-28T21:41:34.927Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fludarabine-phosphate-b-cell-acute-lymphoblastic-leukemia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:34.940Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenadogene-nolparvovec-leber-hereditary-optic-neuropathy-nd4-mu-phase-ii</loc>
    <lastmod>2026-05-28T21:41:34.953Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/relapsed-and-refractory-acute-myeloid-le</loc>
    <lastmod>2026-05-28T21:41:34.966Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-butyrate-hirschsprung-s-disease-congenital-megaco-phase-iii</loc>
    <lastmod>2026-05-28T21:41:34.979Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lad106-inflammatory-diseases-phase-i</loc>
    <lastmod>2026-05-28T21:41:34.992Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gb-0895-severe-uncontrolled-asthma-asthma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:35.006Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zanubrutinib-peripheral-anti-mag-neuropathy-waldenstr-phase-ii</loc>
    <lastmod>2026-05-28T21:41:35.024Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obinutuzumab-idiopathic-nephrotic-syndrome-phase-iv</loc>
    <lastmod>2026-05-28T21:41:35.037Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/brimonidine-tartrate-myopia-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:35.051Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/advanced-solid-tumors-phase-i-2</loc>
    <lastmod>2026-05-28T21:41:35.064Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nnc1679-0001-type-2-diabetes-phase-i</loc>
    <lastmod>2026-05-28T21:41:35.077Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ax-0810-cholestatic-liver-disease-phase-i</loc>
    <lastmod>2026-05-28T21:41:35.091Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tln-372-kras-mutant-advanced-or-metastatic-solid-phase-i</loc>
    <lastmod>2026-05-28T21:41:35.104Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bay-3620122-vasodilatory-shock-phase-i</loc>
    <lastmod>2026-05-28T21:41:35.117Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/advanced-metastatic-pancreatic-adenocarc-phase-iii</loc>
    <lastmod>2026-05-28T21:41:35.130Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rilvegostomig-biliary-tract-cancer-cholangiocarcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:35.143Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-95566692-non-hodgkin-lymphoma-diffuse-large-b-cel-phase-i</loc>
    <lastmod>2026-05-28T21:41:35.156Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/angiotensin-ii-liver-cancer-primary-or-secondary-phase-ii</loc>
    <lastmod>2026-05-28T21:41:35.169Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rly-2608-pik3ca-mutated-hormone-receptor-positive-phase-iii</loc>
    <lastmod>2026-05-28T21:41:35.184Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sonlicromanol-hydrochloride-long-covid-phase-ii</loc>
    <lastmod>2026-05-28T21:41:35.197Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lonapegsomatropin-turner-syndrome-idiopathic-short-stature-phase-iii</loc>
    <lastmod>2026-05-28T21:41:35.210Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acp-204-tartrate-lewy-body-dementia-psychosis-dementia-wi-phase-ii</loc>
    <lastmod>2026-05-28T21:41:35.223Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-valproate-adenomyosis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:35.236Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/olea-europaea-pollen-depigmented-polymer-allergic-rhinoconjunctivitis-asthma</loc>
    <lastmod>2026-05-28T21:41:35.249Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/finerenone-chronic-kidney-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:41:35.262Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ropivacaine-hydrochloride-knee-osteoarthritis-not-applicable</loc>
    <lastmod>2026-05-28T21:41:35.275Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/osimertinib-non-small-cell-lung-cancer-egfr-mutated-phase-ii</loc>
    <lastmod>2026-05-28T21:41:35.289Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylsalicylic-acid-non-cardioembolic-ischemic-stroke-ischae-phase-iv</loc>
    <lastmod>2026-05-28T21:41:35.302Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/6-thio-alfa-d-glucopyranosyl-6-thio-alfa-chronic-obstructive-pulmonary-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:35.315Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trospium-chloride-xanomeline-tartrate-schizophrenia-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:35.329Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ipilimumab-head-and-neck-squamous-cell-carcinoma-or-phase-iii</loc>
    <lastmod>2026-05-28T21:41:35.343Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/flumazenil-major-depressive-disorder-bipolar-depres-not-applicable</loc>
    <lastmod>2026-05-28T21:41:35.357Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/im-101-generalized-myasthenia-gravis-ocular-mya-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:35.370Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/asp5834-advanced-unresectable-or-metastatic-soli-phase-i</loc>
    <lastmod>2026-05-28T21:41:35.383Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ropivacaine-hydrochloride-hip-osteoarthritis-postoperative-pain-phase-iv</loc>
    <lastmod>2026-05-28T21:41:35.396Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd1163-rheumatoid-arthritis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:35.410Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/flutemetamol-18f-post-covid-syndrome-long-covid-not-applicable</loc>
    <lastmod>2026-05-28T21:41:35.423Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rilzabrutinib-immune-thrombocytopenia-itp-autoimmune-t-phase-iii</loc>
    <lastmod>2026-05-28T21:41:35.436Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ublituximab-relapsing-multiple-sclerosis-phase-ii-phase-iii</loc>
    <lastmod>2026-05-28T21:41:35.450Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ciltacabtagene-autoleucel-newly-diagnosed-multiple-myeloma-multipl-phase-ii</loc>
    <lastmod>2026-05-28T21:41:35.463Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mk-7228-atherosclerosis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:35.477Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bcx17725-netherton-syndrome-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:35.491Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sotatercept-pulmonary-arterial-hypertension-phase-iii</loc>
    <lastmod>2026-05-28T21:41:35.504Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tenofovir-alafenamide-multiple-sclerosis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:35.517Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ds9051b-adrenocortical-carcinoma-metastatic-cast-phase-i</loc>
    <lastmod>2026-05-28T21:41:35.530Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vga039-von-willebrand-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:41:35.543Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/luxdegalutamide-metastatic-castration-resistant-prostate-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:35.556Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-papillomavirus-type-31-l1-protein-human-papillomavirus-infection-phase-iv</loc>
    <lastmod>2026-05-28T21:41:35.570Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-viable-wharton-s-jelly-derive-traumatic-spinal-cord-injury-phase-i</loc>
    <lastmod>2026-05-28T21:41:35.583Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/blinatumomab-acute-lymphoblastic-leukaemia-all-cd19-p-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:35.596Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gilteritinib-acute-myeloid-leukaemia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:35.609Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ascorbic-acid-sodium-ascorbate-potassium-colonic-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:41:35.622Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tulmimetostat-metastatic-hormone-sensitive-prostate-ca-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:35.636Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly3537031-liver-impairment-hepatic-insufficiency-h-phase-iii</loc>
    <lastmod>2026-05-28T21:41:35.649Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/blinatumomab-granulomatosis-with-polyangiitis-systemi-phase-ii</loc>
    <lastmod>2026-05-28T21:41:35.663Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nbi-1117570-schizophrenia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:35.676Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aprepitant-skin-toxicities-associated-with-epiderma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:35.690Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/idor-1117-2520c-chronic-plaque-psoriasis-moderate-to-sev-phase-ii</loc>
    <lastmod>2026-05-28T21:41:35.703Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/spy072-rheumatoid-arthritis-psoriatic-arthritis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:35.716Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/r2r01-cardiac-surgery-associated-acute-kidney-phase-ii</loc>
    <lastmod>2026-05-28T21:41:35.730Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/4-iodophenylalanine-i-131-glioblastoma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:35.743Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-chronic-kidney-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:41:35.756Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regn7041-non-infectious-uveitis-posterior-segment-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:35.770Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ferrous-sulfate-iron-deficiency-phase-iv</loc>
    <lastmod>2026-05-28T21:41:35.783Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/kras-altered-advanced-or-metastatic-soli-phase-i</loc>
    <lastmod>2026-05-28T21:41:35.796Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/empasiprubart-achr-ab-seropositive-generalized-myasthe-phase-ii</loc>
    <lastmod>2026-05-28T21:41:35.809Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tarperprumig-anca-associated-vasculitis-granulomatosi-phase-ii</loc>
    <lastmod>2026-05-28T21:41:35.822Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/brexanolone-caprilcerbate-major-depressive-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:41:35.835Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dfc413-labelled-with-lutetium-177-colorectal-cancer-pancreatic-ductal-aden-phase-i</loc>
    <lastmod>2026-05-28T21:41:35.848Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carboplatin-epithelial-ovarian-cancer-fallopian-tube-phase-ii</loc>
    <lastmod>2026-05-28T21:41:35.863Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/darbepoetin-alfa-candidates-for-liver-transplantation-chr-phase-iv</loc>
    <lastmod>2026-05-28T21:41:35.876Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly4170156-fallopian-tube-cancer-peritoneal-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:35.889Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/arachis-hypogaea-extract-peanut-allergy-phase-iii</loc>
    <lastmod>2026-05-28T21:41:35.902Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vvd-159642-ras-pi3k-inhibitor-advanced-solid-tumors-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:35.916Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mezagitamab-chronic-primary-immune-thrombocytopenia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:35.929Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-606001-late-onset-pompe-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:35.943Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cycloserine-major-depressive-disorder-mdd-major-depr-phase-iv</loc>
    <lastmod>2026-05-28T21:41:35.956Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutetium-177lu-vipivotide-tetraxetan-metastatic-hormone-sensitive-prostate-ca-phase-iii</loc>
    <lastmod>2026-05-28T21:41:35.969Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pneumococcal-polysaccharide-serotype-1-c-pneumococcal-infection-phase-iv</loc>
    <lastmod>2026-05-28T21:41:35.982Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levobupivacaine-labour-epidural-analgesia-phase-iv</loc>
    <lastmod>2026-05-28T21:41:35.995Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tk-6302-advanced-prame-positive-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:41:36.008Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adenosine-st-elevation-myocardial-infarction-stemi-phase-iv</loc>
    <lastmod>2026-05-28T21:41:36.023Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-2-2-10-2-4-3-4-2-2-cyano-4-4-difluor-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:36.036Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cisplatin-non-small-cell-lung-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:41:36.049Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isosorbide-5-mononitrate-normal-tension-glaucoma</loc>
    <lastmod>2026-05-28T21:41:36.062Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/midrix-lung-002-metastatic-non-small-cell-lung-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:36.075Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cetuximab-sarotalocan-recurrent-squamous-cell-carcinoma-of-the-phase-iii</loc>
    <lastmod>2026-05-28T21:41:36.089Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-oxybate-sleep-disturbance-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:36.102Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/verve-201-refractory-hyperlipidemia-phase-i</loc>
    <lastmod>2026-05-28T21:41:36.115Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/propofol-neurocritical-illness-phase-iv</loc>
    <lastmod>2026-05-28T21:41:36.128Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bnt329-advanced-solid-tumours-pancreatic-adenoc-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:36.141Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/benzydamine-hydrochloride-non-streptococcal-pharyngotonsillitis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:36.154Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cefadroxil-staphylococcus-aureus-bacteremia-phase-iv</loc>
    <lastmod>2026-05-28T21:41:36.167Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dermatophagoides-pteronyssinus-dermatoph-allergic-rhinitis-rhinoconjunctivitis-du-phase-ii</loc>
    <lastmod>2026-05-28T21:41:36.180Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cilostazol-migraine-migraine-without-aura-episodic-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:36.194Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mk-4716-non-small-cell-lung-cancer-advanced-or-m</loc>
    <lastmod>2026-05-28T21:41:36.207Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atacicept-iga-nephropathy-igan-berger-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:36.220Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-type-2-diabetes-mellitus-cardiovascular-not-applicable</loc>
    <lastmod>2026-05-28T21:41:36.233Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/baxdrostat-chronic-kidney-disease-hypertension-phase-ii</loc>
    <lastmod>2026-05-28T21:41:36.246Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-tirumotecan-metastatic-cervical-cancer-pd-l1-cps-1-phase-iii</loc>
    <lastmod>2026-05-28T21:41:36.259Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pyridoxal-phosphate-pyridox-am-ine-5-phosphate-oxidase-pnpo-phase-iii</loc>
    <lastmod>2026-05-28T21:41:36.275Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/safinamide-parkinson-s-disease-with-motor-fluctuati-phase-iii</loc>
    <lastmod>2026-05-28T21:41:36.289Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/risankizumab-psoriatic-arthritis-crohn-s-disease-plaq-phase-i</loc>
    <lastmod>2026-05-28T21:41:36.301Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2-4-4-aminomethyl-1-oxo-2h-phthalazin-6-metastatic-non-small-cell-lung-cancer-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:36.315Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/a-dopamine-parkinson-s-disease</loc>
    <lastmod>2026-05-28T21:41:36.329Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/donepezil-hydrochloride-acne-vulgaris-phase-ii</loc>
    <lastmod>2026-05-28T21:41:36.342Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ritlecitinib-vitiligo-phase-iv</loc>
    <lastmod>2026-05-28T21:41:36.354Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-urothelial-carcinoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:36.367Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gd2il18cart-neuroblastoma-osteosarcoma-ewing-sarcoma-phase-i</loc>
    <lastmod>2026-05-28T21:41:36.380Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ipn60300-advanced-or-metastatic-solid-tumours-mal-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:36.394Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/enlicitide-chloride-hyperlipidemia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:36.407Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/deucrictibant-acquired-angioedema-due-to-c1-inhibitor-phase-iii</loc>
    <lastmod>2026-05-28T21:41:36.420Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-acute-myocardial-infarction-phase-iv</loc>
    <lastmod>2026-05-28T21:41:36.434Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sugammadex-non-cardiac-surgical-procedure-requiring-phase-iv</loc>
    <lastmod>2026-05-28T21:41:36.447Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anakinra-acute-myocarditis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:36.460Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/temozolomide-metastatic-colorectal-cancer-colorectal-phase-ii</loc>
    <lastmod>2026-05-28T21:41:36.473Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/severe-gram-negative-bacterial-infection</loc>
    <lastmod>2026-05-28T21:41:36.486Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-igg1-monoclonal-antibody-against-i-hidradenitis-suppurativa-moderate-to-sev-phase-ii</loc>
    <lastmod>2026-05-28T21:41:36.499Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd0292-bronchiectasis-with-chronic-pseudomonas-phase-ii</loc>
    <lastmod>2026-05-28T21:41:36.513Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prasinezumab-parkinson-s-disease-early-stage-parkinso-phase-iii</loc>
    <lastmod>2026-05-28T21:41:36.526Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amo959-psma-positive-metastatic-castration-resi-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:36.539Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/melpida-hereditary-spastic-paraplegia-type-50-sp-phase-ii</loc>
    <lastmod>2026-05-28T21:41:36.552Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/remimazolam-gastric-cancer-pancreatic-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:41:36.565Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gskvx000000034798-gskvx000000048110-gskv-influenza-human-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:36.578Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adx-038-geographic-atrophy-secondary-to-age-rela-phase-ii</loc>
    <lastmod>2026-05-28T21:41:36.592Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tenecteplase-acute-ischemic-stroke-phase-iii</loc>
    <lastmod>2026-05-28T21:41:36.605Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abemaciclib-hormone-receptor-positive-her2-negative-not-applicable</loc>
    <lastmod>2026-05-28T21:41:36.620Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levosimendan-pulmonary-hypertension-heart-failure-wit-phase-iii</loc>
    <lastmod>2026-05-28T21:41:36.633Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/calcifediol-pulmonary-arterial-hypertension-phase-iv</loc>
    <lastmod>2026-05-28T21:41:36.646Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/izalontamab-brengitecan-metastatic-urothelial-cancer-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:36.660Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/psilocybine-major-depressive-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:41:36.673Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/propylene-glycol-atopic-dermatitis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:36.686Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tamoxifen-breast-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:36.699Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rilvegostomig-advanced-solid-tumors-phase-iii</loc>
    <lastmod>2026-05-28T21:41:36.712Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isoniazid-rifampicin-pulmonary-tuberculosis-community-acquire-phase-iv</loc>
    <lastmod>2026-05-28T21:41:36.725Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dns-6288-catecholaminergic-polymorphic-ventricula-phase-ii</loc>
    <lastmod>2026-05-28T21:41:36.738Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ezetimibe-obicetrapib-type-2-diabetes-metabolic-syndrome-eleva-phase-iii</loc>
    <lastmod>2026-05-28T21:41:36.751Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mirvetuximab-soravtansine-ovarian-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:36.764Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/de-oiled-enriched-phospholipids-from-soy-metabolic-dysfunction-associated-steatot-phase-iii</loc>
    <lastmod>2026-05-28T21:41:36.777Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/propofol-rapid-sequence-induction-phase-ii</loc>
    <lastmod>2026-05-28T21:41:36.791Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sufentanil-acute-procedural-pain-oocyte-retrieval-not-applicable</loc>
    <lastmod>2026-05-28T21:41:36.804Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tuberculosis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:36.816Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inavolisib-endocrine-resistant-hormone-receptor-pos-phase-ii</loc>
    <lastmod>2026-05-28T21:41:36.830Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/candesartan-episodic-cluster-headache-phase-iii</loc>
    <lastmod>2026-05-28T21:41:36.843Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azetukalner-bipolar-depression-phase-iii</loc>
    <lastmod>2026-05-28T21:41:36.856Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ectonucleotide-pyrophosphatase-phosphodi-advanced-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:41:36.869Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aganirsen-corneal-neovascularization-in-aniridia-a-phase-ii</loc>
    <lastmod>2026-05-28T21:41:36.882Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/remifentanil-hydrochloride-tracheal-intubation-during-general-anaes-not-applicable</loc>
    <lastmod>2026-05-28T21:41:36.895Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/senicapoc-glioblastoma-malignant-glioma-glioblasto-phase-iii</loc>
    <lastmod>2026-05-28T21:41:36.908Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ro7204239-type-2-diabetes-mellitus-overweight-obes-phase-iii</loc>
    <lastmod>2026-05-28T21:41:36.921Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nucresiran-hereditary-transthyretin-mediated-amyloi-phase-iii</loc>
    <lastmod>2026-05-28T21:41:36.934Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colchicine-type-1-diabetes-not-applicable</loc>
    <lastmod>2026-05-28T21:41:36.948Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sp16-3m-chronic-kidney-disease-valvular-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:36.961Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autx-703-acute-myeloid-leukaemia-relapsed-refract-phase-i</loc>
    <lastmod>2026-05-28T21:41:36.974Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/surovatamig-human-igg4-kappa-monoclonal-large-b-cell-lymphoma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:36.989Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elacestrant-estrogen-receptor-positive-her2-negative-phase-iii</loc>
    <lastmod>2026-05-28T21:41:37.002Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nnc0487-0111-obesity-phase-iii</loc>
    <lastmod>2026-05-28T21:41:37.015Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-hiv-1-infection-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.028Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lebrikizumab-nummular-dermatitis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:37.041Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cervical-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:37.062Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-igg1-monoclonal-antibody-against-t-asthma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.081Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mirikizumab-ulcerative-colitis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.095Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/doravirine-west-nile-virus-infection-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.108Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/revumenib-acute-myeloid-leukemia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.122Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cladribine-healthy-volunteers-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.136Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cagrilintide-obesity-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.149Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/staphylococcus-aureus-bacteraemia-methic-phase-iv</loc>
    <lastmod>2026-05-28T21:41:37.162Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/epoetin-alfa-anemia-of-chronic-kidney-disease-renal-a-phase-iii</loc>
    <lastmod>2026-05-28T21:41:37.175Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mtx-463-idiopathic-pulmonary-fibrosis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.190Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/icotrokinra-icotrokinra-moderately-to-severely-active-crohn-s-di-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:37.203Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/indocyanine-green-solid-neoplasms-of-the-digestive-system-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:37.216Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/epoetin-alfa-renal-anaemia-anaemia-of-chronic-kidney-phase-iii</loc>
    <lastmod>2026-05-28T21:41:37.229Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ap31969-sulfate-atrial-fibrillation-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.242Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-propanediol-diffuse-large-b-cell-lymphoma-follicular-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.255Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amoxicillin-trihydrate-non-st-elevation-myocardial-infarction-s</loc>
    <lastmod>2026-05-28T21:41:37.268Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ivonescimab-recurrent-and-or-metastatic-squamous-cel-phase-iii</loc>
    <lastmod>2026-05-28T21:41:37.281Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/enoxaparin-sodium-venous-malformation-low-flow-venous-lymp-phase-iii</loc>
    <lastmod>2026-05-28T21:41:37.294Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/upadacitinib-erosive-mucosal-lichen-planus-lichen-pla-phase-iv</loc>
    <lastmod>2026-05-28T21:41:37.307Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ropivacaine-hydrochloride-postoperative-pain-after-cardiac-surgery-phase-iv</loc>
    <lastmod>2026-05-28T21:41:37.320Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-690517-type-2-diabetes-hypertension-cardiovascu-phase-iii</loc>
    <lastmod>2026-05-28T21:41:37.333Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-selenite-pentahydrate-advanced-carcinoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:37.346Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-3810944-melanoma-solid-tumours-phase-i</loc>
    <lastmod>2026-05-28T21:41:37.359Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amoxicillin-edentulism-phase-iv</loc>
    <lastmod>2026-05-28T21:41:37.372Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/kayvirus-dsm-33474-kayvirus-dsm-33473-pb-complicated-skin-wounds-infected-wounds-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.385Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ltx-002-sodium-amyotrophic-lateral-sclerosis-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:37.397Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apixaban-chronic-subdural-hematoma-atrial-fibrill-not-applicable</loc>
    <lastmod>2026-05-28T21:41:37.410Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2-4-4-aminomethyl-1-oxo-2h-phthalazin-6-metastatic-pancreatic-ductal-adenocarcin-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:37.424Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belumosudil-mesilate-chronic-graft-versus-host-disease-steroi-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.438Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alg-000184-chronic-hepatitis-b-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.451Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/esketamine-hydrochloride-oral-mucositis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:37.464Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fitusiran-hemophilia-a-hemophilia-b-phase-iii</loc>
    <lastmod>2026-05-28T21:41:37.477Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ttx-381-neuronal-ceroid-lipofuscinosis-type-2-cl-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:37.490Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tuvatexib-actinic-keratosis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.503Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/axatilimab-chronic-graft-versus-host-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.516Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/advanced-solid-tumors-phase-i-3</loc>
    <lastmod>2026-05-28T21:41:37.529Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sonelokimab-psoriatic-arthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:37.542Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/relugolix-prostate-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.555Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/losartan-potassium-hydrochlorothiazide-non-ischemic-cardiomyopathy</loc>
    <lastmod>2026-05-28T21:41:37.568Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nelarabine-lung-cancer-not-applicable</loc>
    <lastmod>2026-05-28T21:41:37.581Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cycloserine-major-depressive-disorder-phase-iv</loc>
    <lastmod>2026-05-28T21:41:37.594Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zipalertinib-non-small-cell-lung-cancer-uncommon-egfr-phase-iii</loc>
    <lastmod>2026-05-28T21:41:37.607Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-2-2-10-2-4-3-4-2-2-cyano-4-4-difluor-graves-orbitopathy-graves-ophthalmopathy-not-applicable</loc>
    <lastmod>2026-05-28T21:41:37.621Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/kup-101a-advanced-solid-tumours-cutaneous-melanom-phase-i</loc>
    <lastmod>2026-05-28T21:41:37.634Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ivonescimab-metastatic-colorectal-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:37.647Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lidocaine-hydrochloride-acute-postoperative-pain-following-breas-phase-iv</loc>
    <lastmod>2026-05-28T21:41:37.660Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/donanemab-alzheimer-s-disease-dementia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:37.673Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/8-ethoxy-n-3r-4s-3-methyl-1-methylsulfon-ovarian-cancer-platinum-resistant-ovaria-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.686Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/activin-signaling-inhibitor-specific-act-pulmonary-arterial-hypertension-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:41:37.699Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-localized-melanoma-resectable-stage-iii-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.712Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly3437943-sodium-metabolic-dysfunction-associated-steatot-phase-iii</loc>
    <lastmod>2026-05-28T21:41:37.726Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/leriglitazone-adrenoleukodystrophy-phase-i</loc>
    <lastmod>2026-05-28T21:41:37.740Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-2s-3r-4-4-difluoro-1-2-hydroxy-2-methy-narcolepsy-type-1-narcolepsy-with-catapl-phase-iii</loc>
    <lastmod>2026-05-28T21:41:37.753Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ds-3790a-hematological-malignancies-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:37.768Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mitazalimab-oral-potentially-malignant-disorder-oral-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.780Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/epinephrine-chronic-spontaneous-urticaria-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.794Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/toripalimab-nasopharyngeal-carcinoma-recurrent-metas-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.807Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-2s-4-4-methyl-1h-imidazol-5-yl-methyl-cutaneous-t-cell-lymphoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.820Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bisoprolol-pericarditis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:37.834Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nurandociguat-chronic-kidney-disease-arterial-hyperten-phase-iii</loc>
    <lastmod>2026-05-28T21:41:37.847Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amphotericin-b-chronic-pulmonary-aspergillosis-phase-ii-phase-iii</loc>
    <lastmod>2026-05-28T21:41:37.860Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/surlorian-autosomal-dominant-ryr1-related-myopathy-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.874Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd4144-sepsis-associated-acute-kidney-injury-ak-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.887Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mesalamine-ulcerative-colitis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.900Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-autoimmune-premature-ovarian-insufficien</loc>
    <lastmod>2026-05-28T21:41:37.914Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gtx-b001-cold-induced-urticaria-chronic-inducible-phase-i</loc>
    <lastmod>2026-05-28T21:41:37.927Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nnc0487-0111-type-2-diabetes-phase-iii</loc>
    <lastmod>2026-05-28T21:41:37.940Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/toldc-multiple-sclerosis-progressive-multiple-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.954Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aj1-11095-ajx-101-myelofibrosis-phase-i</loc>
    <lastmod>2026-05-28T21:41:37.967Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cancer-eligible-for-second-line-treatmen-phase-i</loc>
    <lastmod>2026-05-28T21:41:37.981Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mk-1084-non-squamous-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:37.994Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nefopam-hydrochloride-acute-rheumatological-pain-acute-musculo-phase-ii</loc>
    <lastmod>2026-05-28T21:41:38.008Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gsk5458514-metastatic-castration-resistant-prostate-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:38.021Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atorvastatin-bile-acid-diarrhoea-phase-ii</loc>
    <lastmod>2026-05-28T21:41:38.035Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trospium-chloride-xanomeline-tartrate-bipolar-i-disorder-mania-phase-iii</loc>
    <lastmod>2026-05-28T21:41:38.048Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rimegepant-migraine-phase-iv</loc>
    <lastmod>2026-05-28T21:41:38.062Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levodopa-carbidopa-monohydrate-parkinson-s-disease-motor-fluctuations-i-phase-iii</loc>
    <lastmod>2026-05-28T21:41:38.075Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tuvusertib-astrocytoma-idh1-2-mutant-atrx-mutant-p5-phase-ii</loc>
    <lastmod>2026-05-28T21:41:38.088Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tamoxifen-breast-cancer-not-applicable</loc>
    <lastmod>2026-05-28T21:41:38.102Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cit-013-hidradenitis-suppurativa-phase-ii</loc>
    <lastmod>2026-05-28T21:41:38.115Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cdr132l-heart-failure-phase-ii</loc>
    <lastmod>2026-05-28T21:41:38.128Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/benzydamine-hydrochloride-2-4-dichlorobe-acute-pharyngitis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:38.142Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ursodeoxycholic-acid-immune-checkpoint-inhibitor-induced-chol</loc>
    <lastmod>2026-05-28T21:41:38.155Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/orphenadrine-citrate-paracetamol-diclofe-low-back-pain-phase-iii</loc>
    <lastmod>2026-05-28T21:41:38.169Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gaxilose-hypolactasia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:38.183Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/idarubicin-hydrochloride-cancer-patients-receiving-anthracycline-phase-iv</loc>
    <lastmod>2026-05-28T21:41:38.196Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/chikungunya-virus-strain-chikv-lr2006-op-chikungunya-phase-iv</loc>
    <lastmod>2026-05-28T21:41:38.215Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ropivacaine-hydrochloride-lumbar-fusion-lumbar-arthrodesis-not-applicable</loc>
    <lastmod>2026-05-28T21:41:38.229Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2s-2-cyclopentyl-2-5s-2-2r-3r-3-cyclopro-non-small-cell-lung-cancer-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:38.242Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tafasitamab-immune-thrombocytopenia-itp-autoimmune-h-phase-ii</loc>
    <lastmod>2026-05-28T21:41:38.255Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/treprostinil-palmitil-pulmonary-hypertension-associated-with-i-phase-iii</loc>
    <lastmod>2026-05-28T21:41:38.268Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/brivekimig-hidradenitis-suppurativa-phase-ii</loc>
    <lastmod>2026-05-28T21:41:38.283Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glycopyrronium-bromide-formoterol-fumara-asthma-mild-to-moderate-asthma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:38.298Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ruxolitinib-advanced-solid-tumors-metastatic-clear-c-phase-iii</loc>
    <lastmod>2026-05-28T21:41:38.312Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avx37-102-therapeutic-hepatitis-b-virus-hepatitis-b-chronic-hepatitis-b-phase-i</loc>
    <lastmod>2026-05-28T21:41:38.326Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tucatinib-breast-cancer-non-small-cell-lung-carcin-phase-iii</loc>
    <lastmod>2026-05-28T21:41:38.340Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cannabidiol-severe-neurodevelopmental-disorders-self-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:38.353Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imeroprubart-graves-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:38.367Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mk-4646-hiv-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:41:38.380Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rezafungin-acetate-intra-abdominal-candidiasis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:38.394Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-propanediol-monohydrate-chronic-decompensated-heart-failure-not-applicable</loc>
    <lastmod>2026-05-28T21:41:38.407Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/guselkumab-pouchitis-chronic-pouchitis-relapsing-or-phase-iv</loc>
    <lastmod>2026-05-28T21:41:38.423Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mezigdomide-relapsed-refractory-multiple-myeloma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:38.436Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/irinotecan-hydrochloride-trihydrate-gastric-cancer-with-peritoneal-metastase-phase-ii</loc>
    <lastmod>2026-05-28T21:41:38.449Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nx-5948-chronic-lymphocytic-leukemia-relapsed-re-phase-ii</loc>
    <lastmod>2026-05-28T21:41:38.464Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-metastatic-colorectal-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:38.477Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bempedoic-acid-rheumatoid-arthritis-psoriatic-arthritis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:38.491Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ropivacaine-hydrochloride-urolithiasis-not-applicable</loc>
    <lastmod>2026-05-28T21:41:38.505Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/midazolam-hydrochloride-terminal-illness-requiring-palliative-ca-phase-iv</loc>
    <lastmod>2026-05-28T21:41:38.518Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/axial-spondyloarthritis-phase-i</loc>
    <lastmod>2026-05-28T21:41:38.531Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tulisokibart-ankylosing-spondylitis-radiographic-axia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:38.545Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ziftomenib-acute-myeloid-leukemia-npm1-mutated-acut-phase-iii</loc>
    <lastmod>2026-05-28T21:41:38.559Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-4-fluorophenyl-n-4-7-methoxy-6-methylc-neuroendocrine-tumours-pancreatic-neuroe-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:38.574Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ep102-advanced-solid-tumours-phase-i</loc>
    <lastmod>2026-05-28T21:41:38.588Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/itepekimab-chronic-rhinosinusitis-with-nasal-polyps</loc>
    <lastmod>2026-05-28T21:41:38.602Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/immunostem-type-1-diabetes-mellitus-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:38.617Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ferric-carboxymaltose-pulmonary-hypertension-iron-deficiency-phase-iv</loc>
    <lastmod>2026-05-28T21:41:38.630Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/teriparatide-osteoporotic-vertebral-fractures-osteopo-phase-iv</loc>
    <lastmod>2026-05-28T21:41:38.643Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/canagliflozin-chronic-kidney-disease-stage-5-chronic-k-not-applicable</loc>
    <lastmod>2026-05-28T21:41:38.656Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd3632-acute-myeloid-leukaemia-acute-lymphoblas-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:38.669Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2s-5s-5-4-amino-5-4-2-3-difluorophenoxy-relapsed-refractory-chronic-lymphocytic-phase-iii</loc>
    <lastmod>2026-05-28T21:41:38.682Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly4256984-sporadic-amyotrophic-lateral-sclerosis-a-phase-i</loc>
    <lastmod>2026-05-28T21:41:38.695Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/influenza-a-astrakhan-3212-2020-h5n8-lik-influenza-a-h5n8-influenza-a-h5n1-phase-iv</loc>
    <lastmod>2026-05-28T21:41:38.708Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gaxilose-lactose-intolerance-phase-iv</loc>
    <lastmod>2026-05-28T21:41:38.721Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/indocyanine-green-symptomatic-cholelithiasis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:38.734Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lad191-hidradenitis-suppurativa-phase-ii</loc>
    <lastmod>2026-05-28T21:41:38.747Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lidocaine-hydrochloride-postanesthetic-complications-following-o-phase-iv</loc>
    <lastmod>2026-05-28T21:41:38.761Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/botulinum-toxin-type-a-dystrophic-scar-post-sternotomy-scarring-not-applicable</loc>
    <lastmod>2026-05-28T21:41:38.774Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nitroglycerin-chronic-kidney-disease-coronary-artery-d-phase-iii</loc>
    <lastmod>2026-05-28T21:41:38.787Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amiodarone-hydrochloride-new-onset-atrial-fibrillation-phase-iv</loc>
    <lastmod>2026-05-28T21:41:38.801Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tislelizumab-locally-advanced-rectal-cancer-rectal-ca-phase-ii</loc>
    <lastmod>2026-05-28T21:41:38.814Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zongertinib-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:38.828Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-4-2-4-3-cyanophenyl-piperazin-1-yl-eth-obsessive-compulsive-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:41:38.841Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/humanised-igg1-monoclonal-antibody-again-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:38.855Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/icotrokinra-ulcerative-colitis-moderately-to-severel-phase-iii</loc>
    <lastmod>2026-05-28T21:41:38.870Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tyra-300-b01-non-muscle-invasive-bladder-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:38.883Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tocilizumab-acute-ischemic-stroke-ischaemic-stroke-phase-ii</loc>
    <lastmod>2026-05-28T21:41:38.896Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dupilumab-chronic-obstructive-pulmonary-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:41:38.910Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/folinic-acid-oesophageal-adenocarcinoma-gastroesophag-phase-ii</loc>
    <lastmod>2026-05-28T21:41:38.923Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/4-2-4-difluorophenyl-methyl-2-4-6-7-8-9-diffuse-midline-glioma-primary-malignant-phase-i</loc>
    <lastmod>2026-05-28T21:41:38.936Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ruzasvir-bemnifosbuvir-chronic-hepatitis-c-phase-iii</loc>
    <lastmod>2026-05-28T21:41:38.950Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-3819026-unresectable-advanced-or-metastatic-soli-phase-iii</loc>
    <lastmod>2026-05-28T21:41:38.963Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/brentuximab-vedotin-cutaneous-t-cell-lymphoma-mycosis-fungoi-phase-iii</loc>
    <lastmod>2026-05-28T21:41:38.977Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sufentanil-citrate-severe-acute-trauma-related-pain-phase-iv</loc>
    <lastmod>2026-05-28T21:41:38.991Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bgb-16673-chronic-lymphocytic-leukemia-small-lymph-phase-iii</loc>
    <lastmod>2026-05-28T21:41:39.005Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/maribavir-cytomegalovirus-infection-allogeneic-hem-phase-ii</loc>
    <lastmod>2026-05-28T21:41:39.018Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tersolisib-hemihydrate-hormone-receptor-positive-her2-negative-phase-ii-phase-iii</loc>
    <lastmod>2026-05-28T21:41:39.031Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/muvalaplin-elevated-lipoprotein-a-atherosclerotic-c-phase-iii</loc>
    <lastmod>2026-05-28T21:41:39.048Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nnc0487-0111-nn9490-8152-obesity-phase-iii</loc>
    <lastmod>2026-05-28T21:41:39.061Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/arv-806-kras-g12d-mutated-advanced-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:41:39.074Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dry-extract-from-psilocybe-cubensis-15-2-gambling-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:41:39.088Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efgartigimod-alfa-chronic-immune-thrombocytopenia-itp-idio-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:39.101Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/q702-chronic-graft-versus-host-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:39.114Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ari-her2-her2bbz-car-t-cells-her2-positive-advanced-breast-cancer-adv-phase-i</loc>
    <lastmod>2026-05-28T21:41:39.134Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bms-986506-advanced-clear-cell-renal-cell-carcinoma-phase-i</loc>
    <lastmod>2026-05-28T21:41:39.147Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/testosterone-metastatic-castration-resistant-prostate-phase-ii</loc>
    <lastmod>2026-05-28T21:41:39.160Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/entacapone-levodopa-carbidopa-monohydrat-parkinson-s-disease-not-applicable</loc>
    <lastmod>2026-05-28T21:41:39.173Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-stage-iii-colorectal-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:39.187Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-pertuzumab-her2-positive-early-breast-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:39.200Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ivabradine-ischemic-heart-disease-not-applicable</loc>
    <lastmod>2026-05-28T21:41:39.213Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inebilizumab-immunoglobulin-g4-related-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:41:39.226Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/transpocart19-acute-lymphoblastic-leukemia-cd19-refrac-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:39.240Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/orx750-narcolepsy-idiopathic-hypersomnia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:39.253Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cabergoline-episodic-migraine-migraine</loc>
    <lastmod>2026-05-28T21:41:39.266Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-alpha1-proteinase-inhibitor-alpha-1-antitrypsin-deficiency</loc>
    <lastmod>2026-05-28T21:41:39.279Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tacrolimus-monohydrate-vernal-keratoconjunctivitis-vkc-phase-ii</loc>
    <lastmod>2026-05-28T21:41:39.292Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-non-small-cell-lung-cancer-interstitial-phase-iv</loc>
    <lastmod>2026-05-28T21:41:39.305Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cln-978-sjogren-s-syndrome-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:41:39.319Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fruquintinib-metastatic-oesophagogastric-adenocarcino-phase-iii</loc>
    <lastmod>2026-05-28T21:41:39.333Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/patiromer-end-stage-renal-disease-chronic-dialysis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:39.346Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ona-255-advanced-breast-cancer-metastatic-gastri-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:39.360Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anakinra-sepsis-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:39.374Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cemiplimab-locally-advanced-cervical-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:39.387Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dronedarone-hydrochloride-acute-ischemic-stroke-atrial-fibrillatio-not-applicable</loc>
    <lastmod>2026-05-28T21:41:39.400Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bnt327-metastatic-colorectal-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:39.413Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anumigilimab-sickle-cell-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:39.426Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/7-8-dibromo-5-6-dihydro-9-methyl-2-1-pip-relapsed-or-refractory-metastatic-or-adv-phase-ii</loc>
    <lastmod>2026-05-28T21:41:39.440Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/meropenem-pyogenic-liver-abscess-phase-iv</loc>
    <lastmod>2026-05-28T21:41:39.453Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pf-07868489-pulmonary-arterial-hypertension-phase-ii</loc>
    <lastmod>2026-05-28T21:41:39.468Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-78278343-metastatic-castration-resistant-prostate-phase-iii</loc>
    <lastmod>2026-05-28T21:41:39.481Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/duvakitug-ulcerative-colitis-moderately-to-severel-phase-iii</loc>
    <lastmod>2026-05-28T21:41:39.495Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/co-5122-urea-cycle-disorder-ornithine-transcarba-phase-i</loc>
    <lastmod>2026-05-28T21:41:39.509Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/advanced-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:39.523Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/copper-64cu-chloride-prostate-cancer-biochemical-recurrence-o-phase-iii</loc>
    <lastmod>2026-05-28T21:41:39.537Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tulisokibart-psoriatic-arthritis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:39.550Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/copper-64cu-chloride-prostate-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:39.564Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ciprofloxacin-hydrochloride-ciprofloxaci-febrile-neutropenia-chemotherapy-induced-not-applicable</loc>
    <lastmod>2026-05-28T21:41:39.577Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mycophenolic-acid-advanced-chronic-kidney-disease-post-tra-phase-iv</loc>
    <lastmod>2026-05-28T21:41:39.591Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/blinatumomab-philadelphia-chromosome-positive-b-cell-phase-iii</loc>
    <lastmod>2026-05-28T21:41:39.604Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-cd34-enriched-cell-fraction-t-ischemic-stroke-phase-iv</loc>
    <lastmod>2026-05-28T21:41:39.617Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alks-2680-idiopathic-hypersomnia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:39.630Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cannabidiol-tuberous-sclerosis-complex-sanfilippo-sy-not-applicable</loc>
    <lastmod>2026-05-28T21:41:39.643Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ojr520-chronic-kidney-disease-phase-i</loc>
    <lastmod>2026-05-28T21:41:39.656Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/liquid-extract-of-thyme-1-3-45-3-85-extr-acute-bronchitis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:39.669Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rocuronium-bromide-obesity-not-applicable</loc>
    <lastmod>2026-05-28T21:41:39.682Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ketamine-opioid-use-disorder-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:39.696Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belantamab-mafodotin-relapsed-refractory-multiple-myeloma-phase-i-ii-phase-ii</loc>
    <lastmod>2026-05-28T21:41:39.709Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-bone-marrow-derived-mesenchym-delayed-union-or-non-union-of-long-bone-phase-ii</loc>
    <lastmod>2026-05-28T21:41:39.722Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-hydrochloride-chronic-obstructive-pulmonary-disease-not-applicable</loc>
    <lastmod>2026-05-28T21:41:39.736Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aprotinin-acute-respiratory-distress-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:41:39.749Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levobupivacaine-hip-fracture-not-applicable</loc>
    <lastmod>2026-05-28T21:41:39.762Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mezagitamab-primary-iga-nephropathy-phase-iii</loc>
    <lastmod>2026-05-28T21:41:39.776Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-heart-failure-with-preserved-ejection-fr-phase-iv</loc>
    <lastmod>2026-05-28T21:41:39.790Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-hydrogen-carbonate-potassium-chlo-inadequate-bowel-preparation-not-applicable</loc>
    <lastmod>2026-05-28T21:41:39.803Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ketorolac-trometamol-uncomplicated-acute-appendicitis</loc>
    <lastmod>2026-05-28T21:41:39.816Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eye103-diabetic-macular-edema-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:39.830Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atomoxetine-healthy-volunteers-phase-iv</loc>
    <lastmod>2026-05-28T21:41:39.843Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zasocitinib-psoriatic-arthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:39.857Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clopidogrel-atrial-fibrillation-device-thrombosis-fo-not-applicable</loc>
    <lastmod>2026-05-28T21:41:39.870Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gallium-68-68ga-peritoneal-carcinomatosis-colorectal-ori-phase-i</loc>
    <lastmod>2026-05-28T21:41:39.883Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tg4070-non-small-cell-lung-cancer-non-small-cel-phase-i</loc>
    <lastmod>2026-05-28T21:41:39.896Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-hydrogen-carbonate-sodium-dihydro-chronic-constipation-phase-iv</loc>
    <lastmod>2026-05-28T21:41:39.910Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/df2755a-interstitial-cystitis-bladder-pain-syndr-phase-iii</loc>
    <lastmod>2026-05-28T21:41:39.923Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gilteritinib-non-small-cell-lung-cancer-locally-advan-phase-iii</loc>
    <lastmod>2026-05-28T21:41:39.937Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/irinotecan-hydrochloride-trihydrate-gastric-cancer-gastroesophageal-junction-phase-i</loc>
    <lastmod>2026-05-28T21:41:39.950Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aflibercept-diabetic-macular-edema-phase-iii</loc>
    <lastmod>2026-05-28T21:41:39.964Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tislelizumab-gastric-adenocarcinoma-gastroesophageal-phase-iii</loc>
    <lastmod>2026-05-28T21:41:39.977Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/empagliflozin-type-2-diabetes-chronic-kidney-disease-e</loc>
    <lastmod>2026-05-28T21:41:39.991Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cetuximab-oral-squamous-cell-carcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:40.004Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vh4524184-hiv-1-infection-phase-ii</loc>
    <lastmod>2026-05-28T21:41:40.018Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acoramidis-transthyretin-amyloid-cardiomyopathy-att-phase-iv</loc>
    <lastmod>2026-05-28T21:41:40.032Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/benzydamine-hydrochloride-2-4-dichlorobe-acute-pharyngitis-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:40.045Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/brimonidine-tartrate-taxanes-induced-peripheral-neuropathy-ch-phase-ii</loc>
    <lastmod>2026-05-28T21:41:40.059Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/blinatumomab-b-cell-precursor-acute-lymphoblastic-leu-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:40.072Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-normal-immunoglobulin-iv-b-cell-acute-lymphoblastic-leukaemia-b-c-phase-iii</loc>
    <lastmod>2026-05-28T21:41:40.086Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-hepatocellular-carcinoma-resectable-phase-ii</loc>
    <lastmod>2026-05-28T21:41:40.099Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iadademstat-sickle-cell-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:41:40.127Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexmedetomidine-delirium-not-applicable</loc>
    <lastmod>2026-05-28T21:41:40.141Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cineole-mrsa-colonisation-methicillin-resistant-phase-iii</loc>
    <lastmod>2026-05-28T21:41:40.155Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inebilizumab-generalized-myasthenia-gravis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:40.168Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:40.182Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/saline-chronic-limb-ischemia-critical-limb-isch-phase-iv</loc>
    <lastmod>2026-05-28T21:41:40.195Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/propofol-valvular-heart-disease-not-applicable</loc>
    <lastmod>2026-05-28T21:41:40.209Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ceftriaxone-preterm-prelabor-rupture-of-membranes-pp-phase-iii</loc>
    <lastmod>2026-05-28T21:41:40.225Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/balinatunfib-ulcerative-colitis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:40.239Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imeroprubart-primary-sjogren-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:40.253Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/covid-19-prophylaxis-phase-i</loc>
    <lastmod>2026-05-28T21:41:40.266Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sirolimus-rapamycin-port-wine-stain-phase-ii</loc>
    <lastmod>2026-05-28T21:41:40.280Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fibrin-matrix-glaucoma-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:40.294Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ropivacaine-hydrochloride-chronic-tonsillitis-not-applicable</loc>
    <lastmod>2026-05-28T21:41:40.308Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/huntington-s-disease-phase-i</loc>
    <lastmod>2026-05-28T21:41:40.321Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/temozolomide-diffuse-midline-glioma-h3k27-altered-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:40.334Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fostemsavir-hiv-infection-hiv-1-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:41:40.347Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/empasiprubart-chronic-inflammatory-demyelinating-polyn-phase-iii</loc>
    <lastmod>2026-05-28T21:41:40.360Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/propofol-post-operative-acute-kidney-injury-phase-iv</loc>
    <lastmod>2026-05-28T21:41:40.373Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/magnesium-chloride-hexahydrate-potassium-critical-illness-not-applicable</loc>
    <lastmod>2026-05-28T21:41:40.387Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ela026-secondary-hemophagocytic-lymphohistiocyt-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:40.400Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glyceryl-trinitrate-genitourinary-syndrome-of-menopause-phase-iii</loc>
    <lastmod>2026-05-28T21:41:40.413Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bay-3713372-mtap-deleted-solid-tumors-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:40.427Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inavolisib-endometrial-cancer-advanced-endometrial-phase-ii</loc>
    <lastmod>2026-05-28T21:41:40.440Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lidocaine-hydrochloride-spontaneous-subarachnoid-hemorrhage-head-phase-iii</loc>
    <lastmod>2026-05-28T21:41:40.454Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/act-1004-1239-progressive-multiple-sclerosis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:40.467Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mesalamine-ulcerative-colitis-phase-ii-2</loc>
    <lastmod>2026-05-28T21:41:40.480Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bimekizumab-axial-spondyloarthritis-psoriatic-arthri-phase-iii</loc>
    <lastmod>2026-05-28T21:41:40.493Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mesalamine-ulcerative-colitis-phase-ii-3</loc>
    <lastmod>2026-05-28T21:41:40.506Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/survodutide-healthy-volunteers-phase-iii</loc>
    <lastmod>2026-05-28T21:41:40.519Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/huperzine-a-focal-onset-seizures-focal-epilepsy-phase-ii</loc>
    <lastmod>2026-05-28T21:41:40.533Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/chronic-hepatitis-d-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:41:40.546Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-faecal-microbiota-pooled-autism-spectrum-disorder-gastrointestina-phase-ii</loc>
    <lastmod>2026-05-28T21:41:40.559Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acalabrutinib-mantle-cell-lymphoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:40.572Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/letrozole-estrogen-receptor-positive-er-her2-negat-phase-iv</loc>
    <lastmod>2026-05-28T21:41:40.585Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/baricitinib-rheumatoid-arthritis-psoriatic-arthritis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:40.598Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/laroprovstat-hyperlipidemia-atherosclerotic-cardiovas-phase-iii</loc>
    <lastmod>2026-05-28T21:41:40.647Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/parkinson-s-disease-phase-i-2</loc>
    <lastmod>2026-05-28T21:41:40.660Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/laroprovstat-atherosclerotic-cardiovascular-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:41:40.674Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eosinophilic-esophagitis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:40.687Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pkn605-atrial-fibrillation-phase-ii</loc>
    <lastmod>2026-05-28T21:41:40.699Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/botulinum-toxin-type-a-haemagglutinin-co-chronic-anal-fissure-phase-iv</loc>
    <lastmod>2026-05-28T21:41:40.715Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ampicillin-acute-non-complicated-appendicitis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:40.729Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/xanomeline-tartrate-alzheimer-s-disease-mild-to-moderate-phase-iii</loc>
    <lastmod>2026-05-28T21:41:40.742Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/systemic-lupus-erythematosus-phase-iii</loc>
    <lastmod>2026-05-28T21:41:40.756Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trospium-chloride-xanomeline-tartrate-alzheimer-s-disease-mild-to-moderate-phase-iii</loc>
    <lastmod>2026-05-28T21:41:40.769Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cizutamig-primary-sjogren-s-syndrome-idiopathic-in-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:40.783Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regorafenib-advanced-metastatic-colorectal-cancer-me-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:40.800Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/phleum-pratense-allergic-rhinitis-grass-pollen-induced-a-phase-ii</loc>
    <lastmod>2026-05-28T21:41:40.814Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/valganciclovir-hydrochloride-cytomegalovirus-infection-kidney-transpl-phase-iii</loc>
    <lastmod>2026-05-28T21:41:40.827Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gs-4321-chronic-hepatitis-delta-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:40.841Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/baxdrostat-primary-aldosteronism-primary-hyperaldos-phase-iii</loc>
    <lastmod>2026-05-28T21:41:40.855Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-metastatic-breast-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:41:40.869Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-2-2-10-2-4-3-4-2-2-cyano-4-4-difluor-pulmonary-arterial-hypertension-phase-iii</loc>
    <lastmod>2026-05-28T21:41:40.883Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/barzolvolimab-cold-induced-urticaria-symptomatic-dermo-phase-iii</loc>
    <lastmod>2026-05-28T21:41:40.897Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lazertinib-non-small-cell-lung-cancer-egfr-mutated-phase-ii</loc>
    <lastmod>2026-05-28T21:41:40.910Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vipoglanstat-gs-248-endometriosis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:40.924Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/erythromycin-surgical-site-infection-phase-iv</loc>
    <lastmod>2026-05-28T21:41:40.937Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/major-depressive-disorder-incomplete-res-phase-iii</loc>
    <lastmod>2026-05-28T21:41:40.951Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/darovasertib-uveal-melanoma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:40.965Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutikizumab-rheumatoid-arthritis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:40.979Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd5335-ovarian-cancer-primary-peritoneal-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:40.992Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-acute-myeloid-leukemia-myelodysplastic-s-phase-ii</loc>
    <lastmod>2026-05-28T21:41:41.007Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lti-03-idiopathic-pulmonary-fibrosis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:41.021Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mirikizumab-ulcerative-colitis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:41.034Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/duvakitug-crohn-s-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:41:41.047Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/urokinase-catalytic-domain-fused-with-a-acute-ischemic-stroke-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:41.061Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etrasimod-arginine-ulcerative-colitis-immune-mediated-infla-phase-i</loc>
    <lastmod>2026-05-28T21:41:41.074Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-hydrochloride-li-fraumeni-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:41:41.087Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/unfractionated-heparin-porcine-conjugate-peripheral-arterial-occlusive-disease-ch-phase-ii</loc>
    <lastmod>2026-05-28T21:41:41.101Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vulvar-cancer-vulval-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:41.114Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-cromoglicate-amyotrophic-lateral-sclerosis-als-phase-ii</loc>
    <lastmod>2026-05-28T21:41:41.127Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tocilizumab-rheumatoid-arthritis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:41.140Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/blomia-tropicalis-allergies-phase-ii</loc>
    <lastmod>2026-05-28T21:41:41.153Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/patritumab-deruxtecan-hormone-receptor-positive-her2-negative-phase-iii</loc>
    <lastmod>2026-05-28T21:41:41.167Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sugammadex-neuromuscular-block-phase-iv</loc>
    <lastmod>2026-05-28T21:41:41.181Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/filgotinib-rheumatoid-arthritis</loc>
    <lastmod>2026-05-28T21:41:41.195Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/altizide-micronised-spironolactone-heart-failure-with-reduced-ejection-frac-phase-iv</loc>
    <lastmod>2026-05-28T21:41:41.209Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dream01-sickle-cell-disease-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:41.222Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-acute-graft-versus-host-disease-agvhd-ac-phase-ii</loc>
    <lastmod>2026-05-28T21:41:41.235Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cemiplimab-basal-cell-carcinoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:41.249Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/doxycycline-monohydrate-bacterial-sexually-transmitted-infection-not-applicable</loc>
    <lastmod>2026-05-28T21:41:41.262Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/insulin-gzr4-type-2-diabetes-mellitus-phase-iii</loc>
    <lastmod>2026-05-28T21:41:41.276Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/9-4-cyclohexyloxyphenyl-7-methyl-3-4-dih-major-depressive-disorder-phase-iii</loc>
    <lastmod>2026-05-28T21:41:41.290Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tranexamic-acid-pacemaker-implantation-in-anticoagulated-phase-iii</loc>
    <lastmod>2026-05-28T21:41:41.303Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/til-cells-high-grade-epithelial-ovarian-carcinoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:41.317Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/melatonin-hypoxic-ischemic-encephalopathy-moderate-phase-i</loc>
    <lastmod>2026-05-28T21:41:41.331Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ranolazine-st-elevation-myocardial-infarction-acute-phase-ii</loc>
    <lastmod>2026-05-28T21:41:41.344Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/romosozumab-postmenopausal-osteoporosis-coronary-ath-phase-iv</loc>
    <lastmod>2026-05-28T21:41:41.358Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mycophenolate-sodium-mycophenolic-acid-end-stage-renal-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:41:41.370Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/permethrin-cis-trans-25-75-scabies-phase-iv</loc>
    <lastmod>2026-05-28T21:41:41.384Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/asp3082-metastatic-non-small-cell-lung-cancer-pa-phase-ii</loc>
    <lastmod>2026-05-28T21:41:41.397Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hiv-sosip-v8-2-763-hiv-infection-phase-i</loc>
    <lastmod>2026-05-28T21:41:41.410Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colchicine-hiv-infection-coronary-artery-inflammati-phase-ii</loc>
    <lastmod>2026-05-28T21:41:41.423Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/latanoprost-acid-androgenetic-alopecia-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:41:41.438Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/laroprovstat-heterozygous-familial-hypercholesterolem-phase-iii</loc>
    <lastmod>2026-05-28T21:41:41.452Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nisotirostide-type-2-diabetes-phase-ii</loc>
    <lastmod>2026-05-28T21:41:41.466Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/advanced-solid-tumors-phase-i-4</loc>
    <lastmod>2026-05-28T21:41:41.479Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tocilizumab-rheumatoid-arthritis</loc>
    <lastmod>2026-05-28T21:41:41.493Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/treosulfan-acute-myeloid-leukemia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:41.510Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/syx-5219-atopic-dermatitis-phase-i</loc>
    <lastmod>2026-05-28T21:41:41.524Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alxn2220-transthyretin-amyloid-cardiomyopathy-att-phase-ii</loc>
    <lastmod>2026-05-28T21:41:41.543Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylsalicylic-acid-atherosclerotic-cardiovascular-disease-t-phase-iv</loc>
    <lastmod>2026-05-28T21:41:41.559Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-igg1-bispecific-monoclonal-antibod-atopic-dermatitis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:41.572Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amg-691-asthma-phase-i</loc>
    <lastmod>2026-05-28T21:41:41.586Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ro7795081-type-2-diabetes-mellitus-phase-ii</loc>
    <lastmod>2026-05-28T21:41:41.599Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/asciminib-hydrochloride-acute-lymphoblastic-leukemia-bcr-abl1-po-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:41.613Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clostridium-botulinum-neurotoxin-type-a-platysma-prominence-phase-iii</loc>
    <lastmod>2026-05-28T21:41:41.627Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ropivacaine-hydrochloride-supratentorial-intracranial-surgery-post-not-applicable</loc>
    <lastmod>2026-05-28T21:41:41.640Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/esketamine-hydrochloride-respiratory-distress-syndrome-phase-iv</loc>
    <lastmod>2026-05-28T21:41:41.653Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tenecteplase-acute-ischemic-stroke</loc>
    <lastmod>2026-05-28T21:41:41.666Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/selinexor-soft-tissue-sarcoma-leiomyosarcoma-malig-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:41.679Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inno8-haemophilia-a-haemophilia-a-with-inhibit-phase-iii</loc>
    <lastmod>2026-05-28T21:41:41.692Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pozelimab-geographic-atrophy-phase-i</loc>
    <lastmod>2026-05-28T21:41:41.705Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/molgramostim-peritonitis-secondary-peritonitis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:41.719Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-igg1-kappa-monoclonal-antibody-aga-chronic-obstructive-pulmonary-disease-co-phase-ii</loc>
    <lastmod>2026-05-28T21:41:41.732Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/crn09682-neuroendocrine-neoplasm-metastatic-or-lo-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:41.745Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lysergide-lysergic-acid-diethylamide-lsd-chronic-cluster-headache-phase-iv</loc>
    <lastmod>2026-05-28T21:41:41.758Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/estriol-cervical-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:41:41.771Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/quizartinib-dihydrochloride-acute-myeloid-leukemia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:41.785Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/humanised-igg1-kappa-monoclonal-antibody-atopic-dermatitis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:41.798Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluticasone-propionate-protracted-cough-phase-iii</loc>
    <lastmod>2026-05-28T21:41:41.811Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cenegermin-spastic-cerebral-palsy-phase-ii</loc>
    <lastmod>2026-05-28T21:41:41.827Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oncolytic-adenovirus-encoding-tumor-necr-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:41:41.840Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etoricoxib-postoperative-pain-after-mandibular-thir-phase-iv</loc>
    <lastmod>2026-05-28T21:41:41.853Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/olaparib-metastatic-pancreatic-ductal-adenocarcin-phase-ii</loc>
    <lastmod>2026-05-28T21:41:41.867Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vericiguat-treatment-resistant-hypertension-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:41.880Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ro7837195-moderately-to-severely-active-ulcerative-phase-ii</loc>
    <lastmod>2026-05-28T21:41:41.894Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gsk5460025a-colorectal-cancer-endometrial-cancer-dmm-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:41.908Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-chloride-traumatic-brain-injury-phase-iii</loc>
    <lastmod>2026-05-28T21:41:41.922Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fibrin-matrix-pterygium-phase-iv</loc>
    <lastmod>2026-05-28T21:41:41.935Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly3537021-nausea-vomiting-drug-related-adverse-rea-phase-ii</loc>
    <lastmod>2026-05-28T21:41:41.950Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vedolizumab-phase-iii</loc>
    <lastmod>2026-05-28T21:41:41.963Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/darolutamide-prostate-adenocarcinoma-high-risk-locali-phase-iv</loc>
    <lastmod>2026-05-28T21:41:41.977Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/upadacitinib-acute-anterior-uveitis-axial-spondyloart-phase-iv</loc>
    <lastmod>2026-05-28T21:41:41.991Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clostridium-botulinum-neurotoxin-type-a-severe-primary-dysmenorrhea-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.005Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hydrocortisone-severe-acute-infection-not-applicable</loc>
    <lastmod>2026-05-28T21:41:42.018Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bjt-778-chronic-hepatitis-d-infection-hepatitis-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:42.032Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluoroestradiol-f-18-endometriosis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:42.046Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylcysteine-alcoholic-hepatitis</loc>
    <lastmod>2026-05-28T21:41:42.060Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amivantamab-recurrent-metastatic-head-and-neck-squam-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.074Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bimekizumab-axial-spondyloarthritis-psoriasis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.088Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/testosterone-decanoate-testosterone-isoc-androgen-deficiency-palliative-care-phase-iv</loc>
    <lastmod>2026-05-28T21:41:42.102Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glucagon-heart-failure-with-preserved-ejection-fr-phase-ii</loc>
    <lastmod>2026-05-28T21:41:42.116Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-regulatory-t-cells-with-an-im-ulcerative-colitis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:42.129Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-malignant-melanoma-resected-stage-iib-ii-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.143Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adx-038-complement-mediated-kidney-disease-iga-n-phase-ii</loc>
    <lastmod>2026-05-28T21:41:42.157Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amoxicillin-clavulanic-acid-febrile-urinary-tract-infection-urinary-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:42.171Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colchicine-deep-vein-thrombosis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:42.185Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inclisiran-acute-coronary-syndrome</loc>
    <lastmod>2026-05-28T21:41:42.198Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trospium-chloride-xanomeline-tartrate-agitation-associated-with-alzheimer-s-di-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:42.212Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nirsevimab-respiratory-syncytial-virus-infection-br-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.225Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-serum-albumin-decompensated-hepatic-cirrhosis-acute-ki-phase-iv</loc>
    <lastmod>2026-05-28T21:41:42.238Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pirtobrutinib-mantle-cell-lymphoma-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:42.251Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sugammadex-neuromuscular-blockade</loc>
    <lastmod>2026-05-28T21:41:42.265Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clopidogrel-covert-brain-infarction-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.278Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/12m-1s-2s-n-63s-4s-z-11-ethyl-12-2-s-1-m-non-small-cell-lung-cancer-ras-g12d-muta-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:42.292Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-type-2-diabetes-mellitus-not-applicable</loc>
    <lastmod>2026-05-28T21:41:42.305Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-hydrochloride-type-2-diabetes-mellitus-phase-iv</loc>
    <lastmod>2026-05-28T21:41:42.318Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/loxo-435-ly3866288-vepugratinib-urothelial-carcinoma-bladder-cancer-meta-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.332Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-adipose-tissue-derived-stroma-temporomandibular-joint-osteoarthritis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:42.345Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zenagamtide-overweight-or-obesity-obstructive-sleep-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.359Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ro7795074-type-1-diabetes-obesity-overweight-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.372Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/magnesium-sulfate-preterm-premature-rupture-of-membranes-phase-iv</loc>
    <lastmod>2026-05-28T21:41:42.385Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zenagamtide-overweight-obesity-obstructive-sleep-apn-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.398Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prasterone-dhea-menopause-postmenopausal-sleep-disorder-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.411Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zenagamtide-overweight-or-obesity-type-2-diabetes-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.425Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/chronic-pain-pain-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.438Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zenagamtide-obesity-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:42.451Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-embonate-glioblastoma-idh-wildtype-phase-ii</loc>
    <lastmod>2026-05-28T21:41:42.464Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/daratumumab-multiple-myeloma-newly-diagnosed-multipl-phase-ii</loc>
    <lastmod>2026-05-28T21:41:42.477Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fg001-glioma-meningioma-phase-iv</loc>
    <lastmod>2026-05-28T21:41:42.490Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amoxicillin-sodium-prosthetic-joint-infection-hip-or-knee-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.503Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vg801-1-vg801-2-abca4-associated-retinal-dystrophy-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:42.516Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hematological-malignancies-solid-tumor-m-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.529Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/depemokimab-chronic-obstructive-pulmonary-disease-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:42.543Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ivosidenib-intrahepatic-cholangiocarcinoma-idh1-mut-phase-ii</loc>
    <lastmod>2026-05-28T21:41:42.556Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bitopertin-erythropoietic-protoporphyria-x-linked-p-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.569Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/butan-2-yl-1-methyl-4-4-4-methyl-3-4-pyr-pulmonary-arterial-hypertension-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:42.582Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/valine-arginine-glutamate-alanine-argini-muscle-protein-turnover-chronic-kidney-d-not-applicable</loc>
    <lastmod>2026-05-28T21:41:42.596Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metastatic-esophagogastric-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:42.608Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ixekizumab-psoriatic-arthritis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:42.621Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mirikizumab-crohn-s-disease-obesity-or-overweight-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.635Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/duvakitug-human-igg1-lambda-monoclonal-a-ulcerative-colitis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.649Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mirikizumab-ulcerative-colitis-obesity-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.663Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nitric-oxide-post-operative-period-following-cardiac-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.677Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/perampanel-white-sutton-syndrome-pogz-related-disor-phase-ii</loc>
    <lastmod>2026-05-28T21:41:42.691Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-igg1-monoclonal-antibody-against-h-still-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:42.704Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-triple-negative-breast-cancer-metastatic-phase-ii</loc>
    <lastmod>2026-05-28T21:41:42.717Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dotinurad-gout-hyperuricemia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.729Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-t-cells-transduced-with-a-ret-high-risk-neuroblastoma-relapsed-refract-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:42.742Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/orziloben-intestinal-failure-associated-liver-dise-phase-ii</loc>
    <lastmod>2026-05-28T21:41:42.755Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/progesterone-micronised-menopausal-climacteric-symptoms-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.771Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pit565-rheumatoid-arthritis-phase-i</loc>
    <lastmod>2026-05-28T21:41:42.784Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogenic-bone-marrow-derived-mesenchyma-autoimmune-refractory-epilepsy-rasmussen-phase-i</loc>
    <lastmod>2026-05-28T21:41:42.798Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methylprednisolone-hemisuccinate-postoperative-sequelae-not-applicable</loc>
    <lastmod>2026-05-28T21:41:42.811Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-tirumotecan-triple-negative-breast-cancer-hormone-re-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.824Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-papillomavirus-type-31-l1-protein-hiv-infection-human-papillomavirus-infec-not-applicable</loc>
    <lastmod>2026-05-28T21:41:42.838Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-normal-immunoglobulin-hypogammaglobulinemia-autoimmune-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.851Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/depemokimab-chronic-obstructive-pulmonary-disease-co-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.864Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-advanced-unresectable-or-metastatic-mela</loc>
    <lastmod>2026-05-28T21:41:42.878Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tenecteplase-ischaemic-stroke-large-vessel-occlusion-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.891Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/duvakitug-crohn-s-disease-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:42.904Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fampridine-spinocerebellar-ataxia-sca27b-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.917Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eosinophilic-esophagitis-celiac-disease-phase-i</loc>
    <lastmod>2026-05-28T21:41:42.930Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anifrolumab-primary-antiphospholipid-syndrome-phase-ii</loc>
    <lastmod>2026-05-28T21:41:42.943Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/noradrenaline-tartrate-cardiogenic-shock-phase-iv</loc>
    <lastmod>2026-05-28T21:41:42.956Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-arterial-hypertension-phase-iii</loc>
    <lastmod>2026-05-28T21:41:42.970Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eik1004-bis-tartrate-advanced-solid-tumors-endometrioid-epith-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:42.983Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/follitropin-delta-infertility-phase-ii</loc>
    <lastmod>2026-05-28T21:41:42.996Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/exenatide-gestational-diabetes-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.009Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mk-8527-hiv-1-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:41:43.022Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lamivudine-dolutegravir-sodium-hiv-infection-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:43.034Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-systemic-sclerosis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:43.047Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bupivacaine-hydrochloride-electrical-storm-phase-iv</loc>
    <lastmod>2026-05-28T21:41:43.063Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/botulinum-toxin-type-a-obstetrical-brachial-plexus-palsy-phase-iii</loc>
    <lastmod>2026-05-28T21:41:43.076Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hafnium-oxide-locally-advanced-head-and-neck-squamous-phase-iii</loc>
    <lastmod>2026-05-28T21:41:43.089Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lepodisiran-hepatic-impairment-phase-iii</loc>
    <lastmod>2026-05-28T21:41:43.102Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-1815368-diabetic-macular-edema-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.115Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prednisolone-acute-interstitial-nephritis-tubulointer-phase-iv</loc>
    <lastmod>2026-05-28T21:41:43.128Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bupivacaine-hydrochloride-myofascial-pain-syndrome-of-trapezius-fi-phase-iv</loc>
    <lastmod>2026-05-28T21:41:43.141Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/overweight-obesity-phase-i</loc>
    <lastmod>2026-05-28T21:41:43.153Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fosfomycin-calcium-acute-leukemia-post-chemotherapy-neutrop-phase-iii</loc>
    <lastmod>2026-05-28T21:41:43.179Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/od-07656-hydrochloride-ulcerative-colitis-moderately-to-severel-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.192Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/1s-1-4-3-4-6-fluoro-1-2-benzoxazol-3-yl-major-depressive-disorder-phase-iii</loc>
    <lastmod>2026-05-28T21:41:43.206Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/luspatercept-inherited-anemias-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.219Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-post-acute-sequelae-of-covid-19-long-cov-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.232Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trospium-chloride-xanomeline-tartrate-bipolar-i-disorder-mania-or-mixed-featur-phase-iii</loc>
    <lastmod>2026-05-28T21:41:43.245Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2-4-3-methylamino-1-phenylpropoxy-phenyl-fragile-x-syndrome-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.257Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amoxicillin-trihydrate-potassium-clavula-perianal-abscess-anal-fistula-not-applicable</loc>
    <lastmod>2026-05-28T21:41:43.271Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/respiratory-syncytial-virus-glycoprotein-respiratory-syncytial-virus-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:41:43.283Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/empasiprubart-chronic-inflammatory-demyelinating-polyn-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:43.296Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-papillomavirus-l1-proteins-types-6-high-grade-squamous-intraepithelial-lesi-phase-iii</loc>
    <lastmod>2026-05-28T21:41:43.310Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/triptorelin-acinar-cell-carcinoma-of-prostate-phase-iii</loc>
    <lastmod>2026-05-28T21:41:43.323Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-early-stage-favorable-classical-hodgkin-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.336Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gemcitabine-advanced-biliary-tract-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.348Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eltrombopag-myelodysplastic-syndromes-thrombocytopen-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.362Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methotrexate-rheumatoid-arthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:43.376Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lupuli-flos-dry-alcoholic-extract-valeri-cataract-pars-plana-vitrectomy-phase-iv</loc>
    <lastmod>2026-05-28T21:41:43.389Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zasocitinib-non-segmental-vitiligo-vitiligo-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.403Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-metastatic-colorectal-cancer-colorectal-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.416Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fruquintinib-metastatic-colorectal-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.429Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxygen-necrotizing-soft-tissue-infection-not-applicable</loc>
    <lastmod>2026-05-28T21:41:43.443Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pivekimab-sunirine-acute-myeloid-leukemia-relapsed-or-refra-phase-i</loc>
    <lastmod>2026-05-28T21:41:43.456Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tofacitinib-juvenile-idiopathic-arthritis-not-applicable</loc>
    <lastmod>2026-05-28T21:41:43.469Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vemurafenib-hairy-cell-leukemia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.483Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zoledronic-acid-primary-hyperparathyroidism</loc>
    <lastmod>2026-05-28T21:41:43.498Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/img-007-atopic-dermatitis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.511Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/exenatide-parkinson-s-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:41:43.525Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/datopotamab-deruxtecan-non-small-cell-lung-cancer-non-squamous-phase-iii</loc>
    <lastmod>2026-05-28T21:41:43.538Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ceftazidime-avibactam-bloodstream-infection-hospital-acquired-phase-iv</loc>
    <lastmod>2026-05-28T21:41:43.552Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mepivacaine-hydrochloride-respiratory-disease-not-applicable</loc>
    <lastmod>2026-05-28T21:41:43.565Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/halobetasol-propionate-plaque-psoriasis-phase-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.579Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gepotidacin-urinary-tract-infection-phase-i</loc>
    <lastmod>2026-05-28T21:41:43.592Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elacestrant-dihydrochloride-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.606Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cnd261-anca-associated-vasculitis-anca-igg-posi-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:43.621Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ipilimumab-renal-cell-carcinoma-metastatic-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.636Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dt-101-major-depressive-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.649Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tinzaparin-sodium-advanced-pancreatic-cancer-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:43.662Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexmedetomidine-procedural-sedation-phase-iv</loc>
    <lastmod>2026-05-28T21:41:43.675Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/valaciclovir-hydrochloride-herpes-simplex-virus-type-2-meningitis-h</loc>
    <lastmod>2026-05-28T21:41:43.690Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/testosterone-phase-i</loc>
    <lastmod>2026-05-28T21:41:43.703Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tulisokibart-hidradenitis-suppurativa-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.717Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adeno-associated-viral-vector-serotype-9-ctnnb1-syndrome-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:43.730Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-2-2-10-2-4-3-4-2-2-cyano-4-4-difluor-peritoneal-metastases-phase-iii</loc>
    <lastmod>2026-05-28T21:41:43.743Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-advanced-cancer-metastatic-non-small-cel-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.756Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/blu-808-chronic-inducible-urticaria-chronic-spon-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.769Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adeno-associated-viral-vector-serotype-2-multiple-system-atrophy-parkinson-s-dise-not-applicable</loc>
    <lastmod>2026-05-28T21:41:43.782Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/meropenem-sepsis-serious-infection-phase-iv</loc>
    <lastmod>2026-05-28T21:41:43.795Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/usnoflast-amyotrophic-lateral-sclerosis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.808Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ribociclib-hormone-receptor-positive-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.821Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tinlarebant-stargardt-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:41:43.834Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd0516-metastatic-prostate-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:43.847Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fentanyl-acute-decompensated-heart-failure-refrac-phase-iv</loc>
    <lastmod>2026-05-28T21:41:43.861Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/navenibart-hereditary-angioedema-hereditary-angioed-phase-iii</loc>
    <lastmod>2026-05-28T21:41:43.874Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mitomycin-non-muscle-invasive-bladder-cancer</loc>
    <lastmod>2026-05-28T21:41:43.887Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/navenibart-hereditary-angioedema-hereditary-angioed-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:43.904Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/exemestane-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.918Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hydrogen-atrial-fibrillation-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.931Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amoxicillin-infective-endocarditis-bacterial-endocar-phase-iv</loc>
    <lastmod>2026-05-28T21:41:43.944Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apitegromab-spinal-muscular-atrophy-phase-ii</loc>
    <lastmod>2026-05-28T21:41:43.957Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/insulin-icodec-type-1-diabetes-phase-iii</loc>
    <lastmod>2026-05-28T21:41:43.970Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/remifentanil-hydrochloride-total-knee-arthroplasty-total-hip-arthro-not-applicable</loc>
    <lastmod>2026-05-28T21:41:43.983Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-1015550-interstitial-lung-disease-familial-pulmo-not-applicable</loc>
    <lastmod>2026-05-28T21:41:43.996Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/brentuximab-vedotin-classical-hodgkin-lymphoma-relapsed-or-r-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.010Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-polyclonal-immunoglobulin-g-agains-type-1-diabetes-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.023Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vemurafenib-hairy-cell-leukaemia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.039Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/chf6467-neonatal-hypoxic-ischemic-encephalopathy-phase-iii</loc>
    <lastmod>2026-05-28T21:41:44.052Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-non-small-cell-lung-cancer-metastatic-no-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.068Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s095035-advanced-or-metastatic-solid-tumors-with-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:44.082Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/povorcitinib-hidradenitis-suppurativa-prurigo-nodular-phase-iii</loc>
    <lastmod>2026-05-28T21:41:44.097Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ro7790121-rheumatoid-arthritis-moderate-to-severe-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.111Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/64cu-dota-ae105-glioblastoma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:44.124Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ropinirole-healthy-volunteers</loc>
    <lastmod>2026-05-28T21:41:44.137Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/monobenzon-malignant-melanoma-advanced-or-metastati-not-applicable</loc>
    <lastmod>2026-05-28T21:41:44.150Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vent-03-cutaneous-lupus-erythematosus-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.163Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-tirumotecan-urothelial-carcinoma-bladder-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:44.176Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/empagliflozin-cardiac-surgery-associated-acute-kidney</loc>
    <lastmod>2026-05-28T21:41:44.190Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alks-2680-narcolepsy-type-1-narcolepsy-type-2-idio-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:44.203Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/flortaucipir-18f-alzheimer-s-disease-alzheimer-s-patholog-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.216Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rinatabart-sesutecan-endometrial-cancer-recurrent-endometrial-phase-iii</loc>
    <lastmod>2026-05-28T21:41:44.229Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/xanomeline-tartrate-agitation-associated-with-alzheimer-s-di-phase-iii</loc>
    <lastmod>2026-05-28T21:41:44.252Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-deficient-mismatch-repair-dmmr-colorecta-not-applicable</loc>
    <lastmod>2026-05-28T21:41:44.266Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/simvastatin-alcoholic-liver-disease-chronic-liver-di-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.279Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lebrikizumab-atopic-dermatitis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:44.292Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cart84-relapsed-refractory-t-cell-acute-lymphob-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:44.305Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-adipose-derived-adult-mesench-dry-eye-disease-graft-versus-host-diseas-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.318Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ctps1-inhibitor-stp938-essential-thrombocythaemia-thrombocythae-phase-i</loc>
    <lastmod>2026-05-28T21:41:44.331Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fosaprepitant-post-operative-nausea-and-vomiting-ponv-phase-iii</loc>
    <lastmod>2026-05-28T21:41:44.344Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fludeoxyglucose-18f-alzheimer-s-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:41:44.359Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bms-986517-advanced-solid-tumors-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:44.373Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/botulinum-toxin-type-a-hidradenitis-suppurativa-not-applicable</loc>
    <lastmod>2026-05-28T21:41:44.386Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rinatabart-sesutecan-non-small-cell-lung-cancer-locally-advan-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.399Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-enriched-t-cells-retrovirally-systemic-lupus-erythematosus-with-active-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.413Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adx-324-hereditary-angioedema-phase-iii</loc>
    <lastmod>2026-05-28T21:41:44.427Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/somatropin-short-predicted-height-phase-iii</loc>
    <lastmod>2026-05-28T21:41:44.440Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/o15-water-hydrocephalus-communicating-hydrocephalu-not-applicable</loc>
    <lastmod>2026-05-28T21:41:44.453Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lisocabtagene-maraleucel-primary-central-nervous-system-lymphoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.467Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pomalidomide-chronic-hepatitis-b-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:44.480Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mosunetuzumab-systemic-lupus-erythematosus-lupus-nephr-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.494Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-embonate-actinic-keratosis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.507Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fruquintinib-metastatic-colorectal-cancer-without-liv-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.521Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dostarlimab-locally-advanced-rectal-cancer-pmmr-mss-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.534Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/momelotinib-dihydrochloride-monohydrate-myelodysplastic-syndrome-low-risk-myelod-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.548Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/healthy-volunteers-phase-iii</loc>
    <lastmod>2026-05-28T21:41:44.563Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/piclidenoson-plaque-psoriasis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:44.577Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bupropion-hydrochloride-naltrexone-hydro-obesity-non-alcoholic-fatty-liver-diseas-phase-iv</loc>
    <lastmod>2026-05-28T21:41:44.592Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nucresiran-transthyretin-amyloidosis-with-cardiomyo-phase-iii</loc>
    <lastmod>2026-05-28T21:41:44.606Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rimegepant-migraine-episodic-migraine-phase-iv</loc>
    <lastmod>2026-05-28T21:41:44.619Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-triple-negative-breast-cancer-metastatic-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.634Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tebentafusp-metastatic-uveal-melanoma-metastatic-uve-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.647Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cemiplimab-non-small-cell-lung-cancer-resected-stag-phase-iii</loc>
    <lastmod>2026-05-28T21:41:44.660Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-sodium-phosphate-acute-hypoxemic-respiratory-failure-acut-phase-iii</loc>
    <lastmod>2026-05-28T21:41:44.673Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluvoxamine-maleate-depressive-disorder-phase-iv</loc>
    <lastmod>2026-05-28T21:41:44.687Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mepolizumab-chronic-rhinosinusitis-with-nasal-polyps-phase-iv</loc>
    <lastmod>2026-05-28T21:41:44.700Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atopic-dermatitis-phase-i-2</loc>
    <lastmod>2026-05-28T21:41:44.713Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylcysteine-glycine-l-lysine-acetate-living-donor-renal-transplantation-renal-not-applicable</loc>
    <lastmod>2026-05-28T21:41:44.727Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/evorpacept-breast-cancer-metastatic-breast-cancer-h-phase-i-ii-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.744Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dii235-elevated-lipoprotein-a-lp-a-atherosclero-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.762Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/paclitaxel-borderline-resectable-pancreatic-ductal-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.776Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lebrikizumab-atopic-dermatitis-atopic-eczema-phase-iv</loc>
    <lastmod>2026-05-28T21:41:44.790Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/crgd-zw800-1-squamous-cell-carcinoma-of-the-larynx-an-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:44.803Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pf-08052667-non-muscle-invasive-bladder-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:41:44.816Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/intestifix-multidrug-resistant-enterobacteriaceae-c-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.829Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rilzabrutinib-graves-disease-graves-orbitopathy-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.843Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colecalciferol-healthy-volunteers-phase-iii</loc>
    <lastmod>2026-05-28T21:41:44.856Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gsk5764227-gastrointestinal-neoplasms-colorectal-ca-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:44.870Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ag-946-phosphate-sickle-cell-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.883Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allergenic-extract-of-grass-pollen-mixtu-allergic-rhinoconjunctivitis-grass-polle-phase-ii</loc>
    <lastmod>2026-05-28T21:41:44.896Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/budoprutug-immune-thrombocytopenia-itp-primary-immu-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:44.910Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-igg4-s228p-monoclonal-antibody-aga-venous-thromboembolism-vte-thromboemboli-phase-iii</loc>
    <lastmod>2026-05-28T21:41:44.923Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/influenza-virus-a-darwin-9-2021-san-010-influenza-phase-iii</loc>
    <lastmod>2026-05-28T21:41:44.936Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ciclopirox-onychomycosis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:44.949Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-adipose-tissue-derived-stroma-crohn-s-disease-fistulising-crohn-s-dise-phase-iv</loc>
    <lastmod>2026-05-28T21:41:44.963Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pertechnetate-99mtc-sodium-ovarian-cancer-early-stage-ovarian-cance-phase-iii</loc>
    <lastmod>2026-05-28T21:41:44.977Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/respiratory-syncytial-virus-glycoprotein-respiratory-syncytial-virus-infection-phase-ii</loc>
    <lastmod>2026-05-28T21:41:45.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/daratumumab-myalgic-encephalomyelitis-chronic-fatigu-phase-ii</loc>
    <lastmod>2026-05-28T21:41:45.014Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/synthetic-double-stranded-sirna-oligonuc-hypertriglyceridemia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:45.027Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cytolityc-t-lymphocytes-cytomegalovirus-infection-post-allogenei-phase-ii</loc>
    <lastmod>2026-05-28T21:41:45.040Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gadobutrol-cerebrospinal-fluid-disorders-cognitive</loc>
    <lastmod>2026-05-28T21:41:45.053Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/leuprorelin-acetate-early-breast-cancer-not-applicable</loc>
    <lastmod>2026-05-28T21:41:45.066Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/melatonin-primary-insomnia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:45.080Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zanidatamab-gastroesophageal-adenocarcinoma-metastat-phase-ii</loc>
    <lastmod>2026-05-28T21:41:45.093Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/domvanalimab-neuroendocrine-carcinoma-gastro-enteropa-phase-ii</loc>
    <lastmod>2026-05-28T21:41:45.107Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/teclistamab-multiple-myeloma-relapsed-refractory-mul-phase-ii</loc>
    <lastmod>2026-05-28T21:41:45.120Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adeno-associated-virus-vector-serotype-8-stargardt-disease-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:45.133Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cladribine-multiple-sclerosis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:45.146Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/povetacicept-primary-membranous-nephropathy-membranou-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:45.159Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-type-1-diabetes-phase-iii</loc>
    <lastmod>2026-05-28T21:41:45.173Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ropivacaine-hydrochloride-renal-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:41:45.186Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cangrelor-ischemic-stroke-with-intracranial-large-phase-iv</loc>
    <lastmod>2026-05-28T21:41:45.200Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aldesleukin-systemic-lupus-erythematosus-systemic-sc-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:45.213Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ecubectedin-soft-tissue-sarcoma-other-solid-tumors-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:45.226Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ceftriaxone-respiratory-tract-infections-bacterial-p-not-applicable</loc>
    <lastmod>2026-05-28T21:41:45.240Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aprotinin-human-fibrinogen-calcium-chlor-gastric-cancer-esophagojejunal-anastomot-not-applicable</loc>
    <lastmod>2026-05-28T21:41:45.253Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pelacarsen-atherosclerotic-cardiovascular-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:41:45.267Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eplerenone-hypertension-phase-iv</loc>
    <lastmod>2026-05-28T21:41:45.281Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/platinum-resistant-ovarian-cancer-cdh6-p-phase-i</loc>
    <lastmod>2026-05-28T21:41:45.294Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jx10-acute-ischemic-stroke-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:45.308Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/budoprutug-immune-thrombocytopenia-itp-primary-immu-phase-i-ii-2</loc>
    <lastmod>2026-05-28T21:41:45.321Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylcysteine-amyotrophic-lateral-sclerosis-als-phase-ii</loc>
    <lastmod>2026-05-28T21:41:45.335Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/niraparib-tosylate-monohydrate-urothelial-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:45.349Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ferric-carboxymaltose-gastric-cancer</loc>
    <lastmod>2026-05-28T21:41:45.362Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pravastatin-sodium-intrauterine-growth-restriction-preeclam-phase-iii</loc>
    <lastmod>2026-05-28T21:41:45.376Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cetuximab-metastatic-colorectal-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:41:45.389Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apixaban-roux-en-y-gastric-bypass-phase-iv</loc>
    <lastmod>2026-05-28T21:41:45.403Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-locally-advanced-colon-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:41:45.417Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colchicine-opium-standardized-powdered-t-type-1-diabetes-phase-iv</loc>
    <lastmod>2026-05-28T21:41:45.430Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tibulizumab-hidradenitis-suppurativa-phase-ii</loc>
    <lastmod>2026-05-28T21:41:45.443Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2-4-4-aminomethyl-1-oxo-2h-phthalazin-6-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:45.457Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/omalizumab-episodic-migraine-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:45.472Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/triamcinolone-acetonide-frozen-shoulder-not-applicable</loc>
    <lastmod>2026-05-28T21:41:45.486Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apg777-atopic-dermatitis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:45.501Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azithromycin-cellular-senescence-inflammatory-status-phase-iv</loc>
    <lastmod>2026-05-28T21:41:45.515Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metastatic-solid-tumor-advanced-solid-tu-phase-i</loc>
    <lastmod>2026-05-28T21:41:45.529Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regn17372-relapsed-refractory-multiple-myeloma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:45.543Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/xdivane-melanoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:45.556Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dalteparin-sodium-liver-resection-venous-thromboembolism-phase-iv</loc>
    <lastmod>2026-05-28T21:41:45.570Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lu-ah70212-narcolepsy-phase-i</loc>
    <lastmod>2026-05-28T21:41:45.584Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ale-p03-advanced-or-metastatic-solid-tumors-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:45.597Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gsk4418959a-mismatch-repair-deficient-dmmr-microsate-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:45.611Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/galvokimig-atopic-dermatitis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:45.624Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dabigatran-etexilate-atrial-fibrillation-venous-thromboemboli-not-applicable</loc>
    <lastmod>2026-05-28T21:41:45.637Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxytocin-healthy-volunteers-phase-iii</loc>
    <lastmod>2026-05-28T21:41:45.650Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/botulinum-toxin-type-a-haemagglutinin-co-complex-ventral-hernia-ventral-hernia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:45.663Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dermatophagoides-pteronyssinus-depigment-allergic-rhinoconjunctivitis-asthma-cont-phase-iii</loc>
    <lastmod>2026-05-28T21:41:45.676Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regorafenib-metastatic-colorectal-cancer-ras-mutant-phase-ii</loc>
    <lastmod>2026-05-28T21:41:45.690Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/morphine-hydrochloride-severe-refractory-cancer-pain-phase-iv</loc>
    <lastmod>2026-05-28T21:41:45.703Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clobetasol-propionate-hand-osteoarthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:45.716Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hydrocortisone-pancreatic-cancer-resectable-head-of-pan-phase-iv</loc>
    <lastmod>2026-05-28T21:41:45.730Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly3537031-alcohol-use-disorder-phase-iii</loc>
    <lastmod>2026-05-28T21:41:45.743Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-metastatic-colorectal-cancer-locally-adv-phase-iv</loc>
    <lastmod>2026-05-28T21:41:45.762Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-type-2-diabetes-mellitus-cardiovascular-phase-iv</loc>
    <lastmod>2026-05-28T21:41:45.775Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/verteporfin-primary-localized-prostate-cancer-prosta-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:45.788Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tislelizumab-esophagogastric-adenocarcinoma-gastroeso-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:41:45.801Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/desmopressin-nocturnal-enuresis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:45.815Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/magnesium-sulfate-postoperative-pain-phase-iv</loc>
    <lastmod>2026-05-28T21:41:45.827Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tamoxifen-cystic-fibrosis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:45.841Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/darolutamide-prostate-cancer-hormone-sensitive-prosta-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:45.853Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/survodutide-overweight-obesity-phase-iii</loc>
    <lastmod>2026-05-28T21:41:45.866Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/letrozole-breast-cancer-hr-positive-her2-negative-phase-iii</loc>
    <lastmod>2026-05-28T21:41:45.880Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dronabinol-cannabidiol-multiple-sclerosis-chronic-neuropathic-p-phase-ii</loc>
    <lastmod>2026-05-28T21:41:45.893Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluvoxamine-maleate-post-acute-covid-19-syndrome-post-covid</loc>
    <lastmod>2026-05-28T21:41:45.907Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/th9619-solid-tumors-non-small-cell-lung-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:41:45.921Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ferric-carboxymaltose-chronic-heart-failure-iron-deficiency-phase-iv</loc>
    <lastmod>2026-05-28T21:41:45.934Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cagrilintide-overweight-and-obesity-type-2-diabetes-phase-iii</loc>
    <lastmod>2026-05-28T21:41:45.948Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zigakibart-iga-nephropathy-phase-iii</loc>
    <lastmod>2026-05-28T21:41:45.961Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/encephalitis-japanese-inactivated-whole-japanese-encephalitis-vaccination-phase-iv</loc>
    <lastmod>2026-05-28T21:41:45.974Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cagrilintide-overweight-obesity-phase-iii</loc>
    <lastmod>2026-05-28T21:41:45.987Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-peritoneal-mesothelioma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:45.999Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dota-siglec-9-labelled-with-gallium-68-rheumatoid-arthritis-vasculitis-pulmonar-phase-i</loc>
    <lastmod>2026-05-28T21:41:46.012Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-690517-heart-failure-phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.026Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cusp06-advanced-renal-cell-carcinoma-platinum-r-phase-i</loc>
    <lastmod>2026-05-28T21:41:46.038Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pf-08049820-atopic-dermatitis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:46.052Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-metastatic-triple-negative-breast-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:41:46.065Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dry-extract-from-psilocybe-cubensis-15-2-treatment-resistant-depression-phase-ii</loc>
    <lastmod>2026-05-28T21:41:46.078Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cagrilintide-and-semaglutide-obesity-phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.091Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mitomycin-mitomycin-c-non-muscle-invasive-bladder-cancer-high-phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.104Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/evenamide-treatment-resistant-schizophrenia-schizo-phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.118Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aldesleukin-autism-spectrum-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:41:46.132Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/szv-1287-neuropathic-pain-phase-i</loc>
    <lastmod>2026-05-28T21:41:46.145Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aripiprazole-behaviors-that-challenge-abnormal-behavi-not-applicable</loc>
    <lastmod>2026-05-28T21:41:46.157Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azetukalner-bipolar-depression-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:46.172Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-her2-positive-metastatic-colorectal-canc-phase-ii</loc>
    <lastmod>2026-05-28T21:41:46.185Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/finerenone-heart-failure-left-ventricular-systolic-phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.198Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iloprost-sickle-cell-disease-with-vaso-occlusive-phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.213Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-igg1-kappa-monoclonal-antibody-aga-severe-asthma-phase-iv</loc>
    <lastmod>2026-05-28T21:41:46.226Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/finerenone-heart-failure-with-left-ventricular-syst-phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.239Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ivabradine-hydrochloride-acute-heart-failure-dilated-cardiomyopat-phase-iv</loc>
    <lastmod>2026-05-28T21:41:46.252Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gallium-68ga-human-albumin-as-macroaggre-primary-lung-cancer-pulmonary-metastases-phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.265Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clostridium-botulinum-neurotoxin-type-a-wrinkles-fine-lines</loc>
    <lastmod>2026-05-28T21:41:46.278Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/platelet-concentrate-glaucoma-dry-eye-disease</loc>
    <lastmod>2026-05-28T21:41:46.291Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ad-700-metabolic-dysfunction-phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.304Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-endometrial-cancer-her2-expressing-phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.317Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/linvoseltamab-multiple-myeloma-newly-diagnosed-transpl-phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.330Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/budoprutug-tnt119-systemic-lupus-erythematosus-phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.344Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-glioblastoma-malignant-glioma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.357Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ribociclib-hormone-receptor-positive-her2-negative-phase-iv</loc>
    <lastmod>2026-05-28T21:41:46.370Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/9-4-cyclohexyloxyphenyl-7-methyl-3-4-dih-major-depressive-disorder-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:46.382Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dronabinol-cannabidiol-tuberous-sclerosis-complex-refractory-ep-phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.396Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amoxicillin-clavulanic-acid-acute-uncomplicated-appendicitis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.408Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenalidomide-cutaneous-lupus-erythematosus-phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.421Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bjt-778-chronic-hepatitis-d-infection-hepatitis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.434Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-rheumatoid-arthritis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:46.448Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mt-501-crohn-s-disease-ulcerative-colitis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:46.462Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly4175408-solid-tumor-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:41:46.476Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nicotinic-acid-prediabetes-phase-ii</loc>
    <lastmod>2026-05-28T21:41:46.489Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-advanced-solid-tumors-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:46.502Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regulatory-t-cells-immune-hyperactivation-associated-with-c</loc>
    <lastmod>2026-05-28T21:41:46.516Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/xenon-133xe-radiation-induced-lung-injury-lung-cance-phase-ii</loc>
    <lastmod>2026-05-28T21:41:46.529Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/68ga-ga-nota-ae105-glioma-not-applicable</loc>
    <lastmod>2026-05-28T21:41:46.543Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/caba-201-idiopathic-inflammatory-myopathy-dermato-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:46.561Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/piperacillin-tazobactam-bacterial-infection-infectious-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:41:46.576Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-metastatic-non-small-cell-lung-cancer-ns-phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.590Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dasatinib-asymptomatic-hiv-1-infection-phase-ii</loc>
    <lastmod>2026-05-28T21:41:46.603Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/repinatrabit-phenylketonuria-phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.616Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cannabidiol-head-and-neck-squamous-cell-carcinoma-he-phase-iv</loc>
    <lastmod>2026-05-28T21:41:46.629Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nilotinib-chronic-myeloid-leukaemia-in-remission-c-phase-ii-ctis-2024-519472-69</loc>
    <lastmod>2026-05-28T21:12:14.316Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levosimendan-heart-failure-with-reduced-ejection-frac-phase-iv</loc>
    <lastmod>2026-05-28T21:41:46.642Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methylphenidate-hydrochloride-attention-deficit-hyperactivity-disorder-phase-iv</loc>
    <lastmod>2026-05-28T21:41:46.656Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dupilumab-chronic-rhinosinusitis-with-nasal-polyps-phase-iv</loc>
    <lastmod>2026-05-28T21:41:46.668Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vinorelbine-metastatic-colorectal-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:41:46.681Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-metastatic-breast-cancer-her3-mutant-met-phase-ii</loc>
    <lastmod>2026-05-28T21:41:46.694Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bbo-10203-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:41:46.708Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/concentrate-of-proteolytic-enzymes-enric-venous-leg-ulcer-venous-stasis-ulcer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.721Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/parecoxib-spontaneous-subarachnoid-hemorrhage-phase-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:41:46.734Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/9-4-cyclohexyloxyphenyl-7-methyl-3-4-dih-major-depressive-disorder-phase-iii-3</loc>
    <lastmod>2026-05-28T21:41:46.748Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avacopan-anca-associated-vasculitis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.761Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/9-4-cyclohexyloxyphenyl-7-methyl-3-4-dih-major-depressive-disorder-phase-iii-4</loc>
    <lastmod>2026-05-28T21:41:46.774Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.788Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/9-4-cyclohexyloxyphenyl-7-methyl-3-4-dih-major-depressive-disorder-phase-iii-5</loc>
    <lastmod>2026-05-28T21:41:46.802Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/opevesostat-tosilate-breast-cancer-ovarian-cancer-endometrial-phase-ii</loc>
    <lastmod>2026-05-28T21:41:46.815Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vrdn-003-thyroid-eye-disease-endocrine-ophthalmop-phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.828Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-78278343-metastatic-castration-resistant-prostate-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:46.841Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ciracigene-golparvovec-canavan-disease-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:46.857Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aln-5288-alzheimer-s-disease-phase-i</loc>
    <lastmod>2026-05-28T21:41:46.871Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/thiopental-sodium-major-depressive-disorder-phase-iv</loc>
    <lastmod>2026-05-28T21:41:46.885Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/felzartamab-late-isolated-microvascular-inflammation-phase-ii</loc>
    <lastmod>2026-05-28T21:41:46.899Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/udonitrectag-diabetic-foot-ulcer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:46.912Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/1-3s-8s-9s-10r-13s-14s-17s-3-benzyloxy-1-down-syndrome-phase-ii</loc>
    <lastmod>2026-05-28T21:41:46.925Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vorasidenib-idh-mutant-astrocytoma-who-grade-2-or-3-phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.939Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylcysteine-ultra-high-risk-of-psychosis-first-episo-phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.952Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/coramitug-transthyretin-amyloid-cardiomyopathy-att-phase-iii</loc>
    <lastmod>2026-05-28T21:41:46.966Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/epinephrine-bitartrate-lidocaine-hydroch-hand-surgery-foot-surgery-not-applicable</loc>
    <lastmod>2026-05-28T21:41:46.979Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/palbociclib-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:46.993Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isotretinoin-oligozoospermia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:47.006Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/budesonide-acute-radiation-proctitis-prostate-cance-phase-ii</loc>
    <lastmod>2026-05-28T21:41:47.019Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-a-melanoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:47.033Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tranexamic-acid-hip-fracture-phase-iv</loc>
    <lastmod>2026-05-28T21:41:47.046Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-cutaneous-melanoma-melanoma-stage-iib-me-phase-ii</loc>
    <lastmod>2026-05-28T21:41:47.059Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/felzartamab-iga-nephropathy-phase-iii</loc>
    <lastmod>2026-05-28T21:41:47.073Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dronabinol-cannabidiol-advanced-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:47.086Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gskvx000000044501-urinary-tract-infection-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:47.099Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metolazone-congestive-heart-failure-not-applicable</loc>
    <lastmod>2026-05-28T21:41:47.113Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alxn1920-primary-membranous-nephropathy-phase-ii</loc>
    <lastmod>2026-05-28T21:41:47.126Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/deferoxamine-mesilate-type-1-diabetes-mellitus-phase-ii</loc>
    <lastmod>2026-05-28T21:41:47.139Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regn7508-venous-thromboembolism-vte-phase-iii</loc>
    <lastmod>2026-05-28T21:41:47.152Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/humanised-igg1-monoclonal-antibody-again-obesity-overweight-phase-ii</loc>
    <lastmod>2026-05-28T21:41:47.165Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/budoprutug-tnt119-systemic-lupus-erythematosus-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:47.178Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zorevunersen-sodium-dravet-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:41:47.192Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/esophageal-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:41:47.205Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gentamicin-sulfate-sepsis-not-applicable</loc>
    <lastmod>2026-05-28T21:41:47.218Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obe-cel-refractory-progressive-multiple-sclerosi-phase-i</loc>
    <lastmod>2026-05-28T21:41:47.231Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/r-6-3-3-difluoro-1-methylpiperidin-4-yl-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:47.244Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sovateltide-acute-ischemic-stroke-phase-iii</loc>
    <lastmod>2026-05-28T21:41:47.257Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ro7673396-advanced-solid-tumors-with-ras-mutations-phase-i</loc>
    <lastmod>2026-05-28T21:41:47.270Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bilastine-allergic-rhinoconjunctivitis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:47.283Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sulfur-hexafluoride-hypoxic-ischemic-encephalopathy-neonate-not-applicable</loc>
    <lastmod>2026-05-28T21:41:47.296Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxygen-interstitial-lung-disease-ild-phase-ii</loc>
    <lastmod>2026-05-28T21:41:47.308Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/biotin-methylcrotonylglycinuria-biotinidase-def-phase-iii</loc>
    <lastmod>2026-05-28T21:41:47.321Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ritlecitinib-tosilate-alopecia-areata-phase-iii</loc>
    <lastmod>2026-05-28T21:41:47.334Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nomegestrol-acetate-estradiol-hemihydrat-vulvovaginal-atrophy-vaginal-atrophy-not-applicable</loc>
    <lastmod>2026-05-28T21:41:47.348Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levocarnitine-magnesium-chloride-hexahyd-end-stage-renal-disease-esrd-phase-ii</loc>
    <lastmod>2026-05-28T21:41:47.361Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azacitidine-acute-myeloid-leukemia-myelodysplastic-s-phase-i</loc>
    <lastmod>2026-05-28T21:41:47.374Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/psma-t4-prostate-cancer-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:47.387Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elebsiran-chronic-hepatitis-d-hdv-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:41:47.400Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/furosemide-sodium-peritoneal-dialysis-heart-failure-phase-iv</loc>
    <lastmod>2026-05-28T21:41:47.413Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ro7795081-obesity-overweight-phase-iii</loc>
    <lastmod>2026-05-28T21:41:47.426Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carfilzomib-multiple-myeloma-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:47.440Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/remdesivir-covid-19-phase-ii</loc>
    <lastmod>2026-05-28T21:41:47.452Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/indocyanine-green-melanoma-oral-cavity-cancer-penile-cance-phase-ii</loc>
    <lastmod>2026-05-28T21:41:47.465Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/deupsilocin-besilate-major-depressive-disorder-phase-iii</loc>
    <lastmod>2026-05-28T21:41:47.479Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutetium-177lu-zadavotide-guraxetan-prostate-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:41:47.494Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/major-depressive-disorder-anhedonia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:47.507Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/177lu-psma-i-t-oligometastatic-prostate-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:47.520Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mps-112-mps-106-mps-213-mps-102-mps-216-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:47.533Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/177lu-psma-i-t-psma-positive-advanced-metastatic-solid-phase-ii</loc>
    <lastmod>2026-05-28T21:41:47.546Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lurbinectedin-desmoplastic-small-round-cell-tumor-phase-ii</loc>
    <lastmod>2026-05-28T21:41:47.559Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mitomycin-low-grade-upper-tract-urothelial-carcino-phase-iii</loc>
    <lastmod>2026-05-28T21:41:47.572Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-relapsing-remitting-multiple-sclerosis-m-phase-iv</loc>
    <lastmod>2026-05-28T21:41:47.585Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bumetanide-down-syndrome-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:47.598Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/teclistamab-amyloid-light-chain-amyloidosis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:47.611Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tibulizumab-systemic-sclerosis-systemic-sclerosis-as-phase-ii</loc>
    <lastmod>2026-05-28T21:41:47.625Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly3537031-asthma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:47.639Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-unresectable-stage-iii-iv-metastatic-mel-phase-ii</loc>
    <lastmod>2026-05-28T21:41:47.652Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dienogest-endometriosis-healthy-volunteers-phase-iii</loc>
    <lastmod>2026-05-28T21:41:47.665Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cetuximab-metastatic-colorectal-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:47.679Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iloprost-frostbite-injury-to-extremities-phase-iv</loc>
    <lastmod>2026-05-28T21:41:47.692Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/chlormadinone-acetate-ethinylestradiol-hormonal-contraception-phase-iv</loc>
    <lastmod>2026-05-28T21:41:47.706Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hydrochlorothiazide-hypertrophic-cardiomyopathy-hypertrophic-phase-iv</loc>
    <lastmod>2026-05-28T21:41:47.719Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vonafexor-healthy-volunteers-renal-impairment-meta-phase-i</loc>
    <lastmod>2026-05-28T21:41:47.732Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/benzylpenicillin-sodium-group-g-streptococcal-colonization-group-phase-iv</loc>
    <lastmod>2026-05-28T21:41:47.745Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/4-6-aminopyridazin-3-yl-piperidin-1-yl-5-focal-segmental-glomerulosclerosis-genet</loc>
    <lastmod>2026-05-28T21:41:47.758Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clostridium-botulinum-neurotoxin-serotyp-cervical-dystonia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:47.772Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clone-specific-car-t-cell-therapy-amyloid-light-chain-al-amyloidosis-relap-phase-i</loc>
    <lastmod>2026-05-28T21:41:47.786Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/itraconazole-glioblastoma-multiforme-phase-i</loc>
    <lastmod>2026-05-28T21:41:47.799Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2-amino-9-2r-4r-5r-4-hydroxy-5-hydroxyme-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:47.812Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-benzoate-treatment-resistant-schizophrenia-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:47.825Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rifabutin-prosthetic-joint-infection-prosthesis-re-phase-iv</loc>
    <lastmod>2026-05-28T21:41:47.838Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/esketamine-hydrochloride-healthy-volunteers-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:47.851Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluorouracil-metastatic-colorectal-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:41:47.864Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/riociguat-chronic-thromboembolic-pulmonary-hyperte-phase-iv</loc>
    <lastmod>2026-05-28T21:41:47.878Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/melatonin-psychiatric-disorder-insomnia</loc>
    <lastmod>2026-05-28T21:41:47.891Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methadone-hydrochloride-postoperative-pain-after-cardiac-surgery</loc>
    <lastmod>2026-05-28T21:41:47.904Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/degarelix-metastatic-prostate-cancer-prostate-canc-phase-iv</loc>
    <lastmod>2026-05-28T21:41:47.918Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/omecamtiv-mecarbil-heart-failure-with-reduced-ejection-frac-phase-iii</loc>
    <lastmod>2026-05-28T21:41:47.932Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/linvoseltamab-relapsed-refractory-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:47.947Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oregovomab-advanced-epithelial-ovarian-cancer-fallo-phase-iii</loc>
    <lastmod>2026-05-28T21:41:47.960Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apazunersen-angelman-syndrome-phase-ii</loc>
    <lastmod>2026-05-28T21:41:47.974Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sufentanil-traumatic-limb-injury-pain-in-limb-not-applicable</loc>
    <lastmod>2026-05-28T21:41:47.987Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eptinezumab-migraine-phase-iv</loc>
    <lastmod>2026-05-28T21:41:48.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fianlimab-pleural-mesothelioma-phase-iv</loc>
    <lastmod>2026-05-28T21:41:48.013Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-tirumotecan-endometrial-carcinoma-pmmr-phase-iii</loc>
    <lastmod>2026-05-28T21:41:48.027Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ravulizumab-paroxysmal-nocturnal-hemoglobinuria-pnh</loc>
    <lastmod>2026-05-28T21:41:48.040Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/debio-1453p-gonorrhoea-sexually-transmitted-infectio-phase-i</loc>
    <lastmod>2026-05-28T21:41:48.053Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tislelizumab-non-small-cell-lung-cancer-stage-iii-pd-phase-ii</loc>
    <lastmod>2026-05-28T21:41:48.067Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/idp-121-chronic-lymphocytic-leukemia-b-cell-lymp-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:48.081Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tdt-3-acute-lymphoblastic-leukemia-lymphoblast-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:48.094Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxaliplatin-colon-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:48.107Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aup1602-c-diabetic-foot-ulcer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:48.121Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ipn01195-advanced-solid-tumour-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:48.134Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutetium-177lu-edotreotide-neuroendocrine-tumor-bronchopulmonary-ne-phase-ii</loc>
    <lastmod>2026-05-28T21:41:48.147Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-t-cells-transduced-with-lenti-cd19-positive-relapsed-refractory-b-cell-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:48.160Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-t-cells-transduced-with-a-ret-relapsed-refractory-central-nervous-syst-phase-i</loc>
    <lastmod>2026-05-28T21:41:48.172Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ab521-solid-tumors-clear-cell-renal-cell-carci-phase-i</loc>
    <lastmod>2026-05-28T21:41:48.185Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/probenecid-focal-epilepsy-phase-iv</loc>
    <lastmod>2026-05-28T21:41:48.198Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vis171-systemic-lupus-erythematosus-immune-medi-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:41:48.212Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-r-2-2-amino-3-1h-indol-3-yl-propa-geographic-atrophy-secondary-to-non-neov-phase-ii</loc>
    <lastmod>2026-05-28T21:41:48.225Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sulfur-hexafluoride-vesicoureteral-reflux-phase-iv</loc>
    <lastmod>2026-05-28T21:41:48.238Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zasocitinib-zasocitinib-plaque-psoriasis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:48.251Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-haematopoietic-stem-and-proge-autosomal-recessive-osteopetrosis-tcirg1-phase-i-ii-ctis-2024-518972-30-00</loc>
    <lastmod>2026-05-28T21:12:13.367Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/leniolisib-phosphate-primary-immunodeficiency-phase-iv</loc>
    <lastmod>2026-05-28T21:41:48.264Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/timbetasin-acetate-neurotrophic-keratitis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:48.277Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/migalastat-hydrochloride-fabry-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:41:48.291Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obinutuzumab-primary-membranous-nephropathy-phase-iv</loc>
    <lastmod>2026-05-28T21:41:48.304Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iam1363-her2-altered-relapsed-refractory-maligna-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:48.317Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/riluzole-spinocerebellar-ataxia-type-7-phase-iv</loc>
    <lastmod>2026-05-28T21:41:48.330Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/linezolid-staphylococcus-aureus-bacteremia</loc>
    <lastmod>2026-05-28T21:41:48.344Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluoroethyltyrosine-f-18-acth-dependent-hypercortisolism-cushing-phase-iii</loc>
    <lastmod>2026-05-28T21:41:48.358Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly4057996-type-1-diabetes-type-2-diabetes-healthy-phase-i</loc>
    <lastmod>2026-05-28T21:41:48.371Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-infertility-not-applicable</loc>
    <lastmod>2026-05-28T21:41:48.385Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hydrocortisone-ph-eur-adrenal-hyperplasia-primary-adrenal-insu-phase-iv</loc>
    <lastmod>2026-05-28T21:41:48.398Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lavender-oil-major-depressive-disorder-mild-to-modera-phase-iii</loc>
    <lastmod>2026-05-28T21:41:48.411Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/temozolomide-glioblastoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:48.424Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/visugromab-hepatocellular-carcinoma-unresectable-or-phase-ii</loc>
    <lastmod>2026-05-28T21:41:48.437Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gemcitabine-hydrochloride-intrahepatic-cholangiocarcinoma-non-meta-phase-ii</loc>
    <lastmod>2026-05-28T21:41:48.451Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belimumab-systemic-lupus-erythematosus</loc>
    <lastmod>2026-05-28T21:41:48.464Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fentanyl-breakthrough-cancer-pain-cancer-related-phase-iii</loc>
    <lastmod>2026-05-28T21:41:48.477Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etoposide-medulloblastoma-metastatic-embryonal-cen-phase-ii</loc>
    <lastmod>2026-05-28T21:41:48.491Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-differentiated-thyroid-carcinoma-poorly-phase-ii</loc>
    <lastmod>2026-05-28T21:41:48.504Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cor-1167-sodium-worsening-heart-failure-phase-ii</loc>
    <lastmod>2026-05-28T21:41:48.519Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/triptorelin-endometriosis-adenomyosis-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:48.532Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ptc-vs-tc-post-transplant-viral-reactivation-after-phase-iii</loc>
    <lastmod>2026-05-28T21:41:48.546Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tozorakimab-asthma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:48.560Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/liraglutide-knee-osteoarthritis-knee-synovitis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:48.573Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-hepatocellular-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:48.587Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/treosulfan-ewing-sarcoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:48.600Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/transthyretin-cardiac-amyloidosis</loc>
    <lastmod>2026-05-28T21:41:48.613Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lamivudine-dolutegravir-hiv-1-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:41:48.628Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alectinib-non-small-cell-lung-cancer-alk-positive-phase-ii</loc>
    <lastmod>2026-05-28T21:41:48.641Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/live-bcg-bacilli-bacillus-calmette-gueri-radiologically-isolated-syndrome-phase-iv</loc>
    <lastmod>2026-05-28T21:41:48.654Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/felzartamab-antibody-mediated-rejection-kidney-trans-phase-iii</loc>
    <lastmod>2026-05-28T21:41:48.667Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/coramitug-transthyretin-amyloid-cardiomyopathy-att-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:48.680Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/exemestane-breast-cancer-endocrine-responsive-early-phase-iii</loc>
    <lastmod>2026-05-28T21:41:48.693Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anal-fistula-associated-with-crohn-s-dis</loc>
    <lastmod>2026-05-28T21:41:48.707Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zoledronic-acid-rotator-cuff-tear-osteoporosis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:48.721Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colecalciferol-glycerol-vitamin-d-insufficiency-third-molar-wisd-phase-ii</loc>
    <lastmod>2026-05-28T21:41:48.735Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ghz339-atopic-dermatitis-moderate-to-severe-phase-ii</loc>
    <lastmod>2026-05-28T21:41:48.747Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rly-2608-pik3ca-related-overgrowth-spectrum-pros-phase-ii</loc>
    <lastmod>2026-05-28T21:41:48.762Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/perflubutane-lymphatic-imaging-not-applicable</loc>
    <lastmod>2026-05-28T21:41:48.776Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bgb-16673-chronic-lymphocytic-leukemia-small-lymph-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:48.789Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tt125-802-advanced-non-small-cell-lung-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:48.803Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cetuximab-head-and-neck-squamous-cell-carcinoma-he-phase-ii</loc>
    <lastmod>2026-05-28T21:41:48.816Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bleomycin-basal-cell-carcinoma-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:48.828Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/decitabine-cedazuridine-melanoma-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:48.841Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cetuximab-metastatic-colorectal-cancer-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:48.854Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/epcoritamab-relapsed-or-refractory-waldenstrom-macro-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:48.867Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prasugrel-chronic-coronary-syndrome-phase-iv</loc>
    <lastmod>2026-05-28T21:41:48.881Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/egl-003-atopic-dermatitis-phase-i</loc>
    <lastmod>2026-05-28T21:41:48.894Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/septic-cholestasis-phase-i</loc>
    <lastmod>2026-05-28T21:41:48.907Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zolbetuximab-metastatic-gastroesophageal-adenocarcino-phase-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:41:48.920Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/plasmodium-falciparum-strain-nf54-sporoz-malaria-phase-iv</loc>
    <lastmod>2026-05-28T21:41:48.933Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lysergide-attention-deficit-hyperactivity-disorder-phase-iv</loc>
    <lastmod>2026-05-28T21:41:48.960Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/daratumumab-multiple-myeloma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:48.974Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-phosphate-prostate-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:48.987Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ozanimod-relapsing-multiple-sclerosis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:49.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd6793-chronic-obstructive-pulmonary-disease-co-phase-ii</loc>
    <lastmod>2026-05-28T21:41:49.013Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acalabrutinib-chronic-lymphocytic-leukaemia-cll-small-phase-ii</loc>
    <lastmod>2026-05-28T21:41:49.027Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cxcl12-expressed-by-lactobacillus-wound-healing-skin-wounds-phase-i</loc>
    <lastmod>2026-05-28T21:41:49.042Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anti-t-lymphocyte-immunoglobulin-for-hum-kidney-transplant-borderline-t-cell-reje-not-applicable</loc>
    <lastmod>2026-05-28T21:41:49.056Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/delgocitinib-palmoplantar-pustulosis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:49.069Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/diphtheria-toxoid-tetanus-toxoid-pertuss-pregnancy-not-applicable</loc>
    <lastmod>2026-05-28T21:41:49.099Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n38-1-3-dihydroxypropan-2-yl-2-epi-ampho-invasive-mould-infection-phase-ii</loc>
    <lastmod>2026-05-28T21:41:49.114Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rilvegostomig-metastatic-non-small-cell-lung-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:49.127Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bimekizumab-hidradenitis-suppurativa-axial-spondyloa-phase-iii</loc>
    <lastmod>2026-05-28T21:41:49.140Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methadone-hydrochloride-bone-metastases-cancer-related-bone-pain</loc>
    <lastmod>2026-05-28T21:41:49.154Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ketamine-hydrochloride-bariatric-surgery-not-applicable</loc>
    <lastmod>2026-05-28T21:41:49.167Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pentoxifylline-medication-related-osteonecrosis-of-the-phase-ii</loc>
    <lastmod>2026-05-28T21:41:49.181Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ferric-maltol-iron-deficiency</loc>
    <lastmod>2026-05-28T21:41:49.193Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regn7508-cancer-associated-thrombosis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:49.206Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bretovameran-fibrodysplasia-ossificans-progressiva-fo-phase-iv</loc>
    <lastmod>2026-05-28T21:41:49.219Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pasireotide-post-bariatric-hypoglycaemia-postprandia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:49.232Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/esketamine-hydrochloride-schizophrenia-schizoaffective-disorder-d</loc>
    <lastmod>2026-05-28T21:41:49.245Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/empagliflozin-acute-decompensated-heart-failure-phase-iii</loc>
    <lastmod>2026-05-28T21:41:49.258Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cisplatin-prostate-cancer-castration-resistant-pro-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:49.271Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-peripheral-blood-derived-haem-neuroblastoma-relapsed-or-refractory-hig-phase-iv</loc>
    <lastmod>2026-05-28T21:41:49.283Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anakinra-systemic-juvenile-idiopathic-arthritis-s</loc>
    <lastmod>2026-05-28T21:41:49.299Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pf-07999415-phase-i</loc>
    <lastmod>2026-05-28T21:41:49.313Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ambroxol-parkinson-s-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:41:49.325Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/beta-lactam-antibacterials-penicillins-acute-lower-respiratory-tract-infection-phase-iv</loc>
    <lastmod>2026-05-28T21:41:49.339Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/depemokimab-eosinophilic-asthma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:49.352Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rivaroxaban-short-bowel-syndrome-not-applicable</loc>
    <lastmod>2026-05-28T21:41:49.365Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-type-2-diabetes-not-applicable-ctis-2024-518682-95</loc>
    <lastmod>2026-05-28T21:12:12.808Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2-o-2-methoxyethyl-modified-antisense-ol-angelman-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:41:49.379Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/enlicitide-chloride-heterozygous-familial-hypercholesterolem-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:49.393Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/liraglutide-obesity-not-applicable</loc>
    <lastmod>2026-05-28T21:41:49.406Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levothyroxine-sodium-acute-unilateral-vestibulopathy-auvp-ves-phase-iv</loc>
    <lastmod>2026-05-28T21:41:49.419Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bleomycin-sulfate-locally-advanced-pancreatic-cancer-pancr-phase-ii</loc>
    <lastmod>2026-05-28T21:41:49.432Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/opt101-chronic-kidney-disease-chronic-kidney-di-phase-i</loc>
    <lastmod>2026-05-28T21:41:49.451Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ethinylestradiol-norgestimate-contraception-phase-iv</loc>
    <lastmod>2026-05-28T21:41:49.464Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bjt-778-chronic-hepatitis-d-hepatitis-delta-infe-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:49.477Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-90301900-locally-advanced-head-and-neck-squamous-phase-iii</loc>
    <lastmod>2026-05-28T21:41:49.490Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lmt503-healthy-volunteers-phase-i</loc>
    <lastmod>2026-05-28T21:41:49.503Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ferric-derisomaltose-chronic-heart-failure-iron-deficiency-phase-iii</loc>
    <lastmod>2026-05-28T21:41:49.516Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/maridebart-cafraglutide-obstructive-sleep-apnea-phase-iii</loc>
    <lastmod>2026-05-28T21:41:49.529Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/landiolol-hydrochloride-postoperative-atrial-fibrillation-atrial-phase-iii</loc>
    <lastmod>2026-05-28T21:41:49.542Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ivonescimab-pleural-mesothelioma-phase-iv</loc>
    <lastmod>2026-05-28T21:41:49.556Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-fibroblasts-chronic-refractory-wounds-skin-wound-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:49.569Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/potassium-chloride-ph-eur-sodium-chlorid-amyotrophic-lateral-sclerosis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:49.583Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd5492-systemic-lupus-erythematosus-rheumatoid-phase-i</loc>
    <lastmod>2026-05-28T21:41:49.596Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nintedanib-hereditary-haemorrhagic-telangiectasia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:49.609Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hydroxychloroquine-sulfate-multiple-sclerosis-progressive-multiple-phase-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:41:49.622Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-locally-advanced-rectal-cancer-stage-ii-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:49.635Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-inflammatory-bowel-disease-rheumatic-dis-not-applicable</loc>
    <lastmod>2026-05-28T21:41:49.648Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/risankizumab-ulcerative-colitis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:49.661Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ficerafusp-alfa-head-and-neck-squamous-cell-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:49.674Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-hiv-1-infection-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:49.687Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-neovascular-age-related-macular-degenera-phase-iii</loc>
    <lastmod>2026-05-28T21:41:49.700Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mrna-4157-non-small-cell-lung-cancer-stage-iv-squa-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:49.714Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/silibinin-cushing-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:49.727Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-systemic-lupus-erythematosus</loc>
    <lastmod>2026-05-28T21:41:49.740Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carboplatin-small-cell-lung-cancer-extensive-stage-s-phase-iii</loc>
    <lastmod>2026-05-28T21:41:49.753Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/18f-mc225-alzheimer-s-disease-sporadic-cerebral-am-phase-iv</loc>
    <lastmod>2026-05-28T21:41:49.766Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mesalamine-ulcerative-colitis-phase-ii-4</loc>
    <lastmod>2026-05-28T21:41:49.780Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/folinic-acid-locally-advanced-colon-adenocarcinoma-pm-phase-iii</loc>
    <lastmod>2026-05-28T21:41:49.793Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/v540c-vaccine-human-papillomavirus-infection-phase-i</loc>
    <lastmod>2026-05-28T21:41:49.807Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/izalontamab-brengitecan-non-small-cell-lung-cancer-egfr-mutated-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:49.822Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ciprofloxacin-hydrochloride-ciprofloxaci-bacterial-infection-phase-iv</loc>
    <lastmod>2026-05-28T21:41:49.835Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/guanabenz-acetate-vanishing-white-matter-leukodystrophy-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:49.848Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/km-023-olmsted-syndrome-phase-i</loc>
    <lastmod>2026-05-28T21:41:49.861Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vedolizumab-ulcerative-colitis-crohn-s-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:41:49.875Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-4-1r-4r-4-hydroxy-4-methylcyclohexyl-m-chronic-lymphocytic-leukemia-cll-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:49.888Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iodixanol-breast-lesions-breast-pathology-phase-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:41:49.901Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cutaneous-t-cell-lymphoma-phase-i</loc>
    <lastmod>2026-05-28T21:41:49.914Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/baclofen-cerebral-palsy-not-applicable</loc>
    <lastmod>2026-05-28T21:41:49.927Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/advanced-solid-tumors-phase-i-5</loc>
    <lastmod>2026-05-28T21:41:49.940Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluoroestradiol-f-18-metastatic-hormone-receptor-positive-her-phase-ii</loc>
    <lastmod>2026-05-28T21:41:49.953Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inavolisib-early-stage-pik3ca-mutated-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:49.966Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/evolocumab-atherosclerotic-cardiovascular-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:41:49.978Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/moxifloxacin-acute-appendicitis-uncomplicated-acute-a-not-applicable</loc>
    <lastmod>2026-05-28T21:41:49.993Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd8205-advanced-metastatic-endometrial-cancer-e-phase-iii</loc>
    <lastmod>2026-05-28T21:41:50.007Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/urinary-tract-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:41:50.020Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/luspatercept-myelodysplastic-syndrome-with-del-5q-ane-phase-ii</loc>
    <lastmod>2026-05-28T21:41:50.033Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prednisolone-rheumatoid-arthritis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:50.050Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-cutaneous-melanoma-resectable-high-risk-phase-i</loc>
    <lastmod>2026-05-28T21:41:50.063Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/edoxaban-chronic-thromboembolic-pulmonary-hyperte-phase-iv</loc>
    <lastmod>2026-05-28T21:41:50.076Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pegfilgrastim-severe-chronic-neutropenia-phase-iv</loc>
    <lastmod>2026-05-28T21:41:50.094Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bleximenib-acute-myeloid-leukemia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:50.108Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sotatercept-pulmonary-arterial-hypertension-phase-iv</loc>
    <lastmod>2026-05-28T21:41:50.125Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ex-vivo-fused-normal-allogeneic-human-my-duchenne-muscular-dystrophy-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:50.138Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/daridorexant-nocturnal-enuresis</loc>
    <lastmod>2026-05-28T21:41:50.151Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/leuprorelin-acetate-prostate-cancer-intermediate-risk-locali-phase-iv</loc>
    <lastmod>2026-05-28T21:41:50.164Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-faecal-microbiota-hidradenitis-suppurativa-phase-iv</loc>
    <lastmod>2026-05-28T21:41:50.177Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/xylometazoline-hydrochloride-chronic-obstructive-pulmonary-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:41:50.190Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/morphine-hydrochloride-postoperative-pain-following-elective-ca-phase-iv</loc>
    <lastmod>2026-05-28T21:41:50.204Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cabozantinib-advanced-clear-cell-renal-cell-carcinoma-phase-iv</loc>
    <lastmod>2026-05-28T21:41:50.216Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/landiolol-hydrochloride-cardiac-arrest-ventricular-fibrillation-phase-iv</loc>
    <lastmod>2026-05-28T21:41:50.230Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/indocyanine-green-acute-cholecystitis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:50.243Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cetuximab-colorectal-cancer-metastatic-colorectal-phase-ii</loc>
    <lastmod>2026-05-28T21:41:50.256Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-2-2-10-2-4-3-4-2-2-cyano-4-4-difluor-peyronie-s-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:41:50.269Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-pioglitazone-spironolactone-early-puberty-accelerated-bone-maturatio-phase-ii</loc>
    <lastmod>2026-05-28T21:41:50.282Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/moxifloxacin-uncomplicated-acute-appendicitis</loc>
    <lastmod>2026-05-28T21:41:50.308Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/propofol-neonatal-respiratory-distress-syndrome</loc>
    <lastmod>2026-05-28T21:41:50.321Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gemtuzumab-ozogamicin-acute-promyelocytic-leukemia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:50.334Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-colorectal-cancer-colorectal-cancer-with-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:50.347Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pregabalin-spinal-cord-injury-sci-spasticity-spasti</loc>
    <lastmod>2026-05-28T21:41:50.361Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fosfomycin-calcium-uncomplicated-urinary-tract-infection-phase-iv</loc>
    <lastmod>2026-05-28T21:41:50.374Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/propofol-sedation-during-medical-procedure-bronch-phase-iv</loc>
    <lastmod>2026-05-28T21:41:50.388Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/triptorelin-breast-cancer-acute-leukemia-hodgkin-lym-phase-iii</loc>
    <lastmod>2026-05-28T21:41:50.401Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gilteritinib-acute-myeloid-leukemia-newly-diagnosed-f-phase-ii</loc>
    <lastmod>2026-05-28T21:41:50.414Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/datopotamab-deruxtecan-triple-negative-breast-cancer-brain-meta-phase-ii</loc>
    <lastmod>2026-05-28T21:41:50.427Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ale1-hypophosphatasia-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:50.440Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/insulin-human-persistent-corneal-epithelial-defect-not-applicable</loc>
    <lastmod>2026-05-28T21:41:50.453Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/wef-001-advanced-kras-mutant-solid-tumours-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:50.466Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mannitol-end-stage-renal-disease-kidney-transplan-not-applicable</loc>
    <lastmod>2026-05-28T21:41:50.479Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/68ga-nodaga-glu-cyclo-arg-gly-asp-d-tyr-chronic-ischemic-heart-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:50.492Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexmedetomidine-procedural-sedation-procedural-pain</loc>
    <lastmod>2026-05-28T21:41:50.506Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abd-3001-acute-myeloid-leukemia-relapsed-refracto-phase-i</loc>
    <lastmod>2026-05-28T21:41:50.520Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tacrolimus-lung-transplantation-phase-iii</loc>
    <lastmod>2026-05-28T21:41:50.533Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levosimendan-failure-to-wean-from-invasive-ventilatio-phase-iv</loc>
    <lastmod>2026-05-28T21:41:50.546Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fexofenadine-hydrochloride-advanced-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:50.560Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amoxicillin-clavulanic-acid-malignant-brain-tumor-leptomeningeal-dis-phase-i</loc>
    <lastmod>2026-05-28T21:41:50.573Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sertraline-gastroesophageal-adenocarcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:50.587Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/diclofenac-sodium-macular-hole-vitreomacular-traction-synd-not-applicable</loc>
    <lastmod>2026-05-28T21:41:50.600Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clemizole-hydrochloride-dravet-syndrome-phase-ii</loc>
    <lastmod>2026-05-28T21:41:50.613Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-non-small-cell-lung-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:50.626Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rintatolimod-locally-advanced-pancreatic-adenocarcino-phase-ii</loc>
    <lastmod>2026-05-28T21:41:50.639Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cd19-targeted-car-ink-cells-systemic-lupus-erythematosus-lupus-nephr-phase-iii</loc>
    <lastmod>2026-05-28T21:41:50.651Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/enzalutamide-metastatic-castration-resistant-prostate-phase-iv</loc>
    <lastmod>2026-05-28T21:41:50.668Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bleomycin-vulvar-intraepithelial-neoplasia-vin-gra-phase-ii</loc>
    <lastmod>2026-05-28T21:41:50.680Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nebivolol-hydrochloride-hypertension-juvenile-hypertension</loc>
    <lastmod>2026-05-28T21:41:50.694Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/paracetamol-palliative-care</loc>
    <lastmod>2026-05-28T21:41:50.707Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/esketamine-major-depressive-disorder-phase-iii</loc>
    <lastmod>2026-05-28T21:41:50.720Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bleomycin-sulfate-ph-eur-warthin-s-tumor-phase-iv</loc>
    <lastmod>2026-05-28T21:41:50.739Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-breast-cancer-chemotherapy-induced-cardi-phase-ii</loc>
    <lastmod>2026-05-28T21:41:50.752Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/evo756-potassium-chronic-spontaneous-urticaria-moderate-t-phase-ii</loc>
    <lastmod>2026-05-28T21:41:50.765Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/indocyanine-green-cervical-cancer-vulvar-cancer-vaginal-ca-phase-ii</loc>
    <lastmod>2026-05-28T21:41:50.778Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cannabidiol-healthy-volunteers-phase-iv</loc>
    <lastmod>2026-05-28T21:41:50.792Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-kidney-transplant-recipient-phase-iv</loc>
    <lastmod>2026-05-28T21:41:50.806Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tirzepatide-schizophrenia-alcohol-use-disorder-phase-iv</loc>
    <lastmod>2026-05-28T21:41:50.819Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-kidney-transplant-recipient</loc>
    <lastmod>2026-05-28T21:41:50.833Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vancomycin-hydrochloride-clostridioides-difficile-infection-phase-iv</loc>
    <lastmod>2026-05-28T21:41:50.846Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pyrazinamide-tuberculosis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:50.858Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/magnesium-sulfate-knee-osteoarthritis-gonarthrosis-total-k-phase-iii</loc>
    <lastmod>2026-05-28T21:41:50.871Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/patritumab-deruxtecan-hepatoblastoma-rhabdomyosarcoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:50.884Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hydroxychloroquine-sulfate-cutaneous-mastocytosis-indolent-systemic-not-applicable</loc>
    <lastmod>2026-05-28T21:41:50.897Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-coronary-artery-disease-prediabetes</loc>
    <lastmod>2026-05-28T21:41:50.910Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-chronic-kidney-disease-kidney-failure-le-phase-ii</loc>
    <lastmod>2026-05-28T21:41:50.923Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/magnesium-l-aspartate-hydrochloride-trih-postoperative-hypoparathyroidism-not-applicable</loc>
    <lastmod>2026-05-28T21:41:50.936Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/meropenem-anhydrous-bacteremia-bloodstream-infection-due-to-phase-iv</loc>
    <lastmod>2026-05-28T21:41:50.949Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tumor-infiltrating-lymphocytes-til-metastatic-melanoma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:50.962Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prednisone-systemic-lupus-erythematosus-phase-iv</loc>
    <lastmod>2026-05-28T21:41:50.976Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cemiplimab-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:50.989Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rifampicin-mycobacterium-avium-complex-mac-pulmonar</loc>
    <lastmod>2026-05-28T21:41:51.003Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluconazole-laryngeal-leukoplakia-phase-iv</loc>
    <lastmod>2026-05-28T21:41:51.017Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-peritoneal-metastases-of-colorectal-canc-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:51.030Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tezacaftor-elexacaftor-ivacaftor-cystic-fibrosis-not-applicable</loc>
    <lastmod>2026-05-28T21:41:51.043Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogenic-adipose-tissue-derived-mesench-diabetic-foot-ulcer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:51.056Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cln-978-systemic-lupus-erythematosus-phase-i</loc>
    <lastmod>2026-05-28T21:41:51.069Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-colon-adenocarcinoma-upper-rectal-adenoc-phase-iii</loc>
    <lastmod>2026-05-28T21:41:51.082Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ctx112-systemic-lupus-erythematosus-sle-systemi-phase-i</loc>
    <lastmod>2026-05-28T21:41:51.103Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colecalciferol-graft-versus-host-disease-acute-and-chro-phase-ii</loc>
    <lastmod>2026-05-28T21:41:51.116Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-glaucoma-phase-iv</loc>
    <lastmod>2026-05-28T21:41:51.129Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aortic-stenosis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:51.144Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bfb759-hidradenitis-suppurativa-phase-ii</loc>
    <lastmod>2026-05-28T21:41:51.156Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azithromycin-chronic-atelectasis-cystic-lung-malforma-phase-iv</loc>
    <lastmod>2026-05-28T21:41:51.171Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/omalizumab-asthma-allergic-severe-asthma-phase-iv</loc>
    <lastmod>2026-05-28T21:41:51.183Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/valsartan-kidney-transplant-recipients-post-transp-phase-iv</loc>
    <lastmod>2026-05-28T21:41:51.196Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylsalicylic-acid-chronic-coronary-syndrome-acute-coronary-not-applicable</loc>
    <lastmod>2026-05-28T21:41:51.209Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluoroethoxybenzovesamicol-f-18-apathy-stroke-not-applicable</loc>
    <lastmod>2026-05-28T21:41:51.222Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/wef-001-advanced-kras-mutant-solid-tumours-phase-i-ii-2</loc>
    <lastmod>2026-05-28T21:41:51.236Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/valproic-acid-metastatic-pancreatic-ductal-adenocarcin-phase-ii</loc>
    <lastmod>2026-05-28T21:41:51.249Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/daratumumab-relapsed-refractory-multiple-myeloma-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:41:51.262Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tafamidis-transthyretin-cardiac-amyloidosis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:51.275Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rabbit-anti-human-thymocyte-immunoglobul-acute-myeloid-leukemia-myelodysplastic-s-phase-iv</loc>
    <lastmod>2026-05-28T21:41:51.287Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ramipril-acetylsalicylic-acid-atorvastat-ischemic-heart-disease-acute-coronary-sy-phase-iv</loc>
    <lastmod>2026-05-28T21:41:51.300Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/evolocumab-carotid-artery-stenosis</loc>
    <lastmod>2026-05-28T21:41:51.313Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cefazolin-twin-pregnancy-pregnancy-phase-iv</loc>
    <lastmod>2026-05-28T21:41:51.326Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atacicept-iga-nephropathy-membranous-nephropathy-f-phase-ii-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:51.339Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/enoxaparin-sodium-respiratory-insufficiency-respiratory-fa-phase-iv</loc>
    <lastmod>2026-05-28T21:41:51.353Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-ethyl-8-methyl-1-thia-4-8-diazaspiro-alzheimer-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:51.366Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colorectal-cancer-braf-v600e-mutated-phase-iv</loc>
    <lastmod>2026-05-28T21:41:51.379Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/flutemetamol-18f-preclinical-alzheimer-s-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:41:51.392Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elraglusib-haematological-malignancy-solid-tumor-pa-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:51.405Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/onfekafusp-alfa-basal-cell-carcinoma-cutaneous-squamous-phase-ii</loc>
    <lastmod>2026-05-28T21:41:51.418Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ponsegromab-cancer-cachexia-metastatic-pancreatic-du-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:51.431Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nnc0487-0111-hepatic-impairment-phase-iii</loc>
    <lastmod>2026-05-28T21:41:51.445Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isoflurane-critical-condition-phase-iv</loc>
    <lastmod>2026-05-28T21:41:51.457Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/humanised-igg1-monoclonal-antibody-again-facioscapulohumeral-muscular-dystrophy-f-phase-iii</loc>
    <lastmod>2026-05-28T21:41:51.470Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dermatophagoides-pteronyssinus-allergens-allergic-rhinitis-allergic-rhinoconjunct-phase-ii</loc>
    <lastmod>2026-05-28T21:41:51.483Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ravulizumab-immunoglobulin-a-nephropathy-iga-nephrop-phase-iii</loc>
    <lastmod>2026-05-28T21:41:51.496Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogenic-adipose-tissue-derived-mesench-systemic-sclerosis-systemic-scleroderma-phase-iv</loc>
    <lastmod>2026-05-28T21:41:51.509Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fenfluramine-hydrochloride-myoclonic-astatic-epilepsy-doose-syndrom-phase-iv</loc>
    <lastmod>2026-05-28T21:41:51.522Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/edoxaban-atrial-fibrillation-intracranial-hemorrh-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:51.535Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-chronic-lymphocytic-leukemia-small-lymph-phase-ii</loc>
    <lastmod>2026-05-28T21:41:51.548Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imifoplatin-metastatic-castration-resistant-prostate-phase-i-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:51.562Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-serum-albumin-septic-shock-acute-kidney-injury-not-applicable</loc>
    <lastmod>2026-05-28T21:41:51.575Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pirtobrutinib-immune-thrombocytopenia-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:51.588Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tofacitinib-ulcerative-colitis</loc>
    <lastmod>2026-05-28T21:41:51.600Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allergen-extracts-peanut-extract-nanopar-peanut-allergy-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:51.613Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-diffuse-large-b-cell-lymphoma-not-applicable</loc>
    <lastmod>2026-05-28T21:41:51.626Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lyophilized-bacterial-lysates-of-haemoph-lower-respiratory-tract-infections-wheez-phase-iii</loc>
    <lastmod>2026-05-28T21:41:51.638Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-non-small-cell-lung-cancer-phase-ii-2</loc>
    <lastmod>2026-05-28T21:41:51.651Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hydrocortisone-kidney-transplant-recipient-septic-shock-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:51.664Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ioa-244-advanced-solid-tumours-metastatic-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:41:51.677Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-hydrochloride-invasive-breast-cancer-er-positive-lumin-phase-ii</loc>
    <lastmod>2026-05-28T21:41:51.690Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nirsevimab-respiratory-syncytial-virus-rsv-infectio-phase-iii</loc>
    <lastmod>2026-05-28T21:41:51.703Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etoposide-testicular-seminoma-stage-i-testicular-c-phase-iii</loc>
    <lastmod>2026-05-28T21:41:51.716Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd4063-dilated-cardiomyopathy-pln-r14del-dilate-phase-i</loc>
    <lastmod>2026-05-28T21:41:51.729Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/stroke-phase-i</loc>
    <lastmod>2026-05-28T21:41:51.742Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-triple-negative-breast-cancer-her2-low-m-phase-ii</loc>
    <lastmod>2026-05-28T21:41:51.755Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/losartan-potassium-aortic-stenosis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:51.768Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tulisokibart-rheumatoid-arthritis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:51.781Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/relugolix-intermediate-risk-prostate-cancer-phase-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:41:51.793Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clindamycin-cardiac-surgery-with-extracorporeal-circ-phase-ii</loc>
    <lastmod>2026-05-28T21:41:51.806Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cabozantinib-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:51.819Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/parkinson-s-disease-phase-i-3</loc>
    <lastmod>2026-05-28T21:41:51.832Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/baricitinib-polymyalgia-rheumatica</loc>
    <lastmod>2026-05-28T21:41:51.844Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/spy001-001-moderately-to-severely-active-ulcerative-phase-ii</loc>
    <lastmod>2026-05-28T21:41:51.857Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colchicine-chronic-heart-failure-heart-failure-with-phase-ii</loc>
    <lastmod>2026-05-28T21:41:51.870Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amivantamab-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:51.883Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bleomycin-sulfate-recurrent-vulvar-carcinoma-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:51.896Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trospium-chloride-xanomeline-tartrate-bipolar-i-disorder-mania-or-mixed-featur-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:51.909Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/annamycin-acute-myeloid-leukemia-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:51.922Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-non-small-cell-lung-cancer-stage-iii-non-phase-ii</loc>
    <lastmod>2026-05-28T21:41:51.935Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aurocell-tx-muscle-invasive-bladder-cancer-mibc-phase-i</loc>
    <lastmod>2026-05-28T21:41:51.948Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ferric-derisomaltose-colorectal-cancer-iron-deficiency-phase-iv</loc>
    <lastmod>2026-05-28T21:41:51.961Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sat-3247-oxalate-duchenne-muscular-dystrophy-phase-ii</loc>
    <lastmod>2026-05-28T21:41:51.974Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alteplase-acute-ischemic-stroke-phase-ii</loc>
    <lastmod>2026-05-28T21:41:51.987Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tadalafil-parkinson-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:52.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atorvastatin-non-small-cell-lung-cancer-triple-negati-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:52.013Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nipocalimab-generalized-myasthenia-gravis-myasthenia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.026Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/thn391-alzheimer-s-disease-phase-i</loc>
    <lastmod>2026-05-28T21:41:52.039Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutetium-177lu-zadavotide-guraxetan-recurrent-grade-3-and-grade-4-glioma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:52.052Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/artesunate-cancer-advanced-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.065Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adeno-associated-viral-vector-serotype-8-usher-syndrome-type-1b-ush1b-retinitis-p-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:52.078Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amoxicillin-clavulanic-acid-posterior-urethral-valves-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.097Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sasanlimab-non-muscle-invasive-bladder-cancer-bladd-phase-ii</loc>
    <lastmod>2026-05-28T21:41:52.110Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-generalized-myasthenia-gravis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.124Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aflibercept-neovascular-age-related-macular-degenera-phase-iv</loc>
    <lastmod>2026-05-28T21:41:52.137Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rilvegostomig-advanced-hepatocellular-carcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.150Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/doxorubicin-hydrochloride-recurrent-ovarian-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:52.163Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/skin-inflammation-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.177Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/haloperidol-first-episode-psychosis-remitted-psychos</loc>
    <lastmod>2026-05-28T21:41:52.189Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bw-20805-hereditary-angioedema-hae-type-i-ii-phase-ii</loc>
    <lastmod>2026-05-28T21:41:52.203Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/phosphocreatine-sodium-respiratory-arrest-threatened-airway-tac-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.216Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-hydrochloride-idiopathic-infertility-phase-ii</loc>
    <lastmod>2026-05-28T21:41:52.229Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/synthetic-double-stranded-sirna-oligonuc-severe-hypertriglyceridemia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.242Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carfilzomib-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.255Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/napabucasin-metastatic-pancreatic-adenocarcinoma-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:52.272Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxaliplatin-metastatic-colorectal-cancer-liver-metas-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.285Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trabectedin-soft-tissue-sarcoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:52.298Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/retatrutide-type-2-diabetes-mellitus-diabetes-mellit-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.311Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nitrous-oxide-oxygen-pediatric-respiratory-disorder-phase-iv</loc>
    <lastmod>2026-05-28T21:41:52.323Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogenic-bone-marrow-derived-mesenchyma-relapsed-or-refractory-extracranial-soli-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.336Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/volrustomig-colorectal-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:52.349Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/evolocumab-acute-myocardial-infarction-phase-iv</loc>
    <lastmod>2026-05-28T21:41:52.362Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/resomelagon-idiopathic-membranous-nephropathy-nephro-phase-iv</loc>
    <lastmod>2026-05-28T21:41:52.376Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tucatinib-her2-positive-breast-cancer-breast-cance-phase-i</loc>
    <lastmod>2026-05-28T21:41:52.389Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sepofarsen-leber-congenital-amaurosis-lca-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.402Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/recombinant-varicella-zoster-virus-glyco-rheumatic-diseases-phase-iv</loc>
    <lastmod>2026-05-28T21:41:52.415Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etuvetidigene-autotemcel-wiskott-aldrich-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.428Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dalbavancin-prosthetic-joint-infection-staphylococca</loc>
    <lastmod>2026-05-28T21:41:52.440Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autlogous-keratinocytes-and-fibroblasts-recessive-dystrophic-epidermolysis-bullo-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:52.453Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alanine-arginine-deferoxamine-histidine-liver-transplantation-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.466Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/divarasib-non-small-cell-lung-cancer-non-squamous-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.479Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-pancreatic-cancer-borderline-resectable-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:52.492Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutetium-lu-177-aby-271-her2-positive-metastatic-breast-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:41:52.509Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/osimertinib-egfr-mutated-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.522Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tislelizumab-esophageal-squamous-cell-carcinoma-advan-phase-iv</loc>
    <lastmod>2026-05-28T21:41:52.535Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/12m-1s-2s-n-63s-4s-z-11-ethyl-12-2-s-1-m-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.548Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/piperacillin-as-piperacillin-sodium-pipe-chronic-obstructive-pulmonary-disease-cy-phase-iv</loc>
    <lastmod>2026-05-28T21:41:52.560Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/advanced-solid-tumors-phase-i-6</loc>
    <lastmod>2026-05-28T21:41:52.574Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/citicoline-delirium-cognitive-decline-hip-fracture-phase-iv</loc>
    <lastmod>2026-05-28T21:41:52.587Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dermatophagoides-farinae-allergoid-gluta-allergic-rhinitis-rhinoconjunctivitis-al-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.599Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/umeclidinium-bromide-vilanterol-chronic-obstructive-pulmonary-disease-he-phase-iv</loc>
    <lastmod>2026-05-28T21:41:52.613Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ritlecitinib-tosilate-hidradenitis-suppurativa-phase-ii</loc>
    <lastmod>2026-05-28T21:41:52.625Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inclisiran-primary-hypercholesterolaemia-heterozygo-phase-iv</loc>
    <lastmod>2026-05-28T21:41:52.638Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/stk-012-non-small-cell-lung-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:52.652Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-psychosis-obsessive-compulsive-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:41:52.665Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/midazolam-hydrochloride-preoperative-anxiety-not-applicable</loc>
    <lastmod>2026-05-28T21:41:52.678Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/empagliflozin-metabolic-dysfunction-associated-steatoh-phase-iv</loc>
    <lastmod>2026-05-28T21:41:52.691Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-cutaneous-melanoma-advanced-stage-iii-iv-not-applicable</loc>
    <lastmod>2026-05-28T21:41:52.703Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etx-19477-advanced-solid-malignancies-ovarian-epit-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:52.716Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd5335-advanced-platinum-resistant-epithelial-o-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.729Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutetium-177lu-oxodotreotide-gastroenteropancreatic-neuroendocrine-tu-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.744Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ig-tregs-graft-versus-host-disease-gvhd-allogenei-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:52.757Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gsk5784283-asthma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:52.770Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gozetotide-prostate-cancer-not-applicable</loc>
    <lastmod>2026-05-28T21:41:52.786Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vutrisiran-hereditary-hattr-transthyretin-amyloidos-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.799Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ruxolitinib-acute-lymphoblastic-leukemia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:52.813Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ruxolitinib-atopic-dermatitis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.826Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fecal-microbiota-transplantation-irritable-bowel-syndrome-clostridioides-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.840Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hiv-1-infection-phase-i</loc>
    <lastmod>2026-05-28T21:41:52.853Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/l-ascorbic-acid-complex-regional-pain-syndrome-crps-type-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.866Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-colon-cancer-stage-ii-iii-phase-ii</loc>
    <lastmod>2026-05-28T21:41:52.878Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxycodone-hydrochloride-patients-undergoing-planned-surgery-clas-phase-iv</loc>
    <lastmod>2026-05-28T21:41:52.891Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-microsatellite-instability-high-msi-h-mi-phase-iv</loc>
    <lastmod>2026-05-28T21:41:52.905Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/kayvirus-dsm-33474-kayvirus-dsm-33473-pb-surgical-wound-infection-surgical-wound-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:52.917Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/testosterone-cipionate-paraphilic-disorder-compulsive-sexual-be-phase-iv</loc>
    <lastmod>2026-05-28T21:41:52.930Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/selinexor-relapsed-or-refractory-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.944Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/betamethasone-sodium-phosphate-adenovirus-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.957Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carvedilol-cirrhotic-portal-hypertension-hepatic-ci-phase-iv</loc>
    <lastmod>2026-05-28T21:41:52.969Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nitrous-oxide-oxygen-critical-illness-requiring-mechanical-ve-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.983Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trametinib-acute-lymphoblastic-leukemia-relapsed-or-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:41:52.996Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/infigratinib-achondroplasia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:53.008Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-hepatocellular-carcinoma-phase-i</loc>
    <lastmod>2026-05-28T21:41:53.021Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/floxuridine-intrahepatic-cholangiocarcinoma-unresect-phase-ii</loc>
    <lastmod>2026-05-28T21:41:53.034Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/graphite-pulmonary-embolism-not-applicable</loc>
    <lastmod>2026-05-28T21:41:53.047Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bisoprolol-fumarate-hydrochlorothiazide-idiopathic-ventricular-fibrillation-out</loc>
    <lastmod>2026-05-28T21:41:53.061Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pirfenidone-progressive-pulmonary-fibrosis-idiopathi-phase-ii</loc>
    <lastmod>2026-05-28T21:41:53.074Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/megestrol-acetate-adrenocortical-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:53.088Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lupus-nephritis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:53.101Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/respiratory-syncytial-virus-glycoprotein-inflammatory-rheumatic-disease-rheumatoi-phase-iv</loc>
    <lastmod>2026-05-28T21:41:53.114Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lb-0702-phase-i</loc>
    <lastmod>2026-05-28T21:41:53.128Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/betamethasone-sodium-phosphate-postoperative-lower-limb-edema-primary-h-phase-iv</loc>
    <lastmod>2026-05-28T21:41:53.142Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lb-0702-phase-i-2</loc>
    <lastmod>2026-05-28T21:41:53.155Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/raxtozinameran-sars-cov-2-infection-covid-19-immunity-phase-iv</loc>
    <lastmod>2026-05-28T21:41:53.168Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenalidomide-diffuse-large-b-cell-lymphoma-high-grade-phase-ii</loc>
    <lastmod>2026-05-28T21:41:53.181Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/immunoglobulin-a-immunoglobulin-g-immuno-septic-shock-phase-iii</loc>
    <lastmod>2026-05-28T21:41:53.194Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pfspz-larc2-vaccine-malaria-phase-iii</loc>
    <lastmod>2026-05-28T21:41:53.206Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutetium-177lu-oxodotreotide-midgut-neuroendocrine-tumor-small-intest</loc>
    <lastmod>2026-05-28T21:41:53.219Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxaliplatin-locally-advanced-rectal-cancer-rectal-ca-phase-iii</loc>
    <lastmod>2026-05-28T21:41:53.232Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etoposide-acute-myeloid-leukemia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:53.245Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutetium-177lu-vipivotide-tetraxetan-clear-cell-renal-cell-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:53.258Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eganelisib-acute-myeloid-leukemia-relapsed-refracto-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:53.271Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/icef15-autologous-skeletal-derived-muscl-fecal-incontinence-phase-iii</loc>
    <lastmod>2026-05-28T21:41:53.284Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-chronic-kidney-disease-ckd-chronic-kidne-phase-iv</loc>
    <lastmod>2026-05-28T21:41:53.297Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-solid-tumours-solid-tumours-with-homolog-phase-ii</loc>
    <lastmod>2026-05-28T21:41:53.310Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mibavademab-monogenic-obesity-congenital-leptin-defi-phase-iii</loc>
    <lastmod>2026-05-28T21:41:53.323Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cagrilintide-obesity-postmenopausal-state-phase-iii</loc>
    <lastmod>2026-05-28T21:41:53.336Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dry-extract-from-psilocybe-cubensis-15-2-severe-alcohol-use-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:41:53.349Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluconazole-invasive-fungal-infection-phase-iv</loc>
    <lastmod>2026-05-28T21:41:53.362Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-anca-associated-vasculitis-aav-phase-iv</loc>
    <lastmod>2026-05-28T21:41:53.375Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ac-ala-gly-ser-cys-1-tyr-cys-2-ser-gly-p-penile-squamous-cell-carcinoma-tongue-sq-phase-ii</loc>
    <lastmod>2026-05-28T21:41:53.388Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rondaptivon-pegol-von-willebrand-disease-type-2b-phase-ii</loc>
    <lastmod>2026-05-28T21:41:53.401Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/l-lysine-acetate-l-tryptophan-l-histidin-protein-energy-wasting-in-nephrotic-synd-phase-iii</loc>
    <lastmod>2026-05-28T21:41:53.417Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-faecal-microbiota-pooled-ulcerative-colitis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:53.429Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd4360-gastric-cancer-gastroesophageal-junction-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:53.442Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clindamycin-planned-limb-amputation-phase-iii</loc>
    <lastmod>2026-05-28T21:41:53.454Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cariprazine-schizophrenia-phase-iv</loc>
    <lastmod>2026-05-28T21:41:53.467Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bnt327-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:53.480Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pf-07275315-moderate-to-severe-asthma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:53.492Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/177lu-evg321-small-cell-lung-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:41:53.505Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hafnium-oxide-non-small-cell-lung-cancer-stage-iii-loc-phase-ii</loc>
    <lastmod>2026-05-28T21:41:53.518Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ebastine-metastatic-castration-resistant-prostate-phase-ii</loc>
    <lastmod>2026-05-28T21:41:53.531Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tofacitinib-rheumatoid-arthritis-psoriatic-arthritis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:53.544Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alglucosidase-alfa-pompe-disease-glycogenosis-type-ii-acid-phase-iv</loc>
    <lastmod>2026-05-28T21:41:53.557Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tacrolimus-liver-transplant-rejection-prophylaxis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:53.570Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-metastatic-colorectal-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:53.583Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atorvastatin-philadelphia-negative-chronic-myeloproli-phase-iv</loc>
    <lastmod>2026-05-28T21:41:53.596Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vorolanib-wet-age-related-macular-degeneration-phase-iii</loc>
    <lastmod>2026-05-28T21:41:53.608Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prednisone-idiopathic-iga-nephropathy-phase-iii</loc>
    <lastmod>2026-05-28T21:41:53.621Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hydroxypropylbetadex-niemann-pick-disease-type-c1-phase-iii</loc>
    <lastmod>2026-05-28T21:41:53.635Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/estradiol-postpartum-depression-perinatal-depressi-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:53.648Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/morphine-hydrochloride-healthy-volunteers-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:53.660Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/daratumumab-primary-plasma-cell-leukemia-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:53.674Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tocilizumab-psoriatic-arthritis-rheumatoid-arthritis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:53.686Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-melanoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:53.700Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/healthy-volunteers-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:53.713Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fremanezumab-chronic-migraine-phase-iii</loc>
    <lastmod>2026-05-28T21:41:53.726Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cisplatin-hpv-positive-oropharyngeal-squamous-cell-phase-ii</loc>
    <lastmod>2026-05-28T21:41:53.739Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/botulinum-toxin-type-a-tinnitus-bruxism-jaw-muscle-myalgia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:53.752Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/89zr-zr-dfo-cit-013-inflammatory-mediated-immune-diseases-phase-ii</loc>
    <lastmod>2026-05-28T21:41:53.764Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/omtx705-non-small-cell-lung-cancer-non-squamous-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:53.777Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avelumab-urothelial-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:53.790Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rgt-419b-breast-cancer-estrogen-receptor-positive-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:53.803Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bupropion-hydrochloride-major-depressive-disorder-phase-iv</loc>
    <lastmod>2026-05-28T21:41:53.816Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gt-002-schizophrenia-delusional-disorder-acute-phase-ii</loc>
    <lastmod>2026-05-28T21:41:53.830Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/emrusolmin-multiple-system-atrophy-phase-ii</loc>
    <lastmod>2026-05-28T21:41:53.842Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mps-112-mps-106-mps-213-mps-102-mps-216-non-small-cell-lung-cancer-metastatic-phase-ii</loc>
    <lastmod>2026-05-28T21:41:53.855Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/landiolol-hydrochloride-septic-shock-with-hypercontractility</loc>
    <lastmod>2026-05-28T21:41:53.868Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bv100-healthy-volunteers-acinetobacter-baumann-phase-i</loc>
    <lastmod>2026-05-28T21:41:53.881Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cefiderocol-end-stage-renal-disease-patients-on-peri-phase-iii</loc>
    <lastmod>2026-05-28T21:41:53.893Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenvatinib-squamous-non-small-cell-lung-cancer-hepa-phase-i</loc>
    <lastmod>2026-05-28T21:41:53.906Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-heart-failure-phase-iv</loc>
    <lastmod>2026-05-28T21:41:53.919Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cholecalciferol-colecalciferol-transient-hypercalciuria-phase-iv</loc>
    <lastmod>2026-05-28T21:41:53.931Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/modified-vaccinia-ankara-bavarian-nordic-monkeypox-mpox-phase-ii-phase-iii</loc>
    <lastmod>2026-05-28T21:41:53.944Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2-methoxy-n-4-methoxy-6-1h-pyrazol-1-yl-hormone-receptor-positive-her2-negative-phase-iii</loc>
    <lastmod>2026-05-28T21:41:53.957Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regorafenib-colorectal-adenocarcinoma-stage-iv-no-ev-phase-ii</loc>
    <lastmod>2026-05-28T21:41:53.971Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxytocin-healthy-children-not-applicable</loc>
    <lastmod>2026-05-28T21:41:53.983Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rifampicin-tuberculosis-drug-susceptible-pulmonary-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:54.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avalglucosidase-alfa-pompe-disease-glycogen-storage-disease-t-phase-iv</loc>
    <lastmod>2026-05-28T21:41:54.013Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-metastatic-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:54.026Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/triamcinolone-acetonide-chronic-shoulder-pain-not-applicable</loc>
    <lastmod>2026-05-28T21:41:54.039Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/estradiol-turner-syndrome-phase-iv</loc>
    <lastmod>2026-05-28T21:41:54.052Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pegvisomant-acromegaly-healthy-volunteers-phase-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:41:54.065Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hsp-car19m-diffuse-large-b-cell-lymphoma-mantle-cel-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:54.077Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-4-2-4-3-cyanophenyl-piperazin-1-yl-eth-primary-premature-ejaculation-premature-phase-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:41:54.093Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/napabucasin-metastatic-colorectal-cancer-colorectal-phase-iii</loc>
    <lastmod>2026-05-28T21:41:54.107Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inobrodib-acute-myeloid-leukaemia-higher-risk-myel-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:54.120Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azithromycin-dihydrate-breast-cancer-early-breast-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:41:54.133Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-2-tert-butyl-1-4-4-difluorocyclohexyl-cancer-anorexia-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:54.146Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colecalciferol-cystic-fibrosis-bone-metabolism-disorder-phase-iii</loc>
    <lastmod>2026-05-28T21:41:54.159Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/c3-glomerulopathy-c3g-phase-i</loc>
    <lastmod>2026-05-28T21:41:54.172Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/brexanolone-caprilcerbate-major-depressive-disorder-phase-ii-2</loc>
    <lastmod>2026-05-28T21:41:54.185Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-high-risk-soft-tissue-sarcoma-of-the-ext-phase-ii</loc>
    <lastmod>2026-05-28T21:41:54.199Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bimatoprost-ocular-hypertension-open-angle-glaucoma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:54.212Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluticasone-propionate-salbutamol-sulfat-asthma</loc>
    <lastmod>2026-05-28T21:41:54.225Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atorvastatin-metastatic-prostate-cancer-high-risk-rec-phase-iii</loc>
    <lastmod>2026-05-28T21:41:54.238Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/protrans-synonym-navicorcel-type-1-diabetes-phase-iv-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:54.251Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vx-670-myotonic-dystrophy-type-1-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:54.265Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alzheimer-s-disease-healthy-volunteers-phase-i</loc>
    <lastmod>2026-05-28T21:41:54.278Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dry-extract-from-psilocybe-cubensis-15-2-prolonged-grief-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:41:54.291Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ocrelizumab-multiple-sclerosis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:54.304Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ipilimumab-glioblastoma-astrocytoma-phase-i</loc>
    <lastmod>2026-05-28T21:41:54.317Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ketamine-obsessive-compulsive-disorder-not-applicable</loc>
    <lastmod>2026-05-28T21:41:54.330Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/simvastatin-graves-ophthalmopathy-phase-iii</loc>
    <lastmod>2026-05-28T21:41:54.343Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/empagliflozin-acute-decompensated-heart-failure-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:54.356Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/briquilimab-chronic-urticaria-phase-iv</loc>
    <lastmod>2026-05-28T21:41:54.369Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rilzabrutinib-warm-autoimmune-haemolytic-anaemia-autoi-phase-iii</loc>
    <lastmod>2026-05-28T21:41:54.382Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nimodipine-aneurysmal-subarachnoid-hemorrhage-phase-ii</loc>
    <lastmod>2026-05-28T21:41:54.395Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sigvotatug-vedotin-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:54.408Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-adipose-tissue-derived-stroma-crohn-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:54.420Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imatinib-acute-lymphoblastic-leukaemia-philadelph-phase-ii</loc>
    <lastmod>2026-05-28T21:41:54.433Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isoniazid-tuberculosis-phase-i</loc>
    <lastmod>2026-05-28T21:41:54.446Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/osimertinib-advanced-non-small-cell-lung-cancer-egfr-phase-iv</loc>
    <lastmod>2026-05-28T21:41:54.459Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/axitinib-metastatic-renal-cell-carcinoma-locally-phase-iv</loc>
    <lastmod>2026-05-28T21:41:54.472Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-b-cell-precursor-acute-lymphoblastic-leu-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:54.486Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylsalicylic-acid-st-elevation-myocardial-infarction-stemi-phase-iv</loc>
    <lastmod>2026-05-28T21:41:54.499Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/islatravir-hiv-1-infection-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:54.511Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/irinotecan-hydrochloride-trihydrate-colorectal-cancer-with-liver-limited-met-phase-ii</loc>
    <lastmod>2026-05-28T21:41:54.524Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adeno-associated-viral-vector-serotype-2-parkinson-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:54.537Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rilvegostomig-non-small-cell-lung-cancer-metastatic-no-phase-iii</loc>
    <lastmod>2026-05-28T21:41:54.550Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/irinotecan-hydrochloride-metastatic-colorectal-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:41:54.564Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pneumococcal-polysaccharide-serotype-1-c-chronic-obstructive-pulmonary-disease-co-phase-iv</loc>
    <lastmod>2026-05-28T21:41:54.577Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/healthy-volunteers-phase-iii-3</loc>
    <lastmod>2026-05-28T21:41:54.590Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/valsartan-sacubitril-breast-cancer-post-anthracycline-cardiom-phase-iii</loc>
    <lastmod>2026-05-28T21:41:54.604Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bp1-15205-narcolepsy-phase-i</loc>
    <lastmod>2026-05-28T21:41:54.616Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etuvetidigene-autotemcel-wiskott-aldrich-syndrome-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:54.629Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-3923948-advanced-unresectable-or-metastatic-soli-phase-i</loc>
    <lastmod>2026-05-28T21:41:54.642Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/botulinum-toxin-type-a-haemagglutinin-co-buerger-s-disease</loc>
    <lastmod>2026-05-28T21:41:54.655Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-4-2-4-3-cyanophenyl-piperazin-1-yl-eth-essential-tremor-phase-ii</loc>
    <lastmod>2026-05-28T21:41:54.668Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/angiotensin-ii-acute-kidney-injury-cardiac-surgery-asso</loc>
    <lastmod>2026-05-28T21:41:54.681Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bnt327-advanced-breast-cancer-metastatic-breast-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:54.694Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nefopam-hydrochloride-intubation-mechanical-ventilation-phase-iv</loc>
    <lastmod>2026-05-28T21:41:54.707Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prasterone-dehydroepiandrosterone-dhea-treatment-resistant-depression-phase-iii</loc>
    <lastmod>2026-05-28T21:41:54.720Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sirolimus-cervicofacial-lymphatic-malformation-cys-phase-iv</loc>
    <lastmod>2026-05-28T21:41:54.733Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/3-benzyl-3-methyl-2-3-dihydrobenzofuran-mild-cognitive-impairment-alzheimer-s-di-phase-ii</loc>
    <lastmod>2026-05-28T21:41:54.746Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/daridorexant-chronic-insomnia-disorder-phase-iv</loc>
    <lastmod>2026-05-28T21:41:54.759Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lisdexamfetamine-dimesylate-attention-deficit-hyperactivity-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:41:54.772Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/irinotecan-metastatic-pancreatic-ductal-adenocarcin-phase-ii</loc>
    <lastmod>2026-05-28T21:41:54.785Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-t-cell-precursors-mobilized-p-acute-myeloid-leukaemia-acute-lymphoblas-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:54.800Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-regulatory-macrophages-chronic-limb-threatening-ischemia-periph-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:54.813Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/byon4228-locally-advanced-or-metastatic-solid-tum-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:54.827Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metronidazole-pouchitis-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:54.840Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/treprostinil-pulmonary-hypertension-associated-with-i-phase-iii</loc>
    <lastmod>2026-05-28T21:41:54.853Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-adipose-derived-stem-cells-recalcitrant-lower-limb-nonunion-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:54.866Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/psilocybin-stable-ischemic-heart-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:54.880Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/daratumumab-multiple-myeloma-phase-iv</loc>
    <lastmod>2026-05-28T21:41:54.893Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apalutamide-high-risk-localized-or-locally-advanced-phase-ii</loc>
    <lastmod>2026-05-28T21:41:54.908Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/infliximab-inflammatory-bowel-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:41:54.921Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/f8il10-rheumatoid-arthritis-phase-i</loc>
    <lastmod>2026-05-28T21:41:54.934Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/garadacimab-hereditary-angioedema-hae-hae-c1inh-type-phase-iv</loc>
    <lastmod>2026-05-28T21:41:54.947Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metoclopramide-alzheimer-s-disease-healthy-volunteers-phase-i</loc>
    <lastmod>2026-05-28T21:41:54.960Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/testosterone-turner-syndrome-phase-iv</loc>
    <lastmod>2026-05-28T21:41:54.973Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/testosterone-undecanoate-relapsing-remitting-multiple-sclerosis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:54.986Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/certolizumab-pegol-systemic-lupus-erythematosus-moderate-or-phase-iii</loc>
    <lastmod>2026-05-28T21:41:54.999Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-3820768-advanced-relapsed-or-refractory-ovarian-phase-iii</loc>
    <lastmod>2026-05-28T21:41:55.012Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mesothelin-x-cd47-bispecific-antibody-mesothelin-expressing-solid-tumours-phase-i</loc>
    <lastmod>2026-05-28T21:41:55.027Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/saccharomyces-boulardii-cncm-i-745-lyoph-irritable-bowel-syndrome-non-constipated-phase-iii</loc>
    <lastmod>2026-05-28T21:41:55.040Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lidocaine-hydrochloride-monohydrate-postoperative-critical-care-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:55.053Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levoleucovorin-resected-pancreatic-adenocarcinoma-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:55.066Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tocilizumab-psoriatic-arthritis-rheumatoid-arthritis-phase-ii-2</loc>
    <lastmod>2026-05-28T21:41:55.079Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/psilocybine-depressive-disorder-comorbid-with-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:41:55.092Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dwj155-radiolabelled-with-gallium-68-breast-cancer-non-small-cell-lung-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:41:55.105Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ibuzatrelvir-covid-19-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:55.118Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trontinemab-alzheimer-s-disease-mild-cognitive-impai-phase-iii</loc>
    <lastmod>2026-05-28T21:41:55.131Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allopurinol-hyperuricemia-hypertension-ischaemic-str-phase-iii</loc>
    <lastmod>2026-05-28T21:41:55.146Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belantamab-mafodotin-multiple-myeloma-transplant-ineligible-n-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:55.159Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methylprednisolone-major-surgery-robotic-assisted-laparosco-phase-iv</loc>
    <lastmod>2026-05-28T21:41:55.172Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-2-2-10-2-4-3-4-2-2-cyano-4-4-difluor-post-acute-sequelae-of-covid-19-long-cov-phase-iv</loc>
    <lastmod>2026-05-28T21:41:55.185Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluorouracil-rectal-cancer</loc>
    <lastmod>2026-05-28T21:41:55.198Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/yl201-advanced-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:41:55.224Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/retinitis-pigmentosa-pde6a-linked-retini</loc>
    <lastmod>2026-05-28T21:41:55.237Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hydrocortisone-scheduled-cardiac-surgery-intermediate-h-phase-iii</loc>
    <lastmod>2026-05-28T21:41:55.250Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cetuximab-recurrent-metastatic-head-and-neck-squam-phase-ii</loc>
    <lastmod>2026-05-28T21:41:55.263Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/idh1-mutated-malignancies-solid-tumour-h-phase-iii</loc>
    <lastmod>2026-05-28T21:41:55.276Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cladribine-relapsing-multiple-sclerosis-multiple-sc-not-applicable</loc>
    <lastmod>2026-05-28T21:41:55.289Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pozelimab-paroxysmal-nocturnal-hemoglobinuria-phase-iii</loc>
    <lastmod>2026-05-28T21:41:55.302Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-papillomavirus-type-31-l1-protein-human-papillomavirus-hpv-infection-cervi-phase-iv</loc>
    <lastmod>2026-05-28T21:41:55.317Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gemcitabine-pancreatic-cancer-with-peritoneal-metast-phase-ii</loc>
    <lastmod>2026-05-28T21:41:55.329Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ifinatamab-deruxtecan-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:55.342Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-plasma-protein-alzheimer-s-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:41:55.355Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/estradiol-turner-syndrome-phase-iv-2</loc>
    <lastmod>2026-05-28T21:41:55.368Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/placebo-staphylococcal-prosthetic-valve-endocard-phase-iv</loc>
    <lastmod>2026-05-28T21:41:55.382Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colchicine-inflammatory-cardiomyopathy-myocarditis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:55.395Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-rectal-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:55.408Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/precemtabart-tocentecan-advanced-gastric-cancer-gastric-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:55.421Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cc-97489-multiple-sclerosis-spasticity-phase-ii</loc>
    <lastmod>2026-05-28T21:41:55.434Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cemiplimab-basal-cell-carcinoma-advanced-basal-cell-phase-ii</loc>
    <lastmod>2026-05-28T21:41:55.446Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cemiplimab-melanoma-phase-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:41:55.459Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ulviprubart-inclusion-body-myositis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:55.472Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-colon-cancer-colorectal-cancer-stage-iii-phase-ii</loc>
    <lastmod>2026-05-28T21:41:55.485Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cabazitaxel-prostate-cancer-localized-high-risk-pros-phase-iii</loc>
    <lastmod>2026-05-28T21:41:55.498Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/viral-specific-t-cells-cytomegalovirus-cmv-infection-refractory-phase-i</loc>
    <lastmod>2026-05-28T21:41:55.515Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/peginterferon-alfa-2a-colon-cancer-colonic-adenocarcinoma-pmmr-phase-iv</loc>
    <lastmod>2026-05-28T21:41:55.528Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cannabidiol-recurrent-pericarditis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:55.541Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-alpha1-proteinase-inhibitor-chronic-obstructive-pulmonary-disease-co-phase-ii</loc>
    <lastmod>2026-05-28T21:41:55.554Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tocilizumab-rheumatoid-arthritis-phase-iv-2</loc>
    <lastmod>2026-05-28T21:41:55.567Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tenecteplase-central-retinal-artery-occlusion-phase-iii</loc>
    <lastmod>2026-05-28T21:41:55.580Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bp-cc-001-cartilage-defect-of-the-knee-joint-artic-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:55.593Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/multiple-sclerosis-refractory-multiple-s-not-applicable</loc>
    <lastmod>2026-05-28T21:41:55.605Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cd19-targeted-car-t-cells-idiopathic-inflammatory-myopathy-systemi-phase-i</loc>
    <lastmod>2026-05-28T21:41:55.618Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxygen-lung-resection-surgery-partial-lung-rese-phase-iv</loc>
    <lastmod>2026-05-28T21:41:55.631Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/esomeprazole-obesity-phase-iv</loc>
    <lastmod>2026-05-28T21:41:55.644Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylsalicylic-acid-superficial-venous-malformation-superfic-phase-iii</loc>
    <lastmod>2026-05-28T21:41:55.657Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/irinotecan-hydrochloride-trihydrate-metastatic-colorectal-cancer-mss-pmmr-phase-ii</loc>
    <lastmod>2026-05-28T21:41:55.670Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cervical-cancer</loc>
    <lastmod>2026-05-28T21:41:55.682Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxytocin-induction-of-labour-unfavourable-cervix-not-applicable</loc>
    <lastmod>2026-05-28T21:41:55.695Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ketamine-rapid-sequence-induction-phase-iii</loc>
    <lastmod>2026-05-28T21:41:55.708Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylsalicylic-acid-unruptured-intracranial-aneurysm-phase-iii</loc>
    <lastmod>2026-05-28T21:41:55.721Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dnth103-chronic-inflammatory-demyelinating-polyr-phase-iii</loc>
    <lastmod>2026-05-28T21:41:55.734Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gentamicin-infection-surgical-site-infection-breast-phase-iii</loc>
    <lastmod>2026-05-28T21:41:55.747Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zilebesiran-hypertension-cardiovascular-disease-high-phase-iii</loc>
    <lastmod>2026-05-28T21:41:55.760Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ibuzatrelvir-covid-19-phase-iii-3</loc>
    <lastmod>2026-05-28T21:41:55.773Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/enoxaparin-sodium-severe-trauma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:55.786Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-granulomatous-lymphocytic-interstitial-l-phase-ii</loc>
    <lastmod>2026-05-28T21:41:55.799Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zasocitinib-hidradenitis-suppurativa-phase-ii</loc>
    <lastmod>2026-05-28T21:41:55.824Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dupilumab-non-steroidal-anti-inflammatory-drug-exa-not-applicable</loc>
    <lastmod>2026-05-28T21:41:55.838Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-zirconium-cyclosilicate-hyperkalemia-chronic-kidney-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:41:55.851Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lisdexamfetamine-dimesylate-healthy-volunteers-phase-ii</loc>
    <lastmod>2026-05-28T21:41:55.864Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imeroprubart-chronic-inflammatory-demyelinating-polyn-phase-ii</loc>
    <lastmod>2026-05-28T21:41:55.877Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dorocubicel-allogeneic-umbilical-cord-de-acute-leukemia-myelodysplastic-syndrome-phase-ii</loc>
    <lastmod>2026-05-28T21:41:55.890Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prucalopride-succinate-depression-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:55.903Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dupilumab-severe-asthma-phase-iv</loc>
    <lastmod>2026-05-28T21:41:55.916Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amoxicillin-clavulanic-acid-complicated-acute-appendicitis-not-applicable</loc>
    <lastmod>2026-05-28T21:41:55.929Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/3-3-methanesulfonyl-phenyl-1-propyl-pipe-bipolar-depression-phase-ii</loc>
    <lastmod>2026-05-28T21:41:55.942Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/frexalimab-multiple-sclerosis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:55.955Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/geographic-atrophy-dry-age-related-macul-phase-i</loc>
    <lastmod>2026-05-28T21:41:55.968Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-690517-chronic-kidney-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:55.981Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/faricimab-neovascular-age-related-macular-degenera-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:55.995Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vutrisiran-transthyretin-amyloidosis-with-cardiomyo-phase-iii</loc>
    <lastmod>2026-05-28T21:41:56.008Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tezepelumab-severe-asthma-chronic-rhinosinusitis-wit-not-applicable</loc>
    <lastmod>2026-05-28T21:41:56.022Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ck-301-cutaneous-squamous-cell-carcinoma-unrese-phase-i</loc>
    <lastmod>2026-05-28T21:41:56.034Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methotrexate-metastatic-osteosarcoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:56.047Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-glioblastoma-multiforme-phase-iv</loc>
    <lastmod>2026-05-28T21:41:56.065Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hydrocortisone-pancreatic-resection-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:56.078Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ozekibart-conventional-chondrosarcoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:56.091Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/leniolisib-phosphate-common-variable-immunodeficiency-phase-ii</loc>
    <lastmod>2026-05-28T21:41:56.105Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mze829-apol1-mediated-kidney-disease-proteinuri-phase-ii</loc>
    <lastmod>2026-05-28T21:41:56.118Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/monoclonal-gammopathy-of-renal-significa-phase-iii</loc>
    <lastmod>2026-05-28T21:41:56.131Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/phleum-pratense-pollen-extract-allergic-rhinitis-due-to-pollen-allergic-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:56.143Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/triptorelin-prostate-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:56.156Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allergen-extract-from-phleum-pratense-po-allergic-rhinitis-due-to-grass-pollen-al-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:56.169Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eptacog-alfa-activated-intracerebral-haemorrhage-acute-haemorrh-phase-iii</loc>
    <lastmod>2026-05-28T21:41:56.182Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vedolizumab-inflammatory-bowel-disease-crohn-s-disea-phase-iv</loc>
    <lastmod>2026-05-28T21:41:56.195Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-n-diethyl-2-2-4-2-18-f-fluoroethoxy-ph-drug-resistant-partial-epilepsy-phase-iii</loc>
    <lastmod>2026-05-28T21:41:56.207Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/epinephrine-hydrochloride-major-open-abdominal-surgery-phase-iv</loc>
    <lastmod>2026-05-28T21:41:56.234Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/esketamine-major-depressive-disorder-non-psychotic-phase-iii</loc>
    <lastmod>2026-05-28T21:41:56.246Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/4r-4-3-18f-fluoranyl-5-fluorophenyl-1-3-alzheimer-s-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:41:56.259Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pyruvic-acid-pancreatic-adenocarcinoma-pancreatic-can-phase-iv</loc>
    <lastmod>2026-05-28T21:41:56.273Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ns12137-radiolabelled-with-fluorine-18-healthy-volunteers-phase-i</loc>
    <lastmod>2026-05-28T21:41:56.286Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/flortaucipir-18f-preclinical-alzheimer-s-disease-healthy-phase-iv</loc>
    <lastmod>2026-05-28T21:41:56.299Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zoledronic-acid-chronic-low-back-pain-modic-changes-not-applicable</loc>
    <lastmod>2026-05-28T21:41:56.311Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/betula-pollen-extract-allergic-rhinitis-due-to-birch-pollen-al-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:56.324Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/indapamide-amlodipine-besilate-perindopr-hypertension-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:56.337Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atorvastatin-ischemic-stroke-transient-ischemic-attac-phase-iii</loc>
    <lastmod>2026-05-28T21:41:56.350Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zagociguat-melas-syndrome-phase-iv</loc>
    <lastmod>2026-05-28T21:41:56.363Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elranatamab-multiple-myeloma-phase-ii-2</loc>
    <lastmod>2026-05-28T21:41:56.376Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:56.389Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azithromycin-hysterectomy-postoperative-infection-phase-iv</loc>
    <lastmod>2026-05-28T21:41:56.402Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-non-muscle-invasive-bladder-cancer-high-phase-iii</loc>
    <lastmod>2026-05-28T21:41:56.414Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/t-cell-non-hodgkin-lymphoma-cutaneous-t-phase-i</loc>
    <lastmod>2026-05-28T21:41:56.428Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fentanyl-healthy-volunteers-pain-management-phase-ii</loc>
    <lastmod>2026-05-28T21:41:56.441Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/skb410-high-risk-non-muscle-invasive-bladder-ca-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:56.454Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trametinib-papillary-craniopharyngioma-phase-iv</loc>
    <lastmod>2026-05-28T21:41:56.467Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dinoprostone-premature-rupture-of-membranes-prom-phase-iii</loc>
    <lastmod>2026-05-28T21:41:56.480Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-t-cells-transduced-with-lenti-systemic-sclerosis-scleroderma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:56.494Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-trans-tetrachlorobis-1h-indazole-colorectal-cancer-gastric-cancer-cholang-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:56.506Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/canis-familiaris-553-allergic-rhinitis-due-to-dog-allergy-phase-iv</loc>
    <lastmod>2026-05-28T21:41:56.519Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/entr-601-45-duchenne-muscular-dystrophy-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:56.533Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sirolimus-end-stage-kidney-disease-type-1-diabetes-phase-iv</loc>
    <lastmod>2026-05-28T21:41:56.545Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sirna-nucleic-acid-complex-rna-oligonucl-antibody-mediated-rejection-after-kidney-phase-ii</loc>
    <lastmod>2026-05-28T21:41:56.558Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dextromethorphan-deramciclane-fumarate-agitation-in-alzheimer-s-disease-dementi-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:56.572Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dry-extract-from-psilocybe-cubensis-15-2-alcohol-use-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:41:56.585Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-adipose-tissue-derived-stroma-scarred-vocal-folds-phase-ii</loc>
    <lastmod>2026-05-28T21:41:56.598Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/humanised-igg1-monoclonal-antibody-again-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:56.611Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/talquetamab-multiple-myeloma-newly-diagnosed-transpl-phase-ii</loc>
    <lastmod>2026-05-28T21:41:56.623Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxaliplatin-high-risk-stage-iii-colon-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:56.636Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/balstilimab-basal-cell-carcinoma-squamous-cell-carci-phase-ii</loc>
    <lastmod>2026-05-28T21:41:56.649Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vigabatrin-infantile-spasms-infantile-spasm-syndrom-phase-iv</loc>
    <lastmod>2026-05-28T21:41:56.662Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/olaparib-high-grade-serous-ovarian-cancer-endomet-phase-ii</loc>
    <lastmod>2026-05-28T21:41:56.675Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azathioprine-myocarditis-inflammatory-cardiomyopathy</loc>
    <lastmod>2026-05-28T21:41:56.688Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cit-013-rheumatoid-arthritis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:56.701Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fenofibrate-micronised-type-1-diabetes-mellitus-phase-iv</loc>
    <lastmod>2026-05-28T21:41:56.714Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/letermovir-cytomegalovirus-cmv-infection-in-heart-t-phase-ii</loc>
    <lastmod>2026-05-28T21:41:56.726Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tezepelumab-chronic-obstructive-pulmonary-disease-co-phase-iii</loc>
    <lastmod>2026-05-28T21:41:56.739Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cinnarizine-heart-failure-with-preserved-ejection-fr-phase-iii</loc>
    <lastmod>2026-05-28T21:41:56.752Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/recombinant-vesicular-stomatitis-virus-z-ebola-virus-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:41:56.765Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-phosphate-conjunctival-inflammation-inflammatory-s-not-applicable</loc>
    <lastmod>2026-05-28T21:41:56.778Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avzo-021-advanced-solid-tumors-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:56.791Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bms-986365-metastatic-castration-resistant-prostate-phase-iii</loc>
    <lastmod>2026-05-28T21:41:56.806Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mk-1084-non-small-cell-lung-cancer-kras-g12c-mut-phase-iii</loc>
    <lastmod>2026-05-28T21:41:56.820Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-rectal-cancer-not-applicable</loc>
    <lastmod>2026-05-28T21:41:56.833Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/istradefylline-progressive-multiple-sclerosis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:56.845Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mrna-4157-bladder-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:56.859Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pentavalent-nanobody-consisting-of-two-n-asthma-phase-iv</loc>
    <lastmod>2026-05-28T21:41:56.872Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prednisone-inflammatory-or-autoimmune-disorders-phase-iv</loc>
    <lastmod>2026-05-28T21:41:56.885Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ziltivekimab-acute-myocardial-infarction-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:56.898Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trifluridine-tipiracil-hydrochloride-cholangiocarcinoma-gallbladder-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:56.911Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gallium-68ga-pentixafor-triple-negative-breast-cancer-not-applicable</loc>
    <lastmod>2026-05-28T21:41:56.923Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bromhexine-hydrochloride-sulfamethoxazol-gram-negative-bacteraemia-phase-iv</loc>
    <lastmod>2026-05-28T21:41:56.936Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iopromide-breast-lesions-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:56.949Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/norelgestromin-hormonal-contraception-phase-iv</loc>
    <lastmod>2026-05-28T21:41:56.961Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/daridorexant-opioid-use-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:41:56.974Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/baricitinib-type-1-diabetes-phase-iii</loc>
    <lastmod>2026-05-28T21:41:56.988Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-advanced-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.001Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/remibrutinib-secondary-progressive-multiple-sclerosis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:57.015Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-obesity-antipsychotic-related-obesity-not-applicable</loc>
    <lastmod>2026-05-28T21:41:57.028Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colecalciferol-cholecalciferol-depressive-disorder-bipolar-disorder</loc>
    <lastmod>2026-05-28T21:41:57.040Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levamisole-hydrochloride-steroid-sensitive-idiopathic-nephrotic-s</loc>
    <lastmod>2026-05-28T21:41:57.053Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/xaluritamig-metastatic-castration-resistant-prostate-phase-iii</loc>
    <lastmod>2026-05-28T21:41:57.066Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/orismilast-obesity-phase-iv</loc>
    <lastmod>2026-05-28T21:41:57.080Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glycopyrronium-bromide-neostigmine-methy-residual-neuromuscular-blockade-reappear-phase-iv</loc>
    <lastmod>2026-05-28T21:41:57.093Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-normal-immunoglobulin-hyaluronidas-chronic-inflammatory-demyelinating-polyr-phase-iii</loc>
    <lastmod>2026-05-28T21:41:57.106Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/icosapent-ethyl-aortic-valve-stenosis-phase-iv</loc>
    <lastmod>2026-05-28T21:41:57.119Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iomx-0675-advanced-metastatic-solid-tumors-non-sma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:57.131Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ixazomib-multiple-myeloma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.145Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/opevesostat-metastatic-castration-resistant-prostate-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:57.157Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tamoxifen-citrate-breast-cancer-vulvovaginal-atrophy-phase-iii</loc>
    <lastmod>2026-05-28T21:41:57.171Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ciprofloxacin-vre-carriage-esbl-carriage-phase-iv</loc>
    <lastmod>2026-05-28T21:41:57.186Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/infliximab-ulcerative-colitis</loc>
    <lastmod>2026-05-28T21:41:57.199Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/relacorilant-gynecological-cancers-ovarian-cancer-end-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.212Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/follitropin-beta-female-subfertility-subfertility-requiri-not-applicable</loc>
    <lastmod>2026-05-28T21:41:57.226Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/osimertinib-non-small-cell-lung-cancer-egfr-mutant-phase-iv</loc>
    <lastmod>2026-05-28T21:41:57.238Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pn6047-hydrochloride-mechanical-allodynia-peripheral-neuropat-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.251Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ifinatamab-deruxtecan-metastatic-castration-resistant-prostate-phase-iii</loc>
    <lastmod>2026-05-28T21:41:57.264Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/kyv-101-anca-associated-vasculitis-granulomatosi-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:57.277Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/plx-pad-cells-osteoarthritis-knee-osteoarthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:57.290Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxaliplatin-gastric-adenocarcinoma-diffuse-type-gast-phase-iii</loc>
    <lastmod>2026-05-28T21:41:57.303Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ropivacaine-hydrochloride-postmastectomy-pain-syndrome-chronic-neu-phase-iv</loc>
    <lastmod>2026-05-28T21:41:57.316Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-77242113-psoriatic-arthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:57.329Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bosutinib-chronic-myeloid-leukemia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.342Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-rectal-cancer-colorectal-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.355Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-2-2-10-2-4-3-4-2-2-cyano-4-4-difluor-cholangiocarcinoma-pancreatic-adenocarci-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.368Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fulvestrant-er-positive-her2-negative-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.381Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rivaroxaban-patent-foramen-ovale-atrial-septal-defec-phase-iv</loc>
    <lastmod>2026-05-28T21:41:57.394Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-stage-iii-colon-adenocarcinoma-deficient-phase-iii</loc>
    <lastmod>2026-05-28T21:41:57.407Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fasudil-hydrochloride-idiopathic-parkinson-s-disease-parkinson-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.420Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gadolinium-chelated-polysiloxane-nanopar-glioblastoma-phase-i-ii-ctis-2020-004552-15</loc>
    <lastmod>2026-05-28T21:12:08.736Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/kbp-336-knee-osteoarthritis-obesity-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.432Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-embonate-small-abdominal-aortic-aneurysm-aaa-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.446Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/triamcinolone-acetonide-rheumatoid-arthritis</loc>
    <lastmod>2026-05-28T21:41:57.459Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lisaftoclax-myelodysplastic-syndrome-higher-risk-phase-iii</loc>
    <lastmod>2026-05-28T21:41:57.473Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-n-diethyl-2-4-2-18f-fluoroethoxy-pheny-autoimmune-encephalitis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.487Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gemcitabine-hydrochloride-bladder-cancer-non-muscle-invasive-bladd-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.500Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tarlatamab-small-cell-lung-cancer-extensive-stage-s-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.513Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/xmab942-ulcerative-colitis-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:57.526Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/insulin-human-intestinal-malabsorption-phase-iii</loc>
    <lastmod>2026-05-28T21:41:57.539Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-a-cardiac-arrest-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.552Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/triv-509-atopic-dermatitis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:57.565Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/insulin-human-intestinal-malabsorption-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:57.578Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pumitamig-advanced-solid-tumors-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:57.591Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mk-1084-kras-g12c-mutant-advanced-solid-tumors-n-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.604Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/burn-injury-phase-iii</loc>
    <lastmod>2026-05-28T21:41:57.618Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isatuximab-multiple-myeloma-newly-diagnosed-transpl-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.631Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/parp-inhibitor-fallopian-tube-cancer-ovarian-cancer-ext-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:57.645Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-2-2-10-2-4-3-4-2-2-cyano-4-4-difluor-acute-respiratory-distress-syndrome-non-phase-iv</loc>
    <lastmod>2026-05-28T21:41:57.658Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluciclovine-18f-multiple-myeloma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.671Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/immunoglobulin-a-immunoglobulin-g-immuno-acute-myeloid-leukemia-acute-lymphoblast-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:57.684Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/blinatumomab-acute-lymphoblastic-leukemia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:57.699Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-thiosulfate-peritoneal-carcinomatosis-peritoneal-met-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.712Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-advanced-melanoma-solid-tumors-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.725Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/depression-phase-iii</loc>
    <lastmod>2026-05-28T21:41:57.738Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-2-2-10-2-4-3-4-2-2-cyano-4-4-difluor-neoplasm-suspected-or-previously-treated-phase-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.751Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-770371-head-and-neck-squamous-cell-carcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:57.764Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/platelet-concentrate-erectile-dysfunction-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:57.778Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/synthetic-long-peptides-isa104-chronic-hepatitis-b-phase-i</loc>
    <lastmod>2026-05-28T21:41:57.791Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/paclitaxel-recurrent-or-metastatic-her2-negative-br-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:57.805Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adeno-associated-viral-vector-serotype-r-amyotrophic-lateral-sclerosis-als-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:57.818Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-hydrochloride-papillary-thyroid-carcinoma-phase-iii-ctis-2024-518352-23</loc>
    <lastmod>2026-05-28T21:12:08.580Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-hepatocellular-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.831Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutetium-177lu-edotreotide-neuroendocrine-tumor-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.844Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluorouracil-resectable-pancreatic-head-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.857Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/golcadomide-secondary-central-nervous-system-lymphom-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.870Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vosoritide-hypochondroplasia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:57.883Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bay-2927088-her2-mutation-advanced-solid-tumors-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.896Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/riliprubart-chronic-inflammatory-demyelinating-polyn-not-applicable</loc>
    <lastmod>2026-05-28T21:41:57.909Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azacitidine-myelodysplastic-syndromes-chronic-myelom</loc>
    <lastmod>2026-05-28T21:41:57.922Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/raludotatug-deruxtecan-gastrointestinal-cancers-pancreatic-duct-phase-ii</loc>
    <lastmod>2026-05-28T21:41:57.935Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/revumenib-acute-myeloid-leukemia-npm1-mutated-phase-iii</loc>
    <lastmod>2026-05-28T21:41:57.948Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dipyridamole-acetylsalicylic-acid-asa-unruptured-intracranial-saccular-aneurys-phase-iii</loc>
    <lastmod>2026-05-28T21:41:57.962Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacubitril-valsartan-arrhythmogenic-right-ventricular-cardiom-phase-iii</loc>
    <lastmod>2026-05-28T21:41:57.975Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-2-2-10-2-4-3-4-2-2-cyano-4-4-difluor-peritoneal-carcinomatosis-colorectal-can-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:57.988Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mk-1084-colorectal-cancer-kras-g12c-mutant-local-phase-iii</loc>
    <lastmod>2026-05-28T21:41:58.001Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pneumococcal-polysaccharide-serotypes-co-acute-febrile-illness-increased-risk-for-not-applicable</loc>
    <lastmod>2026-05-28T21:41:58.015Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anti-cd19-car-t-cells-non-hodgkin-lymphoma-diffuse-large-b-cel-phase-i</loc>
    <lastmod>2026-05-28T21:41:58.027Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anakinra-intracerebral-haemorrhage-phase-ii</loc>
    <lastmod>2026-05-28T21:41:58.041Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eplerenone-end-stage-renal-disease-renal-transplant-phase-iii</loc>
    <lastmod>2026-05-28T21:41:58.054Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fondaparinux-sodium-non-st-elevation-myocardial-infarction-n</loc>
    <lastmod>2026-05-28T21:41:58.067Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bleomycin-rectal-cancer-colorectal-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:58.081Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/selumetinib-neurofibromatosis-type-1-nf1-plexiform-n-phase-i</loc>
    <lastmod>2026-05-28T21:41:58.094Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carboplatin-head-and-neck-squamous-cell-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:58.108Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isatuximab-multiple-myeloma-newly-diagnosed-multipl-phase-iii</loc>
    <lastmod>2026-05-28T21:41:58.121Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2-6-18f-fluoro-pyridin-3-yl-9h-dipyrido-concussion-intracerebral-hemorrhage-trau-phase-iv</loc>
    <lastmod>2026-05-28T21:41:58.134Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-microsatellite-stable-mss-pmmr-colorecta-phase-ii</loc>
    <lastmod>2026-05-28T21:41:58.147Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pseudovax-hydrochloride-pseudomyxoma-peritonei-phase-i</loc>
    <lastmod>2026-05-28T21:41:58.160Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/refined-and-quantified-dry-extract-of-gi-cognitive-impairment-associated-with-pos-phase-iv</loc>
    <lastmod>2026-05-28T21:41:58.173Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-sulfoglucosamine-sulfohydrolase-fused-mucopolysaccharidosis-type-iiia-mps-iiia-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:58.186Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cholangitis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:58.199Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-propanediol-chronic-kidney-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:58.212Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-a-cervical-dysplasia-human-papillomavirus-not-applicable</loc>
    <lastmod>2026-05-28T21:41:58.225Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/budesonide-functional-dyspepsia</loc>
    <lastmod>2026-05-28T21:41:58.237Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abbv-cls-628-autosomal-dominant-polycystic-kidney-dis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:58.251Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cascs-heart-failure-ischemic-heart-failure-chr-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:58.264Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/kt-621-moderate-to-severe-atopic-dermatitis-ato-phase-ii</loc>
    <lastmod>2026-05-28T21:41:58.277Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bosentan-giant-cell-arteritis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:58.290Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/futibatinib-colorectal-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:58.303Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trifluridine-and-tipiracil-metastatic-colorectal-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:58.316Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/deucravacitinib-juvenile-psoriatic-arthritis-jpsa-phase-iii</loc>
    <lastmod>2026-05-28T21:41:58.330Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anitocabtagene-autoleucel-multiple-myeloma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:58.343Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azithromycin-chronic-rhinosinusitis-bacterial-sinusit-phase-iv</loc>
    <lastmod>2026-05-28T21:41:58.356Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/citalopram-gastroesophageal-reflux-disease-reflux-h-not-applicable</loc>
    <lastmod>2026-05-28T21:41:58.369Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluorescein-sodium-crohn-s-disease-ileal-not-applicable</loc>
    <lastmod>2026-05-28T21:41:58.381Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/healthy-volunteers-phase-iii-4</loc>
    <lastmod>2026-05-28T21:41:58.394Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tacrolimus-bk-polyomavirus-bkpyv-dnaemia-after-kidn-phase-iv</loc>
    <lastmod>2026-05-28T21:41:58.407Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/posaconazole-acute-myeloid-leukemia-myelodysplastic-s-phase-iv</loc>
    <lastmod>2026-05-28T21:41:58.420Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mesenchymal-stromal-cells-post-operative-recovery-after-hip-fractu-phase-iii</loc>
    <lastmod>2026-05-28T21:41:58.433Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ferric-carboxymaltose-myocardial-infarction-iron-deficiency-phase-iv</loc>
    <lastmod>2026-05-28T21:41:58.446Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isatuximab-multiple-myeloma-newly-diagnosed-phase-iii</loc>
    <lastmod>2026-05-28T21:41:58.460Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-adrenocortical-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:58.472Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amphotericine-b-liposome-chronic-pulmonary-aspergillosis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:58.485Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-advanced-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:58.499Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/graft-versus-host-disease-phase-i</loc>
    <lastmod>2026-05-28T21:41:58.512Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mirvetuximab-soravtansine-platinum-resistant-high-grade-epithelial-phase-ii</loc>
    <lastmod>2026-05-28T21:41:58.525Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cyclophosphamide-estrogen-receptor-positive-her2-negative-phase-iii</loc>
    <lastmod>2026-05-28T21:41:58.540Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imlifidase-neuromyelitis-optica-spectrum-disorder-d-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:41:58.553Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cladribine-secondary-progressive-multiple-sclerosis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:58.566Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/canakinumab-papa-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:41:58.579Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-ovarian-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:58.591Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/irinotecan-hydrochloride-trihydrate-unresectable-peritoneal-metastases-of-co-phase-ii</loc>
    <lastmod>2026-05-28T21:41:58.612Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd9750-metastatic-prostate-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:58.625Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-rectal-cancer-rectal-adenocarcinoma-phase-iv</loc>
    <lastmod>2026-05-28T21:41:58.638Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-oral-squamous-cell-carcinoma-phase-iv</loc>
    <lastmod>2026-05-28T21:41:58.651Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-4-fluorophenyl-n-4-7-methoxy-6-methylc-renal-cell-carcinoma-advanced-renal-cell-phase-iii</loc>
    <lastmod>2026-05-28T21:41:58.664Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/her2-positive-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:41:58.677Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-faecal-microbiota-pooled-ulcerative-colitis-phase-iii</loc>
    <lastmod>2026-05-28T21:41:58.689Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/budesonide-bronchopulmonary-dysplasia-preterm-birth-phase-iii</loc>
    <lastmod>2026-05-28T21:41:58.702Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-4-1r-4r-4-hydroxy-4-methylcyclohexyl-m-chronic-lymphocytic-leukemia-relapsed-re-phase-iii</loc>
    <lastmod>2026-05-28T21:41:58.715Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lidocaine-hydrochloride-monohydrate-chronic-idiopathic-ano-perineal-pain-phase-iii</loc>
    <lastmod>2026-05-28T21:41:58.729Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-acute-myeloid-leukemia-flt3-mutated-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:58.742Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxygen-chemotherapy-induced-peripheral-neuropat</loc>
    <lastmod>2026-05-28T21:41:58.756Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ethinylestradiol-levonorgestrel-migraine-episodic-migraine-menstrually-r-phase-iii</loc>
    <lastmod>2026-05-28T21:41:58.770Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gender-dysphoria-transsexualism-not-applicable</loc>
    <lastmod>2026-05-28T21:41:58.785Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ustekinumab-crohn-s-disease-ulcerative-colitis</loc>
    <lastmod>2026-05-28T21:41:58.799Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tumor-infiltrating-lymphocytes-neoantige-advanced-epithelial-tumors-immune-checkp-phase-iii</loc>
    <lastmod>2026-05-28T21:41:58.812Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aqueous-iodine-solution-5-hyperthyroidism-graves-disease-toxic-nod</loc>
    <lastmod>2026-05-28T21:41:58.825Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-faecal-microbiota-pooled-advanced-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:58.839Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gozetotide-metastatic-clear-cell-renal-cell-carcino-phase-iv</loc>
    <lastmod>2026-05-28T21:41:58.852Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sar442970-crohn-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:58.865Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/telisotuzumab-adizutecan-non-small-cell-lung-cancer-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:58.879Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/empagliflozin-pulmonary-arterial-hypertension-phase-ii</loc>
    <lastmod>2026-05-28T21:41:58.896Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/omaveloxolone-friedreich-s-ataxia-phase-iii</loc>
    <lastmod>2026-05-28T21:41:58.909Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carfilzomib-multiple-myeloma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:58.922Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-head-and-neck-squamous-cell-carcinoma-lo-phase-iii</loc>
    <lastmod>2026-05-28T21:41:58.936Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/paracetamol-patent-ductus-arteriosus-phase-iii</loc>
    <lastmod>2026-05-28T21:41:58.949Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/graft-versus-host-disease-phase-i-2</loc>
    <lastmod>2026-05-28T21:41:58.961Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bortezomib-light-chain-amyloidosis-al-amyloidosis-phase-ii</loc>
    <lastmod>2026-05-28T21:41:58.974Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-non-squamous-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:58.988Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-impacted-retained-lower-third-molar-not-applicable</loc>
    <lastmod>2026-05-28T21:41:59.001Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dimethyl-fumarate-mild-cognitive-impairment-dementia-due-t-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.014Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/olaparib-recurrent-ovarian-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:59.027Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/retinol-palmitate-bronchopulmonary-dysplasia-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.040Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/humanised-igg1-monoclonal-antibody-again-peritoneal-cancer-ovarian-cancer-fallopi-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.053Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/olaparib-brca-wild-type-advanced-ovarian-cancer-f-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.066Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avutometinib-low-grade-serous-ovarian-cancer-recurren-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.082Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mb-cart2219-1-relapsed-refractory-b-cell-malignancies-phase-i</loc>
    <lastmod>2026-05-28T21:41:59.095Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gsk5733584-advanced-solid-tumors-gynecological-canc-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:59.109Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vhb937-alzheimer-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.122Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/t-lymphocytes-transduced-with-a-rv-sfg-c-acute-lymphoblastic-leukemia-relapsed-re-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:59.137Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carboplatin-medulloblastoma-shh-activated-tp53-wild</loc>
    <lastmod>2026-05-28T21:41:59.152Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pyruvic-acid-amyotrophic-lateral-sclerosis-als-transi-phase-iv</loc>
    <lastmod>2026-05-28T21:41:59.166Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxytocin-central-diabetes-insipidus-phase-iv</loc>
    <lastmod>2026-05-28T21:41:59.179Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avelumab-locally-advanced-urothelial-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.194Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/maralixibat-progressive-familial-intrahepatic-choles-phase-iv</loc>
    <lastmod>2026-05-28T21:41:59.208Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/darolutamide-metastatic-castration-resistant-prostate-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.221Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/valproic-acid-sodium-valproate-metastatic-colorectal-cancer-ras-mutated-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.235Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rimegepant-menstrual-migraine-phase-iii</loc>
    <lastmod>2026-05-28T21:41:59.249Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dry-extract-from-psilocybe-cubensis-15-2-chemotherapy-induced-peripheral-neuropat-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.262Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/olaparib-recurrent-ovarian-cancer-high-grade-ovar-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.280Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ranibizumab-neovascular-age-related-macular-degenera-phase-iii</loc>
    <lastmod>2026-05-28T21:41:59.294Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-tirumotecan-triple-negative-breast-cancer-locally-re-phase-iii</loc>
    <lastmod>2026-05-28T21:41:59.307Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-3031185-healthy-volunteer-phase-iii</loc>
    <lastmod>2026-05-28T21:41:59.321Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-t-cells-transduced-with-lenti-systemic-sclerosis-idiopathic-inflammato-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:59.335Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etanercept-sapho-syndrome-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:59.348Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/skb410-advanced-metastatic-solid-tumor-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:59.361Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/temozolomide-diffuse-low-grade-glioma-phase-iv</loc>
    <lastmod>2026-05-28T21:41:59.375Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/itepekimab-chronic-rhinosinusitis-with-nasal-polyps-phase-iii</loc>
    <lastmod>2026-05-28T21:41:59.391Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methylphenidate-hydrochloride-attention-deficit-hyperactivity-disorder-phase-iii</loc>
    <lastmod>2026-05-28T21:41:59.405Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/itepekimab-chronic-rhinosinusitis-with-nasal-polyps-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:59.418Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gemcitabine-perihilar-cholangiocarcinoma-distal-chol-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:59.432Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/1-2-4-2-4-difluorophenoxy-piperidin-1-yl-parkinson-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.445Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-her2-positive-locally-advanced-or-metast-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.458Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-head-and-neck-squamous-cell-carcinoma-he-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.472Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zoledronic-acid-hip-osteoarthritis</loc>
    <lastmod>2026-05-28T21:41:59.485Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-alk-positive-anaplastic-large-cell-lymph-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.499Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mifepristone-early-pregnancy-loss-miscarriage-not-applicable</loc>
    <lastmod>2026-05-28T21:41:59.513Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/deupsilocin-besilate-major-depressive-disorder-phase-iii-2</loc>
    <lastmod>2026-05-28T21:41:59.527Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-advanced-gastroesophageal-carcinoma-her2-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.540Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/arfolitixorin-metastatic-colorectal-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:59.554Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/osteodex-multiple-myeloma-relapsed-refractory-mul-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:59.569Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/doxorubicin-hydrochloride-node-positive-breast-cancer-hormone-rece-phase-iii</loc>
    <lastmod>2026-05-28T21:41:59.583Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zimberelimab-muscle-invasive-bladder-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.597Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mercaptamine-covid-19-sars-cov-2-infection-covid-19-p-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.610Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-melanoma-unresectable-stage-iii-melanoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.624Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dostarlimab-head-and-neck-squamous-cell-carcinoma-hp-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.637Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/loncastuximab-tesirine-diffuse-large-b-cell-lymphoma-dlbcl-high-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.650Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sonidegib-locally-advanced-basal-cell-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.664Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/retroviral-vector-containing-the-common-advanced-melanoma-head-and-neck-squamous-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:59.677Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/visugromab-non-small-cell-lung-cancer-non-squamous-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.691Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-unresectable-melanoma-metastatic-melanom-phase-iii</loc>
    <lastmod>2026-05-28T21:41:59.704Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/visugromab-non-small-cell-lung-cancer-non-squamous-phase-ii-2</loc>
    <lastmod>2026-05-28T21:41:59.719Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd0901-gastroesophageal-adenocarcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.732Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glofitamab-aggressive-b-cell-non-hodgkin-lymphoma-r-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.750Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pomalidomide-smoldering-multiple-myeloma-high-risk-of-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.764Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/osimertinib-non-small-cell-lung-cancer-stage-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.777Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mepolizumab-severe-allergic-and-eosinophilic-asthma-phase-iv</loc>
    <lastmod>2026-05-28T21:41:59.790Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/datopotamab-deruxtecan-locally-advanced-or-metastatic-urothelia-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:41:59.804Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/niraparib-tosilate-monohydrate-endometrial-carcinosarcoma-ovarian-carci-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.818Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenalidomide-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:41:59.832Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/simoctocog-alfa-haemophilia-a-phase-iv</loc>
    <lastmod>2026-05-28T21:41:59.846Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fianlimab-metastatic-solid-tumors-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:59.859Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/polatuzumab-vedotin-diffuse-large-b-cell-lymphoma-dlbcl-phase-iii</loc>
    <lastmod>2026-05-28T21:41:59.872Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dupilumab-severe-asthma</loc>
    <lastmod>2026-05-28T21:41:59.886Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adce-d01-soft-tissue-sarcoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:59.900Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-locally-advanced-or-metastatic-gastroint</loc>
    <lastmod>2026-05-28T21:41:59.913Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glycerol-phenylbutyrate-corticobasal-syndrome-phase-ii</loc>
    <lastmod>2026-05-28T21:41:59.927Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mdg1015-epithelial-ovarian-carcinoma-myxoid-roun-phase-i</loc>
    <lastmod>2026-05-28T21:41:59.940Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ulixertinib-pediatric-low-grade-glioma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:41:59.954Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/l-lysine-acetate-l-tryptophan-l-histidin-chronic-kidney-disease-stage-4-and-5-sar-phase-iii</loc>
    <lastmod>2026-05-28T21:41:59.967Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mixture-of-allergen-extracts-of-dermatop-allergic-rhinoconjunctivitis-due-to-hous-phase-iii</loc>
    <lastmod>2026-05-28T21:41:59.980Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atomoxetine-parkinson-s-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:41:59.994Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/exenatide-paraganglioma-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.007Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/psilocybine-fibromyalgia-phase-iv</loc>
    <lastmod>2026-05-28T21:42:00.021Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/seralutinib-pulmonary-arterial-hypertension-pah-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.035Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-high-risk-resected-melanoma-phase-iii</loc>
    <lastmod>2026-05-28T21:42:00.049Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/setmelanotide-rohhad-syndrome-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.062Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/datopotamab-deruxtecan-hormone-receptor-positive-breast-cancer-phase-ii-phase-iii</loc>
    <lastmod>2026-05-28T21:42:00.075Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pentixafor-gallium-ga-68-multiple-myeloma-symptomatic-multiple-my-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.088Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/enfortumab-vedotin-penile-squamous-cell-carcinoma-locally-a-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.103Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imeroprubart-cutaneous-lupus-erythematosus-subacute-c-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.116Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ro7268489-progressive-multiple-sclerosis-multiple-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.130Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cef-a-zolin-acute-osteomyelitis-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.144Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/propofol-pain-propofol-injection-pain-phase-iv-ctis-2024-514307-34-01</loc>
    <lastmod>2026-05-28T21:12:07.235Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acalabrutinib-diffuse-large-b-cell-lymphoma-dlbcl-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.161Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/choriogonadotropin-alfa-infertility-diminished-ovarian-reserve</loc>
    <lastmod>2026-05-28T21:42:00.174Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vidofludimus-calcium-relapsing-remitting-multiple-sclerosis-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.188Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adalimumab-ulcerative-colitis-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.206Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-govitecan-triple-negative-breast-cancer-early-stag-phase-iii</loc>
    <lastmod>2026-05-28T21:42:00.220Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amantadine-hydrochloride-multiple-sclerosis-phase-iii</loc>
    <lastmod>2026-05-28T21:42:00.234Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/srsd107-venous-thromboembolism-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.247Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/temozolomide-glioblastoma-glioblastoma-multiforme-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:42:00.260Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-fibrinogen-ischemic-stroke-hypofibrinogenemia-post</loc>
    <lastmod>2026-05-28T21:42:00.274Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxygen-chemotherapy-induced-peripheral-neuropat-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.288Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-melanoma-brain-metastases-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.301Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elenestinib-phosphate-indolent-systemic-mastocytosis-smolderin-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:42:00.315Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-peritoneal-metastases-of-colorectal-canc-phase-iii</loc>
    <lastmod>2026-05-28T21:42:00.328Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tulisokibart-crohn-s-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:42:00.341Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluticasone-propionate-eosinophilic-esophagitis-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:00.354Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/letrozole-low-grade-serous-epithelial-ovarian-canc-phase-iii</loc>
    <lastmod>2026-05-28T21:42:00.367Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ianalumab-immune-thrombocytopenia-warm-autoimmune-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.381Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rezafungin-acetate-invasive-candidiasis-candidemia-phase-iv</loc>
    <lastmod>2026-05-28T21:42:00.394Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cobalamin-cobalamin-related-remethylation-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.409Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/phenoxymethylpenicillin-potassium-need-of-oral-bone-augmentation-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:42:00.425Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pf-07328948-heart-failure-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.438Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2r-3r-11br-1-3-4-6-7-11b-hexahydro-9-10-tardive-dyskinesia-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.451Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zinc-acexamate-advanced-chronic-liver-disease-chronic-l-phase-iii</loc>
    <lastmod>2026-05-28T21:42:00.464Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/argipressin-arginine-vasopressin-vasoplegic-shock-norepinephrine-refracto-phase-iii</loc>
    <lastmod>2026-05-28T21:42:00.478Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cefepime-hydrochloride-sepsis-hospital-acquired-sepsis-phase-iii</loc>
    <lastmod>2026-05-28T21:42:00.494Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clostridium-botulinum-neurotoxin-type-a-piriformis-muscle-syndrome-piriformis-sy-phase-iv</loc>
    <lastmod>2026-05-28T21:42:00.508Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rucaparib-ovarian-cancer-primary-peritoneal-cancer-phase-i-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.521Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/midazolam-breech-podalic-or-transverse-fetal-prese-phase-iii</loc>
    <lastmod>2026-05-28T21:42:00.534Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-recurrent-platinum-resistant-ovarian-can-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.548Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cladribine-myasthenia-gravis-seropositive-myastheni-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.562Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-advanced-solid-tumor-phase-i</loc>
    <lastmod>2026-05-28T21:42:00.576Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/olaparib-er-positive-her2-negative-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.589Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/monalizumab-acute-myeloid-leukemia-myelodysplastic-s-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.605Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tabelecleucel-epstein-barr-virus-associated-primary-im-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.618Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenvatinib-malignant-pleural-mesothelioma-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.634Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-breast-cancer-gastroesophageal-adenocarc-phase-i</loc>
    <lastmod>2026-05-28T21:42:00.648Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-t-cells-ex-vivo-modified-with-t-cell-acute-lymphoblastic-leukemia-t-ce-not-applicable-ctis-2024-516617-20-00</loc>
    <lastmod>2026-05-28T21:12:06.981Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-mismatch-repair-deficient-endometrial-ca-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.662Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bay-3547926-hepatocellular-carcinoma-phase-i</loc>
    <lastmod>2026-05-28T21:42:00.675Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly4066434-pancreatic-ductal-adenocarcinoma-non-sma-phase-i</loc>
    <lastmod>2026-05-28T21:42:00.689Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/1-11c-methylpiperidin-4-yl-methyl-5-amin-parkinson-s-disease-prodromal-parkinson-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:42:00.703Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imlifidase-anca-associated-vasculitis-granulomatosi-phase-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.716Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/duvelisib-nodal-t-cell-lymphoma-with-t-follicular-phase-iii</loc>
    <lastmod>2026-05-28T21:42:00.729Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hydroxychloroquine-sulfate-rheumatoid-arthritis-phase-iv</loc>
    <lastmod>2026-05-28T21:42:00.743Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tacrolimus-chronic-kidney-disease-kidney-transplant-phase-iv</loc>
    <lastmod>2026-05-28T21:42:00.756Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/attr-01-epithelial-solid-tumours-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:00.769Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fosfomycin-complicated-urinary-tract-infection-phase-iv</loc>
    <lastmod>2026-05-28T21:42:00.783Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tasimelteon-non-24-hour-sleep-wake-disorder-phase-iii</loc>
    <lastmod>2026-05-28T21:42:00.796Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-acute-coronary-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:42:00.809Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mv130-slg-039-healthy-adult-volunteers-not-applicable</loc>
    <lastmod>2026-05-28T21:42:00.822Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylsalicylic-acid-bipolar-affective-disorder-phase-iv</loc>
    <lastmod>2026-05-28T21:42:00.836Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cl-ad-msc-002-sjogren-s-syndrome-xerostomia-not-applicable</loc>
    <lastmod>2026-05-28T21:42:00.849Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-early-stage-her2-positive-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.864Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atorvastatin-chronic-obstructive-pulmonary-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:42:00.877Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clebopride-hydrogen-maleate-rumination-syndrome</loc>
    <lastmod>2026-05-28T21:42:00.891Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regorafenib-metastatic-colorectal-cancer-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:42:00.904Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gallium-68ga-edotreotide-hepatocellular-carcinoma-gastroenteropan-phase-iii</loc>
    <lastmod>2026-05-28T21:42:00.918Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/golimumab-rheumatoid-arthritis-phase-iv</loc>
    <lastmod>2026-05-28T21:42:00.932Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/finerenone-diabetic-cardiovascular-autonomic-neurop-phase-iv-ctis-2024-516258-23-00</loc>
    <lastmod>2026-05-28T21:12:06.816Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-melanoma-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:42:00.945Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-adipose-derived-adult-mesench-hidradenitis-suppurativa-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:00.959Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-breast-cancer-hormone-receptor-positive-phase-iii</loc>
    <lastmod>2026-05-28T21:42:00.972Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trametinib-neurofibromatosis-type-1-plexiform-neuro-phase-ii</loc>
    <lastmod>2026-05-28T21:42:00.986Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gskvx000000025896-varicella-phase-iii</loc>
    <lastmod>2026-05-28T21:42:01.000Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/paclitaxel-albumin-bound-non-small-cell-lung-cancer-non-squamous-phase-iv</loc>
    <lastmod>2026-05-28T21:42:01.014Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/humanised-igg1-monoclonal-antibody-again-gastroesophageal-junction-cancer-gastric-phase-iii</loc>
    <lastmod>2026-05-28T21:42:01.027Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clofarabine-urothelial-carcinoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:01.041Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regadenoson-chronic-total-occlusion-of-coronary-arte-phase-iv</loc>
    <lastmod>2026-05-28T21:42:01.054Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-early-stage-non-small-cell-lung-cancer</loc>
    <lastmod>2026-05-28T21:42:01.067Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cladribine-relapsing-remitting-multiple-sclerosis-phase-ii</loc>
    <lastmod>2026-05-28T21:42:01.081Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxygen-ankle-trauma-ankle-fracture-phase-iii</loc>
    <lastmod>2026-05-28T21:42:01.094Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:42:01.107Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inositol-trispyrophosphate-hexasodium-metastatic-breast-cancer-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:42:01.121Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dornase-alfa-ischaemic-stroke-acute-ischaemic-stroke-phase-ii</loc>
    <lastmod>2026-05-28T21:42:01.135Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inhibitor-of-the-enzyme-glucosaminyltran-advanced-or-metastatic-solid-tumours-phase-i</loc>
    <lastmod>2026-05-28T21:42:01.148Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iti-1284-generalized-anxiety-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:42:01.161Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/enoxaparin-sodium-fetal-growth-restriction-phase-iv</loc>
    <lastmod>2026-05-28T21:42:01.174Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/p95her2-car-tech2me-autologous-t-cells-breast-cancer-gastric-cancer-endometrial-phase-i</loc>
    <lastmod>2026-05-28T21:42:01.187Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2-6-18f-fluoro-pyridin-3-yl-9h-dipyrido-alzheimer-s-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:42:01.201Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/p95her2-car-t-cells-autologous-breast-cancer-gastric-cancer-endometrial-phase-i</loc>
    <lastmod>2026-05-28T21:42:01.214Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aldesleukin-alzheimer-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:42:01.227Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/maridebart-cafraglutide-heart-failure-with-preserved-ejection-fr-phase-iii</loc>
    <lastmod>2026-05-28T21:42:01.240Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clenbuterol-hydrochloride-spinal-and-bulbar-muscular-atrophy-phase-ii</loc>
    <lastmod>2026-05-28T21:42:01.253Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/maridebart-cafraglutide-atherosclerotic-cardiovascular-disease-o-phase-iii</loc>
    <lastmod>2026-05-28T21:42:01.267Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pioglitazone-metabolic-associated-fatty-liver-disease-not-applicable</loc>
    <lastmod>2026-05-28T21:42:01.280Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methylprednisolone-hydrogen-succinate-chronic-obstructive-pulmonary-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:42:01.293Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pp1493-prosthetic-joint-infection-hip-or-knee-d-phase-ii</loc>
    <lastmod>2026-05-28T21:42:01.306Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cabozantinib-clear-cell-renal-cell-carcinoma-renal-ce-phase-iv-ctis-2023-503317-29-00</loc>
    <lastmod>2026-05-28T21:12:06.599Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regorafenib-rectal-cancer-locally-advanced-stage-ii-phase-ii</loc>
    <lastmod>2026-05-28T21:42:01.319Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dostarlimab-recurrent-ovarian-cancer-recurrent-fallo-phase-iii</loc>
    <lastmod>2026-05-28T21:42:01.333Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zanidatamab-her2-overexpressing-solid-tumors-breast-phase-ii</loc>
    <lastmod>2026-05-28T21:42:01.346Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clonidine-hydrochloride-persistent-spinal-pain-syndrome-type-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:42:01.359Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/erlotinib-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:42:01.372Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colchicine-type-2-diabetes</loc>
    <lastmod>2026-05-28T21:42:01.386Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/radotinib-dihydrochloride-parkinson-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:42:01.399Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bupropion-hydrochloride-naltrexone-hydro-obesity-weight-regain-after-bariatric-su</loc>
    <lastmod>2026-05-28T21:42:01.412Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tenecteplase-acute-ischemic-stroke-phase-iv</loc>
    <lastmod>2026-05-28T21:42:01.425Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apixaban-valvular-heart-disease-aortic-bioprosthe-phase-iii</loc>
    <lastmod>2026-05-28T21:42:01.439Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/teplizumab-type-1-diabetes-mellitus-phase-iii</loc>
    <lastmod>2026-05-28T21:42:01.452Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/valproate-semisodium-status-epilepticus-benzodiazepine-resist-phase-iv</loc>
    <lastmod>2026-05-28T21:42:01.465Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-type-2-diabetes-phase-iv</loc>
    <lastmod>2026-05-28T21:42:01.478Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-cancer-all-types-phase-iv</loc>
    <lastmod>2026-05-28T21:42:01.491Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cabozantinib-bladder-cancer-kidney-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:42:01.504Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/interferon-beta-1b-secondary-progressive-multiple-sclerosis-phase-iii</loc>
    <lastmod>2026-05-28T21:42:01.517Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dcc-3116-advanced-gastrointestinal-stromal-tumor-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:01.529Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tabelecleucel-post-transplant-lymphoproliferative-diso-phase-iii</loc>
    <lastmod>2026-05-28T21:42:01.542Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluorouracil-small-bowel-adenocarcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:42:01.556Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nafarelin-infertility-female-infertility-phase-iv</loc>
    <lastmod>2026-05-28T21:42:01.569Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ipilimumab-skin-cancer-advanced-melanoma-phase-iv</loc>
    <lastmod>2026-05-28T21:42:01.581Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-faecal-microbiota-pooled-colonization-with-multidrug-resistant-gr-phase-iii</loc>
    <lastmod>2026-05-28T21:42:01.594Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/octreotide-acromegaly-phase-iii</loc>
    <lastmod>2026-05-28T21:42:01.607Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ipilimumab-unresectable-stage-iii-iv-melanoma-phase-i-ii-ctis-2024-515218-42-00</loc>
    <lastmod>2026-05-28T21:12:06.434Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ttf-ngr-soft-tissue-sarcoma-leiomyosarcoma-lipos-phase-iii</loc>
    <lastmod>2026-05-28T21:42:01.620Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cabozantinib-gastroenteropancreatic-neuroendocrine-tu-phase-ii</loc>
    <lastmod>2026-05-28T21:42:01.633Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belatacept-heart-graft-dysfunction-chronic-kidney-d-phase-ii</loc>
    <lastmod>2026-05-28T21:42:01.648Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cabergoline-microprolactinoma-prolactin-producing-pi</loc>
    <lastmod>2026-05-28T21:42:01.661Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gsk3862995b-bronchiectasis-phase-ii</loc>
    <lastmod>2026-05-28T21:42:01.674Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenvatinib-locally-advanced-head-and-neck-squamous-phase-ii</loc>
    <lastmod>2026-05-28T21:42:01.687Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/faricimab-subretinal-hyperreflective-material-age-phase-iv</loc>
    <lastmod>2026-05-28T21:42:01.700Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clopidogrel-atrial-fibrillation-ctis-2024-516382-37-00</loc>
    <lastmod>2026-05-28T21:12:06.397Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cln-081-non-small-cell-lung-cancer-with-egfr-exo-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:01.713Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atacicept-iga-nephropathy-phase-iv</loc>
    <lastmod>2026-05-28T21:42:01.726Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/letrozole-low-grade-serous-carcinoma-of-the-ovary-phase-iii</loc>
    <lastmod>2026-05-28T21:42:01.739Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atropine-sulfate-myopia-phase-iv</loc>
    <lastmod>2026-05-28T21:42:01.753Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belatacept-kidney-transplantation-subclinical-antib</loc>
    <lastmod>2026-05-28T21:42:01.766Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/orticumab-atherosclerotic-cardiovascular-disease-m-phase-ii</loc>
    <lastmod>2026-05-28T21:42:01.779Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/plitidepsin-post-covid-19-condition-pcc-post-covid-1-phase-ii</loc>
    <lastmod>2026-05-28T21:42:01.794Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-89402638-metastatic-colorectal-cancer-gastric-can-phase-i</loc>
    <lastmod>2026-05-28T21:42:01.808Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/enzalutamide-prostate-cancer-hot-flush-phase-iii</loc>
    <lastmod>2026-05-28T21:42:01.822Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/heparin-sodium-mitral-regurgitation-atrial-fibrillation-not-applicable</loc>
    <lastmod>2026-05-28T21:42:01.835Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/seladelpar-primary-biliary-cholangitis-compensated</loc>
    <lastmod>2026-05-28T21:42:01.848Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hydrocortisone-cardiac-arrest-post-resuscitation-shock-phase-iii</loc>
    <lastmod>2026-05-28T21:42:01.861Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dotatate-lutetium-177-yttrium-90-gastrointestinal-neuroendocrine-tumour-phase-iii</loc>
    <lastmod>2026-05-28T21:42:01.873Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/melatonin-major-depressive-episode-insomnia-phase-iii</loc>
    <lastmod>2026-05-28T21:42:01.887Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxycodone-hydrochloride-trihydrate-labour-pain-not-applicable</loc>
    <lastmod>2026-05-28T21:42:01.899Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-2-5-difluoro-1-1-biphenyl-4-yl-n-met-genital-herpes-hsv-2-genital-herpes-simp-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:01.912Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/coadministration-of-ga2-sporozoites-with-falciparum-malaria-phase-i</loc>
    <lastmod>2026-05-28T21:42:01.925Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-non-small-cell-lung-cancer-resectable-an-phase-ii</loc>
    <lastmod>2026-05-28T21:42:01.938Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gallium-68ga-chloride-cholangiocarcinoma-pancreatic-carcinoma-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:42:01.951Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gbs-nn-gbs-nn2-group-b-streptococcus-infection-group-b-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:42:01.964Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-metastatic-castration-resistant-prostate-phase-iii</loc>
    <lastmod>2026-05-28T21:42:01.977Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trospium-chloride-xanomeline-tartrate-psychosis-associated-with-alzheimer-s-di-phase-iii</loc>
    <lastmod>2026-05-28T21:42:01.991Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cabozantinib-medullary-thyroid-cancer-metastatic-medu-phase-iv</loc>
    <lastmod>2026-05-28T21:42:02.004Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/onfekafusp-alfa-onfekafusp-alfa-glioblastoma-glioma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:02.025Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/empasiprubart-multifocal-motor-neuropathy-phase-iii</loc>
    <lastmod>2026-05-28T21:42:02.039Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pelacarsen-atherosclerotic-cardiovascular-disease-phase-iii-2</loc>
    <lastmod>2026-05-28T21:42:02.053Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/insulin-glargine-type-1-diabetes-mellitus-phase-i</loc>
    <lastmod>2026-05-28T21:42:02.066Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cilostazol-aneurysmal-subarachnoid-hemorrhage-phase-iii</loc>
    <lastmod>2026-05-28T21:42:02.079Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pegcetacoplan-paroxysmal-nocturnal-hemoglobinuria-phase-ii</loc>
    <lastmod>2026-05-28T21:42:02.092Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/olaparib-pancreatic-adenocarcinoma-advanced-metas-phase-ii</loc>
    <lastmod>2026-05-28T21:42:02.105Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pacritinib-vexas-syndrome-phase-ii</loc>
    <lastmod>2026-05-28T21:42:02.118Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxaliplatin-colon-cancer-obstructive-colon-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:42:02.131Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/irinotecan-pancreatic-ductal-adenocarcinoma-metasta-phase-ii</loc>
    <lastmod>2026-05-28T21:42:02.145Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tislelizumab-hepatocellular-carcinoma-hcc-phase-ii</loc>
    <lastmod>2026-05-28T21:42:02.158Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pioglitazone-chronic-myelogenous-leukaemia-chronic-ph-phase-ii</loc>
    <lastmod>2026-05-28T21:42:02.171Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/kras-g12d-mutant-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:42:02.184Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rtx001-liver-cirrhosis-decompensated-liver-cirr-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:02.197Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lisaftoclax-acute-myeloid-leukemia-phase-iii</loc>
    <lastmod>2026-05-28T21:42:02.210Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/darolutamide-prostate-adenocarcinoma-with-pelvic-lymp-phase-iii</loc>
    <lastmod>2026-05-28T21:42:02.223Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hydrocortisone-post-traumatic-stress-disorder-ptsd-phase-iv</loc>
    <lastmod>2026-05-28T21:42:02.236Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bisoprolol-fumarate-hydrochlorothiazide-premature-ventricular-contractions-pvc-i-phase-iii</loc>
    <lastmod>2026-05-28T21:42:02.249Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/orforglipron-hemicalcium-osteoarthritis-of-the-knee-phase-iii</loc>
    <lastmod>2026-05-28T21:42:02.262Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxaliplatin-gastric-adenocarcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:42:02.275Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tub-030-advanced-solid-tumors-head-and-neck-squa-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:02.287Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/remibrutinib-chronic-inducible-urticaria-chronic-spon-phase-ii</loc>
    <lastmod>2026-05-28T21:42:02.300Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lidocaine-hydrochloride-monohydrate-colon-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:42:02.313Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-adipose-tissue-derived-stroma-diabetic-foot-ulcer-phase-ii</loc>
    <lastmod>2026-05-28T21:42:02.327Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/humanised-igg1-kappa-yte-monoclonal-anti-recurrent-clostridioides-difficile-infec-phase-ii</loc>
    <lastmod>2026-05-28T21:42:02.340Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cap-100-chronic-lymphocytic-leukaemia-cll-relaps-phase-i</loc>
    <lastmod>2026-05-28T21:42:02.353Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/choline-alfoscerate-subthreshold-depression-depression-phase-iv</loc>
    <lastmod>2026-05-28T21:42:02.366Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/brimonidine-tartrate-egfr-inhibitor-induced-folliculitis-meta-phase-ii</loc>
    <lastmod>2026-05-28T21:42:02.379Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tafluprost-exfoliation-glaucoma-ocular-hypertension-phase-iv</loc>
    <lastmod>2026-05-28T21:42:02.392Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/chondroitin-sulfate-sodium-knee-osteoarthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:42:02.405Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gskvx000000025896-varicella-phase-iii-2</loc>
    <lastmod>2026-05-28T21:42:02.418Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/healthy-volunteers-phase-iii-5</loc>
    <lastmod>2026-05-28T21:42:02.431Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-anti-myelin-associated-glycoprotein-anti-phase-iii</loc>
    <lastmod>2026-05-28T21:42:02.444Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cabozantinib-hepatocellular-carcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:42:02.457Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/es2b-c001-her2-positive-breast-cancer-metastatic-b-phase-i</loc>
    <lastmod>2026-05-28T21:42:02.470Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/al-18f-f-fapi-74-fever-of-unknown-origin-fuo-inflammation-not-applicable</loc>
    <lastmod>2026-05-28T21:42:02.483Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/kin-2787-braf-and-or-nras-mutation-positive-solid-phase-iii</loc>
    <lastmod>2026-05-28T21:42:02.496Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylsalicylic-acid-pregnancy-associated-hypertension-pre-ec</loc>
    <lastmod>2026-05-28T21:42:02.510Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/osimertinib-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:42:02.523Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avelumab-metastatic-urothelial-cancer-locally-adv-phase-iv</loc>
    <lastmod>2026-05-28T21:42:02.536Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sargramostim-ovarian-cancer-phase-ii-ctis-2020-004738-39</loc>
    <lastmod>2026-05-28T21:12:05.917Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amoxicillin-sodium-systemic-infections-not-applicable</loc>
    <lastmod>2026-05-28T21:42:02.550Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tranexamic-acid-slipped-capital-femoral-epiphysis-scfe-l-phase-iv</loc>
    <lastmod>2026-05-28T21:42:02.563Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/wal0623-glomerular-kidney-disease-with-proteinur-phase-i</loc>
    <lastmod>2026-05-28T21:42:02.577Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/decitabine-cedazuridine-acute-myeloid-leukaemia-myelodysplastic-phase-ii</loc>
    <lastmod>2026-05-28T21:42:02.592Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/luspatercept-myelodysplastic-syndromes-mds-anemia-due-phase-ii</loc>
    <lastmod>2026-05-28T21:42:02.609Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/decitabine-and-cedazuridine-solid-tumor-acute-myeloid-leukaemia-myel-phase-iii</loc>
    <lastmod>2026-05-28T21:42:02.622Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-4-fluorophenyl-n-4-7-methoxy-6-methylc-clear-cell-renal-cell-carcinoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:02.635Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/decitabine-acute-myeloid-leukaemia-myelodysplastic-phase-iii</loc>
    <lastmod>2026-05-28T21:42:02.647Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/busulfan-high-risk-myeloid-malignancies-myelodysp-phase-ii</loc>
    <lastmod>2026-05-28T21:42:02.661Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-sulfide-nonahydrate-saccharomyces-acute-rhinitis-rhinopharyngitis-rhinosin-phase-iii</loc>
    <lastmod>2026-05-28T21:42:02.673Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ocrelizumab-progressive-multiple-sclerosis-phase-iv</loc>
    <lastmod>2026-05-28T21:42:02.686Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tamoxifen-citrate-breast-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:42:02.700Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/remimazolam</loc>
    <lastmod>2026-05-28T21:42:02.713Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-cord-blood-derived-mononuclea-hypoxic-ischemic-encephalopathy-neonatal-phase-ii</loc>
    <lastmod>2026-05-28T21:42:02.727Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vildagliptin-kidney-transplantation-post-transplant-d-phase-iii</loc>
    <lastmod>2026-05-28T21:42:02.740Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/caspofungin-intra-abdominal-candidiasis-yeast-intra-phase-iii</loc>
    <lastmod>2026-05-28T21:42:02.752Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elranatamab-multiple-myeloma-newly-diagnosed-multipl-phase-iii</loc>
    <lastmod>2026-05-28T21:42:02.771Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-adipose-derived-mesenchymal-s-stevens-johnson-syndrome-toxic-epidermal-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:02.784Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ferumoxytol-iron-deficiency-anemia-chronic-kidney-di-phase-iii</loc>
    <lastmod>2026-05-28T21:42:02.797Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-ascorbate-sepsis-acute-respiratory-distress-syndro-phase-iii</loc>
    <lastmod>2026-05-28T21:42:02.810Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-sodium-phosphate-multiple-myeloma-relapsed-multiple-myelo-phase-ii</loc>
    <lastmod>2026-05-28T21:42:02.823Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylsalicylic-acid-atrial-fibrillation-not-applicable</loc>
    <lastmod>2026-05-28T21:42:02.837Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-conjugated-to-n-succinyldesf-advanced-her2-positive-breast-cancer-met-phase-ii</loc>
    <lastmod>2026-05-28T21:42:02.849Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/o3r-5671-pro-inflammatory-bowel-disease-psoriasis-phase-i</loc>
    <lastmod>2026-05-28T21:42:02.864Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azathioprine-myelin-oligodendrocyte-glycoprotein-anti-phase-iii</loc>
    <lastmod>2026-05-28T21:42:02.877Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-metastatic-colorectal-cancer-locally-adv-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:02.890Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/meropenem-vaborbactam-complicated-urinary-tract-infection-acut-phase-ii</loc>
    <lastmod>2026-05-28T21:42:02.903Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/naronapride-idiopathic-gastroparesis-diabetic-gastro-phase-i</loc>
    <lastmod>2026-05-28T21:42:02.917Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-igg1-monoclonal-antibody-against-t-graves-disease-thyroid-eye-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:42:02.930Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clonidine-hydrochloride-colorectal-cancer-postoperative-acute-pa-phase-iv</loc>
    <lastmod>2026-05-28T21:42:02.944Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-advanced-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:42:02.957Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cobicistat-ovarian-cancer-cancer-not-applicable</loc>
    <lastmod>2026-05-28T21:42:02.971Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/retifanlimab-merkel-cell-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:42:02.985Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cisplatin-gastric-adenocarcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:42:02.998Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eculizumab-atypical-haemolytic-uraemic-syndrome-hyp-phase-iii</loc>
    <lastmod>2026-05-28T21:42:03.011Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylsalicylic-acid-intracerebral-haemorrhage-phase-iv</loc>
    <lastmod>2026-05-28T21:42:03.024Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atropine-sulfate-myopia-phase-iii</loc>
    <lastmod>2026-05-28T21:42:03.038Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trifluridine-tipiracil-hydrochloride-metastatic-colorectal-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:42:03.051Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/18f-fapi-74-connective-tissue-disease-associated-int-phase-ii</loc>
    <lastmod>2026-05-28T21:42:03.064Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nimorazole-squamous-cell-carcinoma-of-the-head-and</loc>
    <lastmod>2026-05-28T21:42:03.078Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vixarelimab-ulcerative-colitis-moderate-to-severe-ul-phase-iii</loc>
    <lastmod>2026-05-28T21:42:03.091Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-early-breast-cancer-her2-positive-early-phase-iii</loc>
    <lastmod>2026-05-28T21:42:03.104Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxygen-pulmonary-hypertension-coronary-microvas-phase-iv</loc>
    <lastmod>2026-05-28T21:42:03.117Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belimumab-immune-thrombocytopenia-phase-iii</loc>
    <lastmod>2026-05-28T21:42:03.132Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adalimumab-crohn-s-disease-ulcerative-colitis-phase-iv</loc>
    <lastmod>2026-05-28T21:42:03.145Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levosimendan-functional-tricuspid-regurgitation-phase-iii</loc>
    <lastmod>2026-05-28T21:42:03.159Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-iodide-131i-metastatic-differentiated-thyroid-carcin-phase-ii</loc>
    <lastmod>2026-05-28T21:42:03.173Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cangrelor-tetrasodium-acute-ischemic-stroke-phase-iii</loc>
    <lastmod>2026-05-28T21:42:03.186Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluorouracil-gastroesophageal-junction-adenocarcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:42:03.200Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inavolisib-hormone-receptor-positive-her2-negative-phase-iii</loc>
    <lastmod>2026-05-28T21:42:03.213Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-unresectable-and-or-metastatic-solid-tum-phase-ii</loc>
    <lastmod>2026-05-28T21:42:03.226Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ferumoxytol-iron-deficiency-anemia-phase-iii</loc>
    <lastmod>2026-05-28T21:42:03.239Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-pulmonary-large-cell-neuroendocrine-carc-phase-ii</loc>
    <lastmod>2026-05-28T21:42:03.252Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxytocin-benzodiazepine-dependence-phase-ii</loc>
    <lastmod>2026-05-28T21:42:03.265Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dotatate-copper-64cu-chloride-neuroendocrine-neoplasms-gastroenteropan-phase-ii</loc>
    <lastmod>2026-05-28T21:42:03.278Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/linaprazan-glurate-erosive-gastroesophageal-reflux-disease-phase-i</loc>
    <lastmod>2026-05-28T21:42:03.292Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/brentuximab-vedotin-classical-hodgkin-lymphoma-hodgkin-lymph-phase-ii</loc>
    <lastmod>2026-05-28T21:42:03.305Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/indocyanine-green-thyroid-diseases-hypoparathyroidism-hypo-phase-iii</loc>
    <lastmod>2026-05-28T21:42:03.318Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alteplase-acute-pulmonary-embolism-intermediate-hi-phase-iv</loc>
    <lastmod>2026-05-28T21:42:03.331Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-emtansine-her2-positive-breast-cancer-advanced-bre-phase-ii</loc>
    <lastmod>2026-05-28T21:42:03.344Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tiratricol-monocarboxylate-transporter-8-mct8-defic-phase-iv</loc>
    <lastmod>2026-05-28T21:42:03.357Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belantamab-mafodotin-relapsed-refractory-multiple-myeloma-mul-phase-ii</loc>
    <lastmod>2026-05-28T21:42:03.370Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/temozolomide-neuroblastoma-relapsed-high-risk-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:03.384Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/deucrictibant-hereditary-angioedema-phase-iii</loc>
    <lastmod>2026-05-28T21:42:03.397Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/talazoparib-urothelial-carcinoma-locally-advanced-or-phase-iv</loc>
    <lastmod>2026-05-28T21:42:03.409Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/deucrictibant-hereditary-angioedema-phase-iii-2</loc>
    <lastmod>2026-05-28T21:42:03.423Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-cutaneous-squamous-cell-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:42:03.437Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anakinra-kawasaki-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:42:03.450Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/10-1074-ls-hiv-1-infection-hiv-phase-ii</loc>
    <lastmod>2026-05-28T21:42:03.463Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obinutuzumab-lupus-nephritis-systemic-lupus-erythemat-phase-iii</loc>
    <lastmod>2026-05-28T21:42:03.477Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levetiracetam-down-syndrome-alzheimer-s-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:42:03.490Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/platelet-concentrate-autologous-microfat-radiocarpal-osteoarthritis-phase-ii</loc>
    <lastmod>2026-05-28T21:42:03.503Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belantamab-mafodotin-relapsed-refractory-multiple-myeloma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:03.516Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-triple-negative-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:42:03.530Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-acute-myeloid-leukaemia-favourable-risk-phase-ii</loc>
    <lastmod>2026-05-28T21:42:03.543Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bgb-16673-relapsed-or-refractory-b-cell-malignanci-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:03.556Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gemtuzumab-ozogamicin-acute-myeloid-leukaemia-aml-myelodysplas-phase-iii-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:03.570Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rhinophage-2a-cocktail-chronic-rhinosinusitis-staphylococcus-au-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:03.584Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cisplatin-hepatoblastoma-hepatocellular-carcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:42:03.600Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-cd34-haematopoietic-stem-and-glioblastoma-multiforme-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:03.614Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ruxolitinib-polycythemia-vera-phase-iii</loc>
    <lastmod>2026-05-28T21:42:03.627Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-tumour-infiltrating-lymphocyt-germ-cell-tumor-germ-cell-tumor-refracto-phase-ii</loc>
    <lastmod>2026-05-28T21:42:03.641Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cisplatin-oropharyngeal-squamous-cell-carcinoma-or-phase-iii</loc>
    <lastmod>2026-05-28T21:42:03.655Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd4512-b-cell-acute-lymphoblastic-leukemia-b-al-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:03.668Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-early-stage-colorectal-cancer-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:42:03.681Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/humanised-igg1-monoclonal-antibody-again-colorectal-cancer-cancer-cachexia-phase-ii</loc>
    <lastmod>2026-05-28T21:42:03.695Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ruxolitinib-primary-haemophagocytic-lymphohistiocyto-phase-iv</loc>
    <lastmod>2026-05-28T21:42:03.708Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/recombinant-varicella-zoster-virus-glyco-herpes-zoster-not-applicable</loc>
    <lastmod>2026-05-28T21:42:03.721Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-t-lymphoid-progenitor-cells-htlp-hematologic-malignancies-acute-myeloid-l-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:03.735Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ascorbic-acid-sodium-ascorbate-potassium-comparison-of-diagnostic-tools-not-applicable</loc>
    <lastmod>2026-05-28T21:42:03.748Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-minimal-change-nephrotic-syndrome-phase-ii</loc>
    <lastmod>2026-05-28T21:42:03.761Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prednisone-prednisone-sarcoidosis-pulmonary-sarcoidosis-phase-iii</loc>
    <lastmod>2026-05-28T21:42:03.775Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/melphalan-refractory-metastatic-colorectal-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:42:03.788Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-faecal-microbiota-pooled-severe-irritable-bowel-syndrome-ibs-phase-iii</loc>
    <lastmod>2026-05-28T21:42:03.801Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/valemetostat-tosilate-advanced-metastatic-or-recurrent-solid-t-phase-ii</loc>
    <lastmod>2026-05-28T21:42:03.814Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ciprofloxacin-hydrochloride-ciprofloxaci-community-acquired-pneumonia-phase-iv</loc>
    <lastmod>2026-05-28T21:42:03.828Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/botulinum-toxin-type-a-haemagglutinin-co-ischemic-stroke-haemorrhagic-stroke-phase-iv</loc>
    <lastmod>2026-05-28T21:42:03.841Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gsk4771261-autosomal-dominant-polycystic-kidney-dis-phase-i</loc>
    <lastmod>2026-05-28T21:42:03.854Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/csm-gw-septic-shock-community-acquired-phase-ii</loc>
    <lastmod>2026-05-28T21:42:03.867Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ddcart-cd19-acute-lymphocytic-leukaemia-recurrent-phase-ii</loc>
    <lastmod>2026-05-28T21:42:03.880Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levonorgestrel-post-medical-abortion-contraception-phase-iv</loc>
    <lastmod>2026-05-28T21:42:03.894Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mercaptamine-pulmonary-tuberculosis-phase-ii</loc>
    <lastmod>2026-05-28T21:42:03.907Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/precemtabart-tocentecan-non-small-cell-lung-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:03.922Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/infliximab-sarcoidosis-phase-iii</loc>
    <lastmod>2026-05-28T21:42:03.936Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-esophageal-squamous-cell-carcinoma-esoph-phase-ii</loc>
    <lastmod>2026-05-28T21:42:03.949Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trofolastat-prostate-cancer-not-applicable</loc>
    <lastmod>2026-05-28T21:42:03.962Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rheumatoid-arthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:42:03.975Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/esketamine-hydrochloride-out-of-hospital-cardiac-arrest-phase-ii</loc>
    <lastmod>2026-05-28T21:42:03.989Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-urothelial-carcinoma-of-the-upper-urinar-phase-ii</loc>
    <lastmod>2026-05-28T21:42:04.002Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belimumab-cryoglobulinemia-vasculitis-mixed-cryogl-phase-ii</loc>
    <lastmod>2026-05-28T21:42:04.016Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sirolimus-diffuse-intrinsic-pontine-glioma-phase-ii</loc>
    <lastmod>2026-05-28T21:42:04.029Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isoprenaline-hydrochloride-cardiac-arrest-phase-iv</loc>
    <lastmod>2026-05-28T21:42:04.041Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fosmanogepix-invasive-mold-infection-aspergillus-infe-phase-iii</loc>
    <lastmod>2026-05-28T21:42:04.055Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tarlatamab-poorly-differentiated-pulmonary-neuroend-phase-iii</loc>
    <lastmod>2026-05-28T21:42:04.068Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/propofol-cardiac-arrest-status-epilepticus-coma-not-applicable</loc>
    <lastmod>2026-05-28T21:42:04.081Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/secukinumab-takayasu-arteritis-phase-ii</loc>
    <lastmod>2026-05-28T21:42:04.094Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:42:04.107Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oseltamivir-severe-influenza-phase-iii</loc>
    <lastmod>2026-05-28T21:42:04.121Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-chronic-myeloid-leukaemia-phase-iv</loc>
    <lastmod>2026-05-28T21:42:04.134Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/encorafenib-braf-v600e-mutant-metastatic-non-small-c-phase-ii</loc>
    <lastmod>2026-05-28T21:42:04.148Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belantamab-mafodotin-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:42:04.161Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sonelokimab-psoriatic-arthritis-phase-iii-2</loc>
    <lastmod>2026-05-28T21:42:04.174Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/platelet-concentrate-lateral-epicondylitis-tennis-elbow-not-applicable</loc>
    <lastmod>2026-05-28T21:42:04.188Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ceralasertib-non-small-cell-lung-cancer-small-cell-lu-phase-i</loc>
    <lastmod>2026-05-28T21:42:04.201Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/asciminib-hydrochloride-chronic-myeloid-leukaemia-phase-iv</loc>
    <lastmod>2026-05-28T21:42:04.215Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/povidone-iodine-covid-19-influenza-a-respiratory-syncyti-phase-iv</loc>
    <lastmod>2026-05-28T21:42:04.228Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-hydrochloride-gestational-diabetes-mellitus-phase-iii</loc>
    <lastmod>2026-05-28T21:42:04.241Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-breast-cancer-her2-positive-breast-cance-phase-ii</loc>
    <lastmod>2026-05-28T21:42:04.267Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sirolimus-tuberous-sclerosis-complex-drug-resistan-phase-iii</loc>
    <lastmod>2026-05-28T21:42:04.282Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutropin-alfa-infertility-tubal-factor-infertility-mal-phase-ii</loc>
    <lastmod>2026-05-28T21:42:04.295Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ribociclib-breast-cancer-hormone-receptor-positive-phase-iii</loc>
    <lastmod>2026-05-28T21:42:04.309Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pelareorep-gastrointestinal-cancers-metastatic-colo-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:04.322Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ponatinib-philadelphia-chromosome-positive-acute-l-phase-ii</loc>
    <lastmod>2026-05-28T21:42:04.336Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-triple-negative-breast-cancer-metastatic-phase-ii</loc>
    <lastmod>2026-05-28T21:42:04.350Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/landiolol-hydrochloride-low-cardiac-output-syndrome-phase-iv</loc>
    <lastmod>2026-05-28T21:42:04.363Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-platinum-sensitive-recurrent-ovarian-can-phase-ii</loc>
    <lastmod>2026-05-28T21:42:04.376Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/filgotinib-ulcerative-colitis-phase-iii-2</loc>
    <lastmod>2026-05-28T21:42:04.403Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iptacopan-hydrochloride-paroxysmal-nocturnal-haemoglobinuria-phase-iii</loc>
    <lastmod>2026-05-28T21:42:04.417Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/leuprorelin-acetate-adenomyosis-infertility-phase-iv</loc>
    <lastmod>2026-05-28T21:42:04.430Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/paclitaxel-breast-cancer-stage-iii-breast-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:42:04.443Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/valganciclovir-cytomegalovirus-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:42:04.456Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/morphine-chronic-obstructive-pulmonary-disease-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:04.473Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-t-regulatory-cells-expressing-liver-transplant-rejection-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:04.486Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apixaban-post-operative-atrial-fibrillation-after-phase-iv</loc>
    <lastmod>2026-05-28T21:42:04.499Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenvatinib-ewing-sarcoma-recurrent-ewing-sarcoma-pr-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:42:04.512Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd9550-obesity-overweight-phase-ii</loc>
    <lastmod>2026-05-28T21:42:04.526Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ferric-derisomaltose-iron-deficiency-anaemia</loc>
    <lastmod>2026-05-28T21:42:04.539Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fentanyl-citrate-hypoxic-ischemic-encephalopathy-perinata-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:42:04.552Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/3s-6s-9s-12r-15s-18s-21s-24s-30s-33s-34r-atopic-keratoconjunctivitis-phase-iii</loc>
    <lastmod>2026-05-28T21:42:04.565Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/varegacestat-desmoid-tumour-aggressive-fibromatosis-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:42:04.578Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isoprenaline-hydrochloride-cardiac-arrest</loc>
    <lastmod>2026-05-28T21:42:04.591Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/paclitaxel-albumin-bound-pancreatic-ductal-adenocarcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:42:04.607Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-metastatic-colorectal-cancer-colorectal</loc>
    <lastmod>2026-05-28T21:42:04.620Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/thiopental-sodium-neonatal-general-anaesthesia</loc>
    <lastmod>2026-05-28T21:42:04.633Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2-6-18f-fluoro-pyridin-3-yl-9h-dipyrido-alzheimer-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:42:04.646Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/orforglipron-obstructive-sleep-apnea-overweight-or-ob-phase-iii</loc>
    <lastmod>2026-05-28T21:42:04.659Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/12m-1s-2s-n-63s-4s-z-11-ethyl-12-2-s-1-m-metastatic-pancreatic-ductal-adenocarcin-phase-iii</loc>
    <lastmod>2026-05-28T21:42:04.673Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dalteparin-sodium-acute-critical-illness-not-applicable</loc>
    <lastmod>2026-05-28T21:42:04.686Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atropine-sulfate-monohydrate-myopia</loc>
    <lastmod>2026-05-28T21:42:04.699Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isatuximab-multiple-myeloma-relapsed-multiple-myelo-phase-ii</loc>
    <lastmod>2026-05-28T21:42:04.714Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amiloride-hydrochloride-dihydrate-migraine-with-aura</loc>
    <lastmod>2026-05-28T21:42:04.727Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gskvx000000025896-varicella-chickenpox-phase-iii</loc>
    <lastmod>2026-05-28T21:42:04.743Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cefazolin-infection-prophylaxis-not-applicable</loc>
    <lastmod>2026-05-28T21:42:04.757Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atenolol-chlortalidone-spontaneous-coronary-artery-dissection-phase-iv</loc>
    <lastmod>2026-05-28T21:42:04.772Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/everolimus-breast-cancer-er-positive-her2-negative-phase-iii</loc>
    <lastmod>2026-05-28T21:42:04.785Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atorvastatin-hyperlipidemia-not-applicable</loc>
    <lastmod>2026-05-28T21:42:04.799Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eftilagimod-alpha-non-small-cell-lung-cancer-urothelial-ca-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:42:04.812Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belantamab-mafodotin-newly-diagnosed-multiple-myeloma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:04.825Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/risankizumab-crohn-s-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:42:04.838Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-non-small-cell-lung-cancer-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:42:04.851Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2-2-3-4-2-18f-fluoranylethoxy-phenyl-7-m-huntington-s-disease-pre-symptomatic-hun-phase-iii</loc>
    <lastmod>2026-05-28T21:42:04.877Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alzheimer-s-disease-phase-i</loc>
    <lastmod>2026-05-28T21:42:04.890Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imeroprubart-graves-disease-phase-ii-2</loc>
    <lastmod>2026-05-28T21:42:04.904Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bosentan-uncontrolled-arterial-hypertension-phase-iv</loc>
    <lastmod>2026-05-28T21:42:04.917Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efgartigimod-alfa-generalized-myasthenia-gravis-phase-iv</loc>
    <lastmod>2026-05-28T21:42:04.930Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elritercept-myelodysplastic-syndrome-mds-phase-iii</loc>
    <lastmod>2026-05-28T21:42:04.944Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tobevibart-chronic-hepatitis-d-hdv-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:42:04.957Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/healthy-volunteers-phase-i</loc>
    <lastmod>2026-05-28T21:42:04.971Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mecasermin-rinfabate-bronchopulmonary-dysplasia-chronic-lung-phase-ii</loc>
    <lastmod>2026-05-28T21:42:04.985Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylsalicylic-acid-colon-adenocarcinoma-resected-with-pi3k-phase-iii</loc>
    <lastmod>2026-05-28T21:42:04.998Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lunsekimig-chronic-rhinosinusitis-with-nasal-polyps-phase-iv</loc>
    <lastmod>2026-05-28T21:42:05.011Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sirolimus-superficial-arteriovenous-malformation-phase-ii</loc>
    <lastmod>2026-05-28T21:42:05.024Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/golexanolone-primary-biliary-cholangitis-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:05.037Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-disodium-phosphate-ischaemic-heart-disease-valvular-heart-d</loc>
    <lastmod>2026-05-28T21:42:05.051Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/botulinum-toxin-persistent-post-traumatic-headache-post-not-applicable</loc>
    <lastmod>2026-05-28T21:42:05.064Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sonidegib-nevoid-basal-cell-carcinoma-syndrome-bas-phase-ii</loc>
    <lastmod>2026-05-28T21:42:05.080Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lumc-bob1-b7-tcr-1-b-cell-acute-lymphoblastic-leukemia-mult-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:05.094Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:42:05.111Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/psilocybine-major-depression-treatment-resistant-dep-phase-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:42:05.124Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alpelisib-hormone-receptor-positive-her2-negative-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:42:05.137Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trametinib-dimethyl-sulfoxide-histiocytic-cell-proliferation-langerhan-phase-ii</loc>
    <lastmod>2026-05-28T21:42:05.151Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bleximenib-acute-myeloid-leukemia-phase-iii-2</loc>
    <lastmod>2026-05-28T21:42:05.164Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-alpha1-proteinase-inhibitor-severe-alpha-1-antitrypsin-deficiency-aa-phase-iii</loc>
    <lastmod>2026-05-28T21:42:05.179Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/izalontamab-brengitecan-breast-cancer-triple-negative-breast-can-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:42:05.192Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-govitecan-extensive-stage-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:42:05.212Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/exenatide-type-1-diabetes-mellitus-phase-iv</loc>
    <lastmod>2026-05-28T21:42:05.226Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ivonescimab-advanced-biliary-tract-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:42:05.240Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/escherichia-coli-strain-nissle-1917-non-infectious-uveitis-autoimmune-uveiti-phase-iv</loc>
    <lastmod>2026-05-28T21:42:05.254Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-advanced-metastatic-non-squamous-non-sma-phase-iii</loc>
    <lastmod>2026-05-28T21:42:05.267Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly3372993-dominantly-inherited-alzheimer-s-disease-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:42:05.281Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tazemetostat-diffuse-large-b-cell-lymphoma-dlbcl-high-phase-i-ii-phase-ii</loc>
    <lastmod>2026-05-28T21:42:05.295Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-intrahepatic-cholangiocarcinoma-biliary-phase-ii</loc>
    <lastmod>2026-05-28T21:42:05.309Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/irbesartan-acute-kidney-injury-phase-iii</loc>
    <lastmod>2026-05-28T21:42:05.326Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/niraparib-tosilate-monohydrate-advanced-ovarian-cancer-peritoneal-carci-phase-iii</loc>
    <lastmod>2026-05-28T21:42:05.340Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amoxicillin-chronic-low-back-pain-non-specific-low-b-not-applicable</loc>
    <lastmod>2026-05-28T21:42:05.353Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adeno-associated-viral-vector-serotype-2-retinitis-pigmentosa-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:05.366Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tetrafluoroborate-ion-f-18-differentiated-thyroid-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:42:05.379Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nucleic-acid-heart-failure-with-reduced-ejection-frac-phase-ii</loc>
    <lastmod>2026-05-28T21:42:05.394Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-human-adipose-perivascular-st-pancreatic-ductal-adenocarcinoma-locally-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:05.408Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nucleic-acid-heart-failure-with-preserved-ejection-fr-phase-ii</loc>
    <lastmod>2026-05-28T21:42:05.421Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prednisone-erythema-multiforme-severe-phase-iii</loc>
    <lastmod>2026-05-28T21:42:05.435Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fludeoxyglucose-18f-histiocytic-cell-proliferation-langerhan-phase-iv</loc>
    <lastmod>2026-05-28T21:42:05.448Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/letermovir-cytomegalovirus-infection-post-allogenei-phase-iv</loc>
    <lastmod>2026-05-28T21:42:05.461Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/canakinumab-myelodysplastic-syndromes-lower-risk-mye-phase-ii</loc>
    <lastmod>2026-05-28T21:42:05.475Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-her2-expressing-advanced-or-metastatic-c-phase-i</loc>
    <lastmod>2026-05-28T21:42:05.488Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylsalicylic-acid-st-elevation-myocardial-infarction</loc>
    <lastmod>2026-05-28T21:42:05.504Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/malignant-neoplasm-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:42:05.529Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vosoritide-turner-syndrome-shox-deficiency-noonan-s-phase-ii</loc>
    <lastmod>2026-05-28T21:42:05.543Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/docetaxel-metastatic-squamous-cell-carcinoma-of-th-phase-ii</loc>
    <lastmod>2026-05-28T21:42:05.559Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eplerenone-renal-transplant-phase-iii</loc>
    <lastmod>2026-05-28T21:42:05.572Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/advanced-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:42:05.585Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tuvusertib-m1774-advanced-solid-tumours-metastatic-or-loc-phase-i</loc>
    <lastmod>2026-05-28T21:42:05.598Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adalimumab-crohn-s-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:42:05.616Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alpelisib-meningioma-phase-i</loc>
    <lastmod>2026-05-28T21:42:05.629Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/indapamide-hemihydrate-post-surgical-hypoparathyroidism-hypopar-phase-iv</loc>
    <lastmod>2026-05-28T21:42:05.642Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metronidazole-glucose-complicated-acute-appendicitis-phase-iii</loc>
    <lastmod>2026-05-28T21:42:05.655Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-disodium-phosphate-out-of-hospital-cardiac-arrest-phase-iv</loc>
    <lastmod>2026-05-28T21:42:05.668Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/antithrombin-iii-human-congenital-antithrombin-deficiency-phase-iii</loc>
    <lastmod>2026-05-28T21:42:05.681Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-apotransferrin-congenital-atransferrinaemia-hypotransfe-phase-ii</loc>
    <lastmod>2026-05-28T21:42:05.694Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avelumab-renal-cell-carcinoma-clear-cell-renal-ce-phase-ii</loc>
    <lastmod>2026-05-28T21:42:05.707Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tirzepatide-overweight-obesity-polycystic-ovary-synd-phase-iv</loc>
    <lastmod>2026-05-28T21:42:05.719Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pregabalin-peripheral-neuropathic-pain-phase-iv</loc>
    <lastmod>2026-05-28T21:42:05.732Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluorouracil-gastric-adenocarcinoma-with-peritoneal-m-phase-iii</loc>
    <lastmod>2026-05-28T21:42:05.745Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vemurafenib-histiocytic-disorders-langerhans-cell-hi-phase-ii</loc>
    <lastmod>2026-05-28T21:42:05.758Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imvt-1402-generalized-myasthenia-gravis-phase-iii</loc>
    <lastmod>2026-05-28T21:42:05.771Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-alpha1-proteinase-inhibitor-alcohol-associated-hepatitis-phase-iv</loc>
    <lastmod>2026-05-28T21:42:05.784Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-metastatic-breast-cancer-brca1-2-mutated-phase-ii</loc>
    <lastmod>2026-05-28T21:42:05.797Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imeroprubart-rheumatoid-arthritis-acpa-positive-phase-ii</loc>
    <lastmod>2026-05-28T21:42:05.810Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/doravirine-hiv-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:42:05.823Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clostridium-botulinum-neurotoxin-type-a-chronic-migraine-phase-iii</loc>
    <lastmod>2026-05-28T21:42:05.836Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/healthy-volunteer-phase-iii</loc>
    <lastmod>2026-05-28T21:42:05.849Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-microsatellite-stable-metastatic-colorec-phase-ii</loc>
    <lastmod>2026-05-28T21:42:05.862Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/temozolomide-colorectal-cancer-stage-ii-pt4-stage-iii-phase-ii</loc>
    <lastmod>2026-05-28T21:42:05.875Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ertapenem-acute-cholecystitis-not-applicable</loc>
    <lastmod>2026-05-28T21:42:05.888Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/huntington-s-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:42:05.901Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zirconium-89zr-girentuximab-von-hippel-lindau-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:42:05.914Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cemiplimab-merkel-cell-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:42:05.927Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenalidomide-multiple-myeloma-newly-diagnosed-multipl-phase-iii</loc>
    <lastmod>2026-05-28T21:42:05.940Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-metastatic-colorectal-cancer-metastatic-phase-ii</loc>
    <lastmod>2026-05-28T21:42:05.953Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nizubaglustat-niemann-pick-type-c-disease-gm1-ganglios-phase-iii</loc>
    <lastmod>2026-05-28T21:42:05.966Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clobetasol-propionate-bullous-pemphigoid-phase-iv</loc>
    <lastmod>2026-05-28T21:42:05.979Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sotatercept-pulmonary-hypertension-heart-failure-wit-phase-ii</loc>
    <lastmod>2026-05-28T21:42:05.992Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-adipose-derived-adult-mesench-fecal-incontinence-phase-ii</loc>
    <lastmod>2026-05-28T21:42:06.006Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/macitentan-pulmonary-arterial-hypertension-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.019Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-umbilical-cord-blood-derived-systemic-sclerosis-rheumatoid-arthritis-phase-ii</loc>
    <lastmod>2026-05-28T21:42:06.032Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/neuropathic-pain-phase-i</loc>
    <lastmod>2026-05-28T21:42:06.046Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imiquimod-actinic-keratosis-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:42:06.059Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aln-htt02-huntington-s-disease-phase-i</loc>
    <lastmod>2026-05-28T21:42:06.072Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/18f-aci-15916-parkinson-s-disease-dementia-with-lewy-b-phase-i</loc>
    <lastmod>2026-05-28T21:42:06.086Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clostridium-botulinum-neurotoxin-type-a-episodic-migraine-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.099Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levetiracetam-intracerebral-haemorrhage-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.113Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ipn01203-advanced-solid-tumour-metastatic-solid-t-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:06.125Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/valsartan-sacubitril-transthyretin-cardiac-amyloidosis-heart</loc>
    <lastmod>2026-05-28T21:42:06.139Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/familial-polycythemia-epo-gene-mutation-phase-i</loc>
    <lastmod>2026-05-28T21:42:06.153Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lisaftoclax-chronic-lymphocytic-leukemia-small-lymph-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:06.166Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ublituximab-relapsing-multiple-sclerosis-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.179Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenvatinib-vulvar-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:42:06.192Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/paclitaxel-albumin-bound-non-metastatic-muscle-invasive-bladder-c-phase-ii</loc>
    <lastmod>2026-05-28T21:42:06.205Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pioglitazone-non-segmental-vitiligo-phase-iv</loc>
    <lastmod>2026-05-28T21:42:06.218Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clopidogrel-non-st-elevation-acute-coronary-syndrome-phase-iv</loc>
    <lastmod>2026-05-28T21:42:06.231Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/recombinant-mutated-extracellular-domain-generalised-myasthenia-gravis-myasthenia-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:06.244Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aminolevulinic-acid-hydrochloride-recurrent-glioblastoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:06.257Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/xl092-clear-cell-renal-cell-carcinoma-non-clea-phase-i</loc>
    <lastmod>2026-05-28T21:42:06.269Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/recombinant-human-interferon-gamma-1b-sustained-immunosuppression-icu-acquired-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.282Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cabozantinib-metastatic-renal-cell-carcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.295Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gallium-citrate-ga-68-prosthetic-joint-infection-phase-ii</loc>
    <lastmod>2026-05-28T21:42:06.310Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aga2118-postmenopausal-osteoporosis-phase-ii</loc>
    <lastmod>2026-05-28T21:42:06.323Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/d-l-lysine-acetylsalicylate-acetylsalicy-atrial-fibrillation-left-atrial-appendag-phase-iv</loc>
    <lastmod>2026-05-28T21:42:06.335Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ro7790121-atopic-dermatitis-phase-ii</loc>
    <lastmod>2026-05-28T21:42:06.348Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etentamig-multiple-myeloma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:06.361Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-stage-iib-melanoma-stage-iic-melanoma-phase-ii</loc>
    <lastmod>2026-05-28T21:42:06.374Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ribociclib-hormone-receptor-positive-her2-negative-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.387Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/precemtabart-tocentecan-pancreatic-ductal-adenocarcinoma-metasta-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:06.401Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-hepatocellular-carcinoma-phase-ii-2</loc>
    <lastmod>2026-05-28T21:42:06.414Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ravulizumab-delayed-graft-function-after-kidney-tran-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.427Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bnt327-small-cell-lung-cancer-extensive-stage-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.441Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd9793-hepatocellular-carcinoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:06.454Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bnt327-bispecific-antibody-against-vascu-non-small-cell-lung-cancer-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:42:06.467Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/selgantolimod-chronic-hepatitis-b-phase-iv</loc>
    <lastmod>2026-05-28T21:42:06.480Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tildrakizumab-genital-psoriasis-plaque-psoriasis-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.494Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rotigotine-autosomal-dominant-polycystic-kidney-dis-phase-iv</loc>
    <lastmod>2026-05-28T21:42:06.507Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly3372993-alzheimer-s-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.519Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ropivacaine-anesthesia-intensive-care-not-applicable</loc>
    <lastmod>2026-05-28T21:42:06.532Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bay-3389934-sepsis-sepsis-induced-coagulopathy-coagu-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.545Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/febuxostat-gout-phase-iv</loc>
    <lastmod>2026-05-28T21:42:06.559Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cyclophosphamide-medulloblastoma-ependymoma-atypical-tera-phase-ii</loc>
    <lastmod>2026-05-28T21:42:06.572Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tinzaparin-sodium-pulmonary-embolism-not-applicable</loc>
    <lastmod>2026-05-28T21:42:06.585Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/doxapram-hydrochloride-monohydrate-apnea-of-prematurity-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.598Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-77242113-moderate-to-severe-plaque-psoriasis-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.611Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hsp-car30-classical-hodgkin-lymphoma-cd30-non-hodg-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:06.624Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenomorelin-ischemic-stroke-stroke-phase-ii</loc>
    <lastmod>2026-05-28T21:42:06.637Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/emicizumab-von-willebrand-disease-type-3-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.649Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/invasive-aspergillosis-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.662Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ruxolitinib-polycythemia-vera-essential-thrombocythe-phase-ii</loc>
    <lastmod>2026-05-28T21:42:06.675Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/teprotumumab-thyroid-eye-disease-graves-ophthalmopath-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.688Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/onfekafusp-alfa-glioblastoma-phase-ii</loc>
    <lastmod>2026-05-28T21:42:06.702Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ceftriaxone-viral-lower-respiratory-tract-infection-not-applicable</loc>
    <lastmod>2026-05-28T21:42:06.715Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etoposide-localized-digestive-neuroendocrine-carci-phase-ii</loc>
    <lastmod>2026-05-28T21:42:06.729Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-non-squamous-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.742Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etoposide-localized-digestive-neuroendocrine-carci-phase-ii-2</loc>
    <lastmod>2026-05-28T21:42:06.755Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prax-628-focal-epilepsy-primary-generalized-tonic-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.769Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-iodide-131i-hyperthyroidism-solitary-hyperactive-hot-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.783Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.796Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/recombinant-neisseria-meningitidis-group-healthy-volunteers-neisseria-meningitidi-phase-iv</loc>
    <lastmod>2026-05-28T21:42:06.809Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/golcadomide-follicular-lymphoma-relapsed-refractory-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.823Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elsunersen-antisense-oligonucleotide-seq-scn2a-developmental-and-epileptic-enceph-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.839Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-induced-pluripotent-stem-cell-heart-failure-heart-failure-with-reduced-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:06.852Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-4-1r-4r-4-hydroxy-4-methylcyclohexyl-m-mantle-cell-lymphoma-relapsed-or-refract-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.866Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adagrasib-non-small-cell-lung-cancer-kras-g12c-mut-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.879Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cerebrolysin-concentrate-traumatic-brain-injury-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.892Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/golcadomide-follicular-b-cell-non-hodgkin-s-lymphoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:06.909Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vx-264-type-1-diabetes-mellitus-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:06.922Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ad-o51-4-advanced-solid-tumour-solid-tumour-phase-i</loc>
    <lastmod>2026-05-28T21:42:06.935Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hydroxychloroquine-sulfate-recurrent-pregnancy-loss-phase-iv</loc>
    <lastmod>2026-05-28T21:42:06.948Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zilovertamab-vedotin-diffuse-large-b-cell-lymphoma-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.961Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/enzalutamide-metastatic-prostate-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:42:06.974Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/faricimab-polypoidal-choroidal-vasculopathy-phase-iv</loc>
    <lastmod>2026-05-28T21:42:06.987Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pioglitazone-chronic-myeloid-leukemia-chronic-phase-phase-ii</loc>
    <lastmod>2026-05-28T21:42:07.001Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sulodexide-phase-ii</loc>
    <lastmod>2026-05-28T21:42:07.014Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ale-p02-squamous-non-small-cell-lung-carcinoma-a-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:07.027Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-4r-4-carboxy-o-4-4-7-10-tris-carboxy-3-metastatic-castration-resistant-prostate-phase-iii</loc>
    <lastmod>2026-05-28T21:42:07.040Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/non-hodgkin-lymphoma-chronic-lymphocytic-phase-iii</loc>
    <lastmod>2026-05-28T21:42:07.053Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bgb-11417-mature-b-cell-malignancies-phase-i</loc>
    <lastmod>2026-05-28T21:42:07.066Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/idarubicin-hydrochloride-hepatocellular-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:42:07.081Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylsalicylic-acid-female-infertility-phase-iii</loc>
    <lastmod>2026-05-28T21:42:07.094Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efgartigimod-alfa-primary-immune-thrombocytopenia-itp-phase-iii</loc>
    <lastmod>2026-05-28T21:42:07.107Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxytocin-borderline-personality-disorder</loc>
    <lastmod>2026-05-28T21:42:07.120Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anti-insulin-receptor-human-monoclonal-a-tumor-associated-hyperinsulinism-insulin-phase-iii</loc>
    <lastmod>2026-05-28T21:42:07.133Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anhydrous-benzoyl-peroxide-cutibacterium-acnes-infection-shoulder-p-phase-iii</loc>
    <lastmod>2026-05-28T21:42:07.146Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avelumab-gestational-trophoblastic-neoplasia-low-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:07.159Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isatuximab-multiple-myeloma-newly-diagnosed-multipl-phase-ii</loc>
    <lastmod>2026-05-28T21:42:07.172Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dolutegravir-rilpivirine-hiv-1-infection-phase-iv</loc>
    <lastmod>2026-05-28T21:42:07.185Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/5-fluorouracil-metastatic-colorectal-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:07.198Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-obesity-phase-iii</loc>
    <lastmod>2026-05-28T21:42:07.210Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belatacept-kidney-transplant-not-applicable</loc>
    <lastmod>2026-05-28T21:42:07.223Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/itepekimab-chronic-rhinosinusitis-without-nasal-pol-phase-iv</loc>
    <lastmod>2026-05-28T21:42:07.236Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mirtazapine-rett-syndrome-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:42:07.249Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/izaflortaucipir-18f-down-syndrome-alzheimer-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:42:07.262Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pyruvic-acid-glioblastoma-multiforme-cancer-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:42:07.275Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mitapivat-sickle-cell-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:42:07.288Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clindamycin-staphylococcus-aureus-bacteremia-phase-iv</loc>
    <lastmod>2026-05-28T21:42:07.301Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/crd-4730-catecholaminergic-polymorphic-ventricula-phase-ii</loc>
    <lastmod>2026-05-28T21:42:07.314Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zagociguat-melas-syndrome-mitochondrial-encephalomy-phase-ii</loc>
    <lastmod>2026-05-28T21:42:07.327Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-ebv-specific-cytotoxic-t-lymp-multiple-sclerosis-phase-i</loc>
    <lastmod>2026-05-28T21:42:07.341Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-anal-cancer-squamous-cell-carcinoma-of-a-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:07.354Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ict01-advanced-stage-relapsed-refractory-cance-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:07.367Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pneumococcal-polysaccharide-conjugate-an-asplenia-not-applicable</loc>
    <lastmod>2026-05-28T21:42:07.380Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/focal-epilepsy-phase-iv</loc>
    <lastmod>2026-05-28T21:42:07.393Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-metastatic-breast-cancer-hormone-recepto-phase-ii</loc>
    <lastmod>2026-05-28T21:42:07.406Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxycodone-hydrochloride-coronary-artery-disease-aortic-valve-dis-not-applicable</loc>
    <lastmod>2026-05-28T21:42:07.420Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ceralasertib-advanced-solid-tumor-phase-iii</loc>
    <lastmod>2026-05-28T21:42:07.433Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oric-944-prostate-cancer-metastatic-prostate-canc-phase-i</loc>
    <lastmod>2026-05-28T21:42:07.446Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/balstilimab-metastatic-colorectal-cancer-pmmr-mss-me-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:07.459Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zilovertamab-vedotin-diffuse-large-b-cell-lymphoma-phase-ii</loc>
    <lastmod>2026-05-28T21:42:07.472Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dasatinib-chronic-myeloid-leukaemia-phase-ii</loc>
    <lastmod>2026-05-28T21:42:07.487Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atorvastatin-breast-cancer-early-breast-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:42:07.500Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/irinotecan-hydrochloride-trihydrate-colorectal-adenocarcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:42:07.513Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/noradrenaline-tartrate-hypotension-during-anesthesia</loc>
    <lastmod>2026-05-28T21:42:07.525Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/losartan-potassium-hydrochlorothiazide-osteogenesis-imperfecta-phase-ii</loc>
    <lastmod>2026-05-28T21:42:07.538Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamfetamine-sulfate-attention-deficit-hyperactivity-disorder-phase-iv</loc>
    <lastmod>2026-05-28T21:42:07.551Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/budigalimab-urothelial-carcinoma-metastatic-urotheli-phase-ii</loc>
    <lastmod>2026-05-28T21:42:07.564Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-mesenchymal-stem-cells-systemic-sclerosis-diffuse-systemic-scle-phase-iv</loc>
    <lastmod>2026-05-28T21:42:07.577Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glutathione-reduced-sodium-salt-decompensated-cirrhosis-phase-iv</loc>
    <lastmod>2026-05-28T21:42:07.590Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/almagate-gastroesophageal-reflux-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:42:07.603Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/budesonide-primary-iga-nephropathy-phase-iii</loc>
    <lastmod>2026-05-28T21:42:07.616Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-2-hydroxylinoleate-metastatic-pancreatic-ductal-adenocarcin-phase-i-phase-ii</loc>
    <lastmod>2026-05-28T21:42:07.629Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/breast-cancer</loc>
    <lastmod>2026-05-28T21:42:07.642Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anastrozole-breast-cancer-node-positive-hormone-rece-phase-iii</loc>
    <lastmod>2026-05-28T21:42:07.655Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ropivacaine-hydrochloride-inguinal-hernia-not-applicable</loc>
    <lastmod>2026-05-28T21:42:07.668Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/denosumab-acute-charcot-foot-charcot-neuroarthropa</loc>
    <lastmod>2026-05-28T21:42:07.680Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tenecteplase-acute-ischemic-stroke-ischemic-stroke-wi-not-applicable</loc>
    <lastmod>2026-05-28T21:42:07.693Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apixaban-philadelphia-negative-myeloproliferative-phase-iii</loc>
    <lastmod>2026-05-28T21:42:07.706Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/flubhpve6e7-human-papillomavirus-infection-hpv-assoc-phase-iii</loc>
    <lastmod>2026-05-28T21:42:07.719Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clopidogrel-non-valvular-atrial-fibrillation-phase-iv</loc>
    <lastmod>2026-05-28T21:42:07.733Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/maridebart-cafraglutide-obesity-overweight-phase-iii</loc>
    <lastmod>2026-05-28T21:42:07.746Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/risankizumab-inflammatory-bowel-disease-ulcerative-co-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:07.759Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/maridebart-cafraglutide-type-2-diabetes-mellitus-obesity-overwei-phase-iii</loc>
    <lastmod>2026-05-28T21:42:07.772Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azacitidine-myelodysplastic-syndrome-idh1-mutated-phase-ii</loc>
    <lastmod>2026-05-28T21:42:07.785Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bms-986504-advanced-solid-tumors-phase-iii</loc>
    <lastmod>2026-05-28T21:42:07.798Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regn5054-advanced-solid-tumor-phase-i</loc>
    <lastmod>2026-05-28T21:42:07.811Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/relatlimab-clear-cell-renal-cell-carcinoma-resectab-phase-ii</loc>
    <lastmod>2026-05-28T21:42:07.823Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pravastatin-sodium-breast-cancer-radiation-induced-breast-f-phase-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:42:07.836Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/enfortumab-vedotin-neuroendocrine-carcinoma-nec-neuroendocr-phase-ii</loc>
    <lastmod>2026-05-28T21:42:07.849Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/calcium-folinate-pentahydrate-colorectal-liver-metastases-phase-iii</loc>
    <lastmod>2026-05-28T21:42:07.863Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bupivacaine-breast-cancer-postoperative-pain-phase-iii</loc>
    <lastmod>2026-05-28T21:42:07.876Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lacosamide-status-epilepticus-phase-iii</loc>
    <lastmod>2026-05-28T21:42:07.889Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-adipose-tissue-derived-stroma-thumb-carpometacarpal-osteoarthritis-rhi-phase-ii</loc>
    <lastmod>2026-05-28T21:42:07.904Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hepatocellular-carcinoma</loc>
    <lastmod>2026-05-28T21:42:07.930Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imatinib-acute-lymphoblastic-leukemia-philadelphi-phase-iii</loc>
    <lastmod>2026-05-28T21:42:07.943Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/esketamine-hydrochloride-subarachnoid-hemorrhage-intracerebral-he</loc>
    <lastmod>2026-05-28T21:42:07.956Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clic-1901-cart-acute-lymphoblastic-leukaemia-b-all-b-ce-phase-iv-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:42:07.969Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/empagliflozin-anthracycline-induced-cardiotoxicity-can-phase-iii</loc>
    <lastmod>2026-05-28T21:42:07.982Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-small-cell-carcinoma-of-the-ovary-hyperc-phase-ii</loc>
    <lastmod>2026-05-28T21:42:07.996Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/h-gly-lys-tyr-gly-phe-tyr-thr-his-val-ph-epidermolysis-bullosa-dystrophic-epiderm-phase-ii</loc>
    <lastmod>2026-05-28T21:42:08.009Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxaliplatin-small-bowel-adenocarcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:42:08.022Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ro7790121-moderate-to-severe-atopic-dermatitis-phase-ii</loc>
    <lastmod>2026-05-28T21:42:08.035Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dry-extract-from-psilocybe-cubensis-15-2-anorexia-nervosa-phase-ii</loc>
    <lastmod>2026-05-28T21:42:08.049Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cabozantinib-renal-cell-carcinoma-phase-iv</loc>
    <lastmod>2026-05-28T21:42:08.062Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-glucagon-like-peptide-2-analogue-l-short-bowel-syndrome-associated-intestin-phase-ii</loc>
    <lastmod>2026-05-28T21:42:08.075Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/1r-3s-3-3-5-methoxymethyl-2-methylpyrazo-advanced-breast-cancer-ovarian-cancer-sm-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:08.089Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tremelimumab-locally-advanced-cholangiocarcinoma-chol-phase-ii</loc>
    <lastmod>2026-05-28T21:42:08.103Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gefurulimab-generalized-myasthenia-gravis-achr-posit-phase-iii</loc>
    <lastmod>2026-05-28T21:42:08.116Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogenic-sclerocorneal-limbus-stem-deri-corneal-trophic-ulcer-corneal-stromal-th-phase-i</loc>
    <lastmod>2026-05-28T21:42:08.129Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/folic-acid-metastatic-renal-cell-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:42:08.144Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dry-extract-from-psilocybe-cubensis-15-2-cocaine-use-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:42:08.157Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dasatinib-chronic-myeloid-leukemia-phase-iii</loc>
    <lastmod>2026-05-28T21:42:08.180Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aldesleukin-myelodysplastic-syndrome-with-excess-bla-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:08.193Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ninerafaxstat-trihydrochloride-monohydra-non-obstructive-hypertrophic-cardiomyopa-phase-ii</loc>
    <lastmod>2026-05-28T21:42:08.207Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cytarabine-relapsing-remitting-multiple-sclerosis-phase-iv</loc>
    <lastmod>2026-05-28T21:42:08.220Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/betamethasone-sodium-phosphate-bronchiolitis-acute-wheezing-phase-iv</loc>
    <lastmod>2026-05-28T21:42:08.233Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/indocyanine-green-colorectal-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:42:08.247Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gadoteridol-gadolinium-based-contrast-agent-exposure-phase-iv</loc>
    <lastmod>2026-05-28T21:42:08.260Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bisoprolol-fumarate-hydrochlorothiazide-non-obstructive-hypertrophic-cardiomyopa</loc>
    <lastmod>2026-05-28T21:42:08.273Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/humanised-igg1-kappa-fragment-antibody-t-myotonic-dystrophy-type-1-phase-iii</loc>
    <lastmod>2026-05-28T21:42:08.286Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rivaroxaban-acute-coronary-syndrome-atrial-fibrillat-phase-iv-ctis-2024-515433-15-02</loc>
    <lastmod>2026-05-28T21:12:02.873Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/paclitaxel-albumin-bound-locally-advanced-pancreatic-adenocarcino-phase-ii</loc>
    <lastmod>2026-05-28T21:42:08.300Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/18f-pi-2620-corticobasal-syndrome-progressive-supran-not-applicable</loc>
    <lastmod>2026-05-28T21:42:08.313Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylsalicylic-acid-malignant-neoplasm-patients-scheduled-fo-phase-iv</loc>
    <lastmod>2026-05-28T21:42:08.326Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imatinib-mesilate-gastrointestinal-stromal-tumor-phase-iii</loc>
    <lastmod>2026-05-28T21:42:08.339Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/risankizumab-psoriatic-arthritis-phase-ii</loc>
    <lastmod>2026-05-28T21:42:08.353Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apixaban-multiple-myeloma-total-knee-replacement-not-applicable</loc>
    <lastmod>2026-05-28T21:42:08.366Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sildenafil-rectal-cancer-erectile-dysfunction-post-phase-iii</loc>
    <lastmod>2026-05-28T21:42:08.381Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cannabidiol-severe-alcohol-use-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:42:08.395Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lisocabtagene-maraleucel-hematologic-disease-immune-effector-cell-not-applicable</loc>
    <lastmod>2026-05-28T21:42:08.408Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fusidic-acid-periprosthetic-joint-infection-hip-perip-phase-iv</loc>
    <lastmod>2026-05-28T21:42:08.421Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pyruvic-acid-heart-failure-phase-ii</loc>
    <lastmod>2026-05-28T21:42:08.435Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-79635322-multiple-myeloma-phase-i</loc>
    <lastmod>2026-05-28T21:42:08.448Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/valsartan-sacubitril-ischemic-heart-failure-with-mid-range-ej-phase-iii</loc>
    <lastmod>2026-05-28T21:42:08.461Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-2-2-10-2-4-3-4-2-2-cyano-4-4-difluor-idiopathic-inflammatory-myopathy-crohn-s-phase-iv</loc>
    <lastmod>2026-05-28T21:42:08.474Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tetanus-toxoid-systemic-sclerosis-systemic-lupus-erythe-not-applicable</loc>
    <lastmod>2026-05-28T21:42:08.486Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/humanised-igg1-lalaps-yte-monoclonal-ant-idiopathic-pulmonary-fibrosis-phase-ii</loc>
    <lastmod>2026-05-28T21:42:08.499Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ltg-001-osteoarthritis-of-the-knee-phase-ii</loc>
    <lastmod>2026-05-28T21:42:08.512Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/arsenic-trioxide-myelodysplastic-syndromes-low-risk-myelo-phase-i</loc>
    <lastmod>2026-05-28T21:42:08.525Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/empagliflozin-hypertrophic-cardiomyopathy-phase-iii</loc>
    <lastmod>2026-05-28T21:42:08.538Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sugammadex-sodium-general-anesthesia-not-applicable-ctis-2024-516415-24</loc>
    <lastmod>2026-05-28T21:12:02.773Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amoxicillin-sodium-erysipelas-lower-limb-phase-iv</loc>
    <lastmod>2026-05-28T21:42:08.551Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/leuprorelin-acetate-prostate-adenocarcinoma-high-risk-of-rec-phase-iii</loc>
    <lastmod>2026-05-28T21:42:08.565Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/benzylpenicillin-procaine-benzathine-ben-serious-bacterial-infections-in-critical-not-applicable</loc>
    <lastmod>2026-05-28T21:42:08.578Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxaliplatin-metastatic-grade-3-poorly-differentiated-phase-ii</loc>
    <lastmod>2026-05-28T21:42:08.592Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/blomia-tropicalis-extract-allergy-to-blomia-tropicalis-phase-iv</loc>
    <lastmod>2026-05-28T21:42:08.605Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxaliplatin-colon-cancer-stage-ii-phase-iii</loc>
    <lastmod>2026-05-28T21:42:08.618Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tarlatamab-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:42:08.631Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/botulinum-toxin-type-a-chronic-cluster-headache</loc>
    <lastmod>2026-05-28T21:42:08.644Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-epithelioid-malignant-pleural-mesothelio-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:08.657Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cholecalciferol-colecalciferol-sepsis-pneumonia</loc>
    <lastmod>2026-05-28T21:42:08.670Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly3410738-idh1-idh2-mutant-advanced-solid-tumours-phase-i</loc>
    <lastmod>2026-05-28T21:42:08.683Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/wt1-lamp-mrna-dc-glioblastoma-who-grade-iv-phase-iv</loc>
    <lastmod>2026-05-28T21:42:08.696Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etanercept-juvenile-idiopathic-arthritis</loc>
    <lastmod>2026-05-28T21:42:08.709Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cefoxitin-sodium-colorectal-surgery-phase-iii</loc>
    <lastmod>2026-05-28T21:42:08.722Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efpegerglucagon-congenital-hyperinsulinism-chi-phase-ii</loc>
    <lastmod>2026-05-28T21:42:08.735Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bortezomib-recurrent-grade-iv-glioma-glioblastoma-g-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:08.747Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anakinra-virus-negative-myocarditis-phase-ii</loc>
    <lastmod>2026-05-28T21:42:08.761Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sabatolimab-myelodysplastic-syndromes-mds-chronic-my-phase-ii</loc>
    <lastmod>2026-05-28T21:42:08.774Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alitretinoin-hand-eczema</loc>
    <lastmod>2026-05-28T21:42:08.787Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/arlocabtagene-autoleucel-relapsed-or-refractory-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:42:08.799Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rabies-virus-inactivated-strain-flury-le-rabies-pre-exposure-prophylaxis-phase-iii</loc>
    <lastmod>2026-05-28T21:42:08.813Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/varnimcabtagene-autoleucel-acute-lymphoblastic-leukemia-phase-ii</loc>
    <lastmod>2026-05-28T21:42:08.826Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hdp-101-relapsed-or-refractory-multiple-myeloma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:08.838Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ferric-derisomaltose-hip-fracture-not-applicable</loc>
    <lastmod>2026-05-28T21:42:08.852Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/131i-tlx101-glioblastoma-multiforme-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:42:08.866Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/emapalumab-sepsis-phase-ii</loc>
    <lastmod>2026-05-28T21:42:08.879Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/leriglitazone-cerebral-adrenoleukodystrophy-cald-phase-iii</loc>
    <lastmod>2026-05-28T21:42:08.892Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dinutuximab-beta-ewing-sarcoma-phase-i</loc>
    <lastmod>2026-05-28T21:42:08.905Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acoramidis-hydrochloride-transthyretin-amyloid-cardiomyopathy-att-phase-iii</loc>
    <lastmod>2026-05-28T21:42:08.918Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/florbetaben-18f-cardiac-amyloidosis-al-amyloidosis-phase-iii</loc>
    <lastmod>2026-05-28T21:42:08.931Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carboplatin-breast-cancer-her2-negative-breast-cance-phase-ii</loc>
    <lastmod>2026-05-28T21:42:08.944Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-iga-vasculitis-igav-phase-iii</loc>
    <lastmod>2026-05-28T21:42:08.957Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cabotegravir-hiv-1-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:42:08.970Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxaliplatin-colon-cancer-colonic-cancer-stage-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:42:08.982Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylsalicylic-acid-acute-ischemic-stroke-due-to-large-vesse-phase-iii</loc>
    <lastmod>2026-05-28T21:42:08.995Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/wt1-mrna-dc-acute-myeloid-leukemia-phase-ii</loc>
    <lastmod>2026-05-28T21:42:09.008Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ferric-derisomaltose-heart-failure-iron-deficiency-mild-cogni-phase-iv</loc>
    <lastmod>2026-05-28T21:42:09.021Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abatacept-giant-cell-arteritis-phase-iii</loc>
    <lastmod>2026-05-28T21:42:09.034Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etrasimod-arginine-ulcerative-colitis-phase-iii</loc>
    <lastmod>2026-05-28T21:42:09.047Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ruxolitinib-thalassemia-chronic-graft-versus-host-di-phase-iv</loc>
    <lastmod>2026-05-28T21:42:09.060Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-t-cells-transduced-with-the-l-solid-tumors-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:09.073Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ianalumab-lupus-nephritis-phase-iii</loc>
    <lastmod>2026-05-28T21:42:09.086Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/collagenase-dupuytren-s-contracture-phase-iii</loc>
    <lastmod>2026-05-28T21:42:09.099Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atorvastatin-metastatic-breast-cancer-metastatic-ovar-phase-ii</loc>
    <lastmod>2026-05-28T21:42:09.112Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tranexamic-acid-placenta-previa-postpartum-hemorrhage-phase-iii</loc>
    <lastmod>2026-05-28T21:42:09.125Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aztreonam-detrusor-overactivity-multiple-sclerosis-phase-iii</loc>
    <lastmod>2026-05-28T21:42:09.138Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/filgrastim-toxic-epidermal-necrolysis-lyell-syndrom-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:42:09.151Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/verapamil-type-1-diabetes-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:09.164Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colecalciferol-cholecalciferol-allergic-rhinitis-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:42:09.176Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azacitidine-cedazuridine-myelodysplastic-syndrome-chronic-myelomo-phase-i-phase-ii-phase-iii</loc>
    <lastmod>2026-05-28T21:42:09.190Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-acute-myeloid-leukemia-phase-ii</loc>
    <lastmod>2026-05-28T21:42:09.203Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/brepocitinib-tosilate-non-infectious-uveitis-intermediate-uvei-phase-iii</loc>
    <lastmod>2026-05-28T21:42:09.216Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/perflubutane-breast-cancer-melanoma-head-and-neck-can-not-applicable</loc>
    <lastmod>2026-05-28T21:42:09.231Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/relatlimab-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:42:09.244Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bisacodyl-fecal-incontinence-phase-iii</loc>
    <lastmod>2026-05-28T21:42:09.256Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-epstein-barr-virus-infection-post-transp-phase-iv</loc>
    <lastmod>2026-05-28T21:42:09.269Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/roginolisib-myelofibrosis-refractory-to-jak-inhibito-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:09.282Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/agmb-101-liver-cirrhosis-phase-i</loc>
    <lastmod>2026-05-28T21:42:09.295Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylsalicylic-acid-colorectal-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:42:09.308Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/luspatercept-myelodysplastic-syndrome-mds-lower-risk-phase-iii</loc>
    <lastmod>2026-05-28T21:42:09.321Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sar442970-ulcerative-colitis-phase-ii</loc>
    <lastmod>2026-05-28T21:42:09.334Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-classical-hodgkin-lymphoma-refractory-or-phase-ii</loc>
    <lastmod>2026-05-28T21:42:09.347Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-locally-advanced-rectal-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:42:09.360Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-classical-hodgkin-lymphoma-early-stage-c-phase-ii</loc>
    <lastmod>2026-05-28T21:42:09.373Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/healthy-volunteer-trial-phase-i</loc>
    <lastmod>2026-05-28T21:42:09.389Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/valsartan-marfan-syndrome-loeys-dietz-syndrome-vas-phase-iii</loc>
    <lastmod>2026-05-28T21:42:09.408Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nirogacestat-hydrobromide-desmoid-tumour-aggressive-fibromatosis-phase-iv</loc>
    <lastmod>2026-05-28T21:42:09.421Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-idiopathic-nephrotic-syndrome-steroid-de-phase-iii</loc>
    <lastmod>2026-05-28T21:42:09.434Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mitapivat-sickle-cell-disease-anemia-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:42:09.448Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vancomycin-total-joint-replacement-hip-or-knee-not-applicable</loc>
    <lastmod>2026-05-28T21:42:09.461Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-genetically-modified-t-lympho-primary-plasma-cell-leukaemia-phase-ii</loc>
    <lastmod>2026-05-28T21:42:09.474Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tarlatamab-small-cell-lung-cancer-small-cell-lung-c-phase-ii</loc>
    <lastmod>2026-05-28T21:42:09.487Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apalutamide-metastatic-prostate-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:42:09.500Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/piperacillin-as-piperacillin-sodium-pipe-periampullary-neoplasm-ampullary-hepatop-phase-iii</loc>
    <lastmod>2026-05-28T21:42:09.513Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-chronic-right-heart-failure-phase-ii</loc>
    <lastmod>2026-05-28T21:42:09.526Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-a-eosinophilic-asthma-phase-iii</loc>
    <lastmod>2026-05-28T21:42:09.539Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/donepezil-alzheimer-s-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:42:09.553Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azacitidine-acute-myeloid-leukemia-phase-iii</loc>
    <lastmod>2026-05-28T21:42:09.566Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/surovatamig-human-igg4-kappa-monoclonal-mantle-cell-lymphoma-diffuse-large-b-cel-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:09.580Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-disodium-phosphate-lung-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:42:09.593Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/botulinum-toxin-type-a-trapeziometacarpal-osteoarthritis-rhizar-phase-iii</loc>
    <lastmod>2026-05-28T21:42:09.610Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/kras-g12c-mutated-non-small-cell-lung-ca-phase-iii</loc>
    <lastmod>2026-05-28T21:42:09.622Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/duvakitug-crohn-s-disease-ulcerative-colitis-phase-ii</loc>
    <lastmod>2026-05-28T21:42:09.635Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-papillomavirus-type-31-l1-protein-human-papillomavirus-infection-phase-iv-2</loc>
    <lastmod>2026-05-28T21:42:09.648Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belumosudil-mesilate-multiple-myeloma-relapsed-or-refractory-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:09.663Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxaliplatin-rectal-adenocarcinoma-locally-advanced-r-phase-ii</loc>
    <lastmod>2026-05-28T21:42:09.676Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mycobaterium-obuense-strain-nctc-13365-h-colorectal-cancer-colorectal-cancer-stag-phase-ii</loc>
    <lastmod>2026-05-28T21:42:09.689Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/daratumumab-primary-plasma-cell-leukemia-plasma-cell-phase-ii</loc>
    <lastmod>2026-05-28T21:42:09.702Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/18f-fludarabine-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:42:09.715Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/taplucainium-chloride-refractory-chronic-cough-unexplained-chr-phase-ii</loc>
    <lastmod>2026-05-28T21:42:09.728Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/geh200520-injection-malignant-solid-tumor-head-and-neck-squa-phase-i</loc>
    <lastmod>2026-05-28T21:42:09.742Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mitapivat-pyruvate-kinase-deficiency-phase-iii</loc>
    <lastmod>2026-05-28T21:42:09.755Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluorouracil-advanced-pancreatic-cancer-pancreatic-ad-phase-iii</loc>
    <lastmod>2026-05-28T21:42:09.768Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mitapivat-pyruvate-kinase-deficiency-phase-iii-2</loc>
    <lastmod>2026-05-28T21:42:09.781Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cemiplimab-cutaneous-squamous-cell-carcinoma-resect-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:42:09.793Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anx007-dry-age-related-macular-degeneration-wit-phase-iii</loc>
    <lastmod>2026-05-28T21:42:09.806Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ultevursen-retinitis-pigmentosa-phase-ii</loc>
    <lastmod>2026-05-28T21:42:09.819Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ultevursen-retinitis-pigmentosa-phase-ii-2</loc>
    <lastmod>2026-05-28T21:42:09.833Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carboplatin-esophageal-cancer-esophageal-squamous-ce-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:09.846Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/e2814-dominantly-inherited-alzheimer-s-disease-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:42:09.859Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isatuximab-multiple-myeloma-relapsed-or-refractory-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:09.871Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rezvilutamide-metastatic-hormone-sensitive-prostate-ca-phase-iii</loc>
    <lastmod>2026-05-28T21:42:09.885Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zoledronic-acid-monohydrate-knee-osteoarthritis-osteoarthritis-of-th-phase-ii</loc>
    <lastmod>2026-05-28T21:42:09.897Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belantamab-mafodotin-multiple-myeloma-relapsed-or-refractory-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:09.910Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/myrrh-coffee-charcoal-dry-extract-from-c-irritable-bowel-syndrome-with-diarrhoea-phase-iv</loc>
    <lastmod>2026-05-28T21:42:09.923Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isatuximab-multiple-myeloma-relapsed-or-refractory-phase-i-ii-2</loc>
    <lastmod>2026-05-28T21:42:09.935Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bexicaserin-hydrochloride-developmental-and-epileptic-encephalopat-phase-iii-2</loc>
    <lastmod>2026-05-28T21:42:09.949Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-pemphigus-vulgaris-pemphigus-foliaceus-phase-iv</loc>
    <lastmod>2026-05-28T21:42:09.961Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/saracatinib-fibrodysplasia-ossificans-progressiva-phase-ii</loc>
    <lastmod>2026-05-28T21:42:09.975Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vrdn-003-thyroid-eye-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:42:09.988Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-mucous-membrane-pemphigoid-phase-iii</loc>
    <lastmod>2026-05-28T21:42:10.001Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vrdn-003-thyroid-eye-disease-phase-iii-2</loc>
    <lastmod>2026-05-28T21:42:10.014Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/esmolol-hydrochloride-liver-cirrhosis-type-2-diabetes-mellitus-phase-iii</loc>
    <lastmod>2026-05-28T21:42:10.027Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mexiletine-hydrochloride-non-dystrophic-myotonias-myotonia-congen-phase-iii</loc>
    <lastmod>2026-05-28T21:42:10.040Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-gastric-cancer-metastatic-gastric-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:42:10.053Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avapritinib-systemic-mastocytosis-phase-iv</loc>
    <lastmod>2026-05-28T21:42:10.066Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-chronic-myelomonocytic-leukemia-higher-r-phase-ii</loc>
    <lastmod>2026-05-28T21:42:10.079Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-2-2-10-2-4-3-4-2-2-cyano-4-4-difluor-pancreatic-cancer-bile-duct-cancer-gastr-phase-ii</loc>
    <lastmod>2026-05-28T21:42:10.092Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alpelisib-hormone-receptor-positive-her2-negative-phase-ii</loc>
    <lastmod>2026-05-28T21:42:10.105Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-myelodysplastic-syndromes-acute-myeloid-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:10.119Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ustekinumab-ulcerative-colitis-phase-iii</loc>
    <lastmod>2026-05-28T21:42:10.132Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azacitidine-myelodysplastic-syndromes-higher-risk-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:10.145Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/daratumumab-multiple-myeloma-with-extramedullary-dis-phase-ii</loc>
    <lastmod>2026-05-28T21:42:10.158Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/encoberminogene-rezmadenovec-refractory-angina-pectoris-coronary-arte-phase-ii</loc>
    <lastmod>2026-05-28T21:42:10.171Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cldn6-car-t-solid-tumors-non-small-cell-lung-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:10.184Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-cd34-haematopoietic-stem-and-mucopolysaccharidosis-type-i-hurler-synd-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:10.198Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/kyv-101-rheumatoid-arthritis-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:10.211Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-aortic-stenosis</loc>
    <lastmod>2026-05-28T21:42:10.224Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dalbavancin-catheter-related-bloodstream-infection-d-phase-iii</loc>
    <lastmod>2026-05-28T21:42:10.237Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dsimc-end-stage-liver-disease-liver-transplant</loc>
    <lastmod>2026-05-28T21:42:10.250Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rucaparib-ovarian-epithelial-cancer-primary-perito-phase-iii</loc>
    <lastmod>2026-05-28T21:42:10.263Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-glioblastoma-phase-ii-ctis-2021-000565-32</loc>
    <lastmod>2026-05-28T21:12:01.853Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-igg1-hexavalent-antibody-against-t-head-and-neck-squamous-cell-carcinoma-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:42:10.276Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anakinra-inflammatory-dilated-cardiomyopathy-phase-ii</loc>
    <lastmod>2026-05-28T21:42:10.289Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/epinephrine-cardiorespiratory-arrest-at-birth-phase-ii</loc>
    <lastmod>2026-05-28T21:42:10.302Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-plasma-protein-neuromuscular-scoliosis-adolescent-idiop-phase-iv</loc>
    <lastmod>2026-05-28T21:42:10.315Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-tirumotecan-non-muscle-invasive-bladder-cancer-inter</loc>
    <lastmod>2026-05-28T21:42:10.328Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levodopa-neurodevelopmental-disorder-ctnnb1-rare-phase-iv</loc>
    <lastmod>2026-05-28T21:42:10.340Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/paclitaxel-recurrent-metastatic-squamous-cell-carci-phase-ii</loc>
    <lastmod>2026-05-28T21:42:10.353Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gentamicin-complicated-appendicitis-acute-appendici-not-applicable</loc>
    <lastmod>2026-05-28T21:42:10.366Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxygen-hypoxemic-acute-respiratory-failure-not-applicable</loc>
    <lastmod>2026-05-28T21:42:10.379Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/benralizumab-severe-asthma-asthma-phase-iv</loc>
    <lastmod>2026-05-28T21:42:10.391Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluorouracil-gastric-cancer-gastroesophageal-junction-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:42:10.404Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/domperidone-type-1-diabetes-phase-iii</loc>
    <lastmod>2026-05-28T21:42:10.417Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/type-i-interferonopathies-phase-iii</loc>
    <lastmod>2026-05-28T21:42:10.432Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rinatabart-sesutecan-platinum-resistant-ovarian-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:42:10.445Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bexicaserin-hydrochloride-dravet-syndrome-severe-myoclonic-epileps-phase-iii</loc>
    <lastmod>2026-05-28T21:42:10.459Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-mature-dendritic-cells-loaded-glioblastoma-phase-ii</loc>
    <lastmod>2026-05-28T21:42:10.472Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vimseltinib-tenosynovial-giant-cell-tumor-advanced-c-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:10.485Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/4-methyl-1h-pyrazol-4-yl-benzyl-6-7-3-py-gastrointestinal-stromal-tumour-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:10.498Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/disitamab-vedotin-her2-expressing-advanced-breast-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:10.511Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clostridium-botulinum-neurotoxin-type-a-postoperative-pancreatic-fistula-phase-iii</loc>
    <lastmod>2026-05-28T21:42:10.524Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/luxdegalutamide-metastatic-hormone-sensitive-prostate-ca-phase-ii</loc>
    <lastmod>2026-05-28T21:42:10.537Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rocuronium-bromide-respiratory-distress-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:42:10.550Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tasimelteon-insomnia-disorder-phase-iii</loc>
    <lastmod>2026-05-28T21:42:10.563Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-hepatocellular-carcinoma-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:42:10.575Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sotorasib-advanced-pancreatic-adenocarcinoma-pancr-phase-iii</loc>
    <lastmod>2026-05-28T21:42:10.589Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-type-1-diabetes-double-diabetes-phase-iii</loc>
    <lastmod>2026-05-28T21:42:10.602Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pacritinib-primary-myelofibrosis-post-polycythaemia-phase-iii</loc>
    <lastmod>2026-05-28T21:42:10.615Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-breast-cancer-inflammatory-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:42:10.628Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluorouracil-head-and-neck-squamous-cell-carcinoma-re-phase-ii</loc>
    <lastmod>2026-05-28T21:42:10.641Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ribociclib-hormone-receptor-positive-hr-her2-negati-phase-iv</loc>
    <lastmod>2026-05-28T21:42:10.654Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dmd06-mab-duchenne-muscular-dystrophy-phase-i-ii</loc>
    <lastmod>2026-05-28T21:42:10.667Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alfentanil-hydrochloride-severe-acute-pain-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:42:10.680Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obesity-right-heart-failure-phase-i</loc>
    <lastmod>2026-05-28T21:42:10.693Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-normal-immunoglobulin-covid-19-severely-impaired-b-cell-functi-phase-ii</loc>
    <lastmod>2026-05-28T21:42:10.706Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adalimumab-folliculitis-decalvans-phase-ii</loc>
    <lastmod>2026-05-28T21:42:10.719Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-sarcoma-melanoma-triple-negative-breast-phase-i</loc>
    <lastmod>2026-05-28T21:42:10.733Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atumelnant-congenital-adrenal-hyperplasia-phase-iv</loc>
    <lastmod>2026-05-28T21:42:10.746Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/taletrectinib-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:46:46.292Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ensifentrine-non-cystic-fibrosis-bronchiectasis-phase-ii</loc>
    <lastmod>2026-05-28T21:46:46.333Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vincristine-sulfate-retinoblastoma-phase-iv</loc>
    <lastmod>2026-05-28T21:46:46.360Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/palbociclib-hormone-receptor-positive-her2-negative-phase-iii</loc>
    <lastmod>2026-05-28T21:46:46.385Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glioblastoma-who-grade-iv-glioma-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:46:46.409Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aprepitant-obstructive-sleep-apnea-syndrome-essenti-phase-ii</loc>
    <lastmod>2026-05-28T21:46:46.432Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colecalciferol-type-2-diabetes-mellitus-phase-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:46:46.458Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-albumin-solution-liver-transplantation-phase-iv</loc>
    <lastmod>2026-05-28T21:46:46.482Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methylprednisolone-hydrogen-succinate-idiopathic-pulmonary-fibrosis-acute-exac-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:46:46.507Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mycophenolic-acid-kidney-transplant-renal-insufficiency-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:46:46.530Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutetium-177lu-oxodotreotide-gastroenteropancreatic-neuroendocrine-tu-phase-iv</loc>
    <lastmod>2026-05-28T21:46:46.554Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/furosemide-dyspnea-advanced-lung-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:46:46.578Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tafasitamab-malignant-b-cell-lymphoma-diffuse-large-phase-ii</loc>
    <lastmod>2026-05-28T21:46:46.604Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/meropenem-vaborbactam-gram-negative-bacterial-infections-compl-phase-ii</loc>
    <lastmod>2026-05-28T21:46:46.625Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/melatonin-chronic-low-back-pain</loc>
    <lastmod>2026-05-28T21:46:46.653Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/melphalan-flufenamide-multiple-myeloma-relapsed-refractory-mul-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:46:46.672Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cevostamab-systemic-lupus-erythematosus-lupus-nephr-phase-iii</loc>
    <lastmod>2026-05-28T21:46:46.694Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atropine-sulfate-myopia-not-applicable</loc>
    <lastmod>2026-05-28T21:46:46.717Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dazukibart-idiopathic-inflammatory-myopathy-dermato-phase-iii</loc>
    <lastmod>2026-05-28T21:46:46.736Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/duochol-oral-cholera-vaccine-cholera-phase-i</loc>
    <lastmod>2026-05-28T21:46:46.759Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atorvastatin-arrhythmogenic-cardiomyopathy-acm-arrhyt-phase-ii</loc>
    <lastmod>2026-05-28T21:46:46.786Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/risankizumab-psoriasis-plaque-psoriasis-phase-iv</loc>
    <lastmod>2026-05-28T21:46:46.800Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxygen-weaning-failure-weaning-of-mechanical-ve-phase-iv</loc>
    <lastmod>2026-05-28T21:46:46.826Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-tolerogenic-dendritic-cells-kidney-transplant-phase-iii</loc>
    <lastmod>2026-05-28T21:46:46.846Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regorafenib-bone-sarcoma-phase-ii</loc>
    <lastmod>2026-05-28T21:46:46.873Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/niraparib-squamous-cell-carcinoma-of-the-head-and-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:46.896Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carboplatin-stage-ii-seminoma-phase-iv</loc>
    <lastmod>2026-05-28T21:46:46.923Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/phospholipid-fraction-porcine-lung-respiratory-distress-syndrome-rds-phase-ii</loc>
    <lastmod>2026-05-28T21:46:46.941Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mepolizumab-chronic-rhinosinusitis-with-nasal-polypo</loc>
    <lastmod>2026-05-28T21:46:46.968Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/golcadomide-relapsed-or-refractory-peripheral-t-cell-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:46.983Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/neratinib-her2-positive-breast-cancer-hormone-rece-phase-ii</loc>
    <lastmod>2026-05-28T21:46:47.004Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/epirubicin-hydrochloride-breast-cancer-not-applicable</loc>
    <lastmod>2026-05-28T21:46:47.030Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vidofludimus-calcium-relapsing-multiple-sclerosis-phase-iii-2</loc>
    <lastmod>2026-05-28T21:46:47.053Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tezepelumab-eosinophilic-granulomatosis-with-polyang-phase-ii</loc>
    <lastmod>2026-05-28T21:46:47.069Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-muscle-invasive-bladder-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:46:47.086Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/enasidenib-mesilate-paediatric-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:47.107Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-metastatic-pancreatic-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:47.121Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levobupivacaine-colorectal-cancer-not-applicable</loc>
    <lastmod>2026-05-28T21:46:47.143Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/midazolam-perioperative-anxiety-phase-iii</loc>
    <lastmod>2026-05-28T21:46:47.170Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cannabidiol-post-traumatic-stress-disorder-anxiety-d-phase-iv</loc>
    <lastmod>2026-05-28T21:46:47.187Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adalimumab-crohn-s-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:46:47.211Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mifamurtide-high-grade-osteosarcoma-high-risk-osteos-phase-ii</loc>
    <lastmod>2026-05-28T21:46:47.236Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vidofludimus-calcium-progressive-multiple-sclerosis-phase-ii</loc>
    <lastmod>2026-05-28T21:46:47.250Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-iodide-131i-differentiated-thyroid-cancer-papillary-phase-iii</loc>
    <lastmod>2026-05-28T21:46:47.264Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sunitinib-advanced-soft-tissue-sarcoma-advanced-bo-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:47.288Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rapcabtagene-autoleucel-rheumatoid-arthritis-sjogren-s-syndrome-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:47.305Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avalglucosidase-alfa-glycogen-storage-disease-type-ii-pompe-d-phase-iv</loc>
    <lastmod>2026-05-28T21:46:47.322Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inclisiran-homozygous-familial-hypercholesterolemia-phase-iii</loc>
    <lastmod>2026-05-28T21:46:47.341Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mesalazine-lynch-syndrome-phase-iv</loc>
    <lastmod>2026-05-28T21:46:47.359Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inclisiran-heterozygous-familial-hypercholesterolem-phase-iii</loc>
    <lastmod>2026-05-28T21:46:47.373Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/omalizumab-chronic-spontaneous-urticaria-phase-iii</loc>
    <lastmod>2026-05-28T21:46:47.386Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ferric-carboxymaltose-anemia-peripheral-artery-disease-chronic-phase-iv</loc>
    <lastmod>2026-05-28T21:46:47.409Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aro-atxn2-spinocerebellar-ataxia-type-2-phase-i</loc>
    <lastmod>2026-05-28T21:46:47.427Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dasatinib-chronic-myeloid-leukemia-phase-iv</loc>
    <lastmod>2026-05-28T21:46:47.450Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-fluoride-18f-psoriasis-phase-iv</loc>
    <lastmod>2026-05-28T21:46:47.463Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-t-cells-ex-vivo-modified-with-t-cell-acute-lymphoblastic-leukaemia-t-c-phase-i</loc>
    <lastmod>2026-05-28T21:46:47.483Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-igg4-kappa-monoclonal-antibody-aga-pulmonary-arterial-hypertension-phase-ii</loc>
    <lastmod>2026-05-28T21:46:47.503Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/1-4-diamino-2-3-dicyano-1-4-bis-o-aminop-subarachnoid-haemorrhage-phase-i</loc>
    <lastmod>2026-05-28T21:46:47.523Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/msv-allo-lupus-nephritis-phase-ii</loc>
    <lastmod>2026-05-28T21:46:47.546Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fludeoxyglucose-18f-aortic-stenosis-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:46:47.566Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/omtx705-advanced-solid-tumors-carcinoma-leiomyos-phase-i</loc>
    <lastmod>2026-05-28T21:46:47.591Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gallium-68ga-evg321-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:46:47.609Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dupilumab-lichen-simplex-chronicus-neurodermatitis-phase-iii</loc>
    <lastmod>2026-05-28T21:46:47.632Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/chadox1-thivconsvx-hiv-infection-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:47.646Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-govitecan-muscle-invasive-bladder-cancer-urothelia-phase-ii</loc>
    <lastmod>2026-05-28T21:46:47.660Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tucatinib-her2-positive-breast-cancer-locally-adva-phase-iii</loc>
    <lastmod>2026-05-28T21:46:47.676Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/a49-glioblastoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:47.701Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tofacitinib-juvenile-idiopathic-arthritis-phase-iv</loc>
    <lastmod>2026-05-28T21:46:47.718Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/darolutamide-localised-very-high-risk-prostate-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:46:47.747Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bisoprolol-fumarate-heart-failure-in-remission-not-applicable</loc>
    <lastmod>2026-05-28T21:46:47.771Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/teropavimab-hiv-infection-primary-hiv-infection-phase-ii</loc>
    <lastmod>2026-05-28T21:46:47.795Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/minocycline-hydrochloride-major-depressive-disorder-phase-iv</loc>
    <lastmod>2026-05-28T21:46:47.821Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxaliplatin-colorectal-cancer-peritoneal-metastases-phase-ii</loc>
    <lastmod>2026-05-28T21:46:47.838Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/teicoplanin-cystic-fibrosis-staphylococcus-aureus-in-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:46:47.857Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mezagitamab-primary-immune-thrombocytopenia-chronic-phase-iii</loc>
    <lastmod>2026-05-28T21:46:47.871Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colecalciferol-severe-vitamin-d-deficiency-critical-ill-phase-iii</loc>
    <lastmod>2026-05-28T21:46:47.893Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/transfer-factor-tfi-recurrent-respiratory-tract-infections-r</loc>
    <lastmod>2026-05-28T21:46:47.906Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-glioblastoma-glioblastoma-mgmt-promoter-phase-ii</loc>
    <lastmod>2026-05-28T21:46:47.925Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methylprednisolone-aceponate-mild-to-moderate-atopic-dermatitis-atopi-phase-iii</loc>
    <lastmod>2026-05-28T21:46:47.943Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efgartigimod-alfa-primary-sjogren-s-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:46:47.957Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/treg02-kidney-transplantation-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:47.979Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-bone-marrow-derived-mesenchym-knee-osteoarthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:46:47.996Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dupilumab-lichen-simplex-chronicus-lsc-neurodermat-phase-iii</loc>
    <lastmod>2026-05-28T21:46:48.012Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tirbanibulin-actinic-keratosis-phase-iv</loc>
    <lastmod>2026-05-28T21:46:48.026Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/transpocart19-relapsed-or-refractory-b-cell-lymphoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:48.045Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zoledronic-acid-monohydrate-high-grade-osteosarcoma-phase-iii</loc>
    <lastmod>2026-05-28T21:46:48.059Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/his203-crm197-knee-osteoarthritis-phase-ii</loc>
    <lastmod>2026-05-28T21:46:48.076Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/b-phuket-3073-2013-like-virus-b-phuket-3-stable-coronary-artery-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:46:48.092Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venglustat-gaucher-disease-type-3-phase-iii</loc>
    <lastmod>2026-05-28T21:46:48.118Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vedolizumab-inflammatory-bowel-disease-ulcerative-co-not-applicable</loc>
    <lastmod>2026-05-28T21:46:48.131Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apl-101-bozitinib-non-small-cell-lung-cancer-central-nervo-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:48.155Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/silexan-80-mg-healthy-volunteers-phase-iii</loc>
    <lastmod>2026-05-28T21:46:48.169Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/botulinum-toxin-atc-m03ax01-myogenous-temporomandibular-disorders-tm-phase-iv</loc>
    <lastmod>2026-05-28T21:46:48.187Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/orforglipron-hemicalcium-stress-urinary-incontinence-urinary-inco-phase-iii</loc>
    <lastmod>2026-05-28T21:46:48.206Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cenerimod-systemic-lupus-erythematosus-phase-iii</loc>
    <lastmod>2026-05-28T21:46:48.227Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cerebrolysin-concentrate-ischaemic-stroke-stroke</loc>
    <lastmod>2026-05-28T21:46:48.249Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/irinotecan-hydrochloride-trihydrate-rectal-cancer-recurrent-rectal-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:46:48.263Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cpft-trifluoroacetate-infertility-phase-iii</loc>
    <lastmod>2026-05-28T21:46:48.288Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/chronic-post-stroke-aphasia-phase-iv</loc>
    <lastmod>2026-05-28T21:46:48.306Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gallium-68ga-chloride-venous-thromboembolism-occult-malignancy-phase-iii</loc>
    <lastmod>2026-05-28T21:46:48.325Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abemaciclib-breast-cancer-hormone-receptor-positive-phase-ii</loc>
    <lastmod>2026-05-28T21:46:48.345Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tranexamic-acid-hip-osteoarthritis-osteoarthritis-phase-iv</loc>
    <lastmod>2026-05-28T21:46:48.362Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/daratumumab-multiple-myeloma-phase-ii-2</loc>
    <lastmod>2026-05-28T21:46:48.384Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/myrrh-coffee-charcoal-dry-extract-from-c-irritable-bowel-syndrome-with-diarrhoea-phase-iv-2</loc>
    <lastmod>2026-05-28T21:46:48.398Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexmedetomidine-pediatric-surgery-postoperative-pain-phase-iv</loc>
    <lastmod>2026-05-28T21:46:48.418Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-non-small-cell-lung-cancer-unresectable-phase-ii</loc>
    <lastmod>2026-05-28T21:46:48.443Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anti-pancreatic-adenocarcinoma-upregulat-advanced-metastatic-pancreatic-adenocarc-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:48.466Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ispaghula-husk-low-anterior-resection-syndrome-lars-aft-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:46:48.483Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/risankizumab-ulcerative-colitis-phase-iii-2</loc>
    <lastmod>2026-05-28T21:46:48.502Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/doxorubicin-hydrochloride-triple-negative-breast-cancer-hormone-re-phase-ii</loc>
    <lastmod>2026-05-28T21:46:48.516Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efgartigimod-alfa-systemic-sclerosis-phase-ii</loc>
    <lastmod>2026-05-28T21:46:48.538Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/osimertinib-non-small-cell-lung-cancer-egfr-mutated</loc>
    <lastmod>2026-05-28T21:46:48.553Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mecloderm-cream-test-cutaneous-candidiasis-candidiasis-of-ski</loc>
    <lastmod>2026-05-28T21:46:48.566Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/revumenib-acute-myeloid-leukemia-phase-iii</loc>
    <lastmod>2026-05-28T21:46:48.580Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vx-993-painful-diabetic-peripheral-neuropathy-phase-ii</loc>
    <lastmod>2026-05-28T21:46:48.599Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-diabetic-macular-oedema-phase-ii</loc>
    <lastmod>2026-05-28T21:46:48.622Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clozapine-parkinson-s-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:46:48.638Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-myelodysplastic-syndrome-chronic-myelomo-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:48.657Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ketamine-hydrochloride-borderline-personality-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:46:48.670Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colecalciferol-severe-vitamin-d-deficiency-phase-iv</loc>
    <lastmod>2026-05-28T21:46:48.688Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-chronic-lymphocytic-leukaemia-treatment-phase-ii</loc>
    <lastmod>2026-05-28T21:46:48.701Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nadofaragene-firadenovec-low-grade-upper-tract-urothelial-carcino-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:48.715Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isatuximab-multiple-myeloma-phase-ii</loc>
    <lastmod>2026-05-28T21:46:48.731Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluorouracil-pancreatic-ductal-adenocarcinoma-resecte-phase-iii</loc>
    <lastmod>2026-05-28T21:46:48.744Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/deoxyribonucleic-acid-ribonucleic-acid-s-recurrent-orofacial-herpes-oral-herpes-h-phase-iv</loc>
    <lastmod>2026-05-28T21:46:48.758Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allergenic-extract-of-olea-europaea-poll-allergic-rhinitis-rhinoconjunctivitis-al-phase-iii</loc>
    <lastmod>2026-05-28T21:46:48.776Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/olaparib-extensive-stage-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:46:48.794Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pirfenidone-acute-respiratory-distress-syndrome-ards-phase-iii</loc>
    <lastmod>2026-05-28T21:46:48.814Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allergenic-extract-of-juniperus-oxycedru-allergic-rhinitis-allergic-rhinoconjunct-phase-iii</loc>
    <lastmod>2026-05-28T21:46:48.832Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/men2312-kat6-inhibitor-advanced-er-positive-her2-negative-breas-phase-i</loc>
    <lastmod>2026-05-28T21:46:48.845Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isatuximab-pure-red-cell-aplasia-post-allogeneic-he-phase-ii</loc>
    <lastmod>2026-05-28T21:46:48.865Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inclisiran-heterozygous-familial-hypercholesterolae-phase-iii</loc>
    <lastmod>2026-05-28T21:46:48.879Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apremilast-recurrent-aphthous-stomatitis-phase-iii</loc>
    <lastmod>2026-05-28T21:46:48.893Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/piperacillin-sodium-tazobactam-sodium-burn-injury-requiring-excision-and-autog-phase-iii</loc>
    <lastmod>2026-05-28T21:46:48.906Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/liv001-ulcerative-colitis-phase-i</loc>
    <lastmod>2026-05-28T21:46:48.920Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-metastatic-uveal-melanoma-phase-iv</loc>
    <lastmod>2026-05-28T21:46:48.939Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apixaban-intrahepatic-non-cirrhotic-portal-hypert-phase-iii</loc>
    <lastmod>2026-05-28T21:46:48.953Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sgt-003-human-microdystrophin-duchenne-muscular-dystrophy-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:48.972Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sirolimus-cutaneous-sarcoidosis-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:46:48.986Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-b-cell-acute-lymphoblastic-leukaemia-b-a-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:49.007Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mk-1084-non-small-cell-lung-cancer-non-squamous-phase-iii</loc>
    <lastmod>2026-05-28T21:46:49.021Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ceftazidime-sepsis-gram-negative-sepsis-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:46:49.038Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/frexalimab-multiple-sclerosis-phase-iii-2</loc>
    <lastmod>2026-05-28T21:46:49.058Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levetiracetam-refractory-focal-onset-epilepsy-drug-res-phase-iii</loc>
    <lastmod>2026-05-28T21:46:49.072Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-90189892-acute-myeloid-leukemia-relapsed-or-refra-phase-i</loc>
    <lastmod>2026-05-28T21:46:49.094Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/basimglurant-trigeminal-neuralgia-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:46:49.108Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/teprenone-teprenone-postoperative-atrial-fibrillation-phase-iv</loc>
    <lastmod>2026-05-28T21:46:49.122Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avalotcagene-ontaparvovec-ornithine-transcarbamylase-deficiency-la-phase-iii</loc>
    <lastmod>2026-05-28T21:46:49.137Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/osimertinib-non-small-cell-lung-cancer-egfr-mutated-2</loc>
    <lastmod>2026-05-28T21:46:49.151Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/naltrexone-hydrochloride-compulsive-sexual-behaviour-disorder-phase-iii</loc>
    <lastmod>2026-05-28T21:46:49.166Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-chronic-lymphocytic-leukemia-relapsed-re-phase-ii</loc>
    <lastmod>2026-05-28T21:46:49.180Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/roginolisib-uveal-melanoma-ocular-melanoma-advanced-phase-ii</loc>
    <lastmod>2026-05-28T21:46:49.201Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/exemestane-luminal-a-breast-cancer-hormone-receptor-phase-ii</loc>
    <lastmod>2026-05-28T21:46:49.220Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cannabidiol-irritable-bowel-syndrome-with-diarrhea-i-phase-ii</loc>
    <lastmod>2026-05-28T21:46:49.243Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-pseudomyxoma-peritonei-phase-iv</loc>
    <lastmod>2026-05-28T21:46:49.258Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-primary-central-nervous-system-diffuse-l-phase-iii</loc>
    <lastmod>2026-05-28T21:46:49.278Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/leriglitazone-rett-syndrome-phase-ii</loc>
    <lastmod>2026-05-28T21:46:49.296Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vo659-spinocerebellar-ataxia-type-1-spinocereb-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:49.316Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd4512-b-cell-non-hodgkin-lymphoma-relapsed-ref-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:49.335Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/spesolimab-pyoderma-gangrenosum</loc>
    <lastmod>2026-05-28T21:46:49.350Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/demerecviridae-bacteriophage-against-kle-ventilator-associated-pneumonia-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:49.369Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-non-squamous-non-small-cell-lung-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:46:49.384Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dnajb1-prkaca-trifluoracetate-fibrolamellar-hepatocellular-carcinoma-t-phase-i</loc>
    <lastmod>2026-05-28T21:46:49.399Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iti-1284-agitation-associated-with-alzheimer-s-de-phase-ii</loc>
    <lastmod>2026-05-28T21:46:49.418Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-colon-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:46:49.438Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etoposide-phosphate-primary-central-nervous-system-lymphoma-phase-ii</loc>
    <lastmod>2026-05-28T21:46:49.451Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-multiple-sclerosis-phase-iii</loc>
    <lastmod>2026-05-28T21:46:49.468Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ocrelizumab-multiple-sclerosis-phase-iv</loc>
    <lastmod>2026-05-28T21:46:49.482Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lidocaine-hydrochloride-monohydrate-subarachnoid-hemorrhage-phase-iv</loc>
    <lastmod>2026-05-28T21:46:49.496Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sorafenib-hepatocellular-carcinoma-renal-cell-carc-phase-iii</loc>
    <lastmod>2026-05-28T21:46:49.514Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prednisolone-idiopathic-retroperitoneal-fibrosis-phase-iv</loc>
    <lastmod>2026-05-28T21:46:49.528Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bortezomib-autoimmune-encephalitis-autoantibody-pos-phase-ii</loc>
    <lastmod>2026-05-28T21:46:49.546Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gallium-citrate-ga-68-prosthetic-valve-infective-endocarditis-phase-ii</loc>
    <lastmod>2026-05-28T21:46:49.572Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/18f-fluoro-peg-folate-giant-cell-arteritis-large-vessel-giant-phase-ii</loc>
    <lastmod>2026-05-28T21:46:49.587Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/escitalopram-oxalate-compulsive-sexual-behaviour-disorder-phase-iii</loc>
    <lastmod>2026-05-28T21:46:49.601Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fosnetupitant-prodrug-of-netupitant-and-chemotherapy-induced-nausea-and-vomiting-phase-ii-phase-iii</loc>
    <lastmod>2026-05-28T21:46:49.617Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zirconium-89zr-crefmirlimab-berdoxam-giant-cell-arteritis-rheumatoid-arthriti-phase-ii</loc>
    <lastmod>2026-05-28T21:46:49.634Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trabectedin-mesenchymal-chondrosarcoma-hey1-ncoa2-po-phase-ii</loc>
    <lastmod>2026-05-28T21:46:49.649Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/c1-esterase-inhibitor-human-traumatic-brain-injury-phase-iv</loc>
    <lastmod>2026-05-28T21:46:49.662Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/propofol-pain-phase-iv</loc>
    <lastmod>2026-05-28T21:46:49.681Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etoposide-high-risk-myelodysplastic-syndrome-acute-phase-ii</loc>
    <lastmod>2026-05-28T21:46:49.697Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ng004-acute-incomplete-cervical-spinal-cord-in-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:49.713Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fludarabine-phosphate-high-risk-myelodysplastic-syndrome-acute-phase-ii</loc>
    <lastmod>2026-05-28T21:46:49.727Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/estriol-vaginal-atrophy-phase-ii</loc>
    <lastmod>2026-05-28T21:46:49.740Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mepivacaine-hydrochloride-ischemic-stroke-phase-iv</loc>
    <lastmod>2026-05-28T21:46:49.755Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-2-2-10-2-4-3-4-2-2-cyano-4-4-difluor-pleural-mesothelioma-phase-iv</loc>
    <lastmod>2026-05-28T21:46:49.769Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/interferon-alfa-interleukin-1-interleuki-non-genital-warts-common-warts-plantar-w</loc>
    <lastmod>2026-05-28T21:46:49.786Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/attention-deficit-hyperactivity-disorder-phase-iii</loc>
    <lastmod>2026-05-28T21:46:49.804Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-adipose-derived-mesenchymal-s-degenerative-disc-disease-not-applicable</loc>
    <lastmod>2026-05-28T21:46:49.818Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/norucholic-acid-primary-sclerosing-cholangitis</loc>
    <lastmod>2026-05-28T21:46:49.833Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/navtemadlin-primary-myelofibrosis-post-polycythemia-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:49.850Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gemcitabine-pancreatic-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:46:49.864Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rosuvastatin-fenofibrate-dyslipidaemia-phase-iii</loc>
    <lastmod>2026-05-28T21:46:49.882Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/1-4-6-amino-5-4-phenoxy-phenyl-pyrimidin-myelofibrosis-indolent-systemic-mastocyt-phase-ii</loc>
    <lastmod>2026-05-28T21:46:49.900Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxygen-postoperative-desaturation-hypoxaemia-ri-phase-iv</loc>
    <lastmod>2026-05-28T21:46:49.914Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/telisotuzumab-adizutecan-non-small-cell-lung-cancer-non-squamous-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:49.928Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tx000045-pulmonary-hypertension-heart-failure-wit-phase-ii</loc>
    <lastmod>2026-05-28T21:46:49.942Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mcla-129-non-small-cell-lung-cancer-solid-tumours-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:49.956Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rilvegostomig-metastatic-squamous-non-small-cell-lung-phase-iii</loc>
    <lastmod>2026-05-28T21:46:49.970Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amg-193-non-small-cell-lung-cancer-mtap-deleted-phase-ii</loc>
    <lastmod>2026-05-28T21:46:49.984Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/potassium-hydroxide-actinic-keratosis-phase-iii</loc>
    <lastmod>2026-05-28T21:46:50.002Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-her2-positive-early-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.021Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ibrutinib-mantle-cell-lymphoma-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:46:50.035Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/14c-abbv-932-healthy-volunteers-phase-iii</loc>
    <lastmod>2026-05-28T21:46:50.052Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ivosidenib-cholangiocarcinoma-cholangiocarcinoma-wi-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:50.067Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zl-1310-small-cell-lung-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:46:50.083Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glycopyrronium-bromide-formoterol-fumara-asthma-uncontrolled-asthma</loc>
    <lastmod>2026-05-28T21:46:50.097Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/epcoritamab-relapsed-refractory-large-b-cell-lymphom-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.111Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zampilimab-idiopathic-pulmonary-fibrosis-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.129Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sepiapterin-phenylketonuria-pku-phase-iii</loc>
    <lastmod>2026-05-28T21:46:50.143Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/voriconazole-candidemia-uncomplicated-candidemia-phase-iii</loc>
    <lastmod>2026-05-28T21:46:50.157Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/esmolol-hydrochloride-laparoscopic-cholecystectomy-not-applicable</loc>
    <lastmod>2026-05-28T21:46:50.174Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pegaspargase-acute-lymphoblastic-leukaemia-all</loc>
    <lastmod>2026-05-28T21:46:50.188Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/4-4-cyano-2-1-r-4s-6-propan-2-ylcarbamoy-advanced-colorectal-cancer-non-msi-h-dmm-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.207Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levosimendan-aneurysmal-subarachnoid-hemorrhage-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.223Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prucalopride-gastro-oesophageal-reflux-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:46:50.237Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/voclosporin-lupus-nephritis-systemic-lupus-erythemat-not-applicable</loc>
    <lastmod>2026-05-28T21:46:50.256Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clemastine-schizophrenia-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.270Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mbf-362-primary-dysmenorrhea-phase-i</loc>
    <lastmod>2026-05-28T21:46:50.288Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/platelet-concentrate-diminished-ovarian-reserve-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.305Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/spvn20-end-stage-rod-cone-dystrophy-hereditary-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:50.320Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/naxitamab-ewing-s-sarcoma-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.333Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nvg-2089-immune-thrombocytopenia-itp-primary-immu-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.350Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eplontersen-transthyretin-mediated-amyloid-cardiomyo-phase-iii</loc>
    <lastmod>2026-05-28T21:46:50.365Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tarlatamab-neuroendocrine-carcinoma-of-the-digestiv-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.379Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-wharton-s-jelly-derived-mesen-fibrotic-interstitial-lung-disease-idiop-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:50.395Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ustekinumab-crohn-s-disease-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:46:50.414Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isatuximab-multiple-myeloma-plasma-cell-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:46:50.431Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levosimendan-heart-failure-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.445Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dasatinib-amnestic-mild-cognitive-impairment-alzhe-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.459Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/duloxetine-functional-somatic-disorder-phase-iv</loc>
    <lastmod>2026-05-28T21:46:50.472Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/entinostat-high-risk-relapsed-or-refractory-maligna-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:50.488Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-kaposi-s-sarcoma-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.502Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd7798-crohn-s-disease-active-ileal-crohn-s-dis-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.518Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-igg1-lambda-fab-fragment-against-t-asthma-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.531Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/interferon-alfa-deoxyribonucleic-acid-in-epstein-barr-virus-infection-phase-iv</loc>
    <lastmod>2026-05-28T21:46:50.545Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/leflunomide-polymyalgia-rheumatica-phase-iii</loc>
    <lastmod>2026-05-28T21:46:50.559Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-acute-myeloid-leukemia-phase-ii-2</loc>
    <lastmod>2026-05-28T21:46:50.576Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cebsulfase-alfa-metachromatic-leukodystrophy-late-infant-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.590Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dermatophagoides-farinae-allergies-phase-iv</loc>
    <lastmod>2026-05-28T21:46:50.604Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/navepegritide-achondroplasia-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.617Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/toripalimab-advanced-hepatocellular-carcinoma-hepato-phase-iii</loc>
    <lastmod>2026-05-28T21:46:50.632Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/budesonide-glycopyrronium-bromide-formot-chronic-obstructive-pulmonary-disease-not-applicable</loc>
    <lastmod>2026-05-28T21:46:50.651Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/olaparib-triple-negative-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.668Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apixaban-intracerebral-haemorrhage-atrial-fibrill-not-applicable</loc>
    <lastmod>2026-05-28T21:46:50.682Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pivekimab-sunirine-acute-myeloid-leukemia-cd123-positive-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:50.696Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dermatophagoides-farinae-allergoid-gluta-allergic-rhinitis-rhinoconjunctivitis-al-phase-iii-2</loc>
    <lastmod>2026-05-28T21:46:50.710Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alpelisib-dent-2-disease-dent-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.724Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/deuruxolitinib-alopecia-areata-phase-iii</loc>
    <lastmod>2026-05-28T21:46:50.739Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pivekimab-sunirine-acute-myeloid-leukemia-other-hematologic-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:50.753Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zigakibart-iga-nephropathy-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.766Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tucatinib-metastatic-colorectal-cancer-her2-positi-phase-iii</loc>
    <lastmod>2026-05-28T21:46:50.784Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-metastatic-solid-tumours-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.798Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/3s-3-s-3a-s-10a-s-6-chloro-3-3-chloro-2-solid-tumours-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.815Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amg-732-thyroid-eye-disease-graves-ophthalmopath-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:50.829Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-80948543-and-other-cd3-tces-relapsed-refractory-b-cell-non-hodgkin-l-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:50.842Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/encorafenib-colon-cancer-braf-v600e-mutated-localize-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.857Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tezacaftor-deutivacaftor-vanzacaftor-cystic-fibrosis-phase-iii</loc>
    <lastmod>2026-05-28T21:46:50.870Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methyl-aminolevulinate-extra-mammary-paget-disease-of-the-vulva-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.884Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metyrapone-mild-autonomous-cortisol-secretion-phase-iv</loc>
    <lastmod>2026-05-28T21:46:50.898Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tilt-123-melanoma-phase-iii</loc>
    <lastmod>2026-05-28T21:46:50.911Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rapcabtagene-autoleucel-idiopathic-inflammatory-myopathies-sever-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.925Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/indocyanine-green-pulmonary-metastases-rhabdomyosarcoma-no-phase-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.939Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iph4502-advanced-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:46:50.956Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mirvetuximab-soravtansine-ovarian-cancer-recurrent-fallopian-tube-phase-ii</loc>
    <lastmod>2026-05-28T21:46:50.970Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:46:50.984Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ceftriaxone-sodium-lidocaine-hydrochlori-community-acquired-pneumonia-hospital-ac-phase-iii</loc>
    <lastmod>2026-05-28T21:46:50.999Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regorafenib-melanoma-malignant-melanoma-stage-iii-ma-phase-ii</loc>
    <lastmod>2026-05-28T21:46:51.012Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avelumab-solid-tumors-phase-iii</loc>
    <lastmod>2026-05-28T21:46:51.026Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rubidium-chloride-kidney-carcinoma-renal-cell-carcinoma-phase-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:46:51.045Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sarilumab-rheumatoid-arthritis</loc>
    <lastmod>2026-05-28T21:46:51.059Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lisaftoclax-chronic-lymphocytic-leukemia-small-lymph-phase-iii</loc>
    <lastmod>2026-05-28T21:46:51.076Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gsk4527363-systemic-lupus-erythematosus-connective-phase-i</loc>
    <lastmod>2026-05-28T21:46:51.092Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ezabenlimab-anal-canal-squamous-cell-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:46:51.106Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zirconium-89zr-girentuximab-clear-cell-renal-cell-carcinoma-metastat-phase-iii</loc>
    <lastmod>2026-05-28T21:46:51.120Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dazucorilant-amyotrophic-lateral-sclerosis-phase-ii</loc>
    <lastmod>2026-05-28T21:46:51.134Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/enfortumab-vedotin-advanced-melanoma-metastatic-melanoma-phase-ii</loc>
    <lastmod>2026-05-28T21:46:51.148Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/orforglipron-hemicalcium-obesity-overweight-phase-iii</loc>
    <lastmod>2026-05-28T21:46:51.162Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/yellow-fever-virus-strain-17d-204-live-a-yellow-fever-not-applicable</loc>
    <lastmod>2026-05-28T21:46:51.176Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/relacorilant-cort-125134-endogenous-cushing-syndrome-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:46:51.189Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mosunetuzumab-chronic-lymphocytic-leukemia-relapsed-or-phase-iii</loc>
    <lastmod>2026-05-28T21:46:51.207Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clostridium-botulinum-neurotoxin-type-a-degenerative-rotator-cuff-tendinopathy-phase-ii</loc>
    <lastmod>2026-05-28T21:46:51.226Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-phosphate-primary-immune-thrombocytopenia-phase-iii</loc>
    <lastmod>2026-05-28T21:46:51.242Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/plasma-congenital-heart-disease-perioperative-c-not-applicable</loc>
    <lastmod>2026-05-28T21:46:51.255Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/olaparib-glioblastoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:51.269Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tozinameran-covid-19-phase-iv</loc>
    <lastmod>2026-05-28T21:46:51.290Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nanobody-against-macrophage-mannose-rece-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:46:51.304Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/povetacicept-immunoglobulin-a-nephropathy-igan-phase-iii</loc>
    <lastmod>2026-05-28T21:46:51.318Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-leptomeningeal-disease-phase-i-ctis-2021-001795-42</loc>
    <lastmod>2026-05-28T21:11:59.531Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cabozantinib-metastatic-clear-cell-renal-cell-carcino-phase-ii</loc>
    <lastmod>2026-05-28T21:46:51.332Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efgartigimod-alfa-ocular-myasthenia-gravis-phase-iii</loc>
    <lastmod>2026-05-28T21:46:51.347Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methotrexate-pulmonary-sarcoidosis-phase-iv</loc>
    <lastmod>2026-05-28T21:46:51.361Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ginisortamab-metastatic-pancreatic-ductal-adenocarcin-phase-ii</loc>
    <lastmod>2026-05-28T21:46:51.378Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-metastatic-non-squamous-non-small-cell-l-phase-iii</loc>
    <lastmod>2026-05-28T21:46:51.392Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/crinecerfont-congenital-adrenal-hyperplasia-phase-ii</loc>
    <lastmod>2026-05-28T21:46:51.406Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sotorasib-colorectal-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:46:51.419Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acalabrutinib-marginal-zone-lymphoma-relapsed-or-refra-phase-ii</loc>
    <lastmod>2026-05-28T21:46:51.433Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/intestifix-recurrent-urinary-tract-infection-phase-ii</loc>
    <lastmod>2026-05-28T21:46:51.451Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amiodarone-hydrochloride-persistent-atrial-fibrillation-phase-iv</loc>
    <lastmod>2026-05-28T21:46:51.465Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapansutrile-acute-gout-flare-gout-flare-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:46:51.478Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/romiplostim-thrombocytopenia-phase-iii-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:46:51.492Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regadenoson-myocardial-perfusion-abnormalities-kawas-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:51.506Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-govitecan-non-small-cell-lung-cancer-brain-metasta-phase-ii</loc>
    <lastmod>2026-05-28T21:46:51.520Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ipratropium-bromide-monohydrate-acute-asthma-acute-asthma-exacerbation-phase-iii</loc>
    <lastmod>2026-05-28T21:46:51.534Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pf-07868489-pulmonary-arterial-hypertension-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:51.551Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/small-cell-lung-cancer-small-cell-lung-c-phase-iii</loc>
    <lastmod>2026-05-28T21:46:51.565Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/malignant-pleural-mesothelioma-epithelio-phase-i</loc>
    <lastmod>2026-05-28T21:46:51.579Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-metastatic-colorectal-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:46:51.593Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ari0008-diffuse-intrinsic-pontine-glioma-dipg-phase-i</loc>
    <lastmod>2026-05-28T21:46:51.607Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/phleum-pratense-pollen-depigmented-polym-allergic-rhinoconjunctivitis-asthma-phase-iii</loc>
    <lastmod>2026-05-28T21:46:51.621Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cannabidiol-advanced-hepatocellular-carcinoma-phase-iv</loc>
    <lastmod>2026-05-28T21:46:51.634Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mrna-002-grna-001-primary-hyperoxaluria-type-1-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:51.648Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenacapavir-islatravir-hiv-1-infection-phase-iii-2</loc>
    <lastmod>2026-05-28T21:46:51.662Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cyclophosphamide-breast-cancer-advanced-breast-cancer-met-phase-ii</loc>
    <lastmod>2026-05-28T21:46:51.676Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aldesleukin-type-1-diabetes-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:46:51.692Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anoc-001-pancreatic-ductal-adenocarcinoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:51.709Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cetuximab-unknown-primary-tumour-of-the-head-and-n-phase-ii</loc>
    <lastmod>2026-05-28T21:46:51.723Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/follitropin-alfa-female-infertility-low-ovarian-sensitivi-phase-iv</loc>
    <lastmod>2026-05-28T21:46:51.737Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/3-3-methanesulfonyl-phenyl-1-propyl-pipe-depression-phase-ii</loc>
    <lastmod>2026-05-28T21:46:51.751Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/relatlimab-cervical-cancer-cervical-squamous-cell-c-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:46:51.768Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carfilzomib-multiple-myeloma-phase-iii-2</loc>
    <lastmod>2026-05-28T21:46:51.782Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/esketamine-post-craniotomy-headache-temporal-lobe-e-phase-iv</loc>
    <lastmod>2026-05-28T21:46:51.796Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/liothyronine-sodium-hypothyroidism-autoimmune-hypothyroidism-phase-iii</loc>
    <lastmod>2026-05-28T21:46:51.810Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/midostaurin-acute-myeloid-leukemia-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:51.828Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/befiradol-18f-cluster-headache-episodic-cluster-headac-phase-ii</loc>
    <lastmod>2026-05-28T21:46:51.841Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iron-oxide-e172-glioblastoma-phase-iv</loc>
    <lastmod>2026-05-28T21:46:51.860Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/simeticone-sodium-hydrogen-carbonate-pot-hip-fracture-phase-iv-ctis-2024-513871-42-00</loc>
    <lastmod>2026-05-28T21:11:59.169Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ambroxol-hydrochloride-clenbuterol-hydro-gaucher-disease-type-3-phase-iii</loc>
    <lastmod>2026-05-28T21:46:51.874Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/radium-ra-223-dichloride-metastatic-castration-resistant-prostate-phase-iii</loc>
    <lastmod>2026-05-28T21:46:51.887Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nio752-alzheimer-s-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:46:51.901Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-non-small-cell-lung-cancer-brain-metasta-phase-ii</loc>
    <lastmod>2026-05-28T21:46:51.915Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-non-small-cell-lung-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:46:51.928Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sevuparin-chronic-kidney-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:46:51.942Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/follitropin-delta-oocyte-donation-oocyte-donors-not-applicable</loc>
    <lastmod>2026-05-28T21:46:51.956Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gsk5733584-for-injection-ovarian-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:46:51.970Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vibegron-neurogenic-detrusor-overactivity-ndo-neu-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:46:51.983Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/masupirdine-alzheimer-s-disease-dementia-with-agitat-phase-iii</loc>
    <lastmod>2026-05-28T21:46:51.997Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gsk5764227-small-cell-lung-cancer-extensive-stage-s-phase-iii</loc>
    <lastmod>2026-05-28T21:46:52.012Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pseudoephedrine-hydrochloride-healthy-volunteers-phase-iv</loc>
    <lastmod>2026-05-28T21:46:52.026Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zasocitinib-ulcerative-colitis-crohn-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:46:52.041Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/phenoxymethylpenicillin-recurrent-erysipelas-in-lower-limbs-phase-iii</loc>
    <lastmod>2026-05-28T21:46:52.055Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/teclistamab-multiple-myeloma-phase-ii</loc>
    <lastmod>2026-05-28T21:46:52.069Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-her2-positive-esophageal-adenocarcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:46:52.083Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nefopam-hydrochloride-postoperative-pain-after-total-knee-arth-phase-ii</loc>
    <lastmod>2026-05-28T21:46:52.096Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fs222-advanced-malignancies-advanced-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:46:52.110Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylsalicylic-acid-colorectal-cancer-stage-ii-iii-with-soma-phase-iii</loc>
    <lastmod>2026-05-28T21:46:52.124Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mosliciguat-pulmonary-hypertension-associated-with-i-phase-ii</loc>
    <lastmod>2026-05-28T21:46:52.137Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vorasidenib-idh1-mutant-glioma-idh2-mutant-glioma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:52.151Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/axitinib-papillary-renal-cell-carcinoma-prcc-type-phase-ii</loc>
    <lastmod>2026-05-28T21:46:52.164Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glepaglutide-short-bowel-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:46:52.178Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluocinolone-acetonide-diabetic-macular-oedema-phase-iv</loc>
    <lastmod>2026-05-28T21:46:52.192Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tinzaparin-sodium-epithelial-ovarian-cancer-fallopian-tube-phase-iv</loc>
    <lastmod>2026-05-28T21:46:52.206Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/b-phuket-3073-2013-like-strain-b-phuket-healthy-individuals</loc>
    <lastmod>2026-05-28T21:46:52.220Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lovotibeglogene-autotemcel-sickle-cell-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:46:52.234Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cisplatin-squamous-cell-carcinoma-of-the-larynx-sq-phase-iii</loc>
    <lastmod>2026-05-28T21:46:52.247Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-hepatocellular-carcinoma-intermediate-st-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:46:52.261Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cisplatin-malignant-tumors-of-paranasal-sinuses-sa-phase-iii</loc>
    <lastmod>2026-05-28T21:46:52.274Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glucose-severe-burns-phase-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:46:52.288Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-zirconium-cyclosilicate-chronic-heart-failure-chronic-kidney-dis-phase-iv</loc>
    <lastmod>2026-05-28T21:46:52.301Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tezepelumab-chronic-rhinosinusitis-with-nasal-polyps-phase-iii</loc>
    <lastmod>2026-05-28T21:46:52.319Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-4-1r-4r-4-hydroxy-4-methylcyclohexyl-m-chronic-lymphocytic-leukemia-previously-phase-ii</loc>
    <lastmod>2026-05-28T21:46:52.332Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/enasidenib-mesilate-myelodysplastic-syndrome-with-idh2-mutat-phase-ii</loc>
    <lastmod>2026-05-28T21:46:52.351Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/interferon-alfa-ciclosporin-a-interleuki-human-papillomavirus-infection-high-risk-phase-iv</loc>
    <lastmod>2026-05-28T21:46:52.369Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/infigratinib-achondroplasia-phase-ii-2</loc>
    <lastmod>2026-05-28T21:46:52.383Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/xaluritamig-metastatic-castration-resistant-prostate-phase-iii-2</loc>
    <lastmod>2026-05-28T21:46:52.397Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efgartigimod-alfa-generalized-myasthenia-gravis-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:46:52.411Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nipocalimab-sjogren-s-disease-sjogren-s-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:46:52.425Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amivantamab-colorectal-cancer-kras-nras-and-braf-wil-phase-iii</loc>
    <lastmod>2026-05-28T21:46:52.439Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alpha-1-proteinase-inhibitor-human-pulmonary-emphysema-due-to-alpha-1-antit-phase-iii</loc>
    <lastmod>2026-05-28T21:46:52.453Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amivantamab-left-sided-colorectal-cancer-kras-nras-a-phase-iii</loc>
    <lastmod>2026-05-28T21:46:52.467Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/flunarizine-hydrochloride-migraine-not-applicable</loc>
    <lastmod>2026-05-28T21:46:52.481Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ozanimod-relapsing-remitting-multiple-sclerosis-phase-iv</loc>
    <lastmod>2026-05-28T21:46:52.495Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-b-cell-acute-lymphoblastic-leukaemia-chi-not-applicable</loc>
    <lastmod>2026-05-28T21:46:52.509Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dornase-alfa-pleural-empyema-not-applicable</loc>
    <lastmod>2026-05-28T21:46:52.523Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lunsekimig-asthma-phase-ii</loc>
    <lastmod>2026-05-28T21:46:52.538Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/everolimus-kidney-transplantation-nk-mediated-kidne-phase-iv</loc>
    <lastmod>2026-05-28T21:46:52.552Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dronabinol-chronic-obstructive-pulmonary-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:46:52.566Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-resistant-hypertension-obesity-phase-iii</loc>
    <lastmod>2026-05-28T21:46:52.580Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levosimendan-cardiogenic-shock-phase-iii</loc>
    <lastmod>2026-05-28T21:46:52.594Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lyophilized-bacterial-lysates-of-haemoph-recurrent-respiratory-tract-infections-r-phase-iv</loc>
    <lastmod>2026-05-28T21:46:52.608Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/visugromab-muscle-invasive-bladder-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:46:52.625Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/potassium-canrenoate-trometamol-brain-death-organ-donors-phase-iv</loc>
    <lastmod>2026-05-28T21:46:52.639Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rapcabtagene-autoleucel-myasthenia-gravis-treatment-resistant-ge-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:52.653Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lithium-carbonate-tbr1-related-neurocognitive-disorder-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:52.667Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ibuprofen-acute-myocarditis-not-applicable</loc>
    <lastmod>2026-05-28T21:46:52.681Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ads-019-myotonic-dystrophy-type-1-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:52.695Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capivasertib-hr-positive-her2-negative-advanced-breas-phase-iii</loc>
    <lastmod>2026-05-28T21:46:52.714Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-acute-heart-failure</loc>
    <lastmod>2026-05-28T21:46:52.732Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/3r-n-3-5-2-cyclopropylpyrimidin-5-yl-1h-tumors-harboring-braf-alterations-primar-phase-ii</loc>
    <lastmod>2026-05-28T21:46:52.746Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glofitamab-aggressive-b-cell-lymphoma-diffuse-large-phase-ii</loc>
    <lastmod>2026-05-28T21:46:52.761Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eight-treg-end-stage-renal-disease-chronic-renal-fa-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:52.775Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/l-glutamic-acid-acute-kidney-injury-heart-failure-ischem-phase-iii</loc>
    <lastmod>2026-05-28T21:46:52.789Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/budesonide-glycopyrronium-bromide-formot-chronic-obstructive-pulmonary-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:46:52.809Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/th1579-hematological-malignancies-acute-myeloid-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:52.826Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lysergide-generalized-anxiety-disorder-phase-iii</loc>
    <lastmod>2026-05-28T21:46:52.840Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/humanised-igg4-monoclonal-antibody-again-ovarian-cancer-recurrent-ovarian-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:52.855Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tezacaftor-deutivacaftor-vanzacaftor-cystic-fibrosis-phase-iii-2</loc>
    <lastmod>2026-05-28T21:46:52.873Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-polymyalgia-rheumatica-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:46:52.887Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/propranolol-hydrochloride-malignant-solid-tumor-desmoid-tumor-mali-phase-i</loc>
    <lastmod>2026-05-28T21:46:52.900Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-chronic-lymphocytic-leukaemia-cll-ighv-u-phase-iv</loc>
    <lastmod>2026-05-28T21:46:52.914Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/maridebart-cafraglutide-type-2-diabetes-mellitus-phase-ii</loc>
    <lastmod>2026-05-28T21:46:52.928Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clobetasol-propionate-vulval-lichen-sclerosus-lichen-sclerosus-phase-iii</loc>
    <lastmod>2026-05-28T21:46:52.942Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bempedoic-acid-coronary-artery-disease-myocardial-infar-phase-iii</loc>
    <lastmod>2026-05-28T21:46:52.955Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/18f-fluoro-peg-folate-rheumatoid-arthritis-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:46:52.969Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/exagamglogene-autotemcel-severe-sickle-cell-disease-sickle-cell-a-phase-iii</loc>
    <lastmod>2026-05-28T21:46:52.983Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ropivacaine-hydrochloride-periacetabular-osteotomy-not-applicable</loc>
    <lastmod>2026-05-28T21:46:52.997Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azithromycin-sarcoidosis-phase-iv</loc>
    <lastmod>2026-05-28T21:46:53.012Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avelumab-squamous-cell-carcinoma-of-head-and-neck-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.026Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aminolevulinic-acid-hydrochloride-glioblastoma-high-grade-glioma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:53.040Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tulisokibart-crohn-s-disease-ulcerative-colitis-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.054Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cannabidiol-prostate-cancer-castration-resistant-pro-phase-iv</loc>
    <lastmod>2026-05-28T21:46:53.067Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/teplizumab-type-1-diabetes-stage-3-type-1-diabetes-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.081Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isoflurane-delirium-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.096Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-hepatocellular-carcinoma-intermediate-st-phase-ii</loc>
    <lastmod>2026-05-28T21:46:53.109Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rilvegostomig-non-small-cell-lung-cancer-non-squamous-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.123Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/frexalimab-multiple-sclerosis-phase-ii</loc>
    <lastmod>2026-05-28T21:46:53.137Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-triple-negative-breast-cancer-inoperable-phase-ii</loc>
    <lastmod>2026-05-28T21:46:53.154Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/brigatinib-non-small-cell-lung-cancer-alk-positive-phase-ii</loc>
    <lastmod>2026-05-28T21:46:53.167Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-stage-iii-melanoma-phase-iii-2</loc>
    <lastmod>2026-05-28T21:46:53.181Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dabrafenib-cancer-rare-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:46:53.195Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bispecific-protein-with-a-high-affinity-chronic-hiv-infection-hiv-infection-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:53.209Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lentiviral-vector-derived-from-the-equin-usher-syndrome-type-1b-phase-iv</loc>
    <lastmod>2026-05-28T21:46:53.223Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/leriglitazone-cerebral-x-linked-adrenoleukodystrophy-c-phase-ii</loc>
    <lastmod>2026-05-28T21:46:53.237Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/influenza-virus-b-austria-1359417-2021-l-influenza-not-applicable-ctis-2024-513933-18-00</loc>
    <lastmod>2026-05-28T21:11:58.575Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2-6-18f-fluoro-pyridin-3-yl-9h-dipyrido-neurodegenerative-diseases-phase-iv</loc>
    <lastmod>2026-05-28T21:46:53.251Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-non-small-cell-lung-cancer-phase-ii-2</loc>
    <lastmod>2026-05-28T21:46:53.264Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/temozolomide-locally-advanced-rectal-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:46:53.278Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mesenchymal-stromal-cells-ex-vivo-cultur-traumatic-brain-injury-phase-ii</loc>
    <lastmod>2026-05-28T21:46:53.292Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-ethyl-2-4-7-4-ethylsulfonylamino-cyclo-relapsed-or-refractory-acute-leukemia-phase-i-ii-phase-ii</loc>
    <lastmod>2026-05-28T21:46:53.305Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fostemsavir-hiv-1-infection-multi-drug-resistant-hiv-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.319Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levobupivacaine-chronic-postsurgical-pain-inguinal-ingui-not-applicable</loc>
    <lastmod>2026-05-28T21:46:53.333Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hydroxycarbamide-sickle-cell-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:46:53.347Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zimislecel-type-1-diabetes-mellitus-impaired-hypogl-phase-i-ii-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.360Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levocarnitine-glucose-monohydrate-xylito-end-stage-renal-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.374Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/denosumab-breast-cancer-brca1-gene-mutation-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.388Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dextran-sulfate-low-molecular-weight-amyotrophic-lateral-sclerosis-phase-ii</loc>
    <lastmod>2026-05-28T21:46:53.402Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/palbociclib-breast-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.416Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.430Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mitapivat-sickle-cell-anaemia-sickle-cell-disease</loc>
    <lastmod>2026-05-28T21:46:53.444Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/buprenorphine-naloxone-opioid-use-disorder-chronic-non-cancer-p-phase-iv</loc>
    <lastmod>2026-05-28T21:46:53.457Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/225ac-psma-i-t-metastatic-prostate-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:46:53.471Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/immunoglobulin-a-immunoglobulin-g-immuno-secondary-peritonitis-quaternary-periton-phase-ii</loc>
    <lastmod>2026-05-28T21:46:53.485Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-rectal-cancer-adenocarcinoma-of-the-rect-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:53.498Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methylprednisolone-hemisuccinate-digestive-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.512Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/enzalutamide-prostate-cancer-high-risk-non-metastatic-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.525Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-anal-carcinoma-locally-advanced-anal-can-phase-ii</loc>
    <lastmod>2026-05-28T21:46:53.539Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/propranolol-hydrochloride-angiosarcoma-undifferentiated-pleomorphi-phase-ii</loc>
    <lastmod>2026-05-28T21:46:53.553Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cart45ra-nkg2d-cells-sarcoma-advanced-sarcoma-phase-i</loc>
    <lastmod>2026-05-28T21:46:53.567Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rinvecalinase-alfa-acute-ischemic-stroke-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:46:53.581Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/floxuridin-intrahepatic-cholangiocarcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:46:53.595Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-triple-negative-breast-cancer-stage-i-phase-ii</loc>
    <lastmod>2026-05-28T21:46:53.613Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/celecoxib-major-depressive-disorder-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.629Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ifosfamide-germ-cell-tumor-relapsed-or-refractory-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.644Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lomustine-medulloblastoma-not-applicable</loc>
    <lastmod>2026-05-28T21:46:53.662Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/moma-313-advanced-or-metastatic-solid-tumours-phase-i</loc>
    <lastmod>2026-05-28T21:46:53.676Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/betibeglogene-autotemcel-beta-thalassaemia-transfusion-dependent-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.689Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trifluridine-tipiracil-hydrochloride-metastatic-colorectal-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:46:53.707Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lentiviral-vector-containing-the-human-a-stargardt-disease-stargardt-macular-dege-phase-iv</loc>
    <lastmod>2026-05-28T21:46:53.725Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elivaldogene-autotemcel-cerebral-adrenoleukodystrophy-cald-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.742Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ceralasertib-advanced-triple-negative-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:46:53.756Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/advanced-solid-tumors-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.771Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lucerastat-fabry-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.785Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-propanediol-atrial-fibrillation-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.799Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vancomycin-clostridium-difficile-infection-hematopo-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.812Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dasatinib-hiv-infection-phase-ii</loc>
    <lastmod>2026-05-28T21:46:53.829Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clobetasol-propionate-postoperative-ocular-inflammation-and-pa-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.843Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/folic-acid-sudden-sensorineural-hearing-loss-ssnhl-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.857Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-a-aortic-valve-stenosis-aortic-valve-calci-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.877Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/brincidofovir-adenovirus-viremia-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.891Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-tec-patellofemoral-osteoarthritis-knee-osteo-phase-ii</loc>
    <lastmod>2026-05-28T21:46:53.905Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mexiletine-myotonic-disorders-nondystrophic-myotoni</loc>
    <lastmod>2026-05-28T21:46:53.919Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxytocin-psychological-distress-phase-iv</loc>
    <lastmod>2026-05-28T21:46:53.933Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-relatlimab-non-small-cell-lung-cancer-non-squamous-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.946Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/teriflunomide-multiple-sclerosis-phase-iii</loc>
    <lastmod>2026-05-28T21:46:53.960Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-recurrent-prostate-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:46:53.974Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amyotrophic-lateral-sclerosis-not-applicable</loc>
    <lastmod>2026-05-28T21:46:53.989Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apalutamide-prostate-adenocarcinoma-biochemically-re-phase-iii</loc>
    <lastmod>2026-05-28T21:46:54.009Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fosfomycin-acute-bacterial-prostatitis-phase-iv</loc>
    <lastmod>2026-05-28T21:46:54.023Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/baxdrostat-heart-failure-type-2-diabetes-mellitus-phase-iii</loc>
    <lastmod>2026-05-28T21:46:54.037Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/camlipixant-refractory-chronic-cough-unexplained-chr-phase-iii</loc>
    <lastmod>2026-05-28T21:46:54.051Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colchicine-ischemic-stroke-transient-ischaemic-atta-phase-iii</loc>
    <lastmod>2026-05-28T21:46:54.064Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/camlipixant-refractory-chronic-cough-unexplained-chr-phase-iii-2</loc>
    <lastmod>2026-05-28T21:46:54.078Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/plitidepsin-viral-diseases-other-specified-diseases-phase-i</loc>
    <lastmod>2026-05-28T21:46:54.092Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gsk5764227-advanced-solid-tumours-phase-i</loc>
    <lastmod>2026-05-28T21:46:54.106Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regorafenib-bone-sarcoma-osteosarcoma-metastatic-cho-phase-ii</loc>
    <lastmod>2026-05-28T21:46:54.119Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/istem-01-hesc-derived-retinal-pigment-ep-retinitis-pigmentosa-rpe-related-retinal-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:54.133Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ensartinib-x-396-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:46:54.146Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylsalicylic-acid-high-risk-for-lung-cancer-systemic-infla-phase-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:46:54.160Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-peripheral-blood-mononuclear-living-donor-kidney-transplantation-kidn-phase-ii</loc>
    <lastmod>2026-05-28T21:46:54.173Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fludarabine-phosphate-relapsed-refractory-aggressive-b-cell-no-phase-ii</loc>
    <lastmod>2026-05-28T21:46:54.187Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pirtobrutinib-richter-transformation-dlbcl-type-chroni-phase-iii</loc>
    <lastmod>2026-05-28T21:46:54.202Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nimotuzumab-diffuse-intrinsic-pontine-glioma-brain-s-phase-ii</loc>
    <lastmod>2026-05-28T21:46:54.216Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/silymarin-metabolic-dysfunction-associated-steatot-phase-iii</loc>
    <lastmod>2026-05-28T21:46:54.230Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-cd34-haematopoietic-stem-and-severe-combined-immunodeficiency-scid-du-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:54.244Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mesenchymal-stem-cells-stress-urinary-incontinence-mixed-urinar-phase-iii</loc>
    <lastmod>2026-05-28T21:46:54.258Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/recombinant-neisseria-meningitidis-group-asplenia-phase-iii</loc>
    <lastmod>2026-05-28T21:46:54.272Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dermatophagoides-pteronyssinus-allergies-phase-iv</loc>
    <lastmod>2026-05-28T21:46:54.286Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clostridium-botulinum-neurotoxin-type-a-postoperative-atrial-fibrillation-atrial-phase-iii</loc>
    <lastmod>2026-05-28T21:46:54.300Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/doravirine-hiv-1-infection-hiv-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:46:54.313Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ursodeoxycholic-acid-hepatorenal-polycystic-diseases-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:46:54.327Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-glioblastoma-phase-iii</loc>
    <lastmod>2026-05-28T21:46:54.340Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-meningitidis-group-c-strain-c11-polysa-invasive-meningococcal-disease-sepsis-me-not-applicable</loc>
    <lastmod>2026-05-28T21:46:54.354Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/18f-fluoro-peg-folate-acpa-positive-arthralgia-arthralgia-phase-iv</loc>
    <lastmod>2026-05-28T21:46:54.371Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutetium-177-labelled-6a10-antibody-fab-glioblastoma-high-grade-glioma-phase-i</loc>
    <lastmod>2026-05-28T21:46:54.385Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-pediatric-solid-tumor-glioma-brain-tumor-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:54.399Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-squamous-cell-carcinoma-of-the-skin-loca-phase-ii</loc>
    <lastmod>2026-05-28T21:46:54.413Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isatuximab-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:46:54.427Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-metastatic-colorectal-cancer-malignant-s-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:54.441Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regtivex-kidney-transplantation-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:54.455Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vimseltinib-tenosynovial-giant-cell-tumor-phase-iii</loc>
    <lastmod>2026-05-28T21:46:54.469Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/degarelix-prostate-cancer-locally-advanced-prostat-phase-iii</loc>
    <lastmod>2026-05-28T21:46:54.483Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cisplatin-cancer-head-and-neck-cancer-bladder-canc-not-applicable</loc>
    <lastmod>2026-05-28T21:46:54.499Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eftilagimod-alfa-non-small-cell-lung-cancer-advanced-meta-phase-iii</loc>
    <lastmod>2026-05-28T21:46:54.515Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-small-cell-lung-cancer-limited-stage-phase-ii</loc>
    <lastmod>2026-05-28T21:46:54.529Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/misoprostol-uterine-fibroid-phase-iv</loc>
    <lastmod>2026-05-28T21:46:54.543Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-peripheral-blood-derived-cd56-sarcoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:54.557Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ltp001-pulmonary-arterial-hypertension-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:54.572Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prednisolone-facial-nerve-palsy-bell-s-palsy-phase-iv</loc>
    <lastmod>2026-05-28T21:46:54.587Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-govitecan-metastatic-solid-tumors-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:46:54.601Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trametinib-metastatic-pancreatic-adenocarcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:46:54.615Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-her2-positive-gastroesophageal-adenocarc-phase-ii</loc>
    <lastmod>2026-05-28T21:46:54.628Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/omalizumab-severe-allergic-asthma-allergic-asthma-phase-iv</loc>
    <lastmod>2026-05-28T21:46:54.642Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/varnimcabtagene-autoleucel-acute-lymphoblastic-leukemia-phase-ii-2</loc>
    <lastmod>2026-05-28T21:46:54.656Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atorvastatin-coronary-artery-disease-not-applicable</loc>
    <lastmod>2026-05-28T21:46:54.670Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/choriogonadotropin-alfa-infertility-phase-iv</loc>
    <lastmod>2026-05-28T21:46:54.683Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenalidomide-multiple-myeloma-newly-diagnosed-multipl-phase-iii-2</loc>
    <lastmod>2026-05-28T21:46:54.697Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/argipressin-disseminated-cancer-not-applicable</loc>
    <lastmod>2026-05-28T21:46:54.711Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/empagliflozin-type-2-diabetes-phase-ii</loc>
    <lastmod>2026-05-28T21:46:54.725Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/saruparib-prostate-cancer-brca1-brca2-mutated-high-phase-iii</loc>
    <lastmod>2026-05-28T21:46:54.739Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/brigatinib-anaplastic-large-cell-lymphoma-inflammat-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:54.753Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levothyroxine-sodium-obesity-subclinical-hypothyroidism-metab</loc>
    <lastmod>2026-05-28T21:46:54.767Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly3962681-parkinson-s-disease-phase-i</loc>
    <lastmod>2026-05-28T21:46:54.782Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/m-18f-fluorobenzylguanidine-pheochromocytoma-phase-iv</loc>
    <lastmod>2026-05-28T21:46:54.796Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/milrinone-aneurysmal-subarachnoid-hemorrhage</loc>
    <lastmod>2026-05-28T21:46:54.810Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clear-cell-renal-cell-carcinoma-phase-i</loc>
    <lastmod>2026-05-28T21:46:54.824Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/argipressin-septic-shock-phase-iii</loc>
    <lastmod>2026-05-28T21:46:54.838Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/selinexor-diffuse-large-b-cell-lymphoma-dlbcl-rela-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:46:54.851Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isatuximab-relapsed-multiple-myeloma-phase-ii</loc>
    <lastmod>2026-05-28T21:46:54.865Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/selinexor-myelofibrosis-phase-ii</loc>
    <lastmod>2026-05-28T21:46:54.879Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-small-cell-lung-cancer-limited-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:46:54.893Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/treosulfan-myelofibrosis-primary-myelofibrosis-seco-phase-ii</loc>
    <lastmod>2026-05-28T21:46:54.907Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ferumoxtran-10-rectal-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:46:54.920Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/flecainide-patent-foramen-ovale-atrial-arrhythmia-i-phase-iii</loc>
    <lastmod>2026-05-28T21:46:54.935Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dupilumab-asthma</loc>
    <lastmod>2026-05-28T21:46:54.948Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/quemliclustat-pancreatic-ductal-adenocarcinoma-pdac-me-phase-iii</loc>
    <lastmod>2026-05-28T21:46:54.963Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/recombinant-human-surfactant-protein-d-bronchopulmonary-dysplasia-bpd-prematuri-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:46:54.979Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/celecoxib-colon-adenocarcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:46:54.994Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ropivacaine-hydrochloride-inguinal-hernia-phase-iii</loc>
    <lastmod>2026-05-28T21:46:55.007Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/emavusertib-primary-central-nervous-system-lymphoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:55.021Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/paracetamol-acetaminophen-healthy-volunteer-phase-iv</loc>
    <lastmod>2026-05-28T21:46:55.035Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-fluoride-18f-transthyretin-amyloid-cardiomyopathy-al-phase-iv</loc>
    <lastmod>2026-05-28T21:46:55.050Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carfilzomib-multiple-myeloma-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:46:55.065Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anaesthesia-for-free-flap-breast-reconst-phase-iii</loc>
    <lastmod>2026-05-28T21:46:55.079Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/measles-virus-edmonston-enders-mumps-vir-measles-not-applicable</loc>
    <lastmod>2026-05-28T21:46:55.093Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gallium-68-labelled-r54-68ga-ga-r54-advanced-solid-tumours-cxcr4-positive-br-phase-i</loc>
    <lastmod>2026-05-28T21:46:55.107Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pneumococcal-polysaccharide-serotypes-23-vaccination-response</loc>
    <lastmod>2026-05-28T21:46:55.121Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iti-1284-generalized-anxiety-disorder-phase-ii-2</loc>
    <lastmod>2026-05-28T21:46:55.136Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cetuximab-glioblastoma-phase-i</loc>
    <lastmod>2026-05-28T21:46:55.150Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/infliximab-ulcerative-colitis-crohn-s-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:46:55.166Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adalimumab-crohn-s-disease-spondyloarthritis-rheuma-phase-iii</loc>
    <lastmod>2026-05-28T21:46:55.180Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cefepime-prosthetic-joint-infection-infection-of-phase-iv</loc>
    <lastmod>2026-05-28T21:46:55.194Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluoxetine-pedophilic-disorder-hebephilia-phase-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:46:55.207Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/selinexor-peripheral-t-cell-lymphoma-relapsed-or-r-phase-ii</loc>
    <lastmod>2026-05-28T21:46:55.222Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n2-3-2-2h-1-2-3-triazol-2-yl-propan-2-yl-parkinson-s-disease-lrrk2-associated-par-phase-ii</loc>
    <lastmod>2026-05-28T21:46:55.236Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amoxicillin-clavulanic-acid-urinary-tract-infection-caused-by-esbl-p-phase-iv</loc>
    <lastmod>2026-05-28T21:46:55.250Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluorouracil-colorectal-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:46:55.264Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ofatumumab-multiple-sclerosis-relapsing-remitting-m-phase-iii</loc>
    <lastmod>2026-05-28T21:46:55.278Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tocilizumab-behcet-s-disease-associated-uveitis-behc-phase-ii</loc>
    <lastmod>2026-05-28T21:46:55.292Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/respiratory-syncytial-virus-subgroup-a-s-allogeneic-hematopoietic-stem-cell-trans-phase-ii</loc>
    <lastmod>2026-05-28T21:46:55.306Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lamivudine-hiv-infection-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:46:55.320Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/paraffin-white-soft-atopic-dermatitis-phase-iii</loc>
    <lastmod>2026-05-28T21:46:55.334Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/solriamfetol-idiopathic-hypersomnia-phase-iv</loc>
    <lastmod>2026-05-28T21:46:55.348Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-metastatic-colorectal-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:55.362Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lactose-monohydrate-peripheral-arterial-disease-pad</loc>
    <lastmod>2026-05-28T21:46:55.376Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dry-extract-from-psilocybe-cubensis-15-2-depression-major-depressive-disorder-mod-phase-iv</loc>
    <lastmod>2026-05-28T21:46:55.390Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bleomycin-cutaneous-or-subcutaneous-malignancy</loc>
    <lastmod>2026-05-28T21:46:55.403Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-faecal-microbiota-recurrent-pouchitis-ulcerative-colitis-w-phase-iii</loc>
    <lastmod>2026-05-28T21:46:55.417Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cannabidiol-glioblastoma-phase-0-phase-iii</loc>
    <lastmod>2026-05-28T21:46:55.431Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prednisolone-anca-associated-vasculitis-rapidly-progr-phase-iv</loc>
    <lastmod>2026-05-28T21:46:55.444Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxymetazoline-hydrochloride-acquired-blepharoptosis-phase-iii</loc>
    <lastmod>2026-05-28T21:46:55.458Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/neu-411-maleate-parkinson-s-disease-early-parkinson-s-di-phase-ii</loc>
    <lastmod>2026-05-28T21:46:55.472Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/telmisartan-compensated-advanced-chronic-liver-disea-phase-ii</loc>
    <lastmod>2026-05-28T21:46:55.486Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-normal-immunoglobulin-bk-virus-infection-kidney-transplantatio-phase-iv</loc>
    <lastmod>2026-05-28T21:46:55.501Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/exagamglogene-autotemcel-ctx001-transfusion-dependent-beta-thalassemia-phase-iii</loc>
    <lastmod>2026-05-28T21:46:55.514Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/perflutren-indeterminate-kidney-lesions-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:55.529Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/raludotatug-deruxtecan-advanced-metastatic-solid-tumors-endomet-phase-ii</loc>
    <lastmod>2026-05-28T21:46:55.545Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rabies-virus-inactivated-healthy-volunteers-ctis-2024-514428-18-00</loc>
    <lastmod>2026-05-28T21:11:57.373Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/direclidine-schizophrenia-acute-schizophrenia-phase-iii</loc>
    <lastmod>2026-05-28T21:46:55.559Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atogepant-chronic-migraine-phase-iii</loc>
    <lastmod>2026-05-28T21:46:55.573Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/palbociclib-hormone-receptor-positive-hr-her2-negati-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:46:55.586Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/panitumumab-metastatic-colorectal-cancer-ras-and-bra-phase-ii</loc>
    <lastmod>2026-05-28T21:46:55.600Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/edoxaban-porto-sinusoidal-vascular-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:46:55.614Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/permethrin-scabies-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:46:55.632Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/norfloxacin-portal-hypertension-decompensated-cirrho-phase-ii</loc>
    <lastmod>2026-05-28T21:46:55.646Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ko-2806-pancreatic-ductal-adenocarcinoma-colorec-phase-i</loc>
    <lastmod>2026-05-28T21:46:55.659Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-t-cells-transduced-with-lenti-relapsed-or-refractory-cd19-positive-b-c-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:55.673Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/remibrutinib-hidradenitis-suppurativa-moderate-to-sev-phase-iii</loc>
    <lastmod>2026-05-28T21:46:55.687Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amoxicillin-clavulanic-acid-ventilator-associated-pneumonia-intensiv-phase-iii</loc>
    <lastmod>2026-05-28T21:46:55.701Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dky709-nasopharyngeal-carcinoma-triple-negative-phase-i</loc>
    <lastmod>2026-05-28T21:46:55.714Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ripretinib-advanced-gastrointestinal-stromal-tumour-phase-iii</loc>
    <lastmod>2026-05-28T21:46:55.728Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/remibrutinib-hidradenitis-suppurativa-phase-iii</loc>
    <lastmod>2026-05-28T21:46:55.742Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/al-18f-f-fapi-74-advanced-gastric-cancer-not-applicable</loc>
    <lastmod>2026-05-28T21:46:55.760Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lacutamab-peripheral-t-cell-lymphoma-relapsed-refr-phase-ii</loc>
    <lastmod>2026-05-28T21:46:55.774Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iomeprol-breast-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:46:55.788Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/estradiol-hemihydrate-gender-dysphoria-phase-iii</loc>
    <lastmod>2026-05-28T21:46:55.802Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zoledronic-acid-monohydrate-vertebral-metastases-metastatic-bone-dis-phase-iii</loc>
    <lastmod>2026-05-28T21:46:55.816Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-renal-cell-carcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:46:55.830Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/infliximab-axial-spondyloarthritis-phase-iv</loc>
    <lastmod>2026-05-28T21:46:55.844Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/barzolvolimab-chronic-spontaneous-urticaria-phase-iii-2</loc>
    <lastmod>2026-05-28T21:46:55.858Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/primary-ciliary-dyskinesia-chronic-pulmo-phase-iii</loc>
    <lastmod>2026-05-28T21:46:55.871Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tarlatamab-small-cell-lung-cancer-small-cell-lung-c-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:55.885Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efanesoctocog-alfa-haemophilia-a-not-applicable</loc>
    <lastmod>2026-05-28T21:46:55.898Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rikkunshito-functional-dyspepsia-phase-iii</loc>
    <lastmod>2026-05-28T21:46:55.912Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-triple-negative-breast-cancer-metastatic-phase-ii-2</loc>
    <lastmod>2026-05-28T21:46:55.927Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/terbinafine-distal-subungual-onychomycosis-phase-ii</loc>
    <lastmod>2026-05-28T21:46:55.941Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/betamethasone-sodium-phosphate-severe-influenza-influenza-a-or-b-infect-phase-iii</loc>
    <lastmod>2026-05-28T21:46:55.955Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-prostate-cancer-oligometastatic-hormone-phase-ii</loc>
    <lastmod>2026-05-28T21:46:55.969Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ademetionine-major-depressive-disorder-phase-iii</loc>
    <lastmod>2026-05-28T21:46:55.983Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lanreotide-well-differentiated-gastro-intestinal-ne-phase-iv</loc>
    <lastmod>2026-05-28T21:46:56.001Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ademetionine-major-depressive-disorder-phase-iii-2</loc>
    <lastmod>2026-05-28T21:46:56.015Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tezepelumab-severe-asthma-asthma-phase-iii</loc>
    <lastmod>2026-05-28T21:46:56.029Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adalimumab-juvenile-idiopathic-arthritis-phase-iv</loc>
    <lastmod>2026-05-28T21:46:56.043Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apixaban-autoimmune-hemolytic-anemia-phase-ii</loc>
    <lastmod>2026-05-28T21:46:56.057Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ro7790121-ulcerative-colitis-moderately-to-severel-phase-iii</loc>
    <lastmod>2026-05-28T21:46:56.070Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/respiratory-syncytial-virus-glycoprotein-respiratory-syncytial-virus-infection-phase-ii-2</loc>
    <lastmod>2026-05-28T21:46:56.084Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/telisotuzumab-adizutecan-gastric-adenocarcinoma-gastroesophageal-phase-ii</loc>
    <lastmod>2026-05-28T21:46:56.098Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/xelafaslatide-atrophic-age-related-macular-degeneratio-phase-ii</loc>
    <lastmod>2026-05-28T21:46:56.111Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gastroenteropancreatic-neuroendocrine-tu-phase-iii</loc>
    <lastmod>2026-05-28T21:46:56.125Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oatd-02-advanced-solid-tumours-colorectal-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:46:56.139Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-hiv-infection-obesity-phase-ii</loc>
    <lastmod>2026-05-28T21:46:56.153Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abemaciclib-metastatic-breast-cancer-estrogen-recept-phase-iii</loc>
    <lastmod>2026-05-28T21:46:56.167Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-metastatic-non-small-cell-lung-cancer-pd-phase-iii</loc>
    <lastmod>2026-05-28T21:46:56.181Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prednisone-hepatotoxicity-phase-iv</loc>
    <lastmod>2026-05-28T21:46:56.195Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/indocyanine-green-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:46:56.209Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-gastric-adenocarcinoma-oesophageal-adeno-phase-ii</loc>
    <lastmod>2026-05-28T21:46:56.223Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-melanoma-non-small-cell-lung-cancer-non-phase-iii</loc>
    <lastmod>2026-05-28T21:46:56.237Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acasunlimab-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:46:56.250Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/botulinum-toxin-type-a-haemagglutinin-co-spastic-equinovarus-post-stroke-first-ev-phase-iv</loc>
    <lastmod>2026-05-28T21:46:56.264Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/olaparib-brca-mutated-ovarian-cancer-epithelial-o-phase-iii</loc>
    <lastmod>2026-05-28T21:46:56.278Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogenic-adipose-derived-adult-mesenchy-venous-leg-ulcer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:56.292Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/osteochondritis-dissecans-femoral-cartil-phase-i</loc>
    <lastmod>2026-05-28T21:46:56.306Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/triamcinolone-acetonide-sudden-sensorineural-hearing-loss-phase-iv</loc>
    <lastmod>2026-05-28T21:46:56.320Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anti-fc-fragment-of-igg-receptor-iib-mon-indolent-b-cell-non-hodgkin-lymphoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:56.334Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dinutuximab-beta-neuroblastoma-recurrent-progressive-or-r-phase-iii</loc>
    <lastmod>2026-05-28T21:46:56.348Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-faecal-microbiota-haematological-malignancy-post-allogenei-phase-ii</loc>
    <lastmod>2026-05-28T21:46:56.361Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-adult-salivary-gland-stem-cel-head-and-neck-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:46:56.376Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-her2-positive-gastric-cancer-her2-positi-phase-iii</loc>
    <lastmod>2026-05-28T21:46:56.390Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/poractant-alfa-neonatal-respiratory-distress-syndrome-phase-iv</loc>
    <lastmod>2026-05-28T21:46:56.404Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zasocitinib-psoriatic-arthritis-phase-iii-2</loc>
    <lastmod>2026-05-28T21:46:56.418Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/platelet-concentrate-chronic-omalgia-rotator-cuff-tendinopath-phase-iii</loc>
    <lastmod>2026-05-28T21:46:56.432Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/progesterone-infertility-phase-iii</loc>
    <lastmod>2026-05-28T21:46:56.446Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/5-6-dibromo-4-nitro-2-piperidin-4-yl-1-p-aggressive-b-cell-non-hodgkin-lymphoma-r-phase-ii</loc>
    <lastmod>2026-05-28T21:46:56.459Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/corabotase-glabellar-frown-lines-phase-iii</loc>
    <lastmod>2026-05-28T21:46:56.473Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cusatuzumab-acute-myeloid-leukemia-phase-iii</loc>
    <lastmod>2026-05-28T21:46:56.488Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxaliplatin-advanced-colorectal-cancer-ras-wild-type-phase-iv</loc>
    <lastmod>2026-05-28T21:46:56.502Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-head-and-neck-squamous-cell-carcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:46:56.516Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-advanced-solid-malignancies-phase-i</loc>
    <lastmod>2026-05-28T21:46:56.530Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-89853413-acute-myeloid-leukemia-myelodysplastic-s-phase-i</loc>
    <lastmod>2026-05-28T21:46:56.544Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ficerafusp-alfa-recurrent-or-metastatic-head-and-neck-sq-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:46:56.558Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ocrelizumab-multiple-sclerosis-phase-iv-2</loc>
    <lastmod>2026-05-28T21:46:56.572Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hepatocellular-carcinoma-advanced-or-met-phase-i</loc>
    <lastmod>2026-05-28T21:46:56.586Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pomalidomide-hiv-1-infection-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:56.606Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/simvastatin-recurrent-pancreatitis-acute-pancreatiti-phase-iv</loc>
    <lastmod>2026-05-28T21:46:56.620Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ro7795068-obesity-phase-iii-2</loc>
    <lastmod>2026-05-28T21:46:56.633Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tislelizumab-small-cell-lung-cancer-extensive-stage-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:56.648Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/onfekafusp-alfa-soft-tissue-sarcoma-advanced-soft-tissue-phase-iii</loc>
    <lastmod>2026-05-28T21:46:56.661Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/testosterone-respiratory-failure-requiring-invasive-m-phase-iv</loc>
    <lastmod>2026-05-28T21:46:56.675Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/moxifloxacin-multidrug-resistant-pulmonary-tuberculos-phase-iii</loc>
    <lastmod>2026-05-28T21:46:56.689Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-muscle-precursor-cells-mitochondrial-myopathy-m-3243a-g-mitocho-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:56.703Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ruxolitinib-vitiligo-phase-iii</loc>
    <lastmod>2026-05-28T21:46:56.717Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/multiple-sclerosis-not-applicable</loc>
    <lastmod>2026-05-28T21:46:56.731Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imsidolimab-advanced-solid-tumors-lymphoma-metastati-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:56.745Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-albumin-solution-perioperative-fluid-therapy-in-laparosco-not-applicable</loc>
    <lastmod>2026-05-28T21:46:56.766Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tedizolid-phosphate-pulmonary-tuberculosis-phase-ii</loc>
    <lastmod>2026-05-28T21:46:56.780Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/morphine-hydrochloride-trihydrate-cesarean-section-not-applicable</loc>
    <lastmod>2026-05-28T21:46:56.794Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sonelokimab-psoriatic-arthritis-axial-spondyloarthri-phase-ii</loc>
    <lastmod>2026-05-28T21:46:56.808Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/landiolol-hydrochloride-septic-shock-microcirculatory-dysfunctio-phase-iii</loc>
    <lastmod>2026-05-28T21:46:56.821Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efgartigimod-alfa-primary-immune-thrombocytopenia-phase-iii</loc>
    <lastmod>2026-05-28T21:46:56.835Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atrasentan-hydrochloride-immunoglobulin-a-nephropathy-iga-nephrop-phase-iii</loc>
    <lastmod>2026-05-28T21:46:56.849Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/64cu-psma-i-t-prostate-cancer-prostate-adenocarcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:46:56.863Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dnth103-multifocal-motor-neuropathy-phase-ii</loc>
    <lastmod>2026-05-28T21:46:56.877Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tobevibart-chronic-hepatitis-b-chronic-hepatitis-b-phase-iv</loc>
    <lastmod>2026-05-28T21:46:56.891Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-acute-myeloid-leukemia-myelodysplastic-s-phase-iii</loc>
    <lastmod>2026-05-28T21:46:56.905Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nitrous-oxide-oxygen-surgery-under-general-anesthesia-phase-iv</loc>
    <lastmod>2026-05-28T21:46:56.919Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obrixtamig-bi-764532-small-cell-lung-cancer-neuroendocrine-tu-phase-i</loc>
    <lastmod>2026-05-28T21:46:56.933Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mocravimod-acute-myeloid-leukemia-phase-iii</loc>
    <lastmod>2026-05-28T21:46:56.947Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zasocitinib-psoriatic-arthritis-phase-iii-3</loc>
    <lastmod>2026-05-28T21:46:56.961Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/risankizumab-crohn-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:46:56.978Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexmedetomidine-general-anaesthesia-outpatient-surgery</loc>
    <lastmod>2026-05-28T21:46:56.992Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isatuximab-newly-diagnosed-multiple-myeloma-phase-ii</loc>
    <lastmod>2026-05-28T21:46:57.007Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/recombinant-human-ectonucleotide-pyropho-ectonucleotide-pyrophosphatase-phosphodi-phase-iii</loc>
    <lastmod>2026-05-28T21:46:57.020Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sulfasalazine-non-favorable-acute-myeloid-leukemia-acu-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:57.035Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mitapivat-transfusion-dependent-alpha-thalassemia-phase-iii</loc>
    <lastmod>2026-05-28T21:46:57.048Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/telisotuzumab-adizutecan-metastatic-colorectal-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:46:57.062Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-albumin-solution-endometrial-cancer-intermediate-risk-end-phase-iii</loc>
    <lastmod>2026-05-28T21:46:57.085Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/7-ethyl-10-hydroxycamptothecin-sn-38-pancreatic-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:46:57.098Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/calcium-folinate-pentahydrate-esophageal-adenocarcinoma-early-stage-ct-phase-ii</loc>
    <lastmod>2026-05-28T21:46:57.112Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/follitropin-alfa-breast-cancer-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:46:57.134Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/axatilimab-chronic-graft-versus-host-disease-phase-ii-2</loc>
    <lastmod>2026-05-28T21:46:57.148Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-multiple-myeloma-phase-ii</loc>
    <lastmod>2026-05-28T21:46:57.161Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/niraparib-tosilate-monohydrate-glioblastoma-mgmt-promoter-unmethylated-phase-iii</loc>
    <lastmod>2026-05-28T21:46:57.175Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avelumab-urothelial-carcinoma-muscle-invasive-bla</loc>
    <lastmod>2026-05-28T21:46:57.189Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pemigatinib-recurrent-or-metastatic-solid-tumour-wit-phase-ii</loc>
    <lastmod>2026-05-28T21:46:57.203Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bortezomib-relapsed-acute-lymphoblastic-leukemia-al-phase-ii</loc>
    <lastmod>2026-05-28T21:46:57.216Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atogepant-menstrual-migraine-phase-iii</loc>
    <lastmod>2026-05-28T21:46:57.231Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lidocaine-hydrochloride-first-degree-perineal-laceration-not-applicable</loc>
    <lastmod>2026-05-28T21:46:57.245Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/m5542-healthy-volunteer-phase-i</loc>
    <lastmod>2026-05-28T21:46:57.259Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/streptococcus-agalactiae-haemophilus-inf-recurrent-lower-respiratory-tract-infect-phase-iv</loc>
    <lastmod>2026-05-28T21:46:57.273Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sirolimus-tuberous-sclerosis-complex-epilepsy-tsc-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:46:57.287Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-skin-derived-abcb5-positive-d-chronic-venous-leg-ulcer-phase-iii</loc>
    <lastmod>2026-05-28T21:46:57.301Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elacestrant-advanced-breast-cancer-er-positive-her2-phase-iii</loc>
    <lastmod>2026-05-28T21:46:57.315Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methylprednisolone-acetate-adhesive-capsulitis-frozen-shoulder-not-applicable</loc>
    <lastmod>2026-05-28T21:46:57.330Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isaralgagene-civaparvovec-fabry-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:46:57.343Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ag-181-phenylketonuria-phase-iii</loc>
    <lastmod>2026-05-28T21:46:57.357Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ro7790121-crohn-s-disease-moderately-to-severely-a-phase-iii</loc>
    <lastmod>2026-05-28T21:46:57.371Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cangrelor-tetrasodium-cardiogenic-shock-cardiac-arrest-acute-m-phase-ii</loc>
    <lastmod>2026-05-28T21:46:57.385Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adrc001-radiation-induced-xerostomia-post-radiot-phase-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:46:57.399Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allopurinol-sodium-neonatal-brain-injury-critical-congenita-phase-iii</loc>
    <lastmod>2026-05-28T21:46:57.413Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efgartigimod-alfa-idiopathic-inflammatory-myopathy-iim-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:46:57.427Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rilzabrutinib-immunoglobulin-g4-related-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:46:57.441Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/letetresgene-autoleucel-non-small-cell-lung-cancer-synovial-sarc-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:57.455Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clostridium-botulinum-neurotoxin-serotyp-glabellar-frown-lines-forehead-lines-lat-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:57.469Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mitomycin-c-non-muscle-invasive-bladder-cancer</loc>
    <lastmod>2026-05-28T21:46:57.483Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-mucosal-melanoma-melanoma-phase-ii</loc>
    <lastmod>2026-05-28T21:46:57.497Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mitomycin-peritoneal-metastases-of-colorectal-canc-phase-iv</loc>
    <lastmod>2026-05-28T21:46:57.513Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atumelnant-classic-congenital-adrenal-hyperplasia-c-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:46:57.528Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/natalizumab-relapsing-remitting-multiple-sclerosis-m-phase-iv</loc>
    <lastmod>2026-05-28T21:46:57.541Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bp1-7881-eosinophilic-esophagitis-phase-iii</loc>
    <lastmod>2026-05-28T21:46:57.555Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/onasemnogene-abeparvovec-spinal-muscular-atrophy-phase-iii</loc>
    <lastmod>2026-05-28T21:46:57.569Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/5-8-dichloro-2-4-methoxy-6-methyl-2-oxo-metastatic-castration-sensitive-prostate-phase-iii</loc>
    <lastmod>2026-05-28T21:46:57.583Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gallium-68ga-tezatabep-matraxetan-breast-cancer-metastatic-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:46:57.597Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-papillomavirus-type-31-l1-protein-high-grade-cervical-intraepithelial-lesi-phase-ii</loc>
    <lastmod>2026-05-28T21:46:57.610Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-resectable-gastric-cancer-resectable-gas-phase-ii</loc>
    <lastmod>2026-05-28T21:46:57.628Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/telitacicept-systemic-lupus-erythematosus-moderately-phase-iii</loc>
    <lastmod>2026-05-28T21:46:57.642Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pm534-advanced-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:46:57.655Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/psilocybine-treatment-resistant-depression-phase-iv</loc>
    <lastmod>2026-05-28T21:46:57.674Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/recombinant-human-ectonucleotide-pyropho-ectonucleotide-pyrophosphatase-phosphodi-phase-ii</loc>
    <lastmod>2026-05-28T21:46:57.687Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ro7790121-moderately-to-severely-active-crohn-s-di-phase-iii</loc>
    <lastmod>2026-05-28T21:46:57.701Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-nasopharyngeal-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:46:57.716Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rapcabtagene-autoleucel-relapsing-multiple-sclerosis-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:57.729Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/darbepoetin-alfa-perinatal-arterial-ischemic-stroke-pais-phase-iv</loc>
    <lastmod>2026-05-28T21:46:57.743Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ovx033-coronavirus-infection-sarbecoviruses-dis-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:57.757Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obexelimab-relapsing-multiple-sclerosis-relapsing-r-phase-ii</loc>
    <lastmod>2026-05-28T21:46:57.771Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/crizotinib-neurofibromatosis-type-2-phase-ii</loc>
    <lastmod>2026-05-28T21:46:57.785Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-non-small-cell-lung-cancer-resectable-st-phase-ii</loc>
    <lastmod>2026-05-28T21:46:57.798Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/onfekafusp-alfa-unresectable-and-or-metastatic-soft-tiss-phase-ii</loc>
    <lastmod>2026-05-28T21:46:57.812Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-atigotatug-extensive-stage-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:46:57.826Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iti-1284-psychosis-associated-with-alzheimer-s-di-phase-iv</loc>
    <lastmod>2026-05-28T21:46:57.840Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/satoreotide-trizoxetan-gallium-ga68-neuroblastoma-not-applicable</loc>
    <lastmod>2026-05-28T21:46:57.854Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sarilumab-systemic-juvenile-idiopathic-arthritis-j-phase-iv</loc>
    <lastmod>2026-05-28T21:46:57.868Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anifrolumab-systemic-lupus-erythematosus-moderate-to-phase-iii</loc>
    <lastmod>2026-05-28T21:46:57.881Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dronabinol-palmidrol-tourette-syndrome-phase-ii</loc>
    <lastmod>2026-05-28T21:46:57.895Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etifoxine-hydrochloride-major-depressive-disorder-bipolar-depres-phase-iv</loc>
    <lastmod>2026-05-28T21:46:57.909Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pf-07220060-monohydrate-advanced-breast-cancer-metastatic-breast-phase-iii</loc>
    <lastmod>2026-05-28T21:46:57.923Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/asciminib-hydrochloride-chronic-myeloid-leukaemia-bcr-abl1-phase-ii</loc>
    <lastmod>2026-05-28T21:46:57.937Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/egl-001-advanced-solid-tumors-metastatic-solid-t-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:57.950Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/betaine-citrate-functional-dyspepsia-not-applicable</loc>
    <lastmod>2026-05-28T21:46:57.964Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-4-fluorophenyl-n-4-7-methoxy-6-methylc-metastatic-colorectal-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:46:57.979Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ipilimumab-non-small-cell-lung-cancer-non-squamous-phase-ii</loc>
    <lastmod>2026-05-28T21:46:57.992Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dry-extract-from-psilocybe-cubensis-15-2-treatment-resistant-depression-phase-ii-2</loc>
    <lastmod>2026-05-28T21:46:58.006Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-unresectable-hepatocellular-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:46:58.020Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:46:58.035Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fosfomycin-healthy-volunteers-critical-illness-phase-iii</loc>
    <lastmod>2026-05-28T21:46:58.048Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aly688er-non-alcoholic-steatohepatitis-nash-phase-i</loc>
    <lastmod>2026-05-28T21:46:58.062Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etuvetidigene-autotemcel-wiskott-aldrich-syndrome-phase-iv</loc>
    <lastmod>2026-05-28T21:46:58.076Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-enriched-t-cells-retrovirally-relapsed-or-refractory-b-cell-acute-lymp-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:58.090Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/furosemide-acute-heart-failure-not-applicable</loc>
    <lastmod>2026-05-28T21:46:58.103Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-normal-immunoglobulin-iv-langerhans-cell-histiocytosis-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:46:58.117Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efruxifermin-non-alcoholic-steatohepatitis-nash-metab-phase-iii</loc>
    <lastmod>2026-05-28T21:46:58.131Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aripiprazole-refractory-major-depression-disorder-rmd-phase-iii-ctis-2024-512672-34-00</loc>
    <lastmod>2026-05-28T21:11:56.036Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/psmaxcd3-bispecific-antibody-prostate-cancer-castration-resistant-pro-phase-i</loc>
    <lastmod>2026-05-28T21:46:58.145Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-head-and-neck-squamous-cell-carcinoma-re-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:46:58.159Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elacestrant-breast-cancer-er-positive-her2-negative-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:58.174Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-advanced-melanoma-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:46:58.188Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/letermovir-congenital-cytomegalovirus-infection-mat-phase-iii</loc>
    <lastmod>2026-05-28T21:46:58.202Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levocarnitine-magnesium-chloride-hexahyd-congestive-heart-failure-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:46:58.215Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/danicamtiv-dilated-cardiomyopathy-genetic-dilated-c-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:46:58.229Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fludarabine-phosphate-acute-lymphoblastic-leukaemia-not-applicable</loc>
    <lastmod>2026-05-28T21:46:58.244Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mycobacterium-bovis-bacillus-calmette-gu-non-muscle-invasive-bladder-cancer-high-phase-ii</loc>
    <lastmod>2026-05-28T21:46:58.258Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ibrutinib-mantle-cell-lymphoma-phase-ii</loc>
    <lastmod>2026-05-28T21:46:58.272Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/medi0618-migraine-episodic-migraine-phase-ii</loc>
    <lastmod>2026-05-28T21:46:58.285Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/balinatunfib-crohn-s-disease-ulcerative-colitis-phase-ii</loc>
    <lastmod>2026-05-28T21:46:58.299Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/detalimogene-voraplasmid-non-muscle-invasive-bladder-cancer-nmibc-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:58.313Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/paclitaxel-metastatic-pancreatic-cancer-pancreatic-phase-ii</loc>
    <lastmod>2026-05-28T21:46:58.327Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ianalumab-primary-immune-thrombocytopenia-phase-iii</loc>
    <lastmod>2026-05-28T21:46:58.341Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imatinib-mesilate-chronic-myeloid-leukaemia-phase-iv</loc>
    <lastmod>2026-05-28T21:46:58.355Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rilpivirine-hiv-1-infection-phase-iv</loc>
    <lastmod>2026-05-28T21:46:58.368Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hydrocortisone-primary-adrenal-insufficiency-phase-iv</loc>
    <lastmod>2026-05-28T21:46:58.382Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rivaroxaban-with-lactose-monohydrate-exc-intracardiac-thrombus-phase-iii</loc>
    <lastmod>2026-05-28T21:46:58.396Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trametinib-metastatic-malignancy-braf-gene-mutation-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:58.410Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mitomycin-non-muscle-invasive-bladder-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:46:58.424Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pertuzumab-breast-cancer-early-her2-positive-breast-phase-iii</loc>
    <lastmod>2026-05-28T21:46:58.437Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-non-small-cell-lung-cancer-stage-i-ii-eg-phase-iii</loc>
    <lastmod>2026-05-28T21:46:58.451Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/recombinant-varicella-zoster-virus-glyco-psoriasis-vulgaris-psoriatic-arthritis-phase-iv</loc>
    <lastmod>2026-05-28T21:46:58.465Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/exagamglogene-autotemcel-sickle-cell-disease-transfusion-dependen-phase-iv</loc>
    <lastmod>2026-05-28T21:46:58.480Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iopamidol-peripheral-arterial-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:46:58.494Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hydroxychloroquine-sulfate-iga-nephropathy-phase-iii</loc>
    <lastmod>2026-05-28T21:46:58.508Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-bone-marrow-derived-mononucle-chronic-limb-threatening-ischemia-diabet-phase-iv</loc>
    <lastmod>2026-05-28T21:46:58.522Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-t-cells-transduced-with-lenti-multiple-myeloma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:58.536Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nifedipine-preterm-premature-rupture-of-membranes-p-phase-iii</loc>
    <lastmod>2026-05-28T21:46:58.552Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iloprost-trometamol-infectious-pulmonary-endotheliopathy-res-phase-iv</loc>
    <lastmod>2026-05-28T21:46:58.566Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dnth103-generalized-myasthenia-gravis-phase-ii</loc>
    <lastmod>2026-05-28T21:46:58.579Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/resamirigene-bilparvovec-x-linked-myotubular-myopathy-xlmtm-phase-i-phase-ii-phase-iii</loc>
    <lastmod>2026-05-28T21:46:58.594Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abatacept-igg4-related-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:46:58.607Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-immunoglobulin-g1-constant-region-x-linked-hypohidrotic-ectodermal-dysplas-phase-ii</loc>
    <lastmod>2026-05-28T21:46:58.621Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/18f-psma-1007-clinically-significant-prostate-cancer-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:46:58.635Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imatinib-mesilate-gastrointestinal-stromal-tumor-advanced-phase-iv</loc>
    <lastmod>2026-05-28T21:46:58.649Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/floxuridin-resectable-colorectal-liver-metastases-n-not-applicable</loc>
    <lastmod>2026-05-28T21:46:58.663Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anastrozole-locally-advanced-or-metastatic-low-grade-phase-iv</loc>
    <lastmod>2026-05-28T21:46:58.676Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/1-5r-2-4-5-chloro-2-pyrimidinyl-1-piperi-systemic-autoimmune-rheumatic-disease-as</loc>
    <lastmod>2026-05-28T21:46:58.690Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gallium-68ga-pentixafor-primary-aldosteronism-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:46:58.704Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/afamitresgene-autoleucel-myxoid-round-cell-liposarcoma-synovial-s-phase-ii</loc>
    <lastmod>2026-05-28T21:46:58.718Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/crofelemer-microvillus-inclusion-disease-mvid-phase-ii</loc>
    <lastmod>2026-05-28T21:46:58.731Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tiragolumab-head-and-neck-squamous-cell-carcinoma-hn-phase-ii</loc>
    <lastmod>2026-05-28T21:46:58.745Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/progesterone-infertility-phase-iv</loc>
    <lastmod>2026-05-28T21:46:58.759Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutetium-177lu-oxodotreotide-recurrent-or-relapsed-solid-tumours-expr-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:58.772Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/axicabtagene-ciloleucel-diffuse-large-b-cell-lymphoma-phase-ii</loc>
    <lastmod>2026-05-28T21:46:58.786Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-hypochlorite-diabetic-foot-ulcer-phase-iii</loc>
    <lastmod>2026-05-28T21:46:58.800Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/l-lysine-hydrochloride-l-arginine-hydroc-somatostatin-receptor-positive-solid-tum-phase-i</loc>
    <lastmod>2026-05-28T21:46:58.813Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/repotrectinib-advanced-solid-tumors-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:58.827Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sertraline-anorexia-nervosa-phase-iii</loc>
    <lastmod>2026-05-28T21:46:58.840Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/chimeric-locked-nucleic-acid-and-ribonuc-angelman-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:46:58.855Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-765063-head-and-neck-squamous-cell-carcinoma-he-phase-iii</loc>
    <lastmod>2026-05-28T21:46:58.868Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2-o-2-methoxyethyl-modified-antisense-ol-angelman-syndrome-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:58.888Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pancreas-powder-pancreatin-pancreatic-exocrine-insufficiency-post-p-phase-iii</loc>
    <lastmod>2026-05-28T21:46:58.901Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aavanc80-5-hotof-aavanc80-3-hotof-sensorineural-hearing-loss-due-to-otof-o-not-applicable</loc>
    <lastmod>2026-05-28T21:46:58.915Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/exs73565-chronic-lymphocytic-leukemia-richter-s-t-phase-i</loc>
    <lastmod>2026-05-28T21:46:58.929Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tx200-tr101-kidney-transplant-rejection-not-applicable</loc>
    <lastmod>2026-05-28T21:46:58.942Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rp2-solid-tumours</loc>
    <lastmod>2026-05-28T21:46:58.956Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vsf1-01-hearing-loss-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:58.970Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/visugromab-advanced-stage-relapsed-refractory-solid-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:58.984Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adp-a2m4cd8-urothelial-cancer-esophageal-cancer-gast-phase-iii</loc>
    <lastmod>2026-05-28T21:46:58.999Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pramipexole-major-depressive-disorder-anhedonia-phase-iii</loc>
    <lastmod>2026-05-28T21:46:59.012Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/stroke-phase-iii</loc>
    <lastmod>2026-05-28T21:46:59.046Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-zirconium-zr-89-neurofibromatosis-type-2-nf2-related-sch-phase-ii</loc>
    <lastmod>2026-05-28T21:46:59.027Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/temozolomide-glioblastoma-phase-iv</loc>
    <lastmod>2026-05-28T21:46:59.061Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vamorolone-duchenne-muscular-dystrophy-phase-iv</loc>
    <lastmod>2026-05-28T21:46:59.075Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxygen-hypoplastic-left-heart-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:46:59.092Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pyruvic-acid-autosomal-dominant-polycystic-kidney-dis-phase-iv</loc>
    <lastmod>2026-05-28T21:46:59.105Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pyruvic-acid-hepatocellular-carcinoma-primary-liver-c-phase-iv</loc>
    <lastmod>2026-05-28T21:46:59.119Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levothyroxine-hodgkin-lymphoma-non-hodgkin-lymphoma-me-phase-iii</loc>
    <lastmod>2026-05-28T21:46:59.134Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ifosfamide-squamous-cell-carcinoma-of-the-penis-phase-ii</loc>
    <lastmod>2026-05-28T21:46:59.148Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bleomycin-unresectable-pancreatic-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:46:59.162Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/balinatunfib-crohn-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:46:59.176Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/crgd-zw800-1-oral-cancer-squamous-cell-carcinoma-of-t-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:59.192Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sapablursen-polycythemia-vera-phlebotomy-dependent-p-phase-ii</loc>
    <lastmod>2026-05-28T21:46:59.206Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azithromycin-childhood-asthma-phase-iv</loc>
    <lastmod>2026-05-28T21:46:59.220Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-crispr-cas9-mediated-genetica-solid-malignancy-hematologic-malignancy-not-applicable</loc>
    <lastmod>2026-05-28T21:46:59.235Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ulipristal-acetate-uterine-fibroids-not-applicable</loc>
    <lastmod>2026-05-28T21:46:59.249Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ketamine-hydrochloride-chronic-depression-phase-ii</loc>
    <lastmod>2026-05-28T21:46:59.263Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/incb123667-advanced-or-metastatic-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:46:59.277Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/e-coli-polysaccharide-neurogenic-bladder-recurrent-urinary-tra-phase-iii</loc>
    <lastmod>2026-05-28T21:46:59.291Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tinzaparin-sodium-pancreatic-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:46:59.305Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nanobody-against-macrophage-mannose-rece-cardiac-sarcoidosis-phase-iv</loc>
    <lastmod>2026-05-28T21:46:59.319Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avapritinib-indolent-systemic-mastocytosis-systemic-phase-ii</loc>
    <lastmod>2026-05-28T21:46:59.333Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-anca-associated-vasculitis-end-stage-ren-not-applicable</loc>
    <lastmod>2026-05-28T21:46:59.346Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/savolitinib-non-small-cell-lung-cancer-egfr-mutant-m-phase-ii</loc>
    <lastmod>2026-05-28T21:46:59.360Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-high-grade-glioma-brain-metastases-phase-iii</loc>
    <lastmod>2026-05-28T21:46:59.374Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/empagliflozin-chronic-kidney-disease</loc>
    <lastmod>2026-05-28T21:46:59.388Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/18f-fluoroestradiol-breast-cancer-luminal-a-breast-cancer-er-phase-ii</loc>
    <lastmod>2026-05-28T21:46:59.402Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cetrelimab-muscle-invasive-bladder-cancer-mibc-blad-phase-ii</loc>
    <lastmod>2026-05-28T21:46:59.416Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/guselkumab-psoriatic-arthritis-phase-iv</loc>
    <lastmod>2026-05-28T21:46:59.430Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iodixanol-female-infertility-not-applicable</loc>
    <lastmod>2026-05-28T21:46:59.443Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mtx46943-alzheimer-s-disease-phase-i</loc>
    <lastmod>2026-05-28T21:46:59.457Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/savolitinib-non-small-cell-lung-cancer-egfr-mutant-n-phase-ii</loc>
    <lastmod>2026-05-28T21:46:59.471Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/luxdegalutamide-metastatic-castration-resistant-prostate-phase-ii</loc>
    <lastmod>2026-05-28T21:46:59.484Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prednisolone-sodium-phosphate-rhinovirus-induced-wheezing-not-applicable</loc>
    <lastmod>2026-05-28T21:46:59.498Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/caffeine-citrate-extubation-failure-bronchopulmonary-dysp-phase-iv</loc>
    <lastmod>2026-05-28T21:46:59.512Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ketamine-hydrochloride-major-depressive-disorder-treatment-resi-phase-iii</loc>
    <lastmod>2026-05-28T21:46:59.526Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ruxolitinib-hidradenitis-suppurativa-phase-iii</loc>
    <lastmod>2026-05-28T21:46:59.540Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ketamine-hydrochloride-major-depressive-disorder-treatment-resi-phase-iii-2</loc>
    <lastmod>2026-05-28T21:46:59.554Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/advanced-solid-tumors-phase-i-7</loc>
    <lastmod>2026-05-28T21:46:59.568Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adrenal-insufficiency-phase-ii</loc>
    <lastmod>2026-05-28T21:46:59.582Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/irinotecan-metastatic-colorectal-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:46:59.596Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-normal-immunoglobulin-idiopathic-inflammatory-myopathy-dermato-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:46:59.610Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ion464-multiple-system-atrophy-phase-i</loc>
    <lastmod>2026-05-28T21:46:59.624Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glepaglutide-short-bowel-syndrome-intestinal-failure-phase-iii</loc>
    <lastmod>2026-05-28T21:46:59.638Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ethanol-anhydrous-hypertension-phase-iii</loc>
    <lastmod>2026-05-28T21:46:59.652Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bemarituzumab-fgfr2b-positive-advanced-or-metastatic-g-phase-ii</loc>
    <lastmod>2026-05-28T21:46:59.666Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/necvax-neo1-triple-negative-breast-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:59.680Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-2-2-10-2-4-3-4-2-2-cyano-4-4-difluor-pancreatic-ductal-adenocarcinoma-pancrea-not-applicable</loc>
    <lastmod>2026-05-28T21:46:59.694Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bbo-8520-non-small-cell-lung-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:46:59.707Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutetium-177-dota-tate-somatostatin-receptor-positive-tumours-phase-i</loc>
    <lastmod>2026-05-28T21:46:59.721Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/buprenorphine-major-depressive-episode-clinical-depres-phase-iv</loc>
    <lastmod>2026-05-28T21:46:59.735Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vinblastine-sulfate-cisplatin-early-triple-negative-breast-cancer-tnbc-phase-ii</loc>
    <lastmod>2026-05-28T21:46:59.749Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alanine-arginine-deferoxamine-histidine-kidney-transplantation-liver-transplanta-phase-iii</loc>
    <lastmod>2026-05-28T21:46:59.762Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cobamamide-levocarnitine-septic-shock-acute-kidney-injury-not-applicable</loc>
    <lastmod>2026-05-28T21:46:59.776Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/patritumab-deruxtecan-colorectal-carcinoma-biliary-tract-carci-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:59.792Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-1831169-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:46:59.805Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-non-small-cell-lung-cancer-phase-ii-3</loc>
    <lastmod>2026-05-28T21:46:59.819Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-muscle-invasive-bladder-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:46:59.832Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clonidine-hydrochloride-procedural-pain-during-eye-examination-f-not-applicable</loc>
    <lastmod>2026-05-28T21:46:59.846Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fitusiran-severe-hemophilia-a-severe-hemophilia-b</loc>
    <lastmod>2026-05-28T21:46:59.860Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vinblastine-sulfate-cisplatin-dedifferentiated-liposarcoma-myxoid-lipo-phase-iii</loc>
    <lastmod>2026-05-28T21:46:59.873Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/secretin-synthetic-human-pancreatic-cancer-intraductal-papillary-phase-iii</loc>
    <lastmod>2026-05-28T21:46:59.887Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jk06-unresectable-locally-advanced-or-metasta-phase-i-ii</loc>
    <lastmod>2026-05-28T21:46:59.901Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rilvegostomig-her2-positive-locally-advanced-or-metast-phase-iii</loc>
    <lastmod>2026-05-28T21:46:59.915Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-schizophrenia-spectrum-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:46:59.929Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-locally-recurrent-rectal-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:46:59.942Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-advanced-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:46:59.957Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-adipose-derived-mesenchymal-s-ischemic-stroke-acute-ischemic-stroke-phase-iv</loc>
    <lastmod>2026-05-28T21:46:59.971Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-fibrinogen-bleeding-in-patients-undergoing-complex-phase-iii</loc>
    <lastmod>2026-05-28T21:46:59.988Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-chronic-inflammatory-demyelinating-polyn-not-applicable</loc>
    <lastmod>2026-05-28T21:47:00.002Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-unresectable-melanoma-advanced-melanoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:00.015Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-small-cell-lung-cancer-extensive-stage-a-phase-ii</loc>
    <lastmod>2026-05-28T21:47:00.029Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iks03-advanced-b-cell-non-hodgkin-lymphoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:00.043Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mitoxantrone-hydrochloride-acute-myeloid-leukemia-aml-chronic-lymph-not-applicable</loc>
    <lastmod>2026-05-28T21:47:00.057Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/equine-immunoglobulin-f-ab-2-fragments-t-hemolytic-uremic-syndrome-shiga-toxin-pr-phase-iii</loc>
    <lastmod>2026-05-28T21:47:00.071Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/daratumumab-myalgic-encephalomyelitis-chronic-fatigu-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:00.085Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-advanced-solid-tumors-phase-i-2</loc>
    <lastmod>2026-05-28T21:47:00.099Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zilucoplan-generalized-myasthenia-gravis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:00.113Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/budesonide-eosinophilic-esophagitis-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:00.127Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/byon4228-sirp-directed-monoclonal-antibo-relapsed-refractory-cd20-positive-b-cell-phase-i</loc>
    <lastmod>2026-05-28T21:47:00.140Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxytocin-synthetic-autism-spectrum-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:47:00.154Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexmedetomidine-hydrochloride-general-anaesthesia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:00.167Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rimegepant-migraine-episodic-migraine-phase-iii</loc>
    <lastmod>2026-05-28T21:47:00.182Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/stp938-ctps1-inhibitor-solid-tumor-ovarian-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:47:00.196Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-mantle-cell-lymphoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:00.209Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/datopotamab-deruxtecan-non-small-cell-lung-cancer-non-squamous-phase-ii</loc>
    <lastmod>2026-05-28T21:47:00.223Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ifinatamab-deruxtecan-extensive-stage-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:00.237Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-advanced-hormone-receptor-positive-her2-phase-ii</loc>
    <lastmod>2026-05-28T21:47:00.251Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zenocutuzumab-solid-tumour-non-small-cell-lung-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:00.265Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iberdomide-multiple-myeloma-newly-diagnosed-multipl-phase-ii</loc>
    <lastmod>2026-05-28T21:47:00.279Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ticagrelor-coronary-artery-disease-requiring-percut-phase-iv</loc>
    <lastmod>2026-05-28T21:47:00.293Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/drospirenone-decreased-bone-mineral-density-oral-cont-phase-iv</loc>
    <lastmod>2026-05-28T21:47:00.307Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutetium-177lu-vipivotide-tetraxetan-metastatic-castration-resistant-prostate-phase-i</loc>
    <lastmod>2026-05-28T21:47:00.321Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/padeliporfin-upper-tract-urothelial-carcinoma-low-gra-phase-iii</loc>
    <lastmod>2026-05-28T21:47:00.334Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/paclitaxel-head-and-neck-squamous-cell-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:00.348Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pttl-colorectal-cancer-advanced-colorectal-ca-phase-i</loc>
    <lastmod>2026-05-28T21:47:00.361Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mbs8-1v270-advanced-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:47:00.376Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hypothalamic-phospholipids-major-depressive-disorder-phase-iv</loc>
    <lastmod>2026-05-28T21:47:00.390Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pneumococcal-polysaccharide-serotype-6a-pneumococcal-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:00.404Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-non-small-cell-lung-cancer-pancoast-tumo-phase-ii</loc>
    <lastmod>2026-05-28T21:47:00.417Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/furosemide-furosemide-ph-eur-fluid-overload-not-applicable</loc>
    <lastmod>2026-05-28T21:47:00.431Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rcs-21-healthy-volunteers-phase-i</loc>
    <lastmod>2026-05-28T21:47:00.445Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-oligometastatic-renal-cell-carcinoma-met-phase-ii</loc>
    <lastmod>2026-05-28T21:47:00.458Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metastatic-colorectal-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:00.472Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zw191-advanced-solid-tumors-endometrial-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:47:00.486Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/calcium-folinate-pentahydrate-metastatic-colorectal-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:00.501Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cyanocobalamin-phospholipid-from-cerebra-chronic-low-back-pain-phase-iv</loc>
    <lastmod>2026-05-28T21:47:00.516Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pemetrexed-advanced-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:00.529Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/respiratory-syncytial-virus-glycoprotein-respiratory-syncytial-virus-infection-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:00.543Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/donepezil-hydrochloride-neurological-disorders-phase-ii</loc>
    <lastmod>2026-05-28T21:47:00.556Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pabinafusp-alfa-mucopolysaccharidosis-type-ii-hunter-syn-phase-iii</loc>
    <lastmod>2026-05-28T21:47:00.570Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rct2100-cystic-fibrosis-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:00.584Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-hydrochloride-hiv-infection-phase-ii</loc>
    <lastmod>2026-05-28T21:47:00.598Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/breast-cancer-not-applicable</loc>
    <lastmod>2026-05-28T21:47:00.612Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/siponimod-secondary-progressive-multiple-sclerosis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:00.626Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-govitecan-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:00.640Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-govitecan-triple-negative-breast-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:00.654Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-cd4-and-cd8-t-lymphocytes-ex-cytomegalovirus-cmv-infection-epstein-ba-phase-iii</loc>
    <lastmod>2026-05-28T21:47:00.668Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methotrexate-giant-cell-arteritis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:00.683Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nedosiran-primary-hyperoxaluria-phase-iii</loc>
    <lastmod>2026-05-28T21:47:00.698Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nepafenac-cataract-phase-iv</loc>
    <lastmod>2026-05-28T21:47:00.712Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ntr-641-acute-ischemic-stroke-phase-i</loc>
    <lastmod>2026-05-28T21:47:00.726Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oric-114-advanced-solid-tumors-with-egfr-or-her2-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:00.740Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prednisolone-acute-laryngitis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:00.754Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vosoritide-hypochondroplasia-phase-ii</loc>
    <lastmod>2026-05-28T21:47:00.768Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-prediabetes</loc>
    <lastmod>2026-05-28T21:47:00.782Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nedosiran-primary-hyperoxaluria-type-1-phase-ii</loc>
    <lastmod>2026-05-28T21:47:00.795Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/perflubutane-pancreatic-ductal-adenocarcinoma-locally-phase-iv</loc>
    <lastmod>2026-05-28T21:47:00.809Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imatinib-gastrointestinal-stromal-tumor-phase-iii</loc>
    <lastmod>2026-05-28T21:47:00.823Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/xxx-malignant-solid-tumour-expressing-ceacam-phase-i</loc>
    <lastmod>2026-05-28T21:47:00.839Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/patritumab-deruxtecan-non-small-cell-lung-cancer-egfr-mutated-phase-ii</loc>
    <lastmod>2026-05-28T21:47:00.853Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alfa-d-mannose-1-phosphate-dipotassium-pmm2-cdg-phosphomannomutase-2-congenital-phase-ii</loc>
    <lastmod>2026-05-28T21:47:00.867Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/infliximab-takayasu-arteritis-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:00.881Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-unresectable-oesophageal-cancer-oesophag-phase-ii</loc>
    <lastmod>2026-05-28T21:47:00.895Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-limited-stage-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:00.909Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ulefnersen-amyotrophic-lateral-sclerosis-als-fus-mu-phase-i-ii-phase-iii</loc>
    <lastmod>2026-05-28T21:47:00.922Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/futibatinib-malignant-solid-tumors-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:00.936Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/breast-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:00.949Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/doravirine-islatravir-hiv-1-infection-hiv-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:47:00.964Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ravulizumab-iga-nephropathy-idiopathic-iga-nephropat</loc>
    <lastmod>2026-05-28T21:47:00.978Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-hepatocellular-carcinoma-advanced-phase-iii</loc>
    <lastmod>2026-05-28T21:47:00.992Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-chronic-lymphocytic-leukemia-small-lymph-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:01.006Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rilvegostomig-non-small-cell-lung-cancer-adenocarcinom-phase-iii</loc>
    <lastmod>2026-05-28T21:47:01.020Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cagrilintide-semaglutide-obesity-phase-iii</loc>
    <lastmod>2026-05-28T21:47:01.034Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acenocoumarol-colorectal-polyps-colorectal-lesions-req-phase-iv-ctis-2024-512194-27</loc>
    <lastmod>2026-05-28T21:11:54.269Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/digitoxin-pancreatic-adenocarcinoma-pancreatic-can-phase-ii</loc>
    <lastmod>2026-05-28T21:47:01.048Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/epinephrine-lidocaine-hydrochloride-distal-radius-fracture-not-applicable</loc>
    <lastmod>2026-05-28T21:47:01.061Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-nasopharyngeal-carcinoma-recurrent-metas-phase-ii</loc>
    <lastmod>2026-05-28T21:47:01.075Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/telitacicept-generalized-myasthenia-gravis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:01.089Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/procarbazine-primary-central-nervous-system-diffuse-l-phase-iii</loc>
    <lastmod>2026-05-28T21:47:01.103Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/baricitinib-dermatomyositis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:01.117Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ferric-derisomaltose-restless-legs-syndrome-phase-iv</loc>
    <lastmod>2026-05-28T21:47:01.131Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lazertinib-non-small-cell-lung-cancer-egfr-mutant-a-phase-ii</loc>
    <lastmod>2026-05-28T21:47:01.145Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colecalciferol-healthy-volunteers-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:01.158Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/selinexor-diffuse-large-b-cell-lymphoma-dlbcl-rela-phase-ii</loc>
    <lastmod>2026-05-28T21:47:01.172Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bicalutamide-unfavorable-intermediate-risk-prostate-c-phase-iv</loc>
    <lastmod>2026-05-28T21:47:01.186Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mk-1084-non-small-cell-lung-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:01.200Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tezepelumab-severe-asthma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:01.214Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/4-3-cyanomethyl-3-3-5-dimethyl-1h-1-h-4-prurigo-nodularis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:01.227Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amoxicillin-trihydrate-community-acquired-alveolar-pneumonia-not-applicable</loc>
    <lastmod>2026-05-28T21:47:01.242Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/escherichia-coli-dsm-17252-irritable-bowel-syndrome-diarrhea-predom-phase-iv</loc>
    <lastmod>2026-05-28T21:47:01.255Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/4-3-cyanomethyl-3-3-5-dimethyl-1h-1-h-4-prurigo-nodularis-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:01.269Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/extracellular-vesicle-enriched-secretome-non-ischemic-dilated-cardiomyopathy-phase-i</loc>
    <lastmod>2026-05-28T21:47:01.283Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/valemetostat-metastatic-castration-resistant-prostate-phase-i</loc>
    <lastmod>2026-05-28T21:47:01.297Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/esketamine-hydrochloride-complex-regional-pain-syndrome-phase-iv</loc>
    <lastmod>2026-05-28T21:47:01.311Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cyclophosphamide-ependymoma-not-applicable</loc>
    <lastmod>2026-05-28T21:47:01.324Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zoledronic-acid-monohydrate-postmenopausal-osteoporosis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:01.339Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cholangiocarcinoma-pancreatic-cancer-col-phase-iii</loc>
    <lastmod>2026-05-28T21:47:01.353Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zirconium-89zr-crefmirlimab-berdoxam-metastatic-melanoma-unresectable-melanom-phase-ii</loc>
    <lastmod>2026-05-28T21:47:01.367Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-765423-idiopathic-pulmonary-fibrosis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:01.381Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-urothelial-carcinoma-of-the-bladder-inva-phase-ii</loc>
    <lastmod>2026-05-28T21:47:01.394Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-faecal-microbiota-pooled-type-2-diabetes-mellitus-phase-iii</loc>
    <lastmod>2026-05-28T21:47:01.408Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trospium-chloride-xanomeline-tartrate-bipolar-i-disorder-mania-or-mania-with-m-phase-iii</loc>
    <lastmod>2026-05-28T21:47:01.422Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/esketamine-hydrochloride-major-depressive-disorder-bipolar-depres</loc>
    <lastmod>2026-05-28T21:47:01.436Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/certolizumab-pegol-recurrent-implantation-failure-infertili-phase-iii</loc>
    <lastmod>2026-05-28T21:47:01.449Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mitomycin-non-muscle-invasive-bladder-cancer-bladd</loc>
    <lastmod>2026-05-28T21:47:01.463Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tobevibart-chronic-hepatitis-d-hdv-infection-phase-ii</loc>
    <lastmod>2026-05-28T21:47:01.477Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tacrolimus-antisynthetase-syndrome-related-intersti-phase-iii</loc>
    <lastmod>2026-05-28T21:47:01.492Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fludeoxyglucose-18f-breast-cancer-neuroendocrine-neoplasm-ly-phase-ii</loc>
    <lastmod>2026-05-28T21:47:01.510Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bilayer-engineered-collagen-hydrogel-bas-full-thickness-skin-defects-phase-ii</loc>
    <lastmod>2026-05-28T21:47:01.524Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-hydrochloride-type-1-diabetes-vascular-calcification-phase-iii</loc>
    <lastmod>2026-05-28T21:47:01.537Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ivabradine-hydrochloride-septic-shock-phase-iii</loc>
    <lastmod>2026-05-28T21:47:01.551Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-faecal-microbiota-pooled-ulcerative-colitis-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:01.565Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bilayer-engineered-collagen-hydrogel-bas-deep-partial-thickness-burns-full-thickn-phase-ii</loc>
    <lastmod>2026-05-28T21:47:01.579Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-t-cells-expressing-cd8a-and-a-recurrent-ovarian-cancer-mage-a4-positiv-phase-ii</loc>
    <lastmod>2026-05-28T21:47:01.592Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2-1-3-6-1e-hydroxyimino-methyl-5-methyl-scleroderma-associated-digital-ulcers-phase-ii</loc>
    <lastmod>2026-05-28T21:47:01.606Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bupivacaine-hydrochloride-anhydrous-postoperative-recovery-after-elective-mi-not-applicable</loc>
    <lastmod>2026-05-28T21:47:01.620Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-triple-negative-breast-cancer-metastatic-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:01.633Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vna-318-cognitive-impairment-phase-i</loc>
    <lastmod>2026-05-28T21:47:01.648Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cyclophosphamide-luminal-b-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:01.662Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pentixather-yttrium-90-primary-central-nervous-system-lymphoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:01.676Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-hydrogen-carbonate-labor-induction-childbirth-phase-iii</loc>
    <lastmod>2026-05-28T21:47:01.689Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colchicine-peripheral-arterial-disease-intermittent-phase-iii</loc>
    <lastmod>2026-05-28T21:47:01.703Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/wve-006-alpha-1-antitrypsin-deficiency-aatd-alph-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:01.716Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/loncastuximab-tesirine-relapsed-or-refractory-b-cell-non-hodgki-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:01.730Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-2-2-10-2-4-3-4-2-2-cyano-4-4-difluor-giant-cell-arteritis-polymyalgia-rheumat-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:01.743Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/deferiprone-pelizaeus-merzbacher-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:47:01.758Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sirolimus-familial-adenomatous-polyposis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:01.772Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tolinapant-astx660-locally-advanced-rectal-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:47:01.786Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isoflurane-intracranial-hemorrhage-severe-traumatic-phase-iv</loc>
    <lastmod>2026-05-28T21:47:01.799Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clodronate-disodium-knee-osteoarthritis-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:01.813Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/giroctocogene-fitelparvovec-hemophilia-a-moderately-severe-to-severe-phase-iii</loc>
    <lastmod>2026-05-28T21:47:01.827Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-govitecan-endometrial-cancer-recurrent-or-persiste-phase-iii</loc>
    <lastmod>2026-05-28T21:47:01.841Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apixaban-short-bowel-syndrome-phase-iv</loc>
    <lastmod>2026-05-28T21:47:01.855Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-metastatic-non-small-cell-lung-cancer-no-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:47:01.869Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/al-18f-f-fapi-74-oesophagogastric-adenocarcinoma-pancreat-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:01.883Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/motixafortide-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:01.896Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glycerol-phenylbutyrate-pyruvate-dehydrogenase-deficiency-phase-ii</loc>
    <lastmod>2026-05-28T21:47:01.910Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/icosapent-ethyl-acute-myocardial-infarction</loc>
    <lastmod>2026-05-28T21:47:01.924Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-metastatic-colorectal-cancer-msi-h-dmmr-phase-ii</loc>
    <lastmod>2026-05-28T21:47:01.937Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/baricitinib-calcium-pyrophosphate-deposition-disease-phase-ii-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:01.951Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2r-4r-1-3-chloro-2-fluorobenzyl-4-3-fluo-neuroblastoma-phase-i</loc>
    <lastmod>2026-05-28T21:47:01.965Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/temozolomide-brain-stem-glioma-malignant-glioma-phase-iv</loc>
    <lastmod>2026-05-28T21:47:01.979Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iohexol-acute-abdomen-impaired-renal-function-eg-not-applicable</loc>
    <lastmod>2026-05-28T21:47:01.992Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adipose-derived-stromal-vascular-fractio-inclusion-body-myositis-phase-i</loc>
    <lastmod>2026-05-28T21:47:02.006Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levocarnitine-magnesium-chloride-hexahyd-end-stage-kidney-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:02.020Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/betamethasone-sodium-phosphate-multiple-myeloma-relapsed-multiple-myelo-phase-iii</loc>
    <lastmod>2026-05-28T21:47:02.035Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/progesterone-micronised-insomnia-climacteric-symptoms-not-applicable</loc>
    <lastmod>2026-05-28T21:47:02.049Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/taldefgrobep-alfa-spinal-muscular-atrophy-phase-iii</loc>
    <lastmod>2026-05-28T21:47:02.064Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/advanced-solid-tumor-phase-i</loc>
    <lastmod>2026-05-28T21:47:02.078Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/flutemetamol-18f-alzheimer-s-disease-progressive-supranuc-phase-iv</loc>
    <lastmod>2026-05-28T21:47:02.092Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avelumab-head-and-neck-squamous-cell-carcinoma-re-phase-ii</loc>
    <lastmod>2026-05-28T21:47:02.107Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tremelimumab-malignant-mesothelioma-pleural-mesotheli-phase-ii</loc>
    <lastmod>2026-05-28T21:47:02.121Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nadunolimab-triple-negative-breast-cancer-advanced-t-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:02.134Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tarlatamab-extensive-stage-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:02.149Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenalidomide-multiple-myeloma-phase-iv</loc>
    <lastmod>2026-05-28T21:47:02.163Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tarlatamab-small-cell-lung-cancer-relapsed-refracto-phase-ii</loc>
    <lastmod>2026-05-28T21:47:02.177Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amivantamab-non-small-cell-lung-cancer-egfr-mutated-phase-iii</loc>
    <lastmod>2026-05-28T21:47:02.191Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apalutamide-prostate-cancer-high-risk-prostate-adeno-phase-ii</loc>
    <lastmod>2026-05-28T21:47:02.206Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapansutrile-type-2-diabetes-mellitus-phase-ii</loc>
    <lastmod>2026-05-28T21:47:02.219Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutetium-177lu-vipivotide-tetraxetan-metastatic-castration-resistant-prostate-phase-ii</loc>
    <lastmod>2026-05-28T21:47:02.233Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/givinostat-duchenne-muscular-dystrophy-phase-ii</loc>
    <lastmod>2026-05-28T21:47:02.247Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anifrolumab-non-segmental-vitiligo-phase-ii</loc>
    <lastmod>2026-05-28T21:47:02.260Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-propanediol-type-2-diabetes-mellitus-phase-iv</loc>
    <lastmod>2026-05-28T21:47:02.275Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/molgramostim-autoimmune-pulmonary-alveolar-proteinosi-phase-iii</loc>
    <lastmod>2026-05-28T21:47:02.289Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxygen-acute-pulmonary-embolism-not-applicable</loc>
    <lastmod>2026-05-28T21:47:02.302Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/encorafenib-metastatic-or-unresectable-locally-advan-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:47:02.316Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/car20-nap-t-diffuse-large-b-cell-lymphoma-mantle-cel-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:02.329Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dornase-alfa-acute-respiratory-distress-syndrome-seve-phase-iii</loc>
    <lastmod>2026-05-28T21:47:02.343Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etoposide-hemophagocytic-lymphohistiocytosis-hlh-phase-iii</loc>
    <lastmod>2026-05-28T21:47:02.356Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/diltiazem-hydrochloride-angina-coronary-microvascular-dysfunctio-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:02.370Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etoposide-hemophagocytic-lymphohistiocytosis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:02.384Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nadofaragene-firadenovec-non-muscle-invasive-bladder-cancer-inter-phase-iii</loc>
    <lastmod>2026-05-28T21:47:02.398Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/esmolol-hydrochloride-cardiogenic-shock-phase-iv</loc>
    <lastmod>2026-05-28T21:47:02.412Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/protamine-sulfate-severe-aortic-stenosis-not-applicable</loc>
    <lastmod>2026-05-28T21:47:02.426Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/polyinosinic-polycytidylic-acid-basal-cell-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:02.440Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dostarlimab-endometrial-cancer-mmrd-msi-h-stage-ii-i-phase-ii</loc>
    <lastmod>2026-05-28T21:47:02.454Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sotorasib-non-small-cell-lung-cancer-colorectal-ca-phase-i-ii-phase-ii</loc>
    <lastmod>2026-05-28T21:47:02.468Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/genetically-modified-t-cells-ror1-target-adrenocortical-carcinoma-breast-cancer-c-phase-i</loc>
    <lastmod>2026-05-28T21:47:02.481Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efgartigimod-alfa-generalized-myasthenia-gravis-achr-ab-se-phase-iii</loc>
    <lastmod>2026-05-28T21:47:02.495Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/naloxegol-oxalate-traumatic-brain-injury-subarachnoid-haem-phase-iii</loc>
    <lastmod>2026-05-28T21:47:02.509Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/danicopan-paroxysmal-nocturnal-hemoglobinuria-phase-iii</loc>
    <lastmod>2026-05-28T21:47:02.523Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/paroxetine-hydrochloride-major-depressive-disorder</loc>
    <lastmod>2026-05-28T21:47:02.538Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zidesamtinib-advanced-ros1-positive-non-small-cell-lu-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:02.552Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/loncastuximab-tesirine-mantle-cell-lymphoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:02.566Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lorlatinib-advanced-ros1-positive-non-small-cell-lu-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:02.580Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isatuximab-multiple-myeloma-high-risk-multiple-myel-phase-ii</loc>
    <lastmod>2026-05-28T21:47:02.593Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-hodgkin-lymphoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:02.607Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-cervicobrachial-neuralgia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:02.621Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hct116-a-hct116-b-ht-29-a-ht-29-b-lovo-b-colorectal-cancer-unresectable-locally-a-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:02.634Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/daratumumab-t-cell-acute-lymphoblastic-leukemia-very-phase-ii</loc>
    <lastmod>2026-05-28T21:47:02.648Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ixazomib-citrate-multiple-myeloma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:02.663Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-muscle-invasive-bladder-cancer-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:02.677Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-hydrochloride-esophageal-adenocarcinoma-phase-iv</loc>
    <lastmod>2026-05-28T21:47:02.691Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/olaparib-high-grade-epithelial-ovarian-cancer-fal-phase-ii</loc>
    <lastmod>2026-05-28T21:47:02.705Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amoxicillin-trihydrate-community-acquired-pneumonia-lower-respi-phase-iv</loc>
    <lastmod>2026-05-28T21:47:02.719Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/afatinib-egfr-mutated-t790m-negative-non-small-ce-phase-iv</loc>
    <lastmod>2026-05-28T21:47:02.732Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ifezuntirgene-inilparvovec-huntington-s-disease-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:02.748Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/crofelemer-short-bowel-syndrome-and-intestinal-fail-phase-ii</loc>
    <lastmod>2026-05-28T21:47:02.761Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atorvastatin-post-operative-atrial-fibrillation-atria-phase-iv</loc>
    <lastmod>2026-05-28T21:47:02.776Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/felzartamab-late-antibody-mediated-renal-transplant-phase-iv</loc>
    <lastmod>2026-05-28T21:47:02.790Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colesevelam-hydrochloride-bile-acid-diarrhoea-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:02.805Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pirtobrutinib-chronic-lymphocytic-leukemia-small-lymph-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:02.818Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/non-small-cell-lung-cancer-egfr-mutant-n-phase-iii</loc>
    <lastmod>2026-05-28T21:47:02.832Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venglustat-fabry-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:02.846Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nucleic-acid-product-substance-entry-in-alcohol-related-liver-disease-alcohol-re-phase-ii</loc>
    <lastmod>2026-05-28T21:47:02.860Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/taladegib-idiopathic-pulmonary-fibrosis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:02.874Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vinorelbine-ewing-sarcoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:02.889Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/odronextamab-b-cell-non-hodgkin-lymphoma-follicular-l-phase-ii</loc>
    <lastmod>2026-05-28T21:47:02.902Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/filgotinib-polyarticular-juvenile-idiopathic-arthri-phase-iii</loc>
    <lastmod>2026-05-28T21:47:02.917Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nk-92-5-28-z-cells-glioblastoma-her2-positive-glioblastoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:02.930Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-collecting-duct-carcinoma-renal-medullar-phase-ii</loc>
    <lastmod>2026-05-28T21:47:02.945Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bimekizumab-psoriatic-arthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:02.958Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pirtobrutinib-mantle-cell-lymphoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:02.973Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elranatamab-relapsed-refractory-multiple-myeloma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:02.990Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ivosidenib-acute-myeloid-leukemia-aml-idh1-mutated-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:03.004Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/naporafenib-melanoma-brafv600-or-nras-mutant-phase-ii</loc>
    <lastmod>2026-05-28T21:47:03.019Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bfb759-atopic-dermatitis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:03.033Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/siponimod-fumaric-acid-multiple-sclerosis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:03.047Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ianalumab-diffuse-cutaneous-systemic-sclerosis-dcs-phase-ii</loc>
    <lastmod>2026-05-28T21:47:03.061Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methylprednisolone-kidney-transplant-phase-iv</loc>
    <lastmod>2026-05-28T21:47:03.075Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zanidatamab-endometrial-cancer-colorectal-cancer-hea-phase-ii</loc>
    <lastmod>2026-05-28T21:47:03.090Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apixaban-venous-malformation-phase-ii</loc>
    <lastmod>2026-05-28T21:47:03.104Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gadoteric-acid-breast-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:47:03.118Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anhydrous-lidocaine-hydrochloride-post-dural-puncture-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:47:03.132Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-decompensated-liver-cirrhosis-liver-cirr-phase-ii</loc>
    <lastmod>2026-05-28T21:47:03.146Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutetium-177lu-oxodotreotide-small-intestine-neuroendocrine-tumour-st-phase-iii</loc>
    <lastmod>2026-05-28T21:47:03.159Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ibrutinib-waldenstrom-macroglobulinemia-phase-iv</loc>
    <lastmod>2026-05-28T21:47:03.173Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prednisone-kidney-transplantation-not-applicable</loc>
    <lastmod>2026-05-28T21:47:03.187Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ramipril-st-elevation-myocardial-infarction-myoca-phase-iv</loc>
    <lastmod>2026-05-28T21:47:03.201Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tumor-infiltrating-lymphocytes-tils-advanced-or-metastatic-triple-negative-b-phase-i</loc>
    <lastmod>2026-05-28T21:47:03.215Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-95597528-asthma-mild-to-moderate-phase-i</loc>
    <lastmod>2026-05-28T21:47:03.229Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/frexalimab-focal-segmental-glomerulosclerosis-minim-phase-ii</loc>
    <lastmod>2026-05-28T21:47:03.243Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluorouracil-pancreatic-adenocarcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:03.257Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hexaminolevulinate-non-muscle-invasive-bladder-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:47:03.272Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-major-depressive-disorder-obesity-overwe</loc>
    <lastmod>2026-05-28T21:47:03.286Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methotrexate-relapsed-primary-central-nervous-system-phase-i</loc>
    <lastmod>2026-05-28T21:47:03.300Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ropivacaine-hydrochloride-acute-low-back-pain-non-specific-low-bac-not-applicable</loc>
    <lastmod>2026-05-28T21:47:03.315Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tezepelumab-chronic-obstructive-pulmonary-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:47:03.329Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/piperacillin-sodium-tazobactam-sodium-acute-exacerbation-of-chronic-obstructiv-phase-iii</loc>
    <lastmod>2026-05-28T21:47:03.343Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tacrolimus-pediatric-kidney-transplant-recipients-k</loc>
    <lastmod>2026-05-28T21:47:03.356Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vusolimogene-oderparepvec-solid-tumors-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:03.369Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/montelukast-peripheral-arterial-disease-lower-limb-i-phase-iii</loc>
    <lastmod>2026-05-28T21:47:03.383Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-post-acute-sequelae-of-sars-cov-2-infect-phase-iii</loc>
    <lastmod>2026-05-28T21:47:03.398Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sulfur-hexafluoride-adnexal-torsion-not-applicable</loc>
    <lastmod>2026-05-28T21:47:03.413Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/estradiol-valerate-subfertility-phase-iv</loc>
    <lastmod>2026-05-28T21:47:03.426Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-post-acute-sequelae-of-sars-cov-2-infect-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:03.440Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-stage-iii-non-small-cell-lung-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:47:03.453Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/defosbarasertib-extensive-stage-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:03.467Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prednisolone-acetate-central-serous-chorioretinopathy-chronic-phase-iii</loc>
    <lastmod>2026-05-28T21:47:03.482Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/onasemnogene-abeparvovec-spinal-muscular-atrophy-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:03.495Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oberotatug-ravtansine-cd205-positive-recurrent-metastatic-soli-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:03.510Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tasquinimod-myelofibrosis-primary-myelofibrosis-post-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:03.524Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amlodipine-irbesartan-arterial-hypertension-high-blood-pressur-not-applicable</loc>
    <lastmod>2026-05-28T21:47:03.540Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-acute-myocardial-infarction-heart-failur-phase-iii</loc>
    <lastmod>2026-05-28T21:47:03.555Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-sodium-phosphate-anterior-cruciate-ligament-rupture-anter-phase-iii</loc>
    <lastmod>2026-05-28T21:47:03.568Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/7-8-dibromo-5-6-dihydro-9-methyl-2-1-pip-primary-myelofibrosis-secondary-myelofib-phase-ii</loc>
    <lastmod>2026-05-28T21:47:03.582Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/perflutren-glioblastoma-idh-wild-type-phase-ii</loc>
    <lastmod>2026-05-28T21:47:03.596Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-enriched-t-cells-retrovirally-secondary-malignancy-following-car-t-cel-phase-iv</loc>
    <lastmod>2026-05-28T21:47:03.611Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/177lu-rhpsma-10-1-metastatic-castration-resistant-prostate-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:03.625Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tremelimumab-non-small-cell-lung-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:03.640Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/donepezil-hydrochloride-anorexia-nervosa-phase-iv</loc>
    <lastmod>2026-05-28T21:47:03.653Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/art0380-mesilate-alnodesertib-advanced-or-metastatic-solid-tumours-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:03.667Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iohexol-sickle-cell-anaemia-vaso-occlusive-crisi-not-applicable</loc>
    <lastmod>2026-05-28T21:47:03.681Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nadroparin-calcium-subarachnoid-hemorrhage-phase-iv</loc>
    <lastmod>2026-05-28T21:47:03.695Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-cd34-enriched-cells-from-pati-fanconi-anemia-subtype-a-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:03.709Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/varnimcabtagene-autoleucel-diffuse-large-b-cell-lymphoma-dlbcl-rela-phase-ii</loc>
    <lastmod>2026-05-28T21:47:03.723Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/potassium-chloride-ph-eur-sodium-chlorid-bronchiectasis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:03.737Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/thioctic-acid-alpha-lipoic-acid-diabetic-sensorimotor-polyneuropathy-phase-ii</loc>
    <lastmod>2026-05-28T21:47:03.750Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atidarsagene-autotemcel-metachromatic-leukodystrophy-late-juveni-phase-iii</loc>
    <lastmod>2026-05-28T21:47:03.764Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nvdx3-distal-radius-fracture-lumbar-spondyloli-not-applicable</loc>
    <lastmod>2026-05-28T21:47:03.778Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-t-cells-transduced-with-the-l-cutaneous-melanoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:03.792Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-2-2-10-2-4-3-4-2-2-cyano-4-4-difluor-solid-tumors-phase-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:47:03.806Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/olaparib-head-and-neck-squamous-cell-carcinoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:03.820Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tasimelteon-delayed-sleep-wake-phase-disorder-dswpd-phase-iii</loc>
    <lastmod>2026-05-28T21:47:03.835Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bezafibrate-primary-sclerosing-cholangitis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:03.849Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pasireotide-synovial-sarcoma-desmoplastic-small-roun-phase-ii</loc>
    <lastmod>2026-05-28T21:47:03.862Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxaliplatin-rectal-cancer-intermediate-and-high-risk-phase-iii</loc>
    <lastmod>2026-05-28T21:47:03.878Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bmn-351-duchenne-muscular-dystrophy-phase-iv</loc>
    <lastmod>2026-05-28T21:47:03.892Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aripiprazole-autism-spectrum-disorder-phase-iv</loc>
    <lastmod>2026-05-28T21:47:03.905Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apitegromab-spinal-muscular-atrophy-type-2-spinal-mu-phase-iii</loc>
    <lastmod>2026-05-28T21:47:03.919Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rmc-6291-non-small-cell-lung-cancer-pancreatic-du-phase-i</loc>
    <lastmod>2026-05-28T21:47:03.933Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/quemliclustat-upper-gastrointestinal-tract-cancer-adva-phase-ii</loc>
    <lastmod>2026-05-28T21:47:03.947Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/idroxioleic-acid-glioblastoma-newly-diagnosed-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:03.961Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cemiplimab-cutaneous-squamous-cell-carcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:03.975Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/daratumumab-rheumatoid-arthritis-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:03.989Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/5-8-dichloro-2-4-methoxy-6-methyl-2-oxo-metastatic-castration-resistant-prostate-phase-iii</loc>
    <lastmod>2026-05-28T21:47:04.002Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zolbetuximab-advanced-gastric-adenocarcinoma-gastroes-phase-ii</loc>
    <lastmod>2026-05-28T21:47:04.016Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etavopivat-sickle-cell-disease-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:04.030Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenvatinib-localized-renal-cell-carcinoma-renal-cle-phase-ii</loc>
    <lastmod>2026-05-28T21:47:04.044Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/topiramate-human-immunodeficiency-virus-1-hiv-1-inf-phase-i-ii-phase-ii</loc>
    <lastmod>2026-05-28T21:47:04.058Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mitapivat-non-transfusion-dependent-alpha-thalasse-phase-iii</loc>
    <lastmod>2026-05-28T21:47:04.072Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methotrexate-rheumatoid-arthritis-seropositive-rheuma-phase-iv</loc>
    <lastmod>2026-05-28T21:47:04.087Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belantamab-mafodotin-multiple-myeloma-relapsed-refractory-mul-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:04.102Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-lactate-diabetic-ketoacidosis-not-applicable</loc>
    <lastmod>2026-05-28T21:47:04.116Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ampicillin-sodium-enterococcus-faecalis-infective-endocard-phase-iv</loc>
    <lastmod>2026-05-28T21:47:04.130Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tovorafenib-craniopharyngioma-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:04.144Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-congenital-adrenal-hyperplasia-congenita-phase-ii</loc>
    <lastmod>2026-05-28T21:47:04.158Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alisertib-sodium-hormone-receptor-positive-her2-negative-phase-ii</loc>
    <lastmod>2026-05-28T21:47:04.171Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sar446523-relapsed-refractory-multiple-myeloma-phase-i</loc>
    <lastmod>2026-05-28T21:47:04.188Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/olverembatinib-philadelphia-chromosome-positive-acute-l-phase-iii</loc>
    <lastmod>2026-05-28T21:47:04.202Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carvedilol-compensated-liver-cirrhosis-child-pugh-a-phase-iii</loc>
    <lastmod>2026-05-28T21:47:04.217Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/olverembatinib-chronic-myeloid-leukemia-chronic-phase-phase-iii</loc>
    <lastmod>2026-05-28T21:47:04.231Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/5-8-dichloro-2-4-methoxy-6-methyl-2-oxo-metastatic-castration-resistant-prostate-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:04.245Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-papilloma-l2-antigen-cyclic-di-amp-human-papillomavirus-hpv-infection-proph-phase-i</loc>
    <lastmod>2026-05-28T21:47:04.259Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azacitidine-myelodysplastic-syndrome-mixed-myelodysp-phase-ii</loc>
    <lastmod>2026-05-28T21:47:04.273Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eteplirsen-duchenne-muscular-dystrophy-phase-iii</loc>
    <lastmod>2026-05-28T21:47:04.286Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zolbetuximab-gastric-adenocarcinoma-gastroesophageal-phase-iii</loc>
    <lastmod>2026-05-28T21:47:04.300Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elamipretide-trihydrochloride-dry-age-related-macular-degeneration-dry-phase-iii</loc>
    <lastmod>2026-05-28T21:47:04.315Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-follicular-lymphoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:04.329Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mirikizumab-crohn-s-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:04.343Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colecalciferol-diffuse-large-b-cell-lymphoma-follicular-phase-iii</loc>
    <lastmod>2026-05-28T21:47:04.356Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abatacept-rheumatoid-arthritis</loc>
    <lastmod>2026-05-28T21:47:04.370Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obinutuzumab-follicular-lymphoma-follicular-b-cell-no-phase-iii</loc>
    <lastmod>2026-05-28T21:47:04.384Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/simvastatin-spontaneous-lobar-intracerebral-hemorrha-phase-ii</loc>
    <lastmod>2026-05-28T21:47:04.398Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/daratumumab-plasmablastic-lymphoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:04.412Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/kqb198-advanced-solid-malignancies-phase-i</loc>
    <lastmod>2026-05-28T21:47:04.426Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/baricitinib-rheumatoid-arthritis-refractory-rheumato-phase-iii</loc>
    <lastmod>2026-05-28T21:47:04.439Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ocrelizumab-relapsing-remitting-multiple-sclerosis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:04.453Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belumosudil-mesilate-chronic-graft-versus-host-disease-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:04.468Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-1703880-advanced-solid-tumours-phase-i</loc>
    <lastmod>2026-05-28T21:47:04.482Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/r3r01-diabetic-kidney-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:47:04.496Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/afatinib-fanconi-anemia-squamous-cell-carcinoma-o-phase-i-ii-phase-ii</loc>
    <lastmod>2026-05-28T21:47:04.510Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/indocyanine-green-total-hysterectomy-not-applicable</loc>
    <lastmod>2026-05-28T21:47:04.523Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/calcium-folinate-metastatic-pancreatic-adenocarcinoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:04.537Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/kqb198-advanced-hematologic-malignancies-hemato-phase-iii</loc>
    <lastmod>2026-05-28T21:47:04.550Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/linvoseltamab-relapsed-refractory-multiple-myeloma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:04.564Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pegargiminase-glioblastoma-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:04.578Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly3437943-sodium-obesity-phase-iii</loc>
    <lastmod>2026-05-28T21:47:04.592Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-hepatocellular-carcinoma-non-resectable-phase-ii</loc>
    <lastmod>2026-05-28T21:47:04.606Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/everolimus-hepatocellular-carcinoma-phase-i</loc>
    <lastmod>2026-05-28T21:47:04.619Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/68ga-nota-abscint-her2-metastatic-breast-cancer-other-metastati-phase-ii</loc>
    <lastmod>2026-05-28T21:47:04.633Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-small-cell-lung-cancer-extensive-stage-phase-ii</loc>
    <lastmod>2026-05-28T21:47:04.647Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluorouracil-actinic-keratosis-not-applicable</loc>
    <lastmod>2026-05-28T21:47:04.660Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ropivacaine-hydrochloride-lumbar-arthrodesis-spinal-arthrodesis</loc>
    <lastmod>2026-05-28T21:47:04.677Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/naporafenib-nras-mutant-cutaneous-melanoma-unresecta-phase-iii</loc>
    <lastmod>2026-05-28T21:47:04.691Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sasanlimab-muscle-invasive-bladder-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:04.705Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imetelstat-sodium-myelodysplastic-syndromes-mds-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:04.719Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levofloxacin-community-acquired-pneumonia-phase-iv</loc>
    <lastmod>2026-05-28T21:47:04.734Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levofloxacin-community-acquired-pneumonia-phase-iv-2</loc>
    <lastmod>2026-05-28T21:47:04.748Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/3-4-dimethyl-n-2-phenyl-1h-pyrrolo-2-3-b-advanced-systemic-mastocytosis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:04.761Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sonelokimab-hidradenitis-suppurativa-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:04.775Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colchicine-osteoarthritis-knee-osteoarthritis-hip-o-phase-iv</loc>
    <lastmod>2026-05-28T21:47:04.789Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/exl01-crohn-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:47:04.803Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cobolimab-relapsed-refractory-tumours-melanoma-hod-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:04.817Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ray121-immune-mediated-necrotizing-myopathy-ant-phase-i</loc>
    <lastmod>2026-05-28T21:47:04.831Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/db-oto-5-db-oto-3-congenital-hearing-loss-due-to-biallelic-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:04.844Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-soft-tissue-sarcoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:04.858Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/testosterone-late-onset-hypogonadism-non-metastatic-p-phase-iii</loc>
    <lastmod>2026-05-28T21:47:04.872Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/berotralstat-hereditary-angioedema-phase-iii</loc>
    <lastmod>2026-05-28T21:47:04.886Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/propranolol-hydrochloride-retinopathy-of-prematurity-phase-ii</loc>
    <lastmod>2026-05-28T21:47:04.899Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sotorasib-non-small-cell-lung-cancer-unresectable-phase-ii</loc>
    <lastmod>2026-05-28T21:47:04.913Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pervi-fus-pervi-neo-11902a-ewing-sarcoma-alveolar-rhabdomyosarcoma-phase-i-ii-ctis-2018-000515-24</loc>
    <lastmod>2026-05-28T21:11:52.111Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zanubrutinib-b-cell-malignancies-phase-iii</loc>
    <lastmod>2026-05-28T21:47:04.927Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tafasitamab-acute-b-lineage-lymphoblastic-leukemia-a-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:04.940Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/meclofenamate-sodium-glioblastoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:04.954Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxygen-extremely-preterm-birth-gestational-age-phase-iii</loc>
    <lastmod>2026-05-28T21:47:04.968Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apg777-atopic-dermatitis-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:04.981Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/deupirfenidone-idiopathic-pulmonary-fibrosis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:04.996Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/berotralstat-hereditary-angioedema-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:05.010Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/finerenone-chronic-kidney-disease-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:05.023Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amg-193-thoracic-tumors-with-homozygous-mtap-del-phase-iii</loc>
    <lastmod>2026-05-28T21:47:05.037Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alteplase-intermediate-high-risk-acute-pulmonary-e-phase-iii</loc>
    <lastmod>2026-05-28T21:47:05.051Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/leuprorelin-acetate-biochemical-recurrence-of-prostate-cance-phase-iii</loc>
    <lastmod>2026-05-28T21:47:05.066Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sevabertinib-non-small-cell-lung-cancer-with-her2-erb-phase-iii</loc>
    <lastmod>2026-05-28T21:47:05.079Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zongertinib-non-small-cell-lung-cancer-solid-tumours-phase-i</loc>
    <lastmod>2026-05-28T21:47:05.093Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/brigatinib-non-small-cell-lung-cancer-alk-positive-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:05.107Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alectinib-non-small-cell-lung-cancer-resectable-st-phase-i-ii-phase-iii</loc>
    <lastmod>2026-05-28T21:47:05.121Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/selinexor-myelofibrosis-thrombocytopenia-phase-ii</loc>
    <lastmod>2026-05-28T21:47:05.135Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly4170156-ovarian-cancer-endometrial-cancer-cervic-phase-i</loc>
    <lastmod>2026-05-28T21:47:05.150Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylsalicylic-acid-breast-cancer-colon-cancer-rectal-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:05.163Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/stem-cell-derived-dopamine-neurons-parkinson-s-disease-not-applicable</loc>
    <lastmod>2026-05-28T21:47:05.178Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-t-cells-transduced-with-lenti-refractory-systemic-autoimmune-diseases-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:05.191Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/theo-260-high-grade-serous-ovarian-cancer-endomet-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:05.205Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/orf-virus-based-covid-19-vaccine-covid-19-sars-cov-2-infection-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:05.219Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ketoprofen-pneumothorax-not-applicable</loc>
    <lastmod>2026-05-28T21:47:05.233Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dabigatran-etexilate-colorectal-polyps-not-applicable</loc>
    <lastmod>2026-05-28T21:47:05.247Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/exidavnemab-parkinson-s-disease-multiple-system-atro-phase-ii</loc>
    <lastmod>2026-05-28T21:47:05.260Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/doxorubicin-hydrochloride-malignant-pleural-effusion-pleural-carci-phase-iv</loc>
    <lastmod>2026-05-28T21:47:05.274Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/salbutamol-mild-asthma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:05.287Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/botaretigene-sparoparvovec-x-linked-retinitis-pigmentosa-rpgr-assoc-phase-iii</loc>
    <lastmod>2026-05-28T21:47:05.301Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/letrozole-epithelial-ovarian-cancer-fallopian-tube-phase-iii</loc>
    <lastmod>2026-05-28T21:47:05.315Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ag-120-acute-myeloid-leukaemia-advanced-hematol-phase-i</loc>
    <lastmod>2026-05-28T21:47:05.329Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-idiopathic-steroid-sensitive-nephrotic-s-phase-iv</loc>
    <lastmod>2026-05-28T21:47:05.343Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iduronate-2-sulfatase-fused-to-a-fc-poly-mucopolysaccharidosis-type-ii-hunter-syn-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:05.357Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abemaciclib-hormone-receptor-positive-her2-negative-phase-iv</loc>
    <lastmod>2026-05-28T21:47:05.370Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carfilzomib-smoldering-multiple-myeloma-multiple-mye-phase-ii</loc>
    <lastmod>2026-05-28T21:47:05.385Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-multiple-myeloma-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:05.398Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tuvusertib-epithelial-ovarian-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:05.412Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-urothelial-carcinoma-bladder-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:05.426Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/axitinib-metastatic-renal-cell-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:05.439Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/olaparib-metastatic-pancreatic-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:05.453Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capivasertib-hormone-receptor-positive-her2-negative-phase-iii</loc>
    <lastmod>2026-05-28T21:47:05.467Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/epcoritamab-diffuse-large-b-cell-lymphoma-relapsed-o-phase-iii</loc>
    <lastmod>2026-05-28T21:47:05.481Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methylprednisolone-aceponate-atopic-dermatitis-mild-to-moderate-atopi-phase-iii</loc>
    <lastmod>2026-05-28T21:47:05.497Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/olaptesed-pegol-glioblastoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:05.511Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glycopyrronium-bromide-asthma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:05.524Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/donepezil-hydrochloride-parkinson-s-disease-parkinson-s-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:47:05.538Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/humanised-igg1-monoclonal-antibody-again-myotonic-dystrophy-type-1-phase-iii</loc>
    <lastmod>2026-05-28T21:47:05.552Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regorafenib-recurrent-meningioma-meningioma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:05.566Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aficamten-obstructive-hypertrophic-cardiomyopathy-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:05.580Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allopurinol-sodium-hypoxic-ischemic-encephalopathy-hie-neon-phase-iii</loc>
    <lastmod>2026-05-28T21:47:05.594Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bepranemab-progressive-supranuclear-palsy-phase-iii</loc>
    <lastmod>2026-05-28T21:47:05.608Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/potassium-chloride-sodium-chloride-calci-acute-pancreatitis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:05.622Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alprazolam-stereotypical-prolonged-seizure</loc>
    <lastmod>2026-05-28T21:47:05.636Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ropivacaine-head-and-neck-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:05.650Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amlitelimab-alopecia-areata-phase-ii</loc>
    <lastmod>2026-05-28T21:47:05.664Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efinopegdutide-metabolic-dysfunction-associated-steatoh-phase-ii</loc>
    <lastmod>2026-05-28T21:47:05.678Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metastatic-or-locally-advanced-solid-tum-phase-i</loc>
    <lastmod>2026-05-28T21:47:05.692Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sub197397-non-small-cell-lung-cancer-kras-g12c-pos-phase-iii</loc>
    <lastmod>2026-05-28T21:47:05.706Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amlitelimab-coeliac-disease-non-responsive-celiac-di-phase-ii</loc>
    <lastmod>2026-05-28T21:47:05.719Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-classical-hodgkin-lymphoma-primary-media-phase-ii</loc>
    <lastmod>2026-05-28T21:47:05.733Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/necvax-neo1-advanced-solid-tumors-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:05.747Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/u3-1402-non-small-cell-lung-cancer-metastatic-or-phase-iii</loc>
    <lastmod>2026-05-28T21:47:05.761Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pazopanib-glioblastoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:05.775Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-her2-positive-metastatic-breast-cancer-m-phase-iii</loc>
    <lastmod>2026-05-28T21:47:05.789Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/asciminib-hydrochloride-chronic-myeloid-leukemia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:05.803Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eplontersen-hereditary-transthyretin-mediated-amyloi-not-applicable</loc>
    <lastmod>2026-05-28T21:47:05.818Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tamoxifen-myelofibrosis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:05.831Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pyrimethamine-hiv-1-infection-phase-ii</loc>
    <lastmod>2026-05-28T21:47:05.845Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acute-graft-versus-host-disease-grade-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:05.859Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/verapamil-short-coupled-idiopathic-ventricular-fib-phase-ii</loc>
    <lastmod>2026-05-28T21:47:05.873Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vancomycin-prosthetic-joint-infection-phase-ii</loc>
    <lastmod>2026-05-28T21:47:05.887Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cisplatin-non-small-cell-lung-cancer-non-squamous-phase-iv</loc>
    <lastmod>2026-05-28T21:47:05.900Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/setrusumab-osteogenesis-imperfecta-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:05.914Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/varicella-virus-oka-strain-live-attenuat-pediatric-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:47:05.928Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apazunersen-angelman-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:47:05.942Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/envudeucitinib-moderate-to-severe-plaque-psoriasis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:05.955Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-metastatic-melanoma-unresectable-melanom-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:05.969Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capsaicin-digital-osteoarthritis-finger-osteoarthr</loc>
    <lastmod>2026-05-28T21:47:05.983Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levobupivacaine-hydrochloride-visible-esophageal-lesions-pre-cancerous-not-applicable</loc>
    <lastmod>2026-05-28T21:47:05.996Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ublituximab-relapsing-multiple-sclerosis-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:06.010Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mek-1-2-inhibitor-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:47:06.024Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ag-120-acute-myeloid-leukemia-newly-diagnosed-i-phase-i</loc>
    <lastmod>2026-05-28T21:47:06.043Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adeno-associated-viral-vector-serotype-r-huntington-s-disease-early-manifest-hunt-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:06.057Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anitocabtagene-autoleucel-relapsed-refractory-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:06.070Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/noradrenaline-tartrate-acute-myocardial-infarction-with-cardiog-phase-iv</loc>
    <lastmod>2026-05-28T21:47:06.085Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/kyv-101-anti-cd19-car-t-cells-primary-progressive-multiple-sclerosis-s-phase-ii</loc>
    <lastmod>2026-05-28T21:47:06.099Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tezepelumab-progressive-pulmonary-fibrosis-interstit-phase-ii</loc>
    <lastmod>2026-05-28T21:47:06.113Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/magnesium-chloride-hexahydrate-potassium-neurosurgery-phase-iv</loc>
    <lastmod>2026-05-28T21:47:06.126Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pegvaliase-pegvaliase-phenylketonuria-phase-iii</loc>
    <lastmod>2026-05-28T21:47:06.140Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/brentuximab-diffuse-large-b-cell-lymphoma-lymphoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:06.157Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adezunap-borderline-personality-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:47:06.171Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/olaparib-brca-mutated-advanced-ovarian-cancer-fig-phase-iii</loc>
    <lastmod>2026-05-28T21:47:06.184Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/enpatoran-subacute-cutaneous-lupus-erythematosus-d-phase-ii</loc>
    <lastmod>2026-05-28T21:47:06.198Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imatinib-primary-breast-cancer-triple-negative-br-phase-iv</loc>
    <lastmod>2026-05-28T21:47:06.212Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mitomycin-non-muscle-invasive-bladder-cancer-non-m-phase-iv</loc>
    <lastmod>2026-05-28T21:47:06.225Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-non-small-cell-lung-cancer-synchronous-o-phase-ii</loc>
    <lastmod>2026-05-28T21:47:06.239Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/senicapoc-progressive-fibrotic-interstitial-lung-d-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:06.253Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-urothelial-carcinoma-muscle-invasive-bla-phase-iv</loc>
    <lastmod>2026-05-28T21:47:06.266Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/crizotinib-solid-tumor-phase-iv</loc>
    <lastmod>2026-05-28T21:47:06.280Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cabozantinib-neuroendocrine-neoplasia-neuroendocrine-phase-ii</loc>
    <lastmod>2026-05-28T21:47:06.294Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atorvastatin-melanoma-atherosclerosis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:06.308Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/solrikitug-eosinophilic-esophagitis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:06.322Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inclisiran-inclisiran-sodium-non-obstructive-coronary-artery-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:06.336Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/estriol-breast-cancer-vulvovaginal-atrophy-phase-iv</loc>
    <lastmod>2026-05-28T21:47:06.351Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nazartinib-advanced-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:06.365Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/darolutamide-prostate-cancer-hormone-naive-phase-ii</loc>
    <lastmod>2026-05-28T21:47:06.384Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-craniopharyngioma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:06.398Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mat2a-inhibitor-advanced-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:47:06.412Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ro7568282-parkinson-s-disease-phase-i</loc>
    <lastmod>2026-05-28T21:47:06.425Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lecanemab-ban2401-preclinical-alzheimer-s-disease-early-pr</loc>
    <lastmod>2026-05-28T21:47:06.439Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/al-18f-f-fapi-74-prostate-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:47:06.453Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/botulinum-toxin-type-a-post-stroke-spasticity-phase-iv</loc>
    <lastmod>2026-05-28T21:47:06.467Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clostridium-botulinum-neurotoxin-serotyp-episodic-migraine-chronic-migraine-phase-ii</loc>
    <lastmod>2026-05-28T21:47:06.481Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nnc0519-0130-chronic-kidney-disease-type-2-diabetes-m-phase-ii</loc>
    <lastmod>2026-05-28T21:47:06.497Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd5492-b-cell-malignancies-diffuse-large-b-cell-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:06.511Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/advanced-or-metastatic-carcinoma-phase-i</loc>
    <lastmod>2026-05-28T21:47:06.525Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pramipexole-dihydrochloride-monohydrate-obsessive-compulsive-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:47:06.539Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sotorasib-non-small-cell-lung-cancer-locally-advan-phase-ii</loc>
    <lastmod>2026-05-28T21:47:06.553Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lyophilized-bacterial-lysates-of-haemoph-recurrent-wheezing-chronic-wheezing-phase-ii</loc>
    <lastmod>2026-05-28T21:47:06.574Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eptinezumab-chronic-migraine-phase-iii</loc>
    <lastmod>2026-05-28T21:47:06.588Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colecalciferol-vitamin-d-deficiency-phase-iv</loc>
    <lastmod>2026-05-28T21:47:06.602Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ianalumab-sjogren-s-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:47:06.616Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/monomethyl-auristatin-e-linked-to-a-sarc-advanced-solid-tumours-associated-with-e-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:06.631Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ceritinib-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:06.644Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-90106848-inflammatory-conditions-immune-system-di-phase-i</loc>
    <lastmod>2026-05-28T21:47:06.658Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cyclophosphamide-soft-tissue-sarcoma-advanced-soft-tissue-phase-iii</loc>
    <lastmod>2026-05-28T21:47:06.672Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/remibrutinib-chronic-spontaneous-urticaria-phase-iii</loc>
    <lastmod>2026-05-28T21:47:06.685Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zenagamtide-overweight-obesity-type-2-diabetes-phase-iii</loc>
    <lastmod>2026-05-28T21:47:06.699Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/al-18f-f-fapi-74-colon-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:47:06.713Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cart19-cells-relapsed-refractory-acute-lymphoblastic-phase-i</loc>
    <lastmod>2026-05-28T21:47:06.727Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/wharton-s-jelly-derived-umbilical-cord-m-respiratory-viral-disease-covid-19-influ-phase-iii</loc>
    <lastmod>2026-05-28T21:47:06.740Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azacitidine-acute-myeloid-leukemia-phase-ii</loc>
    <lastmod>2026-05-28T21:47:06.754Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutetium-177lu-edotreotide-gastroenteropancreatic-neuroendocrine-tu-phase-iii</loc>
    <lastmod>2026-05-28T21:47:06.768Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/olaparib-metastatic-castration-resistant-prostate-phase-iii</loc>
    <lastmod>2026-05-28T21:47:06.782Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxaliplatin-metastatic-colorectal-cancer-ras-and-bra-phase-ii</loc>
    <lastmod>2026-05-28T21:47:06.795Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylsalicylic-acid-acute-pneumonia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:06.809Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-glycocholate-sodium-butyrate-postoperative-obesity-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:06.823Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ianalumab-ianalumab-warm-autoimmune-haemolytic-anaemia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:06.836Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-chronic-myelomonocytic-leukemia-phase-ii</loc>
    <lastmod>2026-05-28T21:47:06.850Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metolazone-acute-heart-failure-acute-decompensated-phase-iii</loc>
    <lastmod>2026-05-28T21:47:06.864Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/enzalutamide-metastatic-castration-sensitive-prostate-phase-iii</loc>
    <lastmod>2026-05-28T21:47:06.878Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/olaparib-breast-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:06.891Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nicotinamide-ulcerative-colitis-phase-ii-iii-ctis-2024-510807-13-00</loc>
    <lastmod>2026-05-28T21:11:51.073Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cladribine-relapsing-remitting-multiple-sclerosis-m</loc>
    <lastmod>2026-05-28T21:47:06.905Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/denosumab-fibrous-dysplasia-mccune-albright-syndro</loc>
    <lastmod>2026-05-28T21:47:06.918Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etavopivat-sickle-cell-disease-thalassaemia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:06.932Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rivaroxaban-hypertrophic-cardiomyopathy</loc>
    <lastmod>2026-05-28T21:47:06.945Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/resmetirom-non-alcoholic-steatohepatitis-nash-liver-phase-iii</loc>
    <lastmod>2026-05-28T21:47:06.959Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pramlintide-acetate-obesity-prediabetes</loc>
    <lastmod>2026-05-28T21:47:06.973Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lu-ah69593-narcolepsy-cataplexy-phase-iii</loc>
    <lastmod>2026-05-28T21:47:06.988Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/irinotecan-hydrochloride-trihydrate-pancreatic-ductal-adenocarcinoma-resecta-phase-iii</loc>
    <lastmod>2026-05-28T21:47:07.002Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iberdomide-multiple-myeloma-relapsed-and-refractory-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:07.016Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-chronic-lymphocytic-leukemia-phase-ii</loc>
    <lastmod>2026-05-28T21:47:07.030Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/temozolomide-glioma-who-grade-2-or-3-phase-iii</loc>
    <lastmod>2026-05-28T21:47:07.044Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nitrous-oxide-oxygen-idiopathic-sudden-sensorineural-hearing-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:07.057Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gs-1720-hiv-1-infection-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:07.072Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/89zr-ced88004s-large-b-cell-lymphoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:07.085Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/furosemide-nephrolithiasis-ureteral-stone-not-applicable</loc>
    <lastmod>2026-05-28T21:47:07.099Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/verapamil-hydrochloride-type-1-diabetes-mellitus-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:07.113Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/simvastatin-primary-sclerosing-cholangitis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:07.127Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tamsulosin-hydrochloride-nephrolithiasis-ureteral-stone-not-applicable</loc>
    <lastmod>2026-05-28T21:47:07.140Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cisplatin-head-and-neck-squamous-cell-carcinoma-lo</loc>
    <lastmod>2026-05-28T21:47:07.154Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/molgramostim-autoimmune-pulmonary-alveolar-proteinosi-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:07.168Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tianeptine-sodium-post-covid-cognitive-impairment-phase-iv</loc>
    <lastmod>2026-05-28T21:47:07.185Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tranexamic-acid-morbid-obesity-phase-iii</loc>
    <lastmod>2026-05-28T21:47:07.199Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/botulinum-toxin-type-a-forehead-wrinkling-focal-hyperhidrosis-f-not-applicable</loc>
    <lastmod>2026-05-28T21:47:07.213Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ubamatamab-ovarian-cancer-endometrial-cancer-fallop-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:07.227Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mifepristone-post-traumatic-stress-disorder-treatment-phase-iv</loc>
    <lastmod>2026-05-28T21:47:07.240Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s230815-2-kcnt1-related-developmental-and-epilepti-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:07.254Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ceritinib-non-small-cell-lung-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:47:07.268Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/denosumab-type-2-diabetes-postmenopausal-osteoporo</loc>
    <lastmod>2026-05-28T21:47:07.281Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/palbociclib-breast-cancer-hormone-receptor-positive-phase-iii</loc>
    <lastmod>2026-05-28T21:47:07.295Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/degarelix-advanced-prostate-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:07.309Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apomorphine-hydrochloride-hemihydrate-parkinson-s-disease-phase-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:47:07.323Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dostarlimab-locally-advanced-rectal-cancer-mismatch-phase-ii</loc>
    <lastmod>2026-05-28T21:47:07.336Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-hydrochloride-rheumatoid-arthritis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:07.350Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/resmetirom-non-alcoholic-steatohepatitis-nash-cirrh-phase-iii</loc>
    <lastmod>2026-05-28T21:47:07.363Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/chimeric-monoclonal-antibody-against-car-early-rectal-cancer-high-grade-dysplasia-phase-ii</loc>
    <lastmod>2026-05-28T21:47:07.377Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-neuronal-progenitor-stem-cells-progressive-multiple-sclerosis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:07.390Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/chimeric-monoclonal-antibody-against-car-rectal-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:07.404Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belzutifan-advanced-renal-cell-carcinoma-clear-cell-phase-iii</loc>
    <lastmod>2026-05-28T21:47:07.417Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-hydrochloride-glioblastoma-grade-4-phase-iv</loc>
    <lastmod>2026-05-28T21:47:07.431Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/idp-121-small-cell-lung-cancer-relapsed-metastat-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:07.444Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tocilizumab-chronic-active-antibody-mediated-rejecti-phase-iii</loc>
    <lastmod>2026-05-28T21:47:07.458Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-hydrochloride-precocious-puberty-overweight-phase-ii</loc>
    <lastmod>2026-05-28T21:47:07.471Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aminolevulinic-acid-hydrochloride-ovarian-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:07.485Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mexiletine-hydrochloride-myotonic-dystrophy-type-1-myotonic-dystr-phase-iii</loc>
    <lastmod>2026-05-28T21:47:07.499Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clopidogrel-systemic-sclerosis-raynaud-phenomenon-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:07.513Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capmatinib-cmet-dependent-malignancies-advanced-can-phase-iv</loc>
    <lastmod>2026-05-28T21:47:07.527Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dostarlimab-non-mucinous-epithelial-ovarian-cancer-s-phase-iii</loc>
    <lastmod>2026-05-28T21:47:07.540Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutetium-177lu-oxodotreotide-neuroendocrine-tumor-intestinal-well-dif-phase-ii</loc>
    <lastmod>2026-05-28T21:47:07.555Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-brain-radionecrosis-brain-metastases-phase-iii</loc>
    <lastmod>2026-05-28T21:47:07.569Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2-o-2-methoxyethyl-d-ribose-antisense-ol-alexander-disease-phase-i-phase-ii-phase-iii</loc>
    <lastmod>2026-05-28T21:47:07.583Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zolbetuximab-metastatic-pancreatic-adenocarcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:07.597Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methylprednisolone-acute-myocarditis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:07.611Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd0901-sonesitatug-vedotin-locally-advanced-unresectable-or-metasta-phase-ii</loc>
    <lastmod>2026-05-28T21:47:07.625Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lorazepam-dementia-agitated-behaviour</loc>
    <lastmod>2026-05-28T21:47:07.638Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluorouracil-ampullary-adenocarcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:07.651Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/testosterone-low-ovarian-reserve-androgen-receptor-po-not-applicable</loc>
    <lastmod>2026-05-28T21:47:07.665Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ciclosporin-takotsubo-syndrome-phase-ii</loc>
    <lastmod>2026-05-28T21:47:07.679Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/testosterone-low-ovarian-reserve-according-to-bologna-phase-iv</loc>
    <lastmod>2026-05-28T21:47:07.692Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-690517-chronic-kidney-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:07.706Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lvt-001-covid-19-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:07.720Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eftilagimod-alfa-metastatic-breast-cancer-her2-negative-l-phase-ii-phase-iii</loc>
    <lastmod>2026-05-28T21:47:07.733Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-her2-positive-breast-cancer-brain-metast-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:07.747Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tarlatamab-extensive-stage-small-cell-lung-cancer-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:07.761Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obexelimab-systemic-lupus-erythematosus-phase-ii</loc>
    <lastmod>2026-05-28T21:47:07.775Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ketamine-hydrochloride-aortic-stenosis-not-applicable</loc>
    <lastmod>2026-05-28T21:47:07.788Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iberdomide-relapsed-or-refractory-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:07.802Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ile-ala-leu-ile-leu-glu-pro-ile-cys-cys-acute-graft-versus-host-disease-agvhd-phase-ii</loc>
    <lastmod>2026-05-28T21:47:07.816Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tenofovir-alafenamide-chronic-hepatitis-b-phase-iv</loc>
    <lastmod>2026-05-28T21:47:07.830Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-tumour-infiltrating-lymphocyt-metastatic-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:07.844Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ab-1002-congestive-heart-failure-non-ischaemic-c-phase-ii</loc>
    <lastmod>2026-05-28T21:47:07.858Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tapentadol-hydrochloride-chronic-postoperative-pain</loc>
    <lastmod>2026-05-28T21:47:07.872Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/chimeric-monoclonal-antibody-against-car-brain-metastases-colorectal-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:07.885Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-blastic-plasmacytoid-dendritic-cell-neop-phase-ii</loc>
    <lastmod>2026-05-28T21:47:07.899Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tarlatamab-idh-mutant-high-grade-glioma-other-high-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:07.913Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metronidazole-pancreatoduodenectomy-whipple-procedure-not-applicable</loc>
    <lastmod>2026-05-28T21:47:07.926Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/siremadlin-advanced-metastatic-solid-tumours-phase-iv</loc>
    <lastmod>2026-05-28T21:47:07.940Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/olaparib-advanced-metastatic-solid-tumors-phase-ii</loc>
    <lastmod>2026-05-28T21:47:07.954Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/doxribtimine-doxecitine-thymidine-kinase-2-deficiency-mitochondr-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:07.968Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cusatuzumab-acute-myeloid-leukemia-phase-ii</loc>
    <lastmod>2026-05-28T21:47:07.983Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/irinotecan-hydrochloride-locally-advanced-resectable-rectal-cance-phase-iii</loc>
    <lastmod>2026-05-28T21:47:07.997Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imp761-autoimmune-disease-phase-i</loc>
    <lastmod>2026-05-28T21:47:08.011Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regorafenib-rhabdomyosarcoma-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:47:08.025Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/diclofenac-sodium-knee-osteoarthritis-not-applicable</loc>
    <lastmod>2026-05-28T21:47:08.039Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluorouracil-pancreatic-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:47:08.053Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rocatinlimab-prurigo-nodularis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:08.066Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ropivacaine-hallux-valgus-not-applicable</loc>
    <lastmod>2026-05-28T21:47:08.083Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lidocaine-hydrochloride-acute-ischemic-stroke-not-applicable</loc>
    <lastmod>2026-05-28T21:47:08.097Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/formoterol-fumarate-postoperative-pulmonary-complications-phase-iii</loc>
    <lastmod>2026-05-28T21:47:08.112Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-urothelial-carcinoma-of-the-bladder-uppe-phase-ii</loc>
    <lastmod>2026-05-28T21:47:08.125Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pucotenlimab-locally-advanced-head-and-neck-squamous-phase-ii</loc>
    <lastmod>2026-05-28T21:47:08.139Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ixekizumab-axial-spondyloarthritis-psoriatic-arthri-not-applicable</loc>
    <lastmod>2026-05-28T21:47:08.153Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-chronic-lymphocytic-leukemia-small-lymph-phase-ii</loc>
    <lastmod>2026-05-28T21:47:08.166Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tovorafenib-pediatric-low-grade-glioma-raf-altered-phase-iii</loc>
    <lastmod>2026-05-28T21:47:08.180Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/brentuximab-vedotin-diffuse-large-b-cell-lymphoma-dlbcl-non-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:08.194Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dimethyl-fumarate-age-related-macular-degeneration-geograp-phase-ii</loc>
    <lastmod>2026-05-28T21:47:08.208Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/namodenoson-non-alcoholic-steatohepatitis-nash-with-phase-ii</loc>
    <lastmod>2026-05-28T21:47:08.222Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inclisiran-inclisiran-sodium-atherosclerotic-cardiovascular-disease-a-phase-iii</loc>
    <lastmod>2026-05-28T21:47:08.236Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/malignant-melanoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:08.249Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/crizanlizumab-sickle-cell-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:47:08.263Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nx-5948-relapsed-or-refractory-b-cell-malignanci-phase-i</loc>
    <lastmod>2026-05-28T21:47:08.276Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutikizumab-hidradenitis-suppurativa-phase-iii</loc>
    <lastmod>2026-05-28T21:47:08.289Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belantamab-mafodotin-relapsed-refractory-multiple-myeloma-mul-phase-iii</loc>
    <lastmod>2026-05-28T21:47:08.303Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-adipose-derived-mesenchymal-s-chronic-active-antibody-mediated-rejecti-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:08.317Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/11c-hsp990-alzheimer-s-disease-amyotrophic-lateral-phase-i</loc>
    <lastmod>2026-05-28T21:47:08.330Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ambroxol-hydrochloride-dementia-with-lewy-bodies-phase-ii</loc>
    <lastmod>2026-05-28T21:47:08.344Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pertuzumab-advanced-locally-advanced-or-metastatic-phase-iv</loc>
    <lastmod>2026-05-28T21:47:08.357Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fezolinetant-vasomotor-symptoms-hot-flashes-hormone-r-phase-iii</loc>
    <lastmod>2026-05-28T21:47:08.370Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iptacopan-anca-associated-vasculitis-granulomatosi-phase-ii</loc>
    <lastmod>2026-05-28T21:47:08.384Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-membranous-nephropathy-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:08.398Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexpanthenol-radiation-induced-oral-mucositis-head-an-phase-iii</loc>
    <lastmod>2026-05-28T21:47:08.411Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/goserelin-prostate-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:47:08.426Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inotuzumab-ozogamicin-b-cell-acute-lymphoblastic-leukemia-mini-phase-ii</loc>
    <lastmod>2026-05-28T21:47:08.439Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/letrozole-estrogen-receptor-positive-her2-negative-phase-iii</loc>
    <lastmod>2026-05-28T21:47:08.454Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azacitidine-myelodysplastic-syndrome-high-risk-phase-iii</loc>
    <lastmod>2026-05-28T21:47:08.468Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elacestrant-hormone-receptor-positive-her2-negative-phase-ii</loc>
    <lastmod>2026-05-28T21:47:08.481Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-non-small-cell-lung-cancer-stage-iii-phase-ii</loc>
    <lastmod>2026-05-28T21:47:08.494Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/influenza-a-h1n1-wsn-1933-nucleoprotein-influenza-phase-ii</loc>
    <lastmod>2026-05-28T21:47:08.515Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-hepatocellular-carcinoma-unresectable-phase-ii</loc>
    <lastmod>2026-05-28T21:47:08.529Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-soft-tissue-sarcoma-localised-and-operab-phase-ii</loc>
    <lastmod>2026-05-28T21:47:08.542Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lidocaine-hydrochloride-monohydrate-anorexia-nervosa-phase-ii</loc>
    <lastmod>2026-05-28T21:47:08.556Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cobimetinib-advanced-metastatic-soft-tissue-sarcoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:08.569Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alanine-arginine-deferoxamine-histidine-heart-transplantation-phase-ii</loc>
    <lastmod>2026-05-28T21:47:08.583Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hdm201-advanced-metastatic-soft-tissue-sarcoma</loc>
    <lastmod>2026-05-28T21:47:08.597Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rem-422-myb-mrna-degrader-relapsed-refractory-acute-myeloid-leukae-phase-i</loc>
    <lastmod>2026-05-28T21:47:08.611Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tucatinib-her2-positive-metastatic-breast-cancer-w-phase-ii</loc>
    <lastmod>2026-05-28T21:47:08.625Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etentamig-multiple-myeloma-phase-i-ii-2</loc>
    <lastmod>2026-05-28T21:47:08.639Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/propofol-external-cephalic-version-not-applicable</loc>
    <lastmod>2026-05-28T21:47:08.652Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ascorbic-acid-cardiac-surgery-open-heart-surgery-cardi-phase-ii</loc>
    <lastmod>2026-05-28T21:47:08.670Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/modified-vaccinia-ankara-bavarian-nordic-mpox-monkeypox</loc>
    <lastmod>2026-05-28T21:47:08.684Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/talazoparib-metastatic-castration-resistant-prostate-phase-ii</loc>
    <lastmod>2026-05-28T21:47:08.697Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elafibranor-primary-biliary-cholangitis-pbc-phase-iii</loc>
    <lastmod>2026-05-28T21:47:08.711Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sultiame-obstructive-sleep-apnea-obstructive-slee-phase-ii</loc>
    <lastmod>2026-05-28T21:47:08.732Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-acute-myeloid-leukaemia-acute-myeloid-le-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:08.745Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tazemetostat-relapsed-refractory-follicular-lymphoma-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:47:08.759Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ziftomenib-relapsed-or-refractory-acute-myeloid-leu-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:08.774Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/propranolol-hydrochloride-andersen-tawil-syndrome-multifocal-ectop-not-applicable</loc>
    <lastmod>2026-05-28T21:47:08.788Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/florquinitau-18f-cognitive-impairment-mild-cognitive-impa-phase-iv</loc>
    <lastmod>2026-05-28T21:47:08.801Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cabotegravir-sodium-hiv-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:47:08.815Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-systemic-sclerosis-associated-interstiti-phase-iii</loc>
    <lastmod>2026-05-28T21:47:08.828Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd7798-crohn-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:47:08.842Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rabies-virus-inactivated-strain-flury-le-viral-infections-phase-iv</loc>
    <lastmod>2026-05-28T21:47:08.856Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dupilumab-asthma-uncontrolled-asthma-phase-iv</loc>
    <lastmod>2026-05-28T21:47:08.870Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cmr316-idiopathic-pulmonary-fibrosis-phase-i</loc>
    <lastmod>2026-05-28T21:47:08.883Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/benralizumab-hypereosinophilic-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:47:08.897Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/radium-ra-223-dichloride-castration-resistant-prostate-cancer-met-phase-iii</loc>
    <lastmod>2026-05-28T21:47:08.911Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/advanced-solid-tumors-with-met-genetic-a-phase-i</loc>
    <lastmod>2026-05-28T21:47:08.925Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levetiracetam-septic-shock-phase-iii</loc>
    <lastmod>2026-05-28T21:47:08.939Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutetium-177lu-edotreotide-gastroenteropancreatic-neuroendocrine-tu-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:08.953Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxygen-fibrotic-interstitial-lung-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:47:08.967Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imatinib-chronic-myeloid-leukemia-chronic-phase-phase-iv</loc>
    <lastmod>2026-05-28T21:47:08.981Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gemtuzumab-ozogamicin-acute-myeloid-leukemia-favorable-interme-phase-iii</loc>
    <lastmod>2026-05-28T21:47:08.995Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apraglutide-short-bowel-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.008Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-chronic-lymphocytic-leukemia-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:09.022Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ropivacaine-hydrochloride-hip-pain-phase-iv</loc>
    <lastmod>2026-05-28T21:47:09.036Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-advanced-solid-tumors-haematological-mal-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:09.050Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/emactuzumab-tenosynovial-giant-cell-tumour-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.063Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/teclistamab-newly-diagnosed-multiple-myeloma-multipl-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.077Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-acute-myeloid-leukemia-phase-ii-3</loc>
    <lastmod>2026-05-28T21:47:09.092Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tranexamic-acid-postoperative-bleeding-surgical-wound-co-phase-iv</loc>
    <lastmod>2026-05-28T21:47:09.105Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imlifidase-crigler-najjar-syndrome-phase-ii</loc>
    <lastmod>2026-05-28T21:47:09.120Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anakinra-cystic-fibrosis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:09.134Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bio89-100-metabolic-dysfunction-associated-steatoh-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.147Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rbd5044-sodium-mixed-dyslipidemia-phase-ii</loc>
    <lastmod>2026-05-28T21:47:09.161Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/selinexor-multiple-myeloma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:09.175Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-n-5-4-1-benzo-d-1-3-dioxol-5-yl-ethyl-progressive-supranuclear-palsy-phase-ii</loc>
    <lastmod>2026-05-28T21:47:09.189Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/temozolomide-medulloblastoma-high-risk-medulloblastom-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.203Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly3938577-type-1-diabetes-mellitus-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.217Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atropine-sulfate-monohydrate-myopia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.231Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carvedilol-idiopathic-ventricular-arrhythmias-ventr-phase-iv</loc>
    <lastmod>2026-05-28T21:47:09.245Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-acute-myeloid-leukemia-npm1-mutated-phase-ii</loc>
    <lastmod>2026-05-28T21:47:09.258Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fosfomycin-trometamol-male-urinary-tract-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.272Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zongertinib-her2-mutated-or-her2-overexpressing-ampl-phase-ii</loc>
    <lastmod>2026-05-28T21:47:09.287Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/humanised-igg1-kappa-fragment-antibody-t-myotonic-dystrophy-type-1-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:09.301Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cloxacillin-sodium-staphylococcus-aureus-infection-phase-iv</loc>
    <lastmod>2026-05-28T21:47:09.315Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adagrasib-non-small-cell-lung-cancer-kras-g12c-mut-phase-ii</loc>
    <lastmod>2026-05-28T21:47:09.329Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/crispr-til-advanced-or-metastatic-melanoma-malignan-phase-i</loc>
    <lastmod>2026-05-28T21:47:09.342Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/brigatinib-advanced-alk-positive-non-small-cell-lun-phase-ii</loc>
    <lastmod>2026-05-28T21:47:09.357Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/crispr-til-advanced-or-metastatic-melanoma-malignan-phase-i-2</loc>
    <lastmod>2026-05-28T21:47:09.371Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-hydrochloride-hellp-syndrome-preterm-pre-eclampsia-hyp-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.385Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/triglycerides-medium-chain-soya-oil-end-stage-kidney-disease-on-chronic-hemo-phase-ii</loc>
    <lastmod>2026-05-28T21:47:09.398Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rapcabtagene-autoleucel-diffuse-cutaneous-systemic-sclerosis-dcs-phase-ii</loc>
    <lastmod>2026-05-28T21:47:09.412Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/diazepam-benzodiazepine-dependence-opioid-depende-phase-ii</loc>
    <lastmod>2026-05-28T21:47:09.426Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/innate-immune-system-modulation-healthy-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.440Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexmedetomidine-thoracoscopic-lung-resection-surgery-phase-iv</loc>
    <lastmod>2026-05-28T21:47:09.453Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alteplase-acute-ischemic-stroke-due-to-large-vesse</loc>
    <lastmod>2026-05-28T21:47:09.467Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rebisufligene-etisparvovec-mucopolysaccharidosis-type-iiia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.480Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/177lu-lu-nns309-colorectal-cancer-breast-cancer-non-smal-phase-i</loc>
    <lastmod>2026-05-28T21:47:09.494Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amoxicillin-trihydrate-peri-implant-disease-oral-microbiome-alt-not-applicable</loc>
    <lastmod>2026-05-28T21:47:09.507Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pneumococcal-polysaccharide-serotype-1-c-hiv-infection-phase-i-ctis-2023-510354-16-00</loc>
    <lastmod>2026-05-28T21:11:49.652Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-govitecan-her2-negative-breast-cancer-breast-cance-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.521Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fragment-antibody-targeting-human-tfr1-c-duchenne-muscular-dystrophy-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:09.535Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/depemokimab-hypereosinophilic-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.549Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-3-4-acetamidophenyl-2-methoxypropanoic-acne-vulgaris-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.563Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nirmatrelvir-coronavirus-disease-2019-covid-19-post-a-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.577Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cemdisiran-paroxysmal-nocturnal-hemoglobinuria-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.590Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tebentafusp-uveal-melanoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.604Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/petosemtamab-head-and-neck-squamous-cell-carcinoma-pd-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.619Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/petosemtamab-head-and-neck-squamous-cell-carcinoma-re-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.633Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alfacalcidol-secondary-hyperparathyroidism-phase-iv</loc>
    <lastmod>2026-05-28T21:47:09.647Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/erdafitinib-urothelial-cancer-metastatic-urothelial-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:09.660Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-chronic-lymphocytic-leukaemia-small-lymp-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.674Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bms-986470-sickle-cell-disease-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:09.687Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dostarlimab-cervical-cancer-locally-advanced-cervica-phase-ii</loc>
    <lastmod>2026-05-28T21:47:09.701Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methotrexate-rheumatoid-arthritis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:09.718Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-thiosulfate-calcinosis-cutis-systemic-sclerosis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:09.732Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nintedanib-unicentric-castleman-disease-hyaline-vas-phase-iv</loc>
    <lastmod>2026-05-28T21:47:09.746Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aldesleukin-neuroendocrine-tumors-soft-tissue-sarcom-phase-ii</loc>
    <lastmod>2026-05-28T21:47:09.759Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mepacrine-intestinal-giardiasis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:09.773Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-esophageal-cancer-adenocarcinoma-of-the-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:09.786Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-muscle-invasive-bladder-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.799Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/insulin-human-stress-hyperglycemia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.813Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/quizartinib-dihydrochloride-acute-myeloid-leukemia-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:09.827Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/goserelin-early-breast-cancer-hormone-receptor-pos-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.841Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inebilizumab-neuromyelitis-optica-spectrum-disorder-n-phase-ii</loc>
    <lastmod>2026-05-28T21:47:09.855Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-cutaneous-malignant-melanoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.868Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-3-4-acetamidophenyl-2-methoxypropanoic-acne-vulgaris-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:09.882Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zanubrutinib-chronic-lymphocytic-leukemia-small-lymph-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.896Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zanidatamab-gastroesophageal-adenocarcinoma-gea-esop-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.910Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tranexamic-acid-intraoperative-bleeding-transfusion-requ-not-applicable</loc>
    <lastmod>2026-05-28T21:47:09.924Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aldesleukin-primary-sclerosing-cholangitis-mucous-me-phase-ii</loc>
    <lastmod>2026-05-28T21:47:09.938Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/osimertinib-stage-ia2-ia3-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.951Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/axatilimab-chronic-graft-versus-host-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.965Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/riliprubart-antibody-mediated-rejection-amr-transpla-phase-ii</loc>
    <lastmod>2026-05-28T21:47:09.979Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ziftomenib-relapsed-refractory-acute-myeloid-leukem-phase-iii</loc>
    <lastmod>2026-05-28T21:47:09.993Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tirbanibulin-actinic-keratosis-phase-iv-2</loc>
    <lastmod>2026-05-28T21:47:10.007Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/solifenacin-succinate-daytime-urinary-incontinence-childhood-u-not-applicable</loc>
    <lastmod>2026-05-28T21:47:10.020Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rifampicin-tuberculosis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:10.034Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/barzolvolimab-prurigo-nodularis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:10.048Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ticagrelor-acute-coronary-syndrome</loc>
    <lastmod>2026-05-28T21:47:10.062Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/l-acetylleucine-niemann-pick-disease-type-c-phase-iii</loc>
    <lastmod>2026-05-28T21:47:10.075Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/19cp02-multiple-myeloma-b-cell-non-hodgkin-lymp-phase-iii</loc>
    <lastmod>2026-05-28T21:47:10.089Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/erdafitinib-urothelial-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:10.103Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sirolimus-thyroid-eye-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:10.116Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isoflurane-cardiogenic-shock-phase-iii</loc>
    <lastmod>2026-05-28T21:47:10.130Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxaliplatin-gastric-cancer-with-peritoneal-carcinoma-phase-iv</loc>
    <lastmod>2026-05-28T21:47:10.144Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ivosidenib-myelodysplastic-syndrome-hma-naive-myelo-phase-iii</loc>
    <lastmod>2026-05-28T21:47:10.157Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/benralizumab-eosinophilic-granulomatosis-with-polyang-phase-iii</loc>
    <lastmod>2026-05-28T21:47:10.171Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rapcabtagene-autoleucel-systemic-lupus-erythematosus-lupus-nephr-phase-ii</loc>
    <lastmod>2026-05-28T21:47:10.185Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/upadacitinib-psoriatic-arthritis-axial-spondyloarthri-phase-iv</loc>
    <lastmod>2026-05-28T21:47:10.199Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/3-2-6-dichlorophenyl-2-3-dihydro-1-methy-advanced-solid-tumours-ccne1-amplificati-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:10.213Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-acute-myeloid-leukemia-secondary-to-myel-phase-ii</loc>
    <lastmod>2026-05-28T21:47:10.227Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allergenic-extract-of-grass-pollen-mixtu-allergic-rhinoconjunctivitis-grass-polle-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:10.240Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ponatinib-bcr-abl1-like-acute-lymphoblastic-leukem-phase-ii</loc>
    <lastmod>2026-05-28T21:47:10.254Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-gastrointestinal-cancer-colon-cancer-col-phase-ii</loc>
    <lastmod>2026-05-28T21:47:10.268Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mesenchymal-stromal-cells-ex-vivo-cultur-multiple-sclerosis-primary-progressive-m-phase-iv</loc>
    <lastmod>2026-05-28T21:47:10.282Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/7-8-dibromo-5-6-dihydro-9-methyl-2-1-pip-myelodysplastic-syndromes-mds-lower-risk-phase-ii</loc>
    <lastmod>2026-05-28T21:47:10.296Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pariglasgene-brecaparvovec-glycogen-storage-disease-type-ia-gsdia-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:10.310Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zp9830-autoimmune-diseases-phase-i</loc>
    <lastmod>2026-05-28T21:47:10.323Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-multiple-myeloma-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:10.337Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/difelikefalin-pruritus-chronic-kidney-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:47:10.351Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carvedilol-takotsubo-syndrome-acute-cardiac-insuffi-phase-iv</loc>
    <lastmod>2026-05-28T21:47:10.365Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/argx-119-congenital-myasthenic-syndrome-dok7-rela-phase-i</loc>
    <lastmod>2026-05-28T21:47:10.378Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clonidine-hydrochloride-delirium-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:10.393Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly4101174-advanced-metastatic-solid-tumor-solid-tu-phase-i</loc>
    <lastmod>2026-05-28T21:47:10.407Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/edoxaban-aortic-stenosis-aortic-valve-stenosis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:10.420Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acalabrutinib-mantle-cell-lymphoma-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:10.434Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/al-18f-f-fapi-74-pancreatic-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:47:10.447Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/esomeprazole-magnesium-trihydrate-liver-cirrhosis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:10.461Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bromhexine-hydrochloride-sulfamethoxazol-benign-prostatic-hyperplasia-not-applicable</loc>
    <lastmod>2026-05-28T21:47:10.475Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/loncastuximab-tesirine-high-grade-b-cell-lymphoma-diffuse-large-phase-ii</loc>
    <lastmod>2026-05-28T21:47:10.489Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dornase-alfa-germ-cell-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:10.503Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dornase-alfa-subarachnoid-haemorrhage-phase-ii-ctis-2023-509627-40-00</loc>
    <lastmod>2026-05-28T21:11:48.935Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alectinib-metastatic-colorectal-cancer-colorectal-phase-ii</loc>
    <lastmod>2026-05-28T21:47:10.517Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ibuprofen-acute-neck-pain-neck-pain-not-applicable</loc>
    <lastmod>2026-05-28T21:47:10.531Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/blinatumomab-acute-lymphoblastic-leukaemia-mixed-phen-phase-iii</loc>
    <lastmod>2026-05-28T21:47:10.545Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-3-4-acetamidophenyl-2-methoxypropanoic-acne-vulgaris-phase-iii-3</loc>
    <lastmod>2026-05-28T21:47:10.558Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vibrio-alginolyticus-collagenase-peyronie-s-disease-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:10.572Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylcarnitine-hydrochloride-amyotrophic-lateral-sclerosis-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:10.586Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/midazolam-neurocognitive-disorders-agitation-in-ol-phase-iv</loc>
    <lastmod>2026-05-28T21:47:10.599Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tremelimumab-colorectal-cancer-metastatic-endometrial-phase-ii</loc>
    <lastmod>2026-05-28T21:47:10.613Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-1808-advanced-solid-tumors-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:10.626Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/6s-9as-8-6-3-4-ethyl-1-piperazinyl-1-aze-hepatocellular-carcinoma-colorectal-canc-phase-i</loc>
    <lastmod>2026-05-28T21:47:10.640Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/medi5752-advanced-solid-tumours-phase-i</loc>
    <lastmod>2026-05-28T21:47:10.654Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anti-fc-fragment-of-igg-receptor-iib-mon-advanced-solid-tumors-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:10.668Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prednisone-behcet-s-syndrome-deep-venous-thrombosis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:10.682Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/volrustomig-advanced-renal-cell-carcinoma-phase-i</loc>
    <lastmod>2026-05-28T21:47:10.695Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/urinary-incontinence-phase-i</loc>
    <lastmod>2026-05-28T21:47:10.709Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colistimethate-sodium-bronchiectasis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:10.722Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cagrilintide-semaglutide-type-2-diabetes-phase-iii</loc>
    <lastmod>2026-05-28T21:47:10.736Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-adipose-derived-mesenchymal-s-stress-urinary-incontinence-post-prostat-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:10.750Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colorectal-cancer-with-peritoneal-metast-phase-iii</loc>
    <lastmod>2026-05-28T21:47:10.763Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ovarian-cancer-relapsed-metastatic-breas-not-applicable</loc>
    <lastmod>2026-05-28T21:47:10.777Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inotuzumab-ozogamicin-acute-lymphoblastic-leukemia-b-cell-prec-phase-ii</loc>
    <lastmod>2026-05-28T21:47:10.792Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efgartigimod-alfa-autoimmune-dementia-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:10.806Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:10.820Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sabirnetug-alzheimer-s-disease-mild-cognitive-impai-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:10.834Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vhb937-amyotrophic-lateral-sclerosis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:10.847Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gemcitabine-recurrent-glioblastoma-glioblastoma-mult-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:47:10.861Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zelenectide-pevedotin-nectin-4-expressing-advanced-malignancie-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:10.875Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pamidronate-disodium-sternocostoclavicular-hyperostosis-chron-phase-iii</loc>
    <lastmod>2026-05-28T21:47:10.889Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vedolizumab-ulcerative-colitis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:10.903Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rag1-lv-cd34-cells-severe-combined-immunodeficiency-rag1-de-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:10.920Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tetanus-toxoid-neisseria-meningitidis-gr-meningococcal-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:47:10.934Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/triamcinolone-hexacetonide-carpal-tunnel-syndrome-phase-iv</loc>
    <lastmod>2026-05-28T21:47:10.948Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/stx-241-non-small-cell-lung-cancer-nsclc-locally-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:10.961Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/kyv-101-generalized-myasthenia-gravis-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:10.975Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/brimonidine-open-angle-glaucoma-pseudoexfoliation-gl-phase-iv</loc>
    <lastmod>2026-05-28T21:47:10.989Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/midazolam-acute-agitation</loc>
    <lastmod>2026-05-28T21:47:11.002Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vincristine-sulfate-neuroblastoma-phase-i</loc>
    <lastmod>2026-05-28T21:47:11.016Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dydrogesterone-female-infertility-not-applicable</loc>
    <lastmod>2026-05-28T21:47:11.030Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isatuximab-multiple-myeloma-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:11.045Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cagrilintide-semaglutide-type-2-diabetes-painful-diabetic-periphe-phase-ii</loc>
    <lastmod>2026-05-28T21:47:11.058Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/golcadomide-diffuse-large-b-cell-lymphoma-high-risk-phase-iii</loc>
    <lastmod>2026-05-28T21:47:11.072Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zanubrutinib-mantle-cell-lymphoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:11.087Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/datopotamab-deruxtecan-hormone-receptor-positive-her2-negative-phase-iii</loc>
    <lastmod>2026-05-28T21:47:11.102Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amiodarone-hydrochloride-out-of-hospital-cardiac-arrest-initial-s-not-applicable</loc>
    <lastmod>2026-05-28T21:47:11.116Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-advanced-breast-cancer-non-small-cell-lu-phase-iii</loc>
    <lastmod>2026-05-28T21:47:11.131Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ifinatamab-deruxtecan-small-cell-lung-cancer-extensive-stage-s-phase-iii</loc>
    <lastmod>2026-05-28T21:47:11.144Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dostarlimab-endometrial-cancer-mismatch-repair-defic-phase-iii</loc>
    <lastmod>2026-05-28T21:47:11.158Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/datopotamab-deruxtecan-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:11.172Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efavirenz-alzheimer-s-disease-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:11.186Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-breast-cancer-hormone-receptor-positive-phase-iv</loc>
    <lastmod>2026-05-28T21:47:11.199Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/epcoritamab-diffuse-large-b-cell-lymphoma-high-grade-phase-ii</loc>
    <lastmod>2026-05-28T21:47:11.213Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lithium-carbonate-bipolar-disorder-type-ii-not-applicable</loc>
    <lastmod>2026-05-28T21:47:11.227Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nepafenac-fuchs-dystrophy-phase-iv</loc>
    <lastmod>2026-05-28T21:47:11.240Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mesalazine-ulcerative-colitis-phase-iii-ctis-2023-509606-30-00</loc>
    <lastmod>2026-05-28T21:11:48.637Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mezigdomide-relapsed-or-refractory-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:11.255Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-non-small-cell-lung-cancer-stage-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:47:11.269Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/panitumumab-colon-cancer-colorectal-cancer-stage-iii-ctis-2023-509851-15-00</loc>
    <lastmod>2026-05-28T21:11:48.619Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-small-cell-lung-cancer-limited-stage-phase-iii</loc>
    <lastmod>2026-05-28T21:47:11.283Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/golimumab-peripheral-spondyloarthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:11.297Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etranacogene-dezaparvovec-hemophilia-b-severe-or-moderately-severe-phase-iii</loc>
    <lastmod>2026-05-28T21:47:11.310Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-her2-positive-locally-advanced-or-metast-phase-ii</loc>
    <lastmod>2026-05-28T21:47:11.324Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rapcabtagene-autoleucel-systemic-lupus-erythematosus-lupus-nephr-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:11.338Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/triheptanoin-long-chain-fatty-acid-oxidation-disorder-phase-iii</loc>
    <lastmod>2026-05-28T21:47:11.352Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bepirovirsen-sodium-chronic-hepatitis-b-hiv-infection-phase-ii</loc>
    <lastmod>2026-05-28T21:47:11.365Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-4-fluorophenyl-n-4-7-methoxy-6-methylc-clear-cell-renal-cell-carcinoma-metastat-phase-i</loc>
    <lastmod>2026-05-28T21:47:11.379Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regn7075-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:11.393Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/axitinib-medulloblastoma-ependymoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:11.407Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colecalciferol-vitamin-d3-metastatic-pancreatic-adenocarcinoma-pre-phase-ii</loc>
    <lastmod>2026-05-28T21:47:11.420Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/meldonium-heart-failure-with-preserved-ejection-fr-phase-iv</loc>
    <lastmod>2026-05-28T21:47:11.435Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tezacaftor-elexacaftor-ivacaftor-cystic-fibrosis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:11.448Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rezpegaldesleukin-alopecia-areata-phase-ii</loc>
    <lastmod>2026-05-28T21:47:11.462Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ibrutinib-chronic-lymphocytic-leukemia-small-lymph-phase-ii</loc>
    <lastmod>2026-05-28T21:47:11.476Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/risperidone-schizophrenia-schizophreniform-disorder-not-applicable</loc>
    <lastmod>2026-05-28T21:47:11.490Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-her2-positive-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:11.504Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/filgotinib-rheumatoid-arthritis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:11.519Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ublituximab-relapsing-multiple-sclerosis-myasthenia-phase-i</loc>
    <lastmod>2026-05-28T21:47:11.532Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zoledronic-acid-hip-fracture-phase-iv</loc>
    <lastmod>2026-05-28T21:47:11.547Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/darolutamide-localized-prostate-cancer-prostate-cance-phase-iii</loc>
    <lastmod>2026-05-28T21:47:11.560Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/panitumumab-metastatic-colorectal-cancer-left-sided-phase-iii</loc>
    <lastmod>2026-05-28T21:47:11.574Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/solifenacin-succinate-overactive-bladder-daytime-urinary-incon-not-applicable</loc>
    <lastmod>2026-05-28T21:47:11.588Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levobupivacaine-aortic-valve-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:47:11.601Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belantamab-mafodotin-multiple-myeloma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:11.615Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/doxorubicin-hydrochloride-high-grade-soft-tissue-sarcoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:11.629Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bacteriophage-urinary-tract-infection-neurogenic-bladd-phase-i</loc>
    <lastmod>2026-05-28T21:47:11.643Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-2-2-10-2-4-3-4-2-2-cyano-4-4-difluor-malignant-melanoma-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:11.656Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nirmatrelvir-covid-19-sars-cov-2-infection-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:11.670Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adalimumab-rheumatoid-arthritis-not-applicable</loc>
    <lastmod>2026-05-28T21:47:11.683Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/heparin-sodium-multiple-myeloma-lymphoma-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:11.697Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/advanced-prame-positive-cancers-malignan-phase-i</loc>
    <lastmod>2026-05-28T21:47:11.710Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methylprednisolone-acetate-and-lidocaine-acute-alcoholic-hepatitis-severe-acute-a-phase-iii</loc>
    <lastmod>2026-05-28T21:47:11.724Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bintrafusp-alfa-soft-tissue-sarcoma-locally-advanced-or-phase-ii</loc>
    <lastmod>2026-05-28T21:47:11.737Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-melanoma-resected-stage-iib-iii-phase-ii</loc>
    <lastmod>2026-05-28T21:47:11.751Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tocilizumab-chronic-pancreatitis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:11.765Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/resiquimod-sulfate-pancreatic-cancer-virus-associated-tumor-phase-ii</loc>
    <lastmod>2026-05-28T21:47:11.778Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/respiratory-syncytial-virus-glycoprotein-respiratory-syncytial-virus-infection-phase-iii-3</loc>
    <lastmod>2026-05-28T21:47:11.792Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/betamethasone-dipropionate-betamethasone-degenerative-meniscal-lesion-not-applicable</loc>
    <lastmod>2026-05-28T21:47:11.806Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cabergoline-endometriosis</loc>
    <lastmod>2026-05-28T21:47:11.819Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cart-19-22-t-cells-acute-lymphoblastic-leukemia-b-cell-rela-phase-i</loc>
    <lastmod>2026-05-28T21:47:11.832Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amikacin-sulfate-acute-pyelonephritis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:11.846Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/enalapril-maleate-venous-malformation-phase-iv</loc>
    <lastmod>2026-05-28T21:47:11.859Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-hydrogen-carbonate-potassium-chlo-constipation-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:11.873Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trichostatin-a-relapsed-or-refractory-hematologic-malig-phase-i</loc>
    <lastmod>2026-05-28T21:47:11.887Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amikacin-ventilator-associated-tracheobronchitis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:11.900Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rivaroxaban-atrial-fibrillation-percutaneous-coronar-phase-iii</loc>
    <lastmod>2026-05-28T21:47:11.915Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/m3554-anti-gd2-adc-advanced-solid-tumors-soft-tissue-sarcom-phase-i</loc>
    <lastmod>2026-05-28T21:47:11.929Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-faecal-microbiota-pooled-crohn-s-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:11.943Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acalabrutinib-chronic-lymphocytic-leukaemia-moderate-t-phase-iv</loc>
    <lastmod>2026-05-28T21:47:11.957Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hydroxychloroquine-sulfate-primary-sjogren-s-syndrome-phase-ii</loc>
    <lastmod>2026-05-28T21:47:11.971Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eye103-diabetic-macular-edema-phase-ii-iii-2</loc>
    <lastmod>2026-05-28T21:47:11.984Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cabergoline-non-functioning-pituitary-adenoma-phase-iv</loc>
    <lastmod>2026-05-28T21:47:11.998Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alendronic-acid-alendronate-osteoporosis</loc>
    <lastmod>2026-05-28T21:47:12.012Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alpha-1-proteinase-inhibitor-human-pulmonary-emphysema-due-to-alpha-1-antit-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:12.026Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tenecteplase-acute-ischemic-stroke-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:12.040Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/everolimus-age-related-bone-loss-phase-iv</loc>
    <lastmod>2026-05-28T21:47:12.055Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rivaroxaban-lower-limb-trauma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:12.069Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rusfertide-polycythemia-vera-phase-iii</loc>
    <lastmod>2026-05-28T21:47:12.083Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iptacopan-paroxysmal-nocturnal-haemoglobinuria-pnh-phase-iii</loc>
    <lastmod>2026-05-28T21:47:12.097Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-cutaneous-melanoma-completely-resected-s-phase-i</loc>
    <lastmod>2026-05-28T21:47:12.111Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cemdisiran-paroxysmal-nocturnal-haemoglobinuria-phase-iii</loc>
    <lastmod>2026-05-28T21:47:12.125Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/midostaurin-flt3-mutated-acute-myeloid-leukemia-acut-phase-ii</loc>
    <lastmod>2026-05-28T21:47:12.138Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/upadacitinib-crohn-s-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:12.152Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxygen-ph-eur-prematurity-very-low-birth-weight-phase-iii</loc>
    <lastmod>2026-05-28T21:47:12.166Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dostarlimab-rectal-adenocarcinoma-locally-advanced-r-phase-ii</loc>
    <lastmod>2026-05-28T21:47:12.180Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ciclosporin-atopic-dermatitis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:12.194Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/loxo-783-advanced-breast-cancer-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:47:12.208Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/irinotecan-hydrochloride-trihydrate-locally-advanced-rectal-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:47:12.221Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zongertinib-metastatic-gastric-adenocarcinoma-gastro-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:12.235Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-idiopathic-steroid-sensitive-nephrotic-s-phase-iii</loc>
    <lastmod>2026-05-28T21:47:12.249Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/guselkumab-juvenile-psoriatic-arthritis-ulcerative-phase-iii</loc>
    <lastmod>2026-05-28T21:47:12.263Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/girentuximab-labelled-with-astatine-211-non-muscle-invasive-bladder-cancer-refra-phase-i</loc>
    <lastmod>2026-05-28T21:47:12.276Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amikacin-sulfate-ventilator-associated-pneumonia-gram-neg-phase-ii</loc>
    <lastmod>2026-05-28T21:47:12.290Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pozelimab-geographic-atrophy-secondary-to-age-rela-phase-iii</loc>
    <lastmod>2026-05-28T21:47:12.305Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venglustat-fabry-disease-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:12.320Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-3032950-ulcerative-colitis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:12.333Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-690517-heart-failure-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:12.347Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pf-07220060-monohydrate-breast-cancer-hr-positive-her2-negative-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:12.360Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/linezolid-sepsis-septic-shock</loc>
    <lastmod>2026-05-28T21:47:12.374Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lidocaine-hydrochloride-lung-cancer-not-applicable</loc>
    <lastmod>2026-05-28T21:47:12.388Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trontinemab-alzheimer-s-disease-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:12.402Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regorafenib-advanced-or-metastatic-solid-tumors-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:12.415Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/heparin-extracorporeal-membrane-oxygenation-ecmo-phase-iii</loc>
    <lastmod>2026-05-28T21:47:12.429Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/retifanlimab-undifferentiated-pleomorphic-sarcoma-ret-phase-ii</loc>
    <lastmod>2026-05-28T21:47:12.443Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oncofap-23-radiolabelled-with-lutetium-1-fap-positive-metastatic-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:47:12.457Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/radiprodil-grin-related-neurodevelopmental-disorder-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:47:12.471Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nipocalimab-fetal-and-neonatal-alloimmune-thrombocyt-phase-iii</loc>
    <lastmod>2026-05-28T21:47:12.484Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ifinatamab-deruxtecan-esophageal-squamous-cell-carcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:12.499Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxytocin-schizophrenia-spectrum-disorders-phase-ii</loc>
    <lastmod>2026-05-28T21:47:12.513Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ifinatamab-deruxtecan-small-cell-lung-cancer-extensive-stage-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:12.527Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/encorafenib-solid-tumors-not-applicable</loc>
    <lastmod>2026-05-28T21:47:12.542Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxygen-acute-hamstring-injury-not-applicable</loc>
    <lastmod>2026-05-28T21:47:12.556Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inotuzumab-ozogamicin-relapsed-precursor-b-cell-acute-lymphobl-phase-iii</loc>
    <lastmod>2026-05-28T21:47:12.571Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aln-961583-cerebral-amyloid-angiopathy-dutch-type-c-phase-ii</loc>
    <lastmod>2026-05-28T21:47:12.585Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/betahistine-dihydrochloride-meniere-s-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:12.598Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bio89-100-metabolic-dysfunction-associated-steatoh-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:12.612Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/encorafenib-metastatic-colorectal-cancer-braf-v600e-phase-ii</loc>
    <lastmod>2026-05-28T21:47:12.625Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-2-2-10-2-4-3-4-2-2-cyano-4-4-difluor-ductal-carcinoma-in-situ-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:12.639Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lb-208-solid-tumor-lymphoma-phase-i</loc>
    <lastmod>2026-05-28T21:47:12.653Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zimberelimab-non-small-cell-lung-cancer-metastatic-no-phase-iii</loc>
    <lastmod>2026-05-28T21:47:12.667Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2r-3r-11br-1-3-4-6-7-11b-hexahydro-9-10-tardive-dyskinesia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:12.680Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tulisokibart-systemic-sclerosis-associated-with-inter-phase-iv</loc>
    <lastmod>2026-05-28T21:47:12.694Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autogene-cevumeran-colorectal-cancer-resected-stage-ii-high-phase-ii</loc>
    <lastmod>2026-05-28T21:47:12.708Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clonazepam-burning-mouth-syndrome-phase-iv</loc>
    <lastmod>2026-05-28T21:47:12.725Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ribociclib-advanced-hormone-receptor-positive-hr-br-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:12.738Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cart45ra-nkg2d-cells-b-cell-acute-lymphoblastic-leukemia-rela-phase-i</loc>
    <lastmod>2026-05-28T21:47:12.752Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mosunetuzumab-follicular-lymphoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:12.765Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elvn-002-1-her2-positive-solid-tumours-colorectal-a-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:12.781Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluocinolone-acetonide-non-infectious-uveitis-affecting-the-pos-phase-iii</loc>
    <lastmod>2026-05-28T21:47:12.795Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-bone-marrow-derived-mesenchym-severe-ocular-chemical-burn-phase-ii</loc>
    <lastmod>2026-05-28T21:47:12.808Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avelumab-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:12.822Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/narsoplimab-haematopoietic-stem-cell-transplant-asso-phase-ii</loc>
    <lastmod>2026-05-28T21:47:12.835Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/paclitaxel-albumin-bound-metastatic-pancreatic-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:12.849Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-colorectal-cancer-dmmr-locally-advanced-phase-ii</loc>
    <lastmod>2026-05-28T21:47:12.862Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/irinotecan-metastatic-pancreatic-ductal-adenocarcin-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:12.876Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tofacitinib-ulcerative-colitis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:12.889Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-muscle-invasive-bladder-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:12.903Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/escitalopram-major-depressive-disorder-bipolar-disord-not-applicable</loc>
    <lastmod>2026-05-28T21:47:12.917Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tocilizumab-esophageal-adenocarcinoma-esophageal-can-phase-ii</loc>
    <lastmod>2026-05-28T21:47:12.930Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/psilocybine-psychogenic-non-epileptic-seizures-phase-iv</loc>
    <lastmod>2026-05-28T21:47:12.944Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etrinabdione-peripheral-arterial-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:47:12.957Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/locally-advanced-or-metastatic-melanoma-phase-i</loc>
    <lastmod>2026-05-28T21:47:12.971Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sotagliflozin-type-1-diabetes-mellitus-chronic-kidney-phase-iv</loc>
    <lastmod>2026-05-28T21:47:12.985Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carboplatin-testicular-seminoma-stage-iia-b-phase-ii</loc>
    <lastmod>2026-05-28T21:47:12.999Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avb-101-frontotemporal-dementia-with-progranulin-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:13.013Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amivantamab-advanced-non-small-cell-lung-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:47:13.027Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ifinatamab-deruxtecan-endometrial-cancer-head-and-neck-squamou-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:13.040Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ceralasertib-advanced-or-metastatic-non-small-cell-lu-phase-iii</loc>
    <lastmod>2026-05-28T21:47:13.055Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rosuvastatin-cardiovascular-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:47:13.069Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/4-3-5-6-dihydro-2-trifluoromethyl-1-2-4-metastatic-castration-resistant-prostate-phase-iii</loc>
    <lastmod>2026-05-28T21:47:13.083Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venlafaxine-hydrochloride-depressive-disorder-in-remission-phase-iv</loc>
    <lastmod>2026-05-28T21:47:13.097Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belimumab-systemic-sclerosis-associated-interstiti-phase-iii</loc>
    <lastmod>2026-05-28T21:47:13.111Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ro7121932-multiple-sclerosis-phase-i</loc>
    <lastmod>2026-05-28T21:47:13.125Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-colorectal-peritoneal-metastases-phase-ii</loc>
    <lastmod>2026-05-28T21:47:13.138Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rosuvastatin-healthy-volunteers-phase-ii</loc>
    <lastmod>2026-05-28T21:47:13.153Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adipose-tissue-derived-mesenchymal-strom-primary-progressive-multiple-sclerosis-phase-i</loc>
    <lastmod>2026-05-28T21:47:13.167Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iptacopan-c3-glomerulopathy-idiopathic-immune-comp-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:13.181Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zirconium-89zr-crefmirlimab-berdoxam-breast-cancer-esophageal-cancer-melanoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:13.195Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mps-112-mps-106-mps-213-mps-102-mps-216-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:13.209Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/volrustomig-non-small-cell-lung-cancer-solid-tumours-phase-ii</loc>
    <lastmod>2026-05-28T21:47:13.224Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pf-06835375-primary-immune-thrombocytopenia-phase-ii</loc>
    <lastmod>2026-05-28T21:47:13.238Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/magnesium-hydroxide-advanced-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:47:13.251Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iptacopan-hydrochloride-lupus-nephritis-lupus-nephritis-class-ii-phase-ii</loc>
    <lastmod>2026-05-28T21:47:13.265Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tilsotolimod-sodium-cutaneous-melanoma-pt3-4-clinically-node-phase-ii</loc>
    <lastmod>2026-05-28T21:47:13.280Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iptacopan-c3-glomerulopathy-phase-iii</loc>
    <lastmod>2026-05-28T21:47:13.294Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rilzabrutinib-warm-autoimmune-hemolytic-anemia-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:13.307Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tetracyclines-viral-respiratory-tract-infection-phase-iv</loc>
    <lastmod>2026-05-28T21:47:13.321Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-thiosulfate-pentahydrate-primary-raynaud-s-phenomenon-phase-iv</loc>
    <lastmod>2026-05-28T21:47:13.335Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/18f-aci-19626-alzheimer-s-disease-amyotrophic-lateral-phase-i</loc>
    <lastmod>2026-05-28T21:47:13.349Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenacapavir-hiv-1-infection-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:13.363Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/psilocybine-chronic-obstructive-pulmonary-disease-am-phase-ii</loc>
    <lastmod>2026-05-28T21:47:13.377Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clotrimazole-bacterial-vaginosis-high-risk-pregnancy-phase-iii</loc>
    <lastmod>2026-05-28T21:47:13.391Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/risedronate-sodium-dilated-cardiomyopathy-dilated-cardiomyo-phase-iv</loc>
    <lastmod>2026-05-28T21:47:13.405Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/encorafenib-metastatic-colorectal-cancer-braf-v600e-phase-iii</loc>
    <lastmod>2026-05-28T21:47:13.418Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dupilumab-atopic-dermatitis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:13.433Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-stage-ii-cutaneous-melanoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:13.447Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gsk4381562-advanced-solid-tumour-solid-tumour-phase-i</loc>
    <lastmod>2026-05-28T21:47:13.461Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acalabrutinib-diffuse-large-b-cell-lymphoma-non-germin-phase-iii</loc>
    <lastmod>2026-05-28T21:47:13.475Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/remibrutinib-relapsing-multiple-sclerosis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:13.490Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acalabrutinib-relapsed-refractory-marginal-zone-lympho-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:13.503Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acalabrutinib-chronic-lymphocytic-leukemia-relapsed-or-phase-iii</loc>
    <lastmod>2026-05-28T21:47:13.517Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acalabrutinib-chronic-lymphocytic-leukemia-treatment-n-phase-iii</loc>
    <lastmod>2026-05-28T21:47:13.531Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acalabrutinib-chronic-lymphocytic-leukemia-richter-s-s-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:13.545Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acalabrutinib-chronic-lymphocytic-leukemia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:13.559Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-advanced-solid-tumours-non-small-cell-lu-phase-i</loc>
    <lastmod>2026-05-28T21:47:13.573Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acalabrutinib-chronic-lymphocytic-leukemia-high-risk-phase-iii</loc>
    <lastmod>2026-05-28T21:47:13.586Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-pertuzumab-her2-positive-early-breast-cancer-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:13.600Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/secukinumab-non-radiographic-axial-spondyloarthritis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:13.614Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trametinib-metastatic-melanoma-non-small-cell-lung-phase-iv</loc>
    <lastmod>2026-05-28T21:47:13.629Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-tirumotecan-gastroesophageal-adenocarcinoma-gastric-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:13.643Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vanglusagene-ensiparvovec-late-onset-pompe-disease-pompe-disease-g-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:13.657Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/synthetic-double-stranded-sirna-oligonuc-severe-hypertriglyceridemia-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:13.670Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ticagrelor-severe-symptomatic-aortic-stenosis-not-applicable</loc>
    <lastmod>2026-05-28T21:47:13.684Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bnt116-advanced-non-small-cell-lung-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:47:13.698Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obinutuzumab-follicular-lymphoma-early-stage-phase-iii</loc>
    <lastmod>2026-05-28T21:47:13.712Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dabrafenib-mesylate-braf-v600-mutant-cancers-phase-iv</loc>
    <lastmod>2026-05-28T21:47:13.726Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-locally-advanced-or-metastatic-solid-tum-phase-i</loc>
    <lastmod>2026-05-28T21:47:13.740Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/datopotamab-deruxtecan-triple-negative-breast-cancer-locally-re-phase-iii</loc>
    <lastmod>2026-05-28T21:47:13.754Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-polycystic-ovary-syndrome</loc>
    <lastmod>2026-05-28T21:47:13.767Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mr0005-gr0015-alpha-1-antitrypsin-deficiency-aatd-asso-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:13.782Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexmedetomidine-neonatal-respiratory-distress-neonatal-p-phase-iii</loc>
    <lastmod>2026-05-28T21:47:13.795Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avelumab-gastric-cancer-gastroesophageal-junction-phase-ii</loc>
    <lastmod>2026-05-28T21:47:13.809Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ovarian-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:47:13.822Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acalabrutinib-chronic-lymphocytic-leukemia-small-lymph-phase-ii</loc>
    <lastmod>2026-05-28T21:47:13.836Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/remibrutinib-relapsing-multiple-sclerosis-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:13.850Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/synthetic-double-stranded-sirna-oligonuc-severe-hypertriglyceridemia-phase-iii-3</loc>
    <lastmod>2026-05-28T21:47:13.864Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fulvestrant-invasive-lobular-breast-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:13.878Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluorouracil-esophagogastric-adenocarcinoma-advanced-phase-ii</loc>
    <lastmod>2026-05-28T21:47:13.892Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colistimethate-sodium-bronchiectasis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:13.905Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/remibrutinib-relapsing-multiple-sclerosis-phase-iii-3</loc>
    <lastmod>2026-05-28T21:47:13.919Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-albumin-solution-ischemic-stroke-phase-ii</loc>
    <lastmod>2026-05-28T21:47:13.933Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-88998377-relapsed-or-refractory-b-cell-non-hodgki-phase-i</loc>
    <lastmod>2026-05-28T21:47:13.947Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ucp2-omp72-omp64-omp65-omp66-indolent-non-hodgkin-s-lymphoma-follicul-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:13.960Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-77242113-psoriatic-arthritis-active-psoriatic-art-phase-iii</loc>
    <lastmod>2026-05-28T21:47:13.974Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/docetaxel-non-metastatic-gastric-adenocarcinoma-no-phase-iv</loc>
    <lastmod>2026-05-28T21:47:13.988Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/art6043-metastatic-solid-tumors-advanced-solid-t-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:14.002Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-t-cells-transduced-with-lenti-acute-myeloid-leukemia-aml-relapsed-refr-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:14.016Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eletriptan-hbr-acute-spinal-cord-injury-spinal-cord-inj-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:14.029Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cetuximab-metastatic-colorectal-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:14.043Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/donidalorsen-hereditary-angioedema-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:14.057Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly3819469-sodium-atherosclerotic-cardiovascular-disease-e-phase-iii</loc>
    <lastmod>2026-05-28T21:47:14.071Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colorectal-cancer-with-liver-metastases-phase-iii</loc>
    <lastmod>2026-05-28T21:47:14.084Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mevrometostat-castration-resistant-prostate-cancer-fol-phase-i</loc>
    <lastmod>2026-05-28T21:47:14.098Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etavopivat-sickle-cell-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:14.113Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lorlatinib-advanced-alk-positive-non-small-cell-lun-phase-iii</loc>
    <lastmod>2026-05-28T21:47:14.127Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-early-stage-rectal-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:14.141Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-extrahepatic-cholangiocarcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:14.156Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carboplatin-adult-medulloblastoma-medulloblastoma-phase-iv</loc>
    <lastmod>2026-05-28T21:47:14.169Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methylprednisolone-acetate-lidocaine-hyd-arthritis-of-the-temporomandibular-joint-phase-iv</loc>
    <lastmod>2026-05-28T21:47:14.183Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/remibrutinib-generalized-myasthenia-gravis-myasthenia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:14.200Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elafibranor-primary-sclerosing-cholangitis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:14.214Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apalutamide-castration-resistant-prostate-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:14.228Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/evorpacept-advanced-her2-overexpressing-gastric-ade-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:14.245Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/argipressin-septic-shock-phase-iv</loc>
    <lastmod>2026-05-28T21:47:14.258Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/evolocumab-acute-myocardial-infarction-nstemi-and-s-phase-iv</loc>
    <lastmod>2026-05-28T21:47:14.272Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluorouracil-resectable-gastric-adenocarcinoma-gastro-phase-ii</loc>
    <lastmod>2026-05-28T21:47:14.286Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/teverelix-advanced-prostate-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:47:14.303Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isis-678354-sodium-salt-familial-chylomicronemia-syndrome-fcs-phase-iii</loc>
    <lastmod>2026-05-28T21:47:14.318Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/spesolimab-generalized-pustular-psoriasis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:14.331Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clopidogrel-pancreatic-ductal-adenocarcinoma-pancrea-phase-iii</loc>
    <lastmod>2026-05-28T21:47:14.348Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/unresectable-or-metastatic-solid-tumours-phase-iii</loc>
    <lastmod>2026-05-28T21:47:14.362Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glutamate-decarboxylase-2-human-recombin-latent-autoimmune-diabetes-in-adults-lad-phase-iv-ctis-2019-002692-34</loc>
    <lastmod>2026-05-28T21:11:46.679Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rtp-026-sodium-st-elevation-myocardial-infarction-stemi-phase-iv</loc>
    <lastmod>2026-05-28T21:47:14.376Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aficamten-hypertrophic-cardiomyopathy-phase-ii</loc>
    <lastmod>2026-05-28T21:47:14.389Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-hydrochloride-hand-osteoarthritis-osteoarthritis</loc>
    <lastmod>2026-05-28T21:47:14.403Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sildenafil-hypoxic-ischemic-encephalopathy-neonatal-phase-ii-phase-iii</loc>
    <lastmod>2026-05-28T21:47:14.417Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenvatinib-vulvar-cancer-squamous-cell-carcinoma-of-phase-ii</loc>
    <lastmod>2026-05-28T21:47:14.430Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-non-small-cell-lung-cancer-advanced-non-phase-ii-phase-iii</loc>
    <lastmod>2026-05-28T21:47:14.444Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/a-turkey-turkey-1-05-h5n1-like-strain-ni-avian-influenza-seasonal-influenza-phase-iv</loc>
    <lastmod>2026-05-28T21:47:14.458Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ethyl-esters-of-iodised-fatty-acids-from-infertility-phase-iv</loc>
    <lastmod>2026-05-28T21:47:14.471Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cagrilintide-obesity-type-2-diabetes-phase-iii</loc>
    <lastmod>2026-05-28T21:47:14.485Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-764524-diabetic-retinopathy-phase-iv</loc>
    <lastmod>2026-05-28T21:47:14.499Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ociperlimab-solid-tumors-haematological-malignancies-phase-iii</loc>
    <lastmod>2026-05-28T21:47:14.513Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/crinecerfont-classic-congenital-adrenal-hyperplasia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:14.527Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vosoritide-achondroplasia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:14.541Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aminohippuric-acid-chronic-kidney-disease-kidney-failure-not-applicable</loc>
    <lastmod>2026-05-28T21:47:14.555Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-faecal-microbiota-pooled-decompensated-cirrhosis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:14.569Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elranatamab-multiple-myeloma-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:14.583Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/indocyanine-green-hypothyroidism-hypoparathyroidism-not-applicable</loc>
    <lastmod>2026-05-28T21:47:14.598Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/empagliflozin-hyponatremia-phase-iv</loc>
    <lastmod>2026-05-28T21:47:14.612Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/erdafitinib-advanced-solid-tumor-non-hodgkin-lymphom-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:14.626Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sotagliflozin-post-bariatric-hypoglycaemia-phase-iv</loc>
    <lastmod>2026-05-28T21:47:14.640Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regn7999-non-transfusion-dependent-beta-thalassem-phase-ii</loc>
    <lastmod>2026-05-28T21:47:14.654Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mycobacterium-bovis-bacillus-calmette-gu-respiratory-syncytial-virus-infection-phase-ii</loc>
    <lastmod>2026-05-28T21:47:14.667Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dupilumab-indolent-systemic-mastocytosis-with-skin-phase-iii</loc>
    <lastmod>2026-05-28T21:47:14.681Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fludeoxyglucose-18f-metastatic-breast-cancer-not-applicable</loc>
    <lastmod>2026-05-28T21:47:14.695Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vedolizumab-ulcerative-colitis-crohn-s-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:14.708Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ropivacaine-hydrochloride-total-hip-arthroplasty-not-applicable</loc>
    <lastmod>2026-05-28T21:47:14.722Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/finerenone-heart-failure-hfmref-hfpef-phase-iii</loc>
    <lastmod>2026-05-28T21:47:14.737Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methotrexate-myeloid-hematological-malignancy-lymphoi-phase-ii</loc>
    <lastmod>2026-05-28T21:47:14.750Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sasanlimab-non-muscle-invasive-bladder-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:14.765Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tolerogenic-dendritic-cells-type-1-diabetes-phase-i</loc>
    <lastmod>2026-05-28T21:47:14.779Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mepolizumab-severe-asthma-eosinophilic-asthma-not-applicable</loc>
    <lastmod>2026-05-28T21:47:14.792Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-95437446-non-small-cell-lung-cancer-colorectal-ca-phase-i</loc>
    <lastmod>2026-05-28T21:47:14.806Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/talazoparib-metastatic-castration-resistant-prostate-phase-iii</loc>
    <lastmod>2026-05-28T21:47:14.820Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ianalumab-rheumatoid-arthritis-sjogren-s-syndrome-phase-ii</loc>
    <lastmod>2026-05-28T21:47:14.834Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/linaprazan-glurate-erosive-esophagitis-due-to-gastroesophag-phase-iii</loc>
    <lastmod>2026-05-28T21:47:14.848Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abelacimab-atrial-fibrillation-phase-ii</loc>
    <lastmod>2026-05-28T21:47:14.862Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/177lu-fap-2286-non-small-cell-lung-cancer-pancreatic-du-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:14.876Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/panitumumab-metastatic-colorectal-cancer-ras-braf-wi-phase-ii</loc>
    <lastmod>2026-05-28T21:47:14.890Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ifinatamab-deruxtecan-small-cell-lung-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:14.903Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/liver-transplant-ischemia-reperfusion-in-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:14.917Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bp1-7881a-eosinophilic-esophagitis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:14.930Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-endometrial-cancer-advanced-or-recurrent-phase-iii</loc>
    <lastmod>2026-05-28T21:47:14.944Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/talazoparib-malignant-pleural-mesothelioma-malignant-phase-ii</loc>
    <lastmod>2026-05-28T21:47:14.957Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-765063-non-small-cell-lung-cancer-melanoma-head-phase-iii</loc>
    <lastmod>2026-05-28T21:47:14.977Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obinutuzumab-cryoglobulinemia-vasculitis-mixed-cryogl-phase-ii-ctis-2023-508930-33-00</loc>
    <lastmod>2026-05-28T21:11:46.392Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/multi-peptide-s-and-xs15-tlr1-2-ligand-acute-myeloid-leukemia-phase-i</loc>
    <lastmod>2026-05-28T21:47:14.991Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/izorlisib-mesilate-triple-negative-breast-cancer-hr-positiv-phase-ii</loc>
    <lastmod>2026-05-28T21:47:15.005Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-malignant-pleural-mesothelioma-epithelio-phase-ii</loc>
    <lastmod>2026-05-28T21:47:15.019Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carboplatin-nephroblastoma-wilms-tumour-metastatic-s-phase-iii</loc>
    <lastmod>2026-05-28T21:47:15.033Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-acute-myeloid-leukemia-phase-i</loc>
    <lastmod>2026-05-28T21:47:15.047Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/al8326-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:15.063Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rivaroxaban-coronary-artery-disease-atrial-fibrillat-phase-iv</loc>
    <lastmod>2026-05-28T21:47:15.078Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vedolizumab-crohn-s-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:15.092Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/diacerein-generalized-epidermolysis-bullosa-simple-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:15.107Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dupilumab-chronic-pruritus-of-unknown-origin-cpuo</loc>
    <lastmod>2026-05-28T21:47:15.120Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-malignant-melanoma-in-transit-metastases-phase-i-ii-phase-ii</loc>
    <lastmod>2026-05-28T21:47:15.134Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/perindopril-tert-butylamine-heart-failure-phase-iii</loc>
    <lastmod>2026-05-28T21:47:15.148Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-a-heart-failure-with-reduced-ejection-frac-phase-iii</loc>
    <lastmod>2026-05-28T21:47:15.161Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ozanimod-ulcerative-colitis-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:15.175Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tremelimumab-resectable-hepatocellular-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:15.189Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dnl593-frontotemporal-dementia-frontotemporal-d-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:15.203Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pyruvic-acid-diabetic-kidney-disease-type-1-diabetes-phase-iv</loc>
    <lastmod>2026-05-28T21:47:15.217Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belantamab-mafodotin-primary-immune-thrombocytopenia-phase-ii</loc>
    <lastmod>2026-05-28T21:47:15.231Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-scfv-2-fab-fusion-protein-against-thyroid-eye-disease-graves-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:15.245Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/momelotinib-dihydrochloride-monohydrate-vexas-syndrome-myelodysplastic-syndrome-phase-ii</loc>
    <lastmod>2026-05-28T21:47:15.258Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abrocitinib-atopic-dermatitis-moderate-to-severe-ato-phase-iii</loc>
    <lastmod>2026-05-28T21:47:15.271Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cpk850-retinitis-pigmentosa-rlbp1-associated-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:15.285Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ambrisentan-pulmonary-arterial-hypertension-phase-iii</loc>
    <lastmod>2026-05-28T21:47:15.299Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ipilimumab-thymoma-type-b3-thymic-carcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:15.313Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imetelstat-sodium-myelofibrosis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:15.326Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adipose-tissue-derived-mesenchymal-strom-critical-limb-ischemia-phase-i</loc>
    <lastmod>2026-05-28T21:47:15.340Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ruxotemitide-malignant-melanoma-resectable-stage-iii-phase-ii</loc>
    <lastmod>2026-05-28T21:47:15.354Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belzutifan-von-hippel-lindau-disease-associated-ren-phase-ii</loc>
    <lastmod>2026-05-28T21:47:15.367Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abrocitinib-moderate-to-severe-atopic-dermatitis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:15.381Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-tec-patellofemoral-osteoarthritis-knee-osteo-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:15.395Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vedolizumab-moderately-to-severely-active-crohn-s-di-phase-iv</loc>
    <lastmod>2026-05-28T21:47:15.408Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tebentafusp-metastatic-uveal-melanoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:15.422Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/darunavir-hiv-1-and-hepatitis-b-virus-hbv-co-infec-phase-iv</loc>
    <lastmod>2026-05-28T21:47:15.436Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cetuximab-metastatic-colorectal-cancer-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:15.449Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-non-small-cell-lung-cancer-colorectal-ca-phase-i</loc>
    <lastmod>2026-05-28T21:47:15.463Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iduronate-2-sulfatase-fused-to-a-fc-poly-mucopolysaccharidosis-type-ii-hunter-syn-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:15.477Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/psilocybin-major-depressive-disorder-anhedonia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:15.491Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/seltorexant-major-depressive-disorder-insomnia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:15.506Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vusolimogene-oderparepvec-advanced-melanoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:15.519Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rbd1016-chronic-hepatitis-d-hepatitis-d-phase-ii</loc>
    <lastmod>2026-05-28T21:47:15.534Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/buloxibutid-idiopathic-pulmonary-fibrosis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:15.548Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apalutamide-metastatic-hormone-sensitive-prostate-ca-phase-iii</loc>
    <lastmod>2026-05-28T21:47:15.562Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly03010-schizophrenia-phase-ii</loc>
    <lastmod>2026-05-28T21:47:15.575Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/al8326-small-cell-lung-cancer-non-small-cell-lu-phase-ii</loc>
    <lastmod>2026-05-28T21:47:15.588Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gembrax-metastatic-pancreatic-adenocarcinoma-phase-iv</loc>
    <lastmod>2026-05-28T21:47:15.602Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ponatinib-philadelphia-chromosome-positive-acute-l-phase-iii</loc>
    <lastmod>2026-05-28T21:47:15.616Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vedolizumab-crohn-s-disease-moderately-to-severely-a-phase-iii</loc>
    <lastmod>2026-05-28T21:47:15.630Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd0305-multiple-myeloma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:15.647Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colchicine-lower-extremity-artery-disease</loc>
    <lastmod>2026-05-28T21:47:15.662Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hydroxycarbamide-acute-myeloid-leukaemia-aml-newly-diagno-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:15.677Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bhv-7000-refractory-focal-onset-epilepsy-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:15.691Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cannabis-sativa-flower-9-thc-and-other-c-diabetic-peripheral-neuropathic-pain-phase-ii</loc>
    <lastmod>2026-05-28T21:47:15.704Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:15.718Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alpelisib-pik3ca-related-overgrowth-spectrum-pros-phase-ii</loc>
    <lastmod>2026-05-28T21:47:15.732Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isatuximab-relapsed-refractory-multiple-myeloma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:15.747Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lidocaine-hydrochloride-implantation-of-cardiac-implantable-elec-not-applicable</loc>
    <lastmod>2026-05-28T21:47:15.761Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fyb202-chronic-inflammatory-diseases-psoriasis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:15.776Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/paclitaxel-non-small-cell-lung-cancer-resectable-ea-phase-ii</loc>
    <lastmod>2026-05-28T21:47:15.792Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/maribavir-cytomegalovirus-cmv-infection-post-trans-phase-iii</loc>
    <lastmod>2026-05-28T21:47:15.806Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/baricitinib-type-1-diabetes-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:15.826Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-her2-positive-breast-cancer-advanced-bre-phase-ii</loc>
    <lastmod>2026-05-28T21:47:15.840Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sufentanil-chronic-postsurgical-pain-chronic-postsu-not-applicable</loc>
    <lastmod>2026-05-28T21:47:15.854Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lu-ag09222-migraine-phase-ii</loc>
    <lastmod>2026-05-28T21:47:15.868Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-systemic-sclerosis-associated-interstiti-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:15.883Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/caspofungin-pneumocystis-jirovecii-pneumonia-phase-ii</loc>
    <lastmod>2026-05-28T21:47:15.897Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vedolizumab-ulcerative-colitis-crohn-s-disease-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:15.910Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lebrikizumab-perennial-allergic-rhinitis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:15.925Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/osimertinib-non-small-cell-lung-cancer-egfr-mutation-phase-iii</loc>
    <lastmod>2026-05-28T21:47:15.939Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/irinotecan-hydrochloride-metastatic-colorectal-cancer-braf-v600e-phase-ii</loc>
    <lastmod>2026-05-28T21:47:15.953Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-triple-negative-breast-cancer-early-brea-phase-ii</loc>
    <lastmod>2026-05-28T21:47:15.967Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apalutamide-metastatic-castration-resistant-prostate-phase-iii</loc>
    <lastmod>2026-05-28T21:47:15.980Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexmedetomidine-preterm-infant-requiring-sedation-during-phase-iii</loc>
    <lastmod>2026-05-28T21:47:15.994Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-multiple-myeloma-phase-iii-3</loc>
    <lastmod>2026-05-28T21:47:16.008Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/izaflortaucipir-18f-progressive-supranuclear-palsy-parkinson-phase-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:47:16.022Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/odevixibat-alagille-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:47:16.036Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylsalicylic-acid-multi-vessel-coronary-artery-disease-wit-phase-iv</loc>
    <lastmod>2026-05-28T21:47:16.050Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iberdomide-relapsed-refractory-multiple-myeloma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:16.064Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dermatophagoides-pteronyssinus-enriched-allergic-rhinitis-allergic-rhinoconjunct-phase-iii</loc>
    <lastmod>2026-05-28T21:47:16.078Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elranatamab-multiple-myeloma-phase-iii-3</loc>
    <lastmod>2026-05-28T21:47:16.092Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gabapentin-radicular-leg-pain-not-applicable</loc>
    <lastmod>2026-05-28T21:47:16.107Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/h-l-tryphophanyl-l-seryl-glycyl-l-trypto-amyotrophic-lateral-sclerosis-als-phase-ii</loc>
    <lastmod>2026-05-28T21:47:16.121Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/saruparib-metastatic-prostate-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:16.139Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-4-1r-4r-4-hydroxy-4-methylcyclohexyl-m-myeloid-malignancies-acute-myeloid-leuke-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:16.153Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-embonate-portal-hypertension-cirrhosis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:16.167Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/finerenone-heart-failure-acute-heart-failure-phase-iii</loc>
    <lastmod>2026-05-28T21:47:16.180Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ravulizumab-neuromyelitis-optica-spectrum-disorder-a-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:16.194Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isatuximab-relapsed-and-or-refractory-multiple-myel-phase-iii</loc>
    <lastmod>2026-05-28T21:47:16.208Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trametinib-low-grade-glioma-mixed-glio-neuronal-tum-phase-ii</loc>
    <lastmod>2026-05-28T21:47:16.222Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alprazolam-prolonged-seizure-stereotypical-prolonge-phase-iv</loc>
    <lastmod>2026-05-28T21:47:16.236Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tecaginlimab-malignant-solid-tumour-melanoma-non-smal-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:16.250Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-oropharyngeal-squamous-cell-carcinoma-lo-phase-ii</loc>
    <lastmod>2026-05-28T21:47:16.263Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alpelisib-pik3ca-related-overgrowth-spectrum-pros-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:16.277Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ribociclib-breast-cancer-estrogen-receptor-positive-phase-ii</loc>
    <lastmod>2026-05-28T21:47:16.290Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/grass-pollen-allergen-extract-modified-w-seasonal-allergic-rhinitis-allergic-rhin-phase-iii</loc>
    <lastmod>2026-05-28T21:47:16.304Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/demerecviridae-bacteriophage-against-kle-ventilator-associated-pneumonia-phase-i-ii-2</loc>
    <lastmod>2026-05-28T21:47:16.318Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2-s-4-s-7-3-amino-2-fluoro-5-methyl-6-tr-advanced-solid-tumor-with-kras-p-g12c-mu-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:16.332Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bhv-7000-refractory-focal-onset-epilepsy-phase-ii-iii-2</loc>
    <lastmod>2026-05-28T21:47:16.346Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/milvexian-atherothrombotic-and-thromboembolic-diso-phase-iii</loc>
    <lastmod>2026-05-28T21:47:16.360Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cdr404-solid-tumor-phase-i</loc>
    <lastmod>2026-05-28T21:47:16.374Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fordadistrogene-movaparvovec-duchenne-muscular-dystrophy-phase-iii</loc>
    <lastmod>2026-05-28T21:47:16.388Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dsb2455-breast-cancer-ovarian-cancer-metastatic-phase-i</loc>
    <lastmod>2026-05-28T21:47:16.401Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zamtocabtagene-autoleucel-diffuse-large-b-cell-lymphoma-dlbcl-rela-phase-ii</loc>
    <lastmod>2026-05-28T21:47:16.415Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rp2-metastatic-uveal-melanoma-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:16.429Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/non-squamous-non-small-cell-lung-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:16.443Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/medroxyprogesterone-acetate-female-infertility-phase-iv</loc>
    <lastmod>2026-05-28T21:47:16.456Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/myb-mrna-degrader-adenoid-cystic-carcinoma-phase-i</loc>
    <lastmod>2026-05-28T21:47:16.470Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lebrikizumab-chronic-rhinosinusitis-with-nasal-polyps-phase-iii</loc>
    <lastmod>2026-05-28T21:47:16.484Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/64cu-cu-psma-r2-metastatic-prostate-cancer-adenocarcinom-phase-i</loc>
    <lastmod>2026-05-28T21:47:16.498Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cemiplimab-non-small-cell-lung-cancer-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:16.512Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ponatinib-philadelphia-chromosome-positive-acute-l-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:16.526Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/noradrenaline-tartrate-ischemic-stroke-stroke-phase-iii</loc>
    <lastmod>2026-05-28T21:47:16.540Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-2s-3r-4-4-difluoro-1-2-hydroxy-2-methy-narcolepsy-type-1-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:16.555Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iptacopan-iga-nephropathy-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:16.569Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-ovarian-cancer-fallopian-tube-cancer-per-phase-iv</loc>
    <lastmod>2026-05-28T21:47:16.583Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-papillomavirus-hpv-l1-virus-like-p-human-papillomavirus-hpv-infection-cervi-phase-iii</loc>
    <lastmod>2026-05-28T21:47:16.597Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gozetotide-alf-18-hepatocellular-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:16.610Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azetukalner-focal-epilepsy-phase-ii</loc>
    <lastmod>2026-05-28T21:47:16.625Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abacavir-lamivudine-systemic-lupus-erythematosus-phase-ii</loc>
    <lastmod>2026-05-28T21:47:16.639Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iopofosine-131i-18-p-iodophenyl-octadecy-waldenstrom-macroglobulinemia-phase-ii</loc>
    <lastmod>2026-05-28T21:47:16.652Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ixekizumab-type-1-diabetes-phase-ii</loc>
    <lastmod>2026-05-28T21:47:16.666Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aminolevulinic-acid-hydrochloride-colorectal-carcinoma-phase-iv</loc>
    <lastmod>2026-05-28T21:47:16.680Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cor-1167-chronic-heart-failure-phase-i</loc>
    <lastmod>2026-05-28T21:47:16.693Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nicotinamide-acute-kidney-injury-phase-iii</loc>
    <lastmod>2026-05-28T21:47:16.707Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-coronary-artery-disease-prediabetes-coro-phase-iv</loc>
    <lastmod>2026-05-28T21:47:16.721Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/frexalimab-systemic-lupus-erythematosus-phase-ii</loc>
    <lastmod>2026-05-28T21:47:16.739Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ianalumab-systemic-lupus-erythematosus-phase-iii</loc>
    <lastmod>2026-05-28T21:47:16.754Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obinutuzumab-idiopathic-nephrotic-syndrome-steroid-de-phase-iii</loc>
    <lastmod>2026-05-28T21:47:16.768Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/brentuximab-vedotin-advanced-stage-hodgkin-lymphoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:16.781Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-thiosulfate-pentahydrate-ectopic-ossification-ippsd2-calcinosis-e-phase-ii</loc>
    <lastmod>2026-05-28T21:47:16.795Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-cerebral-arteriovenous-malformation-phase-iv</loc>
    <lastmod>2026-05-28T21:47:16.809Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cabozantinib-undifferentiated-pleomorphic-sarcoma-ost-phase-ii</loc>
    <lastmod>2026-05-28T21:47:16.822Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-zirconium-cyclosilicate-hyperkalaemia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:16.836Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cytisinicline-cytisine-nicotine-dependence-chronic-kidney-disea-phase-iv</loc>
    <lastmod>2026-05-28T21:47:16.850Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/chronic-hepatitis-b-chronic-hepatitis-b-phase-i</loc>
    <lastmod>2026-05-28T21:47:16.863Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-stage-iii-cutaneous-melanoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:16.877Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/chronic-hepatitis-b-phase-i</loc>
    <lastmod>2026-05-28T21:47:16.891Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belantamab-mafodotin-relapsed-refractory-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:16.905Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rifampicin-infection-associated-with-osteosynthesis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:16.919Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apremilast-epidermolysis-bullosa-simplex-phase-iv</loc>
    <lastmod>2026-05-28T21:47:16.933Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oki-219-advanced-solid-tumors-advanced-breast-ca-phase-i</loc>
    <lastmod>2026-05-28T21:47:16.947Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/osimertinib-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:16.960Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-pertuzumab-her2-positive-early-stage-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:16.974Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pirfenidone-progressive-pulmonary-fibrosis-pulmonary-phase-ii</loc>
    <lastmod>2026-05-28T21:47:16.989Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-pancreatic-cancer-borderline-resectable-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:17.003Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/everolimus-meningioma-who-grade-2-meningioma-who-gr-phase-ii</loc>
    <lastmod>2026-05-28T21:47:17.018Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-tirumotecan-colorectal-cancer-pancreatic-ductal-aden-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:17.032Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aln-app-early-onset-alzheimer-s-disease-phase-i</loc>
    <lastmod>2026-05-28T21:47:17.045Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-locoregional-hepatocellular-carcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:17.060Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cd7-cart01-relapsed-refractory-cd7-positive-t-cell-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:17.074Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/saccharomyces-boulardii-cncm-i-745-lyoph-erythema-migrans-early-lyme-borreliosis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:17.089Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/riliprubart-chronic-inflammatory-demyelinating-polyn-phase-iii</loc>
    <lastmod>2026-05-28T21:47:17.103Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/crizanlizumab-sickle-cell-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:17.117Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/teclistamab-multiple-myeloma-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:17.131Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lorundrostat-hypertension-phase-iii</loc>
    <lastmod>2026-05-28T21:47:17.144Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adeno-associated-viral-vector-serotype-8-achromatopsia-cnga3-linked-achromatopsia</loc>
    <lastmod>2026-05-28T21:47:17.158Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jjp-1212-rheumatoid-arthritis-linear-iga-bullous-phase-i</loc>
    <lastmod>2026-05-28T21:47:17.172Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nbi-1076986-movement-disorders-phase-i</loc>
    <lastmod>2026-05-28T21:47:17.186Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cabozantinib-bladder-carcinoma-urothelial-carcinoma-n-phase-ii</loc>
    <lastmod>2026-05-28T21:47:17.200Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly3437943-sodium-obesity-overweight-atherosclerotic-cardi-phase-iii</loc>
    <lastmod>2026-05-28T21:47:17.214Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gs-1427-ulcerative-colitis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:17.227Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ads-010-facioscapulohumeral-muscular-dystrophy-f-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:17.245Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lamivudine-doravirine-tenofovir-disoprox-hiv-1-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:47:17.259Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carboplatin-ovarian-epithelial-cancer-ovarian-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:17.273Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-hepatocellular-carcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:17.287Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methoxsalen-acute-graft-versus-host-disease-grade-ii-phase-ii</loc>
    <lastmod>2026-05-28T21:47:17.300Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/norepinephrine-perioperative-hypotension-intraoperative-phase-iii</loc>
    <lastmod>2026-05-28T21:47:17.314Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/valaciclovir-primary-cytomegalovirus-cmv-infection-phase-ii</loc>
    <lastmod>2026-05-28T21:47:17.327Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zn-a-1041-her2-positive-advanced-solid-tumours-loc-phase-i</loc>
    <lastmod>2026-05-28T21:47:17.340Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dermatophagoides-pteronyssinus-enriched-allergic-rhinitis-rhinoconjunctivitis-ho-phase-iii</loc>
    <lastmod>2026-05-28T21:47:17.354Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amoxicillin-sodium-uncomplicated-enterococcal-bacteremia-phase-iv</loc>
    <lastmod>2026-05-28T21:47:17.367Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anti-t-lymphocyte-immunoglobulin-for-hum-type-1-diabetes-mellitus-phase-iv</loc>
    <lastmod>2026-05-28T21:47:17.381Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dostarlimab-squamous-cell-carcinoma-of-head-and-neck-phase-iii</loc>
    <lastmod>2026-05-28T21:47:17.395Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acalabrutinib-chronic-lymphocytic-leukemia-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:17.408Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ivosidenib-conventional-chondrosarcoma-locally-adva-phase-iii</loc>
    <lastmod>2026-05-28T21:47:17.422Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cd19-car-lenti-allo-b-cell-acute-lymphoblastic-leukemia-rela-phase-i</loc>
    <lastmod>2026-05-28T21:47:17.435Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/esketamine-hydrochloride-endometriosis</loc>
    <lastmod>2026-05-28T21:47:17.448Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/liraglutide-obesity-phase-iii</loc>
    <lastmod>2026-05-28T21:47:17.462Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-chronic-kidney-disease-kidney-failure-he-phase-iii</loc>
    <lastmod>2026-05-28T21:47:17.476Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ianalumab-systemic-lupus-erythematosus-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:17.490Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/garetosmab-fibrodysplasia-ossificans-progressiva-phase-iii</loc>
    <lastmod>2026-05-28T21:47:17.504Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/delafloxacin-pseudomonas-aeruginosa-bacteremia-phase-iv</loc>
    <lastmod>2026-05-28T21:47:17.517Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/furmonertinib-non-small-cell-lung-cancer-egfr-or-her2-phase-iii</loc>
    <lastmod>2026-05-28T21:47:17.531Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/teclistamab-relapsed-refractory-multiple-myeloma-phase-i</loc>
    <lastmod>2026-05-28T21:47:17.545Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lonapegsomatropin-achondroplasia-phase-iv</loc>
    <lastmod>2026-05-28T21:47:17.558Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amivantamab-head-and-neck-squamous-cell-carcinoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:17.572Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mirodenafil-dihydrochloride-alzheimer-s-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:17.586Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/diphtheria-toxoid-tetanus-toxoid-pertuss-pertussis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:17.599Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamfetamine-sulfate-amphetamine-use-disorder-opioid-use-diso-phase-iv</loc>
    <lastmod>2026-05-28T21:47:17.612Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/arbaclofen-autism-spectrum-disorder-phase-iii</loc>
    <lastmod>2026-05-28T21:47:17.626Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rilvegostomig-non-small-cell-lung-cancer-advanced-non-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:17.640Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tacrolimus-monohydrate-chronic-kidney-disease-kidney-transplant-not-applicable</loc>
    <lastmod>2026-05-28T21:47:17.654Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tacrolimus-liver-transplantation-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:17.667Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eblasakimab-atopic-dermatitis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:17.681Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/niraparib-tosilate-monohydrate-ovarian-cancer-oligometastatic-progressi-phase-ii</loc>
    <lastmod>2026-05-28T21:47:17.695Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/indocyanine-green-resectable-malignant-liver-tumour-phase-iv</loc>
    <lastmod>2026-05-28T21:47:17.708Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/para-chloro-2-18f-fluoroethyl-etomidate-primary-aldosteronism-not-applicable</loc>
    <lastmod>2026-05-28T21:47:17.724Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-non-small-cell-lung-cancer-nsclc-squamou-phase-iii</loc>
    <lastmod>2026-05-28T21:47:17.744Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/morf-057-moderately-to-severely-active-crohn-s-di-phase-ii</loc>
    <lastmod>2026-05-28T21:47:17.758Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pitolisant-hydrochloride-prader-willi-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:47:17.772Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ipilimumab-metastatic-uveal-melanoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:17.786Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-govitecan-locally-advanced-metastatic-urothelial-c-phase-ii</loc>
    <lastmod>2026-05-28T21:47:17.799Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mexiletine-hydrochloride-myotonic-dystrophy-type-1-myotonic-dystr-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:17.813Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anti-t-lymphocyte-immunoglobulin-for-hum-peripheral-t-cell-lymphoma-ptcl-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:17.826Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd0901-gastric-cancer-gastroesophageal-junction-phase-iii</loc>
    <lastmod>2026-05-28T21:47:17.840Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mezigdomide-relapsed-or-refractory-multiple-myeloma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:17.853Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd0901-gastric-cancer-gastroesophageal-junction-phase-ii</loc>
    <lastmod>2026-05-28T21:47:17.867Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acasunlimab-endometrial-carcinoma-urothelial-carcino-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:17.880Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-cancellous-bone-meniscus-tear-meniscus-injury-not-applicable</loc>
    <lastmod>2026-05-28T21:47:17.894Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluasterone-cushing-s-syndrome-phase-ii</loc>
    <lastmod>2026-05-28T21:47:17.908Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ipilimumab-glioblastoma-glioblastoma-multiforme-phase-i</loc>
    <lastmod>2026-05-28T21:47:17.921Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lanifibranor-non-alcoholic-steatohepatitis-nash-phase-iii</loc>
    <lastmod>2026-05-28T21:47:17.935Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elinzanetant-vasomotor-symptoms-hot-flashes-due-to-ad-phase-iii</loc>
    <lastmod>2026-05-28T21:47:17.950Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lebrikizumab-atopic-dermatitis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:17.964Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/patritumab-deruxtecan-egfr-mutation-positive-advanced-non-smal-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:17.978Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allo-quadcar01-t-relapsed-or-refractory-b-cell-non-hodgki-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:17.991Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gtaexs617-advanced-solid-tumours-non-small-cell-lu-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:18.005Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/talquetamab-multiple-myeloma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:18.018Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-persistent-or-recurrent-epithelial-ovari-phase-ii</loc>
    <lastmod>2026-05-28T21:47:18.032Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gallium-68ga-chloride-inflammatory-disorders-phase-iv</loc>
    <lastmod>2026-05-28T21:47:18.046Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/roxadustat-cardiovascular-disease-risk-factors-meta</loc>
    <lastmod>2026-05-28T21:47:18.059Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efgartigimod-alfa-antibody-mediated-rejection-phase-ii</loc>
    <lastmod>2026-05-28T21:47:18.073Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rmc-6291-non-small-cell-lung-cancer-pancreatic-ad-phase-iii</loc>
    <lastmod>2026-05-28T21:47:18.086Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/infliximab-ulcerative-colitis-crohn-s-disease-infla-phase-iv</loc>
    <lastmod>2026-05-28T21:47:18.100Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/balcinrenone-dapagliflozin-heart-failure-chronic-kidney-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:18.113Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vedolizumab-crohn-s-disease-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:18.127Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-phosphate-hospital-acquired-pneumonia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:18.141Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/baclofen-spinal-cord-injury-phase-iv</loc>
    <lastmod>2026-05-28T21:47:18.155Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ozekibart-ewing-sarcoma-colorectal-adenocarcinoma-phase-i-phase-ii</loc>
    <lastmod>2026-05-28T21:47:18.169Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amlitelimab-atopic-dermatitis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:18.183Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/everolimus-postmenopausal-bone-loss-accelerated-ske-phase-iv</loc>
    <lastmod>2026-05-28T21:47:18.197Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trontinemab-alzheimer-s-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:18.210Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sotatercept-pulmonary-arterial-hypertension-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:18.224Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/perflubutane-crohn-s-disease-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:18.238Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-biosimilar-to-pembrolizuma-early-stage-non-squamous-non-small-cell</loc>
    <lastmod>2026-05-28T21:47:18.252Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-advanced-renal-cell-carcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:18.265Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obecabtagene-autoleucel-severe-refractory-systemic-lupus-erythem-phase-i</loc>
    <lastmod>2026-05-28T21:47:18.279Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/midomafetamine-hydrochloride-post-traumatic-stress-disorder-treatment-phase-iv</loc>
    <lastmod>2026-05-28T21:47:18.292Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sotorasib-non-small-cell-lung-cancer-kras-p-g12c-m-phase-iii</loc>
    <lastmod>2026-05-28T21:47:18.306Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/d-l-lysine-acetylsalicylate-aortic-stenosis-not-applicable</loc>
    <lastmod>2026-05-28T21:47:18.321Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avutometinib-low-grade-serous-ovarian-cancer-recurren-phase-iii</loc>
    <lastmod>2026-05-28T21:47:18.334Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-hepatocellular-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:18.348Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tafasitamab-follicular-lymphoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:18.361Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/recombinant-neisseria-meningitidis-group-asplenia-phase-iv</loc>
    <lastmod>2026-05-28T21:47:18.375Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-immunodeficiency-virus-hiv-infecti-phase-i</loc>
    <lastmod>2026-05-28T21:47:18.389Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/melphalan-uveal-melanoma-liver-metastases-phase-iii</loc>
    <lastmod>2026-05-28T21:47:18.402Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-alpha-1-proteinase-inhibitor-immun-alpha-1-antitrypsin-deficiency-aatd-emph-phase-ii</loc>
    <lastmod>2026-05-28T21:47:18.416Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methylprednisolone-hydrogen-succinate-neuroendocrine-cell-hyperplasia-of-infan-phase-ii</loc>
    <lastmod>2026-05-28T21:47:18.429Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/177lu-lu-akir001-anaplastic-thyroid-cancer-thyroid-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:47:18.443Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/esketamine-bipolar-disorder-depressive-episode-phase-ii</loc>
    <lastmod>2026-05-28T21:47:18.456Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/repotrectinib-ros1-positive-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:18.470Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/brivaracetam-childhood-absence-epilepsy-juvenile-abse-not-applicable</loc>
    <lastmod>2026-05-28T21:47:18.483Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/itepekimab-chronic-obstructive-pulmonary-disease</loc>
    <lastmod>2026-05-28T21:47:18.498Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/secukinumab-polymyalgia-rheumatica-phase-iii</loc>
    <lastmod>2026-05-28T21:47:18.512Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mepolizumab-chronic-rhinosinusitis-with-nasal-polyps-phase-iv-2</loc>
    <lastmod>2026-05-28T21:47:18.526Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dupilumab-chronic-rhinosinusitis-with-nasal-polyps-phase-iv-2</loc>
    <lastmod>2026-05-28T21:47:18.539Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/stiripentol-primary-hyperoxaluria-ph-ph1-ph2-ph3-phase-iii</loc>
    <lastmod>2026-05-28T21:47:18.553Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/18f-mc225-treatment-resistant-depression-major-dep-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:18.566Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/niraparib-abiraterone-acetate-metastatic-castration-resistant-prostate-phase-ii</loc>
    <lastmod>2026-05-28T21:47:18.581Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/d-l-lysine-acetylsalicylate-chronic-total-occlusion-of-coronary-arte-phase-iii</loc>
    <lastmod>2026-05-28T21:47:18.595Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anti-sars-cov-2-polyclonal-hyperimmune-g-covid-19</loc>
    <lastmod>2026-05-28T21:47:18.609Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apixaban-venous-thromboembolism-phase-iv-2</loc>
    <lastmod>2026-05-28T21:47:18.622Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amlitelimab-atopic-dermatitis-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:18.636Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pemafibrate-nonalcoholic-steatohepatitis-nash-with-l-phase-ii</loc>
    <lastmod>2026-05-28T21:47:18.649Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tisagenlecleucel-b-cell-acute-lymphoblastic-leukemia-high-phase-ii</loc>
    <lastmod>2026-05-28T21:47:18.667Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cyclophosphamide-lymphoblastic-lymphoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:18.680Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/disodium-folinate-locally-advanced-resectable-colon-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:18.694Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/1-6-4m-4-5-chloro-6-methyl-1h-indazol-4-kras-g12c-mutant-advanced-solid-tumors-n-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:18.708Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rasburicase-sepsis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:18.722Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-2-2-10-2-4-3-4-2-2-cyano-4-4-difluor-er-positive-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:18.736Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bispecific-antibody-targeting-ceacam5-an-colorectal-cancer-locally-advanced-or-me-phase-i</loc>
    <lastmod>2026-05-28T21:47:18.750Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rilvegostomig-advanced-her2-expressing-biliary-tract-c-phase-iii</loc>
    <lastmod>2026-05-28T21:47:18.764Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ceacam5-x-cd3-antibody-locally-advanced-or-metastatic-colorecta-phase-i</loc>
    <lastmod>2026-05-28T21:47:18.778Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-obesity-phase-iv</loc>
    <lastmod>2026-05-28T21:47:18.793Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rilvegostomig-endometrial-cancer-her2-expressing-endom-phase-iii</loc>
    <lastmod>2026-05-28T21:47:18.807Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nex-22a-type-2-diabetes-phase-i</loc>
    <lastmod>2026-05-28T21:47:18.820Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-tirumotecan-epithelial-ovarian-cancer-primary-perito-phase-iii</loc>
    <lastmod>2026-05-28T21:47:18.834Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-tirumotecan-non-small-cell-lung-cancer-resectable-cl-phase-iii</loc>
    <lastmod>2026-05-28T21:47:18.848Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levosimendan-cardiogenic-shock-phase-ii</loc>
    <lastmod>2026-05-28T21:47:18.862Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/momelotinib-dihydrochloride-monohydrate-primary-myelofibrosis-post-polycythaemia-phase-iv</loc>
    <lastmod>2026-05-28T21:47:18.876Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/patritumab-deruxtecan-non-small-cell-lung-cancer-egfr-mutated-phase-iii</loc>
    <lastmod>2026-05-28T21:47:18.890Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-tirumotecan-recurrent-ovarian-cancer-platinum-sensit-phase-iii</loc>
    <lastmod>2026-05-28T21:47:18.904Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/al-18f-f-fapi-74-cholangiocarcinoma-not-applicable</loc>
    <lastmod>2026-05-28T21:47:18.918Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etentamig-abbv-383-relapsed-or-refractory-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:18.931Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lisaftoclax-chronic-lymphocytic-leukemia-small-lymph-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:18.945Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glofitamab-relapsed-or-refractory-b-cell-non-hodgki-phase-iii</loc>
    <lastmod>2026-05-28T21:47:18.959Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isatuximab-t-cell-acute-lymphoblastic-leukemia-rela-phase-ii</loc>
    <lastmod>2026-05-28T21:47:18.973Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-non-small-cell-lung-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:18.987Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/risankizumab-axial-spondyloarthritis-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:19.001Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-marginal-zone-lymphoma-extranodal-margin-phase-ii</loc>
    <lastmod>2026-05-28T21:47:19.014Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-msi-h-dmmr-gastric-cancer-msi-h-dmmr-gas-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:19.029Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pirtobrutinib-chronic-lymphocytic-leukemia-small-lymph-phase-iii-3</loc>
    <lastmod>2026-05-28T21:47:19.043Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/modified-vaccinia-ankara-bavarian-nordic-mpox-infection</loc>
    <lastmod>2026-05-28T21:47:19.057Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/timrepigene-emparvovec-choroideremia-x-linked-retinitis-pigment-phase-iii</loc>
    <lastmod>2026-05-28T21:47:19.071Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vancomycin-infective-endocarditis</loc>
    <lastmod>2026-05-28T21:47:19.085Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/treosulfan-acute-myeloid-leukemia-myelodysplastic-s-phase-ii</loc>
    <lastmod>2026-05-28T21:47:19.099Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obefazimod-moderate-to-severe-ulcerative-colitis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:19.114Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/breast-cancer-not-applicable-2</loc>
    <lastmod>2026-05-28T21:47:19.128Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elranatamab-relapsed-refractory-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:19.144Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/copper-sulphate-anhydrous-stannous-chlor-allergic-contact-dermatitis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:19.159Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abbv-453-small-lymphocytic-lymphoma-chronic-lymph-phase-iii</loc>
    <lastmod>2026-05-28T21:47:19.172Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cyclophosphamide-anca-associated-vasculitis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:19.186Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gozetotide-metastatic-hormone-sensitive-prostate-ca-phase-iii</loc>
    <lastmod>2026-05-28T21:47:19.200Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/setmelanotide-obesity-monogenic-obesity-pomc-pcsk1-lep-phase-iii</loc>
    <lastmod>2026-05-28T21:47:19.214Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxybutynin-breast-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:19.228Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-metastatic-gastric-adenocarcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:19.246Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ocrelizumab-neurological-disorder-multiple-sclerosis-not-applicable</loc>
    <lastmod>2026-05-28T21:47:19.260Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenalidomide-multiple-myeloma-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:19.274Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dronabinol-cannabidiol-refractory-epilepsy-phase-iii</loc>
    <lastmod>2026-05-28T21:47:19.287Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-high-risk-her2-positive-breast-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:19.301Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gb-0895-asthma-chronic-obstructive-pulmonary-dis-phase-i</loc>
    <lastmod>2026-05-28T21:47:19.316Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/intestifix-liver-cirrhosis-ascites-phase-ii</loc>
    <lastmod>2026-05-28T21:47:19.330Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/quizartinib-dihydrochloride-acute-myeloid-leukemia-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:19.345Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/g-strophanthin-acute-heart-failure-phase-iv</loc>
    <lastmod>2026-05-28T21:47:19.358Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/maq-001-metastatic-melanoma-lung-cancer-renal-ce-phase-i</loc>
    <lastmod>2026-05-28T21:47:19.372Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trometamol-sodium-dihydrogen-phosphate-d-cardiovascular-surgery-phase-iv</loc>
    <lastmod>2026-05-28T21:47:19.386Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/db-1303-endometrial-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:19.399Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutetium-177lu-vipivotide-tetraxetan-metastatic-castration-resistant-prostate-phase-iii</loc>
    <lastmod>2026-05-28T21:47:19.415Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gsk4532990a-non-alcoholic-fatty-liver-disease-nonalc-phase-ii</loc>
    <lastmod>2026-05-28T21:47:19.429Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nvl-655-neladalkib-advanced-alk-positive-non-small-cell-lun-phase-iii</loc>
    <lastmod>2026-05-28T21:47:19.443Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alectinib-advanced-or-metastatic-non-small-cell-lu-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:19.457Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ocrelizumab-multiple-sclerosis-phase-iv-3</loc>
    <lastmod>2026-05-28T21:47:19.471Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gemcitabine-intrahepatic-cholangiocarcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:19.485Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/entrectinib-non-small-cell-lung-cancer-ros1-gene-rea-phase-iii</loc>
    <lastmod>2026-05-28T21:47:19.498Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/deferoxamine-mesilate-pulmonary-aspergillosis-allergic-broncho-phase-iv</loc>
    <lastmod>2026-05-28T21:47:19.512Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/enzalutamide-prostate-cancer-metastatic-prostate-canc-phase-ii</loc>
    <lastmod>2026-05-28T21:47:19.529Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/225ac-psma-trillium-bay-3563254-metastatic-castration-resistant-prostate-phase-i</loc>
    <lastmod>2026-05-28T21:47:19.543Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tulisokibart-crohn-s-disease-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:19.557Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elritercept-myelodysplastic-syndrome-anemia-phase-ii</loc>
    <lastmod>2026-05-28T21:47:19.570Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avalglucosidase-alfa-late-onset-pompe-disease-pompe-disease</loc>
    <lastmod>2026-05-28T21:47:19.585Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/finerenone-chronic-kidney-disease</loc>
    <lastmod>2026-05-28T21:47:19.599Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tafasitamab-diffuse-large-b-cell-lymphoma-dlbcl-rela-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:19.613Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutetium-177lu-oxodotreotide-gastroenteropancreatic-neuroendocrine-tu-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:19.627Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ds-3939a-metastatic-solid-tumor-advanced-solid-tu-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:19.641Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/baloxavir-marboxil-pneumonia</loc>
    <lastmod>2026-05-28T21:47:19.654Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methylphenidate-cancer-related-fatigue-brain-tumor-phase-iii</loc>
    <lastmod>2026-05-28T21:47:19.669Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/op-1250-palazestrant-er-positive-her2-negative-advanced-breas-phase-iii</loc>
    <lastmod>2026-05-28T21:47:19.682Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-advanced-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:19.696Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/direclidine-schizophrenia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:19.710Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efgartigimod-alfa-chronic-inflammatory-demyelinating-polyn-phase-ii</loc>
    <lastmod>2026-05-28T21:47:19.724Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/secukinumab-plaque-psoriasis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:19.737Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/baricitinib-systemic-juvenile-idiopathic-arthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:19.751Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/humanised-igg4-kappa-monoclonal-antibody-ulcerative-colitis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:19.764Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bosentan-coronary-vasospasm-coronary-vasomotor-dy-phase-iii</loc>
    <lastmod>2026-05-28T21:47:19.778Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gilteritinib-acute-myeloid-leukemia-phase-ii</loc>
    <lastmod>2026-05-28T21:47:19.792Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/selpercatinib-non-small-cell-lung-cancer-medullary-thy-phase-iv</loc>
    <lastmod>2026-05-28T21:47:19.805Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-metastatic-colorectal-cancer-unresectabl-phase-iii</loc>
    <lastmod>2026-05-28T21:47:19.825Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/losartan-potassium-glioblastoma-brain-metastases-from-non-s-phase-ii</loc>
    <lastmod>2026-05-28T21:47:19.839Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cd19-targeted-car-t-cells-myasthenia-gravis-progressive-multiple-s-phase-i</loc>
    <lastmod>2026-05-28T21:47:19.853Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abbv-cls-484-metastatic-or-locally-advanced-tumours-a-phase-i</loc>
    <lastmod>2026-05-28T21:47:19.866Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/satralizumab-neuromyelitis-optica-spectrum-disorder-a-phase-iii</loc>
    <lastmod>2026-05-28T21:47:19.881Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fingolimod-multiple-sclerosis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:19.895Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pralatrexate-peripheral-t-cell-lymphoma-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:19.909Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/disitamab-vedotin-breast-cancer-her2-positive-and-her2-low-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:19.923Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/osimertinib-non-small-cell-lung-cancer-unresectable-phase-ii</loc>
    <lastmod>2026-05-28T21:47:19.937Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nmd670-myasthenia-gravis-achr-musk-antibody-pos-phase-ii</loc>
    <lastmod>2026-05-28T21:47:19.951Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dasatinib-cytokine-release-syndrome-relapsed-refra-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:19.965Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/perampanel-childhood-epilepsy-epilepsy-phase-iv</loc>
    <lastmod>2026-05-28T21:47:19.979Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rivaroxaban-hip-osteoarthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:19.992Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iph5201-non-small-cell-lung-cancer-stage-ii-iii-phase-ii</loc>
    <lastmod>2026-05-28T21:47:20.006Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rosuvastatin-calcium-statin-intolerance-high-cardiovascular-r-phase-iv</loc>
    <lastmod>2026-05-28T21:47:20.021Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cladribine-generalized-myasthenia-gravis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:20.034Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/darolutamide-castration-resistant-prostate-cancer-oli-phase-iii</loc>
    <lastmod>2026-05-28T21:47:20.048Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/recombinant-chimeric-bacteriophage-endol-nasal-colonization-with-methicillin-susc-phase-i</loc>
    <lastmod>2026-05-28T21:47:20.062Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/relatlimab-muscle-invasive-bladder-cancer-urothelia-phase-ii</loc>
    <lastmod>2026-05-28T21:47:20.076Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methotrexate-rheumatoid-arthritis-phase-iv-2</loc>
    <lastmod>2026-05-28T21:47:20.089Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vitiligo-phase-iv</loc>
    <lastmod>2026-05-28T21:47:20.102Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/selpercatinib-ret-fusion-positive-solid-tumor-medullar-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:20.116Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/finerenone-chronic-kidney-disease-2</loc>
    <lastmod>2026-05-28T21:47:20.130Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pirtobrutinib-chronic-lymphocytic-leukemia-small-lymph-phase-iii-4</loc>
    <lastmod>2026-05-28T21:47:20.144Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutetium-177lu-oxodotreotide-gastroenteropancreatic-neuroendocrine-tu-phase-ii</loc>
    <lastmod>2026-05-28T21:47:20.158Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/patritumab-deruxtecan-locally-advanced-or-metastatic-solid-tum-phase-ii</loc>
    <lastmod>2026-05-28T21:47:20.172Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ketorolac-estrogen-receptor-positive-early-breast-phase-iv</loc>
    <lastmod>2026-05-28T21:47:20.186Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ketamine-hydrochloride-major-depressive-disorder-treatment-resi-phase-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:47:20.200Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/platelet-concentrate-low-back-pain-intervertebral-disc-degene</loc>
    <lastmod>2026-05-28T21:47:20.213Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aav9-ctnt-cobag3-bag3-associated-dilated-cardiomyopathy-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:20.227Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isatuximab-smoldering-multiple-myeloma-plasma-cell-phase-iii</loc>
    <lastmod>2026-05-28T21:47:20.241Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mk-1167-alzheimer-s-disease-dementia-phase-ii</loc>
    <lastmod>2026-05-28T21:47:20.255Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inavolisib-solid-tumor-phase-ii</loc>
    <lastmod>2026-05-28T21:47:20.268Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prosetin-amyotrophic-lateral-sclerosis-phase-i</loc>
    <lastmod>2026-05-28T21:47:20.282Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/linezolid-bacterial-infection-postoperative-infect-phase-iv</loc>
    <lastmod>2026-05-28T21:47:20.296Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aprepitant-postoperative-nausea-and-vomiting-phase-iv</loc>
    <lastmod>2026-05-28T21:47:20.309Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-1015550-chemical-1-5r-2-4-5-chloro-2-idiopathic-pulmonary-fibrosis-progressiv-phase-iii</loc>
    <lastmod>2026-05-28T21:47:20.323Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-2-2-10-2-4-3-4-2-2-cyano-4-4-difluor-er-positive-breast-cancer-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:20.339Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/raxtozinameran-type-1-diabetes-islet-autoimmunity-phase-iv</loc>
    <lastmod>2026-05-28T21:47:20.353Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vancomycin-hydrochloride-infectious-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:20.366Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/copper-sulphate-anhydrous-stannous-chlor-allergic-contact-dermatitis-eczema-phase-iii</loc>
    <lastmod>2026-05-28T21:47:20.380Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pentixather-yttrium-90-non-hodgkin-lymphoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:20.393Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/permethrin-scabies-phase-iii</loc>
    <lastmod>2026-05-28T21:47:20.406Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-resectable-soft-tissue-sarcoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:20.419Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/raludotatug-deruxtecan-platinum-resistant-high-grade-serous-ova-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:20.433Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-kidney-transplantation-phase-iv</loc>
    <lastmod>2026-05-28T21:47:20.448Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/linvoseltamab-relapsed-or-refractory-systemic-light-ch-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:20.461Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-pancreatic-islets-periampullary-carcinoma-pancreatic-cance-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:20.475Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-non-small-cell-lung-cancer-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:20.489Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isotretinoin-acne</loc>
    <lastmod>2026-05-28T21:47:20.510Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-4-1r-4r-4-hydroxy-4-methylcyclohexyl-m-multiple-myeloma-relapsed-refractory-mul-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:20.524Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fulvestrant-advanced-breast-cancer-hormone-receptor-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:20.538Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vosilasarm-breast-cancer-hormone-receptor-positive-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:20.552Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sb27-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:20.566Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/placebo-seasonal-allergic-rhinitis-allergic-rhin-phase-iii</loc>
    <lastmod>2026-05-28T21:47:20.579Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bilayer-engineered-collagen-hydrogel-bas-deep-partial-thickness-and-full-thicknes-phase-iii</loc>
    <lastmod>2026-05-28T21:47:20.593Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/idh305-advanced-malignancies-with-idh1-r132-mut-phase-i</loc>
    <lastmod>2026-05-28T21:47:20.607Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dronabinol-cannabidiol-neurodegenerative-diseases-amyotrophic-l-phase-ii</loc>
    <lastmod>2026-05-28T21:47:20.620Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oms906-paroxysmal-nocturnal-hemoglobinuria-pnh-phase-ii</loc>
    <lastmod>2026-05-28T21:47:20.634Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ray121-bullous-pemphigoid-behcet-s-syndrome-der-phase-i</loc>
    <lastmod>2026-05-28T21:47:20.647Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ziclumeran-single-guide-rna-targeting-th-hereditary-transthyretin-amyloidosis-wit-not-applicable</loc>
    <lastmod>2026-05-28T21:47:20.661Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tern-701-chronic-myeloid-leukemia-phase-i</loc>
    <lastmod>2026-05-28T21:47:20.675Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/4-3-cyanomethyl-3-3-5-dimethyl-1h-1-h-4-hidradenitis-suppurativa-phase-iii</loc>
    <lastmod>2026-05-28T21:47:20.688Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/valemetostat-tosylate-peripheral-t-cell-lymphoma-adult-t-cell-phase-ii</loc>
    <lastmod>2026-05-28T21:47:20.701Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aaa802-psma-positive-metastatic-hormone-sensiti-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:20.715Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clostridium-botulinum-neurotoxin-serotyp-upper-limb-spasticity-post-stroke-upper-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:20.729Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vafidemstat-schizophrenia-phase-ii</loc>
    <lastmod>2026-05-28T21:47:20.742Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/valine-alanine-arginine-histidine-isoleu-oesophagectomy-phase-iv</loc>
    <lastmod>2026-05-28T21:47:20.756Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amiodarone-hydrochloride-atrial-fibrillation</loc>
    <lastmod>2026-05-28T21:47:20.770Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-inflammatory-breast-cancer-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:20.783Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mosaic-hbcoreag-chronic-hepatitis-b-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:20.797Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/platelet-concentrate-dry-eye-disease-not-applicable</loc>
    <lastmod>2026-05-28T21:47:20.810Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/satralizumab-myelin-oligodendrocyte-glycoprotein-anti-phase-iii</loc>
    <lastmod>2026-05-28T21:47:20.824Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ion440-mecp2-duplication-syndrome-mds-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:20.838Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/caba-201-systemic-lupus-erythematosus-lupus-nephr-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:20.851Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-muscle-invasive-bladder-cancer-urothelia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:20.865Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mb-hucart19-1-b-cell-precursor-acute-lymphoblastic-leu-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:20.878Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cetrelimab-high-risk-non-muscle-invasive-bladder-ca-phase-iii</loc>
    <lastmod>2026-05-28T21:47:20.892Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-gastric-cancer-gastroesophageal-junction-phase-iii</loc>
    <lastmod>2026-05-28T21:47:20.906Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tsr-022-advanced-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:47:20.923Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isatuximab-multiple-myeloma-plasma-cell-myeloma-phase-iv</loc>
    <lastmod>2026-05-28T21:47:20.936Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/db-1303-breast-cancer-her2-low-hormone-receptor-phase-iii</loc>
    <lastmod>2026-05-28T21:47:20.950Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zilovertamab-vedotin-b-cell-acute-lymphoblastic-leukemia-diff-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:20.964Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acp-204-tartrate-alzheimer-s-disease-psychosis-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:20.978Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/d-l-lysine-acetylsalicylate-acetylsalicy-chronic-coronary-syndrome-acute-coronary-not-applicable</loc>
    <lastmod>2026-05-28T21:47:20.992Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly3200882-metastatic-cancer-solid-tumor-phase-i</loc>
    <lastmod>2026-05-28T21:47:21.006Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cefazolin-inguinal-hernia-femoral-hernia-not-applicable</loc>
    <lastmod>2026-05-28T21:47:21.019Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elranatamab-multiple-myeloma-phase-ii-3</loc>
    <lastmod>2026-05-28T21:47:21.033Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abemaciclib-metastatic-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:21.046Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenalidomide-diffuse-large-b-cell-lymphoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:21.060Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-triple-negative-breast-cancer-metastatic-phase-ii</loc>
    <lastmod>2026-05-28T21:47:21.073Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/divarasib-non-small-cell-lung-cancer-advanced-non-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:21.087Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elebsiran-chronic-hepatitis-d-hdv-infection-phase-ii</loc>
    <lastmod>2026-05-28T21:47:21.101Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-2-2-10-2-4-3-4-2-2-cyano-4-4-difluor-triple-negative-breast-cancer-breast-can-not-applicable</loc>
    <lastmod>2026-05-28T21:47:21.114Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ustekinumab-juvenile-psoriatic-arthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:21.128Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sar444336-microscopic-colitis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:21.141Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ravulizumab-immunoglobulin-a-nephropathy-igan-phase-iii</loc>
    <lastmod>2026-05-28T21:47:21.155Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ranibizumab-neovascular-age-related-macular-degenera-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:21.169Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metyrapone-adrenal-incidentaloma-subclinical-cushin-phase-iv</loc>
    <lastmod>2026-05-28T21:47:21.182Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/propofol-valvular-heart-disease-coronary-heart-di-phase-iv</loc>
    <lastmod>2026-05-28T21:47:21.196Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tifcemalimab-small-cell-lung-cancer-limited-stage-phase-iii</loc>
    <lastmod>2026-05-28T21:47:21.210Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bifikafusp-alfa-malignant-melanoma-malignant-melanoma-st-phase-iii</loc>
    <lastmod>2026-05-28T21:47:21.224Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/selpercatinib-ret-altered-solid-tumors-primary-central-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:21.238Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-skin-derived-adult-keratinocy-basal-cell-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:21.253Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-77242113-moderate-to-severe-plaque-psoriasis-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:21.266Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pirtobrutinib-mantle-cell-lymphoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:21.280Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxaliplatin-metastatic-colorectal-adenocarcinoma-gas-phase-ii</loc>
    <lastmod>2026-05-28T21:47:21.295Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/recombinant-human-ectonucleotide-pyropho-ectonucleotide-pyrophosphatase-phosphodi-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:21.308Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-hepatocellular-carcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:21.322Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efgartigimod-alfa-generalized-myasthenia-gravis-myasthenia-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:21.336Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/platelet-concentrate-genitourinary-syndrome-of-menopause-not-applicable</loc>
    <lastmod>2026-05-28T21:47:21.349Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gemcitabine-hydrochloride-high-risk-non-muscle-invasive-bladder-ca-phase-iii</loc>
    <lastmod>2026-05-28T21:47:21.364Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/platelet-concentrate-dry-eye-disease-not-applicable-2</loc>
    <lastmod>2026-05-28T21:47:21.377Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/romiplostim-chemotherapy-induced-thrombocytopenia-no-phase-iii</loc>
    <lastmod>2026-05-28T21:47:21.391Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/infliximab-crohn-s-disease-inflammatory-bowel-disea-phase-iv</loc>
    <lastmod>2026-05-28T21:47:21.405Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/erdafitinib-non-muscle-invasive-bladder-cancer-inter-phase-iii</loc>
    <lastmod>2026-05-28T21:47:21.418Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/kd050-advanced-solid-tumors-non-small-cell-lun-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:21.432Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acp-204-tartrate-alzheimer-s-disease-psychosis-alzheimer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:21.446Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prp-platelet-rich-plasma-knee-osteoarthritis-not-applicable</loc>
    <lastmod>2026-05-28T21:47:21.460Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prasinezumab-early-parkinson-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:47:21.474Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-non-small-cell-lung-cancer-advanced-meta-phase-iii</loc>
    <lastmod>2026-05-28T21:47:21.488Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-membranous-nephropathy-not-applicable</loc>
    <lastmod>2026-05-28T21:47:21.502Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-normal-immunoglobulin-iv-chronic-immune-thrombocytopenia-itp-phase-iii</loc>
    <lastmod>2026-05-28T21:47:21.516Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/selumetinib-selumetinib-hyd-sulfate-neurofibromatosis-type-1-nf1-with-sympto-phase-iii</loc>
    <lastmod>2026-05-28T21:47:21.529Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/64cu-dota-ae105-prostate-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:21.543Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ocrelizumab-multiple-sclerosis</loc>
    <lastmod>2026-05-28T21:47:21.557Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/munc-cd34-familial-hemophagocytic-lymphohistiocyto-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:21.570Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/locally-advanced-rectal-cancer-rectal-ca-phase-i</loc>
    <lastmod>2026-05-28T21:47:21.584Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pneumococcal-polysaccharide-conjugate-mu-prevention-of-pneumococcal-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:21.598Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vibrio-alginolyticus-collagenase-dupuytren-s-contracture-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:21.613Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/povetacicept-autoimmune-cytopenias-warm-autoimmune-he-phase-iv</loc>
    <lastmod>2026-05-28T21:47:21.626Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/antithrombin-iii-human-acquired-antithrombin-iii-deficiency-hep-phase-iii</loc>
    <lastmod>2026-05-28T21:47:21.640Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ibrutinib-follicular-lymphoma-chronic-lymphocytic-phase-iv</loc>
    <lastmod>2026-05-28T21:47:21.654Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rapcabtagene-autoleucel-high-risk-large-b-cell-lymphoma-chronic-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:21.667Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/grt-001-ulcerative-colitis-phase-i</loc>
    <lastmod>2026-05-28T21:47:21.681Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-pertuzumab-her2-positive-unresectable-locally-advan-phase-ii</loc>
    <lastmod>2026-05-28T21:47:21.694Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belantamab-mafodotin-multiple-myeloma-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:21.708Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apixaban-end-stage-renal-disease-on-chronic-perit</loc>
    <lastmod>2026-05-28T21:47:21.721Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd8421-er-positive-her2-negative-advanced-breas-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:21.735Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/empasiprubart-multifocal-motor-neuropathy-phase-ii</loc>
    <lastmod>2026-05-28T21:47:21.748Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-advanced-solid-tumors-phase-i-ii-2</loc>
    <lastmod>2026-05-28T21:47:21.762Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methoxyflurane-99-9-acute-myocardial-infarction-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:21.775Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tozorakimab-severe-viral-lung-infections-phase-iii</loc>
    <lastmod>2026-05-28T21:47:21.789Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/patidegib-hydrochloride-isopropanolate-gorlin-syndrome-basal-cell-carcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:21.804Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clarithromycin-community-acquired-pneumonia-sepsis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:21.817Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lufepirsen-persistent-corneal-epithelial-defect-phase-ii</loc>
    <lastmod>2026-05-28T21:47:21.831Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/domvanalimab-gastric-adenocarcinoma-gastroesophageal-phase-iii</loc>
    <lastmod>2026-05-28T21:47:21.845Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/navitoclax-myelofibrosis-myeloproliferative-neoplas-phase-i</loc>
    <lastmod>2026-05-28T21:47:21.858Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cevostamab-multiple-myeloma-relapsed-or-refractory-phase-iii</loc>
    <lastmod>2026-05-28T21:47:21.872Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/syn2-coronary-artery-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:47:21.886Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adalimumab-ulcerative-colitis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:21.899Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metyrapone-primary-bilateral-macronodular-adrenal-h-phase-iii</loc>
    <lastmod>2026-05-28T21:47:21.912Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/futibatinib-solid-tumor-esophageal-cancer-pancreatic-phase-ii</loc>
    <lastmod>2026-05-28T21:47:21.929Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/molnupiravir-covid-19-sars-cov-2-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:47:21.943Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carboplatin-triple-negative-breast-cancer-high-risk-phase-ii</loc>
    <lastmod>2026-05-28T21:47:21.957Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levobupivacaine-total-hip-arthroplasty-not-applicable</loc>
    <lastmod>2026-05-28T21:47:21.970Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ruxolitinib-myelofibrosis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:21.984Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bomedemstat-myeloproliferative-neoplasms-essential-t-phase-iii</loc>
    <lastmod>2026-05-28T21:47:21.998Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cetrelimab-muscle-invasive-bladder-cancer-muscle-in-phase-iii</loc>
    <lastmod>2026-05-28T21:47:22.011Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-non-small-cell-lung-cancer-phase-iii-3</loc>
    <lastmod>2026-05-28T21:47:22.026Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/risankizumab-ulcerative-colitis-phase-iii-3</loc>
    <lastmod>2026-05-28T21:47:22.039Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/influenza-virus-b-michigan-01-2021-influ-influenza-obesity-type-2-diabetes-phase-iv</loc>
    <lastmod>2026-05-28T21:47:22.054Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-bone-sarcoma-osteosarcoma-ewing-sarcoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:22.067Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ziltivekimab-heart-failure-with-mildly-reduced-ejecti-phase-iii</loc>
    <lastmod>2026-05-28T21:47:22.081Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rapcabtagene-autoleucel-b-cell-lymphoma-b-cell-acute-leukaemia-m-phase-iii</loc>
    <lastmod>2026-05-28T21:47:22.095Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-tirumotecan-gastroesophageal-adenocarcinoma-gastric-phase-i-ii-2</loc>
    <lastmod>2026-05-28T21:47:22.109Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carboplatin-metastatic-castration-resistant-prostate-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:22.122Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/skb264-advanced-non-small-cell-lung-cancer-non-phase-ii</loc>
    <lastmod>2026-05-28T21:47:22.137Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-locally-advanced-cervical-cancer-high-ri-phase-ii</loc>
    <lastmod>2026-05-28T21:47:22.151Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mitomycin-formulation-contains-poloxamer-non-muscle-invasive-bladder-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:22.164Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belimumab-systemic-lupus-erythematosus-lupus-nephr-phase-ii</loc>
    <lastmod>2026-05-28T21:47:22.178Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-non-alcoholic-steatohepatitis-nash-phase-iii</loc>
    <lastmod>2026-05-28T21:47:22.192Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adeno-associated-virus-vector-serotype-8-hemophilia-b-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:22.206Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ferumoxtran-10-esophageal-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:47:22.220Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/desmopressin-acetate-trihydrate-severe-hyponatremia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:22.233Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sulfur-hexafluoride-fetal-growth-restriction-phase-iv</loc>
    <lastmod>2026-05-28T21:47:22.246Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/valoctocogene-roxaparvovec-hemophilia-a-phase-iv</loc>
    <lastmod>2026-05-28T21:47:22.260Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mirabegron-healthy-volunteers-phase-ii</loc>
    <lastmod>2026-05-28T21:47:22.274Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dantrolene-sodium-glabellar-lines-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:22.287Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/advanced-solid-tumour-not-applicable</loc>
    <lastmod>2026-05-28T21:47:22.302Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/selinexor-advanced-soft-tissue-sarcoma-leiomyosarc-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:22.322Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ari0003-cells-relapsed-refractory-b-cell-aggressive-ly-phase-i</loc>
    <lastmod>2026-05-28T21:47:22.335Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-glioblastoma-multiforme-phase-iv</loc>
    <lastmod>2026-05-28T21:47:22.349Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elritercept-myelofibrosis-primary-myelofibrosis-post-phase-ii</loc>
    <lastmod>2026-05-28T21:47:22.363Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mosunetuzumab-follicular-lymphoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:22.377Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lomustine-glioblastoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:22.390Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cerebrovascular-arteriovenous-malformati-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:47:22.404Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methyl-aminolevulinate-hydrochloride-frontal-fibrosing-alopecia-phase-ii</loc>
    <lastmod>2026-05-28T21:47:22.419Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/11c-modag-005-radiolabelled-pet-radiolig-parkinson-s-disease-multiple-system-atro-phase-i</loc>
    <lastmod>2026-05-28T21:47:22.433Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/irritable-bowel-syndrome-phase-iv</loc>
    <lastmod>2026-05-28T21:47:22.446Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-normal-immunoglobulin-iv-paraneoplastic-sensory-neuropathy-with-a-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:22.460Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alteplase-acute-ischemic-stroke-anterior-circulati-phase-iii</loc>
    <lastmod>2026-05-28T21:47:22.474Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cagrilintide-nnc0174-0833-semaglutide-nn-overweight-obesity-phase-iii</loc>
    <lastmod>2026-05-28T21:47:22.488Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ziltivekimab-atherosclerotic-cardiovascular-disease-c-phase-iii</loc>
    <lastmod>2026-05-28T21:47:22.502Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/concizumab-haemophilia-a-haemophilia-b-phase-iii</loc>
    <lastmod>2026-05-28T21:47:22.515Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cagrilintide-semaglutide-cardiovascular-disease-type-2-diabetes-m-phase-iii</loc>
    <lastmod>2026-05-28T21:47:22.532Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/giredestrant-estrogen-receptor-positive-her2-negative-phase-iii</loc>
    <lastmod>2026-05-28T21:47:22.545Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gsk3862995b-chronic-obstructive-pulmonary-disease-phase-i</loc>
    <lastmod>2026-05-28T21:47:22.559Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belantamab-mafodotin-relapsed-refractory-multiple-myeloma-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:22.573Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cctx-001-acute-myeloid-leukemia-relapsed-refracto-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:22.587Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-renal-cell-carcinoma-phase-i-ii-phase-ii</loc>
    <lastmod>2026-05-28T21:47:22.600Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/concizumab-haemophilia-a-haemophilia-b-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:22.614Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/triptorelin-menopause-phase-iv</loc>
    <lastmod>2026-05-28T21:47:22.635Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cal101-idiopathic-pulmonary-fibrosis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:22.649Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/berubicin-hydrochloride-primary-central-nervous-system-lymphoma-phase-i</loc>
    <lastmod>2026-05-28T21:47:22.663Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ranibizumab-neovascular-age-related-macular-degenera-phase-iii-3</loc>
    <lastmod>2026-05-28T21:47:22.676Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aldesleukin-pancreatic-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:22.690Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-4-1r-4r-4-hydroxy-4-methylcyclohexyl-m-previously-untreated-chronic-lymphocytic-phase-iii</loc>
    <lastmod>2026-05-28T21:47:22.704Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/somapacitan-short-stature-small-for-gestational-age-phase-iii</loc>
    <lastmod>2026-05-28T21:47:22.718Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rifamycin-sodium-left-sided-ulcerative-colitis-ulcerative-phase-ii</loc>
    <lastmod>2026-05-28T21:47:22.732Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glofitamab-diffuse-large-b-cell-lymphoma-relapsed-r-phase-iii</loc>
    <lastmod>2026-05-28T21:47:22.746Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/intestifix-hepatocellular-carcinoma-non-resectable-phase-ii</loc>
    <lastmod>2026-05-28T21:47:22.759Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alectinib-alk-positive-non-small-cell-lung-cancer</loc>
    <lastmod>2026-05-28T21:47:22.776Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-melanoma-malignant-melanoma-stage-ii-mal-phase-iii</loc>
    <lastmod>2026-05-28T21:47:22.792Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ziltivekimab-acute-myocardial-infarction-type-1-phase-iii</loc>
    <lastmod>2026-05-28T21:47:22.805Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etentamig-abbv-383-relapsed-refractory-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:22.819Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/farletuzumab-ecteriblin-platinum-resistant-ovarian-cancer-triple-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:22.832Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bepirovirsen-chronic-hepatitis-b-phase-ii</loc>
    <lastmod>2026-05-28T21:47:22.846Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alectinib-alk-positive-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:22.860Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/benzylpenicillin-sodium-staphylococcus-aureus-bacteraemia-staphy-not-applicable</loc>
    <lastmod>2026-05-28T21:47:22.874Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/niraparib-abiraterone-acetate-prostate-cancer-metastatic-hormone-sensi-phase-iii</loc>
    <lastmod>2026-05-28T21:47:22.888Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amikacin-mycobacterium-xenopi-pulmonary-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:47:22.902Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mk-4830-renal-cell-carcinoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:22.915Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-papillomavirus-type-31-l1-protein-vulvar-high-grade-squamous-intraepitheli</loc>
    <lastmod>2026-05-28T21:47:22.929Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/macitentan-pulmonary-arterial-hypertension-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:22.943Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hexaminolevulinate-non-muscle-invasive-bladder-cancer-phase-iv-2</loc>
    <lastmod>2026-05-28T21:47:22.956Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lisdexamfetamine-dimesylate-attention-deficit-hyperactivity-disorder-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:22.970Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/somapacitan-short-stature-in-children-born-small-for-phase-ii</loc>
    <lastmod>2026-05-28T21:47:22.984Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-type-2-diabetes-diabetic-retinopathy-phase-iii</loc>
    <lastmod>2026-05-28T21:47:22.999Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxytocin-synthetic-autism-spectrum-disorder-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:23.013Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/giredestrant-breast-cancer-estrogen-receptor-positive-phase-iii</loc>
    <lastmod>2026-05-28T21:47:23.027Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carboplatin-solid-tumours-with-homologous-recombinat-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:23.041Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apalutamide-metastatic-hormone-naive-prostate-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:23.055Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pravastatin-sodium-hypercholesterolemia-cardiovascular-risk-phase-iv</loc>
    <lastmod>2026-05-28T21:47:23.069Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/morphine-sulfate-limb-injuries-traumatic-pain</loc>
    <lastmod>2026-05-28T21:47:23.082Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dimethyl-fumarate-adrenomyeloneuropathy-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:23.096Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sotorasib-amg-510-advanced-solid-tumors-kras-p-g12c-mutati-phase-iii</loc>
    <lastmod>2026-05-28T21:47:23.110Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly3484356-breast-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:23.123Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/selpercatinib-non-small-cell-lung-cancer-ret-fusion-po-phase-iii</loc>
    <lastmod>2026-05-28T21:47:23.137Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mrna-4157-non-small-cell-lung-cancer-resectable-no-phase-iii</loc>
    <lastmod>2026-05-28T21:47:23.151Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abemaciclib-prostate-cancer-metastatic-castration-re-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:23.165Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ipn01194-pancreatic-ductal-adenocarcinoma-melanom-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:23.179Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/stx-721-pfl-721-non-small-cell-lung-cancer-locally-advan</loc>
    <lastmod>2026-05-28T21:47:23.193Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluconazole-fungal-infection-phase-iv</loc>
    <lastmod>2026-05-28T21:47:23.207Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd3470-advanced-metastatic-solid-tumours-with-m-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:23.220Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/imgn151-endometrial-cancer-recurrent-epithelial-phase-i</loc>
    <lastmod>2026-05-28T21:47:23.235Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/exl01-metastatic-gastric-adenocarcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:23.248Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/repotrectinib-advanced-solid-tumors-phase-i-ii-2</loc>
    <lastmod>2026-05-28T21:47:23.262Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dersimelagon-phosphate-erythropoietic-protoporphyria-x-linked-p-phase-iii</loc>
    <lastmod>2026-05-28T21:47:23.276Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ustekinumab-ulcerative-colitis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:23.289Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adeno-associated-virus-serotype-8-expres-limb-girdle-muscular-dystrophy-type-r5-l-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:23.303Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/daratumumab-multiple-myeloma-relapsed-and-or-refract-phase-ii</loc>
    <lastmod>2026-05-28T21:47:23.317Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-locoregionally-advanced-penile-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:23.333Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ocrelizumab-progressive-multiple-sclerosis-primary-p-phase-iv</loc>
    <lastmod>2026-05-28T21:47:23.346Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/recombinant-human-interferon-gamma-1b-post-aggressive-immunosuppression-immuno-phase-ii</loc>
    <lastmod>2026-05-28T21:47:23.360Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-tumour-infiltrating-lymphocyt-melanoma-non-small-cell-lung-cancer-cerv-phase-ii</loc>
    <lastmod>2026-05-28T21:47:23.374Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anakinra-familial-mediterranean-fever-phase-iii</loc>
    <lastmod>2026-05-28T21:47:23.388Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/risankizumab-crohn-s-disease-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:23.402Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zanubrutinib-mantle-cell-lymphoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:23.416Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-86974680-advanced-non-small-cell-lung-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:47:23.430Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cenobamate-primary-generalized-tonic-clonic-seizure-phase-iii</loc>
    <lastmod>2026-05-28T21:47:23.444Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tsr-042-anti-pd-1-monoclonal-antibody-advanced-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:47:23.457Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-gastric-cancer-gastroesophageal-junction-phase-ii</loc>
    <lastmod>2026-05-28T21:47:23.471Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anifrolumab-proliferative-lupus-nephritis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:23.485Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/depemokimab-eosinophilic-granulomatosis-with-polyang-phase-iii</loc>
    <lastmod>2026-05-28T21:47:23.499Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zamtocabtagene-autoleucel-relapsed-refractory-mature-b-cell-neopla-phase-ii</loc>
    <lastmod>2026-05-28T21:47:23.513Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-1015550-systemic-sclerosis-associated-interstiti-phase-ii</loc>
    <lastmod>2026-05-28T21:47:23.527Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bimekizumab-moderate-to-severe-plaque-psoriasis-psor-phase-iii</loc>
    <lastmod>2026-05-28T21:47:23.540Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/177lu-lu-dota-tate-glioblastoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:23.554Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-4-fluorophenyl-n-4-7-methoxy-6-methylc-recurrent-or-metastatic-head-and-neck-sq-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:23.568Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lorlatinib-non-small-cell-lung-cancer-alk-positive-phase-ii</loc>
    <lastmod>2026-05-28T21:47:23.582Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/deucravacitinib-psoriatic-arthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:23.596Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/faricimab-myopic-choroidal-neovascularization-phase-iii</loc>
    <lastmod>2026-05-28T21:47:23.610Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/linvoseltamab-relapsed-refractory-multiple-myeloma-mul-phase-iii</loc>
    <lastmod>2026-05-28T21:47:23.626Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/golcadomide-relapsed-or-refractory-aggressive-large-phase-ii</loc>
    <lastmod>2026-05-28T21:47:23.639Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-faecal-microbiota-pooled-recurrent-diverticulitis-acute-diverticu-phase-ii</loc>
    <lastmod>2026-05-28T21:47:23.653Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-locally-advanced-rectal-cancer-rectal-ca-not-applicable</loc>
    <lastmod>2026-05-28T21:47:23.667Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prasterone-genitourinary-syndrome-of-menopause-brea-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:23.680Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/darovasertib-metastatic-uveal-melanoma-hla-a2-negativ-phase-ii-iii-2</loc>
    <lastmod>2026-05-28T21:47:23.694Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-diffuse-large-b-cell-lymphoma-phase-iv</loc>
    <lastmod>2026-05-28T21:47:23.707Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etentamig-relapsed-or-refractory-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:23.720Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/upadacitinib-non-segmental-vitiligo-phase-iii</loc>
    <lastmod>2026-05-28T21:47:23.734Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/5-4-2s-5s-5-4-chlorobenzyl-2-methylmorph-pulmonary-sarcoidosis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:23.748Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/influenza-virus-b-austria-1359417-2021-l-influenza</loc>
    <lastmod>2026-05-28T21:47:23.761Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-metastatic-colorectal-cancer-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:23.775Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gemcitabine-hydrochloride-non-muscle-invasive-bladder-cancer-nmibc-phase-ii</loc>
    <lastmod>2026-05-28T21:47:23.788Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amivantamab-non-small-cell-lung-cancer-egfr-exon-20-phase-iii</loc>
    <lastmod>2026-05-28T21:47:23.802Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tofacitinib-ulcerative-colitis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:23.816Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acalabrutinib-chronic-lymphocytic-leukaemia-cll-high-r-phase-iii</loc>
    <lastmod>2026-05-28T21:47:23.830Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dermatophagoides-farinae-extract-dermato-house-dust-mite-allergy-allergic-rhiniti-phase-iii</loc>
    <lastmod>2026-05-28T21:47:23.844Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sertraline-bipolar-depression-phase-iv</loc>
    <lastmod>2026-05-28T21:47:23.857Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gdc-6036-advanced-or-metastatic-solid-tumour-with-phase-i</loc>
    <lastmod>2026-05-28T21:47:23.871Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/afamelanotide-healthy-volunteers-phase-ii</loc>
    <lastmod>2026-05-28T21:47:23.884Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-umbilical-cord-tissue-derived-chronic-antibody-mediated-rejection-cabm-phase-ii</loc>
    <lastmod>2026-05-28T21:47:23.905Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/18-mer-antisense-oligonucleotide-complem-autosomal-dominant-optic-atrophy-heredit-phase-i</loc>
    <lastmod>2026-05-28T21:47:23.954Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cevostamab-relapsed-refractory-multiple-myeloma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:24.011Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carboplatin-large-cell-neuroendocrine-carcinoma-of-t-phase-ii</loc>
    <lastmod>2026-05-28T21:47:24.025Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/opevesostat-tosilate-metastatic-castration-resistant-prostate-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:24.039Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/calcium-chloride-potassium-chloride-sodi-coronary-artery-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:47:24.053Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ciltacabtagene-autoleucel-multiple-myeloma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:24.067Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zamtocabtagene-autoleucel-relapsed-refractory-diffuse-large-b-cell-phase-ii</loc>
    <lastmod>2026-05-28T21:47:24.081Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apalutamide-high-risk-recurrent-prostate-cancer-prev-phase-iii</loc>
    <lastmod>2026-05-28T21:47:24.094Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lazertinib-advanced-non-small-cell-lung-cancer-non-phase-iii</loc>
    <lastmod>2026-05-28T21:47:24.108Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-bone-marrow-derived-stem-cell-amyotrophic-lateral-sclerosis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:24.121Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ciltacabtagene-autoleucel-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:24.135Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dota-cys-ath001-labelled-with-gallium-68-metabolic-dysfunction-associated-steatoh-phase-i</loc>
    <lastmod>2026-05-28T21:47:24.149Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methylphenidate-hydrochloride-kbg-syndrome-not-applicable</loc>
    <lastmod>2026-05-28T21:47:24.163Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/epcoritamab-primary-central-nervous-system-diffuse-l-phase-ii</loc>
    <lastmod>2026-05-28T21:47:24.177Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/crohn-s-disease-psoriasis-phase-i</loc>
    <lastmod>2026-05-28T21:47:24.191Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tarlatamab-small-cell-lung-cancer-small-cell-lung-c-phase-i</loc>
    <lastmod>2026-05-28T21:47:24.206Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efavirenz-niemann-pick-disease-type-c-phase-iv-ctis-2019-004498-18</loc>
    <lastmod>2026-05-28T21:11:40.286Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-urothelial-carcinoma-bladder-non-small-c-not-applicable</loc>
    <lastmod>2026-05-28T21:47:24.220Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bl-b01d1-non-small-cell-lung-cancer-other-solid-t-phase-i</loc>
    <lastmod>2026-05-28T21:47:24.234Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-renal-cell-carcinoma-metastatic-renal-ce-phase-ii</loc>
    <lastmod>2026-05-28T21:47:24.248Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ro7269162-prodromal-alzheimer-s-disease-alzheimer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:24.262Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bimekizumab-psoriatic-arthritis-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:24.276Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inavolisib-hormone-receptor-positive-her2-negative-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:24.290Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adeno-associated-virus-serotype-rh79-con-ornithine-transcarbamylase-deficiency-ot-phase-i-phase-ii-phase-iii</loc>
    <lastmod>2026-05-28T21:47:24.303Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obinutuzumab-primary-membranous-nephropathy-membranou-phase-iii</loc>
    <lastmod>2026-05-28T21:47:24.317Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/baricitinib-uveitis-juvenile-idiopathic-arthritis-as-phase-iii</loc>
    <lastmod>2026-05-28T21:47:24.331Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/camellia-sinensis-green-tea-leaf-extract-anal-high-grade-squamous-intraepithelial-phase-iv</loc>
    <lastmod>2026-05-28T21:47:24.344Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methyl-e-6s-7-1-2-2-ethylbutylamino-2-ox-celiac-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:47:24.358Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clostridium-botulinum-neurotoxin-type-a-lower-limb-spasticity-post-stroke-spasti-phase-iii</loc>
    <lastmod>2026-05-28T21:47:24.372Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cetrelimab-advanced-solid-tumors-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:24.386Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vorasidenib-grade-2-glioma-oligodendroglioma-or-astr-phase-iii</loc>
    <lastmod>2026-05-28T21:47:24.399Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etoposide-malignant-extracranial-germ-cell-tumours-phase-iii</loc>
    <lastmod>2026-05-28T21:47:24.413Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mosunetuzumab-relapsed-refractory-follicular-lymphoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:24.427Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/baricitinib-juvenile-idiopathic-arthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:24.441Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/selpercatinib-non-small-cell-lung-cancer-ret-fusion-po-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:24.454Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etranacogene-dezaparvovec-hemophilia-b-phase-iii</loc>
    <lastmod>2026-05-28T21:47:24.468Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-oxybate-cerebral-amyloid-angiopathy-phase-ii</loc>
    <lastmod>2026-05-28T21:47:24.482Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-breast-cancer-metastatic-breast-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:24.496Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ritlecitinib-tosilate-non-segmental-vitiligo-phase-iii</loc>
    <lastmod>2026-05-28T21:47:24.509Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/daratumumab-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:24.523Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-breast-cancer-her2-low-with-brain-metast-phase-ii</loc>
    <lastmod>2026-05-28T21:47:24.537Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efanesoctocog-alfa-haemophilia-a-severe-haemophilia-a-phase-ii</loc>
    <lastmod>2026-05-28T21:47:24.551Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-relapsed-or-refractory-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:24.565Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mitomycin-non-muscle-invasive-bladder-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:24.578Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ciltacabtagene-autoleucel-multiple-myeloma-phase-iv</loc>
    <lastmod>2026-05-28T21:47:24.592Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/navepegritide-achondroplasia-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:24.605Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colchicine-heart-failure-ischemic-heart-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:24.619Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/surovatamig-non-hodgkin-lymphoma-diffuse-large-b-cel-phase-ii</loc>
    <lastmod>2026-05-28T21:47:24.633Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-adipose-tissue-derived-mesenc-knee-osteoarthritis-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:24.646Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alxn2220-transthyretin-amyloid-cardiomyopathy-att-phase-iii</loc>
    <lastmod>2026-05-28T21:47:24.659Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tirzepatide-chronic-kidney-disease-obesity-overweigh-phase-ii</loc>
    <lastmod>2026-05-28T21:47:24.673Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/livmoniplimab-non-small-cell-lung-cancer-non-squamous-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:24.687Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prednisone-ocular-myasthenia-gravis-myasthenia-grav-not-applicable</loc>
    <lastmod>2026-05-28T21:47:24.701Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vx-670-myotonic-dystrophy-type-1-phase-i-ii-2</loc>
    <lastmod>2026-05-28T21:47:24.714Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elacestrant-hormone-receptor-positive-her2-negative-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:24.728Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/5-4-2s-5s-5-4-chlorobenzyl-2-methylmorph-active-pulmonary-sarcoidosis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:24.742Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/risankizumab-juvenile-psoriatic-arthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:24.757Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/surabgene-lomparvovec-neovascular-age-related-macular-degenera-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:24.770Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/3-fluoro-5-2ar-4s-1-1-2-2-4-pentafluoro-advanced-liver-cancer-hepatocellular-car-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:24.783Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/povorcitinib-vitiligo-phase-iii</loc>
    <lastmod>2026-05-28T21:47:24.797Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zanubrutinib-cold-agglutinin-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:47:24.810Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tacrolimus-liver-transplantation-phase-iv</loc>
    <lastmod>2026-05-28T21:47:24.824Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mesenchymal-stromal-cells-ex-vivo-cultur-steroid-refractory-acute-graft-versus-ho-phase-iii</loc>
    <lastmod>2026-05-28T21:47:24.838Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/radiprodil-tuberous-sclerosis-complex-focal-cortica-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:24.851Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-78278343-metastatic-castration-resistant-prostate-phase-i</loc>
    <lastmod>2026-05-28T21:47:24.865Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ocrelizumab-primary-progressive-multiple-sclerosis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:24.879Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ketoprofen-postoperative-pain-after-cardiac-surgery</loc>
    <lastmod>2026-05-28T21:47:24.892Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bleximenib-acute-myeloid-leukemia-phase-i</loc>
    <lastmod>2026-05-28T21:47:24.906Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/palazestrant-op-1250-estrogen-receptor-positive-er-her2-negat-phase-iii</loc>
    <lastmod>2026-05-28T21:47:24.920Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/botensilimab-gastric-cancer-msi-h-dmmr-gastro-oesopha-phase-iii</loc>
    <lastmod>2026-05-28T21:47:24.933Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amivantamab-non-small-cell-lung-cancer-egfr-mutated-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:24.947Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anhydrous-lidocaine-hydrochloride-glaucoma-phase-iv</loc>
    <lastmod>2026-05-28T21:47:24.960Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-endotoxemia-induced-systemic-inflammator-phase-ii</loc>
    <lastmod>2026-05-28T21:47:24.974Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tarlatamab-limited-stage-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:24.995Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/finerenone-type-1-diabetes-phase-iv</loc>
    <lastmod>2026-05-28T21:47:25.010Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abbv-400-locally-advanced-or-metastatic-solid-tum-phase-i</loc>
    <lastmod>2026-05-28T21:47:25.023Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dostarlimab-recurrent-endometrial-cancer-advanced-en-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.037Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/povorcitinib-nonsegmental-vitiligo-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.051Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efgartigimod-alfa-generalized-myasthenia-gravis-phase-ii-iii-2</loc>
    <lastmod>2026-05-28T21:47:25.066Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/teicoplanin-acute-myeloid-leukemia</loc>
    <lastmod>2026-05-28T21:47:25.079Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zanubrutinib-waldenstrom-macroglobulinemia-phase-iv</loc>
    <lastmod>2026-05-28T21:47:25.093Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-metastatic-colorectal-cancer-advanced-co-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.107Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amivantamab-egfr-mutated-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.120Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elranatamab-smoldering-multiple-myeloma-high-risk-sm-phase-ii</loc>
    <lastmod>2026-05-28T21:47:25.134Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/daratumumab-multiple-myeloma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:25.148Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ocrelizumab-primary-progressive-multiple-sclerosis-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:25.162Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fianlimab-malignant-melanoma-unresectable-locally-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.175Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-schizophrenia-spectrum-disorders-obesity-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.189Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/argipressin-liver-transplantation-acute-kidney-injur-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.203Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/534-respiratory-syncytial-virus-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.216Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/epoetin-alfa-traumatic-injury-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.230Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/andexanet-alfa-healthy-volunteers-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.243Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/emicizumab-hemophilia-a-phase-iv</loc>
    <lastmod>2026-05-28T21:47:25.257Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aln-snca-parkinson-s-disease-phase-i</loc>
    <lastmod>2026-05-28T21:47:25.273Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rilvegostomig-biliary-tract-adenocarcinoma-intrahepati-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.287Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/remibrutinib-chronic-inducible-urticaria-cindu-cold-u-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.301Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amoxicillin-trihydrate-penicillin-allergy-not-applicable</loc>
    <lastmod>2026-05-28T21:47:25.315Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gozetotide-prostate-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.329Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-2s-1-4-bis-2-4-chloro-3-fluorophe-vanishing-white-matter-disease-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:25.342Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zenagamtide-overweight-or-obesity-knee-osteoarthriti-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.356Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-2-2-10-2-4-3-4-2-2-cyano-4-4-difluor-gastrointestinal-cancers-hepatocellular-not-applicable</loc>
    <lastmod>2026-05-28T21:47:25.370Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cobicistat-non-small-cell-lung-cancer-egfr-mutated-phase-iv</loc>
    <lastmod>2026-05-28T21:47:25.383Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adrc001-hypertrophic-scarring-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:25.397Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/everolimus-diffuse-intrinsic-pontine-glioma-dipg-di-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.411Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/litifilimab-systemic-lupus-erythematosus-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.425Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-metastatic-her2-positive-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:25.439Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ahyc-tnbc-triple-negative-breast-cancer</loc>
    <lastmod>2026-05-28T21:47:25.452Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-a-underweight-phase-ii</loc>
    <lastmod>2026-05-28T21:47:25.466Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutikizumab-ulcerative-colitis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:25.480Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iron-oxide-nanoparticles-rectal-cancer-mesorectal-lymph-node-meta-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.495Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alxn1850-hypophosphatasia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.509Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/triple-negative-breast-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:25.522Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colchicine-acute-myocarditis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.537Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-melanoma-renal-cell-carcinoma-non-small-phase-ii</loc>
    <lastmod>2026-05-28T21:47:25.550Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abemaciclib-early-stage-breast-cancer-hormone-recept-phase-ii</loc>
    <lastmod>2026-05-28T21:47:25.564Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly3484356-breast-cancer-endometrial-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.578Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metastatic-neuroendocrine-prostate-cance-phase-i</loc>
    <lastmod>2026-05-28T21:47:25.592Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/selpercatinib-medullary-thyroid-cancer-ret-mutant-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.606Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mavacamten-symptomatic-obstructive-hypertrophic-car-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.619Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-igg1-monoclonal-antibody-against-s-pancreatic-ductal-adenocarcinoma-resecte-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:25.633Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zasocitinib-crohn-s-disease-moderately-to-severely-a-phase-ii</loc>
    <lastmod>2026-05-28T21:47:25.647Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bms-986453-relapsed-refractory-multiple-myeloma-phase-i</loc>
    <lastmod>2026-05-28T21:47:25.661Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tofersen-amyotrophic-lateral-sclerosis-sod1-assoc-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.675Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rabbit-anti-human-thymocyte-immunoglobul-haematological-malignancies-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:25.689Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hmb-001-glanzmann-thrombasthenia-glanzmann-s-dis-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:25.702Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/litifilimab-systemic-lupus-erythematosus-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:25.716Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etanercept-giant-cell-arteritis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:25.730Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/datopotamab-deruxtecan-advanced-or-metastatic-non-small-cell-lu-phase-i-phase-ii</loc>
    <lastmod>2026-05-28T21:47:25.744Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/esketamine-major-depressive-disorder-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:25.757Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/litifilimab-subacute-cutaneous-lupus-erythematosus-c-phase-ii-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.771Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ocrelizumab-multiple-sclerosis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.785Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ketamine-major-depressive-disorder-with-current-s-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.799Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vincristine-sulfate-richter-s-syndrome-diffuse-large-b-cell-phase-ii</loc>
    <lastmod>2026-05-28T21:47:25.813Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ianalumab-systemic-lupus-erythematosus-phase-iii-3</loc>
    <lastmod>2026-05-28T21:47:25.827Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ciltacabtagene-autoleucel-multiple-myeloma-relapsed-lenalidomide-r-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.841Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mirvetuximab-soravtansine-recurrent-ovarian-cancer-with-high-folat-phase-ii</loc>
    <lastmod>2026-05-28T21:47:25.854Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/datopotamab-deruxtecan-triple-negative-breast-cancer-hormone-re-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.869Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amlitelimab-atopic-dermatitis</loc>
    <lastmod>2026-05-28T21:47:25.883Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/datopotamab-deruxtecan-triple-negative-breast-cancer-residual-i-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.896Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/her3-dxd-inoperable-advanced-breast-cancer-her2-p-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:25.914Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/navenibart-hereditary-angioedema-hereditary-angioed-phase-ii</loc>
    <lastmod>2026-05-28T21:47:25.928Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cerebrolysin-concentrate-cadasil-cerebral-autosomal-dominant-arte-phase-ii</loc>
    <lastmod>2026-05-28T21:47:25.942Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-765179-advanced-head-and-neck-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:47:25.955Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efanesoctocog-alfa-haemophilia-a-phase-iii</loc>
    <lastmod>2026-05-28T21:47:25.969Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mycophenolate-mofetil-kidney-transplantation-phase-iv</loc>
    <lastmod>2026-05-28T21:47:25.983Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/xmab24306-locally-advanced-or-metastatic-solid-tum-phase-i</loc>
    <lastmod>2026-05-28T21:47:25.996Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/crovalimab-paroxysmal-nocturnal-hemoglobinuria-pnh-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.011Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-lactate-post-anoxic-brain-injury-post-cardiac-ar-phase-iv</loc>
    <lastmod>2026-05-28T21:47:26.025Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fisetin-healthy-volunteers-multimorbidity-phase-i-phase-ii</loc>
    <lastmod>2026-05-28T21:47:26.039Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/osimertinib-non-small-cell-lung-cancer-stage-ib-iiia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.053Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fenfluramine-hydrochloride-cdkl5-deficiency-disorder-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.067Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obinutuzumab-lupus-nephritis-class-iii-or-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:47:26.080Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-87704916-advanced-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:47:26.094Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belantamab-mafodotin-relapsed-refractory-multiple-myeloma-phase-i</loc>
    <lastmod>2026-05-28T21:47:26.114Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rivaroxaban-end-stage-renal-disease-chronic-hemodial-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:26.128Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ferric-carboxymaltose-acute-coronary-syndrome-phase-iv</loc>
    <lastmod>2026-05-28T21:47:26.142Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bnt314-advanced-or-metastatic-malignant-solid-t-phase-i</loc>
    <lastmod>2026-05-28T21:47:26.156Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/technetium-99mtc-certolizumab-pegol-axial-spondyloarthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.169Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/candesartan-chronic-cluster-headache-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.183Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/doxorubicin-hydrochloride-aggressive-b-cell-lymphoma-diffuse-large-phase-iv</loc>
    <lastmod>2026-05-28T21:47:26.196Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alxn1850-hypophosphatasia-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:26.210Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eci830-hormone-receptor-positive-her2-negative-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:26.223Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tarlatamab-small-cell-lung-cancer-extensive-stage-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.237Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/18f-fluorocholine-multiple-myeloma-phase-iv</loc>
    <lastmod>2026-05-28T21:47:26.250Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-non-small-cell-lung-cancer-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:26.264Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adeno-associated-viral-vector-serotype-2-parkinson-s-disease-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:26.278Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amivantamab-non-small-cell-lung-cancer-nsclc-with-on-phase-ii</loc>
    <lastmod>2026-05-28T21:47:26.291Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-adipose-derived-mesenchymal-s-systemic-sclerosis-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:26.305Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fasudil-hydrochloride-alzheimer-s-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:47:26.319Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cisplatin-anal-squamous-cell-carcinoma-locally-adv-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.333Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/crovalimab-paroxysmal-nocturnal-hemoglobinuria-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.346Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tinengotinib-cholangiocarcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.360Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cervical-cancer-cervical-cancer-stage-i-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.374Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adeno-associated-virus-serotype-9-vector-danon-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:47:26.388Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-muscle-invasive-urothelial-carcinoma-uro-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:26.403Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/emicizumab-hemophilia-a-hemophilia-a-without-inhibi-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.416Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etelcalcetide-secondary-hyperparathyroidism-secondary-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.430Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/biib115-spinal-muscular-atrophy-phase-i</loc>
    <lastmod>2026-05-28T21:47:26.443Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-normal-immunoglobulin-hyaluronidas-primary-immunodeficiency-diseases-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.457Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/baxdrostat-chronic-kidney-disease-hypertension-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.470Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nusinersen-spinal-muscular-atrophy-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.484Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ipilimumab-stage-ii-melanoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:26.498Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/baxdrostat-chronic-kidney-disease-hypertension-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:26.513Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/remifentanil-hydrochloride-obesity-postoperative-pain-phase-iv</loc>
    <lastmod>2026-05-28T21:47:26.526Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/crovalimab-atypical-hemolytic-uremic-syndrome-ahus-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.540Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abatacept-rheumatoid-arthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.553Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ds-1062a-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:26.567Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nusinersen-spinal-muscular-atrophy-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:26.580Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-chronic-kidney-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:47:26.594Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/patritumab-deruxtecan-u3-1402-advanced-breast-cancer-hormone-receptor-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:26.608Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/brentuximab-vedotin-hodgkin-lymphoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:26.621Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/epcoritamab-follicular-lymphoma-relapsed-or-refracto-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.635Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sebetralstat-hereditary-angioedema-type-i-or-ii-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.649Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-esophageal-squamous-cell-carcinoma-local-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.663Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/non-absorbed-cation-exchange-polymer-chronic-kidney-disease-stage-3b-4-phase-iv</loc>
    <lastmod>2026-05-28T21:47:26.676Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tin816-sepsis-associated-acute-kidney-injury-ac-phase-ii</loc>
    <lastmod>2026-05-28T21:47:26.690Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-tirumotecan-advanced-urothelial-carcinoma-urothelial-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:26.704Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glofitamab-relapsed-refractory-b-cell-non-hodgkin-l-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:26.718Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cytarabine-acute-myeloid-leukaemia-flt3-mutation-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.732Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/botulinum-toxin-type-a-chronic-pelvic-pain-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.745Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/peginterferon-beta-1a-relapsing-remitting-multiple-sclerosis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.759Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gedatolisib-metastatic-castration-resistant-prostate-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:26.773Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/selumetinib-neurofibromatosis-type-1-nf1-with-plexif-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:26.787Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/posaconazole-invasive-fungal-infection-phase-ii</loc>
    <lastmod>2026-05-28T21:47:26.800Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/octreotide-neuroendocrine-tumor-grade-i-ii-not-applicable</loc>
    <lastmod>2026-05-28T21:47:26.814Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/humanised-igg4-kappa-monoclonal-antibody-hidradenitis-suppurativa-moderate-to-sev-phase-ii</loc>
    <lastmod>2026-05-28T21:47:26.833Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/1-6-ethyl-8-fluoro-4-methyl-3-3-methyl-1-major-depressive-disorder-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.847Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acalabrutinib-chronic-lymphocytic-leukaemia-small-lymp-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.860Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ficlatuzumab-head-and-neck-squamous-cell-carcinoma-hp-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.874Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/seralutinib-pulmonary-arterial-hypertension-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.887Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amivantamab-non-small-cell-lung-cancer-egfr-mutated-phase-ii</loc>
    <lastmod>2026-05-28T21:47:26.901Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/repotrectinib-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.914Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/filgotinib-juvenile-idiopathic-arthritis-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.928Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/risdiplam-spinal-muscular-atrophy-phase-ii</loc>
    <lastmod>2026-05-28T21:47:26.941Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-her2-expressing-or-her2-mutated-advanced-not-applicable</loc>
    <lastmod>2026-05-28T21:47:26.955Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tozorakimab-chronic-obstructive-pulmonary-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:26.968Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/radium-ra-223-dichloride-metastatic-castration-resistant-prostate-phase-iv</loc>
    <lastmod>2026-05-28T21:47:26.981Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ceftazidime-avibactam-bacterial-infection-in-critically-ill-pa-phase-iv</loc>
    <lastmod>2026-05-28T21:47:26.995Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ceftriaxone-sodium-threatened-late-miscarriage-threatened-a-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.009Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sparsentan-proteinuric-glomerular-diseases-focal-se-phase-ii</loc>
    <lastmod>2026-05-28T21:47:27.023Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nitrous-oxide-oxygen-suicidal-ideation-phase-iv</loc>
    <lastmod>2026-05-28T21:47:27.036Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acp-204-tartrate-dementia-with-lewy-bodies-lewy-body-deme-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.050Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/icotrokinra-inflammatory-conditions-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.063Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ds101-diabetic-retinopathy-phase-i</loc>
    <lastmod>2026-05-28T21:47:27.077Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cisplatin-hpv-positive-oropharyngeal-squamous-cell-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.091Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/chemical-described-in-product-record-non-small-cell-lung-cancer-ras-mutated-n-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:27.105Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-non-small-cell-lung-cancer-phase-ii-3</loc>
    <lastmod>2026-05-28T21:47:27.119Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rimegepant-sulfate-chronic-migraine-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.133Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/perflubutane-focal-liver-lesion-phase-iv</loc>
    <lastmod>2026-05-28T21:47:27.146Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamfetamine-sulfate-piracetam-cocaine-use-disorder-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.160Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/treprostinil-palmitil-pulmonary-arterial-hypertension-phase-ii</loc>
    <lastmod>2026-05-28T21:47:27.173Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/3-4-methylpiperazine-1-carbonyl-7-oxabic-microsatellite-stable-colorectal-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:27.187Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aciclovir-herpes-simplex-virus-oropharyngeal-react-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.201Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gallium-68ga-pentixafor-primary-aldosteronism-primary-hyperaldos-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:27.215Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sparsentan-iga-nephropathy-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.228Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/risankizumab-psoriatic-arthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.242Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/risankizumab-psoriatic-arthritis-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:27.256Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-faecal-microbiota-pooled-primary-sclerosing-cholangitis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:27.269Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/esomeprazole-magnesium-erosive-esophagitis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.283Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/99mtc-euk-so3-cy5-mas3-prostate-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:47:27.297Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/selatogrel-acute-myocardial-infarction-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.310Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mosunetuzumab-follicular-lymphoma-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:27.325Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/encorafenib-unresectable-or-metastatic-melanoma-braf-phase-ii</loc>
    <lastmod>2026-05-28T21:47:27.339Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/epinephrine-bitartrate-out-of-hospital-cardiac-arrest-cardiac-a-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.352Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/epcoritamab-diffuse-large-b-cell-lymphoma-b-cell-non-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:27.366Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nipocalimab-idiopathic-inflammatory-myopathies-iim-phase-ii</loc>
    <lastmod>2026-05-28T21:47:27.379Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/al-18f-f-fapi-74-carcinoma-of-unknown-primary-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:27.393Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/everolimus-metastatic-breast-cancer-estrogen-recept-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:27.406Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abbv-319-follicular-lymphoma-chronic-lymphocytic-phase-i</loc>
    <lastmod>2026-05-28T21:47:27.420Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acalabrutinib-chronic-lymphocytic-leukemia-cll-small-l-phase-ii</loc>
    <lastmod>2026-05-28T21:47:27.433Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluticasone-propionate-salbutamol-sulfat-asthma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.446Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-tirumotecan-gastric-adenocarcinoma-gastroesophageal-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.460Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belumosudil-mesilate-chronic-graft-versus-host-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.474Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cannabidiol-breast-cancer-early-hormone-receptor-pos-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.490Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bomedemstat-essential-thrombocythemia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.504Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cannabidiol-early-breast-cancer-hormone-receptor-pos-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.517Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sonlicromanol-primary-mitochondrial-disease-m-3243a-g-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.530Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexrazoxane-diffuse-large-b-cell-lymphoma-dlbcl-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.544Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-atrial-fibrillation-acute-kidney-injury-phase-iv</loc>
    <lastmod>2026-05-28T21:47:27.558Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nemolizumab-atopic-dermatitis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.571Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-87890387-advanced-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:47:27.585Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-her2-positive-metastatic-breast-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:27.599Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tos-358-colorectal-cancer-cervical-cancer-endome-phase-i</loc>
    <lastmod>2026-05-28T21:47:27.612Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-tirumotecan-hormone-receptor-positive-hr-her2-negati-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.626Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-type-2-diabetes-diabetic-foot-ulcer-phase-iv</loc>
    <lastmod>2026-05-28T21:47:27.640Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-non-muscle-invasive-bladder-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.653Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-3720931-cystic-fibrosis-not-applicable</loc>
    <lastmod>2026-05-28T21:47:27.668Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/star0602-unresectable-locally-advanced-or-metasta-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:27.681Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/triamcinolone-acetonide-esophageal-strictures-following-esophage-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.695Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/star0602-unresectable-locally-advanced-or-metasta-phase-i-ii-2</loc>
    <lastmod>2026-05-28T21:47:27.709Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ponatinib-acute-lymphoblastic-leukaemia-philadelph-phase-ii</loc>
    <lastmod>2026-05-28T21:47:27.722Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/treprostinil-progressive-pulmonary-fibrosis-pulmonary-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.736Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bimekizumab-hidradenitis-suppurativa-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.750Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/opevesostat-tosilate-metastatic-castration-resistant-prostate-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.764Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nipocalimab-warm-autoimmune-hemolytic-anemia-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:27.779Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methyl-1r-2s-3s-5s-8-e-4-18f-fluoranylbu-traumatic-brain-injury-traumatic-coma-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:27.793Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/emrusolmin-multiple-system-atrophy-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:27.806Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rilvegostomig-her2-expressing-gastric-cancer-her2-expr-phase-i-ii-phase-ii</loc>
    <lastmod>2026-05-28T21:47:27.820Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pasireotide-diaspartate-post-bariatric-hypoglycaemia-phase-ii</loc>
    <lastmod>2026-05-28T21:47:27.833Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/finerenone-chronic-kidney-disease-proteinuria-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.847Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/humanised-igg1-monoclonal-antibody-again-metastatic-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.861Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/valganciclovir-glioblastoma-multiforme-who-grade-iv-phase-ii</loc>
    <lastmod>2026-05-28T21:47:27.875Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/exl01-faecalibacterium-prausnitzii-singl-non-small-cell-lung-cancer-advanced-meta-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:27.888Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/epcoritamab-diffuse-large-b-cell-lymphoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:27.902Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ondansetron-metastatic-colorectal-cancer-colorectal-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.916Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ofatumumab-relapsing-multiple-sclerosis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:27.929Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pc14586-solid-tumours-with-tp53-y220c-mutation-l-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:27.943Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/epcoritamab-diffuse-large-b-cell-lymphoma-b-cell-lym-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.956Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zelenectide-pevedotin-urothelial-carcinoma-transitional-cell-c-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:27.970Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-her2-positive-metastatic-breast-cancer-a-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.984Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-phosphate-respiratory-distress-due-to-upper-airway-phase-iii</loc>
    <lastmod>2026-05-28T21:47:27.999Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/satralizumab-anti-nmdar-encephalitis-anti-lgi1-enceph-phase-iii</loc>
    <lastmod>2026-05-28T21:47:28.015Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/linvoseltamab-monoclonal-gammopathy-of-undetermined-si-phase-ii</loc>
    <lastmod>2026-05-28T21:47:28.030Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/epcoritamab-chronic-lymphocytic-leukemia-richter-s-s-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:28.043Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-advanced-ovarian-cancer-primary-peritone-phase-ii-ctis-2021-004278-76</loc>
    <lastmod>2026-05-28T21:11:37.252Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/16-base-single-stranded-rna-targeting-mi-myotonic-dystrophy-type-1-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:28.057Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-tirumotecan-endometrial-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:28.072Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/humanised-igg1-monoclonal-antibody-again-myotonic-dystrophy-type-1-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:28.086Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ketamine-traumatic-brain-injury</loc>
    <lastmod>2026-05-28T21:47:28.100Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obinutuzumab-systemic-lupus-erythematosus-phase-iii</loc>
    <lastmod>2026-05-28T21:47:28.113Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-extensive-stage-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:28.127Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/survodutide-obesity-non-alcoholic-steatohepatitis-na-phase-iii</loc>
    <lastmod>2026-05-28T21:47:28.142Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vedolizumab-chronic-pouchitis-pouchitis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:28.161Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mupirocin-impetigo-phase-iii</loc>
    <lastmod>2026-05-28T21:47:28.175Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bevacizumab-pancreatic-well-differentiated-neuroendo-phase-iv</loc>
    <lastmod>2026-05-28T21:47:28.189Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ciprofloxacin-bronchiectasis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:28.203Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-hepatocellular-carcinoma-intermediate-st-phase-iii</loc>
    <lastmod>2026-05-28T21:47:28.217Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/epcoritamab-diffuse-large-b-cell-lymphoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:28.233Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rocuronium-postoperative-residual-neuromuscular-blo-not-applicable</loc>
    <lastmod>2026-05-28T21:47:28.249Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abemaciclib-breast-cancer-hr-her2-advanced-metastati-phase-iii</loc>
    <lastmod>2026-05-28T21:47:28.263Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tirzepatide-overweight-obesity-coronary-artery-disea</loc>
    <lastmod>2026-05-28T21:47:28.276Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/navtemadlin-myelofibrosis-primary-myelofibrosis-seco-phase-iii</loc>
    <lastmod>2026-05-28T21:47:28.290Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elranatamab-multiple-myeloma-phase-ii-4</loc>
    <lastmod>2026-05-28T21:47:28.304Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lomustine-glioblastoma-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:28.318Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sot201-advanced-metastatic-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:47:28.331Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/guselkumab-psoriatic-arthritis-phase-iv-2</loc>
    <lastmod>2026-05-28T21:47:28.345Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ziftomenib-acute-myeloid-leukemia-mixed-phenotype-a-phase-i</loc>
    <lastmod>2026-05-28T21:47:28.360Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tezepelumab-eosinophilic-esophagitis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:28.374Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nitrous-oxide-oxygen-major-neurocognitive-disorder-depressive-phase-iv</loc>
    <lastmod>2026-05-28T21:47:28.388Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxytocin-autism-spectrum-disorder-not-applicable</loc>
    <lastmod>2026-05-28T21:47:28.402Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-2-hydroxylinoleate-relapsed-refractory-neuroblastoma-other-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:28.415Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/micronised-spironolactone-spironolactone-atrial-fibrillation-with-preserved-left</loc>
    <lastmod>2026-05-28T21:47:28.429Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elafibranor-primary-biliary-cholangitis-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:28.442Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methyl-1-6-1s-1-cyclopropylethyl-amino-2-eosinophilic-granulomatosis-with-polyang-phase-ii</loc>
    <lastmod>2026-05-28T21:47:28.456Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/peptide-mixture-tyr-met-phe-pro-etc-acute-myeloid-leukemia-aml-second-or-lat-phase-iii</loc>
    <lastmod>2026-05-28T21:47:28.470Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adenosine-chronic-coronary-syndrome-ischemic-heart-phase-iv</loc>
    <lastmod>2026-05-28T21:47:28.484Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bt8009-urothelial-cancer-locally-advanced-uroth-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:28.498Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prx005-early-alzheimer-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:47:28.513Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fazirsiran-alpha-1-antitrypsin-deficiency-associate-phase-iii</loc>
    <lastmod>2026-05-28T21:47:28.527Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-phosphate-knee-arthroscopy-phase-iii</loc>
    <lastmod>2026-05-28T21:47:28.541Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/epcoritamab-b-cell-non-hodgkin-lymphoma-diffuse-larg-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:28.555Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-govitecan-pd-l1-negative-metastatic-triple-negativ-phase-iii</loc>
    <lastmod>2026-05-28T21:47:28.568Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/budesonide-chronic-obstructive-pulmonary-disease-co-not-applicable</loc>
    <lastmod>2026-05-28T21:47:28.582Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/epcoritamab-b-cell-lymphoma-non-hodgkin-b-cell-lymph-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:28.596Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-govitecan-triple-negative-breast-cancer-metastatic-phase-iii</loc>
    <lastmod>2026-05-28T21:47:28.609Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ascorbic-acid-ubiquinol-mitochondrial-disorders-cerebellar-ataxi-phase-ii</loc>
    <lastmod>2026-05-28T21:47:28.623Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dostarlimab-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:28.636Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/diclofenac-sodium-metastatic-melanoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:28.650Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bomedemstat-essential-thrombocythemia-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:28.663Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/guselkumab-ulcerative-colitis-phase-ii</loc>
    <lastmod>2026-05-28T21:47:28.677Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/camizestrant-advanced-breast-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:28.690Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/guselkumab-golimumab-crohn-s-disease-moderately-to-severely-a-phase-ii</loc>
    <lastmod>2026-05-28T21:47:28.704Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/poltreg-t1d-type-1-diabetes-mellitus-stage-1-prediab-phase-ii</loc>
    <lastmod>2026-05-28T21:47:28.718Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gemtuzumab-ozogamicin-acute-myeloid-leukemia-phase-ii</loc>
    <lastmod>2026-05-28T21:47:28.731Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/guselkumab-fistulizing-perianal-crohn-s-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:28.745Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/palbociclib-early-estrogen-receptor-positive-er-brea-phase-ii</loc>
    <lastmod>2026-05-28T21:47:28.758Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trospium-chloride-xanomeline-tartrate-psychosis-associated-with-alzheimer-s-di-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:28.772Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/guselkumab-crohn-s-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:28.787Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glofitamab-relapsed-refractory-b-cell-non-hodgkin-l-phase-i-ii-2</loc>
    <lastmod>2026-05-28T21:47:28.801Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/incb000928-fibrodysplasia-ossificans-progressiva-phase-ii</loc>
    <lastmod>2026-05-28T21:47:28.814Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/guselkumab-crohn-s-disease-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:28.828Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mezigdomide-relapsed-or-refractory-multiple-myeloma-phase-i-ii-2</loc>
    <lastmod>2026-05-28T21:47:28.841Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/idursulfase-hunter-syndrome-cognitive-impairment-not-applicable</loc>
    <lastmod>2026-05-28T21:47:28.856Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/guselkumab-crohn-s-disease-moderately-to-severely-a-phase-iii</loc>
    <lastmod>2026-05-28T21:47:28.870Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/protein-other-moderate-severe-atopic-dermatitis-atopic-phase-ii</loc>
    <lastmod>2026-05-28T21:47:28.883Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alectinib-alk-fusion-positive-solid-tumors-alk-fus-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:28.897Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/xmab24306-relapsed-refractory-multiple-myeloma-mul-phase-iii</loc>
    <lastmod>2026-05-28T21:47:28.910Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/guselkumab-psoriatic-arthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:28.924Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-87189401-advanced-prostate-cancer-prostate-cancer-phase-i</loc>
    <lastmod>2026-05-28T21:47:28.938Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenvatinib-advanced-esophageal-squamous-cell-carcin-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:28.952Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ag13909-cushing-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:47:28.966Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-cervical-hsil-cin-2-3-vulvar-intraepithe-phase-ii</loc>
    <lastmod>2026-05-28T21:47:28.980Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-her2-expressing-tumors-phase-ii</loc>
    <lastmod>2026-05-28T21:47:28.994Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/non-hodgkin-lymphoma-b-cell-non-hodgkin-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.007Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/camizestrant-early-breast-cancer-er-positive-her2-neg-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.021Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/guselkumab-ulcerative-colitis-moderately-to-severel-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.039Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-87801493-non-hodgkin-lymphoma-phase-i</loc>
    <lastmod>2026-05-28T21:47:29.054Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dazodalibep-sjogren-s-syndrome-sjogren-s-syndrome-wi-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.068Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/guselkumab-psoriatic-arthritis-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:29.082Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/risdiplam-spinal-muscular-atrophy-phase-iv</loc>
    <lastmod>2026-05-28T21:47:29.095Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/loncastuximab-tesirine-diffuse-large-b-cell-lymphoma-relapsed-o-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.109Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/upadacitinib-atopic-dermatitis-moderate-to-severe-ato-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.123Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obinutuzumab-idiopathic-nephrotic-syndrome-childhood-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.138Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-high-risk-hepatocellular-carcinoma-hcc-h-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.152Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belzupacap-sarotalocan-primary-indeterminate-lesion-small-choro-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.165Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/emiplacel-knee-osteoarthritis-osteoarthritis-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:29.179Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-capecitabine-triple-negative-breast-cancer-residual-d-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.194Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atorvastatin-graves-ophthalmopathy-graves-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:47:29.207Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fostemsavir-trometamol-hiv-1-infection-phase-iv</loc>
    <lastmod>2026-05-28T21:47:29.221Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/protein-other-locally-advanced-or-metastatic-non-small-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:29.235Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apomorphine-hydrochloride-hemihydrate-disorder-of-consciousness-severe-brain-i-phase-iv</loc>
    <lastmod>2026-05-28T21:47:29.248Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methylprednisolone-sodium-succinate-acute-myocarditis-severe-cardiac-inflamm-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.261Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-her2-positive-early-stage-breast-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.275Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/datopotamab-deruxtecan-advanced-non-small-cell-lung-cancer-non-phase-ii</loc>
    <lastmod>2026-05-28T21:47:29.289Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alpelisib-lymphatic-malformation-associated-with-p-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:29.303Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mrna-4157-renal-cell-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:29.317Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hereditary-haemochromatosis-type-1-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.330Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colistin-sulfate-tobramycin-esophageal-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.344Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amlodipine-reversible-cerebral-vasoconstriction-syn-phase-iv</loc>
    <lastmod>2026-05-28T21:47:29.358Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cemiplimab-fianlimab-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:29.371Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pegtibatinase-classical-homocystinuria-cystathionine-b-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.386Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/luspatercept-myelodysplastic-syndrome-lower-risk-myel-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.400Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/miglustat-late-onset-pompe-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.414Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-zibotentan-chronic-kidney-disease-with-high-protein-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.428Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bimekizumab-juvenile-idiopathic-arthritis-enthesitis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.442Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metastatic-colorectal-cancer-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:29.456Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/giredestrant-endometrial-cancer-endometrial-cancer-st-phase-ii</loc>
    <lastmod>2026-05-28T21:47:29.470Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/guselkumab-ulcerative-colitis-moderately-to-severel-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:29.484Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/healthy-volunteers-phase-iii-6</loc>
    <lastmod>2026-05-28T21:47:29.498Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bezafibrate-primary-biliary-cholangitis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.511Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ro7502175-locally-advanced-or-metastatic-solid-tum-phase-i</loc>
    <lastmod>2026-05-28T21:47:29.525Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-77242113-moderate-to-severe-plaque-psoriasis-plaq-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.540Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/guselkumab-crohn-s-disease-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:29.554Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/migraine-trigeminal-nerve-disorder-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.568Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/telisotuzumab-adizutecan-colorectal-cancer-metastatic-colorectal-phase-ii</loc>
    <lastmod>2026-05-28T21:47:29.582Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clostridium-botulinum-neurotoxin-type-a-temporomandibular-disorder-phase-iv</loc>
    <lastmod>2026-05-28T21:47:29.596Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tafasitamab-follicular-lymphoma-marginal-zone-lympho-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.610Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tocilizumab-sickle-cell-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.623Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ro7247669-tobemstomig-urothelial-carcinoma-locally-advanced-or-phase-ii</loc>
    <lastmod>2026-05-28T21:47:29.638Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zanubrutinib-chronic-lymphocytic-leukemia-small-lymph-phase-ii</loc>
    <lastmod>2026-05-28T21:47:29.651Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-her2-positive-breast-cancer-recurrent-ov-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.665Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-non-small-cell-lung-cancer-locally-advan-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.678Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-triple-negative-breast-cancer-breast-can-phase-ii</loc>
    <lastmod>2026-05-28T21:47:29.693Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/camizestrant-estrogen-receptor-positive-her2-negative-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.707Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/m2rlab-acute-kidney-injury-post-cardiac-surgery-phase-ii</loc>
    <lastmod>2026-05-28T21:47:29.720Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/datopotamab-deruxtecan-non-small-cell-lung-cancer-non-squamous-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:29.733Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glutathione-myocardial-injury-pneumonia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.747Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/livmoniplimab-hepatocellular-carcinoma-locally-advance-phase-ii-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:29.760Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lazertinib-non-small-cell-lung-cancer-egfr-mutated-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:29.774Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tinlarebant-geographic-atrophy-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.788Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cemiplimab-non-small-cell-lung-cancer-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:29.801Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etanercept-juvenile-idiopathic-arthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.816Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tominersen-huntington-s-disease-prodromal-and-early-phase-ii</loc>
    <lastmod>2026-05-28T21:47:29.829Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tadalafil-rectal-cancer-sexual-dysfunction-phase-ii</loc>
    <lastmod>2026-05-28T21:47:29.843Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capivasertib-breast-cancer-hormone-receptor-positive-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.856Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sildenafil-univentricular-heart-fontan-procedure-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.870Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clostridium-botulinum-neurotoxin-type-a-incisional-hernia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.884Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/entrectinib-locally-advanced-or-metastatic-solid-tum-phase-ii</loc>
    <lastmod>2026-05-28T21:47:29.897Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dazodalibep-sjogren-s-syndrome-sjogren-s-syndrome-wi-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:29.912Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clindamycin-tretinoin-papulopustular-acne-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.926Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capivasertib-metastatic-hormone-sensitive-prostate-ca-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.939Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-extensive-stage-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.953Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iptacopan-atypical-hemolytic-uremic-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:47:29.967Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cd19-targeted-car-t-cells-systemic-sclerosis-rheumatoid-arthritis-phase-i</loc>
    <lastmod>2026-05-28T21:47:29.980Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glofitamab-diffuse-large-b-cell-lymphoma-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:29.994Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-non-small-cell-lung-cancer-stage-iii-n2-phase-ii</loc>
    <lastmod>2026-05-28T21:47:30.008Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zanubrutinib-splenic-marginal-zone-lymphoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.022Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/givinostat-duchenne-muscular-dystrophy-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.035Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/6-fluoro-5-4-5-fluoro-2-methyl-3-oxo-4h-advanced-solid-malignancies-ovarian-canc-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:30.049Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-melanoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:30.063Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lamivudine-doravirine-tenofovir-disoprox-hiv-infection-not-applicable</loc>
    <lastmod>2026-05-28T21:47:30.077Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/admilparant-progressive-pulmonary-fibrosis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.091Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/asp2138-gastroesophageal-junction-adenocarcinoma-phase-i</loc>
    <lastmod>2026-05-28T21:47:30.106Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-muscle-invasive-bladder-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.120Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/admilparant-idiopathic-pulmonary-fibrosis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.134Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iberdomide-multiple-myeloma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:30.148Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-tirumotecan-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.162Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anifrolumab-cutaneous-lupus-erythematosus-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.176Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-squamous-cell-carcinoma-of-head-and-neck-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.190Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mca-derived-mesenchymal-stromal-cells-ms-kidney-transplant-rejection-biopsy-prove-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.204Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/risdiplam-spinal-muscular-atrophy-phase-iv-2</loc>
    <lastmod>2026-05-28T21:47:30.217Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prasinezumab-parkinson-s-disease-early-idiopathic-phase-ii</loc>
    <lastmod>2026-05-28T21:47:30.231Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ziclumeran-lonvoguran-hereditary-angioedema-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:30.244Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/edotreotide-breast-cancer-metastatic-breast-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:47:30.257Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anifrolumab-polymyositis-dermatomyositis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.273Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gt005-geographic-atrophy-secondary-to-age-rela-phase-ii</loc>
    <lastmod>2026-05-28T21:47:30.286Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/finerenone-type-2-diabetes-mellitus-chronic-kidney-not-applicable</loc>
    <lastmod>2026-05-28T21:47:30.300Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alectinib-non-small-cell-lung-cancer-locally-advan-phase-i-phase-ii-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.313Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/flortaucipir-18f-alzheimer-s-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:47:30.327Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/disitamab-vedotin-head-and-neck-cancer-ovarian-cancer-non-phase-ii</loc>
    <lastmod>2026-05-28T21:47:30.341Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/baricitinib-atopic-dermatitis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.354Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carisbamate-lennox-gastaut-syndrome</loc>
    <lastmod>2026-05-28T21:47:30.368Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-igg1-monoclonal-antibody-against-h-autoinflammatory-disease-nlrc4-gain-of-f-phase-ii</loc>
    <lastmod>2026-05-28T21:47:30.382Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/noradrenaline-tartrate-critical-illness-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.395Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ursodeoxycholic-acid-rhegmatogenous-retinal-detachment-not-applicable</loc>
    <lastmod>2026-05-28T21:47:30.409Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-type-1-diabetes-mellitus-chronic-kidney-phase-ii</loc>
    <lastmod>2026-05-28T21:47:30.423Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bimekizumab-moderate-to-severe-plaque-psoriasis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.436Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/crovalimab-atypical-hemolytic-uremic-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.450Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ipilimumab-malignant-pleural-mesothelioma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:30.464Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pentoxifylline-oligospermia-asthenozoospermia-male-infe-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:30.477Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/delandistrogene-moxeparvovec-duchenne-muscular-dystrophy-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.491Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/teclistamab-multiple-myeloma-phase-ii-3</loc>
    <lastmod>2026-05-28T21:47:30.504Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lumateperone-major-depressive-disorder-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.518Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ip-001-novel-immuno-adjuvant-colorectal-liver-metastases-not-applicable</loc>
    <lastmod>2026-05-28T21:47:30.531Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-bone-marrow-mononuclear-cells-hard-to-heal-wounds-difficult-to-heal-wo</loc>
    <lastmod>2026-05-28T21:47:30.545Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tucatinib-her2-positive-breast-cancer-locally-adva-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:30.559Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/niraparib-tosilate-monohydrate-her2-negative-brca-mutated-breast-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.572Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capivasertib-metastatic-castration-resistant-prostate-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.586Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tisotumab-vedotin-non-small-cell-lung-cancer-pancreatic-ca-phase-ii</loc>
    <lastmod>2026-05-28T21:47:30.600Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tildrakizumab-chronic-plaque-psoriasis-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:30.613Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/the-0504-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:47:30.627Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lamivudine-dolutegravir-sodium-hiv-1-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.640Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cannabinol-alcohol-dependence-phase-ii</loc>
    <lastmod>2026-05-28T21:47:30.654Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/deucravacitinib-moderate-to-severe-plaque-psoriasis-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:30.668Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ivonescimab-metastatic-squamous-non-small-cell-lung-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.681Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cannabinol-alcohol-dependence-alcohol-use-disorder-phase-ii</loc>
    <lastmod>2026-05-28T21:47:30.695Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etranacogene-dezaparvovec-hemophilia-b-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:30.708Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/camizestrant-estrogen-receptor-positive-her2-negative-phase-ii</loc>
    <lastmod>2026-05-28T21:47:30.722Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/domvanalimab-muscle-invasive-bladder-cancer-bladder-c-phase-ii</loc>
    <lastmod>2026-05-28T21:47:30.735Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-obesity-heart-failure-with-reduced-eject-phase-iv</loc>
    <lastmod>2026-05-28T21:47:30.749Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-tirumotecan-triple-negative-breast-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.762Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/karxt-psychosis-associated-with-alzheimer-s-di-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.777Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fludarabine-phosphate-hematological-malignancy-allogeneic-haem-phase-iv</loc>
    <lastmod>2026-05-28T21:47:30.791Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/opevesostat-tosilate-metastatic-castration-resistant-prostate-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:30.805Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/volrustomig-locally-advanced-cervical-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.820Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/morphine-sulfate-fibrotic-interstitial-lung-disease-inter</loc>
    <lastmod>2026-05-28T21:47:30.834Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-her2-positive-advanced-or-metastatic-non-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.847Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alnuctamab-relapsed-and-or-refractory-multiple-myel-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:30.861Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/al-18f-f-fapi-74-progressive-pulmonary-fibrosis-pulmonary-not-applicable</loc>
    <lastmod>2026-05-28T21:47:30.875Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gemcitabine-non-muscle-invasive-bladder-cancer-inter-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.888Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amg-193-advanced-mtap-null-solid-tumors-non-smal-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:30.902Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/datopotamab-deruxtecan-triple-negative-breast-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.920Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amg-509-metastatic-castration-resistant-prostate-phase-i</loc>
    <lastmod>2026-05-28T21:47:30.934Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/erenumab-episodic-migraine-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.947Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-deruxtecan-non-small-cell-lung-cancer-with-her2-exo-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.961Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/frexalimab-multiple-sclerosis-secondary-progressive-phase-iii</loc>
    <lastmod>2026-05-28T21:47:30.975Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elacestrant-dihydrochloride-breast-cancer-hormone-receptor-positive-phase-ii</loc>
    <lastmod>2026-05-28T21:47:30.989Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tacrolimus-breast-cancer-related-lymphedema-lymphed-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:31.003Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sar441344-multiple-sclerosis-relapsing-multiple-sc-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.017Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/blinatumomab-acute-lymphoblastic-leukaemia-b-cell-pre-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.031Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mrna-4157-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.045Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylsalicylic-acid-coronary-artery-disease-not-applicable</loc>
    <lastmod>2026-05-28T21:47:31.059Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efepoetin-alfa-anemia-in-chronic-kidney-disease-on-dial-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.073Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/enlicitide-chloride-hypercholesterolemia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.087Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/molgramostim-breast-cancer-her2-positive-breast-cance-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.101Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-chloride-coma-disorders-of-consciousness-due-to-a-phase-i-phase-ii</loc>
    <lastmod>2026-05-28T21:47:31.115Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-govitecan-differentiated-thyroid-carcinoma-radioac-phase-ii</loc>
    <lastmod>2026-05-28T21:47:31.128Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/retinal-degenerative-diseases-stargardt-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.143Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bosutinib-chronic-myeloid-leukemia-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:31.157Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/olpasiran-atherosclerotic-cardiovascular-disease-c-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.171Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zongertinib-non-small-cell-lung-cancer-non-squamous-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.186Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/finerenone-chronic-kidney-disease-proteinuria-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:31.200Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regorafenib-solid-malignant-tumors-phase-ii</loc>
    <lastmod>2026-05-28T21:47:31.215Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nipocalimab-fetal-and-neonatal-alloimmune-thrombocyt-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:31.228Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ocrelizumab-relapsing-remitting-multiple-sclerosis-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:31.242Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/platelet-concentrate-diabetic-foot-ulcer-peripheral-arterial-not-applicable</loc>
    <lastmod>2026-05-28T21:47:31.256Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/danicopan-paroxysmal-nocturnal-haemoglobinuria-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.269Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/propranolol-post-traumatic-stress-disorder-phase-iv</loc>
    <lastmod>2026-05-28T21:47:31.283Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/crizotinib-neuroblastoma-rhabdomyosarcoma-inflammat-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:31.296Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/18f-psma-1007-prostate-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.310Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/68ga-dpi-4452-clear-cell-renal-cell-carcinoma-pancreat-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:31.324Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/al-18f-f-fapi-74-progressive-pulmonary-fibrosis-pulmonary-not-applicable-2</loc>
    <lastmod>2026-05-28T21:47:31.338Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/docetaxel-prostate-cancer-metastatic-castration-re-phase-iv</loc>
    <lastmod>2026-05-28T21:47:31.352Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cytarabine-daunorubicin-acute-myeloid-leukaemia-aml-aml-with-mye-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.368Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/surabgene-lomparvovec-neovascular-age-related-macular-degenera-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.382Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amoxicillin-community-acquired-pneumonia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.396Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obinutuzumab-lupus-nephritis-systemic-lupus-erythemat-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:31.410Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/incb000928-anemia-due-to-myelofibrosis-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:31.424Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.440Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/triple-negative-breast-cancer-early-rela-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:31.454Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/empagliflozin-cardiogenic-shock-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.468Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abbv-101-b-cell-malignancies-non-hodgkin-b-cell-l-phase-i</loc>
    <lastmod>2026-05-28T21:47:31.482Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-early-her2-positive-breast-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.495Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/c1-esterase-inhibitor-human-hereditary-angioedema-hereditary-angioed-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.509Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mepivacaine-hydrochloride-postoperative-pain-phase-iv</loc>
    <lastmod>2026-05-28T21:47:31.522Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-metastatic-non-squamous-non-small-cell-l</loc>
    <lastmod>2026-05-28T21:47:31.537Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/talquetamab-relapsed-or-refractory-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.551Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/teclistamab-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.565Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/midostaurin-acute-myeloid-leukemia-aml-myelodysplast-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.579Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/patritumab-deruxtecan-hormone-receptor-positive-hr-her2-negati-phase-ii</loc>
    <lastmod>2026-05-28T21:47:31.592Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mogamulizumab-cutaneous-t-cell-lymphoma-mycosis-fungoi-phase-ii</loc>
    <lastmod>2026-05-28T21:47:31.606Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-non-small-cell-lung-cancer-phase-ii-4</loc>
    <lastmod>2026-05-28T21:47:31.620Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-thymic-carcinoma-nasopharyngeal-cancer-a-phase-i</loc>
    <lastmod>2026-05-28T21:47:31.635Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cenerimod-systemic-lupus-erythematosus-moderate-to-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:31.649Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/givinostat-polycythaemia-vera-jak2v617f-positive-po-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.663Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/infliximab-acute-severe-ulcerative-colitis-acute-ul-phase-iv</loc>
    <lastmod>2026-05-28T21:47:31.678Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-chronic-lymphocytic-leukemia-small-lymph-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:31.692Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenzumestrocel-articular-cartilage-defect-phase-ii</loc>
    <lastmod>2026-05-28T21:47:31.705Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-non-small-cell-lung-cancer-phase-ii-5</loc>
    <lastmod>2026-05-28T21:47:31.719Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/daratumumab-multiple-myeloma-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:31.733Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/coramitug-transthyretin-amyloid-cardiomyopathy-att-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:47:31.747Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pivmecillinam-hydrochloride-febrile-urinary-tract-infection-e-coli-phase-ii</loc>
    <lastmod>2026-05-28T21:47:31.760Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/temozolomide-glioblastoma-glioblastoma-multiforme-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.774Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azd5335-platinum-resistant-recurrent-ovarian-can-phase-i</loc>
    <lastmod>2026-05-28T21:47:31.788Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/teclistamab-relapsed-refractory-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.801Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ptt-4256-solid-tumours-renal-cell-carcinoma-clear-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:31.815Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ritlecitinib-tosilate-non-segmental-vitiligo-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:31.829Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/teclistamab-relapsed-refractory-multiple-myeloma-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:31.842Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bnt327-triple-negative-breast-cancer-tnbc-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.858Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inca033989-myeloproliferative-neoplasms-myelofibros-phase-i</loc>
    <lastmod>2026-05-28T21:47:31.872Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/teclistamab-relapsed-refractory-multiple-myeloma-phase-i-ii-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.886Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hydroquinone-tretinoin-melasma-facial-melasma</loc>
    <lastmod>2026-05-28T21:47:31.900Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/talquetamab-multiple-myeloma-relapsed-or-refractory-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.914Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/talquetamab-multiple-myeloma-relapsed-or-refractory-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:31.928Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nomlabofusp-friedreich-s-ataxia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.942Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/20-hydroxyecdysone-sarcopenia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.956Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/teclistamab-relapsed-refractory-multiple-myeloma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:31.969Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-normal-immunoglobulin-multiple-myeloma-secondary-immunodeficie-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.983Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutetium-177lu-vipivotide-tetraxetan-de-novo-metastatic-hormone-sensitive-pro-phase-iii</loc>
    <lastmod>2026-05-28T21:47:31.997Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apremilast-juvenile-psoriatic-arthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.011Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ursodeoxycholic-acid-recurrent-acute-biliary-pancreatitis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:32.026Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methotrexate-erosive-osteoarthritis-phase-iv</loc>
    <lastmod>2026-05-28T21:47:32.040Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methotrexate-burkitt-lymphoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.054Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metastatic-gastric-adenocarcinoma-advanc-phase-iv</loc>
    <lastmod>2026-05-28T21:47:32.068Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sotorasib-metastatic-colorectal-cancer-colorectal-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.082Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly3537982-non-small-cell-lung-cancer-kras-g12c-mut-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.096Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ft819-b-cell-mediated-autoimmune-diseases-phase-i</loc>
    <lastmod>2026-05-28T21:47:32.110Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/baclofen-benzodiazepine-use-disorder-benzodiazepi-phase-ii-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.124Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cevostamab-relapsed-or-refractory-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.137Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amlenetug-multiple-system-atrophy-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.152Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abemaciclib-high-grade-glioma-glioma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:32.165Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-acute-myeloid-leukaemia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.179Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tocotrienol-metastatic-colorectal-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:47:32.193Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/guselkumab-ulcerative-colitis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.206Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/guselkumab-chronic-plaque-psoriasis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.220Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bms-986482-advanced-solid-tumors-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:32.234Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rozanolixizumab-generalized-myasthenia-gravis-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:47:32.247Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-metastatic-renal-cell-carcinoma-not-applicable</loc>
    <lastmod>2026-05-28T21:47:32.261Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-metastatic-colorectal-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:47:32.275Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tiragolumab-esophageal-squamous-cell-carcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.288Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tislelizumab-non-small-cell-lung-cancer-colorectal-ca-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.302Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ponatinib-chronic-myeloid-leukaemia-in-accelerated-phase-ii</loc>
    <lastmod>2026-05-28T21:47:32.316Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bintrafusp-alfa-esophageal-squamous-cell-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:32.330Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/risankizumab-crohn-s-disease-phase-iii-3</loc>
    <lastmod>2026-05-28T21:47:32.343Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/topotecan-retinoblastoma-phase-iv</loc>
    <lastmod>2026-05-28T21:47:32.357Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ferric-carboxymaltose-postpartum-iron-deficiency-anaemia-postp-phase-iv</loc>
    <lastmod>2026-05-28T21:47:32.371Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-advanced-biliary-tract-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.385Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ivonescimab-metastatic-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.399Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/avacopan-anca-associated-vasculitis-aav-granuloma-phase-iv</loc>
    <lastmod>2026-05-28T21:47:32.413Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-muscle-invasive-bladder-cancer-urothelia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.427Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ropivacaine-hydrochloride-monohydrate-acute-low-back-pain-lumbar-pain-not-applicable</loc>
    <lastmod>2026-05-28T21:47:32.441Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pabinafusp-alfa-mucopolysaccharidosis-type-ii-hunter-syn-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:32.455Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxybutynin-hydrochloride-spina-bifida-neurogenic-bladder-dysfunct-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.468Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zolbetuximab-gastric-adenocarcinoma-gastroesophageal-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:32.482Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anselamimab-amyloid-light-chain-al-amyloidosis-cardi-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.495Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ruxolitinib-acute-lymphoblastic-leukemia-relapsed-pr-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:32.510Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-pancreatic-ductal-adenocarcinoma-resecta-phase-ii</loc>
    <lastmod>2026-05-28T21:47:32.524Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/group-b-streptococcus-capsular-polysacch-group-b-streptococcus-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.538Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dasatinib-acute-lymphoblastic-leukemia-relapsed-or-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:32.552Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/secukinumab-hidradenitis-suppurativa-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.565Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/montelukast-erosive-hand-osteoarthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.582Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/kisima-02-pancreatic-ductal-adenocarcinoma-kras-g1-phase-i</loc>
    <lastmod>2026-05-28T21:47:32.596Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/radium-224-adsorbed-in-calcium-carbonate-high-grade-serous-ovarian-cancer-high-gr-phase-ii</loc>
    <lastmod>2026-05-28T21:47:32.610Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atumelnant-classic-congenital-adrenal-hyperplasia</loc>
    <lastmod>2026-05-28T21:47:32.623Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/18f-meta-fluorobenzylguanidine-neuroblastoma-not-applicable</loc>
    <lastmod>2026-05-28T21:47:32.637Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inebilizumab-immunoglobulin-g4-related-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.651Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/saruparib-metastatic-castration-sensitive-prostate-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.665Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/betamethasone-dipropionate-clotrimazole-candidiasis-of-the-skin-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.678Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/1-6-ethyl-8-fluoro-4-methyl-3-3-methyl-1-major-depressive-disorder-phase-iii-2</loc>
    <lastmod>2026-05-28T21:47:32.692Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-tirumotecan-non-small-cell-lung-cancer-nonsquamous-n-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.706Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/advanced-solid-tumors-phase-i-8</loc>
    <lastmod>2026-05-28T21:47:32.720Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tremelimumab-non-small-cell-lung-cancer-oligometastat-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.734Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trastuzumab-emtansine-her2-positive-breast-cancer-metastatic-b-phase-iv</loc>
    <lastmod>2026-05-28T21:47:32.747Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ivermectin-papulopustular-rosacea-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.761Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etentamig-abbv-383-light-chain-amyloidosis</loc>
    <lastmod>2026-05-28T21:47:32.775Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/xtmab-16-pulmonary-sarcoidosis-phase-i-ii</loc>
    <lastmod>2026-05-28T21:47:32.789Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/osimertinib-non-small-cell-lung-cancer-non-squamous-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.802Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/minoxidil-androgenetic-alopecia-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.816Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/povorcitinib-asthma-phase-ii</loc>
    <lastmod>2026-05-28T21:47:32.830Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-obesity-phase-iv-2</loc>
    <lastmod>2026-05-28T21:47:32.844Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ustekinumab-crohn-s-disease-perianal-fistulising-cro</loc>
    <lastmod>2026-05-28T21:47:32.857Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mitomycin-recurrent-non-muscle-invasive-bladder-ca-phase-iv</loc>
    <lastmod>2026-05-28T21:47:32.870Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-rectal-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:47:32.884Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ribitol-limb-girdle-muscular-dystrophy-2i-lgmd2i-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.899Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-chronic-lymphocytic-leukemia-relapsed-re-phase-ii-2</loc>
    <lastmod>2026-05-28T21:47:32.913Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-phosphate-severe-burns-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.927Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-tirumotecan-metastatic-non-small-cell-lung-cancer-ns-phase-iii</loc>
    <lastmod>2026-05-28T21:47:32.940Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-adipose-derived-mesenchymal-s-abdominal-aortic-aneurysm-phase-iv</loc>
    <lastmod>2026-05-28T21:47:32.954Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cisplatin-ovarian-epithelial-cancer-intraperitonea-phase-iii</loc>
    <lastmod>2026-05-28T21:51:33.210Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/romosozumab-osteogenesis-imperfecta-not-applicable</loc>
    <lastmod>2026-05-28T21:51:33.281Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/niraparib-ovarian-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:33.299Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ritlecitinib-tosilate-alopecia-areata-phase-iii-2</loc>
    <lastmod>2026-05-28T21:51:33.317Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/niraparib-metastatic-prostate-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:51:33.334Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/18f-psma-1007-prostate-cancer-phase-iii-2</loc>
    <lastmod>2026-05-28T21:51:33.350Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nusinersen-spinal-muscular-atrophy-phase-i</loc>
    <lastmod>2026-05-28T21:51:33.367Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-gastric-adenocarcinoma-resectable-stage-phase-iv</loc>
    <lastmod>2026-05-28T21:51:33.385Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regorafenib-arteriovenous-malformations-phase-iii</loc>
    <lastmod>2026-05-28T21:51:33.402Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trabectedin-metastatic-leiomyosarcoma-locally-advanc-phase-ii</loc>
    <lastmod>2026-05-28T21:51:33.419Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-urothelial-carcinoma-unresectable-or-met-phase-iii</loc>
    <lastmod>2026-05-28T21:51:33.440Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belimumab-systemic-sclerosis-associated-interstiti-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:51:33.457Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-tirumotecan-squamous-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:51:33.475Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-764532-glioma-dll3-positive-phase-iii</loc>
    <lastmod>2026-05-28T21:51:33.492Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sotorasib-non-small-cell-lung-cancer-kras-g12c-mut-phase-ii</loc>
    <lastmod>2026-05-28T21:51:33.509Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bictegravir-lenacapavir-hiv-1-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:51:33.527Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gd2il18cart-neuroblastoma-advanced-breast-cancer-ewi-phase-i</loc>
    <lastmod>2026-05-28T21:51:33.542Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cetrelimab-metastatic-prostate-cancer-prostate-canc-phase-iii</loc>
    <lastmod>2026-05-28T21:51:33.559Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/darolutamide-prostate-cancer-intermediate-unfavorable-phase-ii</loc>
    <lastmod>2026-05-28T21:51:33.575Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/voxvoganan-covid-19-covid-like-illness-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:51:33.591Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pegunigalsidase-alfa-fabry-disease-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:51:33.607Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/kk8123-x-linked-hypophosphatemia-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:33.623Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nemtabrutinib-small-lymphocytic-lymphoma-sll-chronic-l-phase-iii</loc>
    <lastmod>2026-05-28T21:51:33.639Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/humanised-igg1-monoclonal-antibody-again-facioscapulohumeral-muscular-dystrophy-phase-ii</loc>
    <lastmod>2026-05-28T21:51:33.663Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/3s-3-6-4-1-4-1r-2s-6-hydroxy-2-phenyl-1-advanced-breast-cancer-metastatic-breast-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:33.680Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nemtabrutinib-chronic-lymphocytic-leukemia-small-lymph-phase-iii</loc>
    <lastmod>2026-05-28T21:51:33.697Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bidridistrogene-xeboparvovec-limb-girdle-muscular-dystrophy-lgmd2e-r4-phase-iii</loc>
    <lastmod>2026-05-28T21:51:33.711Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-solid-tumors</loc>
    <lastmod>2026-05-28T21:51:33.725Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obinutuzumab-granulomatosis-with-polyangiitis-wegener-phase-ii</loc>
    <lastmod>2026-05-28T21:51:33.740Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-gastrointestinal-stromal-tumor-gist-unre-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:51:33.755Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/budesonide-glycopyrronium-bromide-formot-chronic-obstructive-pulmonary-disease-co-phase-iii</loc>
    <lastmod>2026-05-28T21:51:33.772Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methylprednisolone-sodium-succinate-acute-myocarditis-phase-iii</loc>
    <lastmod>2026-05-28T21:51:33.787Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-peripheral-blood-derived-cd4-multiple-myeloma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:33.803Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cancer-pan-tumor-phase-ii</loc>
    <lastmod>2026-05-28T21:51:33.818Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fianlimab-advanced-non-small-cell-lung-cancer-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:51:33.834Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/osimertinib-non-small-cell-lung-cancer-non-small-cel-phase-iv</loc>
    <lastmod>2026-05-28T21:51:33.852Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-90014496-b-cell-non-hodgkin-lymphoma-non-hodgkin-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:33.869Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amivantamab-metastatic-non-small-cell-lung-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:33.883Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iptacopan-atypical-hemolytic-uremic-syndrome-phase-iii-phase-iv</loc>
    <lastmod>2026-05-28T21:51:33.899Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-papillomavirus-l1-proteins-types-6-recipients-of-allogeneic-stem-cell-trans-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:51:33.915Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/semaglutide-obesity-atrial-fibrillation-phase-iv</loc>
    <lastmod>2026-05-28T21:51:33.929Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mosunetuzumab-follicular-lymphoma-relapsed-refractory-phase-ii</loc>
    <lastmod>2026-05-28T21:51:33.946Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/modified-messenger-ribonucleic-acid-enco-propionic-acidemia-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:33.961Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexlansoprazole-nonerosive-gastroesophageal-reflux-disea-phase-ii</loc>
    <lastmod>2026-05-28T21:51:33.976Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/evolocumab-healthy-volunteers-phase-iv</loc>
    <lastmod>2026-05-28T21:51:33.990Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dengue-virus-serotype-2-live-attenuated-dengue-fever-phase-iv</loc>
    <lastmod>2026-05-28T21:51:34.005Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ozanimod-hydrochloride-relapsing-remitting-multiple-sclerosis-phase-iii</loc>
    <lastmod>2026-05-28T21:51:34.020Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gentamicin-sulfate-congenital-ichthyosis-hereditary-ichthyo-phase-ii</loc>
    <lastmod>2026-05-28T21:51:34.035Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tepotinib-non-small-cell-lung-cancer-met-exon-14-m-phase-iii</loc>
    <lastmod>2026-05-28T21:51:34.051Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/entrectinib-pediatric-solid-tumors-primary-central-n-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:34.067Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/disitamab-vedotin-urothelial-carcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:51:34.083Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/short-bowel-syndrome-bacterial-infection</loc>
    <lastmod>2026-05-28T21:51:34.099Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/df-006-chronic-hepatitis-b-phase-i</loc>
    <lastmod>2026-05-28T21:51:34.113Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tarlatamab-small-cell-lung-cancer-brain-metastases-phase-ii</loc>
    <lastmod>2026-05-28T21:51:34.129Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/kite-363-relapsed-and-refractory-b-cell-lymphoma-phase-i</loc>
    <lastmod>2026-05-28T21:51:34.145Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/toxin-type-a-complex-of-clostridium-botu-erectile-dysfunction-phase-iv</loc>
    <lastmod>2026-05-28T21:51:34.159Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tuparstobart-recurrent-metastatic-squamous-cell-carci-phase-ii</loc>
    <lastmod>2026-05-28T21:51:34.174Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/midostaurin-acute-myeloid-leukemia-myelodysplastic-s-phase-ii</loc>
    <lastmod>2026-05-28T21:51:34.189Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rimegepant-acute-migraine-phase-iii</loc>
    <lastmod>2026-05-28T21:51:34.206Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/camizestrant-advanced-breast-cancer-estrogen-receptor-phase-iii</loc>
    <lastmod>2026-05-28T21:51:34.222Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vedolizumab-ulcerative-colitis-crohn-s-disease-phase-iii-3</loc>
    <lastmod>2026-05-28T21:51:34.238Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lauromacrogol-400-spermatocele-hydrocele-phase-iii</loc>
    <lastmod>2026-05-28T21:51:34.255Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/efepoetin-alfa-anemia-due-to-chronic-kidney-disease-on-phase-iii</loc>
    <lastmod>2026-05-28T21:51:34.270Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cart123-cd123-targeted-autologous-car-t-cd123-positive-hematological-malignancie-phase-i</loc>
    <lastmod>2026-05-28T21:51:34.285Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/leniolisib-phosphate-activated-phosphoinositide-3-kinase-delt-phase-iii</loc>
    <lastmod>2026-05-28T21:51:34.300Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tralokinumab-atopic-dermatitis-moderate-to-severe-ato-phase-iii</loc>
    <lastmod>2026-05-28T21:51:34.315Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ixekizumab-psoriatic-arthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:51:34.330Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/axatilimab-chronic-graft-versus-host-disease-phase-ii-3</loc>
    <lastmod>2026-05-28T21:51:34.345Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adeno-associated-virus-serotype-2-encodi-geographic-atrophy-secondary-to-age-rela-phase-iv</loc>
    <lastmod>2026-05-28T21:51:34.361Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/savolitinib-papillary-renal-cell-carcinoma-met-drive-phase-iii</loc>
    <lastmod>2026-05-28T21:51:34.379Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/remibrutinib-chronic-spontaneous-urticaria-phase-iii-2</loc>
    <lastmod>2026-05-28T21:51:34.395Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/linaprazan-glurate-erosive-esophagitis-due-to-gastroesophag-phase-iii-2</loc>
    <lastmod>2026-05-28T21:51:34.410Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anselamimab-al-amyloidosis-cardiac-al-amyloidosis-ma-phase-iii</loc>
    <lastmod>2026-05-28T21:51:34.427Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pelacarsen-calcific-aortic-valve-stenosis-phase-ii</loc>
    <lastmod>2026-05-28T21:51:34.443Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/budesonide-episodic-expiratory-wheezing-phase-iv</loc>
    <lastmod>2026-05-28T21:51:34.457Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ribociclib-hormone-receptor-positive-her2-negative-phase-iii-2</loc>
    <lastmod>2026-05-28T21:51:34.473Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rozanolixizumab-generalized-myasthenia-gravis-phase-iii</loc>
    <lastmod>2026-05-28T21:51:34.489Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mirabegron-healthy-volunteers-phase-ii-2</loc>
    <lastmod>2026-05-28T21:51:34.504Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/giredestrant-estrogen-receptor-positive-her2-negative-phase-iii-2</loc>
    <lastmod>2026-05-28T21:51:34.522Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-advanced-stage-classical-hodgkin-lymphom-phase-ii</loc>
    <lastmod>2026-05-28T21:51:34.539Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/olpasiran-atherosclerotic-cardiovascular-disease-e-phase-iii</loc>
    <lastmod>2026-05-28T21:51:34.554Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clostridia-cluster-xiva-strain-relative-clostridioides-difficile-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:51:34.569Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/modafinil-multiple-sclerosis-relapsing-remitting-m-phase-ii</loc>
    <lastmod>2026-05-28T21:51:34.584Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bimekizumab-palmoplantar-pustulosis-phase-iii</loc>
    <lastmod>2026-05-28T21:51:34.598Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/axatilimab-idiopathic-pulmonary-fibrosis-phase-ii</loc>
    <lastmod>2026-05-28T21:51:34.614Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nemtabrutinib-mantle-cell-lymphoma-chronic-lymphocytic-phase-ii</loc>
    <lastmod>2026-05-28T21:51:34.627Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gadobutrol-idiopathic-normal-pressure-hydrocephalus-phase-ii</loc>
    <lastmod>2026-05-28T21:51:34.644Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adeno-associated-viral-vector-serotype-9-frontotemporal-dementia-ftd-with-progran-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:34.658Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tretinoin-oropharyngeal-squamous-cell-carcinoma-la</loc>
    <lastmod>2026-05-28T21:51:34.672Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/insulin-icodec-type-2-diabetes</loc>
    <lastmod>2026-05-28T21:51:34.688Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/modified-messenger-ribonucleic-acid-enco-propionic-acidemia-phase-i-ii-2</loc>
    <lastmod>2026-05-28T21:51:34.702Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/blinatumomab-acute-lymphoblastic-leukaemia-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:51:34.716Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rezafungin-acetate-chronic-pulmonary-aspergillosis-phase-ii</loc>
    <lastmod>2026-05-28T21:51:34.730Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adipose-tissue-derived-stem-stromal-cell-alzheimer-s-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:51:34.745Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pentixather-radiolabelled-with-lutetium-acute-leukemia-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:34.759Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-malignant-pleural-mesothelioma-phase-iii</loc>
    <lastmod>2026-05-28T21:51:34.775Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cemiplimab-fianlimab-malignant-melanoma-phase-ii-phase-iii</loc>
    <lastmod>2026-05-28T21:51:34.789Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tretinoin-oligometastatic-solid-tumor-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:34.803Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prednisone-giant-cell-arteritis-horton-s-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:51:34.816Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/omeprazole-gastroesophageal-reflux-disease-cow-s-mi</loc>
    <lastmod>2026-05-28T21:51:34.830Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methylprednisolone-methylprednisolone-hy-focal-cerebral-arteriopathy-ischemic-str-phase-iii</loc>
    <lastmod>2026-05-28T21:51:34.847Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tislelizumab-oral-cavity-squamous-cell-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:51:34.863Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly3537982-kras-g12c-mutant-advanced-solid-tumors-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:34.878Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-waldenstrom-s-macroglobulinaemia-phase-ii</loc>
    <lastmod>2026-05-28T21:51:34.894Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sibeprenlimab-sjogren-s-syndrome-phase-ii</loc>
    <lastmod>2026-05-28T21:51:34.909Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-endometrial-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:51:34.922Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-waldenstrom-s-macroglobulinemia-phase-ii</loc>
    <lastmod>2026-05-28T21:51:34.937Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dabrafenib-anaplastic-thyroid-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:51:34.953Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-muscle-invasive-bladder-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:51:34.970Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-cd34-haematopoietic-stem-and-mucopolysaccharidosis-type-i-hurler-synd-phase-iii</loc>
    <lastmod>2026-05-28T21:51:34.985Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/relapsed-or-refractory-multiple-myeloma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:35.001Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/medi5752-metastatic-soft-tissue-sarcoma-phase-i</loc>
    <lastmod>2026-05-28T21:51:35.015Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/venetoclax-small-lymphocytic-lymphoma-chronic-lymph-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:35.030Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fenebrutinib-primary-progressive-multiple-sclerosis-phase-iii</loc>
    <lastmod>2026-05-28T21:51:35.044Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elacestrant-early-breast-cancer-estrogen-receptor-po-phase-iii</loc>
    <lastmod>2026-05-28T21:51:35.061Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tafasitamab-diffuse-large-b-cell-lymphoma-dlbcl-phase-iii</loc>
    <lastmod>2026-05-28T21:51:35.076Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tarlatamab-extensive-stage-small-cell-lung-cancer-s-phase-ii</loc>
    <lastmod>2026-05-28T21:51:35.091Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/furazidine-bacterial-vaginosis-phase-iii</loc>
    <lastmod>2026-05-28T21:51:35.105Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-faecal-microbiota-pooled-non-alcoholic-steatohepatitis-phase-ii</loc>
    <lastmod>2026-05-28T21:51:35.118Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ifinatamab-deruxtecan-squamous-non-small-cell-lung-cancer-stag-phase-ii</loc>
    <lastmod>2026-05-28T21:51:35.133Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/limbal-stem-cell-deficiency</loc>
    <lastmod>2026-05-28T21:51:35.150Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/disitamab-vedotin-urothelial-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:51:35.164Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fibrin-critical-limb-ischemia-phase-i</loc>
    <lastmod>2026-05-28T21:51:35.179Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amiloride-hydrochloride-furosemide-er-positive-her2-negative-breast-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:51:35.192Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/paclitaxel-albumin-bound-metastatic-non-small-cell-lung-cancer-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:51:35.205Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sonelokimab-psoriatic-arthritis-phase-iii-3</loc>
    <lastmod>2026-05-28T21:51:35.219Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ga68-oncofap-colorectal-cancer-gastric-cancer-pancrea-phase-ii</loc>
    <lastmod>2026-05-28T21:51:35.233Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dostarlimab-colon-adenocarcinoma-t4n0-colon-cancer-s-phase-ii</loc>
    <lastmod>2026-05-28T21:51:35.247Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rocatinlimab-asthma-phase-ii</loc>
    <lastmod>2026-05-28T21:51:35.262Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azacitidine-vexas-syndrome-phase-ii</loc>
    <lastmod>2026-05-28T21:51:35.275Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nirsevimab-respiratory-syncytial-virus-rsv-infectio</loc>
    <lastmod>2026-05-28T21:51:35.323Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-advanced-solid-tumors-phase-i-3</loc>
    <lastmod>2026-05-28T21:51:35.362Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rnmb1-rnmb2-nmbpbas1-rnmb3-neisseria-men-meningococcal-disease-phase-ii</loc>
    <lastmod>2026-05-28T21:51:35.401Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/finerenone-chronic-kidney-disease-phase-iii-3</loc>
    <lastmod>2026-05-28T21:51:35.441Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/azenosertib-high-grade-serous-ovarian-cancer-fallopi-phase-ii</loc>
    <lastmod>2026-05-28T21:51:35.474Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apixaban-atrial-fibrillation-phase-iv</loc>
    <lastmod>2026-05-28T21:51:35.489Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/baricitinib-hiv-1-infection-phase-ii</loc>
    <lastmod>2026-05-28T21:51:35.505Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eptinezumab-migraine-chronic-migraine-episodic-migra-phase-iii</loc>
    <lastmod>2026-05-28T21:51:35.551Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sedation-healthy-volunteer-phase-iii</loc>
    <lastmod>2026-05-28T21:51:35.566Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutetium-177lu-edotreotide-neuroendocrine-tumours-phase-iii</loc>
    <lastmod>2026-05-28T21:51:35.581Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rilpivirine-hiv-1-infection</loc>
    <lastmod>2026-05-28T21:51:35.597Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxytocin-breast-cancer-psychological-stress-not-applicable</loc>
    <lastmod>2026-05-28T21:51:35.610Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cytarabine-daunorubicin-acute-myeloid-leukemia-aml-relapsed-refr-phase-i</loc>
    <lastmod>2026-05-28T21:51:35.625Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ivosidenib-acute-myeloid-leukemia-myelodysplastic-s-phase-iii</loc>
    <lastmod>2026-05-28T21:51:35.639Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cc-97540-systemic-lupus-erythematosus-lupus-nephr-phase-ii</loc>
    <lastmod>2026-05-28T21:51:35.677Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ruxolitinib-inclusion-body-myositis-phase-ii</loc>
    <lastmod>2026-05-28T21:51:35.692Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/enlicitide-chloride-atherosclerotic-cardiovascular-disease-a-phase-iii</loc>
    <lastmod>2026-05-28T21:51:35.706Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pst-611-dry-age-related-macular-degeneration-phase-i</loc>
    <lastmod>2026-05-28T21:51:35.719Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ferric-carboxymaltose-anemia-phase-iii</loc>
    <lastmod>2026-05-28T21:51:35.735Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dostarlimab-non-small-cell-lung-cancer-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:51:35.748Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rivaroxaban-carotid-artery-atherosclerosis-periphera-phase-iv</loc>
    <lastmod>2026-05-28T21:51:35.763Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mifepristone-contraception-oral-contraception-phase-iii</loc>
    <lastmod>2026-05-28T21:51:35.777Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-extranodal-marginal-zone-b-cell-lymphoma-phase-ii</loc>
    <lastmod>2026-05-28T21:51:35.818Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/thiamazole-graves-disease-graves-orbitopathy-phase-iii</loc>
    <lastmod>2026-05-28T21:51:35.832Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/temozolomide-wilms-tumor-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:35.849Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/paracetamol-healthy-volunteers-not-applicable</loc>
    <lastmod>2026-05-28T21:51:35.863Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clostridium-botulinum-neurotoxin-type-a-cerebral-palsy-muscle-spasticity-phase-ii</loc>
    <lastmod>2026-05-28T21:51:35.876Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-mesenchymoangioblast-derived-acute-graft-versus-host-disease-high-ris-phase-ii</loc>
    <lastmod>2026-05-28T21:51:35.890Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clemizole-hydrochloride-lennox-gastaut-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:51:35.905Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mk-8294-breast-cancer-cervical-squamous-cell-car-phase-i</loc>
    <lastmod>2026-05-28T21:51:35.920Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adrc-cryptoglandular-perianal-fistula</loc>
    <lastmod>2026-05-28T21:51:35.934Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pacritinib-myelofibrosis-thrombocytopenia-phase-ii</loc>
    <lastmod>2026-05-28T21:51:35.950Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clozapine-schizophrenia-phase-iv</loc>
    <lastmod>2026-05-28T21:51:35.963Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-local-recurrence-of-prostate-cancer-prev-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:35.978Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lidocaine-hydrochloride-monohydrate-major-gastrointestinal-or-abdominal-surg-phase-iii</loc>
    <lastmod>2026-05-28T21:51:35.993Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mitazalimab-metastatic-pancreatic-ductal-adenocarcin-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:36.008Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nipocalimab-hemolytic-disease-of-the-fetus-and-newbo-phase-iii</loc>
    <lastmod>2026-05-28T21:51:36.022Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-traumatic-brain-injury-post-traumatic-br-not-applicable</loc>
    <lastmod>2026-05-28T21:51:36.035Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gad20-209-fsp-a4-gad20-209-fsp-a2-gad20-colorectal-cancer-msi-h-dmmr-metastatic-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:36.050Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sub190378-ro7010939-fenebrutinib-relapsing-multiple-sclerosis-phase-ii</loc>
    <lastmod>2026-05-28T21:51:36.064Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levofloxacin-acute-uncomplicated-appendicitis</loc>
    <lastmod>2026-05-28T21:51:36.079Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acoramidis-hydrochloride-transthyretin-amyloidosis-transthyretin-phase-iii</loc>
    <lastmod>2026-05-28T21:51:36.094Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tocilizumab-relapsed-refractory-b-cell-non-hodgkin-l-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:36.109Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obinutuzumab-minimal-change-disease-nephrotic-syndrom-phase-ii</loc>
    <lastmod>2026-05-28T21:51:36.124Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aflibercept-retinopathy-of-prematurity-rop-phase-iii</loc>
    <lastmod>2026-05-28T21:51:36.138Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/piroxicam-lateral-epicondylitis-phase-iv</loc>
    <lastmod>2026-05-28T21:51:36.151Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/carbidopa-levodopa-parkinson-s-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:51:36.168Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ds101-diabetic-retinopathy-phase-i-2</loc>
    <lastmod>2026-05-28T21:51:36.187Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/niraparib-tosilate-monohydrate-high-grade-ovarian-cancer-hrd-positive-s-phase-ii</loc>
    <lastmod>2026-05-28T21:51:36.202Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/florquinitau-18f-alzheimer-disease-preclinical-and-prodro</loc>
    <lastmod>2026-05-28T21:51:36.220Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ascorbic-acid-sodium-ascorbate-potassium-bowel-preparation-for-colonoscopy-phase-iv</loc>
    <lastmod>2026-05-28T21:51:36.234Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-anca-associated-vasculitis-granulomatosi-not-applicable</loc>
    <lastmod>2026-05-28T21:51:36.248Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mps-112-mps-106-mps-213-mps-102-mps-216-pancreatic-ductal-adenocarcinoma-locally-phase-ii</loc>
    <lastmod>2026-05-28T21:51:36.262Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abbv-706-advanced-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:51:36.276Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/luspatercept-myelodysplastic-syndrome-beta-thalassemi-phase-iii</loc>
    <lastmod>2026-05-28T21:51:36.290Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/l-acetylleucine-ataxia-telangiectasia-phase-iii</loc>
    <lastmod>2026-05-28T21:51:36.305Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etoposide-retinoblastoma-phase-iv</loc>
    <lastmod>2026-05-28T21:51:36.320Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nandrolone-decanoate-sarcopenia-phase-ii</loc>
    <lastmod>2026-05-28T21:51:36.336Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/copanlisib-dihydrochloride-marginal-zone-lymphoma-extranodal-margin-phase-ii</loc>
    <lastmod>2026-05-28T21:51:36.350Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aripiprazole-schizophrenia-first-episode-psychosis-tr-phase-iv</loc>
    <lastmod>2026-05-28T21:51:36.365Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/asciminib-hydrochloride-chronic-myeloid-leukemia-chronic-phase-c-phase-ii</loc>
    <lastmod>2026-05-28T21:51:36.381Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tasadenoturev-high-grade-malignant-brain-neoplasm-high-phase-ii</loc>
    <lastmod>2026-05-28T21:51:36.394Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clopidogrel-stroke-not-applicable</loc>
    <lastmod>2026-05-28T21:51:36.408Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2-3-3-5-dimethyltriazol-4-yl-5-s-oxan-4-myelofibrosis-primary-myelofibrosis-post-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:36.421Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ralinepag-pulmonary-arterial-hypertension-phase-iii</loc>
    <lastmod>2026-05-28T21:51:36.435Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/larotrectinib-sulfate-high-grade-glioma-diffuse-intrinsic-pont-phase-iv</loc>
    <lastmod>2026-05-28T21:51:36.449Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cisplatin-vulvar-cancer-squamous-cell-carcinoma-of-phase-ii</loc>
    <lastmod>2026-05-28T21:51:36.465Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/activated-charcoal-acute-drug-poisoning-intoxication-phase-ii</loc>
    <lastmod>2026-05-28T21:51:36.486Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dacomitinib-non-small-cell-lung-cancer-egfr-mutation-phase-ii</loc>
    <lastmod>2026-05-28T21:51:36.499Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ipilimumab-metastatic-colorectal-cancer-dmmr-msi-phase-ii</loc>
    <lastmod>2026-05-28T21:51:36.514Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/regorafenib-ewing-s-sarcoma-osteosarcoma-refractory-phase-ii</loc>
    <lastmod>2026-05-28T21:51:36.528Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-hydrochloride-polycystic-ovary-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:51:36.543Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lidocaine-hydrochloride-monohydrate-inflammatory-bowel-disease-crohn-s-disea-phase-iv</loc>
    <lastmod>2026-05-28T21:51:36.558Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etidronate-disodium-fahr-s-disease-fahr-s-syndrome-phase-ii</loc>
    <lastmod>2026-05-28T21:51:36.571Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/datopotamab-deruxtecan-egfr-mutated-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:51:36.588Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zanidatamab-biliary-tract-cancer-gallbladder-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:51:36.605Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/selinexor-multiple-myeloma-penta-refractory-multip-phase-ii</loc>
    <lastmod>2026-05-28T21:51:36.620Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/savolitinib-non-small-cell-lung-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:51:36.634Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-hydrochloride-myotonic-dystrophy-type-1-steinert-disea-phase-iii</loc>
    <lastmod>2026-05-28T21:51:36.648Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atezolizumab-squamous-cell-carcinoma-of-the-anal-cana-phase-ii</loc>
    <lastmod>2026-05-28T21:51:36.662Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/testosterone-undecanoate-hypogonadism-type-2-diabetes-mellitus-pr-phase-iv</loc>
    <lastmod>2026-05-28T21:51:36.675Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/epcoritamab-follicular-lymphoma-phase-iii</loc>
    <lastmod>2026-05-28T21:51:36.691Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/s-2-amino-6-2-hydroxypropanoyl-7-8-dihyd-phenylketonuria-pku-phase-iii</loc>
    <lastmod>2026-05-28T21:51:36.705Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abemaciclib-breast-cancer-phase-iii-2</loc>
    <lastmod>2026-05-28T21:51:36.720Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cisplatin-figo-stage-iii-epithelial-ovarian-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:51:36.735Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iag933-mesothelioma-other-solid-tumours-with-hi-phase-i</loc>
    <lastmod>2026-05-28T21:51:36.749Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/botulinum-toxin-type-a-haemagglutinin-co-open-abdomen-phase-iv</loc>
    <lastmod>2026-05-28T21:51:36.764Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/asciminib-hydrochloride-chronic-myeloid-leukemia-phase-iii-2</loc>
    <lastmod>2026-05-28T21:51:36.779Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/progesterone-placenta-previa-preterm-birth</loc>
    <lastmod>2026-05-28T21:51:36.794Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mirikizumab-ulcerative-colitis-crohn-s-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:51:36.808Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ianalumab-lupus-nephritis-phase-iii-2</loc>
    <lastmod>2026-05-28T21:51:36.822Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amy109-endometriosis-phase-ii</loc>
    <lastmod>2026-05-28T21:51:36.837Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gsk5764227-advanced-solid-tumors-colorectal-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:36.853Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aztreonam-avibactam-sodium-sepsis-gram-negative-bacterial-infection-phase-ii</loc>
    <lastmod>2026-05-28T21:51:36.869Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/riliprubart-chronic-inflammatory-demyelinating-polyn-phase-iii-2</loc>
    <lastmod>2026-05-28T21:51:36.884Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-2-2-dimethylamino-ethyl-methylamino-5-non-small-cell-lung-cancer-advanced-or-m-phase-iii</loc>
    <lastmod>2026-05-28T21:51:36.912Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/xtmab-16-pulmonary-sarcoidosis-phase-ii</loc>
    <lastmod>2026-05-28T21:51:36.927Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ketamine-depression-alcohol-use-disorder</loc>
    <lastmod>2026-05-28T21:51:36.941Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2r-5s-tetrahydro-5-2-methyl-1h-furo-3-2-early-parkinson-s-disease-parkinson-s-di-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:51:36.955Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atogepant-migraine-episodic-migraine-phase-iii</loc>
    <lastmod>2026-05-28T21:51:36.969Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/empagliflozin-autosomal-dominant-polycystic-kidney-dis-phase-iv</loc>
    <lastmod>2026-05-28T21:51:36.986Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cemiplimab-adrenocortical-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:51:37.002Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/upadacitinib-alopecia-areata-severe-alopecia-areata-phase-iii</loc>
    <lastmod>2026-05-28T21:51:37.015Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rituximab-immune-thrombocytopenia-itp-phase-iii</loc>
    <lastmod>2026-05-28T21:51:37.031Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/norfloxacin-decompensated-cirrhosis-bacterial-infect-phase-iv</loc>
    <lastmod>2026-05-28T21:51:37.044Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ifosfamide-mature-b-cell-non-hodgkin-lymphoma-cd20-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:37.058Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-faecal-microbiota-pooled-axial-spondyloarthritis-phase-ii</loc>
    <lastmod>2026-05-28T21:51:37.072Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vortioxetine-hydrobromide-schizophrenia-schizophrenia-spectrum-dis</loc>
    <lastmod>2026-05-28T21:51:37.086Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-bone-marrow-derived-mesenchym-knee-osteoarthritis</loc>
    <lastmod>2026-05-28T21:51:37.099Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/at-1501-kidney-transplant-rejection-phase-ii</loc>
    <lastmod>2026-05-28T21:51:37.115Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-bone-marrow-derived-mononucle-diabetic-foot-ulcer-chronic-limb-threate</loc>
    <lastmod>2026-05-28T21:51:37.129Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/barzolvolimab-chronic-spontaneous-urticaria-phase-iii-3</loc>
    <lastmod>2026-05-28T21:51:37.143Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mirikizumab-crohn-s-disease-phase-iii-2</loc>
    <lastmod>2026-05-28T21:51:37.156Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/choline-chloride-intestinal-failure-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:51:37.171Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inavolisib-pik3ca-mutated-hormone-receptor-positive-phase-ii</loc>
    <lastmod>2026-05-28T21:51:37.185Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tiotropium-bromide-chronic-obstructive-pulmonary-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:51:37.200Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cytisinicline-nicotine-dependence-phase-iv</loc>
    <lastmod>2026-05-28T21:51:37.214Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tildrakizumab-lyell-syndrome-toxic-epidermal-necrolysi-phase-iv</loc>
    <lastmod>2026-05-28T21:51:37.229Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prednisone-fabry-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:51:37.243Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rna-nucleic-acid-complex-synonym-aln-640-hereditary-haemorrhagic-telangiectasia-h-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:37.257Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/trontinemab-alzheimer-s-disease-mild-cognitive-impai-phase-iii-2</loc>
    <lastmod>2026-05-28T21:51:37.271Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pirtobrutinib-chronic-lymphocytic-leukemia-phase-ii</loc>
    <lastmod>2026-05-28T21:51:37.286Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iohexol-abdominal-aortic-aneurysm-phase-iv</loc>
    <lastmod>2026-05-28T21:51:37.299Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylsalicylic-acid-colorectal-adenomas-lynch-syndrome-phase-iii</loc>
    <lastmod>2026-05-28T21:51:37.313Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adeno-associated-viral-vector-serotype-9-parkinson-s-disease-with-gba1-mutation-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:37.327Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluorouracil-rectal-adenocarcinoma-locally-advanced-r-phase-iii</loc>
    <lastmod>2026-05-28T21:51:37.342Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxytocin-autism-spectrum-disorder-intellectual-di-ctis-2022-000254-28</loc>
    <lastmod>2026-05-28T21:11:30.363Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/orx750-narcolepsy-idiopathic-hypersomnia-phase-ii-2</loc>
    <lastmod>2026-05-28T21:51:37.357Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/prasugrel-acute-coronary-syndrome-chronic-coronary-not-applicable</loc>
    <lastmod>2026-05-28T21:51:37.371Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nerve-growth-factor-recombinant-r100e-optic-pathway-glioma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:37.386Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bnt327-advanced-lung-cancer-non-small-cell-lung-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:37.400Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pivmecillinam-hydrochloride-gram-negative-bacteremia-not-applicable</loc>
    <lastmod>2026-05-28T21:51:37.413Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-normal-immunoglobulin-non-cystic-fibrosis-bronchiectasis-phase-ii</loc>
    <lastmod>2026-05-28T21:51:37.427Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/telisotuzumab-adizutecan-colorectal-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:51:37.441Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bi-3804379-metabolic-dysfunction-associated-steatoh-phase-i</loc>
    <lastmod>2026-05-28T21:51:37.455Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/polymetastatic-solid-cancers-phase-i</loc>
    <lastmod>2026-05-28T21:51:37.469Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mesenchymal-cells-bronchopulmonary-dysplasia-phase-ii</loc>
    <lastmod>2026-05-28T21:51:37.484Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lutetium-177lu-oxodotreotide-recurrent-meningioma-phase-ii</loc>
    <lastmod>2026-05-28T21:51:37.499Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tezepelumab-chronic-obstructive-pulmonary-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:51:37.513Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/belantamab-mafodotin-newly-diagnosed-multiple-myeloma-multipl-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:37.527Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vancomycin-inflammatory-bowel-disease-ibd-in-remiss-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:51:37.541Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dafsolimab-setaritox-grisnilimab-setarit-diffuse-cutaneous-systemic-sclerosis-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:37.555Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/osimertinib-non-small-cell-lung-cancer-egfr-mutation-phase-iii-2</loc>
    <lastmod>2026-05-28T21:51:37.569Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-govitecan-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:51:37.582Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cariprazine-bipolar-depression-phase-iv</loc>
    <lastmod>2026-05-28T21:51:37.596Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adalimumab-non-infectious-uveitis-not-applicable</loc>
    <lastmod>2026-05-28T21:51:37.609Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/botulinum-toxin-type-a-retrograde-cricopharyngeus-dysfunction-b-not-applicable</loc>
    <lastmod>2026-05-28T21:51:37.623Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vatiquinone-friedreich-ataxia-phase-iii</loc>
    <lastmod>2026-05-28T21:51:37.637Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/secukinumab-moderate-to-severe-psoriasis-not-applicable</loc>
    <lastmod>2026-05-28T21:51:37.653Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mannitol-peritoneal-carcinomatosis-phase-iii</loc>
    <lastmod>2026-05-28T21:51:37.667Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dexamethasone-immune-thrombocytopenia-itp-primary-immu-phase-iii</loc>
    <lastmod>2026-05-28T21:51:37.682Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ifosfamide-resectable-non-metastatic-soft-tissue-sa-phase-iii</loc>
    <lastmod>2026-05-28T21:51:37.696Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/n-n-diethyl-2-2-4-2-18-f-fluoroethoxy-ph-multiple-sclerosis-not-applicable</loc>
    <lastmod>2026-05-28T21:51:37.717Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ifinatamab-deruxtecan-metastatic-castration-resistant-prostate-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:37.730Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/2-4s-6-4-chlorophenyl-1-methyl-4h-benzo-myelofibrosis-myeloproliferative-neoplas-phase-iii</loc>
    <lastmod>2026-05-28T21:51:37.745Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eik1003-advanced-solid-tumors-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:37.759Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rifampicin-hidradenitis-suppurativa-prosthetic-join-not-applicable</loc>
    <lastmod>2026-05-28T21:51:37.772Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/radium-224-adsorbed-in-calcium-carbonate-peritoneal-carcinomatosis-colorectal-car-phase-ii</loc>
    <lastmod>2026-05-28T21:51:37.786Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ethyl-esters-of-iodised-fatty-acids-from-knee-osteoarthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:51:37.800Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inaxaplin-apol1-mediated-proteinuric-kidney-diseas-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:51:37.813Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-biliary-tract-cancer-cholangiocarcinoma-phase-iii</loc>
    <lastmod>2026-05-28T21:51:37.827Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/biotin-huntington-s-disease-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:37.840Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/isb-2001-relapsed-refractory-multiple-myeloma-phase-i</loc>
    <lastmod>2026-05-28T21:51:37.858Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ritlecitinib-tosilate-alopecia-areata-phase-iii-3</loc>
    <lastmod>2026-05-28T21:51:37.873Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amivantamab-advanced-or-metastatic-colorectal-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:37.886Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iptacopan-generalized-myasthenia-gravis-phase-iii</loc>
    <lastmod>2026-05-28T21:51:37.900Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ntx-1955-generalized-anxiety-disorder-phase-iii</loc>
    <lastmod>2026-05-28T21:51:37.914Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ketorolac-trometamol-oncologic-surgery-postoperative-morbidit-phase-iii</loc>
    <lastmod>2026-05-28T21:51:37.927Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jnj-88549968-calr-mutated-myeloproliferative-neoplasm-phase-i</loc>
    <lastmod>2026-05-28T21:51:37.941Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dendritic-cells-frameshift-derived-neope-lynch-syndrome-phase-i</loc>
    <lastmod>2026-05-28T21:51:37.955Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tipapkinogene-sovacivec-hpv-16-positive-recurrent-or-metastatic-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:37.969Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gsk6097608-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:51:37.982Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dak539-advanced-malignant-neoplasms-hepatic-imp-phase-iii</loc>
    <lastmod>2026-05-28T21:51:37.996Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amoxicillin-clavulanic-acid-bloodstream-infection-bacteraemia-sepsis-phase-iv</loc>
    <lastmod>2026-05-28T21:51:38.011Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/jtt-861-monohydrochloride-dihydrate-heart-failure-with-reduced-ejection-frac-phase-ii</loc>
    <lastmod>2026-05-28T21:51:38.024Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etavopivat-sickle-cell-disease-sickle-cell-anemia-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:38.038Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lidocaine-hydrochloride-anesthesia-phase-iv</loc>
    <lastmod>2026-05-28T21:51:38.052Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atirmociclib-metastatic-breast-cancer-triple-negative-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:38.068Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-faecal-microbiota-pooled-postantibiotic-diarrhoea-phase-ii-phase-iv</loc>
    <lastmod>2026-05-28T21:51:38.082Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-papillomavirus-type-31-l1-protein-cutaneous-warts-palmar-and-plantar-phase-iii</loc>
    <lastmod>2026-05-28T21:51:38.096Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bosentan-non-arteritic-anterior-ischemic-optic-ne-phase-iii</loc>
    <lastmod>2026-05-28T21:51:38.112Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/saruparib-advanced-solid-tumours-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:38.127Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sotatercept-pulmonary-arterial-hypertension-idiopath-phase-iv</loc>
    <lastmod>2026-05-28T21:51:38.140Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/niraparib-tosilate-monohydrate-small-cell-lung-cancer-extensive-stage-phase-ii</loc>
    <lastmod>2026-05-28T21:51:38.154Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ruxolitinib-hidradenitis-suppurativa-phase-iii-2</loc>
    <lastmod>2026-05-28T21:51:38.169Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/glioblastoma-multiforme-glioblastoma</loc>
    <lastmod>2026-05-28T21:51:38.182Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-triple-negative-breast-cancer-early-phase-iii</loc>
    <lastmod>2026-05-28T21:51:38.197Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cladribine-acute-myeloid-leukemia-myelodysplastic-s-phase-iv</loc>
    <lastmod>2026-05-28T21:51:38.210Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dupilumab-chronic-rhinosinusitis-with-nasal-polyps-not-applicable-2</loc>
    <lastmod>2026-05-28T21:51:38.224Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sirolimus-familial-adenomatous-polyposis-fap-phase-iii</loc>
    <lastmod>2026-05-28T21:51:38.238Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/florquinitau-18f-alzheimer-s-disease-not-applicable</loc>
    <lastmod>2026-05-28T21:51:38.253Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nivolumab-hepatocellular-carcinoma-phase-iii-2</loc>
    <lastmod>2026-05-28T21:51:38.271Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pembrolizumab-metastatic-cervical-cancer-not-applicable</loc>
    <lastmod>2026-05-28T21:51:38.285Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/phospholipid-fraction-bovine-lung-respiratory-distress-syndrome-in-preterm</loc>
    <lastmod>2026-05-28T21:51:38.300Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/community-acquired-pneumonia-respiratory-not-applicable</loc>
    <lastmod>2026-05-28T21:51:38.315Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/exenatide-acute-ischemic-stroke-phase-ii</loc>
    <lastmod>2026-05-28T21:51:38.331Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-tumor-lysate-loaded-dendritic-stage-iv-colorectal-cancer-metastatic-co-phase-ii</loc>
    <lastmod>2026-05-28T21:51:38.345Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tirzepatide-obesity-phase-iii</loc>
    <lastmod>2026-05-28T21:51:38.358Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/8-ethoxy-n-3r-4s-3-methyl-1-methylsulfon-ovarian-cancer-phase-iii</loc>
    <lastmod>2026-05-28T21:51:38.372Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/deferoxamine-mesilate-aneurysmal-subarachnoid-hemorrhage-subar-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:38.386Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-cd19-directed-car-t-cells-relapsed-or-refractory-cd19-b-cell-neopl-phase-i</loc>
    <lastmod>2026-05-28T21:51:38.400Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cenegermin-traumatic-brain-injury-subacute-moderate-phase-ii</loc>
    <lastmod>2026-05-28T21:51:38.414Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/apixaban-left-ventricular-thrombosis-acute-myocar-phase-iv</loc>
    <lastmod>2026-05-28T21:51:38.429Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylcysteine-amide-mild-cognitive-impairment-alzheimer-s-di-phase-ii</loc>
    <lastmod>2026-05-28T21:51:38.443Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/upadacitinib-long-covid-phase-iii</loc>
    <lastmod>2026-05-28T21:51:38.458Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/upadacitinib-polymyositis-dermatomyositis-antisynthet-phase-ii</loc>
    <lastmod>2026-05-28T21:51:38.472Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ublituximab-relapsing-multiple-sclerosis-phase-iii-3</loc>
    <lastmod>2026-05-28T21:51:38.485Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zodasiran-homozygous-familial-hypercholesterolemia-phase-iii</loc>
    <lastmod>2026-05-28T21:51:38.499Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sacituzumab-govitecan-resectable-non-small-cell-lung-cancer-no-phase-iii</loc>
    <lastmod>2026-05-28T21:51:38.515Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/arog4-01-advanced-refractory-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:51:38.529Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/frexalimab-kidney-transplant-rejection-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:51:38.543Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ly3537982-non-small-cell-lung-cancer-kras-g12c-mut-phase-iii-2</loc>
    <lastmod>2026-05-28T21:51:38.558Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/decitabine-cedazuridine-acute-myeloid-leukemia-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:38.572Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/inavolisib-metastatic-castration-resistant-prostate-phase-ii</loc>
    <lastmod>2026-05-28T21:51:38.586Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/surabgene-lomparvovec-aav8-vector-encodi-neovascular-age-related-macular-degenera-phase-iii</loc>
    <lastmod>2026-05-28T21:51:38.600Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vemurafenib-malignant-solid-tumours-and-haematologic-phase-ii</loc>
    <lastmod>2026-05-28T21:51:38.615Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-adipose-derived-stem-cells-congenital-pseudarthrosis-of-the-tibia-c-phase-iii</loc>
    <lastmod>2026-05-28T21:51:38.628Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-rectal-cancer-locally-advanced-rectal-ca-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:51:38.642Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenvatinib-hepatocellular-carcinoma-bclc-a-phase-ii</loc>
    <lastmod>2026-05-28T21:51:38.655Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colecalciferol-obesity-vitamin-d-deficiency-phase-iv</loc>
    <lastmod>2026-05-28T21:51:38.669Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/multiple-myeloma-phase-iv</loc>
    <lastmod>2026-05-28T21:51:38.682Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/chronic-hepatitis-b-phase-i-2</loc>
    <lastmod>2026-05-28T21:51:38.697Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alkaline-phosphatase-bovine-systemic-inflammation-due-to-cardiopulmo-phase-iii</loc>
    <lastmod>2026-05-28T21:51:38.711Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/relatlimab-non-small-cell-lung-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:51:38.724Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/caffeine-alzheimer-s-disease</loc>
    <lastmod>2026-05-28T21:51:38.738Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tarlatamab-extensive-stage-small-cell-lung-cancer-phase-iii-3</loc>
    <lastmod>2026-05-28T21:51:38.752Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gefurulimab-generalized-myasthenia-gravis-acetylchol-phase-iii</loc>
    <lastmod>2026-05-28T21:51:38.769Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/meropenem-trihydrate-sepsis-phase-iv</loc>
    <lastmod>2026-05-28T21:51:38.783Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/deflazacort-laminopathies-lmna-related-congenital-mu-phase-iv</loc>
    <lastmod>2026-05-28T21:51:38.798Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lenacapavir-human-immunodeficiency-virus-hiv-1-infec-phase-ii</loc>
    <lastmod>2026-05-28T21:51:38.811Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abbv-319-systemic-lupus-erythematosus-sjogren-s-s-phase-iii</loc>
    <lastmod>2026-05-28T21:51:38.825Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/revumenib-acute-myeloid-leukemia-acute-myeloid-leu-phase-iii</loc>
    <lastmod>2026-05-28T21:51:38.839Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ticagrelor-coronary-artery-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:51:38.853Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rilzabrutinib-sickle-cell-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:51:38.872Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sunvozertinib-non-small-cell-lung-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:38.885Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/talquetamab-multiple-myeloma-phase-ii-2</loc>
    <lastmod>2026-05-28T21:51:38.899Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-hydrochloride-myelodysplastic-syndromes-mds-very-low-a-phase-iv</loc>
    <lastmod>2026-05-28T21:51:38.913Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dapagliflozin-acute-kidney-injury-aki-reduced-estimate-phase-iii</loc>
    <lastmod>2026-05-28T21:51:38.926Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/colchicine-also-listed-with-opium-standa-chronic-kidney-disease-moderate-cardiova-phase-iii</loc>
    <lastmod>2026-05-28T21:51:38.940Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lurbinectedin-small-cell-lung-cancer-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:38.954Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-plasma-gelsolin-recombinant-acute-respiratory-distress-syndrome-ards-phase-ii</loc>
    <lastmod>2026-05-28T21:51:38.969Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/litifilimab-systemic-lupus-erythematosus-phase-iii-3</loc>
    <lastmod>2026-05-28T21:51:38.983Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/abbv-969-prostate-cancer-metastatic-castration-re-phase-i</loc>
    <lastmod>2026-05-28T21:51:39.002Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vonicog-alfa-severe-von-willebrand-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:51:39.016Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/talquetamab-multiple-myeloma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:39.029Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-blood-derived-endothelial-pro-peripheral-arterial-disease-critical-lim-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:39.043Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anv600-advanced-solid-tumors-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:39.068Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/elvn-001-chronic-myeloid-leukemia-phase-i</loc>
    <lastmod>2026-05-28T21:51:39.082Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/respiratory-syncytial-virus-subgroup-a-s-respiratory-syncytial-virus-infection-phase-iv</loc>
    <lastmod>2026-05-28T21:51:39.096Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/bupivacaine-hydrochloride-epinephrine-postoperative-pain-after-aortic-valve-re-not-applicable</loc>
    <lastmod>2026-05-28T21:51:39.109Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/dalbavancin-periprosthetic-joint-infection-phase-iv</loc>
    <lastmod>2026-05-28T21:51:39.122Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acoramidis-hydrochloride-transthyretin-amyloidosis-phase-iii</loc>
    <lastmod>2026-05-28T21:51:39.136Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/igg1-trispecific-monoclonal-antibody-aga-relapsed-or-refractory-multiple-myeloma-phase-ii</loc>
    <lastmod>2026-05-28T21:51:39.150Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/atropine-sulfate-progressive-myopia-phase-iii</loc>
    <lastmod>2026-05-28T21:51:39.164Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ezetimibe-obicetrapib-atherosclerotic-cardiovascular-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:51:39.177Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acute-myeloid-leukemia-phase-iii</loc>
    <lastmod>2026-05-28T21:51:39.201Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tu7710-hemophilia-a-hemophilia-b-phase-i</loc>
    <lastmod>2026-05-28T21:51:39.215Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/livmoniplimab-locally-advanced-or-metastatic-solid-tum-phase-i</loc>
    <lastmod>2026-05-28T21:51:39.230Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vusolimogene-oderparepvec-metastatic-melanoma-advanced-solid-tumor-not-applicable</loc>
    <lastmod>2026-05-28T21:51:39.245Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amantadine-hydrochloride-advanced-parkinson-s-disease-phase-iv</loc>
    <lastmod>2026-05-28T21:51:39.259Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/asciminib-hydrochloride-philadelphia-chromosome-positive-chronic-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:39.274Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adalimumab-inflammatory-bowel-disease-ibd-ulcerativ-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:39.287Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/anti-gd2-800cw-neuroblastoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:39.301Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mepolizumab-eosinophilic-granulomatosis-with-polyang</loc>
    <lastmod>2026-05-28T21:51:39.316Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ivosidenib-acute-myeloid-leukaemia-idh1-mutated-acu-phase-ii</loc>
    <lastmod>2026-05-28T21:51:39.335Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/doravirine-islatravir-hiv-1-infection-phase-iii</loc>
    <lastmod>2026-05-28T21:51:39.348Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-non-small-cell-lung-cancer-stage-iii-unr-phase-iii</loc>
    <lastmod>2026-05-28T21:51:39.363Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gadopiclenol-steno-occlusive-vascular-disease-renovas-phase-iii</loc>
    <lastmod>2026-05-28T21:51:39.378Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pemetrexed-disodium-non-small-cell-lung-cancer-non-squamous-phase-iii</loc>
    <lastmod>2026-05-28T21:51:39.391Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/erdafitinib-non-muscle-invasive-bladder-cancer-muscl-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:39.406Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lidocaine-hydrochloride-sickle-cell-disease-phase-iii</loc>
    <lastmod>2026-05-28T21:51:39.419Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gozetotide-prostate-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:51:39.433Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/entrectinib-cancer</loc>
    <lastmod>2026-05-28T21:51:39.447Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/methylprednisolone-acetate-hand-osteoarthritis-phase-iii</loc>
    <lastmod>2026-05-28T21:51:39.460Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-plasma-proteins-with-not-less-than-heart-disease-hypoalbuminemia-phase-iv</loc>
    <lastmod>2026-05-28T21:51:39.475Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylcysteine-amide-n-acetylcysteine-am-hereditary-cystatin-c-amyloid-angiopathy-phase-iv</loc>
    <lastmod>2026-05-28T21:51:39.489Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/non-small-cell-lung-cancer-respiratory-t-phase-i</loc>
    <lastmod>2026-05-28T21:51:39.502Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-oxybate-catatonia</loc>
    <lastmod>2026-05-28T21:51:39.515Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/hiv-infection</loc>
    <lastmod>2026-05-28T21:51:39.529Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/metformin-embonate-type-2-diabetes-post-bariatric-surgery-phase-iii</loc>
    <lastmod>2026-05-28T21:51:39.544Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/osimertinib-non-small-cell-lung-cancer-stage-iii-egf-phase-iii</loc>
    <lastmod>2026-05-28T21:51:39.558Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/argon-oxygen-cardiac-arrest-phase-i-ii-phase-ii</loc>
    <lastmod>2026-05-28T21:51:39.572Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tocilizumab-chondrocalcinosis-calcium-pyrophosphate-phase-iii</loc>
    <lastmod>2026-05-28T21:51:39.585Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/xmab541-advanced-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:51:39.599Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/peginterferon-alfa-2a-metastatic-melanoma-phase-i-ii-ctis-2024-516125-31</loc>
    <lastmod>2026-05-28T21:11:29.476Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gskvx000000025896-varicella-phase-iii-3</loc>
    <lastmod>2026-05-28T21:51:39.612Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lepidoglyphus-destructor-allergies-phase-iv</loc>
    <lastmod>2026-05-28T21:51:39.627Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ziclumeran-mrna-lonvoguran-single-guide-hereditary-angioedema-c1-esterase-inhibi-phase-iii</loc>
    <lastmod>2026-05-28T21:51:39.640Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/budesonide-eosinophilic-oesophagitis-phase-iii</loc>
    <lastmod>2026-05-28T21:51:39.655Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zenagamtide-overweight-or-obesity-knee-osteoarthriti-phase-iii-2</loc>
    <lastmod>2026-05-28T21:51:39.669Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rocuronium-bromide-craniosynostosis-not-applicable</loc>
    <lastmod>2026-05-28T21:51:39.683Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/durvalumab-hepatocellular-carcinoma-phase-ii-3</loc>
    <lastmod>2026-05-28T21:51:39.697Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/paltusotine-carcinoid-syndrome-well-differentiated-n-phase-iii</loc>
    <lastmod>2026-05-28T21:51:39.711Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/flubhpve6e7-immunotherapy-human-papillomavirus-infection-hpv16-ass-phase-i</loc>
    <lastmod>2026-05-28T21:51:39.725Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/obinutuzumab-chronic-lymphocytic-leukemia-small-lymph-phase-ii</loc>
    <lastmod>2026-05-28T21:51:39.739Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cetuximab-metastatic-colorectal-cancer-colorectal-phase-iv</loc>
    <lastmod>2026-05-28T21:51:39.754Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ipatasertib-early-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:51:39.767Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/eltanexor-acute-myeloid-leukemia-npm1-mutated-acut-phase-ii</loc>
    <lastmod>2026-05-28T21:51:39.781Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sodium-lactate-septic-shock-phase-ii</loc>
    <lastmod>2026-05-28T21:51:39.794Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/levofloxacin-acute-pyelonephritis-kidney-transplant-r-phase-iv</loc>
    <lastmod>2026-05-28T21:51:39.808Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nemolizumab-prurigo-nodularis-phase-iii</loc>
    <lastmod>2026-05-28T21:51:39.822Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/vx-407-autosomal-dominant-polycystic-kidney-dis-phase-ii</loc>
    <lastmod>2026-05-28T21:51:39.836Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ot-a201-relapsed-refractory-hematological-malign-phase-i</loc>
    <lastmod>2026-05-28T21:51:39.849Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adalimumab-rheumatoid-arthritis-phase-iv</loc>
    <lastmod>2026-05-28T21:51:39.864Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sugammadex-elective-surgery-requiring-general-anest-not-applicable</loc>
    <lastmod>2026-05-28T21:51:39.877Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/amoxicillin-sinus-floor-elevation-with-guided-bone-r-phase-iv</loc>
    <lastmod>2026-05-28T21:51:39.891Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gallium-68ga-chloride-parotid-gland-carcinoma-not-applicable</loc>
    <lastmod>2026-05-28T21:51:39.904Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/fluorouracil-colorectal-cancer-metastatic-colorectal-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:51:39.917Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sonelokimab-hidradenitis-suppurativa-phase-iii-3</loc>
    <lastmod>2026-05-28T21:51:39.930Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/selumetinib-metastatic-breast-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:51:39.944Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/botulinum-toxin-type-a-haemagglutinin-co-dystonic-tremor-syndrome-not-applicable</loc>
    <lastmod>2026-05-28T21:51:39.958Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/human-monoclonal-igg1-antibody-against-n-endometrial-carcinoma-cervical-carcinoma-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:39.971Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/darolutamide-metastatic-castration-resistant-prostate-phase-ii-2</loc>
    <lastmod>2026-05-28T21:51:39.984Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ubx-303061-b-cell-malignancies-chronic-lymphocytic-phase-i</loc>
    <lastmod>2026-05-28T21:51:39.998Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ticagrelor-st-elevation-myocardial-infarction-stemi</loc>
    <lastmod>2026-05-28T21:51:40.019Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ivabradine-myocardial-injury-after-noncardiac-surge-phase-iii</loc>
    <lastmod>2026-05-28T21:51:40.032Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/retifanlimab-metastatic-upper-gastrointestinal-cancer-phase-ii</loc>
    <lastmod>2026-05-28T21:51:40.045Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/arv-393-advanced-non-hodgkin-lymphoma-phase-i</loc>
    <lastmod>2026-05-28T21:51:40.059Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ibrutinib-chronic-lymphocytic-leukemia-cll-phase-ii</loc>
    <lastmod>2026-05-28T21:51:40.073Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ivosidenib-acute-myeloid-leukemia-aml-myelodysplast-phase-ii</loc>
    <lastmod>2026-05-28T21:51:40.087Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tick-borne-encephalitis-virus-neudoerfl-tick-borne-encephalitis-phase-iv</loc>
    <lastmod>2026-05-28T21:51:40.101Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/ivosidenib-acute-myeloid-leukemia-previously-untrea-phase-iii</loc>
    <lastmod>2026-05-28T21:51:40.114Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/lorlatinib-non-small-cell-lung-cancer-lung-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:51:40.129Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/mavorixafor-chronic-neutropenia-congenital-neutropen-phase-iii</loc>
    <lastmod>2026-05-28T21:51:40.143Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/oxytocin-autism-spectrum-disorder-intellectual-di-phase-iii</loc>
    <lastmod>2026-05-28T21:51:40.157Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tolvaptan-autosomal-recessive-polycystic-kidney-di-phase-iii</loc>
    <lastmod>2026-05-28T21:51:40.170Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/acetylsalicylic-acid-chronic-coronary-syndrome-coronary-arter-phase-iii</loc>
    <lastmod>2026-05-28T21:51:40.184Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cariprazine-hydrochloride-schizophrenia-phase-iii</loc>
    <lastmod>2026-05-28T21:51:40.198Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/iberdomide-multiple-myeloma-phase-iii</loc>
    <lastmod>2026-05-28T21:51:40.211Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/idecabtagene-vicleucel-systemic-lupus-erythematosus-idiopathic-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:40.224Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adeno-associated-viral-vector-serotype-s-gaucher-disease-type-1-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:40.237Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etanercept-alzheimer-s-disease-phase-i-phase-iii</loc>
    <lastmod>2026-05-28T21:51:40.251Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pivmecillinam-hydrochloride-complicated-urinary-tract-infection-cuti-phase-iv</loc>
    <lastmod>2026-05-28T21:51:40.265Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pit565-systemic-lupus-erythematosus-phase-i</loc>
    <lastmod>2026-05-28T21:51:40.279Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/binimetinib-melanoma-with-brain-metastases-braf-v600-phase-ii</loc>
    <lastmod>2026-05-28T21:51:40.293Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/nnc9733-0001-type-2-diabetes-phase-i</loc>
    <lastmod>2026-05-28T21:51:40.307Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rmc-6291-non-small-cell-lung-cancer-ras-g12c-muta-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:40.321Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/treprostinil-sodium-pulmonary-arterial-hypertension-phase-iii</loc>
    <lastmod>2026-05-28T21:51:40.335Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/momelotinib-dihydrochloride-monohydrate-primary-myelofibrosis-post-polycythaemia-phase-ii</loc>
    <lastmod>2026-05-28T21:51:40.348Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/synthetic-double-stranded-sirna-oligonuc-hypertriglyceridemia-phase-iii-2</loc>
    <lastmod>2026-05-28T21:51:40.362Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/tolebrutinib-relapsing-multiple-sclerosis-primary-pro-phase-iii</loc>
    <lastmod>2026-05-28T21:51:40.377Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/sulodexide-venous-thromboembolism-deep-vein-thrombo-phase-iii</loc>
    <lastmod>2026-05-28T21:51:40.391Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alpelisib-hormone-receptor-positive-her2-negative-phase-iii</loc>
    <lastmod>2026-05-28T21:51:40.404Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/surovatamig-rheumatoid-arthritis-systemic-lupus-eryt-phase-iii</loc>
    <lastmod>2026-05-28T21:51:40.419Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/capecitabine-salivary-duct-carcinoma-phase-ii</loc>
    <lastmod>2026-05-28T21:51:40.432Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/spartalizumab-advanced-cancer-solid-tumor-malignant-ne-phase-iii</loc>
    <lastmod>2026-05-28T21:51:40.446Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/autologous-cd34-cells-transcribed-with-l-transfusion-dependent-beta-thalassemia-phase-ii</loc>
    <lastmod>2026-05-28T21:51:40.459Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/clostridium-botulinum-neurotoxin-type-a-glabellar-rhytides-glabellar-frown-lines-phase-iv</loc>
    <lastmod>2026-05-28T21:51:40.474Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/gbs-nn-gbs-nn2-group-b-streptococcus-infection-phase-ii-iii</loc>
    <lastmod>2026-05-28T21:51:40.488Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/roc-101-hydrochloride-pulmonary-arterial-hypertension-pah-pulm-phase-ii</loc>
    <lastmod>2026-05-28T21:51:40.501Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cisplatin-epithelial-ovarian-cancer-fallopian-tube-phase-iii</loc>
    <lastmod>2026-05-28T21:51:40.515Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/afamelanotide-vitiligo-phase-iii</loc>
    <lastmod>2026-05-28T21:51:40.528Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/pf-08046876-advanced-solid-tumors-phase-i</loc>
    <lastmod>2026-05-28T21:51:40.541Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/aminolevulinic-acid-hydrochloride-malignant-pleural-mesothelioma-phase-ii</loc>
    <lastmod>2026-05-28T21:51:40.555Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/cryopyrin-associated-periodic-syndrome-phase-i</loc>
    <lastmod>2026-05-28T21:51:40.568Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/risdiplam-spinal-muscular-atrophy-phase-iii</loc>
    <lastmod>2026-05-28T21:51:40.583Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/baricitinib-preclinical-rheumatoid-arthritis-rheumat-phase-ii</loc>
    <lastmod>2026-05-28T21:51:40.596Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/alpelisib-pik3ca-related-overgrowth-spectrum-pros-phase-ii-3</loc>
    <lastmod>2026-05-28T21:51:40.609Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/benralizumab-severe-eosinophilic-asthma-eosinophilic-phase-iv</loc>
    <lastmod>2026-05-28T21:51:40.622Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/rimegepant-acute-migraine-phase-iii-2</loc>
    <lastmod>2026-05-28T21:51:40.637Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/breast-cancer-colorectal-cancer-prostate-phase-i</loc>
    <lastmod>2026-05-28T21:51:40.650Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/orforglipron-hemicalcium-obesity-overweight-type-2-diabetes-phase-iii</loc>
    <lastmod>2026-05-28T21:51:40.664Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/zolbetuximab-gastric-adenocarcinoma-gastroesophageal-phase-iii-3</loc>
    <lastmod>2026-05-28T21:51:40.677Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/etidronate-disodium-pseudoxanthoma-elasticum-phase-iii</loc>
    <lastmod>2026-05-28T21:51:40.691Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/palbociclib-early-breast-cancer-phase-iv</loc>
    <lastmod>2026-05-28T21:51:40.705Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/allogeneic-fetal-mesenchymal-stem-cells-osteogenesis-imperfecta-type-iii-osteoge-phase-i-ii</loc>
    <lastmod>2026-05-28T21:51:40.717Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
  <url>
    <loc>https://trialagents.com/trials/adipose-derived-stromal-stem-cells-perianal-fistulizing-crohn-s-disease-phase-i</loc>
    <lastmod>2026-05-28T21:51:40.730Z</lastmod>
    <changefreq>weekly</changefreq>
    <priority>0.6</priority>
  </url>
</urlset>
